<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:CYCU="http://cycurion.com/20260331"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2026"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cycu-20260331.xsd" xlink:type="simple"/>
    <context id="From2026-01-01to2026-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesAConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesBConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesCConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesDConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesDConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesDConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesEConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesEConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesFConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesFConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesFConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesFConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesGConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesGConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SeriesAConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SeriesBConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SeriesCConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SeriesDConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesDConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SeriesEConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SeriesFConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesFConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SeriesGConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesAOneConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesAOneConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CommonClassSubjectToRedemptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CYCU:CommonClassSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CommonClassSubjectToRedemptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CYCU:CommonClassSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesDConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesDConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesDConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_SeriesBConvertiblePreferredStockAndSeriesDConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockAndSeriesDConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_SeriesAConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesDConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesDConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_us-gaap_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_us-gaap_CommonStockMember_custom_SeriesBConvertiblePreferredStockAndSeriesDConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockAndSeriesDConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesDConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesDConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:WesternAcquisitionVenturesCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-14</startDate>
            <endDate>2025-02-14</endDate>
        </period>
    </context>
    <context id="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:WesternAcquisitionVenturesCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-14</startDate>
            <endDate>2025-02-14</endDate>
        </period>
    </context>
    <context id="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:WesternAcquisitionVenturesCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-14</startDate>
            <endDate>2025-02-14</endDate>
        </period>
    </context>
    <context id="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:WesternAcquisitionVenturesCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-14</startDate>
            <endDate>2025-02-14</endDate>
        </period>
    </context>
    <context id="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_us-gaap_SeriesCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:WesternAcquisitionVenturesCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-14</startDate>
            <endDate>2025-02-14</endDate>
        </period>
    </context>
    <context id="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_us-gaap_SeriesDPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:WesternAcquisitionVenturesCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-14</startDate>
            <endDate>2025-02-14</endDate>
        </period>
    </context>
    <context id="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:WesternAcquisitionVenturesCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-14</startDate>
            <endDate>2025-02-14</endDate>
        </period>
    </context>
    <context id="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:WesternAcquisitionVenturesCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-14</startDate>
            <endDate>2025-02-14</endDate>
        </period>
    </context>
    <context id="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_custom_SeriesDWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:WesternAcquisitionVenturesCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesDWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-14</startDate>
            <endDate>2025-02-14</endDate>
        </period>
    </context>
    <context id="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_custom_CommonStockWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:WesternAcquisitionVenturesCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:CommonStockWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-14</startDate>
            <endDate>2025-02-14</endDate>
        </period>
    </context>
    <context id="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_custom_SeriesDPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:WesternAcquisitionVenturesCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesDPrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-14</startDate>
            <endDate>2025-02-14</endDate>
        </period>
    </context>
    <context id="From2025-02-142025-02-14_custom_AllianceGlobalPartnersMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:AllianceGlobalPartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-14</startDate>
            <endDate>2025-02-14</endDate>
        </period>
    </context>
    <context id="From2025-02-142025-02-14_custom_SewardAndKisselLLPMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SewardAndKisselLLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-14</startDate>
            <endDate>2025-02-14</endDate>
        </period>
    </context>
    <context id="From2025-02-142025-02-14_custom_BakerAndHostetlerLLPMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:BakerAndHostetlerLLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-14</startDate>
            <endDate>2025-02-14</endDate>
        </period>
    </context>
    <context id="AsOf2025-08-19_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-19</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-04-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <instant>2025-04-11</instant>
        </period>
    </context>
    <context id="AsOf2025-08-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <instant>2025-08-18</instant>
        </period>
    </context>
    <context id="AsOf2025-10-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <instant>2025-10-27</instant>
        </period>
    </context>
    <context id="AsOf2025-10-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <instant>2025-10-26</instant>
        </period>
    </context>
    <context id="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_custom_CommonStockWarrantMember71571109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:WesternAcquisitionVenturesCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CYCU:CommonStockWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-14</startDate>
            <endDate>2025-02-14</endDate>
        </period>
    </context>
    <context id="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_custom_SeriesDPrivatePlacementMember71571109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:WesternAcquisitionVenturesCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CYCU:SeriesDPrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-14</startDate>
            <endDate>2025-02-14</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AdvisoryConsultingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">CYCU:AdvisoryConsultingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AdvisoryConsultingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">CYCU:AdvisoryConsultingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ManagedSecurityServicePracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">CYCU:ManagedSecurityServicePracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ManagedSecurityServicePracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">CYCU:ManagedSecurityServicePracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SoftwareAsAServiceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">CYCU:SoftwareAsAServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SoftwareAsAServiceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">CYCU:SoftwareAsAServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_AdvisoryConsultingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="CYCU:ProductAndServiceAxis">CYCU:AdvisoryConsultingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_custom_AdvisoryConsultingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="CYCU:ProductAndServiceAxis">CYCU:AdvisoryConsultingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_ManagedSecurityServicePracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="CYCU:ProductAndServiceAxis">CYCU:ManagedSecurityServicePracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_custom_ManagedSecurityServicePracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="CYCU:ProductAndServiceAxis">CYCU:ManagedSecurityServicePracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_SoftwareAsAServiceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="CYCU:ProductAndServiceAxis">CYCU:SoftwareAsAServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_custom_SoftwareAsAServiceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="CYCU:ProductAndServiceAxis">CYCU:SoftwareAsAServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_BilledAccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis">CYCU:BilledAccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_BilledAccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis">CYCU:BilledAccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_BilledAccountsReceivableFactoredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis">CYCU:BilledAccountsReceivableFactoredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_BilledAccountsReceivableFactoredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis">CYCU:BilledAccountsReceivableFactoredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_UnbilledRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis">us-gaap:UnbilledRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_UnbilledRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis">us-gaap:UnbilledRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_BilledAccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis">CYCU:BilledAccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_BilledAccountsReceivableFactoredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis">CYCU:BilledAccountsReceivableFactoredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_UnbilledRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis">us-gaap:UnbilledRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CapitalLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">CYCU:CapitalLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CapitalLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">CYCU:CapitalLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ContractualRelationshipMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CYCU:ContractualRelationshipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ContractualRelationshipMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CYCU:ContractualRelationshipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ImplementationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CYCU:ImplementationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ImplementationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CYCU:ImplementationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CYCU:SoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CYCU:SoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SLGInnovationIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SLGInnovationIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-04-29_custom_SLGInnovationIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-29</instant>
        </period>
    </context>
    <context id="From2023-04-292023-04-29_custom_SLGInnovationIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-29</startDate>
            <endDate>2023-04-29</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_SLGInnovationIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_SLGInnovationIncMember_us-gaap_SeriesEPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-03-312025-03-31_custom_SLGInnovationIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-31</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:InitialAllocationOfAssetsAndLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:AdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:EstimatedAllocationOfAssetAandLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:InitialAllocationOfAssetsAndLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:AdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:EstimatedAllocationOfAssetAandLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember_us-gaap_SeriesEPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:InitialAllocationOfAssetsAndLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember_us-gaap_SeriesEPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:AdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember_us-gaap_SeriesEPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:EstimatedAllocationOfAssetAandLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:InitialAllocationOfAssetsAndLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:AdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:EstimatedAllocationOfAssetAandLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:InitialAllocationOfAssetsAndLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:AdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:EstimatedAllocationOfAssetAandLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:InitialAllocationOfAssetsAndLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:AdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:EstimatedAllocationOfAssetAandLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember_us-gaap_SeriesEPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:InitialAllocationOfAssetsAndLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember_us-gaap_SeriesEPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:AdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember_us-gaap_SeriesEPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:EstimatedAllocationOfAssetAandLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:InitialAllocationOfAssetsAndLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:AdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">CYCU:EstimatedAllocationOfAssetAandLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:AxxumTechnologiesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:ShareTransferAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-22</instant>
        </period>
    </context>
    <context id="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember_custom_TwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CYCU:TwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:AxxumTechnologiesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:ShareTransferAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-22</instant>
        </period>
    </context>
    <context id="From2017-11-222017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:AxxumTechnologiesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:ShareTransferAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-11-22</startDate>
            <endDate>2017-11-22</endDate>
        </period>
    </context>
    <context id="AsOf2019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:CloudburstSecurityLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:MembershipInterestPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-03</instant>
        </period>
    </context>
    <context id="AsOf2019-04-03_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember_custom_OneEquityHolderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CYCU:OneEquityHolderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:AxxumTechnologiesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:ShareTransferAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-03</instant>
        </period>
    </context>
    <context id="AsOf2019-04-03_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember_custom_TwoEquityHolderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CYCU:TwoEquityHolderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:AxxumTechnologiesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:ShareTransferAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-03</instant>
        </period>
    </context>
    <context id="From2019-04-032019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember_custom_OneEquityHolderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CYCU:OneEquityHolderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:CloudburstSecurityLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:MembershipInterestPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-03</startDate>
            <endDate>2019-04-03</endDate>
        </period>
    </context>
    <context id="From2019-04-032019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember_custom_TwoEquityHolderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CYCU:TwoEquityHolderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:CloudburstSecurityLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:MembershipInterestPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-03</startDate>
            <endDate>2019-04-03</endDate>
        </period>
    </context>
    <context id="From2019-04-032019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:CloudburstSecurityLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:MembershipInterestPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-03</startDate>
            <endDate>2019-04-03</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-20_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:CloudburstSecurityLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:MembershipInterestPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-20</instant>
        </period>
    </context>
    <context id="From2022-04-202022-04-20_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:CloudburstSecurityLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:MembershipInterestPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-20</startDate>
            <endDate>2022-04-20</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_CloudburstSecurityLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:CloudburstSecurityLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CloudburstSecurityLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:CloudburstSecurityLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SLGInnovationIncMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-03-312025-03-31_custom_SLGInnovationIncMember_us-gaap_SeriesEPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-31</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-03-312025-03-31_custom_SLGInnovationIncMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-31</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember_custom_OneEquityHolderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CYCU:OneEquityHolderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:AxxumTechnologiesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:ShareTransferAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-22</instant>
        </period>
    </context>
    <context id="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember_custom_TwoEquityHolderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CYCU:TwoEquityHolderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:AxxumTechnologiesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:ShareTransferAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-22</instant>
        </period>
    </context>
    <context id="From2025-03-312025-03-31_custom_SLGInnovationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-31</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_SLGInnovationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AxxumTechnologiesLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:AxxumTechnologiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_AxxumTechnologiesLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:AxxumTechnologiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CloudburstSecurityLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:CloudburstSecurityLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CloudburstSecurityLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:CloudburstSecurityLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SLGInnovationIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_AxxumTechnologiesLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:AxxumTechnologiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_CloudburstSecurityLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:CloudburstSecurityLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SLGInnovationIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2017-11-22_custom_RevolvingLineOfCreditMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-22</instant>
        </period>
    </context>
    <context id="From2017-11-222017-11-22_custom_RevolvingLineOfCreditMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-11-22</startDate>
            <endDate>2017-11-22</endDate>
        </period>
    </context>
    <context id="AsOf2019-04-18_custom_RevolvingLineOfCreditMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-18</instant>
        </period>
    </context>
    <context id="From2019-04-182019-04-18_custom_RevolvingLineOfCreditMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-18</startDate>
            <endDate>2019-04-18</endDate>
        </period>
    </context>
    <context id="From2020-06-292020-06-29_custom_RevolvingLineOfCreditMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-06-29</endDate>
        </period>
    </context>
    <context id="From2021-06-302021-06-30_custom_RevolvingLineOfCreditMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-30</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_RevolvingLineOfCreditMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-22</instant>
        </period>
    </context>
    <context id="From2017-11-222017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-11-22</startDate>
            <endDate>2017-11-22</endDate>
        </period>
    </context>
    <context id="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312017ButPriorToJune302018Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">CYCU:OnOrAfterDecember312017ButPriorToJune302018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-22</instant>
        </period>
    </context>
    <context id="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302018ButPriorToJune302019Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">CYCU:OnOrAfterJune302018ButPriorToJune302019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-22</instant>
        </period>
    </context>
    <context id="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302019ButPriorToDecember312019Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">CYCU:OnOrAfterJune302019ButPriorToDecember312019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-22</instant>
        </period>
    </context>
    <context id="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312019ButPriorToJune302020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">CYCU:OnOrAfterDecember312019ButPriorToJune302020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-22</instant>
        </period>
    </context>
    <context id="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302020ButPriorToDecember312020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">CYCU:OnOrAfterJune302020ButPriorToDecember312020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-22</instant>
        </period>
    </context>
    <context id="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312020ButPriorToJune302021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">CYCU:OnOrAfterDecember312020ButPriorToJune302021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-22</instant>
        </period>
    </context>
    <context id="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302021ButPriorToDecember312021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">CYCU:OnOrAfterJune302021ButPriorToDecember312021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-22</instant>
        </period>
    </context>
    <context id="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">CYCU:OnOrAfterDecember312021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-22</instant>
        </period>
    </context>
    <context id="From2019-04-182019-04-18_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-18</startDate>
            <endDate>2019-04-18</endDate>
        </period>
    </context>
    <context id="From2020-06-292020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-06-29</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302020ButPriorToDecember312020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">CYCU:OnOrAfterJune302020ButPriorToDecember312020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-29</instant>
        </period>
    </context>
    <context id="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312020ButPriorToJune302021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">CYCU:OnOrAfterDecember312020ButPriorToJune302021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-29</instant>
        </period>
    </context>
    <context id="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302021ButPriorToDecember312021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">CYCU:OnOrAfterJune302021ButPriorToDecember312021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-29</instant>
        </period>
    </context>
    <context id="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312021ButPriorToJune302022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">CYCU:OnOrAfterDecember312021ButPriorToJune302022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-29</instant>
        </period>
    </context>
    <context id="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302022ButPriorToDecember312022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">CYCU:OnOrAfterJune302022ButPriorToDecember312022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-29</instant>
        </period>
    </context>
    <context id="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312022ButPriorToJune302023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">CYCU:OnOrAfterDecember312022ButPriorToJune302023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-29</instant>
        </period>
    </context>
    <context id="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302023ButPriorToDecember312023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">CYCU:OnOrAfterJune302023ButPriorToDecember312023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-29</instant>
        </period>
    </context>
    <context id="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">CYCU:OnOrAfterDecember312023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-29</instant>
        </period>
    </context>
    <context id="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-29</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_RevolvingLineOfCreditMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">CYCU:RevolvingLineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SLGInnovationIncMember71576953">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SLGInnovationIncMember71576968">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_PromissoryNotesOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_PromissoryNotesOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_PromissoryNotesTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_PromissoryNotesTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_PromissoryNotesThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_PromissoryNotesThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_PromissoryNotesFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_PromissoryNotesFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_PromissoryNotesFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_PromissoryNotesFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_PromissoryNotesSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_PromissoryNotesSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_PromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_PromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_CycurionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CYCU:CycurionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CycurionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CYCU:CycurionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SLGInnovationIncMember71577093">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_PromissoryNotesOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_PromissoryNotesTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_PromissoryNotesThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_PromissoryNotesFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_PromissoryNotesFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_PromissoryNotesSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_PromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2023-03-202023-03-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <startDate>2023-03-20</startDate>
            <endDate>2023-03-20</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <instant>2023-03-20</instant>
        </period>
    </context>
    <context id="From2020-07-162020-07-16_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-16</startDate>
            <endDate>2020-07-16</endDate>
        </period>
    </context>
    <context id="AsOf2020-07-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <instant>2020-07-16</instant>
        </period>
    </context>
    <context id="From2020-07-162020-07-16_custom_EIDLLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:EIDLLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-16</startDate>
            <endDate>2020-07-16</endDate>
        </period>
    </context>
    <context id="From2020-09-302020-09-30_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-30</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-09-30_custom_EIDLLoanMember_custom_SLGInnovationIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:EIDLLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="From2020-09-302020-09-30_custom_EIDLLoanMember_custom_SLGInnovationIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:EIDLLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-30</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_PromissoryNoteMember_custom_SLGInnovationIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2020-09-302020-09-30_custom_PromissoryNoteMember_custom_SLGInnovationIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-30</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_PromissoryNoteMember_custom_SLGInnovationIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CYCU:SLGInnovationIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_ConvertibleNotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_us-gaap_ConvertibleNotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_ConvertibleNotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-04-012025-06-30_us-gaap_ConvertibleNotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-04-012025-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_ConvertibleNotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-09-30_us-gaap_ConvertibleNotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-07-012025-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-09-30_us-gaap_ConvertibleNotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="AsOf2025-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="From2025-10-012025-12-31_us-gaap_ConvertibleNotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-10-012025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <startDate>2025-10-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_ConvertibleNotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_ConvertibleNotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_ConvertibleNotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2025-04-012025-06-30_custom_ConvertibleNotesPayableOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">CYCU:ConvertibleNotesPayableOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_custom_PromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_PromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-04-012025-06-30_custom_PromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_PromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-09-30_custom_PromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-09-30_custom_PromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="From2025-10-012025-12-31_custom_PromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_PromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-22_custom_SixInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CYCU:SixInvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-22</instant>
        </period>
    </context>
    <context id="AsOf2022-03-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <instant>2022-03-22</instant>
        </period>
    </context>
    <context id="AsOf2022-03-22_custom_ThreeInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CYCU:ThreeInvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-22</instant>
        </period>
    </context>
    <context id="AsOf2022-03-22_custom_FifthInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CYCU:FifthInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-22</instant>
        </period>
    </context>
    <context id="AsOf2022-03-22_custom_SixthInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CYCU:SixthInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-22</instant>
        </period>
    </context>
    <context id="AsOf2022-11-22_custom_ThreeUnaffiliatedInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CYCU:ThreeUnaffiliatedInvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-22</instant>
        </period>
    </context>
    <context id="From2022-11-222022-11-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <startDate>2022-11-22</startDate>
            <endDate>2022-11-22</endDate>
        </period>
    </context>
    <context id="AsOf2022-11-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <instant>2022-11-22</instant>
        </period>
    </context>
    <context id="From2022-11-222022-11-22_custom_ThreeUnaffiliatedInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CYCU:ThreeUnaffiliatedInvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-22</startDate>
            <endDate>2022-11-22</endDate>
        </period>
    </context>
    <context id="AsOf2022-11-21_custom_NineUnaffiliatedInvestorsMember_custom_BusinessCombinationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CYCU:NineUnaffiliatedInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:BusinessCombinationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-21</instant>
        </period>
    </context>
    <context id="AsOf2022-11-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <instant>2022-11-21</instant>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_custom_BusinessCombinationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:BusinessCombinationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_custom_BusinessCombinationAgreementMember_us-gaap_SeriesDPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:BusinessCombinationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_custom_BusinessCombinationAgreementMember_custom_SevenUnaffiliatedInvestorsMember_custom_SeriesDWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CYCU:SevenUnaffiliatedInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesDWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:BusinessCombinationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-07-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <instant>2022-07-12</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SeriesAOneConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-14_custom_SeriesAOneConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:WesternAcquisitionVenturesCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-14</instant>
        </period>
    </context>
    <context id="AsOf2025-02-14_custom_SeriesAOneConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:WesternAcquisitionVenturesCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-14</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CommonClassSubjectToRedemptionMember71580718">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:CommonClassSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CommonClassSubjectToRedemptionMember71580718">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:CommonClassSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SeriesAConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PrivatePlacementMember_custom_WesternAcquisitionVenturesCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CYCU:WesternAcquisitionVenturesCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_SeriesBConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CYCU:WesternAcquisitionVenturesCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SeriesBConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:WesternAcquisitionVenturesCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_SeriesCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_SeriesCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:WesternAcquisitionVenturesCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_SeriesDPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_SeriesDConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CYCU:WesternAcquisitionVenturesCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesDConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SeriesDConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:WesternAcquisitionVenturesCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesDConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SeriesDConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesDConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_SeriesFPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_SeriesFPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_SeriesGPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesGPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_SeriesGPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesGPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SeriesGConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_AlphaCapitalAnstaltMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:AlphaCapitalAnstaltMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-12</startDate>
            <endDate>2025-08-12</endDate>
        </period>
    </context>
    <context id="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_M2BFundingCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:M2BFundingCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-12</startDate>
            <endDate>2025-08-12</endDate>
        </period>
    </context>
    <context id="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_AdiFundingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:AdiFundingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-12</startDate>
            <endDate>2025-08-12</endDate>
        </period>
    </context>
    <context id="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_DeltenniumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:DeltenniumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-12</startDate>
            <endDate>2025-08-12</endDate>
        </period>
    </context>
    <context id="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_OsherCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:OsherCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-12</startDate>
            <endDate>2025-08-12</endDate>
        </period>
    </context>
    <context id="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_LexiLondonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:LexiLondonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-12</startDate>
            <endDate>2025-08-12</endDate>
        </period>
    </context>
    <context id="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_IleAssociatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:IleAssociatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-12</startDate>
            <endDate>2025-08-12</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_SeriesABandDConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesABandDConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_WarrantABandDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:WarrantABandDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_CommonStockMember_us-gaap_AcquisitionRelatedCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_SettlementOfDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">CYCU:SettlementOfDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SettlementOfDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">CYCU:SettlementOfDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_EmploymentAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_SLGInnovationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_CommonStockRedemptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CYCU:CommonStockRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SLGInnovationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_PublicWarrantsMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_PublicWarrantsMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-112022-01-11_custom_PipeSubscriptionAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">CYCU:PipeSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-11</startDate>
            <endDate>2022-01-11</endDate>
        </period>
    </context>
    <context id="AsOf2022-01-11_custom_PipeWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">CYCU:PipeWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-11</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_PipeWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">CYCU:PipeWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_PipeWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">CYCU:PipeWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-112022-01-11_custom_PipeWarrantsMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">CYCU:PipeWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-11</startDate>
            <endDate>2022-01-11</endDate>
        </period>
    </context>
    <context id="From2022-01-112022-01-11_custom_PipeWarrantsMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">CYCU:PipeWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-11</startDate>
            <endDate>2022-01-11</endDate>
        </period>
    </context>
    <context id="AsOf2017-11-17_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-17</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_SeriesAWarrantsMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-08-01_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-01</instant>
        </period>
    </context>
    <context id="AsOf2024-04-12_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-12</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesBWarrantsMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-22_custom_SeriesDWarrantsMember_custom_SubordinatedConvertiblePromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:SeriesDWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">CYCU:SubordinatedConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-22</instant>
        </period>
    </context>
    <context id="AsOf2022-11-22_custom_SeriesDWarrantsMember_custom_SubordinatedConvertiblePromissoryNoteOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:SeriesDWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">CYCU:SubordinatedConvertiblePromissoryNoteOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-22</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesDWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:SeriesDWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesDWarrantsMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:SeriesDWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_SeriesDWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:SeriesDWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-04-12_custom_PreFundedWarrantSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:PreFundedWarrantSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-12</instant>
        </period>
    </context>
    <context id="AsOf2025-04-12_custom_WarrantSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:WarrantSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-12</instant>
        </period>
    </context>
    <context id="AsOf2025-12-05_custom_PreFundedWarrantSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:PreFundedWarrantSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-05</instant>
        </period>
    </context>
    <context id="AsOf2025-12-05_custom_WarrantSharesMember_custom_ArmisticeCapitalMasterFundLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:WarrantSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-05</instant>
        </period>
    </context>
    <context id="AsOf2025-12-05_custom_PreFundedWarrantSharesMember_custom_ArmisticeCapitalMasterFundLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:PreFundedWarrantSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-05</instant>
        </period>
    </context>
    <context id="AsOf2025-12-05_custom_ArmisticeCapitalMasterFundLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-05</instant>
        </period>
    </context>
    <context id="AsOf2025-12-04_custom_ArmisticeCapitalMasterFundLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-04</instant>
        </period>
    </context>
    <context id="AsOf2025-04-07_custom_YieldPointNYLLCMember_custom_PreFundedWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:YieldPointNYLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:PreFundedWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-07</instant>
        </period>
    </context>
    <context id="AsOf2025-04-07_custom_PreFundedWarrantMember_custom_YieldPointNYLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:YieldPointNYLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CYCU:PreFundedWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-07</instant>
        </period>
    </context>
    <context id="AsOf2025-02-14_custom_SewardAndKisselLLPMember_custom_PreFundedWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:SewardAndKisselLLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:PreFundedWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-14</instant>
        </period>
    </context>
    <context id="From2025-02-142025-02-14_custom_SewardAndKisselLLPMember_custom_PreFundedWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:SewardAndKisselLLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:PreFundedWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-14</startDate>
            <endDate>2025-02-14</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-14_custom_PreFundedWarrantMember_custom_SewardAndKisselLLPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:SewardAndKisselLLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CYCU:PreFundedWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-14</instant>
        </period>
    </context>
    <context id="AsOf2022-03-08_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-08</instant>
        </period>
    </context>
    <context id="From2022-03-082022-03-08_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-08</startDate>
            <endDate>2022-03-08</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_WarrantsMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_SeriesAConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_SeriesCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_SeriesCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_SeriesDPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SeriesDConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CYCU:WesternAcquisitionVenturesCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesDConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_SeriesEPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_SeriesFPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_SeriesFPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_SeriesGPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesGPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_SeriesGPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesGPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_SeriesGConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_CommonStockMember_custom_SeriesABandDConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesABandDConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_CommonStockMember_custom_WarrantABandDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:WarrantABandDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_CommonStockMember_us-gaap_AcquisitionRelatedCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_CommonStockMember_custom_SettlementOfDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">CYCU:SettlementOfDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_SettlementOfDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">CYCU:SettlementOfDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_CommonStockMember_custom_EmploymentAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_CommonStockMember_custom_SLGInnovationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_CommonStockRedemptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CYCU:CommonStockRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SLGInnovationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:SLGInnovationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_PublicWarrantsMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_PublicWarrantsMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_PipeWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">CYCU:PipeWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-04_custom_PreFundedWarrantSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:PreFundedWarrantSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-04</instant>
        </period>
    </context>
    <context id="AsOf2025-12-04_custom_WarrantSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CYCU:WarrantSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-04</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-04-012025-06-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-09-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-09-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="From2025-10-012025-12-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_CommonClassSubjectToRedemptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CYCU:CommonClassSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_CustomerAMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_custom_CustomerAMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_CustomerBMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_custom_CustomerBMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_CustomerCMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_custom_CustomerCMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_CustomerDMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_custom_CustomerDMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_CustomerOneMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_CustomerTwoMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_CustomerThreeMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CYCU:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-09-202024-09-20_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">CYCU:SponsorPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-20</startDate>
            <endDate>2024-09-20</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-20_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">CYCU:SponsorPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-20</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">CYCU:SponsorPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">CYCU:SponsorPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">CYCU:SponsorPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">CYCU:SponsorPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">CYCU:SponsorPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CYCU:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_TwoDirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CYCU:TwoDirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_TwoDirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CYCU:TwoDirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_TwoDirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CYCU:TwoDirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_TwoDirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CYCU:TwoDirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-12-31_custom_TwoDirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CYCU:TwoDirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-12-31_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SeriesAConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SeriesBConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SeriesBConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SeriesCConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SeriesCConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_custom_SeriesAConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_SeriesBConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_custom_SeriesBConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_SeriesCConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_custom_SeriesCConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesAConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesAConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesBConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesBConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesCConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesCConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesDConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesDConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesDConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesDConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesEConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesEConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_WarrantMember71589000">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesBConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesBConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesCConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesCConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesDConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesDConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesDConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesDConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesEConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesEConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-112022-01-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <startDate>2022-01-11</startDate>
            <endDate>2022-01-11</endDate>
        </period>
    </context>
    <context id="AsOf2022-01-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <instant>2022-01-11</instant>
        </period>
    </context>
    <context id="From2022-01-112022-01-11_custom_AllianceGlobalPartnersMember_custom_TransactionFeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:AllianceGlobalPartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GainContingenciesByNatureAxis">CYCU:TransactionFeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-11</startDate>
            <endDate>2022-01-11</endDate>
        </period>
    </context>
    <context id="From2022-01-112022-01-11_custom_AllianceGlobalPartnersMember_srt_MinimumMember_custom_TransactionFeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:AllianceGlobalPartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GainContingenciesByNatureAxis">CYCU:TransactionFeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-11</startDate>
            <endDate>2022-01-11</endDate>
        </period>
    </context>
    <context id="AsOf2022-01-11_custom_AllianceGlobalPartnersMember_custom_TransactionFeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:AllianceGlobalPartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GainContingenciesByNatureAxis">CYCU:TransactionFeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-11</instant>
        </period>
    </context>
    <context id="AsOf2022-01-11_custom_AllianceGlobalPartnersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:AllianceGlobalPartnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-11</instant>
        </period>
    </context>
    <context id="From2022-01-112022-01-11_custom_AllianceGlobalPartnersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:AllianceGlobalPartnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-11</startDate>
            <endDate>2022-01-11</endDate>
        </period>
    </context>
    <context id="From2022-01-112022-01-11_custom_AllianceGlobalPartnersMember_custom_AmendedTransactionFeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:AllianceGlobalPartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GainContingenciesByNatureAxis">CYCU:AmendedTransactionFeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-11</startDate>
            <endDate>2022-01-11</endDate>
        </period>
    </context>
    <context id="From2022-01-112022-01-11_custom_AllianceGlobalPartnersMember_srt_MinimumMember_custom_AmendedTransactionFeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:AllianceGlobalPartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GainContingenciesByNatureAxis">CYCU:AmendedTransactionFeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-11</startDate>
            <endDate>2022-01-11</endDate>
        </period>
    </context>
    <context id="AsOf2022-01-11_custom_AllianceGlobalPartnersMember_custom_AmendedTransactionFeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:AllianceGlobalPartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GainContingenciesByNatureAxis">CYCU:AmendedTransactionFeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-11</instant>
        </period>
    </context>
    <context id="From2024-11-272024-11-27_custom_SewardAndKisselLLPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CYCU:SewardAndKisselLLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-27</startDate>
            <endDate>2024-11-27</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-27_custom_SewardAndKisselLLPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CYCU:SewardAndKisselLLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-27</instant>
        </period>
    </context>
    <context id="AsOf2025-02-14_custom_SewardAndKisselLLPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CYCU:SewardAndKisselLLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-14</instant>
        </period>
    </context>
    <context id="From2025-02-142025-02-14_custom_SewardAndKisselLLPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CYCU:SewardAndKisselLLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-14</startDate>
            <endDate>2025-02-14</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-14_custom_SewardAndKisselLLPMember_custom_PreFundedWarrantMember71589796">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CYCU:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CYCU:SewardAndKisselLLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-14</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_BakerHostetlerLlpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CYCU:BakerHostetlerLlpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-04-07_custom_EquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:EquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-07</instant>
        </period>
    </context>
    <context id="From2025-04-072025-04-07_custom_EquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:EquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-07</startDate>
            <endDate>2025-04-07</endDate>
        </period>
    </context>
    <context id="AsOf2025-04-07_custom_PreFundedWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CYCU:PreFundedWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-07</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_WarrantMember71590187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-08-062024-08-06_custom_SponsorPromissoryNoteMember_custom_NonRedemptionAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CYCU:SponsorPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:NonRedemptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-06</startDate>
            <endDate>2024-08-06</endDate>
        </period>
    </context>
    <context id="From2024-10-092024-10-09_custom_SponsorPromissoryNoteMember_custom_NonRedemptionAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CYCU:SponsorPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:NonRedemptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-09</startDate>
            <endDate>2024-10-09</endDate>
        </period>
    </context>
    <context id="From2023-12-272023-12-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <startDate>2023-12-27</startDate>
            <endDate>2023-12-27</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <instant>2023-12-27</instant>
        </period>
    </context>
    <context id="From2024-10-302024-10-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <startDate>2024-10-30</startDate>
            <endDate>2024-10-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-10-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <instant>2024-10-30</instant>
        </period>
    </context>
    <context id="From2024-12-012024-12-01_srt_ChiefExecutiveOfficerMember_custom_EmploymentAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2024-12-01</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-01-01_srt_ChiefExecutiveOfficerMember_custom_EmploymentAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-01</endDate>
        </period>
    </context>
    <context id="From2025-06-162025-06-16_custom_EquityIncentivePlanMember_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">CYCU:EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-16</startDate>
            <endDate>2025-06-16</endDate>
        </period>
    </context>
    <context id="From2025-06-162025-06-16_custom_EquityIncentivePlanMember_srt_ChiefFinancialOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">CYCU:EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-16</startDate>
            <endDate>2025-06-16</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_AllianceGlobalPartnersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:AllianceGlobalPartnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_AllianceGlobalPartnersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">CYCU:AllianceGlobalPartnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2024-08-062024-08-06_custom_SponsorMember_custom_NonRedemptionAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CYCU:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:NonRedemptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-06</startDate>
            <endDate>2024-08-06</endDate>
        </period>
    </context>
    <context id="From2024-10-092024-10-09_custom_SponsorMember_custom_NonRedemptionAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CYCU:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CYCU:NonRedemptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-09</startDate>
            <endDate>2024-10-09</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-19_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-19</instant>
        </period>
    </context>
    <context id="From2026-03-252026-03-25_srt_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-25</startDate>
            <endDate>2026-03-25</endDate>
        </period>
    </context>
    <context id="From2026-04-012026-05-12_custom_EquityPurchaseAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">CYCU:EquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-05-12</endDate>
        </period>
    </context>
    <context id="From2026-04-212026-04-21_custom_KustomEntertainmentIncMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:KustomEntertainmentIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-21</startDate>
            <endDate>2026-04-21</endDate>
        </period>
    </context>
    <context id="AsOf2026-04-21_custom_KustomEntertainmentIncMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:KustomEntertainmentIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-21</instant>
        </period>
    </context>
    <context id="AsOf2026-05-07_custom_KustomEntertainmentIncMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CYCU:KustomEntertainmentIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-07</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Subsidiary">
        <measure>CYCU:Subsidiary</measure>
    </unit>
    <unit id="Integer">
        <measure>CYCU:Integer</measure>
    </unit>
    <unit id="Vote">
        <measure>CYCU:Vote</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2026-01-01to2026-03-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2026-01-01to2026-03-31" id="Fact000004">0001868419</dei:EntityCentralIndexKey>
    <us-gaap:RestrictedCashCurrent
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0043"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0049"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DepositAssets
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0058"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0061"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0067"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0070"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0076"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:BankLoanCurrentPortion
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0094"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:FactoringLiability
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0101"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:SubordinatedConvertiblePromissoryNotes
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0103"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0107"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:ConvertiblePreferredStockLiability
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0136"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0161"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0162"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0167"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2025-12-31_custom_CommonClassSubjectToRedemptionMember"
      id="xdx2ixbrl0174"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2025-12-31_custom_CommonClassSubjectToRedemptionMember"
      id="xdx2ixbrl0176"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember"
      id="xdx2ixbrl0200"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-12-31_custom_SeriesAConvertiblePreferredStockMember"
      id="xdx2ixbrl0201"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember"
      id="xdx2ixbrl0219"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-12-31_custom_SeriesBConvertiblePreferredStockMember"
      id="xdx2ixbrl0220"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember"
      id="xdx2ixbrl0238"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-12-31_custom_SeriesCConvertiblePreferredStockMember"
      id="xdx2ixbrl0239"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-12-31_custom_SeriesDConvertiblePreferredStockMember"
      id="xdx2ixbrl0258"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-12-31_custom_SeriesEConvertiblePreferredStockMember"
      id="xdx2ixbrl0276"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-12-31_custom_SeriesEConvertiblePreferredStockMember"
      id="xdx2ixbrl0277"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-12-31_custom_SeriesFConvertiblePreferredStockMember"
      id="xdx2ixbrl0295"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-12-31_custom_SeriesFConvertiblePreferredStockMember"
      id="xdx2ixbrl0296"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterest
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0365"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0392"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0410"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2025-01-012025-12-31"
      id="xdx2ixbrl0421"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0422"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0428"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0454"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0455"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0456"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0457"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0458"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0459"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0464"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0471"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0477"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0479"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0481"
      unitRef="Shares"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityCommonStockRedeemedValue
      contextRef="From2025-01-012025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0485"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityCommonStockRedeemedValue
      contextRef="From2025-01-012025-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0486"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityCommonStockRedeemedValue
      contextRef="From2025-01-012025-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0487"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityCommonStockRedeemedValue
      contextRef="From2025-01-012025-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0488"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0510"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0511"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0512"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-12-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0514"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-12-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0515"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0516"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0525"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0526"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0527"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-12-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0529"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-12-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0530"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0533"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-12-31_us-gaap_ParentMember"
      id="xdx2ixbrl0534"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0535"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-12-31"
      id="xdx2ixbrl0536"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0544"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0545"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0546"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0547"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2025-01-012025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0559"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2025-01-012025-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0560"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2025-01-012025-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0561"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2025-01-012025-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0562"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2025-01-012025-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0569"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability
      contextRef="From2025-01-012025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0574"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability
      contextRef="From2025-01-012025-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0575"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability
      contextRef="From2025-01-012025-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0576"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability
      contextRef="From2025-01-012025-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0577"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement
      contextRef="From2025-01-012025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0589"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement
      contextRef="From2025-01-012025-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0590"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement
      contextRef="From2025-01-012025-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0591"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement
      contextRef="From2025-01-012025-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0592"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0604"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0605"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0606"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0607"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2025-01-012025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0621"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2025-01-012025-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0622"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2025-01-012025-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0623"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2025-01-012025-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0624"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockInExchangeOfConvertibleNotesAndPromissoryNotes
      contextRef="From2025-01-012025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0634"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockInExchangeOfConvertibleNotesAndPromissoryNotes
      contextRef="From2025-01-012025-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0635"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockInExchangeOfConvertibleNotesAndPromissoryNotes
      contextRef="From2025-01-012025-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0636"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockInExchangeOfConvertibleNotesAndPromissoryNotes
      contextRef="From2025-01-012025-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0637"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockInExchangeOfConvertibleNotesAndPromissoryNotes
      contextRef="From2025-01-012025-12-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0639"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValuePrivatePlacementWarrantsIssued
      contextRef="From2025-01-012025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0649"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValuePrivatePlacementWarrantsIssued
      contextRef="From2025-01-012025-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0650"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValuePrivatePlacementWarrantsIssued
      contextRef="From2025-01-012025-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0651"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValuePrivatePlacementWarrantsIssued
      contextRef="From2025-01-012025-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0652"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2025-01-012025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0662"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2025-01-012025-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0663"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2025-01-012025-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0664"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2025-01-012025-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0665"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2025-01-012025-12-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0667"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockForCommonStock
      contextRef="From2025-01-012025-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0680"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockForCommonStock
      contextRef="From2025-01-012025-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0681"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockForCommonStock
      contextRef="From2025-01-012025-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0682"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockForCommonStock
      contextRef="From2025-01-012025-12-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0683"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockForCommonStock
      contextRef="From2025-01-012025-12-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0684"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEquityLine
      contextRef="From2025-01-012025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0696"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEquityLine
      contextRef="From2025-01-012025-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0697"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEquityLine
      contextRef="From2025-01-012025-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0698"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEquityLine
      contextRef="From2025-01-012025-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0699"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEquityLine
      contextRef="From2025-01-012025-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0706"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0711"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0712"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0713"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0715"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0724"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0736"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0742"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0748"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0754"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2024-01-012024-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0760"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0761"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0763"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:SeriesBPreferredStockAndWarrantsIssued
      contextRef="From2024-01-012024-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0766"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:SeriesBPreferredStockAndWarrantsIssued
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0767"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:SeriesBPreferredStockAndWarrantsIssued
      contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0769"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-01-012024-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0774"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0775"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0776"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionsNetOfAdjustments
      contextRef="From2024-01-012024-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0780"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionsNetOfAdjustments
      contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0783"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0786"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0798"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:ShareBasedPaymentArrangementBusinessCombinationRelatedNoncashExpense
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0823"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0835"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0838"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:PaymentsForPromissoryNotes
      contextRef="From2025-01-012025-12-31"
      id="xdx2ixbrl0867"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:CashWithdrawnFromTrustAccountInConnectionWithRedemption
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0874"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:ReleaseOfTrustAccountToCompanysBankAccount
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0877"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0886"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0889"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0895"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="From2025-01-012025-12-31"
      id="xdx2ixbrl0897"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0901"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromBankDebt
      contextRef="From2025-01-012025-12-31"
      id="xdx2ixbrl0903"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfBankDebt
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0907"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:RepaymentOfLoansPayable
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0910"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0913"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2025-01-012025-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0918"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2025-01-012025-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0921"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2024-01-012024-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0925"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2024-01-012024-12-31_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl0928"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="AsOf2024-12-31_us-gaap_UnbilledRevenuesMember"
      id="xdx2ixbrl1096"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl1099"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2025-12-31_us-gaap_EquipmentMember"
      id="xdx2ixbrl1116"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_us-gaap_EquipmentMember"
      id="xdx2ixbrl1118"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-12-31_us-gaap_EquipmentMember"
      id="xdx2ixbrl1120"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2025-12-31_us-gaap_FurnitureAndFixturesMember"
      id="xdx2ixbrl1128"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_us-gaap_FurnitureAndFixturesMember"
      id="xdx2ixbrl1130"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-12-31_us-gaap_FurnitureAndFixturesMember"
      id="xdx2ixbrl1132"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2025-12-31_us-gaap_LeaseholdImprovementsMember"
      id="xdx2ixbrl1140"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_us-gaap_LeaseholdImprovementsMember"
      id="xdx2ixbrl1142"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-12-31_us-gaap_LeaseholdImprovementsMember"
      id="xdx2ixbrl1144"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-12-31_us-gaap_LeaseholdImprovementsMember"
      id="xdx2ixbrl1150"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2025-12-31_custom_CapitalLeaseMember"
      id="xdx2ixbrl1152"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_CapitalLeaseMember"
      id="xdx2ixbrl1154"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-12-31_custom_CapitalLeaseMember"
      id="xdx2ixbrl1156"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2025-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      id="xdx2ixbrl1164"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      id="xdx2ixbrl1166"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      id="xdx2ixbrl1168"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl1176"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl1178"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl1180"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2025-12-31_custom_ContractualRelationshipMember"
      id="xdx2ixbrl1203"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2025-12-31_custom_ContractualRelationshipMember"
      id="xdx2ixbrl1205"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2025-12-31_custom_ContractualRelationshipMember"
      id="xdx2ixbrl1207"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-12-31_custom_ContractualRelationshipMember"
      id="xdx2ixbrl1213"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2025-12-31_custom_ImplementationMember"
      id="xdx2ixbrl1215"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2025-12-31_custom_ImplementationMember"
      id="xdx2ixbrl1217"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2025-12-31_custom_ImplementationMember"
      id="xdx2ixbrl1219"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-12-31_custom_ImplementationMember"
      id="xdx2ixbrl1225"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2025-12-31_custom_SoftwareMember"
      id="xdx2ixbrl1227"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2025-12-31_custom_SoftwareMember"
      id="xdx2ixbrl1229"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2025-12-31_custom_SoftwareMember"
      id="xdx2ixbrl1231"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl1239"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl1241"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl1243"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="From2025-01-012025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl1304"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:BusinessCombinationRecognizedCashAcquired
      contextRef="From2025-01-012025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl1310"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="From2025-01-012025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl1316"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember_us-gaap_SeriesEPreferredStockMember"
      id="xdx2ixbrl1325"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember_us-gaap_SeriesEPreferredStockMember"
      id="xdx2ixbrl1329"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:BusinessCombinationNonCashConsiderationOnAccountsReceivable
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl1333"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl1345"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl1349"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl1353"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:PayrollLiability
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl1361"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesFactoringLiability
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl1365"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl1369"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl1373"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl1377"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:BusinessCombinationEliminationOfInterCompanyBalances
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl1389"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl1393"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Goodwill
      contextRef="AsOf2024-12-31_custom_SLGInnovationIncMember"
      id="xdx2ixbrl1522"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:LoanPayable
      contextRef="AsOf2024-12-31_custom_SLGInnovationIncMember71576968"
      id="xdx2ixbrl1627"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:EconomicInjuryDisasterLoan
      contextRef="AsOf2024-12-31_custom_SLGInnovationIncMember71576968"
      id="xdx2ixbrl1633"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-12-31_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl1678"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2024-12-31_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl1680"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl1682"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:AmortizationOfDebtPremium
      contextRef="From2025-01-012025-03-31_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl1692"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:AmortizationOfDebtPremium
      contextRef="From2025-04-012025-06-30_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl1722"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-06-30_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl1728"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2025-06-30_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl1730"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl1732"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:DebtInstrumentFaceAmountIssued
      contextRef="From2025-07-012025-09-30_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl1734"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:DeferredFinanceCostGross
      contextRef="From2025-07-012025-09-30_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl1736"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:ConvertibleNotesPayableIssuance
      contextRef="From2025-07-012025-09-30"
      id="xdx2ixbrl1738"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-09-30_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl1740"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2025-09-30_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl1742"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2025-09-30"
      id="xdx2ixbrl1744"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:DeferredFinanceCostGross
      contextRef="From2025-10-012025-12-31_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl1748"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2025-12-31_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl1756"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:UnamortizedDiscountAndIssuanceCostsRepayment
      contextRef="From2025-01-012025-03-31_custom_PromissoryNotesMember"
      id="xdx2ixbrl1800"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="From2025-04-012025-06-30_custom_PromissoryNotesMember"
      id="xdx2ixbrl1822"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:UnamortizedDiscountAndIssuanceCostsRepayment
      contextRef="From2025-04-012025-06-30_custom_PromissoryNotesMember"
      id="xdx2ixbrl1830"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2025-04-012025-06-30_custom_PromissoryNotesMember"
      id="xdx2ixbrl1836"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:UnamortizedDiscountAndIssuanceCostsRepayment
      contextRef="From2025-07-012025-09-30_custom_PromissoryNotesMember"
      id="xdx2ixbrl1852"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2025-07-012025-09-30_custom_PromissoryNotesMember"
      id="xdx2ixbrl1858"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:UnamortizedDiscountAndIssuanceCostsConversionToAConvertibleNote
      contextRef="From2025-10-012025-12-31_custom_PromissoryNotesMember"
      id="xdx2ixbrl1874"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2025-10-012025-12-31_custom_PromissoryNotesMember"
      id="xdx2ixbrl1880"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-12-31_custom_PromissoryNotesSixMember"
      id="xdx2ixbrl1922"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:FactoringLiability
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl1985"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedPrefundedWarrantInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2025-04-012025-06-30_us-gaap_WarrantMember"
      id="xdx2ixbrl2259"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2025-04-012025-06-30_us-gaap_WarrantMember"
      id="xdx2ixbrl2265"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2025-07-012025-09-30_us-gaap_WarrantMember"
      id="xdx2ixbrl2283"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <CYCU:WeightedAverageExercisePriceIssuedPrefunded
      contextRef="From2025-10-012025-12-31_us-gaap_WarrantMember"
      id="xdx2ixbrl2295"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2025-12-31_custom_CommonClassSubjectToRedemptionMember"
      id="xdx2ixbrl2465"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2025-12-31_custom_CommonClassSubjectToRedemptionMember"
      id="xdx2ixbrl2467"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisSubordinatedDebtObligations
      contextRef="AsOf2024-12-31_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl2528"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisSubordinatedDebtObligations
      contextRef="AsOf2024-12-31_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl2529"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:ConvertiblePreferredStockLiabilityFairValueDisclosure
      contextRef="AsOf2024-12-31_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl2533"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:ConvertiblePreferredStockLiabilityFairValueDisclosure
      contextRef="AsOf2024-12-31_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl2534"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-12-31_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl2538"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-12-31_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl2539"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-12-31_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl2548"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-12-31_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl2549"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EquityFairValueDisclosure
      contextRef="AsOf2024-12-31_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl2553"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EquityFairValueDisclosure
      contextRef="AsOf2024-12-31_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl2554"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2025-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl2605"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl2628"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2025-01-012025-12-31_custom_SeriesAConvertiblePreferredStockMember"
      id="xdx2ixbrl2666"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2025-01-012025-12-31_custom_SeriesBConvertiblePreferredStockMember"
      id="xdx2ixbrl2669"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2025-01-012025-12-31_custom_SeriesCConvertiblePreferredStockMember"
      id="xdx2ixbrl2672"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2025-01-012025-12-31_custom_SeriesCConvertiblePreferredStockMember"
      id="xdx2ixbrl2675"
      unitRef="Shares"
      xsi:nil="true"/>
    <CYCU:IncrementalCommonSharesAttributableToDilutiveEffectOfExerciseOfInvestorAndPlacementAgentWarrants
      contextRef="From2025-01-012025-12-31"
      id="xdx2ixbrl2678"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-012024-12-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesAConvertiblePreferredStockMember"
      id="xdx2ixbrl2690"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-012024-12-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesBConvertiblePreferredStockMember"
      id="xdx2ixbrl2693"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-012024-12-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesCConvertiblePreferredStockMember"
      id="xdx2ixbrl2696"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-012024-12-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesDConvertiblePreferredStockMember"
      id="xdx2ixbrl2699"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-012024-12-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesEConvertiblePreferredStockMember"
      id="xdx2ixbrl2702"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2026-03-31"
      id="xdx2ixbrl2948"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl2949"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2026-03-31_custom_SeriesAConvertiblePreferredStockMember"
      id="xdx2ixbrl2961"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember"
      id="xdx2ixbrl2962"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2026-03-31_custom_SeriesBConvertiblePreferredStockMember"
      id="xdx2ixbrl2980"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember"
      id="xdx2ixbrl2981"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2026-03-31_custom_SeriesCConvertiblePreferredStockMember"
      id="xdx2ixbrl2999"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember"
      id="xdx2ixbrl3000"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2026-03-31_custom_SeriesEConvertiblePreferredStockMember"
      id="xdx2ixbrl3037"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-12-31_custom_SeriesEConvertiblePreferredStockMember"
      id="xdx2ixbrl3038"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2026-03-31_custom_SeriesFConvertiblePreferredStockMember"
      id="xdx2ixbrl3056"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-12-31_custom_SeriesFConvertiblePreferredStockMember"
      id="xdx2ixbrl3057"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2026-03-31_custom_SeriesGConvertiblePreferredStockMember"
      id="xdx2ixbrl3075"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-12-31_custom_SeriesGConvertiblePreferredStockMember"
      id="xdx2ixbrl3076"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2025-01-012025-03-31"
      id="xdx2ixbrl3150"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="From2026-01-01to2026-03-31"
      id="xdx2ixbrl3152"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InvestmentIncomeNonoperating
      contextRef="From2025-01-012025-03-31"
      id="xdx2ixbrl3165"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2026-01-01to2026-03-31"
      id="xdx2ixbrl3170"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2026-01-01to2026-03-31"
      id="xdx2ixbrl3173"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2026-01-01to2026-03-31"
      id="xdx2ixbrl3182"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2025-01-012025-03-31"
      id="xdx2ixbrl3183"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2025-01-012025-03-31"
      id="xdx2ixbrl3189"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3215"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3216"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3217"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3219"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3220"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3232"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2026-01-012026-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3246"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2026-01-012026-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3247"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2026-01-012026-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3248"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2026-01-012026-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3249"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2026-01-012026-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3250"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2026-01-012026-03-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3251"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2026-01-012026-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3253"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2026-01-012026-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3254"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2026-01-012026-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl3256"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2026-01-012026-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3261"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2026-01-012026-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3262"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2026-01-012026-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3263"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2026-01-012026-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3264"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2026-01-012026-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3265"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2026-01-012026-03-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3266"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2026-01-012026-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3269"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2026-01-012026-03-31_us-gaap_ParentMember"
      id="xdx2ixbrl3270"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2026-01-012026-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl3271"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2026-01-01to2026-03-31"
      id="xdx2ixbrl3272"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-012026-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3278"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-012026-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3279"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-012026-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3280"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-012026-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3281"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-012026-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3282"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-012026-03-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3283"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-012026-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl3284"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-012026-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3285"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2026-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3291"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2026-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3292"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2026-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3293"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2026-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3295"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2026-03-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3296"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2026-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3308"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3322"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3323"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3324"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3325"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3326"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3327"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl3332"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3339"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3345"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3347"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3349"
      unitRef="Shares"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityCommonStockRedeemedValue
      contextRef="From2025-01-012025-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3353"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityCommonStockRedeemedValue
      contextRef="From2025-01-012025-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3354"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityCommonStockRedeemedValue
      contextRef="From2025-01-012025-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3355"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityCommonStockRedeemedValue
      contextRef="From2025-01-012025-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3356"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityCommonStockRedeemedValue
      contextRef="From2025-01-012025-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3357"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityCommonStockRedeemedValue
      contextRef="From2025-01-012025-03-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3358"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityCommonStockRedeemedValue
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl3359"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityCommonStockRedeemedValue
      contextRef="From2025-01-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3360"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityCommonStockRedeemedValue
      contextRef="From2025-01-012025-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3361"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityCommonStockRedeemedValue
      contextRef="From2025-01-012025-03-31_us-gaap_ParentMember"
      id="xdx2ixbrl3362"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityCommonStockRedeemedValue
      contextRef="From2025-01-012025-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl3363"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityCommonStockRedeemedValue
      contextRef="From2025-01-012025-03-31"
      id="xdx2ixbrl3364"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemptionValue
      contextRef="From2025-01-012025-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3370"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemptionValue
      contextRef="From2025-01-012025-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3371"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemptionValue
      contextRef="From2025-01-012025-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3372"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemptionValue
      contextRef="From2025-01-012025-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3373"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemptionValue
      contextRef="From2025-01-012025-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3374"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemptionValue
      contextRef="From2025-01-012025-03-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3375"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemptionValue
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl3376"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemptionValue
      contextRef="From2025-01-012025-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3378"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemptionValue
      contextRef="From2025-01-012025-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl3380"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesLiability
      contextRef="From2025-01-012025-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3390"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesLiability
      contextRef="From2025-01-012025-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3391"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesLiability
      contextRef="From2025-01-012025-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3392"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesLiability
      contextRef="From2025-01-012025-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3393"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesLiability
      contextRef="From2025-01-012025-03-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3394"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesLiability
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl3395"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesLiability
      contextRef="From2025-01-012025-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3397"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesLiability
      contextRef="From2025-01-012025-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl3399"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3404"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3405"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3406"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3408"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-03-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3409"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl3410"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3412"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl3414"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3419"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3420"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3421"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3423"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-03-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3424"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3427"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-03-31_us-gaap_ParentMember"
      id="xdx2ixbrl3428"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl3429"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-03-31"
      id="xdx2ixbrl3430"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3438"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3439"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3440"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3441"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3442"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-03-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3443"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3446"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl3448"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2025-01-012025-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3453"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2025-01-012025-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3454"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2025-01-012025-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3455"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2025-01-012025-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3456"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2025-01-012025-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3457"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2025-01-012025-03-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3458"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2025-01-012025-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3461"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2025-01-012025-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl3463"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability
      contextRef="From2025-01-012025-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3468"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability
      contextRef="From2025-01-012025-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3469"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability
      contextRef="From2025-01-012025-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3470"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability
      contextRef="From2025-01-012025-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3471"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability
      contextRef="From2025-01-012025-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3472"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability
      contextRef="From2025-01-012025-03-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3473"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl3474"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability
      contextRef="From2025-01-012025-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3476"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability
      contextRef="From2025-01-012025-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl3478"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement
      contextRef="From2025-01-012025-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3483"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement
      contextRef="From2025-01-012025-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3484"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement
      contextRef="From2025-01-012025-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3485"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement
      contextRef="From2025-01-012025-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3486"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement
      contextRef="From2025-01-012025-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3487"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement
      contextRef="From2025-01-012025-03-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3488"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement
      contextRef="From2025-01-012025-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3491"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement
      contextRef="From2025-01-012025-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl3493"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3498"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3499"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3500"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3501"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3502"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-03-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3503"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3506"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl3508"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2025-01-012025-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3515"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2025-01-012025-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3516"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2025-01-012025-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3517"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2025-01-012025-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3518"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2025-01-012025-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3519"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2025-01-012025-03-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3520"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl3521"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2025-01-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3522"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-012025-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3528"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-012025-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3529"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-012025-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3530"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-012025-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3531"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-012025-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3532"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-012025-03-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3533"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl3534"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3535"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-012025-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl3538"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3542"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3543"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3545"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-03-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3546"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2025-03-31"
      id="xdx2ixbrl3554"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="AsOf2025-03-31"
      id="xdx2ixbrl3556"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-03-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3568"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-01-012025-03-31"
      id="xdx2ixbrl3582"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:ShareBasedPaymentArrangementBusinessCombinationRelatedNoncashExpense
      contextRef="From2026-01-01to2026-03-31"
      id="xdx2ixbrl3584"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Depreciation
      contextRef="From2026-01-01to2026-03-31"
      id="xdx2ixbrl3590"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="From2026-01-01to2026-03-31"
      id="xdx2ixbrl3593"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2026-01-01to2026-03-31"
      id="xdx2ixbrl3596"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="From2026-01-01to2026-03-31"
      id="xdx2ixbrl3599"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="From2026-01-01to2026-03-31"
      id="xdx2ixbrl3626"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:CashWithdrawnFromTrustAccountInConnectionWithRedemption
      contextRef="From2026-01-01to2026-03-31"
      id="xdx2ixbrl3632"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:ReleaseOfTrustAccountToCompanysBankAccount
      contextRef="From2026-01-01to2026-03-31"
      id="xdx2ixbrl3635"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="From2026-01-01to2026-03-31"
      id="xdx2ixbrl3647"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfBankDebt
      contextRef="From2026-01-01to2026-03-31"
      id="xdx2ixbrl3653"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2026-01-01to2026-03-31"
      id="xdx2ixbrl3656"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2026-01-012026-03-31_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl3659"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2026-01-012026-03-31_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl3662"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="AsOf2026-03-31_us-gaap_UnbilledRevenuesMember"
      id="xdx2ixbrl3779"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="AsOf2026-03-31_us-gaap_UnbilledRevenuesMember"
      id="xdx2ixbrl3782"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="From2026-01-012026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl3858"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:BusinessCombinationRecognizedCashAcquired
      contextRef="From2026-01-012026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl3864"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="From2026-01-012026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl3870"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember_us-gaap_SeriesEPreferredStockMember"
      id="xdx2ixbrl3879"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:BusinessCombinationNonCashConsiderationOnAccountsReceivable
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl3883"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl3895"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl3899"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesFactoringLiability
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl3915"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl3919"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl3923"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl3927"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:BusinessCombinationEliminationOfInterCompanyBalances
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl3939"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      id="xdx2ixbrl3943"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-12-31_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl4224"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2024-12-31_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl4226"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl4228"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:AmortizationOfDebtPremium
      contextRef="From2025-01-012025-03-31_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl4238"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:AmortizationOfDebtPremium
      contextRef="From2025-04-012025-06-30_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl4268"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-06-30_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl4274"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2025-06-30_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl4276"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl4278"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:DebtInstrumentFaceAmountIssued
      contextRef="From2025-07-012025-09-30_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl4280"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:DeferredFinanceCostGross
      contextRef="From2025-07-012025-09-30_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl4282"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:ConvertibleNotesPayableIssuance
      contextRef="From2025-07-012025-09-30"
      id="xdx2ixbrl4284"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-09-30_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl4286"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2025-09-30_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl4288"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2025-09-30"
      id="xdx2ixbrl4290"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:DeferredFinanceCostGross
      contextRef="From2025-10-012025-12-31_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl4294"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2025-12-31_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl4302"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:DebtInstrumentFaceAmountIssued
      contextRef="From2026-01-012026-03-31_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl4308"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:DeferredFinanceCostGross
      contextRef="From2026-01-012026-03-31_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl4310"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:ConvertibleNotesPayableIssuance
      contextRef="From2026-01-01to2026-03-31"
      id="xdx2ixbrl4312"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2026-03-31_us-gaap_ConvertibleNotesPayableMember"
      id="xdx2ixbrl4316"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:UnamortizedDiscountAndIssuanceCostsRepayment
      contextRef="From2025-01-012025-03-31_custom_PromissoryNotesMember"
      id="xdx2ixbrl4368"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="From2025-04-012025-06-30_custom_PromissoryNotesMember"
      id="xdx2ixbrl4390"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:UnamortizedDiscountAndIssuanceCostsRepayment
      contextRef="From2025-04-012025-06-30_custom_PromissoryNotesMember"
      id="xdx2ixbrl4398"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2025-04-012025-06-30_custom_PromissoryNotesMember"
      id="xdx2ixbrl4404"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:UnamortizedDiscountAndIssuanceCostsRepayment
      contextRef="From2025-07-012025-09-30_custom_PromissoryNotesMember"
      id="xdx2ixbrl4420"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2025-07-012025-09-30_custom_PromissoryNotesMember"
      id="xdx2ixbrl4426"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:UnamortizedDiscountAndIssuanceCostsConversionToAConvertibleNote
      contextRef="From2025-10-012025-12-31_custom_PromissoryNotesMember"
      id="xdx2ixbrl4442"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2025-10-012025-12-31_custom_PromissoryNotesMember"
      id="xdx2ixbrl4448"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2026-01-012026-03-31_custom_PromissoryNotesMember"
      id="xdx2ixbrl4462"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2026-03-31_custom_PromissoryNotesMember"
      id="xdx2ixbrl4470"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2026-03-31"
      id="xdx2ixbrl4513"
      unitRef="USD"
      xsi:nil="true"/>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedPrefundedWarrantInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2025-04-012025-06-30_us-gaap_WarrantMember"
      id="xdx2ixbrl4854"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2025-04-012025-06-30_us-gaap_WarrantMember"
      id="xdx2ixbrl4860"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2025-04-012025-06-30_us-gaap_WarrantMember"
      id="xdx2ixbrl4878"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <CYCU:WeightedAverageExercisePriceIssuedPrefunded
      contextRef="From2025-07-012025-09-30_us-gaap_WarrantMember"
      id="xdx2ixbrl4890"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <CYCU:WeightedAverageExercisePriceExercisedPrefunded
      contextRef="From2026-01-012026-03-31_us-gaap_WarrantMember"
      id="xdx2ixbrl4908"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2025-12-31_custom_CommonClassSubjectToRedemptionMember"
      id="xdx2ixbrl5070"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2025-12-31_custom_CommonClassSubjectToRedemptionMember"
      id="xdx2ixbrl5072"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2026-03-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl5189"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2025-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl5191"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2025-01-012025-03-31"
      id="xdx2ixbrl5212"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="From2026-01-01to2026-03-31"
      id="xdx2ixbrl5232"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="From2026-01-01to2026-03-31"
      id="xdx2ixbrl5247"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2026-01-012026-03-31_custom_SeriesAConvertiblePreferredStockMember"
      id="xdx2ixbrl5250"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2026-01-012026-03-31_custom_SeriesBConvertiblePreferredStockMember"
      id="xdx2ixbrl5253"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2026-01-012026-03-31_custom_SeriesCConvertiblePreferredStockMember"
      id="xdx2ixbrl5256"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2026-01-012026-03-31_custom_SeriesCConvertiblePreferredStockMember"
      id="xdx2ixbrl5259"
      unitRef="Shares"
      xsi:nil="true"/>
    <CYCU:IncrementalCommonSharesAttributableToDilutiveEffectOfExerciseOfInvestorAndPlacementAgentWarrants
      contextRef="From2026-01-01to2026-03-31"
      id="xdx2ixbrl5262"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2025-01-012025-03-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesBConvertiblePreferredStockMember"
      id="xdx2ixbrl5274"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2025-01-012025-03-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesCConvertiblePreferredStockMember"
      id="xdx2ixbrl5277"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2025-01-012025-03-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesDConvertiblePreferredStockMember"
      id="xdx2ixbrl5280"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2025-01-012025-03-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesEConvertiblePreferredStockMember"
      id="xdx2ixbrl5283"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2025-01-012025-03-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesEConvertiblePreferredStockMember"
      id="xdx2ixbrl5286"
      unitRef="Shares"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2026-01-01to2026-03-31" id="Fact000013">S-1</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2026-01-01to2026-03-31" id="Fact000014">CYCURION, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2026-01-01to2026-03-31" id="Fact000015">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2026-01-01to2026-03-31" id="Fact000016">86-3720717</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2026-01-01to2026-03-31" id="Fact000017">1640 Boro Place</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2026-01-01to2026-03-31" id="Fact000018">Suite 420C</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2026-01-01to2026-03-31" id="Fact000019">McLean</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2026-01-01to2026-03-31" id="Fact000020">VA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2026-01-01to2026-03-31" id="Fact000021">22102</dei:EntityAddressPostalZipCode>
    <dei:ContactPersonnelName
      contextRef="From2026-01-012026-03-31_dei_BusinessContactMember"
      id="Fact000022">L. Kevin Kelly</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="From2026-01-012026-03-31_dei_BusinessContactMember"
      id="Fact000023">1640 Boro Place</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="From2026-01-012026-03-31_dei_BusinessContactMember"
      id="Fact000024">Suite 420C</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="From2026-01-012026-03-31_dei_BusinessContactMember"
      id="Fact000025">McLean</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="From2026-01-012026-03-31_dei_BusinessContactMember"
      id="Fact000026">VA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="From2026-01-012026-03-31_dei_BusinessContactMember"
      id="Fact000027">22102</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2026-01-01to2026-03-31" id="Fact000028">(703)</dei:CityAreaCode>
    <dei:CityAreaCode
      contextRef="From2026-01-012026-03-31_dei_BusinessContactMember"
      id="Fact000029">(703)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2026-01-01to2026-03-31" id="Fact000030">854-1652</dei:LocalPhoneNumber>
    <dei:LocalPhoneNumber
      contextRef="From2026-01-012026-03-31_dei_BusinessContactMember"
      id="Fact000031">854-1652</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="From2026-01-01to2026-03-31" id="Fact000032">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2026-01-01to2026-03-31" id="Fact000033">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2026-01-01to2026-03-31" id="Fact000034">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2026-01-01to2026-03-31" id="Fact000035">false</dei:EntityExTransitionPeriod>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000040"
      unitRef="USD">5255235</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000041"
      unitRef="USD">38742</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000044"
      unitRef="USD">2048</us-gaap:RestrictedCashCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000046"
      unitRef="USD">2687479</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000047"
      unitRef="USD">10353708</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000050"
      unitRef="USD">434391</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000052"
      unitRef="USD">60133</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000053"
      unitRef="USD">99463</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000055"
      unitRef="USD">8002847</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000056"
      unitRef="USD">10928352</us-gaap:AssetsCurrent>
    <us-gaap:DepositAssets
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000059"
      unitRef="USD">2000000</us-gaap:DepositAssets>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000062"
      unitRef="USD">20321</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000064"
      unitRef="USD">4606981</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000065"
      unitRef="USD">4151981</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000068"
      unitRef="USD">25000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000071"
      unitRef="USD">10351</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:Goodwill
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000073"
      unitRef="USD">20842508</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000074"
      unitRef="USD">6592304</us-gaap:Goodwill>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000077"
      unitRef="USD">1834540</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000079"
      unitRef="USD">25449489</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000080"
      unitRef="USD">14634497</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000082"
      unitRef="USD">33452336</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000083"
      unitRef="USD">25562849</us-gaap:Assets>
    <us-gaap:LinesOfCreditCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000091"
      unitRef="USD">2933396</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LinesOfCreditCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000092"
      unitRef="USD">3249067</us-gaap:LinesOfCreditCurrent>
    <CYCU:BankLoanCurrentPortion
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000095"
      unitRef="USD">774095</CYCU:BankLoanCurrentPortion>
    <us-gaap:LoansPayableCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000097"
      unitRef="USD">669693</us-gaap:LoansPayableCurrent>
    <us-gaap:LoansPayableCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000098"
      unitRef="USD">408516</us-gaap:LoansPayableCurrent>
    <CYCU:FactoringLiability
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000100"
      unitRef="USD">1511678</CYCU:FactoringLiability>
    <CYCU:SubordinatedConvertiblePromissoryNotes
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000104"
      unitRef="USD">3333335</CYCU:SubordinatedConvertiblePromissoryNotes>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000106"
      unitRef="USD">192897</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:OtherNotesPayable
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000109"
      unitRef="USD">2499662</us-gaap:OtherNotesPayable>
    <us-gaap:OtherNotesPayable
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000110"
      unitRef="USD">2486989</us-gaap:OtherNotesPayable>
    <CYCU:LoansPayableRelatedParties
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000112"
      unitRef="USD">123650</CYCU:LoansPayableRelatedParties>
    <CYCU:LoansPayableRelatedParties
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000113"
      unitRef="USD">148088</CYCU:LoansPayableRelatedParties>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000115"
      unitRef="USD">1314772</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000116"
      unitRef="USD">1681774</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000118"
      unitRef="USD">4228337</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000119"
      unitRef="USD">2927135</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000121"
      unitRef="USD">919825</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000122"
      unitRef="USD">979684</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000124"
      unitRef="USD">1347787</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000125"
      unitRef="USD">1591023</us-gaap:InterestPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000127"
      unitRef="USD">1167173</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000128"
      unitRef="USD">1157161</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000130"
      unitRef="USD">16908870</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000131"
      unitRef="USD">18736867</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermLoansPayable
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000133"
      unitRef="USD">300000</us-gaap:LongTermLoansPayable>
    <us-gaap:LongTermLoansPayable
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000134"
      unitRef="USD">146798</us-gaap:LongTermLoansPayable>
    <CYCU:ConvertiblePreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesAOneConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000139"
      unitRef="USDPShares">0.001</CYCU:ConvertiblePreferredStockParOrStatedValuePerShare>
    <CYCU:ConvertiblePreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31_custom_SeriesAOneConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000141"
      unitRef="USDPShares">0.001</CYCU:ConvertiblePreferredStockParOrStatedValuePerShare>
    <CYCU:ConvertiblePreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesAOneConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000143"
      unitRef="Shares">500000</CYCU:ConvertiblePreferredStockSharesAuthorized>
    <CYCU:ConvertiblePreferredStockSharesAuthorized
      contextRef="AsOf2024-12-31_custom_SeriesAOneConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000145"
      unitRef="Shares">500000</CYCU:ConvertiblePreferredStockSharesAuthorized>
    <CYCU:ConvertiblePreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesAOneConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000147"
      unitRef="Shares">0</CYCU:ConvertiblePreferredStockSharesIssued>
    <CYCU:ConvertiblePreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesAOneConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000149"
      unitRef="Shares">0</CYCU:ConvertiblePreferredStockSharesOutstanding>
    <CYCU:ConvertiblePreferredStockSharesIssued
      contextRef="AsOf2024-12-31_custom_SeriesAOneConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000151"
      unitRef="Shares">345528</CYCU:ConvertiblePreferredStockSharesIssued>
    <CYCU:ConvertiblePreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesAOneConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000153"
      unitRef="Shares">345528</CYCU:ConvertiblePreferredStockSharesOutstanding>
    <CYCU:ConvertiblePreferredStockLiability
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000137"
      unitRef="USD">1294117</CYCU:ConvertiblePreferredStockLiability>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000155"
      unitRef="USD">300000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000156"
      unitRef="USD">1440915</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000158"
      unitRef="USD">17208870</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000159"
      unitRef="USD">20177782</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_CommonClassSubjectToRedemptionMember"
      decimals="INF"
      id="Fact000170"
      unitRef="USDPShares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2024-12-31_custom_CommonClassSubjectToRedemptionMember"
      decimals="INF"
      id="Fact000172"
      unitRef="USDPShares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2024-12-31_custom_CommonClassSubjectToRedemptionMember"
      decimals="INF"
      id="Fact000178"
      unitRef="Shares">5796</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2024-12-31_custom_CommonClassSubjectToRedemptionMember"
      decimals="INF"
      id="Fact000180"
      unitRef="Shares">5796</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="AsOf2025-12-31_custom_CommonClassSubjectToRedemptionMember"
      decimals="INF"
      id="Fact000182"
      unitRef="USDPShares">11.03</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="AsOf2024-12-31_custom_CommonClassSubjectToRedemptionMember"
      decimals="INF"
      id="Fact000184"
      unitRef="USDPShares">11.03</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000168"
      unitRef="USD">1917309</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000192"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000194"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000196"
      unitRef="Shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000198"
      unitRef="Shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000203"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000205"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000207"
      unitRef="Shares">110000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000209"
      unitRef="Shares">110000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000211"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000213"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000215"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000217"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000222"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000224"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000226"
      unitRef="Shares">3000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000228"
      unitRef="Shares">3000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000230"
      unitRef="Shares">1</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000232"
      unitRef="Shares">1</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000234"
      unitRef="Shares">3000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000236"
      unitRef="Shares">3000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000241"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000243"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000245"
      unitRef="Shares">5000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000247"
      unitRef="Shares">5000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000249"
      unitRef="Shares">4851</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000251"
      unitRef="Shares">4851</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000253"
      unitRef="Shares">4851</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000255"
      unitRef="Shares">4851</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000260"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000262"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000264"
      unitRef="Shares">6666700</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000266"
      unitRef="Shares">6666700</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000268"
      unitRef="Shares">150000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000270"
      unitRef="Shares">150000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000272"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000274"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="0"
      id="Fact000257"
      unitRef="USD">15</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000279"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000281"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000283"
      unitRef="Shares">100</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-12-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000285"
      unitRef="Shares">100</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000287"
      unitRef="Shares">51</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000289"
      unitRef="Shares">51</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000291"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000293"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000298"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000300"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000302"
      unitRef="Shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-12-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000304"
      unitRef="Shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000306"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000308"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000310"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000312"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000317"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000319"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000321"
      unitRef="Shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000323"
      unitRef="Shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000325"
      unitRef="Shares">143</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000327"
      unitRef="Shares">143</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000329"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000331"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000339"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000341"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000343"
      unitRef="Shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000345"
      unitRef="Shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000347"
      unitRef="Shares">3642501</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000349"
      unitRef="Shares">3642501</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000351"
      unitRef="Shares">391373</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000353"
      unitRef="Shares">391373</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000336"
      unitRef="USD">364</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000337"
      unitRef="USD">38</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000355"
      unitRef="USD">46979762</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000356"
      unitRef="USD">6671081</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000358"
      unitRef="USD">-26879081</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000359"
      unitRef="USD">-3203361</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000361"
      unitRef="USD">20101060</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000362"
      unitRef="USD">3467758</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000364"
      unitRef="USD">-3857594</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000367"
      unitRef="USD">16243466</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000368"
      unitRef="USD">3467758</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000370"
      unitRef="USD">33452336</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000371"
      unitRef="USD">25562849</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000373"
      unitRef="USD">15133647</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000374"
      unitRef="USD">17771485</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000376"
      unitRef="USD">13521329</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000377"
      unitRef="USD">14136742</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000379"
      unitRef="USD">1612318</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000380"
      unitRef="USD">3634743</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000385"
      unitRef="USD">9258199</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000386"
      unitRef="USD">1208630</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000388"
      unitRef="USD">3898867</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000389"
      unitRef="USD">10000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000391"
      unitRef="USD">11870114</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:OperatingExpenses
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000394"
      unitRef="USD">25027180</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000395"
      unitRef="USD">1218630</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000397"
      unitRef="USD">-23414862</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000398"
      unitRef="USD">2416113</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeNonoperating
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000403"
      unitRef="USD">27538</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:InvestmentIncomeNonoperating
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000404"
      unitRef="USD">20211</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000406"
      unitRef="USD">1763831</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000407"
      unitRef="USD">1209502</us-gaap:InterestExpenseNonoperating>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000409"
      unitRef="USD">1221635</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000412"
      unitRef="USD">-129564</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000413"
      unitRef="USD">2779</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000415"
      unitRef="USD">-644222</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000416"
      unitRef="USD">-1186512</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000418"
      unitRef="USD">-24059084</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000419"
      unitRef="USD">1229601</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000424"
      unitRef="USD">-24059084</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000425"
      unitRef="USD">1229601</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000427"
      unitRef="USD">-393376</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000430"
      unitRef="USD">-23665708</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000431"
      unitRef="USD">1229601</us-gaap:NetIncomeLoss>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000433"
      unitRef="USD">-23665708</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000434"
      unitRef="USD">1229601</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-01-012025-12-31"
      decimals="INF"
      id="Fact000439"
      unitRef="USDPShares">-13.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact000440"
      unitRef="USDPShares">4.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-01-012025-12-31"
      decimals="INF"
      id="Fact000442"
      unitRef="USDPShares">-13.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact000443"
      unitRef="USDPShares">1.66</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-01-012025-12-31"
      decimals="INF"
      id="Fact000448"
      unitRef="Shares">1760310</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact000449"
      unitRef="Shares">282437</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-01-012025-12-31"
      decimals="INF"
      id="Fact000451"
      unitRef="Shares">1763643</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact000452"
      unitRef="Shares">904929</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000467"
      unitRef="Shares">5796</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000469"
      unitRef="USD">1917309</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000473"
      unitRef="Shares">3000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000475"
      unitRef="Shares">4851</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000483"
      unitRef="Shares">391373</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000460"
      unitRef="USD">38</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000461"
      unitRef="USD">6671081</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000462"
      unitRef="USD">-3203361</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact000463"
      unitRef="USD">3467758</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000465"
      unitRef="USD">3467758</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <CYCU:TemporaryEquityRedeemedShares
      contextRef="From2025-01-012025-12-31"
      decimals="INF"
      id="Fact000498"
      unitRef="Shares">-3163</CYCU:TemporaryEquityRedeemedShares>
    <CYCU:TemporaryEquityRedeemedValue
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000500"
      unitRef="USD">-1001216</CYCU:TemporaryEquityRedeemedValue>
    <CYCU:TemporaryEquitySharesReleaseOfCommonStockSubjectToRedemption
      contextRef="From2025-01-012025-12-31"
      decimals="INF"
      id="Fact000502"
      unitRef="Shares">-2633</CYCU:TemporaryEquitySharesReleaseOfCommonStockSubjectToRedemption>
    <CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemption
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000504"
      unitRef="USD">-916093</CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemption>
    <CYCU:StockIssuedDuringPeriodSharesReleaseOfCommonStockSubjectToRedemption
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000506"
      unitRef="Shares">2654</CYCU:StockIssuedDuringPeriodSharesReleaseOfCommonStockSubjectToRedemption>
    <CYCU:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesLiability
      contextRef="From2025-01-012025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000508"
      unitRef="Shares">106816</CYCU:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesLiability>
    <CYCU:StockIssuedDuringPeriodSharesPreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000523"
      unitRef="Shares">6666666</CYCU:StockIssuedDuringPeriodSharesPreferredStockInExchangeOfConvertibleNotes>
    <CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000513"
      unitRef="USD">667</CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes>
    <CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000517"
      unitRef="USD">3332668</CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes>
    <CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-12-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact000519"
      unitRef="USD">3333335</CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes>
    <CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000521"
      unitRef="USD">3333335</CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes>
    <CYCU:StockIssuedDuringPeriodSharesCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000538"
      unitRef="Shares">-2999</CYCU:StockIssuedDuringPeriodSharesCommonStockIssuedForConversionOfConvertiblePreferredStock>
    <CYCU:StockIssuedDuringPeriodSharesCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000540"
      unitRef="Shares">-6516666</CYCU:StockIssuedDuringPeriodSharesCommonStockIssuedForConversionOfConvertiblePreferredStock>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000528"
      unitRef="USD">-652</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock>
    <CYCU:StockIssuedDuringPeriodSharesCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_SeriesBConvertiblePreferredStockAndSeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000542"
      unitRef="Shares">420515</CYCU:StockIssuedDuringPeriodSharesCommonStockIssuedForConversionOfConvertiblePreferredStock>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000531"
      unitRef="USD">42</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000532"
      unitRef="USD">610</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000557"
      unitRef="Shares">411730</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000550"
      unitRef="USD">42</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000551"
      unitRef="USD">3664829</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-12-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact000553"
      unitRef="USD">3664871</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000555"
      unitRef="USD">3664871</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000572"
      unitRef="Shares">25200</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000565"
      unitRef="USD">3</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2025-01-012025-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000566"
      unitRef="USD">8999907</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2025-01-012025-12-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact000568"
      unitRef="USD">9000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000570"
      unitRef="USD">9000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <CYCU:StockIssuedDuringPeriodSharesCommonStockIssuedForSettlementOfLiability
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000587"
      unitRef="Shares">19314</CYCU:StockIssuedDuringPeriodSharesCommonStockIssuedForSettlementOfLiability>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000580"
      unitRef="USD">10</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability
      contextRef="From2025-01-012025-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000581"
      unitRef="USD">2123137</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability
      contextRef="From2025-01-012025-12-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact000583"
      unitRef="USD">2123147</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000585"
      unitRef="USD">2123147</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability>
    <CYCU:StockIssuedDuringPeriodSharesCommonStockIssuedForEmploymentAgreement
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000602"
      unitRef="Shares">390789</CYCU:StockIssuedDuringPeriodSharesCommonStockIssuedForEmploymentAgreement>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000595"
      unitRef="USD">30</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement
      contextRef="From2025-01-012025-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000596"
      unitRef="USD">2783566</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement
      contextRef="From2025-01-012025-12-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact000598"
      unitRef="USD">2783596</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000600"
      unitRef="USD">2783596</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement>
    <CYCU:StockIssuedDuringPeriodSharesAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000617"
      unitRef="Shares">51</CYCU:StockIssuedDuringPeriodSharesAcquisitionOfSubsidiary>
    <CYCU:StockIssuedDuringPeriodSharesAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000619"
      unitRef="Shares">33878</CYCU:StockIssuedDuringPeriodSharesAcquisitionOfSubsidiary>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000610"
      unitRef="USD">4</CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000611"
      unitRef="USD">759138</CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-12-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact000613"
      unitRef="USD">759142</CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000615"
      unitRef="USD">759142</CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2025-01-012025-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000629"
      unitRef="USD">10012</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2025-01-012025-12-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact000630"
      unitRef="USD">10012</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2025-01-012025-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000631"
      unitRef="USD">3464218</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000632"
      unitRef="USD">3474230</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <CYCU:StockIssuedDuringPeriodValueConversionOfConvertibleDebt
      contextRef="From2025-01-012025-12-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000647"
      unitRef="USD">3133</CYCU:StockIssuedDuringPeriodValueConversionOfConvertibleDebt>
    <CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockInExchangeOfConvertibleNotesAndPromissoryNotes
      contextRef="From2025-01-012025-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000641"
      unitRef="USD">4183891</CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockInExchangeOfConvertibleNotesAndPromissoryNotes>
    <CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockInExchangeOfConvertibleNotesAndPromissoryNotes
      contextRef="From2025-01-012025-12-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact000643"
      unitRef="USD">4183891</CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockInExchangeOfConvertibleNotesAndPromissoryNotes>
    <CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockInExchangeOfConvertibleNotesAndPromissoryNotes
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000645"
      unitRef="USD">4183891</CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockInExchangeOfConvertibleNotesAndPromissoryNotes>
    <CYCU:StockIssuedDuringPeriodValuePrivatePlacementWarrantsIssued
      contextRef="From2025-01-012025-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000656"
      unitRef="USD">4779962</CYCU:StockIssuedDuringPeriodValuePrivatePlacementWarrantsIssued>
    <CYCU:StockIssuedDuringPeriodValuePrivatePlacementWarrantsIssued
      contextRef="From2025-01-012025-12-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact000658"
      unitRef="USD">4779962</CYCU:StockIssuedDuringPeriodValuePrivatePlacementWarrantsIssued>
    <CYCU:StockIssuedDuringPeriodValuePrivatePlacementWarrantsIssued
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000660"
      unitRef="USD">4779962</CYCU:StockIssuedDuringPeriodValuePrivatePlacementWarrantsIssued>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2025-01-012025-12-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000675"
      unitRef="Shares">-2900</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000677"
      unitRef="Shares">664068</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000668"
      unitRef="USD">66</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2025-01-012025-12-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact000671"
      unitRef="USD">66</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000673"
      unitRef="USD">66</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2025-01-012025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000692"
      unitRef="Shares">-106816</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockForCommonStock
      contextRef="From2025-01-012025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000679"
      unitRef="USD">-11</CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockForCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000694"
      unitRef="Shares">162980</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockForCommonStock
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000685"
      unitRef="USD">16</CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockForCommonStock>
    <CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockForCommonStock
      contextRef="From2025-01-012025-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000686"
      unitRef="USD">390050</CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockForCommonStock>
    <CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockForCommonStock
      contextRef="From2025-01-012025-12-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact000688"
      unitRef="USD">390055</CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockForCommonStock>
    <CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockForCommonStock
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000690"
      unitRef="USD">390055</CYCU:StockIssuedDuringPeriodValueConvertiblePreferredStockForCommonStock>
    <CYCU:StockIssuedDuringPeriodSharesCommonStockIssuedForEquityLine
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000709"
      unitRef="Shares">1120000</CYCU:StockIssuedDuringPeriodSharesCommonStockIssuedForEquityLine>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEquityLine
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000702"
      unitRef="USD">113</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEquityLine>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEquityLine
      contextRef="From2025-01-012025-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000703"
      unitRef="USD">6983688</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEquityLine>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEquityLine
      contextRef="From2025-01-012025-12-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact000705"
      unitRef="USD">6983688</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEquityLine>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEquityLine
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000707"
      unitRef="USD">6983688</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEquityLine>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000726"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000728"
      unitRef="Shares">4851</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000730"
      unitRef="Shares">150000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000714"
      unitRef="USD">15</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000732"
      unitRef="Shares">51</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000734"
      unitRef="Shares">143</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000717"
      unitRef="USD">364</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000718"
      unitRef="USD">46979762</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000719"
      unitRef="USD">-26879081</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact000720"
      unitRef="USD">20101060</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000721"
      unitRef="USD">-3857594</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000722"
      unitRef="USD">16243466</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000744"
      unitRef="Shares">2000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000746"
      unitRef="Shares">282139</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000737"
      unitRef="USD">27</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000738"
      unitRef="USD">9679046</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000739"
      unitRef="USD">-4432962</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000740"
      unitRef="USD">5246111</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000756"
      unitRef="Shares">2000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000758"
      unitRef="Shares">282139</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000749"
      unitRef="USD">27</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000750"
      unitRef="USD">9679046</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000751"
      unitRef="USD">-4432962</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000752"
      unitRef="USD">5246111</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000762"
      unitRef="USD">10000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000764"
      unitRef="USD">10000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <CYCU:SeriesBPreferredStockAndWarrantsIssuedShares
      contextRef="From2024-01-012024-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000772"
      unitRef="Shares">1000</CYCU:SeriesBPreferredStockAndWarrantsIssuedShares>
    <CYCU:SeriesBPreferredStockAndWarrantsIssued
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000768"
      unitRef="USD">1000000</CYCU:SeriesBPreferredStockAndWarrantsIssued>
    <CYCU:SeriesBPreferredStockAndWarrantsIssued
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000770"
      unitRef="USD">1000000</CYCU:SeriesBPreferredStockAndWarrantsIssued>
    <us-gaap:ProfitLoss
      contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000777"
      unitRef="USD">1229601</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000778"
      unitRef="USD">1229601</us-gaap:ProfitLoss>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionsNetOfAdjustments
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000781"
      unitRef="USD">11</CYCU:StockIssuedDuringPeriodValueAcquisitionsNetOfAdjustments>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionsNetOfAdjustments
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000782"
      unitRef="USD">-4017965</CYCU:StockIssuedDuringPeriodValueAcquisitionsNetOfAdjustments>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionsNetOfAdjustments
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000784"
      unitRef="USD">-4017954</CYCU:StockIssuedDuringPeriodValueAcquisitionsNetOfAdjustments>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000792"
      unitRef="Shares">5796</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000794"
      unitRef="Shares">3000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000796"
      unitRef="Shares">391373</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000787"
      unitRef="USD">38</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000788"
      unitRef="USD">6671081</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000789"
      unitRef="USD">-3203361</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000790"
      unitRef="USD">3467758</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000804"
      unitRef="Shares">5796</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000806"
      unitRef="Shares">3000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000808"
      unitRef="Shares">391373</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000799"
      unitRef="USD">38</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000800"
      unitRef="USD">6671081</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000801"
      unitRef="USD">-3203361</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000802"
      unitRef="USD">3467758</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000813"
      unitRef="USD">-24059084</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000814"
      unitRef="USD">1229601</us-gaap:ProfitLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000819"
      unitRef="USD">3898867</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000820"
      unitRef="USD">10000</us-gaap:ShareBasedCompensation>
    <CYCU:ShareBasedPaymentArrangementBusinessCombinationRelatedNoncashExpense
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000822"
      unitRef="USD">9521734</CYCU:ShareBasedPaymentArrangementBusinessCombinationRelatedNoncashExpense>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000825"
      unitRef="USD">242095</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000826"
      unitRef="USD">6566</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:Depreciation
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000828"
      unitRef="USD">20321</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000829"
      unitRef="USD">13341</us-gaap:Depreciation>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000831"
      unitRef="USD">25000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000832"
      unitRef="USD">16667</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000834"
      unitRef="USD">1221635</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000837"
      unitRef="USD">100000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000843"
      unitRef="USD">-363405</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000844"
      unitRef="USD">3492651</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000846"
      unitRef="USD">-39330</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000847"
      unitRef="USD">43448</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000849"
      unitRef="USD">-836585</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000850"
      unitRef="USD">562946</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000852"
      unitRef="USD">-59859</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000853"
      unitRef="USD">345908</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000855"
      unitRef="USD">-119946</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000856"
      unitRef="USD">-20211</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000858"
      unitRef="USD">-12086357</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000859"
      unitRef="USD">-1371281</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000864"
      unitRef="USD">34983</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000865"
      unitRef="USD">2048</us-gaap:CashAcquiredFromAcquisition>
    <CYCU:PaymentsForPromissoryNotes
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000868"
      unitRef="USD">439114</CYCU:PaymentsForPromissoryNotes>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000870"
      unitRef="USD">455000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000871"
      unitRef="USD">448000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <CYCU:CashWithdrawnFromTrustAccountInConnectionWithRedemption
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000873"
      unitRef="USD">1001216</CYCU:CashWithdrawnFromTrustAccountInConnectionWithRedemption>
    <CYCU:ReleaseOfTrustAccountToCompanysBankAccount
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000876"
      unitRef="USD">833324</CYCU:ReleaseOfTrustAccountToCompanysBankAccount>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000879"
      unitRef="USD">1414523</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000880"
      unitRef="USD">-885066</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000885"
      unitRef="USD">3664871</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000888"
      unitRef="USD">1001216</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000891"
      unitRef="USD">4780021</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000892"
      unitRef="USD">1000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000894"
      unitRef="USD">6983688</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000898"
      unitRef="USD">252314</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000900"
      unitRef="USD">315671</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromBankDebt
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000904"
      unitRef="USD">31954</us-gaap:ProceedsFromBankDebt>
    <us-gaap:RepaymentsOfBankDebt
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000906"
      unitRef="USD">775192</us-gaap:RepaymentsOfBankDebt>
    <CYCU:RepaymentOfLoansPayable
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000909"
      unitRef="USD">210843</CYCU:RepaymentOfLoansPayable>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000912"
      unitRef="USD">2376500</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2025-01-012025-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000915"
      unitRef="USD">513200</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2024-01-012024-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000916"
      unitRef="USD">390000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2024-01-012024-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000919"
      unitRef="USD">15000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2024-01-012024-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000922"
      unitRef="USD">15000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2025-01-012025-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000924"
      unitRef="USD">27500</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2025-01-012025-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000927"
      unitRef="USD">101579</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000930"
      unitRef="USD">15886279</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000931"
      unitRef="USD">1689268</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000933"
      unitRef="USD">5214445</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000934"
      unitRef="USD">-567079</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000936"
      unitRef="USD">40790</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000937"
      unitRef="USD">607869</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000939"
      unitRef="USD">5255235</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000940"
      unitRef="USD">40790</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2025-01-012025-12-31" id="Fact000942">&lt;p id="xdx_80C_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zhm1dgv0gbX4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82F_zRvFCaF2ZNxl"&gt;ORGANIZATION
                                            AND DESCRIPTION OF BUSINESS&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cycurion,
Inc. (f/k/a KAE Holdings, Inc.; f/k/a Cyber Secure Solutions, Inc.)(the &#x201c;Company&#x201d;, &#x201c;Cycurion&#x201d;, &#x201c;we&#x201d;,
&#x201c;us&#x201d; or &#x201c;our&#x201d;) was incorporated on &lt;span id="xdx_90E_edei--EntityIncorporationDateOfIncorporation_dd_c20250101__20251231_zE7hoSHn34l5"&gt;October 12, 2017&lt;/span&gt;, in the state of Delaware. Through its subsidiaries, the
Company provides premier information technology security solutions. The Company continually strives to deliver top-notch services in
the areas of risk management, cybersecurity, information assurance, systems engineering and help desk solutions. The Company is headquartered
in McLean, Virginia. On July 14, 2020, the Company changed its corporate name from KAE Holdings, Inc. to Cyber Secure Solutions, Inc.,
and, on February 24, 2021, to Cycurion, Inc.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has &lt;span id="xdx_906_ecustom--NumberOfWhollyOwnedSubsidiariesFirstTier_dc_uPure_c20250101__20251231_zVwqhZyHcY46" title="Number of first tier wholly owned subsidiaries"&gt;two&lt;/span&gt; first-tier wholly-owned subsidiaries, Cycurion Sub, Inc. (formerly Cycurion, Inc., until February 14, 2025) and Cycurion
Crypto Inc., a Delaware corporation formed in July 2025, and &lt;span id="xdx_903_ecustom--NumberOfWhollyOwnedSubsidiariesSecondTier_dc_uPure_c20250101__20251231_zMDYlT9PpeZk" title="Number of second tier wholly owned subsidiaries"&gt;three&lt;/span&gt; indirectly wholly-owned second-tier subsidiaries: (i) Axxum Technologies
LLC (&#x201c;Axxum&#x201d;), a Virginia limited liability company formed in December 2006, (ii) Cloudburst Security LLC (&#x201c;Cloudburst&#x201d;),
a Virginia limited liability company formed in January 2007, and (iii) Cycurion Innovation, Inc., a Delaware corporation formed in September
2021 (&#x201c;Cycurion Innovation&#x201d;), in connection with our acquisition of assets from Sabres Security Ltd. (&#x201c;Sabres&#x201d;),
a leading Israeli-based cybersecurity provider.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Business
Combination&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 14, 2025, the Company completed the business combination and transactions (the &#x201c;Business Combination&#x201d;) as set forth
in an Agreement and Plan of Merger, dated November 21, 2022, as amended on April 26, 2024, December 31, 2024 and February 13, 2025 (the
&#x201c;Merger Agreement&#x201d;), by and among Western Acquisition Ventures Corp. (&#x201c;Western&#x201d;), Western Acquisition Merger
Inc., a Delaware corporation and a wholly-owned subsidiary of Western (&#x201c;Merger Sub&#x201d;), and Cycurion Sub, Inc., a Delaware
corporation formerly known as Cycurion, Inc. (&#x201c;Cycurion Sub&#x201d;). As contemplated by the Merger Agreement, Merger Sub merged
with and into Cycurion Sub with Cycurion Sub as surviving the merger as a wholly-owned subsidiary of Western. In addition, in connection
with the consummation of the Business Combination, Western was renamed &#x201c;Cycurion, Inc.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
a result of the Business Combination, each common share of Cycurion Sub was cancelled and converted into shares of Company Common Stock,
on the terms set forth in the Merger Agreement. Pursuant to the terms of the Merger Agreement, the aggregate number of shares of Company
Common Stock that was delivered as consideration in the Business Combination was capped at &lt;span id="xdx_902_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember_zwitd6C91Qzd" title="Number of preferred stock converted (in shares)"&gt;500,000&lt;/span&gt; shares. Concurrently with the completion
of the Business Combination, the Company issued an aggregate of &lt;span id="xdx_90E_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhtvxZQOWdgd" title="Number of preferred stock converted (in shares)"&gt;218,102&lt;/span&gt; shares of Common Stock, &lt;span id="xdx_90A_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zcyXm5ZKequ8" title="Number of preferred stock converted (in shares)"&gt;106,816&lt;/span&gt; shares of Series A convertible
preferred stock (&#x201c;Series A Convertible Preferred Stock&#x201d;), &lt;span id="xdx_90A_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zMD0GkQrKBU1" title="Number of preferred stock converted (in shares)"&gt;3,000&lt;/span&gt; shares of Series B convertible preferred stock (&#x201c;Series
B Convertible Preferred Stock&#x201d;), &lt;span id="xdx_90F_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zYwngI1hQFL8" title="Number of preferred stock converted (in shares)"&gt;4,851&lt;/span&gt; shares of Series C convertible preferred stock (&#x201c;Series C Convertible Preferred Stock&#x201d;),
&lt;span id="xdx_909_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zPxvk7Sy82Eb" title="Number of preferred stock converted (in shares)"&gt;6,666,666&lt;/span&gt; shares of Series D convertible preferred stock (&#x201c;Series D Convertible Preferred Stock&#x201d;), &lt;span id="xdx_90A_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_z58LS3Q35KUi" title="Number of preferred stock converted (in shares)"&gt;22,696&lt;/span&gt; Series A warrants,
&lt;span id="xdx_908_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zFU2Ezx5Ru4d" title="Number of preferred stock converted (in shares)"&gt;200,000&lt;/span&gt; Series B warrants, &lt;span id="xdx_90A_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDWarrantsMember_zLAQJgVGPowh" title="Number of preferred stock converted (in shares)"&gt;242,424&lt;/span&gt; Series D warrants , &lt;span id="xdx_90F_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockWarrantMember_zxpR5gKlyNA7" title="Number of preferred stock converted (in shares)"&gt;9,006&lt;/span&gt; Common Stock warrants, &lt;span id="xdx_906_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDPrivatePlacementMember_zbXAi8sDZqd4" title="Number of preferred stock converted (in shares)"&gt;15,760&lt;/span&gt; shares of Common Stock issued in connection
with the Series D private placement, &lt;span id="xdx_90A_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--AllianceGlobalPartnersMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5sSOCOMvEdk" title="Number of preferred stock converted (in shares)"&gt;16,667&lt;/span&gt; shares of Common Stock issued to A.G.P./Alliance Global Partners (&#x201c;A.G.P.&#x201d;),
&lt;span id="xdx_900_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--SewardAndKisselLLPMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z6eH6GJ03by8" title="Number of preferred stock converted (in shares)"&gt;8,333&lt;/span&gt; shares of Common Stock issued to Seward &amp;amp; Kissel LLP and &lt;span id="xdx_900_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--BakerAndHostetlerLLPMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFP1KfJ6DsO9" title="Number of preferred stock converted (in shares)"&gt;2,627&lt;/span&gt; shares of Common Stock issued to Baker &amp;amp; Hostetler LLP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Business Combination has been accounted for as a reverse recapitalization in accordance with accounting principles generally accepted
in the United States of America (&#x201c;U.S. GAAP&#x201d;) because Cycurion is the operating company and has been determined to be the
accounting acquirer under Financial Accounting Standards Board&#x2019;s Accounting Standards Codification Topic 805, Business Combinations
(&#x201c;ASC 805&#x201d;), while Western is a blank check company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the reverse recapitalization model, the Business Combination was treated as Cycurion issuing equity for the net assets of Western, with
no goodwill or intangible assets recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;While
Western was the legal acquirer in the Business Combination, because Cycurion Sub, prior to the Business Combination, was deemed the accounting
acquirer, the historical financial statements of Cycurion Sub became the historical financial statements of the combined company upon
the consummation of the Business Combination. As a result, the financial statements reflect (i) the historical operating results of Cycurion
Sub prior to the Business Combination; (ii) the combined results of Western and Cycurion Sub following the closing of the Business Combination;
(iii) the assets and liabilities of Cycurion Sub at their historical cost; and (iv) Cycurion&#x2019;s equity structure for all periods
presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with the applicable guidance, the equity structure has been retroactively restated in all comparative periods up to the closing
date, of the Business Combination to reflect the number of shares of the Company&#x2019;s Common Stock issued to Cycurion Sub Common Stockholders
in connection with the Business Combination. As such, the shares and corresponding capital amounts and earnings per share related to
Cycurion Sub prior to the Business Combination have been retroactively restated as shares reflecting the exchange ratio established in
the Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Going
Concern&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying financial statements have been prepared in conformity with U.S. GAAP, which contemplates continuation of the Company on
a going concern basis. The going concern basis assumes that assets are realized, and liabilities are settled in the ordinary course of
business at amounts disclosed in the financial statements. As of December 31, 2025, there was substantial doubt regarding the Company&#x2019;s
ability to continue as a going concern, as the Company had a net working capital deficit and an accumulated deficit resulting from substantial
losses incurred during the year ended December 31, 2025 and from prior periods. The Company&#x2019;s ability to continue as a going concern
depends upon its ability to market and sell its products to generate positive operating cash flows. As of December 31, 2025, the Company
had an accumulated deficit of $&lt;span id="xdx_90C_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn5n6_di_c20251231_zgUT7yKhAIab" title="Accumulated deficit"&gt;26.9&lt;/span&gt; million and a working capital deficit of $&lt;span id="xdx_90D_ecustom--WorkingCapitalDeficit_iI_pn5n6_c20251231_zvbBpzEMhXN9" title="Working capital deficit"&gt;8.9&lt;/span&gt; million. In addition, the Company had a net cash outflow
of $&lt;span id="xdx_900_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn5n6_di_c20250101__20251231_ztkxcv7s9UFd" title="Net cash used in operating activities"&gt;12.1&lt;/span&gt; million from operating activities during the year ended December 31, 2025. These circumstances continued to give rise to substantial
doubt as to whether the Company will be able to continue as a going concern and did not alleviate the doubt outstanding from 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management&#x2019;s
plan is to continue improving operations to generate positive cash flows and register shares of its Common Stock in order to undertake
a public offering to raise additional capital. Management believes that the valuation and liquidity brought by a public offering of its
securities will allow holders of convertibles notes, and convertible preferred stockholders the mechanism to convert their securities
into Common Stock that will reduce the Company&#x2019;s overall leverage and debt service requirement. If the Company is not able to continue
generating positive operating cash flows, and raise additional capital, there is the risk that the Company may become insolvent.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Emerging
Growth Company&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an emerging growth company as defined in Section 102(b)(1) of the Jumpstart Our Business Start-ups Act of 2012 (the &#x201c;JOBS
Act&#x201d;) which exempts emerging growth companies from being required to comply with new or revised financial accounting standards
until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a
class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards.
The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies, but any such an election to opt out is irrevocable. The Company has elected not to opt out
of such extended transition period, which means that when a standard is issued or revised, and it has different application dates for
public or private companies. The Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;This
may make comparison of the Company&#x2019;s financial statements with another public company that is neither an emerging growth company
nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential
differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Nasdaq
Communications&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 21, 2025, the Company announced that we received formal notification on August 19, 2025 and August 20, 2025 from the Nasdaq Stock
Market (&#x201c;Nasdaq&#x201d;) regarding its previous deficiencies. On August 19, 2025, Nasdaq determined that we comply with Nasdaq Listing
Rule 5450(b)(1)(A), which requires a minimum of $&lt;span id="xdx_90D_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iI_c20250819__srt--RangeAxis__srt--MinimumMember_zYwdiw4p02Ba" title="Stockholders' equity"&gt;10,000,000&lt;/span&gt; in stockholders&#x2019; equity (&#x201c;Equity Rule&#x201d;), based on our Form
10-Q for the period ended June 30, 2025, evidencing stockholders&#x2019; equity of $&lt;span id="xdx_907_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iI_c20250630_ztea1eKF0y5c" title="Stockholders' equity"&gt;10,448,853&lt;/span&gt;. Reference is made to the April 11, 2025
notification for failure to maintain a minimum market value of listed securities of $&lt;span id="xdx_905_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iI_c20250411_zAq3mo4AwN75" title="Stockholders' equity"&gt;50,000,000&lt;/span&gt; over the previous 30 consecutive business
days as set forth in Listing Rule 5450(b)(2)(A) (&#x201c;MVLS Rule&#x201d;). As we are in compliance with the Equity Rule, Nasdaq notified
us that the matter regarding the MVLS Rule is now closed. Additionally, on August 20, 2025, we received formal notification from Nasdaq,
determining that for the last 10 consecutive business days, from August 5, 2025 to August 18, 2025, our market value of publicly held
shares (&#x201c;MVPHS&#x201d;) has been $&lt;span id="xdx_906_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iI_c20250818_zeH4r2eFMKSb" title="Stockholders' equity"&gt;5,000,000&lt;/span&gt; or greater set forth in Nasdaq Listing Rule 5450(b)(1)(C) (&#x201c;MVPHS Rule&#x201d;),
and that we have regained compliance with the MVPHS Rule.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 14, 2025, we received written notice from the staff of Nasdaq Listing Qualifications (the &#x201c;Staff&#x201d;) that it has determined
to commence proceedings to delist our Common Stock from the Nasdaq Global Market. As previously announced in a Current Report filed with
the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;), on April 15, 2025, the Staff notified the Company on April 9, 2025
that, for the prior 30 consecutive business days, the closing bid price of our Common Stock had been below the minimum of $1.00 per share
required for continued listing on The Nasdaq Global Market under Nasdaq Listing Rule 5550(a)(2) (the &#x201c;Bid Price Rule&#x201d;). The
notification letter stated that we would be afforded 180 calendar days, or until October 6, 2025, to regain compliance. The Company did
not regain compliance with the Bid Price Rule by October 6, 2025, and the listed security was subject to delisting from The Nasdaq Global
Market.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 20, 2025, the Company submitted its request to the Nasdaq Global Market to appeal the Staff&#x2019;s determination to a Hearings
Panel (the &#x201c;Panel&#x201d;) pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series, which stayed the suspension
of the Company&#x2019;s securities and the filing of a Form 25-NSE with the SEC that would remove the Company&#x2019;s shares of Common
Stock from listing and registration on The Nasdaq Stock Market. The Company&#x2019;s hearing was scheduled for November 20, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 11, 2025, the Company announced that it received a letter Nasdaq stating that Nasdaq has determined that the Company has regained
compliance with Nasdaq&#x2019;s Bid Price Rule requirement under Listing Rule 5450(a)(1). The Company is now in compliance with Nasdaq
Global Market&#x2019;s listing requirements. Additionally, Nasdaq confirmed that the previously scheduled hearing before the Panel on
November 20, 2025 has been canceled. The Company&#x2019;s securities will continue to be listed and traded on The Nasdaq Stock Market
without interruption and no further communication from Nasdaq has been received as of the date of this filing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Reverse
Stock Split&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 27, 2025, the Company announced a one-for-thirty reverse stock split of the Company&#x2019;s shares of Common Stock, par value
$&lt;span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20251027_zN5mEKhNwSk5" title="Common stock, par value per share (in dollars per share)"&gt;0.0001&lt;/span&gt; per share (the &#x201c;Reverse Stock Split&#x201d;) that took effect with the commencement of business on October 27, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company effected the Reverse Stock Split by filing the Second Amendment to the Second Amended and Restated Certificate of Incorporation
with the Secretary of State of the State of Delaware. The Company&#x2019;s shares of Common Stock began trading on a split-adjusted basis
on The Nasdaq Global Market, when the market opened on October 27, 2025, under the existing trading symbol &#x201c;CYCU&#x201d; and new
CUSIP number 95758L305.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
a result of the Reverse Stock Split, every thirty of the Company&#x2019;s issued shares of Common Stock was combined into one issued share
of Common Stock, without any change to the par value per share and without any change in the total number of authorized shares of Common
Stock. The number of outstanding shares of Common Stock was reduced from approximately &lt;span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20251026_zC034kost3Nj" title="Common stock, outstanding (in shares)"&gt;86,533,435&lt;/span&gt; shares to approximately &lt;span id="xdx_907_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20251027_zsyYNLJN3Qt6" title="Common stock, outstanding (in shares)"&gt;2,884,447&lt;/span&gt; shares.
All disclosures affected in this prospectus, including share counts and warrant counts have been retroactively adjusted to give effect
to the Reverse Stock Split.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;No
fractional shares were issued in connection with the Reverse Stock Split. Stockholders who otherwise held a fraction of a share of Common
Stock of the Company will receive a cash payment (without interest and subject to withholding taxes, as applicable) in lieu thereof at
a price equal to that fraction of a share to which the stockholder would otherwise be entitled, multiplied by the closing price of the
Company&#x2019;s shares on The Nasdaq Global Market on the trading day immediately preceding the effective date of the Reverse Stock Split.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Restricted
Cash&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with the trust agreement between Western and Equiniti Trust Company, LLC, dated January 11, 2022, the Company is permitted
to withdraw interest from the trust account (the &#x201c;Trust Account&#x201d;) to pay its tax obligations, including federal income taxes
and state franchise taxes. The balance of this withdrawal would be presented in restricted cash, but as of December 31, 2025 there are
&lt;span id="xdx_908_eus-gaap--RestrictedCash_iI_do_c20251231_ztCxQDNpKTN1" title="Restricted cash"&gt;no&lt;/span&gt; amounts in restricted cash.&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <dei:EntityIncorporationDateOfIncorporation contextRef="From2025-01-012025-12-31" id="Fact000943">2017-10-12</dei:EntityIncorporationDateOfIncorporation>
    <CYCU:NumberOfWhollyOwnedSubsidiariesFirstTier
      contextRef="From2025-01-012025-12-31"
      decimals="INF"
      id="Fact000945"
      unitRef="Pure">2</CYCU:NumberOfWhollyOwnedSubsidiariesFirstTier>
    <CYCU:NumberOfWhollyOwnedSubsidiariesSecondTier
      contextRef="From2025-01-012025-12-31"
      decimals="INF"
      id="Fact000947"
      unitRef="Pure">3</CYCU:NumberOfWhollyOwnedSubsidiariesSecondTier>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember"
      decimals="INF"
      id="Fact000949"
      unitRef="Shares">500000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000951"
      unitRef="Shares">218102</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact000953"
      unitRef="Shares">106816</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact000955"
      unitRef="Shares">3000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact000957"
      unitRef="Shares">4851</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact000959"
      unitRef="Shares">6666666</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_custom_SeriesAWarrantsMember"
      decimals="INF"
      id="Fact000961"
      unitRef="Shares">22696</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_custom_SeriesBWarrantsMember"
      decimals="INF"
      id="Fact000963"
      unitRef="Shares">200000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_custom_SeriesDWarrantsMember"
      decimals="INF"
      id="Fact000965"
      unitRef="Shares">242424</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_custom_CommonStockWarrantMember"
      decimals="INF"
      id="Fact000967"
      unitRef="Shares">9006</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_custom_SeriesDPrivatePlacementMember"
      decimals="INF"
      id="Fact000969"
      unitRef="Shares">15760</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_AllianceGlobalPartnersMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000971"
      unitRef="Shares">16667</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_SewardAndKisselLLPMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000973"
      unitRef="Shares">8333</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_BakerAndHostetlerLLPMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000975"
      unitRef="Shares">2627</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2025-12-31"
      decimals="-5"
      id="Fact000977"
      unitRef="USD">-26900000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <CYCU:WorkingCapitalDeficit
      contextRef="AsOf2025-12-31"
      decimals="-5"
      id="Fact000979"
      unitRef="USD">8900000</CYCU:WorkingCapitalDeficit>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2025-01-012025-12-31"
      decimals="-5"
      id="Fact000981"
      unitRef="USD">-12100000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-08-19_srt_MinimumMember"
      decimals="0"
      id="Fact000983"
      unitRef="USD">10000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000985"
      unitRef="USD">10448853</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-04-11"
      decimals="0"
      id="Fact000987"
      unitRef="USD">50000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-08-18"
      decimals="0"
      id="Fact000989"
      unitRef="USD">5000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-10-27"
      decimals="INF"
      id="Fact000991"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-10-26"
      decimals="INF"
      id="Fact000993"
      unitRef="Shares">86533435</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-10-27"
      decimals="INF"
      id="Fact000995"
      unitRef="Shares">2884447</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:RestrictedCash
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000997"
      unitRef="USD">0</us-gaap:RestrictedCash>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2025-01-012025-12-31" id="Fact000999">&lt;p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_z2QI6jNqSid4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_826_zobsRNWO1FRk"&gt;SIGNIFICANT
                                            ACCOUNTING POLICIES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_ecustom--BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_zybCv7bicGyh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zX7XpuIngxqj"&gt;Basis
of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements have been prepared in accordance with U.S. GAAP, and the rules and regulations of the
SEC.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
financial statements include the accounts of Cycurion, Inc. (f/k/a KAE Holdings, Inc.; f/k/a Cyber Secure Solutions, Inc.) and its wholly
owned subsidiaries: Cycurion Sub, Inc., Axxum Technologies LLC (&#x201c;Axxum&#x201d;), Cloudburst Security LLC (&#x201c;Cloudburst&#x201d;),
and Cycurion Innovation, Inc. The consolidated financial statements also include the accounts of SLG Innovation Inc. (&#x201c;SLG&#x201d;)
as a result of the master service agreement entered into between the Cycurion and SLG. The Company has determined that the SLG master
service agreement constitutes a business combination as defined by ASC 805, Business Combinations (&#x201c;ASC 805&#x201d;). ASC 805 establishes
principles and requirements as to how the acquirer of a business recognizes and measures in its financial statements the identifiable
assets acquired, the liabilities assumed and any non-controlling interest in the acquiree. The assets acquired and liabilities assumed
were recognized provisionally in the accompanying consolidated balance sheets at their estimated fair values as of March 31, 2025, and
adjusted within a one year period, as required.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 14, 2025, the Company completed its Business Combination with Western a special purpose acquisition company, whereby Western
merged with and into the Company, with the Company surviving the merger. The Business Combination was accounted for as a reverse recapitalization
in accordance with U.S. GAAP, with Cycurion Sub, Inc. treated as the accounting acquirer. Accordingly, the consolidated financial statements
for periods prior to the Business Combination reflect the historical results of Cycurion Sub, Inc., and the equity structure has been
retroactively recast to reflect the number of shares of the Company&#x2019;s Common Stock issued in connection with the Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
fiscal year ends on December 31 and unless otherwise noted, references to fiscal year or fiscal years are for fiscal years ended December
31. The accompanying consolidated financial statements present our financial position as of December 31, 2025, and 2024 and our results
of operations for fiscal years 2025 and 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
significant intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zXMgkIQ6xrB8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_zj7WY8lLAw26"&gt;Reclassifications&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
amounts have been reclassified to improve the clarity and comparability of the financial statements. These reclassifications had no impact
on previously reported total assets, liabilities, equity, net (loss)/income, or cash flows for any periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--ConsolidationVariableInterestEntityPolicy_zezsAxKhhjHf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_z5EYPpJ73nIe"&gt;Variable
Interest Entities&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluates its relationships with other entities to identify whether they are Variable Interest Entities (&#x201c;VIEs&#x201d; or
&#x201c;VIE&#x201d;) and, if so, whether the Company is the primary beneficiary. A VIE is generally an entity that either (a) has an insufficient
amount of equity at risk to finance its activities without additional subordinated financial support, (b) has equity investors who lack
the characteristics of a controlling financial interest, or (c) is structured with non-substantive voting rights. The Company consolidates
VIEs for which it is the primary beneficiary, meaning it has both the power to direct the activities that most significantly impact the
VIEs economic performance and the obligation to absorb losses or the right to receive benefits that could potentially be significant
to the VIE.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025, SLG Innovation, Inc. is consolidated as a VIE. The Company reassesses VIE determinations on an ongoing basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--UseOfEstimates_zEdFTfkEsLpf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zFOHCCDfXEMe"&gt;Use
of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Preparing
consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of revenue, expenses, assets and liabilities, and disclosure of contingent assets and liabilities. The Company regularly
assesses these estimates; however, actual results could differ from those estimates. We base our estimates on historical experience,
currently available information, and various other assumptions that we believe are reasonable under the circumstances.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
evaluates these estimates and assumptions on an ongoing basis, including those relating to revenue recognition on cost estimation on
certain contracts, allowance for credit losses, certain assumptions related to share-based compensation, valuation and impairment of
intangible assets and goodwill, and contingencies. Actual results could differ from those estimates. The impact of changes in estimates
is recorded in the period in which they become known.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--RevenueRecognitionPolicyTextBlock_zwp7puZSc8El" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zjtlLIlGrt8g"&gt;Revenue
Recognition&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;). The Company
accounts for a contract with a customer that is within the scope of this topic only when the five steps of revenue recognition under
ASC 606 are met.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
five core principles will be evaluated for each service provided by the Company and is further supported by applicable guidance in ASC
606 to support the Company&#x2019;s recognition of revenue. Revenue is derived primarily from services provided to the federal government
or state and local governments. The Company enters into agreements with customers that create enforceable rights and obligations and
for which it is probable that the Company will collect the consideration to which it will be entitled as services and solutions are transferred
to the customer. The Company also evaluates whether two or more agreements should be accounted for as one single contract.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
determining the total transaction price, the Company identifies both fixed and variable consideration elements within the contract. The
Company estimates variable consideration as the most likely amount to which the Company expects to be entitled limited to the extent
that it is probable that a significant reversal will not occur in a subsequent period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
contract inception, the Company determines whether the goods or services to be provided are to be accounted for as a single performance
obligation or as multiple performance obligations. For most contracts, the customers require the Company to perform several tasks in
providing an integrated output and, hence, each of these contracts are deemed as having only one performance obligation. When contracts
are separated into multiple performance obligations, the Company allocates the total transaction price to each performance obligation
based on the estimated relative standalone selling prices of the promised services underlying each performance obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;This
evaluation requires professional judgment, and it may impact the timing and pattern of revenue recognition. If multiple performance obligations
are identified, the Company generally uses the cost plus a margin approach to determine the relative standalone selling price of each
performance obligation. The Company does not assess whether a contract contains a significant financing component if the Company expects,
at contract inception, that the period between when payment by the client and the transfer of promised services to the client occur will
be less than one year. The Company currently generates its revenue from two different types of contractual arrangements: firm-fixed-price
contracts (&#x201c;FFP&#x201d;) and time-and-materials (&#x201c;T&amp;amp;M&#x201d;) contracts. The Company generally recognizes revenue over
time as control is transferred to the customer, based on the extent of progress towards satisfaction of the performance obligation. The
selection of the method used to measure progress requires judgment and is dependent on the contract type and the nature of the goods
or services to be provided. Revenue from FFP contracts is generally recognized ratably over the contract term, using a time-based measure
of progress, even if billing is based on other metrics or milestones, including specific deliverables. For T&amp;amp;M contracts, the Company
uses input progress measures to estimate revenue earned based on hours worked on contract performance at negotiated billing rates, plus
direct costs and indirect cost burdens associated with materials and the direct expenses incurred in performance of the contract.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
arrangements generally qualify for the &#x201c;right-to-invoice&#x201d; practical expedient where revenue is recognized in proportion to
billable consideration.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
generated from the Company&#x2019;s FFP contracts is recognized over time as performance obligations are satisfied, based on the transfer
of control to the customer. Revenue is generally recognized using an input method based on labor hours or costs incurred relative to
total estimated costs. Most contracts do not include significant variable consideration, and contract modifications are generally minimal.
Accordingly, the Company&#x2019;s election of available transition practical expedients did not have a material impact on revenue recognition.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
generated from contracts with federal, state, and local governments is primarily recognized over time. Under T&amp;amp;M contracts, the Company
performs services as directed by the customer and generally bills semi-monthly based on labor hours expended. Certain government software
development contracts include defined deliverables and are structured as FFP arrangements, which are generally billed as performance
obligations are satisfied.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
recognition under FFP contracts requires judgment in allocating the transaction price to performance obligations and estimating total
expected costs. Contract terms may extend up to five years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Contract
accounting requires judgment relative to assessing risks and estimating contract revenue and costs and assumptions for schedule and technical
issues. Due to the size and nature of contracts, estimates of revenue and costs are subject to a number of variables. For contract change
orders, claims or similar items, judgment is required for estimating the amounts, assessing the potential for realization and determining
whether realization is probable. Estimates of total contract revenue and costs are continuously monitored during the term of the contract
and are subject to revision as the contract progresses. From time to time, facts develop that require revisions of revenue recognized
or cost estimates. To the extent that a revised estimate affects the current or an earlier period, the cumulative effect of the revision
is recognized in the period in which the facts requiring the revision become known. When estimates of total costs to be incurred on a
contract exceed total revenue, a provision for the entire loss on the contract is recorded in the period in which the loss is determined.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for contract costs in accordance with ASC Topic 340-40, Contracts with Customers. The Company recognizes the cost of
sales of a contract as expense when incurred or at the time a performance obligation is satisfied. The Company recognizes an asset from
the costs to fulfill a contract only if the costs relate directly to a contract, the costs generate or enhance resources that will be
used in satisfying a performance obligation in the future and the costs are expected to be recovered. The incremental costs of obtaining
a contract are capitalized unless the costs would have been incurred regardless of whether the contract was obtained.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_ziyXIxXhWxG8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86B_zVZtKDMfvxH4"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all highly liquid investments with an original maturity of three months or less at the date of acquisition to be cash
equivalents. Cash and cash equivalents are stated at cost, which approximates fair value. The Company&#x2019;s cash balances may, from
time to time, exceed insured limits of $&lt;span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_c20251231_zDqEasEuZDD" title="FDIC insured amount"&gt;250,000&lt;/span&gt; established by the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;). The Company
has not experienced any losses in such accounts and management believes the Company is not exposed to significant credit risk on its
cash balances.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zooo10UK6Kr7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_z50y4KyV8ic7"&gt;Accounts
Receivable and Allowance for Credit Losses&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
receivable includes the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Billed
Receivables:&lt;/span&gt; Billed receivables are balances where an invoice has been prepared and issued and is collectible under standard contract
terms. Where we anticipate that an invoice will be issued within a short period of time and where the funds are considered collectible
within standard contract terms, we include this balance as billed accounts receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Unbilled
Receivables:&lt;/span&gt; Unbilled receivables are balances that have not yet been billed due to timing, most commonly just a month delayed from
the timing of revenue recognition and the actual bill being presented to the customer. The Company has fulfilled all requirements in
order to bill the customer and collect the funds.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company maintains an allowance for credit losses on its accounts receivable, which includes both billed and unbilled receivables measured
at amortized cost. The allowance is a contra-asset account representing management&#x2019;s estimate of amounts not expected to be collected
over the life of the receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company estimates expected credit losses in accordance with ASC Topic 326, Financial Instruments &#x2014; Credit Losses, based on historical
loss experience, current conditions, and reasonable and supportable forecasts. Receivables are evaluated collectively, grouped by similar
risk characteristics, which for the Company primarily reflects the composition of its customer base. Substantially all of the Company&#x2019;s
revenue is derived from contracts with federal, state, and local government entities. Because government obligors generally possess the
legal authority and financial resources to satisfy contractual payment obligations, the Company has experienced minimal credit losses
on its accounts receivable. Qualitative adjustments are applied as necessary to reflect conditions that may differ from historical experience.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
allowance is reviewed and updated at each reporting date. When a specific receivable is determined to be uncollectible, it is written
off against the allowance. Recoveries of amounts previously written off are recognized when received.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zCk2nkrr0HE9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_865_zMVxo5gWPH0c"&gt;Concentrations&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents and
accounts receivable. The Company&#x2019;s customer base is concentrated among U.S. Federal Government agencies, state and local government
agencies and their prime contractors. The Company monitors the financial condition of its customers and the credit quality of its receivable
portfolio and does not require collateral from its customers. Customers representing 10% or more of revenue or accounts receivable are
disclosed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zdMPWaqBAdba" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86A_zj5oDIif1PEe"&gt;Property
and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are recorded at cost less accumulated depreciation and amortization. Depreciation is recorded over the assets&#x2019; estimated
useful lives using the straight-line method, which is three to five years for furniture and equipment. Leasehold improvements are amortized
over the shorter of their useful life or the remaining terms of the lease.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
sale or retirement of property and equipment, the costs and related accumulated depreciation and amortization are eliminated from the
accounts and any gain or loss on such disposition is reflected in the consolidated statements of operations and comprehensive (loss)/income..
Repairs and maintenance costs are expensed as incurred. Major renewals and improvements are capitalized and depreciated over their estimated
useful lives.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_ziGiNUCc833b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_865_zq8IYpkJm5E"&gt;Software
Development Costs&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
account for development costs of software in accordance with ASC Topic 985-20 (&#x201c;ASC 985-20&#x201d;), &#x201c;Software &#x2013; Costs
of Software to be Sold, Leased, or Marketed&#x201d; and ASC Topic 350-40 (&#x201c;ASC 350-40&#x201d;) &#x201c;Internal Use Software,&#x201d;
depending on the intended use of the software being developed. Under ASC 985-20, all costs of developing software prior to establishing
its technological feasibility are research and development costs and are expensed as incurred. Once technological feasibility has been
established, subsequent costs should be capitalized until the software begins to be marketed or is released to customers, after which
the capitalized costs should be amortized and reviewed for impairment. Under ASC 350-40, we capitalize certain software development costs
when the preliminary project stage is completed and the software has entered the application development stage. Once substantial testing
is complete and the software is ready to be used, capitalization of costs ceases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Capitalized
software development costs are amortized on a straight-line basis over the estimated economic life of the application, ranging from two
to five years, beginning when the asset is ready for its intended use.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zRaeQjorYrnb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_zoVDdxBC7Tw7"&gt;Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Goodwill
represents the excess of acquisition consideration over the fair value of net tangible and intangible assets acquired and liabilities
assumed. Goodwill is not amortized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company tests goodwill for impairment at the reporting unit level on an annual basis as of December 31, or more frequently if events
or changes in circumstances indicate that the carrying value of a reporting unit may exceed its fair value. Such circumstances may include,
but are not limited to, a significant adverse change in business climate, loss of key contracts or customers, or negative operating performance
trends.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company may elect to first perform a qualitative assessment to determine whether it is more likely than not that the fair value of a
reporting unit is less than its carrying value. If that threshold is met, or if the Company elects to bypass the qualitative assessment,
a quantitative impairment test is performed by comparing the estimated fair value of the reporting unit to its carrying value, including
goodwill. If the estimated fair value is less than the carrying value, an impairment loss is recognized for the difference, not to exceed
the carrying amount of goodwill assigned to the reporting unit. The Company uses a combination of income and market approaches to estimate
fair value, which involves the use of significant assumptions and judgments, including forecasted operating results and an appropriate
discount rate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s goodwill is amortized and deducted over a 15-year period for tax purposes. See Note 9 - Goodwill for additional information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zv745Edcnyr7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zojUi08DTjpl"&gt;Intangible
Assets&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets with finite useful lives, including contractual relationships, proprietary software and technology, and customer-related intangibles
acquired through business combinations, are recorded at fair value at the date of acquisition and amortized on a straight-line basis
over their estimated useful lives. The Company evaluates intangible assets for impairment whenever events or changes in circumstances
indicate that the carrying amount may not be recoverable. If the carrying amount exceeds the estimated undiscounted future cash flows,
the Company recognizes an impairment charge measured as the excess of the carrying amount over the asset&#x2019;s fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_z9WLtwydUOp6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zy0AoXpjH2n4"&gt;Impairment
of Long-Lived Assets&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company reviews long-lived assets, including property and equipment, finite-lived intangible assets, and right-of-use lease assets, for
impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable.
Recoverability of an asset or asset group is assessed based on a comparison of the carrying amount to the estimated undiscounted future
cash flows expected to be generated by the asset or asset group. If the carrying amount exceeds the estimated undiscounted future cash
flows, the Company recognizes an impairment charge measured as the excess of the carrying value over the fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z6Hqhuo03Sxi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zq93kGcbeoL9"&gt;Fair
Value Measurements&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;U.S.
GAAP provides a framework for measuring fair value and expands disclosures about fair value measurements. The framework requires the
valuation of investments using a three-tiered approach. The statement requires fair value measurement to be classified and disclosed
in one of the following categories:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unadjusted quoted prices
  in active markets that are accessible at the measurement date for identical, unrestricted assets and liabilities;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Quoted prices in markets
  that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or
  liability; or&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level 3:&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prices or valuation techniques
  that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market
  activity).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025 and 2024, we did not have any financial instruments with significant Level 3 inputs and we did not have any financial
instruments that are measured at fair value on a recurring basis. For certain of our non-derivative financial instruments, including
receivables, accounts payable and other accrued liabilities, the carrying amount approximates fair value due to the short-term maturities
of these instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zwxtVY5o8GQ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zhpRbMWFZFFi"&gt;Financial
Instruments &#x2014; Warrants and Convertible Instruments&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for warrants in accordance with ASC 815, &#x201c;Derivatives and Hedging,&#x201d; and ASC 480, &#x201c;Distinguishing Liabilities
from Equity,&#x201d; based on an assessment of the specific terms and applicable authoritative guidance. Warrants that meet the criteria
for equity classification are recorded as a component of additional paid-in capital at the time of issuance and are not subsequently
remeasured. Warrants that do not meet the criteria for equity classification are recorded as liabilities at fair value and are remeasured
at each reporting date, with changes in fair value recognized in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Convertible
instruments are evaluated to determine whether any embedded features require bifurcation and separate accounting as derivative instruments.
The Company evaluates the conversion and other features of its convertible instruments under ASC 815 and ASC 470-20, &#x201c;Debt&#x2014;Debt
with Conversion and Other Options,&#x201d; to determine whether embedded derivatives must be separately accounted for. When the Company
determines that embedded derivatives must be bifurcated, the derivative is initially recorded at fair value, with subsequent changes
in fair value recorded in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--DebtPolicyTextBlock_zEaIXwVBZaif" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_z54nPxe0fkkj"&gt;Debt
Issuance Costs and Debt Discounts&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Costs
incurred in connection with the issuance of debt instruments are recorded as a direct deduction from the carrying amount of the related
debt liability and amortized to interest expense over the contractual term of the debt using the effective interest method. Debt discounts,
including beneficial conversion features, are also amortized to interest expense over the term of the related debt.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zCQ2DkIe0po7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zbO6acIIjhKi"&gt;Stock-Based
Compensation&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for stock-based compensation in accordance with ASC 718, &#x201c;Compensation&#x2014;Stock Compensation.&#x201d; Stock-based
compensation expense for equity-classified awards is measured at the grant date based on the estimated fair value of the award, and is
recognized on a straight-line basis over the requisite service period (generally the vesting period), with forfeitures recognized as
they occur. The fair value of restricted stock units is generally based on the closing market price of the Company&#x2019;s Common Stock
on the date of grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--IncomeTaxPolicyTextBlock_zDWfjSoXcOg5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zVWeIISuyPK"&gt;Income
Taxes&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes in accordance with ASC 740, &#x201c;Income Taxes,&#x201d; using the asset and liability method. Under
this method, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between
the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Deferred
tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary
differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized
in income in the period that includes the enactment date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
valuation allowance is established when it is more likely than not that some or all of the deferred tax assets will not be realized.
In evaluating the need for a valuation allowance, the Company considers all available evidence, both positive and negative, including
historical operating results, projected future taxable income, the expected timing of the reversal of existing temporary differences,
and available tax planning strategies. The Company&#x2019;s assessment of the realization of deferred tax assets is reviewed on a quarterly
basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes the financial statement effects of uncertain tax positions when it is more likely than not, based on the technical
merits, that the position will be sustained upon examination by the taxing authority. The Company classifies interest and penalties related
to uncertain tax positions as a component of income tax expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
for the year ended December 31, 2025, the Company adopted ASU 2023-09, &#x201c;Income Taxes (Topic 740): Improvements to Income Tax Disclosures,&#x201d;
on a prospective basis. The Company has expanded its income tax disclosures to include a tabular rate reconciliation with specific categories,
disclosure of income taxes paid disaggregated by federal, state, and foreign jurisdictions, and other disaggregated disclosures as required
by the ASU.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_zAhu47tSt0kb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zplrarjOMIg1"&gt;(Loss)/Earnings
Per Share&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
(loss)/earnings per share is computed by dividing net (loss)/income attributable to Common Stockholders by the weighted-average number
of shares of Common Stock outstanding during the period. Diluted (loss)/earnings per share is computed by dividing net (loss)/income
attributable to Common Stockholders by the weighted-average number of shares of Common Stock outstanding during the period, adjusted
for the dilutive effect of potentially dilutive securities, including stock options, warrants, convertible preferred stock and convertible
debt, using the treasury stock method or the if-converted method, as applicable. In periods in which the Company reports a net loss,
diluted loss per share is the same as basic loss per share, as the inclusion of potentially dilutive securities would be anti-dilutive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--BusinessCombinationsPolicy_z1CHqW8zKJ4d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_865_zgq7rbrEy5Rc"&gt;Business
Combinations&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
evaluate acquisitions to determine whether it is a business combination or an asset acquisition and accounted for under U.S. GAAP using
the acquisition method in accordance with ASC 805, Business Combinations. The Company allocates the fair value of purchase consideration
to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values. The excess of the fair value
of purchase consideration over the values of these identifiable assets and liabilities, if any, is recorded as goodwill.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accounting for business combinations requires management to make judgments and estimates of the fair value of assets acquired, including
the identification and valuation of intangible assets, as well as liabilities and contingencies assumed. Such judgments and estimates
directly impact the amount of goodwill recognized in connection with an acquisition. Estimating the fair value of acquired assets and
assumed liabilities, including intangibles, requires judgment about expected future cash flows, weighted-average cost of capital, discount
rates and expected long-term growth rates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zqPFQZmVHrr7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zNPus3gB07P4"&gt;Segment
Reporting&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating
segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly
by the chief operating decision maker (&#x201c;CODM&#x201d;) in deciding how to allocate resources and in assessing performance. The Company&#x2019;s
CODM, the Chief Executive Officer, reviews consolidated results of operations to make decisions. The Company maintains one operating
and reportable segment, which is the delivery of products and services in the areas of information technology, electronic warfare, information
warfare and cybersecurity in the governmental and commercial markets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company adopted ASU 2023-07, &#x201c;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,&#x201d; which requires
expanded disclosures about significant segment expenses and other items for single-segment entities, based on the information regularly
presented and reviewed by the CODM. Accordingly, the Company concluded that no additional expense disclosures are required other than
the breakout currently disclosed in the financial statements and footnotes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_zetUtwX9mqhb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zToUglJQMqF1"&gt;Common
Stock Subject to Possible Redemption&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its Common Stock subject to possible redemption in accordance with the guidance in ASC 480. Shares of Common Stock
subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable
Common Stock (including Common Stock that features redemption rights that are either within the control of the holder or subject to redemption
upon the occurrence of uncertain events not solely within the Company&#x2019;s control) is classified as temporary equity. At all other
times, Common Stock is classified as stockholders&#x2019; equity. The Company&#x2019;s shares of Common Stock sold in the initial public
offering of Western feature certain redemption rights that are considered to be outside of the Company&#x2019;s control and subject to
occurrence of uncertain future events.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--AdvertisingCostsPolicyTextBlock_zzTyddUbyHXi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86E_zA2nWjSrOa4h"&gt;Advertising
and Marketing Costs&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Advertising
and marketing costs are expensed as incurred and are included in selling, general and administrative expenses in the consolidated statements
of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zZAbiQKrkhIi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_zlXnf3Gpgdyb"&gt;Recent
Accounting Pronouncements - Adopted&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, the FASB issued ASU 2023-07, &#x201c;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,&#x201d;
which requires public entities, including entities with a single reportable segment, to disclose on an annual and interim basis significant
segment expenses that are regularly provided to the CODM and included within each reported measure of segment profit or loss. The Company
adopted this standard for its fiscal year ended December 31, 2025, and has applied the required disclosures on a retrospective basis
for all periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_ecustom--RecentAccountingPronouncementsNotYetAdoptedPolicyTextBlock_zZrVhxeIu9W" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_z9ezLNSQVeIb"&gt;Recent
Accounting Pronouncements - Not Yet Adopted&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2024, the FASB issued ASU 2024-03, &#x201c;Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation
Disclosures (Subtopic 220-40),&#x201d; which requires public entities to disclose, on both an annual and interim basis, additional information
about certain expense categories in tabular form. The standard is effective for fiscal years beginning after December 15, 2026, and for
interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating
the impact of this standard on its disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
early 2025, the FASB issued ASU 2025-03, &#x201c;Business Combinations (Topic 805): Determining the Accounting Acquirer When a VIE Is
Acquired,&#x201d; which provides clarifying guidance to help entities identify the accounting acquirer in a business combination when
the entity being acquired is a VIE. The Company is currently evaluating the impact of this standard on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
July 2025, the FASB issued ASU No. 2025-05, Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses for Accounts
Receivable and Contract Assets. The amendments in this update provide a practical expedient permitting an entity to assume that conditions
at the balance sheet date remain unchanged over the life of the asset when estimating expected credit losses for current classified accounts
receivable and contract assets. This update is effective for annual periods beginning after December 15, 2025, including interim periods
within those fiscal years. Adoption of this ASU can be applied prospectively for reporting periods after its effective date. Early adoption
is permitted. We are currently evaluating the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated
financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
September 2025, the FASB issued ASU No. 2025-06, Intangibles&#x2014;Goodwill and Other&#x2014;Internal-Use Software (Subtopic 350-40):
Targeted Improvements to the Accounting for Internal-Use Software. The ASU simplifies the capitalization guidance by removing all references
to prescriptive and sequential software development stages (referred to as &#x201c;project stages&#x201d;) throughout ASC 350-40. The ASU
is effective for annual periods beginning after December 15, 2027, and interim periods within those fiscal years. Adoption of this ASU
can be applied prospectively for reporting periods after its effective date; or follow a modified transition approach that is based on
the status of the respective projects and whether software costs were capitalized before the date of adoption; or retrospectively to
any or all prior periods presented in the consolidated financial statements. Early adoption is permitted. We are currently evaluating
the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2025, the FASB issued ASU No. 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business
Entities. The ASU establishes authoritative guidance in GAAP about accounting for government grants received by business entities, clarifies
the appropriate accounting, in an effort to reduce diversity in practice, and increase consistency of application across business entities.
The ASU is effective for annual reporting periods beginning after December 15, 2028, and interim reporting periods within those annual
reporting periods. Adoption of this ASU can be applied a modified prospective approach, a modified retrospective approach, or a retrospective
approach. Early adoption is permitted. We are currently evaluating the provisions of this ASU and do not expect this ASU to have a material
impact on our consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2025, the FASB issued ASU No. 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements. The ASU clarifies interim disclosure
requirements and the applicability of Topic 270. The objective of the amendments is to provide further clarity about the current interim
disclosure requirements. The ASU is effective for interim reporting periods within annual reporting periods beginning after December
15, 2027. Adoption of this ASU can be applied either a prospective or a retrospective approach. Early adoption is permitted. We are currently
evaluating the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2025, the FASB issued ASU No. 2025-12, Codification Improvements. The ASU addresses thirty-three items, representing the changes
to the Codification that (1) clarify, (2) correct errors, or (3) make minor improvements. Generally, the amendments in this Update are
not intended to result in significant changes for most entities. The ASU is effective for interim reporting periods within annual reporting
periods beginning after December 15, 2026. The adoption method of this ASU may vary, on an issue-by-issue basis. Early adoption is permitted.
We are currently evaluating the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial
statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has reviewed all other recently issued accounting pronouncements and does not believe that any such pronouncements will have
a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85A_zptfOpXE0DR9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <CYCU:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock contextRef="From2025-01-012025-12-31" id="Fact001001">&lt;p id="xdx_84E_ecustom--BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_zybCv7bicGyh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zX7XpuIngxqj"&gt;Basis
of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements have been prepared in accordance with U.S. GAAP, and the rules and regulations of the
SEC.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
financial statements include the accounts of Cycurion, Inc. (f/k/a KAE Holdings, Inc.; f/k/a Cyber Secure Solutions, Inc.) and its wholly
owned subsidiaries: Cycurion Sub, Inc., Axxum Technologies LLC (&#x201c;Axxum&#x201d;), Cloudburst Security LLC (&#x201c;Cloudburst&#x201d;),
and Cycurion Innovation, Inc. The consolidated financial statements also include the accounts of SLG Innovation Inc. (&#x201c;SLG&#x201d;)
as a result of the master service agreement entered into between the Cycurion and SLG. The Company has determined that the SLG master
service agreement constitutes a business combination as defined by ASC 805, Business Combinations (&#x201c;ASC 805&#x201d;). ASC 805 establishes
principles and requirements as to how the acquirer of a business recognizes and measures in its financial statements the identifiable
assets acquired, the liabilities assumed and any non-controlling interest in the acquiree. The assets acquired and liabilities assumed
were recognized provisionally in the accompanying consolidated balance sheets at their estimated fair values as of March 31, 2025, and
adjusted within a one year period, as required.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 14, 2025, the Company completed its Business Combination with Western a special purpose acquisition company, whereby Western
merged with and into the Company, with the Company surviving the merger. The Business Combination was accounted for as a reverse recapitalization
in accordance with U.S. GAAP, with Cycurion Sub, Inc. treated as the accounting acquirer. Accordingly, the consolidated financial statements
for periods prior to the Business Combination reflect the historical results of Cycurion Sub, Inc., and the equity structure has been
retroactively recast to reflect the number of shares of the Company&#x2019;s Common Stock issued in connection with the Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
fiscal year ends on December 31 and unless otherwise noted, references to fiscal year or fiscal years are for fiscal years ended December
31. The accompanying consolidated financial statements present our financial position as of December 31, 2025, and 2024 and our results
of operations for fiscal years 2025 and 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
significant intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</CYCU:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2025-01-012025-12-31" id="Fact001003">&lt;p id="xdx_845_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zXMgkIQ6xrB8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_zj7WY8lLAw26"&gt;Reclassifications&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
amounts have been reclassified to improve the clarity and comparability of the financial statements. These reclassifications had no impact
on previously reported total assets, liabilities, equity, net (loss)/income, or cash flows for any periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:ConsolidationVariableInterestEntityPolicy contextRef="From2025-01-012025-12-31" id="Fact001005">&lt;p id="xdx_849_eus-gaap--ConsolidationVariableInterestEntityPolicy_zezsAxKhhjHf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_z5EYPpJ73nIe"&gt;Variable
Interest Entities&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluates its relationships with other entities to identify whether they are Variable Interest Entities (&#x201c;VIEs&#x201d; or
&#x201c;VIE&#x201d;) and, if so, whether the Company is the primary beneficiary. A VIE is generally an entity that either (a) has an insufficient
amount of equity at risk to finance its activities without additional subordinated financial support, (b) has equity investors who lack
the characteristics of a controlling financial interest, or (c) is structured with non-substantive voting rights. The Company consolidates
VIEs for which it is the primary beneficiary, meaning it has both the power to direct the activities that most significantly impact the
VIEs economic performance and the obligation to absorb losses or the right to receive benefits that could potentially be significant
to the VIE.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025, SLG Innovation, Inc. is consolidated as a VIE. The Company reassesses VIE determinations on an ongoing basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:UseOfEstimates contextRef="From2025-01-012025-12-31" id="Fact001007">&lt;p id="xdx_84C_eus-gaap--UseOfEstimates_zEdFTfkEsLpf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zFOHCCDfXEMe"&gt;Use
of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Preparing
consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of revenue, expenses, assets and liabilities, and disclosure of contingent assets and liabilities. The Company regularly
assesses these estimates; however, actual results could differ from those estimates. We base our estimates on historical experience,
currently available information, and various other assumptions that we believe are reasonable under the circumstances.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
evaluates these estimates and assumptions on an ongoing basis, including those relating to revenue recognition on cost estimation on
certain contracts, allowance for credit losses, certain assumptions related to share-based compensation, valuation and impairment of
intangible assets and goodwill, and contingencies. Actual results could differ from those estimates. The impact of changes in estimates
is recorded in the period in which they become known.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2025-01-012025-12-31" id="Fact001009">&lt;p id="xdx_849_eus-gaap--RevenueRecognitionPolicyTextBlock_zwp7puZSc8El" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zjtlLIlGrt8g"&gt;Revenue
Recognition&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;). The Company
accounts for a contract with a customer that is within the scope of this topic only when the five steps of revenue recognition under
ASC 606 are met.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
five core principles will be evaluated for each service provided by the Company and is further supported by applicable guidance in ASC
606 to support the Company&#x2019;s recognition of revenue. Revenue is derived primarily from services provided to the federal government
or state and local governments. The Company enters into agreements with customers that create enforceable rights and obligations and
for which it is probable that the Company will collect the consideration to which it will be entitled as services and solutions are transferred
to the customer. The Company also evaluates whether two or more agreements should be accounted for as one single contract.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
determining the total transaction price, the Company identifies both fixed and variable consideration elements within the contract. The
Company estimates variable consideration as the most likely amount to which the Company expects to be entitled limited to the extent
that it is probable that a significant reversal will not occur in a subsequent period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
contract inception, the Company determines whether the goods or services to be provided are to be accounted for as a single performance
obligation or as multiple performance obligations. For most contracts, the customers require the Company to perform several tasks in
providing an integrated output and, hence, each of these contracts are deemed as having only one performance obligation. When contracts
are separated into multiple performance obligations, the Company allocates the total transaction price to each performance obligation
based on the estimated relative standalone selling prices of the promised services underlying each performance obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;This
evaluation requires professional judgment, and it may impact the timing and pattern of revenue recognition. If multiple performance obligations
are identified, the Company generally uses the cost plus a margin approach to determine the relative standalone selling price of each
performance obligation. The Company does not assess whether a contract contains a significant financing component if the Company expects,
at contract inception, that the period between when payment by the client and the transfer of promised services to the client occur will
be less than one year. The Company currently generates its revenue from two different types of contractual arrangements: firm-fixed-price
contracts (&#x201c;FFP&#x201d;) and time-and-materials (&#x201c;T&amp;amp;M&#x201d;) contracts. The Company generally recognizes revenue over
time as control is transferred to the customer, based on the extent of progress towards satisfaction of the performance obligation. The
selection of the method used to measure progress requires judgment and is dependent on the contract type and the nature of the goods
or services to be provided. Revenue from FFP contracts is generally recognized ratably over the contract term, using a time-based measure
of progress, even if billing is based on other metrics or milestones, including specific deliverables. For T&amp;amp;M contracts, the Company
uses input progress measures to estimate revenue earned based on hours worked on contract performance at negotiated billing rates, plus
direct costs and indirect cost burdens associated with materials and the direct expenses incurred in performance of the contract.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
arrangements generally qualify for the &#x201c;right-to-invoice&#x201d; practical expedient where revenue is recognized in proportion to
billable consideration.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
generated from the Company&#x2019;s FFP contracts is recognized over time as performance obligations are satisfied, based on the transfer
of control to the customer. Revenue is generally recognized using an input method based on labor hours or costs incurred relative to
total estimated costs. Most contracts do not include significant variable consideration, and contract modifications are generally minimal.
Accordingly, the Company&#x2019;s election of available transition practical expedients did not have a material impact on revenue recognition.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
generated from contracts with federal, state, and local governments is primarily recognized over time. Under T&amp;amp;M contracts, the Company
performs services as directed by the customer and generally bills semi-monthly based on labor hours expended. Certain government software
development contracts include defined deliverables and are structured as FFP arrangements, which are generally billed as performance
obligations are satisfied.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
recognition under FFP contracts requires judgment in allocating the transaction price to performance obligations and estimating total
expected costs. Contract terms may extend up to five years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Contract
accounting requires judgment relative to assessing risks and estimating contract revenue and costs and assumptions for schedule and technical
issues. Due to the size and nature of contracts, estimates of revenue and costs are subject to a number of variables. For contract change
orders, claims or similar items, judgment is required for estimating the amounts, assessing the potential for realization and determining
whether realization is probable. Estimates of total contract revenue and costs are continuously monitored during the term of the contract
and are subject to revision as the contract progresses. From time to time, facts develop that require revisions of revenue recognized
or cost estimates. To the extent that a revised estimate affects the current or an earlier period, the cumulative effect of the revision
is recognized in the period in which the facts requiring the revision become known. When estimates of total costs to be incurred on a
contract exceed total revenue, a provision for the entire loss on the contract is recorded in the period in which the loss is determined.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for contract costs in accordance with ASC Topic 340-40, Contracts with Customers. The Company recognizes the cost of
sales of a contract as expense when incurred or at the time a performance obligation is satisfied. The Company recognizes an asset from
the costs to fulfill a contract only if the costs relate directly to a contract, the costs generate or enhance resources that will be
used in satisfying a performance obligation in the future and the costs are expected to be recovered. The incremental costs of obtaining
a contract are capitalized unless the costs would have been incurred regardless of whether the contract was obtained.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2025-01-012025-12-31" id="Fact001011">&lt;p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_ziyXIxXhWxG8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86B_zVZtKDMfvxH4"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all highly liquid investments with an original maturity of three months or less at the date of acquisition to be cash
equivalents. Cash and cash equivalents are stated at cost, which approximates fair value. The Company&#x2019;s cash balances may, from
time to time, exceed insured limits of $&lt;span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_c20251231_zDqEasEuZDD" title="FDIC insured amount"&gt;250,000&lt;/span&gt; established by the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;). The Company
has not experienced any losses in such accounts and management believes the Company is not exposed to significant credit risk on its
cash balances.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashFDICInsuredAmount
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001013"
      unitRef="USD">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="From2025-01-012025-12-31" id="Fact001015">&lt;p id="xdx_84F_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zooo10UK6Kr7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_z50y4KyV8ic7"&gt;Accounts
Receivable and Allowance for Credit Losses&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
receivable includes the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Billed
Receivables:&lt;/span&gt; Billed receivables are balances where an invoice has been prepared and issued and is collectible under standard contract
terms. Where we anticipate that an invoice will be issued within a short period of time and where the funds are considered collectible
within standard contract terms, we include this balance as billed accounts receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Unbilled
Receivables:&lt;/span&gt; Unbilled receivables are balances that have not yet been billed due to timing, most commonly just a month delayed from
the timing of revenue recognition and the actual bill being presented to the customer. The Company has fulfilled all requirements in
order to bill the customer and collect the funds.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company maintains an allowance for credit losses on its accounts receivable, which includes both billed and unbilled receivables measured
at amortized cost. The allowance is a contra-asset account representing management&#x2019;s estimate of amounts not expected to be collected
over the life of the receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company estimates expected credit losses in accordance with ASC Topic 326, Financial Instruments &#x2014; Credit Losses, based on historical
loss experience, current conditions, and reasonable and supportable forecasts. Receivables are evaluated collectively, grouped by similar
risk characteristics, which for the Company primarily reflects the composition of its customer base. Substantially all of the Company&#x2019;s
revenue is derived from contracts with federal, state, and local government entities. Because government obligors generally possess the
legal authority and financial resources to satisfy contractual payment obligations, the Company has experienced minimal credit losses
on its accounts receivable. Qualitative adjustments are applied as necessary to reflect conditions that may differ from historical experience.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
allowance is reviewed and updated at each reporting date. When a specific receivable is determined to be uncollectible, it is written
off against the allowance. Recoveries of amounts previously written off are recognized when received.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2025-01-012025-12-31" id="Fact001017">&lt;p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zCk2nkrr0HE9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_865_zMVxo5gWPH0c"&gt;Concentrations&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents and
accounts receivable. The Company&#x2019;s customer base is concentrated among U.S. Federal Government agencies, state and local government
agencies and their prime contractors. The Company monitors the financial condition of its customers and the credit quality of its receivable
portfolio and does not require collateral from its customers. Customers representing 10% or more of revenue or accounts receivable are
disclosed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2025-01-012025-12-31" id="Fact001019">&lt;p id="xdx_84B_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zdMPWaqBAdba" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86A_zj5oDIif1PEe"&gt;Property
and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are recorded at cost less accumulated depreciation and amortization. Depreciation is recorded over the assets&#x2019; estimated
useful lives using the straight-line method, which is three to five years for furniture and equipment. Leasehold improvements are amortized
over the shorter of their useful life or the remaining terms of the lease.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
sale or retirement of property and equipment, the costs and related accumulated depreciation and amortization are eliminated from the
accounts and any gain or loss on such disposition is reflected in the consolidated statements of operations and comprehensive (loss)/income..
Repairs and maintenance costs are expensed as incurred. Major renewals and improvements are capitalized and depreciated over their estimated
useful lives.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock contextRef="From2025-01-012025-12-31" id="Fact001021">&lt;p id="xdx_843_eus-gaap--ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_ziGiNUCc833b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_865_zq8IYpkJm5E"&gt;Software
Development Costs&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
account for development costs of software in accordance with ASC Topic 985-20 (&#x201c;ASC 985-20&#x201d;), &#x201c;Software &#x2013; Costs
of Software to be Sold, Leased, or Marketed&#x201d; and ASC Topic 350-40 (&#x201c;ASC 350-40&#x201d;) &#x201c;Internal Use Software,&#x201d;
depending on the intended use of the software being developed. Under ASC 985-20, all costs of developing software prior to establishing
its technological feasibility are research and development costs and are expensed as incurred. Once technological feasibility has been
established, subsequent costs should be capitalized until the software begins to be marketed or is released to customers, after which
the capitalized costs should be amortized and reviewed for impairment. Under ASC 350-40, we capitalize certain software development costs
when the preliminary project stage is completed and the software has entered the application development stage. Once substantial testing
is complete and the software is ready to be used, capitalization of costs ceases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Capitalized
software development costs are amortized on a straight-line basis over the estimated economic life of the application, ranging from two
to five years, beginning when the asset is ready for its intended use.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="From2025-01-012025-12-31" id="Fact001023">&lt;p id="xdx_84B_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zRaeQjorYrnb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_zoVDdxBC7Tw7"&gt;Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Goodwill
represents the excess of acquisition consideration over the fair value of net tangible and intangible assets acquired and liabilities
assumed. Goodwill is not amortized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company tests goodwill for impairment at the reporting unit level on an annual basis as of December 31, or more frequently if events
or changes in circumstances indicate that the carrying value of a reporting unit may exceed its fair value. Such circumstances may include,
but are not limited to, a significant adverse change in business climate, loss of key contracts or customers, or negative operating performance
trends.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company may elect to first perform a qualitative assessment to determine whether it is more likely than not that the fair value of a
reporting unit is less than its carrying value. If that threshold is met, or if the Company elects to bypass the qualitative assessment,
a quantitative impairment test is performed by comparing the estimated fair value of the reporting unit to its carrying value, including
goodwill. If the estimated fair value is less than the carrying value, an impairment loss is recognized for the difference, not to exceed
the carrying amount of goodwill assigned to the reporting unit. The Company uses a combination of income and market approaches to estimate
fair value, which involves the use of significant assumptions and judgments, including forecasted operating results and an appropriate
discount rate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s goodwill is amortized and deducted over a 15-year period for tax purposes. See Note 9 - Goodwill for additional information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="From2025-01-012025-12-31" id="Fact001025">&lt;p id="xdx_84C_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zv745Edcnyr7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zojUi08DTjpl"&gt;Intangible
Assets&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets with finite useful lives, including contractual relationships, proprietary software and technology, and customer-related intangibles
acquired through business combinations, are recorded at fair value at the date of acquisition and amortized on a straight-line basis
over their estimated useful lives. The Company evaluates intangible assets for impairment whenever events or changes in circumstances
indicate that the carrying amount may not be recoverable. If the carrying amount exceeds the estimated undiscounted future cash flows,
the Company recognizes an impairment charge measured as the excess of the carrying amount over the asset&#x2019;s fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2025-01-012025-12-31" id="Fact001027">&lt;p id="xdx_843_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_z9WLtwydUOp6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zy0AoXpjH2n4"&gt;Impairment
of Long-Lived Assets&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company reviews long-lived assets, including property and equipment, finite-lived intangible assets, and right-of-use lease assets, for
impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable.
Recoverability of an asset or asset group is assessed based on a comparison of the carrying amount to the estimated undiscounted future
cash flows expected to be generated by the asset or asset group. If the carrying amount exceeds the estimated undiscounted future cash
flows, the Company recognizes an impairment charge measured as the excess of the carrying value over the fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="From2025-01-012025-12-31" id="Fact001029">&lt;p id="xdx_84B_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z6Hqhuo03Sxi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zq93kGcbeoL9"&gt;Fair
Value Measurements&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;U.S.
GAAP provides a framework for measuring fair value and expands disclosures about fair value measurements. The framework requires the
valuation of investments using a three-tiered approach. The statement requires fair value measurement to be classified and disclosed
in one of the following categories:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unadjusted quoted prices
  in active markets that are accessible at the measurement date for identical, unrestricted assets and liabilities;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Quoted prices in markets
  that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or
  liability; or&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level 3:&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prices or valuation techniques
  that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market
  activity).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025 and 2024, we did not have any financial instruments with significant Level 3 inputs and we did not have any financial
instruments that are measured at fair value on a recurring basis. For certain of our non-derivative financial instruments, including
receivables, accounts payable and other accrued liabilities, the carrying amount approximates fair value due to the short-term maturities
of these instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2025-01-012025-12-31" id="Fact001031">&lt;p id="xdx_844_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zwxtVY5o8GQ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zhpRbMWFZFFi"&gt;Financial
Instruments &#x2014; Warrants and Convertible Instruments&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for warrants in accordance with ASC 815, &#x201c;Derivatives and Hedging,&#x201d; and ASC 480, &#x201c;Distinguishing Liabilities
from Equity,&#x201d; based on an assessment of the specific terms and applicable authoritative guidance. Warrants that meet the criteria
for equity classification are recorded as a component of additional paid-in capital at the time of issuance and are not subsequently
remeasured. Warrants that do not meet the criteria for equity classification are recorded as liabilities at fair value and are remeasured
at each reporting date, with changes in fair value recognized in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Convertible
instruments are evaluated to determine whether any embedded features require bifurcation and separate accounting as derivative instruments.
The Company evaluates the conversion and other features of its convertible instruments under ASC 815 and ASC 470-20, &#x201c;Debt&#x2014;Debt
with Conversion and Other Options,&#x201d; to determine whether embedded derivatives must be separately accounted for. When the Company
determines that embedded derivatives must be bifurcated, the derivative is initially recorded at fair value, with subsequent changes
in fair value recorded in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:DebtPolicyTextBlock contextRef="From2025-01-012025-12-31" id="Fact001033">&lt;p id="xdx_848_eus-gaap--DebtPolicyTextBlock_zEaIXwVBZaif" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_z54nPxe0fkkj"&gt;Debt
Issuance Costs and Debt Discounts&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Costs
incurred in connection with the issuance of debt instruments are recorded as a direct deduction from the carrying amount of the related
debt liability and amortized to interest expense over the contractual term of the debt using the effective interest method. Debt discounts,
including beneficial conversion features, are also amortized to interest expense over the term of the related debt.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2025-01-012025-12-31" id="Fact001035">&lt;p id="xdx_842_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zCQ2DkIe0po7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zbO6acIIjhKi"&gt;Stock-Based
Compensation&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for stock-based compensation in accordance with ASC 718, &#x201c;Compensation&#x2014;Stock Compensation.&#x201d; Stock-based
compensation expense for equity-classified awards is measured at the grant date based on the estimated fair value of the award, and is
recognized on a straight-line basis over the requisite service period (generally the vesting period), with forfeitures recognized as
they occur. The fair value of restricted stock units is generally based on the closing market price of the Company&#x2019;s Common Stock
on the date of grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2025-01-012025-12-31" id="Fact001037">&lt;p id="xdx_841_eus-gaap--IncomeTaxPolicyTextBlock_zDWfjSoXcOg5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zVWeIISuyPK"&gt;Income
Taxes&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes in accordance with ASC 740, &#x201c;Income Taxes,&#x201d; using the asset and liability method. Under
this method, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between
the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Deferred
tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary
differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized
in income in the period that includes the enactment date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
valuation allowance is established when it is more likely than not that some or all of the deferred tax assets will not be realized.
In evaluating the need for a valuation allowance, the Company considers all available evidence, both positive and negative, including
historical operating results, projected future taxable income, the expected timing of the reversal of existing temporary differences,
and available tax planning strategies. The Company&#x2019;s assessment of the realization of deferred tax assets is reviewed on a quarterly
basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes the financial statement effects of uncertain tax positions when it is more likely than not, based on the technical
merits, that the position will be sustained upon examination by the taxing authority. The Company classifies interest and penalties related
to uncertain tax positions as a component of income tax expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
for the year ended December 31, 2025, the Company adopted ASU 2023-09, &#x201c;Income Taxes (Topic 740): Improvements to Income Tax Disclosures,&#x201d;
on a prospective basis. The Company has expanded its income tax disclosures to include a tabular rate reconciliation with specific categories,
disclosure of income taxes paid disaggregated by federal, state, and foreign jurisdictions, and other disaggregated disclosures as required
by the ASU.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2025-01-012025-12-31" id="Fact001039">&lt;p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_zAhu47tSt0kb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zplrarjOMIg1"&gt;(Loss)/Earnings
Per Share&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
(loss)/earnings per share is computed by dividing net (loss)/income attributable to Common Stockholders by the weighted-average number
of shares of Common Stock outstanding during the period. Diluted (loss)/earnings per share is computed by dividing net (loss)/income
attributable to Common Stockholders by the weighted-average number of shares of Common Stock outstanding during the period, adjusted
for the dilutive effect of potentially dilutive securities, including stock options, warrants, convertible preferred stock and convertible
debt, using the treasury stock method or the if-converted method, as applicable. In periods in which the Company reports a net loss,
diluted loss per share is the same as basic loss per share, as the inclusion of potentially dilutive securities would be anti-dilutive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:BusinessCombinationsPolicy contextRef="From2025-01-012025-12-31" id="Fact001041">&lt;p id="xdx_847_eus-gaap--BusinessCombinationsPolicy_z1CHqW8zKJ4d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_865_zgq7rbrEy5Rc"&gt;Business
Combinations&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
evaluate acquisitions to determine whether it is a business combination or an asset acquisition and accounted for under U.S. GAAP using
the acquisition method in accordance with ASC 805, Business Combinations. The Company allocates the fair value of purchase consideration
to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values. The excess of the fair value
of purchase consideration over the values of these identifiable assets and liabilities, if any, is recorded as goodwill.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accounting for business combinations requires management to make judgments and estimates of the fair value of assets acquired, including
the identification and valuation of intangible assets, as well as liabilities and contingencies assumed. Such judgments and estimates
directly impact the amount of goodwill recognized in connection with an acquisition. Estimating the fair value of acquired assets and
assumed liabilities, including intangibles, requires judgment about expected future cash flows, weighted-average cost of capital, discount
rates and expected long-term growth rates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="From2025-01-012025-12-31" id="Fact001043">&lt;p id="xdx_84D_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zqPFQZmVHrr7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zNPus3gB07P4"&gt;Segment
Reporting&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating
segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly
by the chief operating decision maker (&#x201c;CODM&#x201d;) in deciding how to allocate resources and in assessing performance. The Company&#x2019;s
CODM, the Chief Executive Officer, reviews consolidated results of operations to make decisions. The Company maintains one operating
and reportable segment, which is the delivery of products and services in the areas of information technology, electronic warfare, information
warfare and cybersecurity in the governmental and commercial markets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company adopted ASU 2023-07, &#x201c;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,&#x201d; which requires
expanded disclosures about significant segment expenses and other items for single-segment entities, based on the information regularly
presented and reviewed by the CODM. Accordingly, the Company concluded that no additional expense disclosures are required other than
the breakout currently disclosed in the financial statements and footnotes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock contextRef="From2025-01-012025-12-31" id="Fact001045">&lt;p id="xdx_840_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_zetUtwX9mqhb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zToUglJQMqF1"&gt;Common
Stock Subject to Possible Redemption&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its Common Stock subject to possible redemption in accordance with the guidance in ASC 480. Shares of Common Stock
subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable
Common Stock (including Common Stock that features redemption rights that are either within the control of the holder or subject to redemption
upon the occurrence of uncertain events not solely within the Company&#x2019;s control) is classified as temporary equity. At all other
times, Common Stock is classified as stockholders&#x2019; equity. The Company&#x2019;s shares of Common Stock sold in the initial public
offering of Western feature certain redemption rights that are considered to be outside of the Company&#x2019;s control and subject to
occurrence of uncertain future events.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="From2025-01-012025-12-31" id="Fact001047">&lt;p id="xdx_84E_eus-gaap--AdvertisingCostsPolicyTextBlock_zzTyddUbyHXi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86E_zA2nWjSrOa4h"&gt;Advertising
and Marketing Costs&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Advertising
and marketing costs are expensed as incurred and are included in selling, general and administrative expenses in the consolidated statements
of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2025-01-012025-12-31" id="Fact001049">&lt;p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zZAbiQKrkhIi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_zlXnf3Gpgdyb"&gt;Recent
Accounting Pronouncements - Adopted&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, the FASB issued ASU 2023-07, &#x201c;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,&#x201d;
which requires public entities, including entities with a single reportable segment, to disclose on an annual and interim basis significant
segment expenses that are regularly provided to the CODM and included within each reported measure of segment profit or loss. The Company
adopted this standard for its fiscal year ended December 31, 2025, and has applied the required disclosures on a retrospective basis
for all periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <CYCU:RecentAccountingPronouncementsNotYetAdoptedPolicyTextBlock contextRef="From2025-01-012025-12-31" id="Fact001051">&lt;p id="xdx_841_ecustom--RecentAccountingPronouncementsNotYetAdoptedPolicyTextBlock_zZrVhxeIu9W" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_z9ezLNSQVeIb"&gt;Recent
Accounting Pronouncements - Not Yet Adopted&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2024, the FASB issued ASU 2024-03, &#x201c;Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation
Disclosures (Subtopic 220-40),&#x201d; which requires public entities to disclose, on both an annual and interim basis, additional information
about certain expense categories in tabular form. The standard is effective for fiscal years beginning after December 15, 2026, and for
interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating
the impact of this standard on its disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
early 2025, the FASB issued ASU 2025-03, &#x201c;Business Combinations (Topic 805): Determining the Accounting Acquirer When a VIE Is
Acquired,&#x201d; which provides clarifying guidance to help entities identify the accounting acquirer in a business combination when
the entity being acquired is a VIE. The Company is currently evaluating the impact of this standard on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
July 2025, the FASB issued ASU No. 2025-05, Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses for Accounts
Receivable and Contract Assets. The amendments in this update provide a practical expedient permitting an entity to assume that conditions
at the balance sheet date remain unchanged over the life of the asset when estimating expected credit losses for current classified accounts
receivable and contract assets. This update is effective for annual periods beginning after December 15, 2025, including interim periods
within those fiscal years. Adoption of this ASU can be applied prospectively for reporting periods after its effective date. Early adoption
is permitted. We are currently evaluating the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated
financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
September 2025, the FASB issued ASU No. 2025-06, Intangibles&#x2014;Goodwill and Other&#x2014;Internal-Use Software (Subtopic 350-40):
Targeted Improvements to the Accounting for Internal-Use Software. The ASU simplifies the capitalization guidance by removing all references
to prescriptive and sequential software development stages (referred to as &#x201c;project stages&#x201d;) throughout ASC 350-40. The ASU
is effective for annual periods beginning after December 15, 2027, and interim periods within those fiscal years. Adoption of this ASU
can be applied prospectively for reporting periods after its effective date; or follow a modified transition approach that is based on
the status of the respective projects and whether software costs were capitalized before the date of adoption; or retrospectively to
any or all prior periods presented in the consolidated financial statements. Early adoption is permitted. We are currently evaluating
the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2025, the FASB issued ASU No. 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business
Entities. The ASU establishes authoritative guidance in GAAP about accounting for government grants received by business entities, clarifies
the appropriate accounting, in an effort to reduce diversity in practice, and increase consistency of application across business entities.
The ASU is effective for annual reporting periods beginning after December 15, 2028, and interim reporting periods within those annual
reporting periods. Adoption of this ASU can be applied a modified prospective approach, a modified retrospective approach, or a retrospective
approach. Early adoption is permitted. We are currently evaluating the provisions of this ASU and do not expect this ASU to have a material
impact on our consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2025, the FASB issued ASU No. 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements. The ASU clarifies interim disclosure
requirements and the applicability of Topic 270. The objective of the amendments is to provide further clarity about the current interim
disclosure requirements. The ASU is effective for interim reporting periods within annual reporting periods beginning after December
15, 2027. Adoption of this ASU can be applied either a prospective or a retrospective approach. Early adoption is permitted. We are currently
evaluating the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2025, the FASB issued ASU No. 2025-12, Codification Improvements. The ASU addresses thirty-three items, representing the changes
to the Codification that (1) clarify, (2) correct errors, or (3) make minor improvements. Generally, the amendments in this Update are
not intended to result in significant changes for most entities. The ASU is effective for interim reporting periods within annual reporting
periods beginning after December 15, 2026. The adoption method of this ASU may vary, on an issue-by-issue basis. Early adoption is permitted.
We are currently evaluating the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial
statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has reviewed all other recently issued accounting pronouncements and does not believe that any such pronouncements will have
a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

</CYCU:RecentAccountingPronouncementsNotYetAdoptedPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="From2025-01-012025-12-31" id="Fact001053">&lt;p id="xdx_804_eus-gaap--RevenueFromContractWithCustomerTextBlock_zv4oAKOZHZA9" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_822_zWqCpocUvwSh"&gt;REVENUE
                                            RECOGNITION&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Advisory
Consulting&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company enters into service agreements with customers that will set forth the responsibilities of both parties, including the type of
service to be delivered, the timing of the delivery of those services, and the associated price per unit for such services. The unit
of measure in the agreement is typically hours. The advisory consulting services represent a single performance obligation, as they constitute
a series of distinct hourly services that are substantially the same and transferred to the customer over time. The revenue from advisory
service agreement will also set forth the timing of payments by the customers which is typically between &lt;span id="xdx_908_ecustom--CustomerPaymentTermDays_dtD_c20250101__20251231__srt--RangeAxis__srt--MinimumMember_zanzvLau4jqg" title="Revenue recognition, expected term"&gt;60&lt;/span&gt; and &lt;span id="xdx_90A_ecustom--CustomerPaymentTermDays_dtD_c20250101__20251231__srt--RangeAxis__srt--MaximumMember_zk2fS1iIDtFf" title="Revenue recognition, expected term"&gt;90&lt;/span&gt; days from the date
that an invoice is issued to the customer. As a practical matter, the Company continuously delivers service to customers, and the customer
receives benefits from those services over time. The revenue advisory consulting is recognized over time as services are rendered, based
on contractual hourly rates, and when the Company has received the aforementioned acknowledgement from its customers that service has
been rendered related to hours accumulated over period of time, such as a week, or two weeks, or a month, which is determined on a customer-by-customer
basis. The Company&#x2019;s contracts do not include terms for returns, or warranties, or guarantees, or rebates, or discounts on the
services rendered. The Company also enters into annual contracts with customers to provide ongoing advisory and consulting services.
Services are delivered continuously over the contract term and customers are billed periodically. The annual service contract represents
a single performance obligation because the services are a series of distinct, substantially similar acts that are inseparable and transferred
over time. Revenue is recognized over time straight-line over the contract term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Managed
Security Service Practice (MSSP)&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
has determined that its managed security service practice is a bundle of cybersecurity software tools, and expert 24x7x365
monitoring and breach resolution service that is accounted for as a single performance obligation that is delivered over time which
is typically a month. The components of the bundle have individual commercial value. However, management believes assigning
stand-alone value to each component is impractical because each component would not be able to be fully implemented or utilized if
not packaged with the other components. Therefore, management believes the MSSP can only be sold as a bundle package over time. At
the time that the Company recognizes revenue, it is has either already received funds in advance from its customer or it is
reasonably assured that it will collect funds from its customer. In the event that funds that are received in advance, they are
accounted for as contract liabilities in the deferred revenue account until the Company fulfills the performance obligation. A
majority of the Company&#x2019;s contracts call for the Company to first deliver service and collect fees thereafter. The Company
typically receives payment for these contracts within &lt;span id="xdx_90C_ecustom--RevenueFromContractWithCustomerPaymentPeriod_dtD_c20250101__20251231__srt--RangeAxis__srt--MinimumMember_zMcnRQmJV1ij" style="display: none" title="Payment received for contracts, term"&gt;30&lt;/span&gt;
thirty to &lt;span id="xdx_905_ecustom--RevenueFromContractWithCustomerPaymentPeriod_dtD_c20250101__20251231__srt--RangeAxis__srt--MaximumMember_zH2yU8gWME6g" style="display: none" title="Payment received for contracts, term"&gt;90&lt;/span&gt; ninety days of delivery of service. The Company does not sell monitoring time, security software-tools, and breach
resolution as stand-alone services, as the customer would not receive the benefits of these items if they were not sold as an
integrated package. The cybersecurity needs to monitor the customer cybersecurity environment regularly, stay up to date on
cyberthreats and solutions, maintain its software tools, and then address threats identified, or rectify situations when customer
environments have been breached. It is not practical or viable to sell these components separately, as customers expect
comprehensive solutions. While the components are separately identifiable, management does not believe they could market the
components individually. The Company&#x2019;s management does not believe their customers can benefit from the individual components
alone, and there are not readily available resources in the market that can be obtained to make those components viable. The
continuous monitoring allows the Company to identify and either neutralize and or rectify breaches by having up to the minute
first-hand information, and the tools allow the Company to implement solutions rapidly. The absence of the components would render
the solutions and service offering significantly devalued and non-competitive in the marketplace.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company believes MSSP meets the criteria to combine the goods and services under a single performance obligation. The Company believes
combined integrated solution is delivered continuously over a period of time. In accordance with the terms of the contract between the
Company and its customers, the Company receives prepayments in advance from its customers, and recognizes those payments to revenues
over a period of time, which is typically each month.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Managed
Service Provider (MSP)&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s managed service provider (MSP) service offering is the provision of IT infrastructure support to customers,
specifically in the areas of desktop support, on-site troubleshooting, and cloud-based network infrastructure troubleshooting. This
service is accounted for as a single performance obligation that is delivered over time, which is typically a month; At the time
that the Company recognizes revenue, it either already received funds in advance from its customer, or it is reasonably assured that
it will collect funds from its customer. In the event that funds that are received in advance, they are accounted for as contract
liabilities in the deferred revenue account until the Company fulfills the performance obligation. A majority of the Company&#x2019;s
contracts call for the Company to first deliver service and collect fees thereafter. The Company typically receives payment for
these contracts within &lt;span id="xdx_906_ecustom--RevenueFromContractWithCustomerPaymentPeriod_dtD_c20250101__20251231__srt--RangeAxis__srt--MinimumMember_zeDx1rOmc185" style="display: none" title="Payment received for contracts, term"&gt;30&lt;/span&gt;
thirty to &lt;span id="xdx_905_ecustom--RevenueFromContractWithCustomerPaymentPeriod_dtD_c20250101__20251231__srt--RangeAxis__srt--MaximumMember_zAvn2KpVaBJl" style="display: none" title="Payment received for contracts, term"&gt;90&lt;/span&gt; ninety days of delivery of service.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;MSP
requires the integration of tools and labor in order for a customer to receive any benefit from the services provided. The Company refers
to the guidance in ASC 606-10-25-19 to provide an analysis regarding this accounting recognition of this integrated service. Under MSP,
the customer cannot receive any benefit purely from labor or individual software tools as a stand-alone service. The tools that the Company
deploys require engineers to decipher results and develop solutions to problems during the service period covered in a contract.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;While
components can be separately identified, they must be used in conjunction with each other to serve the Company&#x2019;s customers. The
Company must continuously make available support engineers to customers whenever they need support and troubleshooting. The service includes
remote resolution of issues or going onsite to customer locations to solve problems. The Company&#x2019;s contracts with customers require
the Company to have these resources available during the length of the contract. Therefore, these services are continuously delivered
as a service over time. Accordingly, the Company recognizes revenue for such MSP contracts on a monthly basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Software
as a service (SaaS)&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
has determined that its software as a service is a suite of cybersecurity tools that are delivered either remotely or on customer
premises. The service is delivered on a monthly basis. The cybersecurity tools are typically sold as a package. However, the
individual components of the suite of tools can either be sold individually or bundled together. Nevertheless, if they are sold
individually, or as a bundle, they are all delivered over time. Accordingly, the Company recognizes revenue over time, which is
typically monthly; At the time that the Company recognizes revenue it has either already received funds in advance from its
customer, or it is reasonably assured that it will collect funds from its customer. In the event that funds that are received in
advance, they are accounted for as contract liabilities in the deferred revenue account until the Company fulfills the performance
obligation. A majority of the Company&#x2019;s contracts call for the Company to first deliver service and collect fees thereafter.
The Company typically receives payment for these contracts within &lt;span id="xdx_906_ecustom--RevenueFromContractWithCustomerPaymentPeriod_dtD_c20250101__20251231__srt--RangeAxis__srt--MinimumMember_zZnmL6PZBPIc" style="display: none" title="Payment received for contracts, term"&gt;30&lt;/span&gt;
thirty to &lt;span id="xdx_908_ecustom--RevenueFromContractWithCustomerPaymentPeriod_dtD_c20250101__20251231__srt--RangeAxis__srt--MaximumMember_zseuSkVBfGH" style="display: none" title="Payment received for contracts, term"&gt;90&lt;/span&gt; ninety days of delivery of service.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s SaaS is delivered continuously over time. It is a subscription service where the Company provisions a suite of security
software tools to its customers accessed via the internet that allows the customers to protect themselves from cyber-attacks using multiple
tools within the suite. This subscription service is recognized to revenue monthly.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--DisaggregationOfRevenueTableTextBlock_zgalOj3Lhnb3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zk1irBXRBiNe" style="display: none"&gt;SCHEDULE OF DISAGGREGATED REVENUES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20250101__20251231_zWqAkHJBR415" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20240101__20241231_zfcYQypj1G09" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    3: Disaggregated Revenue&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--AdvisoryConsultingMember_zXjNE6jkfqAk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Advisory consulting&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,007,827&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,441,216&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ManagedSecurityServicePracticeMember_z0uMPwULhwvf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Managed security service practice (MSSP)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;112,725&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;318,079&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SoftwareAsAServiceMember_zTqwNW3sQbci" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Software as a service
    (Saas)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,095&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,190&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zGyfp6WdFRYi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,133,647&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,771,485&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zJ6rxEiMHO0l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <CYCU:CustomerPaymentTermDays
      contextRef="From2025-01-012025-12-31_srt_MinimumMember"
      id="Fact001055">P60D</CYCU:CustomerPaymentTermDays>
    <CYCU:CustomerPaymentTermDays
      contextRef="From2025-01-012025-12-31_srt_MaximumMember"
      id="Fact001057">P90D</CYCU:CustomerPaymentTermDays>
    <CYCU:RevenueFromContractWithCustomerPaymentPeriod
      contextRef="From2025-01-012025-12-31_srt_MinimumMember"
      id="Fact001059">P30D</CYCU:RevenueFromContractWithCustomerPaymentPeriod>
    <CYCU:RevenueFromContractWithCustomerPaymentPeriod
      contextRef="From2025-01-012025-12-31_srt_MaximumMember"
      id="Fact001061">P90D</CYCU:RevenueFromContractWithCustomerPaymentPeriod>
    <CYCU:RevenueFromContractWithCustomerPaymentPeriod
      contextRef="From2025-01-012025-12-31_srt_MinimumMember"
      id="Fact001063">P30D</CYCU:RevenueFromContractWithCustomerPaymentPeriod>
    <CYCU:RevenueFromContractWithCustomerPaymentPeriod
      contextRef="From2025-01-012025-12-31_srt_MaximumMember"
      id="Fact001065">P90D</CYCU:RevenueFromContractWithCustomerPaymentPeriod>
    <CYCU:RevenueFromContractWithCustomerPaymentPeriod
      contextRef="From2025-01-012025-12-31_srt_MinimumMember"
      id="Fact001067">P30D</CYCU:RevenueFromContractWithCustomerPaymentPeriod>
    <CYCU:RevenueFromContractWithCustomerPaymentPeriod
      contextRef="From2025-01-012025-12-31_srt_MaximumMember"
      id="Fact001069">P90D</CYCU:RevenueFromContractWithCustomerPaymentPeriod>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2025-01-012025-12-31" id="Fact001071">&lt;p id="xdx_899_eus-gaap--DisaggregationOfRevenueTableTextBlock_zgalOj3Lhnb3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zk1irBXRBiNe" style="display: none"&gt;SCHEDULE OF DISAGGREGATED REVENUES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20250101__20251231_zWqAkHJBR415" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20240101__20241231_zfcYQypj1G09" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    3: Disaggregated Revenue&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--AdvisoryConsultingMember_zXjNE6jkfqAk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Advisory consulting&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,007,827&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,441,216&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ManagedSecurityServicePracticeMember_z0uMPwULhwvf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Managed security service practice (MSSP)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;112,725&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;318,079&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SoftwareAsAServiceMember_zTqwNW3sQbci" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Software as a service
    (Saas)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,095&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,190&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zGyfp6WdFRYi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,133,647&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,771,485&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2025-01-012025-12-31_custom_AdvisoryConsultingMember"
      decimals="0"
      id="Fact001073"
      unitRef="USD">15007827</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-01-012024-12-31_custom_AdvisoryConsultingMember"
      decimals="0"
      id="Fact001074"
      unitRef="USD">17441216</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2025-01-012025-12-31_custom_ManagedSecurityServicePracticeMember"
      decimals="0"
      id="Fact001076"
      unitRef="USD">112725</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-01-012024-12-31_custom_ManagedSecurityServicePracticeMember"
      decimals="0"
      id="Fact001077"
      unitRef="USD">318079</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2025-01-012025-12-31_custom_SoftwareAsAServiceMember"
      decimals="0"
      id="Fact001079"
      unitRef="USD">13095</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-01-012024-12-31_custom_SoftwareAsAServiceMember"
      decimals="0"
      id="Fact001080"
      unitRef="USD">12190</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact001082"
      unitRef="USD">15133647</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact001083"
      unitRef="USD">17771485</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="From2025-01-012025-12-31" id="Fact001085">&lt;p id="xdx_802_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zI95snCqAoug" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_828_zAbQaDXymMC4"&gt;ACCOUNTS
                                            RECEIVABLE, NET&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_896_eus-gaap--AccountsReceivableAllowanceForCreditLossTableTextBlock_zfVir888j26k" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BD_znvJQyUimXfa" style="display: none; font-size: 10pt"&gt;SCHEDULE
OF ACCOUNTS RECEIVABLES, NET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20251231_zWCZKGAGIEKa" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20241231_zLfbPbZHnOyf" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    4: Details of Accounts Receivable, Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--AccountsReceivableGrossCurrent_iI_hus-gaap--AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis__custom--BilledAccountsReceivableMember_zHKDQD6yKPnf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Billed accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,518,937&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,513,420&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AccountsReceivableGrossCurrent_iI_hus-gaap--AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis__custom--BilledAccountsReceivableFactoredMember_z1hwW9QYgvCg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Billed accounts receivable - factored&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,591,240&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,840,288&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccountsReceivableGrossCurrent_iI_hus-gaap--AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis__us-gaap--UnbilledRevenuesMember_zEjV4qJF2hq2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unbilled accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;45,325&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1096"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_di_zl3XqQR8EFH7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(468,023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1099"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccountsReceivableNetCurrent_iTI_zwm97dy94j2d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts
    receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,687,479&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,353,708&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_ztKlUdmeKI3d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December 31, 2025, the Company recorded $&lt;span id="xdx_90E_eus-gaap--AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_pn5n6_c20250101__20251231_zrWJhx4Nnsyj" title="Provision for credit losses"&gt;0.5&lt;/span&gt; million for provisions for credit losses, compared to &lt;span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_dc_c20240101__20241231_zqNESjiXx714" title="Provision for credit losses"&gt;zero&lt;/span&gt; U.S. dollars for
the year ended December 31, 2024. During both the year ended December 31, 2025 and 2024, the Company has &lt;span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_do_c20250101__20251231_zpwHCqpgVxyb" title="Write-off of outstanding receivables"&gt;&lt;span id="xdx_908_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_do_c20240101__20241231_zwSO0Bg6RNvi" title="Write-off of outstanding receivables"&gt;no&lt;/span&gt;&lt;/span&gt; write-offs of any outstanding
receivables.&lt;/span&gt;&lt;/p&gt;

</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock contextRef="From2025-01-012025-12-31" id="Fact001087">&lt;p id="xdx_896_eus-gaap--AccountsReceivableAllowanceForCreditLossTableTextBlock_zfVir888j26k" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BD_znvJQyUimXfa" style="display: none; font-size: 10pt"&gt;SCHEDULE
OF ACCOUNTS RECEIVABLES, NET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20251231_zWCZKGAGIEKa" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20241231_zLfbPbZHnOyf" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    4: Details of Accounts Receivable, Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--AccountsReceivableGrossCurrent_iI_hus-gaap--AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis__custom--BilledAccountsReceivableMember_zHKDQD6yKPnf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Billed accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,518,937&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,513,420&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AccountsReceivableGrossCurrent_iI_hus-gaap--AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis__custom--BilledAccountsReceivableFactoredMember_z1hwW9QYgvCg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Billed accounts receivable - factored&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,591,240&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,840,288&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccountsReceivableGrossCurrent_iI_hus-gaap--AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis__us-gaap--UnbilledRevenuesMember_zEjV4qJF2hq2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unbilled accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;45,325&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1096"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_di_zl3XqQR8EFH7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(468,023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1099"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccountsReceivableNetCurrent_iTI_zwm97dy94j2d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts
    receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,687,479&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,353,708&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="AsOf2025-12-31_custom_BilledAccountsReceivableMember"
      decimals="0"
      id="Fact001089"
      unitRef="USD">1518937</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="AsOf2024-12-31_custom_BilledAccountsReceivableMember"
      decimals="0"
      id="Fact001090"
      unitRef="USD">8513420</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="AsOf2025-12-31_custom_BilledAccountsReceivableFactoredMember"
      decimals="0"
      id="Fact001092"
      unitRef="USD">1591240</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="AsOf2024-12-31_custom_BilledAccountsReceivableFactoredMember"
      decimals="0"
      id="Fact001093"
      unitRef="USD">1840288</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="AsOf2025-12-31_us-gaap_UnbilledRevenuesMember"
      decimals="0"
      id="Fact001095"
      unitRef="USD">45325</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001098"
      unitRef="USD">468023</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001101"
      unitRef="USD">2687479</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001102"
      unitRef="USD">10353708</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
      contextRef="From2025-01-012025-12-31"
      decimals="-5"
      id="Fact001104"
      unitRef="USD">500000</us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease>
    <us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact001106"
      unitRef="USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact001108"
      unitRef="USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact001110"
      unitRef="USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2025-01-012025-12-31" id="Fact001112">&lt;p id="xdx_800_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zAdOuZFNb7h5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82E_zkQ2aNuoujGf"&gt;PROPERTY
                                            AND EQUIPMENT, NET&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_895_eus-gaap--PropertyPlantAndEquipmentTextBlock_zJmQFJ0h6dEf" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B1_zcQn3ORrJWQ9" style="display: none"&gt;SCHEDULE OF PROPERTY AND EQUIPMENT, NET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="25" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    5: Details of Property and Equipment, Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="22" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gross
    Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated
    &lt;br/&gt;Depreciation and &lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
    Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gross
    Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated
    &lt;br/&gt;Depreciation and &lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
    Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zyDLV8rbIF28" style="width: 6%; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1116"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zjqRbMkGc7fl" style="width: 6%; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1118"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zRb7xNP4uUNc" style="width: 6%; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1120"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zBPJQmxtn1n3" style="width: 6%; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;125,546&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zfryZp3Nuq7j" style="width: 6%; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(121,869&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zS8GTHIMghkf" style="width: 6%; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,677&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zFAsKhqdJVLe" style="text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1128"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zyQVXc0tQ6Zi" style="text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1130"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zuzMu1To1yC9" style="text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1132"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zRiFgnirFSch" style="text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,339&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zhL8xvumSqn7" style="text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(19,396&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zKvol8NGGsGe" style="text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,943&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z51SjSkNyfJl" style="text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1140"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zanMibwNAMVj" style="text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1142"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zbPqAylTwBJ5" style="text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1144"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z3uAfexd94i3" style="text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;62,721&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_ztE5A3Px4IPj" style="text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(62,721&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zHury8zpx9kc" style="text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1150"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Capital lease&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--CapitalLeaseMember_z1crWHdDKu0h" style="text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1152"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--CapitalLeaseMember_zHl3xuHu0ri1" style="text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1154"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--CapitalLeaseMember_zUx3cW8duObe" style="text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1156"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--CapitalLeaseMember_zpS7QiEOCmGg" style="text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,004&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--CapitalLeaseMember_zR47CZTBuP92" style="text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(19,897&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--CapitalLeaseMember_znKoZI7zd4df" style="text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,107&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zeIQ920Luzkh" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1164"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zSFFUdh0VzKc" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1166"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_z2ThWbnDowJa" style="border-bottom: Black 1pt solid; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1168"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zRBCRA78fAEa" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zHU4HiMfnemc" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(6,906&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zSMVgIggWzij" style="border-bottom: Black 1pt solid; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,594&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property
    and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20251231_zPgz3dXmNmA2" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1176"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20251231_ze4qBkisRnnf" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1178"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20251231_zXygMGNfflY8" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1180"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231_z444qCdY39z" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;251,110&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20241231_zGSk9HaFpOwj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(230,789&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20241231_zNHZn1lcSWVf" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,321&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zh7pCZiBDOLj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December 31, 2025 and 2024, the Company recorded immaterial amounts of depreciation expense in cost of revenue and selling,
general and administrative expenses. Additionally, during the third quarter of 2025, as part of the annual review of property and equipment,
the Company disposed of all assets categorized as property and equipment, which were fully depreciated already or had an immaterial acceleration
of depreciation and amortization.&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2025-01-012025-12-31" id="Fact001114">&lt;p id="xdx_895_eus-gaap--PropertyPlantAndEquipmentTextBlock_zJmQFJ0h6dEf" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B1_zcQn3ORrJWQ9" style="display: none"&gt;SCHEDULE OF PROPERTY AND EQUIPMENT, NET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="25" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    5: Details of Property and Equipment, Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="22" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gross
    Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated
    &lt;br/&gt;Depreciation and &lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
    Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gross
    Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated
    &lt;br/&gt;Depreciation and &lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
    Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zyDLV8rbIF28" style="width: 6%; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1116"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zjqRbMkGc7fl" style="width: 6%; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1118"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zRb7xNP4uUNc" style="width: 6%; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1120"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zBPJQmxtn1n3" style="width: 6%; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;125,546&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zfryZp3Nuq7j" style="width: 6%; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(121,869&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zS8GTHIMghkf" style="width: 6%; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,677&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zFAsKhqdJVLe" style="text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1128"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zyQVXc0tQ6Zi" style="text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1130"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zuzMu1To1yC9" style="text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1132"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zRiFgnirFSch" style="text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,339&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zhL8xvumSqn7" style="text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(19,396&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zKvol8NGGsGe" style="text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,943&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z51SjSkNyfJl" style="text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1140"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zanMibwNAMVj" style="text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1142"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zbPqAylTwBJ5" style="text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1144"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z3uAfexd94i3" style="text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;62,721&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_ztE5A3Px4IPj" style="text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(62,721&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zHury8zpx9kc" style="text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1150"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Capital lease&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--CapitalLeaseMember_z1crWHdDKu0h" style="text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1152"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--CapitalLeaseMember_zHl3xuHu0ri1" style="text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1154"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--CapitalLeaseMember_zUx3cW8duObe" style="text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1156"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--CapitalLeaseMember_zpS7QiEOCmGg" style="text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,004&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--CapitalLeaseMember_zR47CZTBuP92" style="text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(19,897&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--CapitalLeaseMember_znKoZI7zd4df" style="text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,107&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zeIQ920Luzkh" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1164"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zSFFUdh0VzKc" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1166"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_z2ThWbnDowJa" style="border-bottom: Black 1pt solid; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1168"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zRBCRA78fAEa" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zHU4HiMfnemc" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(6,906&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zSMVgIggWzij" style="border-bottom: Black 1pt solid; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,594&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property
    and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20251231_zPgz3dXmNmA2" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1176"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20251231_ze4qBkisRnnf" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1178"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20251231_zXygMGNfflY8" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1180"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231_z444qCdY39z" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;251,110&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20241231_zGSk9HaFpOwj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(230,789&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20241231_zNHZn1lcSWVf" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,321&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-12-31_us-gaap_EquipmentMember"
      decimals="0"
      id="Fact001122"
      unitRef="USD">125546</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_us-gaap_EquipmentMember"
      decimals="0"
      id="Fact001124"
      unitRef="USD">121869</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-12-31_us-gaap_EquipmentMember"
      decimals="0"
      id="Fact001126"
      unitRef="USD">3677</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-12-31_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      id="Fact001134"
      unitRef="USD">26339</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      id="Fact001136"
      unitRef="USD">19396</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-12-31_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      id="Fact001138"
      unitRef="USD">6943</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-12-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      id="Fact001146"
      unitRef="USD">62721</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      id="Fact001148"
      unitRef="USD">62721</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-12-31_custom_CapitalLeaseMember"
      decimals="0"
      id="Fact001158"
      unitRef="USD">23004</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_CapitalLeaseMember"
      decimals="0"
      id="Fact001160"
      unitRef="USD">19897</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-12-31_custom_CapitalLeaseMember"
      decimals="0"
      id="Fact001162"
      unitRef="USD">3107</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="0"
      id="Fact001170"
      unitRef="USD">13500</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="0"
      id="Fact001172"
      unitRef="USD">6906</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="0"
      id="Fact001174"
      unitRef="USD">6594</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001182"
      unitRef="USD">251110</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001184"
      unitRef="USD">230789</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001186"
      unitRef="USD">20321</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock contextRef="From2025-01-012025-12-31" id="Fact001188">&lt;p id="xdx_80A_eus-gaap--ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_zkLkRlHXKcHj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82A_z4G1wPspfxk6"&gt;SOFTWARE
                                            DEVELOPMENT COSTS&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
2024, the Company reclassified software development costs from property and equipment to software development costs. The Company continues
to incur costs to develop new modules, functionalities, and integrations on the previously purchased SaaS platform in order to develop
a new product with differentiated offering. As of December 31, 2025, the SaaS platform is still in the development stage and is not ready
for external sales. &lt;span id="xdx_907_eus-gaap--AdjustmentForAmortization_do_c20250101__20251231_zsmvzUwT95V7" title="Amortization"&gt;&lt;span id="xdx_90F_eus-gaap--AdjustmentForAmortization_do_c20240101__20241231_zmlJQPdZlSz5" title="Amortization"&gt;No&lt;/span&gt;&lt;/span&gt; amortization has been recorded during the years ended December 31, 2025 and 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_ecustom--ScheduleOfSoftwareDevelopmentCostsTableTextBlock_zZEmHPG7Zas5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_zXM66vmNc7jg" style="display: none"&gt;SCHEDULE OF SOFTWARE DEVELOPMENT COSTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20250101__20251231_zcKc3mvrNOq1" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20240101__20241231_zV6D1lGvRlY1" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    6: Capitalized Software Development Costs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--CapitalizedComputerSoftwarePeriodIncreaseDecrease_zXcgXyOAcUTa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Capitalized software development
    costs&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;455,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;448,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zrwT1IvZ0Qp3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact001190"
      unitRef="USD">0</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact001192"
      unitRef="USD">0</us-gaap:AdjustmentForAmortization>
    <CYCU:ScheduleOfSoftwareDevelopmentCostsTableTextBlock contextRef="From2025-01-012025-12-31" id="Fact001194">&lt;p id="xdx_89F_ecustom--ScheduleOfSoftwareDevelopmentCostsTableTextBlock_zZEmHPG7Zas5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_zXM66vmNc7jg" style="display: none"&gt;SCHEDULE OF SOFTWARE DEVELOPMENT COSTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20250101__20251231_zcKc3mvrNOq1" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20240101__20241231_zV6D1lGvRlY1" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    6: Capitalized Software Development Costs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--CapitalizedComputerSoftwarePeriodIncreaseDecrease_zXcgXyOAcUTa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Capitalized software development
    costs&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;455,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;448,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</CYCU:ScheduleOfSoftwareDevelopmentCostsTableTextBlock>
    <us-gaap:CapitalizedComputerSoftwarePeriodIncreaseDecrease
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact001196"
      unitRef="USD">455000</us-gaap:CapitalizedComputerSoftwarePeriodIncreaseDecrease>
    <us-gaap:CapitalizedComputerSoftwarePeriodIncreaseDecrease
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact001197"
      unitRef="USD">448000</us-gaap:CapitalizedComputerSoftwarePeriodIncreaseDecrease>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2025-01-012025-12-31" id="Fact001199">&lt;p id="xdx_807_eus-gaap--IntangibleAssetsDisclosureTextBlock_z7BqDcvZPlvl" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82F_z5U4atoHpYIk"&gt;INTANGIBLE
                                            ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_z1VHNrjOUYHk" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BA_zhKTrBPxZKdj" style="display: none"&gt;SCHEDULE OF INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="25" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    7.1: Details of Intangible Assets, Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="22" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gross
    Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated
    &lt;br/&gt;Depreciation and &lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
    Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gross
    Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated
    &lt;br/&gt;Depreciation and &lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
    Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Contractual relationship&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractualRelationshipMember_zki9GJSB2H75" style="width: 6%; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1203"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractualRelationshipMember_z1zoymFDZGb4" style="width: 6%; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1205"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractualRelationshipMember_zVLu7RgZMqV5" style="width: 6%; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1207"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractualRelationshipMember_zeUVrcQlaiTj" style="width: 6%; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;66,361&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractualRelationshipMember_zag6TfNQa5m7" style="width: 6%; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(66,361&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractualRelationshipMember_z5YESQeTnAna" style="width: 6%; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1213"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Implementation&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ImplementationMember_zgMVxBbLuSXd" style="text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1215"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ImplementationMember_zRiy72S6amT8" style="text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1217"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ImplementationMember_zSsObzZWNIV7" style="text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1219"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ImplementationMember_ze3abmbTMNpl" style="text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;28,099&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ImplementationMember_zBt58ySzrJa" style="text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(28,099&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ImplementationMember_zHOHwTyyLnt8" style="text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1225"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember_zs8mycAgZN5c" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1227"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember_z36zto7yCbFe" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1229"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember_zVzbtNe06bWj" style="border-bottom: Black 1pt solid; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1231"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember_zVdDe1wZw074" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember_zVC9lZvsDTa3" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(75,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember_z5SL8iCjnqi4" style="border-bottom: Black 1pt solid; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;25,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intangible
    assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20251231_zyZwxtXedLj5" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1239"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20251231_zSMWixFhEHQa" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1241"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20251231_zR2wv10ZJlhj" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1243"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20241231_zE7eLSQYkzr9" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;194,460&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20241231_zfmCnY47kIO2" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(169,460&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20241231_zqEbNTbrgtef" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;25,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zwCe33JgV6Je" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_z7zevj1nDVx8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zPHMflrnPs84" style="display: none"&gt;SCHEDULE OF INTANGIBLE ASSET AMORTIZATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20250101__20251231_zaInVGLbcl0h" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20240101__20241231_zGeOS3nrawNd" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    7.2: Details of Intangible Asset Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AmortizationOfIntangibleAssets_zIHytBiapOA4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization expense, presented
    in SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;25,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,667&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zeJveWPmqabb" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2025-01-012025-12-31" id="Fact001201">&lt;p id="xdx_893_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_z1VHNrjOUYHk" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BA_zhKTrBPxZKdj" style="display: none"&gt;SCHEDULE OF INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="25" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    7.1: Details of Intangible Assets, Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="22" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gross
    Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated
    &lt;br/&gt;Depreciation and &lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
    Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gross
    Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated
    &lt;br/&gt;Depreciation and &lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
    Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Contractual relationship&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractualRelationshipMember_zki9GJSB2H75" style="width: 6%; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1203"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractualRelationshipMember_z1zoymFDZGb4" style="width: 6%; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1205"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractualRelationshipMember_zVLu7RgZMqV5" style="width: 6%; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1207"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractualRelationshipMember_zeUVrcQlaiTj" style="width: 6%; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;66,361&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractualRelationshipMember_zag6TfNQa5m7" style="width: 6%; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(66,361&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractualRelationshipMember_z5YESQeTnAna" style="width: 6%; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1213"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Implementation&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ImplementationMember_zgMVxBbLuSXd" style="text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1215"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ImplementationMember_zRiy72S6amT8" style="text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1217"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ImplementationMember_zSsObzZWNIV7" style="text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1219"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ImplementationMember_ze3abmbTMNpl" style="text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;28,099&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ImplementationMember_zBt58ySzrJa" style="text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(28,099&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ImplementationMember_zHOHwTyyLnt8" style="text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1225"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember_zs8mycAgZN5c" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1227"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember_z36zto7yCbFe" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1229"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember_zVzbtNe06bWj" style="border-bottom: Black 1pt solid; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1231"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember_zVdDe1wZw074" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember_zVC9lZvsDTa3" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(75,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember_z5SL8iCjnqi4" style="border-bottom: Black 1pt solid; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;25,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intangible
    assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20251231_zyZwxtXedLj5" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1239"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20251231_zSMWixFhEHQa" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1241"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20251231_zR2wv10ZJlhj" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1243"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20241231_zE7eLSQYkzr9" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;194,460&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20241231_zfmCnY47kIO2" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Depreciation and Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(169,460&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20241231_zqEbNTbrgtef" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Carrying Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;25,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-12-31_custom_ContractualRelationshipMember"
      decimals="0"
      id="Fact001209"
      unitRef="USD">66361</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-12-31_custom_ContractualRelationshipMember"
      decimals="0"
      id="Fact001211"
      unitRef="USD">-66361</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-12-31_custom_ImplementationMember"
      decimals="0"
      id="Fact001221"
      unitRef="USD">28099</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-12-31_custom_ImplementationMember"
      decimals="0"
      id="Fact001223"
      unitRef="USD">-28099</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-12-31_custom_SoftwareMember"
      decimals="0"
      id="Fact001233"
      unitRef="USD">100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-12-31_custom_SoftwareMember"
      decimals="0"
      id="Fact001235"
      unitRef="USD">-75000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-12-31_custom_SoftwareMember"
      decimals="0"
      id="Fact001237"
      unitRef="USD">25000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001245"
      unitRef="USD">194460</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001247"
      unitRef="USD">-169460</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001249"
      unitRef="USD">25000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock contextRef="From2025-01-012025-12-31" id="Fact001251">&lt;p id="xdx_898_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_z7zevj1nDVx8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zPHMflrnPs84" style="display: none"&gt;SCHEDULE OF INTANGIBLE ASSET AMORTIZATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20250101__20251231_zaInVGLbcl0h" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20240101__20241231_zGeOS3nrawNd" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    7.2: Details of Intangible Asset Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AmortizationOfIntangibleAssets_zIHytBiapOA4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization expense, presented
    in SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;25,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,667&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact001253"
      unitRef="USD">25000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact001254"
      unitRef="USD">16667</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2025-01-012025-12-31" id="Fact001256">&lt;p id="xdx_800_eus-gaap--BusinessCombinationDisclosureTextBlock_z4aLnu4pckOb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_823_zoRGFXerndf9"&gt;BUSINESS
                                            COMBINATION&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;SLG
Innovation, Inc.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SLG
is a technology services firm with operations and client contracts deemed to be strategically complementary to the Company&#x2019;s existing
business and long-term growth objectives. As of December 31, 2020, the Company had initiated discussions regarding the potential acquisition
of SLG and had advanced a non-refundable deposit of $&lt;span id="xdx_901_eus-gaap--DepositsAssets_iI_c20201231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zzXNpu06n5Ek" title="Deposits assets"&gt;1,401,923&lt;/span&gt; for cash advances, loans, capitalized transaction costs and accounts receivable
arising from prior business dealings with SLG. On May 13, 2021, the Company entered into an agreement to acquire substantially all of
SLG&#x2019;s assets and certain liabilities, which included a termination right exercisable at the Company&#x2019;s sole discretion prior
to December 31, 2021. This agreement was subsequently amended to limit the acquisition to certain specified assets, primarily identifiable
sales contracts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2024, the refundable deposit had increased to $&lt;span id="xdx_90A_eus-gaap--Deposits_iI_c20241231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zAj1t0UQoYNd" title="Deposits"&gt;2,000,000&lt;/span&gt;, comprising $&lt;span id="xdx_904_eus-gaap--DepositsAssets_iI_c20241231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zPau5Qmi4Kyh" title="Deposits assets"&gt;561,808&lt;/span&gt; in cash advances and loans, $&lt;span id="xdx_908_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_c20241231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zJXuXmwV3QP6" title="Net assets acquired"&gt;20,000&lt;/span&gt; in
due diligence costs, and $&lt;span id="xdx_901_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_c20241231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zIFZBBboRYE3" title="Accounts receivable"&gt;1,418,192&lt;/span&gt; in accounts receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 29, 2023, the Company and SLG executed a unidirectional letter of intent (&#x201c;SLG LOI&#x201d;), which bound SLG to the transaction
but did not obligate the Company. The SLG LOI provided that, unless terminated by the Company on or before April 30, 2024, the Company
would proceed to acquire SLG or substantially all of its assets and liabilities through a structure to be finalized. The agreed-upon
valuation included the $&lt;span id="xdx_903_eus-gaap--DepositsAssets_iI_c20230429__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zgj8ke88cTb1" title="Deposits"&gt;2,000,000&lt;/span&gt; receivable, $&lt;span id="xdx_903_eus-gaap--AccountsPayableOtherCurrent_iI_c20230429__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zvpSo5XUtfgk" title="Accounts payable, other current"&gt;2,136,445&lt;/span&gt; in SLG payables to RCR Technology Corporation (excluding payables incurred within
&lt;span id="xdx_904_ecustom--BusinessCombinationExcludingPayablesIncurredPriorToClosingPeriod_dtD_c20230429__20230429__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zrlh6maOFBdk" title="Business combination, excluding payables incurred prior to closing, period"&gt;90&lt;/span&gt; days prior to closing), and &lt;span id="xdx_902_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20230429__20230429__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zI9quwHu4rW" title="Number of preferred stock converted"&gt;33,212&lt;/span&gt; shares of the Company&#x2019;s capital stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the potential SLG transaction, the Company entered into a separate unidirectional letter of intent with RCR (&#x201c;RCR
LOI&#x201d;) on April 29, 2023, under which the Company would acquire SLG&#x2019;s payables owed to RCR, subject to the closing of the
potential SLG transaction. Consideration for the RCR transaction was to be settled in the form of shares of Common Stock of the Company,
as specified in the RCR LOI.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
transaction contemplated by the SLG LOI did not close and the Company does not expect that it will close. In lieu of such transaction,
and consistent with the economic and business relationship between SLG and the Company for more than the past two years, on March 31,
2025, the Company and SLG entered into a Management Services Agreement (the &#x201c;MSA&#x201d;), pursuant to which SLG memorialized its
formal engagement of the Company to provide the Management Services (as defined in the MSA) on the terms and subject to the conditions
set forth therein. The parties agreed that the Company would continue to retain sole and absolute discretion to select its employees
and/or independent contractors who would perform and support the Management Services; provided that the compensation paid to any such
persons shall not exceed the compensation that would have been paid to a comparable, unaffiliated third party on a commercial, arms-length
basis. SLG agreed to cooperate in good faith with the Company in furtherance of its continued performance of the Management Services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Management Services to be provided by the Company, SLG agreed to pay a fee equal to SLG&#x2019;s &#x201c;operational
cash flow&#x201d; (whether or not the inbound funds included were recognized as revenue under U.S. GAAP and whether or not the outbound
funds were recognized as expenses under U.S. GAAP during the relevant reporting period). For purposes of the MSA, &#x201c;operational
cash flow&#x201d; means (i) all cash and cash-equivalencies received by, or on behalf of, SLG from any source for any reason during any
reporting period &lt;i&gt;&lt;span style="text-decoration: underline"&gt;minus&lt;/span&gt;&lt;/i&gt; (ii) all payments made by, or on behalf of, SLG, all in connection with SLG&#x2019;s business as
historically operated and as managed by the Company in accordance with the provisions of the MSA. If SLG&#x2019;s operational cash flow
during any reporting period is negative, then the Company reserves the right (in its sole and absolute discretion) to advance funds to
SLG in an amount not to exceed such negative cash flow during such period with an interest rate to be determined on a case-by-case basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the execution and delivery of the MSA, the Company and Ed Burns entered into a Release Agreement (the &#x201c;Burns Release
Agreement&#x201d;), pursuant to which the Company acknowledged that it has provided and will continue to provide certain services to SLG
as a subcontractor and Mr. Burns agreed to release certain claims that he had, has, or may have against the Company or SLG in relation
to the terms and conditions of the MSA, the transactions contemplated thereby, or the manner in which the Company and SLG became parties
to the MSA, as well as the relationship between the Company and SLG prior to the date of the MSA and the Company issued to Mr. Burns
&lt;span id="xdx_901_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zZBrPMlVYYCa" title="Common stock, authorized"&gt;33,609&lt;/span&gt; shares of Common Stock and &lt;span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_pid_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_z8BTh9qiTu8e" title="Preferred stock, shares issued"&gt;51&lt;/span&gt; shares of Series E Convertible Preferred Stock with a face value of $&lt;span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zTJTNGpTXTX3" title="Principal amount"&gt;10,000&lt;/span&gt; and conversion price
of $&lt;span id="xdx_908_eus-gaap--PreferredStockConvertibleConversionPrice_iI_pid_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zjaCH0ra7Aai" title="Conversion price"&gt;1.00&lt;/span&gt;. The Company offered a substantially equivalent release agreement to the owner of &lt;span id="xdx_904_ecustom--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestPercentage_iI_pid_dp_uPure_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zgUFlg702sck" title="Business combination, noncontrolling interest, percentage"&gt;49&lt;/span&gt;% of the equity of SLG with a percentage-equivalent
contingent issuance of Common Stock and Series E Convertible Preferred Stock. As of the date of this quarterly report, such other release
has not been accepted or executed and delivered.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 31, 2025, the company entered into a Management Services Agreement and a Release agreement (the &#x201c;Agreement&#x201d;) to gain
control of SLG as a VIE. The total purchase consideration for the VIE contractual relationship of SLG consisted primarily of:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;prepaid
                                            deposit of $&lt;span id="xdx_907_eus-gaap--PaymentsForDeposits_c20250331__20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zIzuSJwbnMfe" title="Principal amount"&gt;2,000,000&lt;/span&gt;;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_znPYukZRMIC5" title="Common stock, shares authorized"&gt;33,609&lt;/span&gt;
                                            shares of Common Stock having par value of $&lt;span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zIT0gseyBfPd" title="Common stock, par value"&gt;0.0001&lt;/span&gt; per share;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--PreferredStockSharesIssued_iI_pid_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zuigcq98NCsc" title="Preferred stock, shares issued"&gt;51&lt;/span&gt;
                                            shares of Series E Convertible Preferred Stock with a face value of $&lt;span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zo6xt0O0isIe" title="Principal amount"&gt;10,000&lt;/span&gt; and conversion
                                            price of $&lt;span id="xdx_90B_eus-gaap--PreferredStockConvertibleConversionPrice_iI_pid_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zY9fgLwrNHub" title="Conversion price"&gt;1.00&lt;/span&gt;; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_909_eus-gaap--IncreaseDecreaseInAccountsAndNotesReceivable_c20250331__20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zdh7F4uFZoWb" title="Accounts receivable"&gt;10,814,147&lt;/span&gt;
                                            of accounts receivable in Cycurion owing from SLG&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has determined that the SLG transaction constitutes a business combination as defined by ASC 805, Business Combinations (&#x201c;ASC
805&#x201d;). ASC 805 establishes principles and requirements as to how the acquirer of a business recognizes and measures in its financial
statements the identifiable assets acquired, the liabilities assumed and any non-controlling interest in the acquiree. The assets acquired
and liabilities assumed were recognized provisionally in the accompanying consolidated balance sheets at their estimated fair values
as of March 31, 2025, and adjusted in the second and third quarter of 2025. The initial accounting for the business combination is not
complete as the Company is in the process of obtaining additional information for the valuation of acquired assets and liabilities, if
any. The provisional amounts are subject to change to the extent that additional information is obtained about the facts and circumstances
that existed as of the acquisition date. Under U.S. GAAP, the measurement period shall not exceed one year from the acquisition date
and the Company will finalize these amounts no later than March 31, 2026. The estimated fair values as of the business combination date
are based on information that existed as of the acquisition date. During the measurement period the Company may adjust provisional amounts
recorded for assets acquired and liabilities assumed to reflect new information that the Company has subsequently obtained regarding
facts and circumstances that existed as of the transaction date. The results of operations for SLG are included in the consolidated results
of Cycurion, Inc. starting April 1, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zuJrhZpp0Pxa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_z7bWrzKmHRyd" style="display: none"&gt;SCHEDULE OF FAIR VALUE OF CONSIDERATION TRANSFERRED ASSETS ACQUIRED LIABILITIES ASSUMED&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--InitialAllocationOfAssetsAndLiabilitiesMember_zs6GeehabEj8" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Initial
                                            Allocation of&lt;/span&gt;&lt;/p&gt; &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Assets
                                            and Liabilities &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AdjustmentsMember_zWsMHUfTjKH7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EstimatedAllocationOfAssetAandLiabilitiesMember_zX5uEjOK4XWe" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Estimated
    Allocation &lt;br/&gt;of Assets and &lt;br/&gt;Liabilities as of &lt;br/&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="13" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    8: SLG Valuation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Initial
                                            Allocation of&lt;/span&gt;&lt;/p&gt; &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Assets
                                            and Liabilities &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Estimated
    Allocation &lt;br/&gt;of Assets and &lt;br/&gt;Liabilities as of &lt;br/&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash
    consideration:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 46%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PaymentsToAcquireBusinessesGross_c20250101__20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--InitialAllocationOfAssetsAndLiabilitiesMember_zuOFEcbyOAKk" style="width: 14%; text-align: right" title="Cash consideration"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PaymentsToAcquireBusinessesGross_c20250101__20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AdjustmentsMember_zNjIadZJTau2" style="width: 14%; text-align: right" title="Cash consideration"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1304"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PaymentsToAcquireBusinessesGross_c20250101__20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EstimatedAllocationOfAssetAandLiabilitiesMember_zA6W4alW5KIf" style="width: 14%; text-align: right" title="Cash consideration"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less:
    cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--BusinessCombinationRecognizedCashAcquired_iN_di_c20250101__20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--InitialAllocationOfAssetsAndLiabilitiesMember_zS0WOW0vVoOl" style="border-bottom: Black 1pt solid; text-align: right" title="Less: cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(34,983&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--BusinessCombinationRecognizedCashAcquired_iN_di_c20250101__20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AdjustmentsMember_z3duuURzvVae" style="border-bottom: Black 1pt solid; text-align: right" title="Less: cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1310"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--BusinessCombinationRecognizedCashAcquired_iN_di_c20250101__20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EstimatedAllocationOfAssetAandLiabilitiesMember_zvfn71HbuBr7" style="border-bottom: Black 1pt solid; text-align: right" title="Less: cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(34,983&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash consideration, net
    of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_c20250101__20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--InitialAllocationOfAssetsAndLiabilitiesMember_zJ1Vfp8mAL8a" style="text-align: right" title="Cash consideration, net of cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,965,017&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_c20250101__20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AdjustmentsMember_zVZ22s9iqNk4" style="text-align: right" title="Cash consideration, net of cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1316"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_c20250101__20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EstimatedAllocationOfAssetAandLiabilitiesMember_zRfyUstTITeg" style="text-align: right" title="Cash consideration, net of cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,965,017&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Noncash consideration:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_iI_hus-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_znWX8OcCx481" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common Stock &lt;span id="xdx_F48_z5IPTjyOald3"&gt;(1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;254,071&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,071&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;504,142&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_iI_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zbEUJwBwVCoh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Series E Convertible Preferred
    Stock &lt;span id="xdx_F49_z1W330aDv5S3"&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;255,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1325"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;255,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_iI_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zWGJVFiy7nad" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Fair value of stock&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;255,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1329"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;255,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--BusinessCombinationNonCashConsiderationOnAccountsReceivable_zyO3vFReohvl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts
    receivable in Cycurion owing from SLG &lt;span id="xdx_F47_zvbd23gygsug"&gt;(3)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,814,147&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1333"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,814,147&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--BusinessCombinationNonCashConsiderationTransferred_iI_zvOcG8Bl2eH5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Noncash
    consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,323,218&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,071&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,573,289&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--BusinessCombinationConsiderationTransferred_iI_zaCHwRQddG1k" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,288,235&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,071&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,538,306&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Assets
    acquired:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_zP45PiiM53I6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,066,581&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1345"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,066,581&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_zcirZzdUsqek" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    identified assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,066,581&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1349"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,066,581&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-decoration: underline; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liabilities
    assumed:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_zuAczs0ndnJ1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,317,052&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1353"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,317,052&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiability_iI_zOU7tKZfryCj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,650&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;54,209&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;64,859&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--PayrollLiability_iI_zWyfoTWpcArj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Payroll liability&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;40,642&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1361"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;40,642&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesFactoringLiability_iI_zG2hop1QN0gf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Factoring liability&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,176,922&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1365"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,176,922&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_iI_zhkIXGpjFEdb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Due to related parties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1369"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable_iI_z35eMsBfSbxb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loans payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;625,222&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1373"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;625,222&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_iI_zAMzjPI59f81" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liabilities
    to Cycurion&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,982,908&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1377"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,982,908&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_z1cddAr7UGSa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    identified liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,171,396&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;54,209&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,225,605&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iNI_di_z1UcIVelTjwb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net identifiable liabilities
    assumed&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,104,815&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(54,209&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,159,024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--BusinessCombinationEliminationOfInterCompanyBalances_iI_zKcgq9iCYVLa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Elimination of inter-company
    balances&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,982,908&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1389"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,982,908&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_iNI_di_zGr35w7iEWb4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,464,218&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1393"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,464,218&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--Goodwill_iI_z3Z36FGzaKs8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,945,924&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;304,280&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,250,204&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_zdQdJm8IdyQg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,288,235&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,071&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,538,306&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F05_zTRuFwXTTyR4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F12_zdGi733P61E4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents the fair value
                                                                                                                                                                of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSERFVUxFIE9GIEZBSVIgVkFMVUUgT0YgQ09OU0lERVJBVElPTiBUUkFOU0ZFUlJFRCBBU1NFVFMgQUNRVUlSRUQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90E_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250331__20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zAq8aQVuo1ca" title="Number of preferred stock converted"&gt;33,609&lt;/span&gt; Common Stock issued in the SLG transaction based on the quoted stock price on the date of issuance.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F0E_zVyGw7BUQt54" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F11_zY1rLDCJKQOd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents the fair value
                                                                                                                                                                of the Series E Convertible Preferred Stock as is converted to Common Stock based on the quoted price Common Stock on the date of
                                                                                                                                                                issuance.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F00_zJexijnOxY0f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1B_zYdIFx1Key85" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents the fair value
                                                                                                                                                                of the accounts receivable in Cycurion owing from SLG.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair value of the
                                                                                                                                                                noncontrolling interest based on NCI&#x2019;s &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSERFVUxFIE9GIEZBSVIgVkFMVUUgT0YgQ09OU0lERVJBVElPTiBUUkFOU0ZFUlJFRCBBU1NFVFMgQUNRVUlSRUQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_900_ecustom--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestPercentage_iI_pid_dp_uPure_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_z874zpJu6UKi" title="Number of preferred stock converted"&gt;49&lt;/span&gt;% interest in the net assets acquired.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Goodwill is calculated as
                                                                                                                                                                Total Consideration paid less the net assets acquired.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8AD_zXETTglsXQcc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:DepositsAssets
      contextRef="AsOf2020-12-31_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact001258"
      unitRef="USD">1401923</us-gaap:DepositsAssets>
    <us-gaap:Deposits
      contextRef="AsOf2024-12-31_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact001260"
      unitRef="USD">2000000</us-gaap:Deposits>
    <us-gaap:DepositsAssets
      contextRef="AsOf2024-12-31_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact001262"
      unitRef="USD">561808</us-gaap:DepositsAssets>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="AsOf2024-12-31_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact001264"
      unitRef="USD">20000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="AsOf2024-12-31_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact001266"
      unitRef="USD">1418192</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:DepositsAssets
      contextRef="AsOf2023-04-29_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact001268"
      unitRef="USD">2000000</us-gaap:DepositsAssets>
    <us-gaap:AccountsPayableOtherCurrent
      contextRef="AsOf2023-04-29_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact001270"
      unitRef="USD">2136445</us-gaap:AccountsPayableOtherCurrent>
    <CYCU:BusinessCombinationExcludingPayablesIncurredPriorToClosingPeriod
      contextRef="From2023-04-292023-04-29_custom_SLGInnovationIncMember"
      id="Fact001272">P90D</CYCU:BusinessCombinationExcludingPayablesIncurredPriorToClosingPeriod>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2023-04-292023-04-29_custom_SLGInnovationIncMember"
      decimals="INF"
      id="Fact001274"
      unitRef="Shares">33212</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember"
      decimals="INF"
      id="Fact001276"
      unitRef="Shares">33609</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember_us-gaap_SeriesEPreferredStockMember"
      decimals="INF"
      id="Fact001278"
      unitRef="Shares">51</us-gaap:PreferredStockSharesIssued>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember_us-gaap_SeriesEPreferredStockMember"
      decimals="0"
      id="Fact001280"
      unitRef="USD">10000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember_us-gaap_SeriesEPreferredStockMember"
      decimals="INF"
      id="Fact001282"
      unitRef="USDPShares">1.00</us-gaap:PreferredStockConvertibleConversionPrice>
    <CYCU:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestPercentage
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember_us-gaap_SeriesEPreferredStockMember"
      decimals="INF"
      id="Fact001284"
      unitRef="Pure">0.49</CYCU:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestPercentage>
    <us-gaap:PaymentsForDeposits
      contextRef="From2025-03-312025-03-31_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact001286"
      unitRef="USD">2000000</us-gaap:PaymentsForDeposits>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember"
      decimals="INF"
      id="Fact001288"
      unitRef="Shares">33609</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember"
      decimals="INF"
      id="Fact001290"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember_us-gaap_SeriesEPreferredStockMember"
      decimals="INF"
      id="Fact001292"
      unitRef="Shares">51</us-gaap:PreferredStockSharesIssued>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember_us-gaap_SeriesEPreferredStockMember"
      decimals="0"
      id="Fact001294"
      unitRef="USD">10000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember_us-gaap_SeriesEPreferredStockMember"
      decimals="INF"
      id="Fact001296"
      unitRef="USDPShares">1.00</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable
      contextRef="From2025-03-312025-03-31_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact001298"
      unitRef="USD">10814147</us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="From2025-01-012025-12-31" id="Fact001300">&lt;p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zuJrhZpp0Pxa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_z7bWrzKmHRyd" style="display: none"&gt;SCHEDULE OF FAIR VALUE OF CONSIDERATION TRANSFERRED ASSETS ACQUIRED LIABILITIES ASSUMED&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--InitialAllocationOfAssetsAndLiabilitiesMember_zs6GeehabEj8" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Initial
                                            Allocation of&lt;/span&gt;&lt;/p&gt; &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Assets
                                            and Liabilities &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AdjustmentsMember_zWsMHUfTjKH7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EstimatedAllocationOfAssetAandLiabilitiesMember_zX5uEjOK4XWe" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Estimated
    Allocation &lt;br/&gt;of Assets and &lt;br/&gt;Liabilities as of &lt;br/&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="13" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    8: SLG Valuation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Initial
                                            Allocation of&lt;/span&gt;&lt;/p&gt; &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Assets
                                            and Liabilities &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Estimated
    Allocation &lt;br/&gt;of Assets and &lt;br/&gt;Liabilities as of &lt;br/&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash
    consideration:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 46%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PaymentsToAcquireBusinessesGross_c20250101__20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--InitialAllocationOfAssetsAndLiabilitiesMember_zuOFEcbyOAKk" style="width: 14%; text-align: right" title="Cash consideration"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PaymentsToAcquireBusinessesGross_c20250101__20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AdjustmentsMember_zNjIadZJTau2" style="width: 14%; text-align: right" title="Cash consideration"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1304"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PaymentsToAcquireBusinessesGross_c20250101__20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EstimatedAllocationOfAssetAandLiabilitiesMember_zA6W4alW5KIf" style="width: 14%; text-align: right" title="Cash consideration"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less:
    cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--BusinessCombinationRecognizedCashAcquired_iN_di_c20250101__20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--InitialAllocationOfAssetsAndLiabilitiesMember_zS0WOW0vVoOl" style="border-bottom: Black 1pt solid; text-align: right" title="Less: cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(34,983&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--BusinessCombinationRecognizedCashAcquired_iN_di_c20250101__20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AdjustmentsMember_z3duuURzvVae" style="border-bottom: Black 1pt solid; text-align: right" title="Less: cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1310"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--BusinessCombinationRecognizedCashAcquired_iN_di_c20250101__20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EstimatedAllocationOfAssetAandLiabilitiesMember_zvfn71HbuBr7" style="border-bottom: Black 1pt solid; text-align: right" title="Less: cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(34,983&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash consideration, net
    of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_c20250101__20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--InitialAllocationOfAssetsAndLiabilitiesMember_zJ1Vfp8mAL8a" style="text-align: right" title="Cash consideration, net of cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,965,017&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_c20250101__20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AdjustmentsMember_zVZ22s9iqNk4" style="text-align: right" title="Cash consideration, net of cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1316"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_c20250101__20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EstimatedAllocationOfAssetAandLiabilitiesMember_zRfyUstTITeg" style="text-align: right" title="Cash consideration, net of cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,965,017&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Noncash consideration:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_iI_hus-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_znWX8OcCx481" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common Stock &lt;span id="xdx_F48_z5IPTjyOald3"&gt;(1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;254,071&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,071&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;504,142&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_iI_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zbEUJwBwVCoh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Series E Convertible Preferred
    Stock &lt;span id="xdx_F49_z1W330aDv5S3"&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;255,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1325"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;255,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_iI_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zWGJVFiy7nad" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Fair value of stock&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;255,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1329"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;255,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--BusinessCombinationNonCashConsiderationOnAccountsReceivable_zyO3vFReohvl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts
    receivable in Cycurion owing from SLG &lt;span id="xdx_F47_zvbd23gygsug"&gt;(3)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,814,147&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1333"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,814,147&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--BusinessCombinationNonCashConsiderationTransferred_iI_zvOcG8Bl2eH5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Noncash
    consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,323,218&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,071&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,573,289&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--BusinessCombinationConsiderationTransferred_iI_zaCHwRQddG1k" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,288,235&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,071&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,538,306&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Assets
    acquired:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_zP45PiiM53I6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,066,581&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1345"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,066,581&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_zcirZzdUsqek" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    identified assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,066,581&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1349"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,066,581&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-decoration: underline; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liabilities
    assumed:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_zuAczs0ndnJ1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,317,052&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1353"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,317,052&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiability_iI_zOU7tKZfryCj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,650&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;54,209&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;64,859&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--PayrollLiability_iI_zWyfoTWpcArj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Payroll liability&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;40,642&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1361"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;40,642&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesFactoringLiability_iI_zG2hop1QN0gf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Factoring liability&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,176,922&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1365"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,176,922&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_iI_zhkIXGpjFEdb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Due to related parties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1369"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable_iI_z35eMsBfSbxb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loans payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;625,222&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1373"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;625,222&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_iI_zAMzjPI59f81" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liabilities
    to Cycurion&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,982,908&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1377"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,982,908&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_z1cddAr7UGSa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    identified liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,171,396&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;54,209&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,225,605&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iNI_di_z1UcIVelTjwb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net identifiable liabilities
    assumed&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,104,815&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(54,209&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,159,024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--BusinessCombinationEliminationOfInterCompanyBalances_iI_zKcgq9iCYVLa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Elimination of inter-company
    balances&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,982,908&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1389"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,982,908&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_iNI_di_zGr35w7iEWb4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,464,218&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1393"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,464,218&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--Goodwill_iI_z3Z36FGzaKs8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,945,924&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;304,280&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,250,204&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_zdQdJm8IdyQg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,288,235&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,071&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,538,306&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F05_zTRuFwXTTyR4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F12_zdGi733P61E4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents the fair value
                                                                                                                                                                of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSERFVUxFIE9GIEZBSVIgVkFMVUUgT0YgQ09OU0lERVJBVElPTiBUUkFOU0ZFUlJFRCBBU1NFVFMgQUNRVUlSRUQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90E_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250331__20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zAq8aQVuo1ca" title="Number of preferred stock converted"&gt;33,609&lt;/span&gt; Common Stock issued in the SLG transaction based on the quoted stock price on the date of issuance.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F0E_zVyGw7BUQt54" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F11_zY1rLDCJKQOd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents the fair value
                                                                                                                                                                of the Series E Convertible Preferred Stock as is converted to Common Stock based on the quoted price Common Stock on the date of
                                                                                                                                                                issuance.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F00_zJexijnOxY0f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1B_zYdIFx1Key85" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents the fair value
                                                                                                                                                                of the accounts receivable in Cycurion owing from SLG.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair value of the
                                                                                                                                                                noncontrolling interest based on NCI&#x2019;s &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSERFVUxFIE9GIEZBSVIgVkFMVUUgT0YgQ09OU0lERVJBVElPTiBUUkFOU0ZFUlJFRCBBU1NFVFMgQUNRVUlSRUQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_900_ecustom--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestPercentage_iI_pid_dp_uPure_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_z874zpJu6UKi" title="Number of preferred stock converted"&gt;49&lt;/span&gt;% interest in the net assets acquired.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Goodwill is calculated as
                                                                                                                                                                Total Consideration paid less the net assets acquired.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="From2025-01-012025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact001302"
      unitRef="USD">2000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="From2025-01-012025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact001306"
      unitRef="USD">2000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <CYCU:BusinessCombinationRecognizedCashAcquired
      contextRef="From2025-01-012025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact001308"
      unitRef="USD">34983</CYCU:BusinessCombinationRecognizedCashAcquired>
    <CYCU:BusinessCombinationRecognizedCashAcquired
      contextRef="From2025-01-012025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact001312"
      unitRef="USD">34983</CYCU:BusinessCombinationRecognizedCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="From2025-01-012025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact001314"
      unitRef="USD">1965017</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="From2025-01-012025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact001318"
      unitRef="USD">1965017</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001320"
      unitRef="USD">254071</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001321"
      unitRef="USD">250071</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001322"
      unitRef="USD">504142</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember_us-gaap_SeriesEPreferredStockMember"
      decimals="0"
      id="Fact001324"
      unitRef="USD">255000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember_us-gaap_SeriesEPreferredStockMember"
      decimals="0"
      id="Fact001326"
      unitRef="USD">255000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember_us-gaap_SeriesEPreferredStockMember"
      decimals="0"
      id="Fact001328"
      unitRef="USD">255000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember_us-gaap_SeriesEPreferredStockMember"
      decimals="0"
      id="Fact001330"
      unitRef="USD">255000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <CYCU:BusinessCombinationNonCashConsiderationOnAccountsReceivable
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact001332"
      unitRef="USD">10814147</CYCU:BusinessCombinationNonCashConsiderationOnAccountsReceivable>
    <CYCU:BusinessCombinationNonCashConsiderationOnAccountsReceivable
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact001334"
      unitRef="USD">10814147</CYCU:BusinessCombinationNonCashConsiderationOnAccountsReceivable>
    <CYCU:BusinessCombinationNonCashConsiderationTransferred
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact001336"
      unitRef="USD">11323218</CYCU:BusinessCombinationNonCashConsiderationTransferred>
    <CYCU:BusinessCombinationNonCashConsiderationTransferred
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      decimals="0"
      id="Fact001337"
      unitRef="USD">250071</CYCU:BusinessCombinationNonCashConsiderationTransferred>
    <CYCU:BusinessCombinationNonCashConsiderationTransferred
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact001338"
      unitRef="USD">11573289</CYCU:BusinessCombinationNonCashConsiderationTransferred>
    <CYCU:BusinessCombinationConsiderationTransferred
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact001340"
      unitRef="USD">13288235</CYCU:BusinessCombinationConsiderationTransferred>
    <CYCU:BusinessCombinationConsiderationTransferred
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      decimals="0"
      id="Fact001341"
      unitRef="USD">250071</CYCU:BusinessCombinationConsiderationTransferred>
    <CYCU:BusinessCombinationConsiderationTransferred
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact001342"
      unitRef="USD">13538306</CYCU:BusinessCombinationConsiderationTransferred>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact001344"
      unitRef="USD">3066581</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact001346"
      unitRef="USD">3066581</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact001348"
      unitRef="USD">3066581</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact001350"
      unitRef="USD">3066581</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact001352"
      unitRef="USD">4317052</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact001354"
      unitRef="USD">4317052</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiability
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact001356"
      unitRef="USD">10650</CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiability>
    <CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiability
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      decimals="0"
      id="Fact001357"
      unitRef="USD">54209</CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiability>
    <CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiability
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact001358"
      unitRef="USD">64859</CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiability>
    <CYCU:PayrollLiability
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact001360"
      unitRef="USD">40642</CYCU:PayrollLiability>
    <CYCU:PayrollLiability
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact001362"
      unitRef="USD">40642</CYCU:PayrollLiability>
    <CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesFactoringLiability
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact001364"
      unitRef="USD">2176922</CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesFactoringLiability>
    <CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesFactoringLiability
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact001366"
      unitRef="USD">2176922</CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesFactoringLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact001368"
      unitRef="USD">18000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact001370"
      unitRef="USD">18000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact001372"
      unitRef="USD">625222</CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable>
    <CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact001374"
      unitRef="USD">625222</CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact001376"
      unitRef="USD">2982908</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact001378"
      unitRef="USD">2982908</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact001380"
      unitRef="USD">10171396</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      decimals="0"
      id="Fact001381"
      unitRef="USD">54209</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact001382"
      unitRef="USD">10225605</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact001384"
      unitRef="USD">7104815</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      decimals="0"
      id="Fact001385"
      unitRef="USD">54209</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact001386"
      unitRef="USD">7159024</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <CYCU:BusinessCombinationEliminationOfInterCompanyBalances
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact001388"
      unitRef="USD">2982908</CYCU:BusinessCombinationEliminationOfInterCompanyBalances>
    <CYCU:BusinessCombinationEliminationOfInterCompanyBalances
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact001390"
      unitRef="USD">2982908</CYCU:BusinessCombinationEliminationOfInterCompanyBalances>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact001392"
      unitRef="USD">3464218</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact001394"
      unitRef="USD">3464218</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:Goodwill
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact001396"
      unitRef="USD">13945924</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      decimals="0"
      id="Fact001397"
      unitRef="USD">304280</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact001398"
      unitRef="USD">14250204</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact001400"
      unitRef="USD">13288235</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      decimals="0"
      id="Fact001401"
      unitRef="USD">250071</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact001402"
      unitRef="USD">13538306</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-03-312025-03-31_custom_SLGInnovationIncMember"
      decimals="INF"
      id="Fact001405"
      unitRef="Shares">33609</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <CYCU:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestPercentage
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember"
      decimals="INF"
      id="Fact001409"
      unitRef="Pure">0.49</CYCU:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestPercentage>
    <us-gaap:GoodwillDisclosureTextBlock contextRef="From2025-01-012025-12-31" id="Fact001411">&lt;p id="xdx_800_eus-gaap--GoodwillDisclosureTextBlock_zbiI7iV28i7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82D_z0spBjnxn2Hk"&gt;GOODWILL&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Acquisition
of Axxum Technologies, LLC.&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 22, 2017, the Company entered into a share transfer agreement with Axxum and the two prior members of Axxum to purchase &lt;span id="xdx_903_eus-gaap--EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_iI_pid_dp_uPure_c20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember_zHid0zeGGjZj" title="Equity interest percentage"&gt;100&lt;/span&gt;%
of the members&#x2019; equity interest in the Company in exchange for $&lt;span id="xdx_90D_eus-gaap--Cash_iI_c20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember_zbO8p67XyK37" title="Cash"&gt;6,500,000&lt;/span&gt; in cash and $&lt;span id="xdx_90F_eus-gaap--ConvertibleSubordinatedDebt_iI_c20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember_zAQPGuwaUND9" title="Convertible subordinated debt"&gt;500,000 &lt;/span&gt;in two subordinated convertible
promissory notes for $&lt;span id="xdx_904_eus-gaap--ConvertibleSubordinatedDebt_iI_c20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember__srt--TitleOfIndividualAxis__custom--TwoMember_zIvIKZD8CPKa" title="Convertible subordinated debt"&gt;250,000&lt;/span&gt; each, payable to the two members of Axxum. Accordingly, Axxum became a wholly-owned subsidiary of the Company.
The Company assessed the carrying value of Axxum&#x2019;s assets and liabilities at the date of acquisition and determined that the carrying
value of those accounts approximated fair value. The difference between the purchase price paid for the acquisition of Axxum and the
net asset value derived from the assets and liabilities of Axxum at the date of acquisition has been recognized as goodwill. Accordingly,
the purchase costs of $&lt;span id="xdx_906_eus-gaap--CashAcquiredInExcessOfPaymentsToAcquireBusiness_c20171122__20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember_zPnqmSWdVcMe" title="Cash acquired in excess of payments to acquire business"&gt;6,500,000&lt;/span&gt; in cash, $&lt;span id="xdx_90C_eus-gaap--NotesPayable_iI_c20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember_zFF1HLKIGOed" title="Promissory notes"&gt;500,000&lt;/span&gt; in promissory notes, and $&lt;span id="xdx_908_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_c20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember_zBMvLw7FtKF5" title="Net assets acquired"&gt;140,005&lt;/span&gt; in capitalized transaction costs, less $&lt;span id="xdx_90A_ecustom--AdjustmentInWorkingCapital_iI_c20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember_zArz29X9Luld" title="Adjustment in working capital"&gt;573,150&lt;/span&gt;
in adjustment in working capital that is recoverable from sellers resulted in a total purchase cost of $&lt;span id="xdx_902_eus-gaap--BusinessCombinationConsiderationTransferred1_c20171122__20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember_zoXPpoURmyT5" title="Adjustment in working capital"&gt;6,566,855&lt;/span&gt;. The net asset value
of Axxum at the date of acquisition was $&lt;span id="xdx_905_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_c20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember_zBJDcd4vVlSi" title="Business combination, recognized asset acquired to liability assumed, excess (less), and goodwill"&gt;1,413,589&lt;/span&gt;. Accordingly, the Company recognized $&lt;span id="xdx_903_eus-gaap--Goodwill_iI_c20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember_zjW5KdaPLbb1" title="Goodwill"&gt;5,153,266&lt;/span&gt; in goodwill related to the acquisition
of Axxum.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Acquisition
of Cloudburst Security, LLC.&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 3, 2019, the Company entered into a membership interest purchase agreement with Cloudburst and its two equity holders to purchase
&lt;span id="xdx_903_eus-gaap--EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_iI_pid_dp_uPure_c20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_zEF9pTnUfhZa" title="Equity interest percentage"&gt;100&lt;/span&gt;% of the issued and outstanding units in exchange for $&lt;span id="xdx_90F_eus-gaap--Cash_iI_c20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_zOuj40f2qn08" title="Cash"&gt;500,000&lt;/span&gt; in cash; $&lt;span id="xdx_90D_eus-gaap--NotesPayable_iI_c20190403__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember__srt--TitleOfIndividualAxis__custom--OneEquityHolderMember_zqtHDorxldDh" title="Promissory notes"&gt;540,000&lt;/span&gt; for a promissory note to one equity holder and $&lt;span id="xdx_904_eus-gaap--NotesPayable_iI_c20190403__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember__srt--TitleOfIndividualAxis__custom--TwoEquityHolderMember_zeAMRCzLcePg" title="Promissory notes"&gt;360,000&lt;/span&gt;
to the other; and &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20190403__20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--OneEquityHolderMember_zOmp2t0eeAfc" title="Stock issued"&gt;111,628&lt;/span&gt; and &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20190403__20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--TwoEquityHolderMember_z6T1v15Xyx5j" title="Stock issued"&gt;74,420&lt;/span&gt; shares of the Company&#x2019;s Common Stock to the two equity holders, respectively, on a post-split
basis. Accordingly, Cloudburst became a wholly-owned subsidiary of the Company. The Company assessed the carrying value of Cloudburst&#x2019;s
assets and liabilities at the date of acquisition and determined that the carrying value of those accounts approximated fair value; the
difference between the purchase price paid for the acquisition of Cloudburst and the net asset value derived from the assets and liabilities
of Cloudburst at the date of acquisition has been recognized as goodwill. The purchase costs of $&lt;span id="xdx_90E_eus-gaap--CashAcquiredInExcessOfPaymentsToAcquireBusiness_c20190403__20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_z4SHb7XGP7Og" title="Cash acquired in excess of payments to acquire business"&gt;500,000&lt;/span&gt; in cash, $&lt;span id="xdx_90A_eus-gaap--NotesPayable_iI_c20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_z4wDk6JHsi87" title="Promissory notes"&gt;900,000&lt;/span&gt; in promissory
notes, $&lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20190403__20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_zhVt3oTe0Nn7" title="Number of shares issued, value"&gt;300,000&lt;/span&gt; in &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20190403__20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_zdyTH9suOfPe" title="Stock issued (in shares)"&gt;186,048&lt;/span&gt; shares of the Company&#x2019;s Common Stock, $&lt;span id="xdx_90E_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_zKFq63Ip6xql" title="Business combination, contingent consideration, asset"&gt;1,400,000&lt;/span&gt; in contingent earnout, $&lt;span id="xdx_908_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_c20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_zEvb7uRQ3wqa" title="Net assets acquired"&gt;62,305&lt;/span&gt; in capitalized transaction
costs, resulted in a total purchase cost of $&lt;span id="xdx_900_eus-gaap--BusinessCombinationConsiderationTransferred1_c20190403__20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_zcpEQmkjAC0d" title="Total consideration"&gt;3,162,305&lt;/span&gt;. The net asset value of Cloudburst at the date of acquisition was $&lt;span id="xdx_907_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_c20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_zK9p96XAb4Df" title="Business combination, recognized asset acquired to liability assumed, excess (less), and goodwill"&gt;323,267&lt;/span&gt;. Accordingly,
the Company recognized $&lt;span id="xdx_906_eus-gaap--Goodwill_iI_c20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_zzqJSMdMn1Af" title="Goodwill"&gt;2,839,038&lt;/span&gt; in goodwill related to the acquisition of Cloudburst. On April 20, 2022, the holders of the (i) $&lt;span id="xdx_909_eus-gaap--NotesPayable_iI_c20220420__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_zXy4V1VBHte2" title="Promissory notes"&gt;900,000&lt;/span&gt;
promissory notes and (ii) &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220420__20220420__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_zFv1zWn4Gr8b" title="Stock issued (in shares)"&gt;186,048&lt;/span&gt; shares of the Company&#x2019;s Common Stock tendered them to the Company for cancellation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Relevant
factors to the Company&#x2019;s assessment of the carrying value of goodwill for both business combinations in accordance to the fair
value hierarchy under the category of level 3 are as follows: estimation of the growth rate of future incoming and outgoing cash flows,
certain elements that comprise the appropriate weighted average cost of capital, such as the equity of potential market participants
for comparability analysis, and the Company&#x2019;s sensitivity to outside factors that would lead to variation in the aforementioned
cash flows and weighted average cost of capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s management reviewed the performance of Cloudburst and its manager during the year ended December 31, 2020 and determined
that Cloudburst had not met the performance targets set forth at the time of acquisition. As a result, the manager of Cloudburst was
dismissed. Management of the Company performed a quantitative analysis of the carrying value of the subsidiary and its related goodwill
by preparing a future discounted cash flow analysis, which included variables such as expectations on future cash flows, calculation
of the cost of capital, and the probability of capturing certain contracts under the framework of Cloudburst being a federal government
approved service provider, and determined that the fair value as of December 31, 2020 was lower than the carrying value that was previously
established at the point of acquisition; accordingly, during the year ended December 31, 2020, the Company determined that the contingent
earnout should be de-recognized, and written off in its entirety in the amount of $&lt;span id="xdx_900_eus-gaap--GoodwillWrittenOffRelatedToSaleOfBusinessUnit_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember_zypTh06g5n32" title="Goodwill, written off related to sale of business unit"&gt;1,400,000&lt;/span&gt; to the Company&#x2019;s result of operations,
and, as a result of the above assessment, the Company recognized an impairment of goodwill in the amount of $&lt;span id="xdx_90B_eus-gaap--GoodwillImpairmentLoss_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember_z08Rx6ejfEb5" title="Goodwill impairment"&gt;1,400,000&lt;/span&gt; that was also
recognized to the Company&#x2019;s results of operations. The Company&#x2019;s ending goodwill related to the acquisition of Cloudburst
after recognizing impairment was $&lt;span id="xdx_909_eus-gaap--Goodwill_iI_c20201231__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember_z1Y1wSuFoj1g" title="Goodwill"&gt;1,439,038&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;SLG
Innovation Inc. Master Service Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company initiated discussions to acquire SLG in late 2020, advancing an initial non-refundable deposit of $&lt;span id="xdx_909_eus-gaap--RestrictedInvestments_iI_pn5n6_c20201231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zhSM3TLprHv8" title="Restricted investments"&gt;1.4&lt;/span&gt; million for loans, capitalized
transaction costs, and accounts receivable. By December 31, 2024, this deposit had increased to $&lt;span id="xdx_90C_eus-gaap--DepositsAssets_iI_pn5n6_c20241231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__srt--RangeAxis__srt--MaximumMember_z29P7jDFTIu3" title="Non-refundable deposits"&gt;2.0&lt;/span&gt; million. On May 13, 2021, the Company
entered into an agreement to acquire substantially all of SLG&#x2019;s assets and certain liabilities, later amended to focus on specific
sales contracts. A unidirectional letter of intent (LOI) was executed on April 29, 2023, binding SLG to the transaction while allowing
the Company the option to proceed. The LOI contemplated a structure involving the $&lt;span id="xdx_900_eus-gaap--DepositsAssets_iI_pn5n6_c20230429__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zCFQZoUq7t35" title="Deposits assets"&gt;2.0&lt;/span&gt; million receivable, $&lt;span id="xdx_904_eus-gaap--AccountsPayableOtherCurrent_iI_pn5n6_c20230429__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_z5okWOoqGuAi" title="Accounts payable, other, current"&gt;2.1&lt;/span&gt; million in SLG payables
to RCR Technology Corporation, and &lt;span id="xdx_903_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20230429__20230429__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zRL1ZPx4tA4j" title="Number of preferred stock converted"&gt;33,212&lt;/span&gt; shares of the Company&#x2019;s capital stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 31, 2025, the Company finalized the MSA and Burns Release Agreement for SLG. The total purchase consideration included the $&lt;span id="xdx_906_eus-gaap--DepositsAssets_iI_pn5n6_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zqLdJmXcKCUd" title="Non-refundable deposits"&gt;2.0&lt;/span&gt;
million prepaid deposit, &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20250331__20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zQxEjUQjYTh9" title="Common stock issued for business combination costs"&gt;33,609&lt;/span&gt; shares of Common Stock (par value $&lt;span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zTwScV3iqWtg" title="Common stock, par value"&gt;0.0001&lt;/span&gt;), &lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20250331__20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zUQhTVcbezVl" title="Common stock issued for business combination costs"&gt;51&lt;/span&gt; shares of Series E Convertible Preferred Stock (face value
$&lt;span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zk08v1l5hTF6" title="Principal amount"&gt;10,000&lt;/span&gt; each, conversion price $&lt;span id="xdx_900_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zJPhjmXxaBGh" title="Conversion price"&gt;1.00&lt;/span&gt;) and $&lt;span id="xdx_90B_eus-gaap--GainLossOnSaleOfAccountsReceivable_c20250331__20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zS6INjMLoCJg" title="Accounts receivable"&gt;10,814,147&lt;/span&gt; of accounts receivable in Cycurion owing from SLG. Additionally, the Company issued
&lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20250331__20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zkBEMdQvXRG4" title="Share based compensation shares"&gt;16,667&lt;/span&gt; shares of Common Stock to assume SLG&#x2019;s share-based payment obligations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
transaction was accounted for as a business combination under ASC 805. As of the transaction date, the fair value of assets acquired
totaled $&lt;span id="xdx_90F_eus-gaap--FairValueOfAssetsAcquired_pn5n6_c20250331__20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_z0t6J3vrkSB9" title="Fair value of assets acquired"&gt;3.1&lt;/span&gt; million, excluding cash of $&lt;span id="xdx_908_eus-gaap--Cash_iI_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zLe0Mvkhk3kd" title="Cash"&gt;34,983&lt;/span&gt; that was netted against cash consideration paid. Liabilities assumed amounted to $&lt;span id="xdx_90D_eus-gaap--Liabilities_iI_pn5n6_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zDCkzGoWOdl9" title="Liabilities"&gt;10.2&lt;/span&gt;
million, including accounts payable, accrued liabilities, payroll liabilities, and loans. After recognizing a non-controlling interest
of $&lt;span id="xdx_908_eus-gaap--MinorityInterest_iI_pn5n6_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_z6UXIShPdk2e" title="Non-controlling interest"&gt;3.5&lt;/span&gt; million, the net assets acquired were negative $&lt;span id="xdx_901_eus-gaap--Assets_iI_pn5n6_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_ztdzBvQhXr6f" title="Assets"&gt;7.1&lt;/span&gt; million. The total consideration transferred exceeded the net assets acquired,
resulting in the recognition of goodwill amounting to $&lt;span id="xdx_90B_eus-gaap--Goodwill_iI_pn5n6_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zlXGoD8zg7nk" title="Goodwill"&gt;14.3&lt;/span&gt; million. This goodwill reflects the strategic value of SLG&#x2019;s operations,
expected synergies, and future growth potential.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p id="xdx_893_eus-gaap--ScheduleOfGoodwillTextBlock_zm4whnGPzP6j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zvJQ6B9tMTzh" style="display: none"&gt;SCHEDULE OF GOODWILL&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20251231_zxWuwRXfrZr" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20241231_zjGpks9PwLLi" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    9: Details of Goodwill&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--Goodwill_iI_hus-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember_zAoJ2c2206Y8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Axxum&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,153,266&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,153,266&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--Goodwill_iI_hus-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember_zE20WOOwi607" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cloudburst&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,439,038&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,439,038&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--Goodwill_iI_hus-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zGXhNEhuhsi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;SLG&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,250,204&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1522"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--Goodwill_iI_z81amJyFEStc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,842,508&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,592,304&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zLU8sDLmVvW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee
      contextRef="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember"
      decimals="INF"
      id="Fact001413"
      unitRef="Pure">1</us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee>
    <us-gaap:Cash
      contextRef="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember"
      decimals="0"
      id="Fact001415"
      unitRef="USD">6500000</us-gaap:Cash>
    <us-gaap:ConvertibleSubordinatedDebt
      contextRef="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember"
      decimals="0"
      id="Fact001417"
      unitRef="USD">500000</us-gaap:ConvertibleSubordinatedDebt>
    <us-gaap:ConvertibleSubordinatedDebt
      contextRef="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember_custom_TwoMember"
      decimals="0"
      id="Fact001419"
      unitRef="USD">250000</us-gaap:ConvertibleSubordinatedDebt>
    <us-gaap:CashAcquiredInExcessOfPaymentsToAcquireBusiness
      contextRef="From2017-11-222017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember"
      decimals="0"
      id="Fact001421"
      unitRef="USD">6500000</us-gaap:CashAcquiredInExcessOfPaymentsToAcquireBusiness>
    <us-gaap:NotesPayable
      contextRef="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember"
      decimals="0"
      id="Fact001423"
      unitRef="USD">500000</us-gaap:NotesPayable>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember"
      decimals="0"
      id="Fact001425"
      unitRef="USD">140005</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <CYCU:AdjustmentInWorkingCapital
      contextRef="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember"
      decimals="0"
      id="Fact001427"
      unitRef="USD">573150</CYCU:AdjustmentInWorkingCapital>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2017-11-222017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember"
      decimals="0"
      id="Fact001429"
      unitRef="USD">6566855</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember"
      decimals="0"
      id="Fact001431"
      unitRef="USD">1413589</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember"
      decimals="0"
      id="Fact001433"
      unitRef="USD">5153266</us-gaap:Goodwill>
    <us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee
      contextRef="AsOf2019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="INF"
      id="Fact001435"
      unitRef="Pure">1</us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee>
    <us-gaap:Cash
      contextRef="AsOf2019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="0"
      id="Fact001437"
      unitRef="USD">500000</us-gaap:Cash>
    <us-gaap:NotesPayable
      contextRef="AsOf2019-04-03_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember_custom_OneEquityHolderMember"
      decimals="0"
      id="Fact001439"
      unitRef="USD">540000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2019-04-03_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember_custom_TwoEquityHolderMember"
      decimals="0"
      id="Fact001441"
      unitRef="USD">360000</us-gaap:NotesPayable>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2019-04-032019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember_custom_OneEquityHolderMember"
      decimals="INF"
      id="Fact001443"
      unitRef="Shares">111628</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2019-04-032019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember_custom_TwoEquityHolderMember"
      decimals="INF"
      id="Fact001445"
      unitRef="Shares">74420</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CashAcquiredInExcessOfPaymentsToAcquireBusiness
      contextRef="From2019-04-032019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="0"
      id="Fact001447"
      unitRef="USD">500000</us-gaap:CashAcquiredInExcessOfPaymentsToAcquireBusiness>
    <us-gaap:NotesPayable
      contextRef="AsOf2019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="0"
      id="Fact001449"
      unitRef="USD">900000</us-gaap:NotesPayable>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2019-04-032019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="0"
      id="Fact001451"
      unitRef="USD">300000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2019-04-032019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="INF"
      id="Fact001453"
      unitRef="Shares">186048</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:BusinessCombinationContingentConsiderationAsset
      contextRef="AsOf2019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="0"
      id="Fact001455"
      unitRef="USD">1400000</us-gaap:BusinessCombinationContingentConsiderationAsset>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="AsOf2019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="0"
      id="Fact001457"
      unitRef="USD">62305</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2019-04-032019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="0"
      id="Fact001459"
      unitRef="USD">3162305</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="AsOf2019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="0"
      id="Fact001461"
      unitRef="USD">323267</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="AsOf2019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="0"
      id="Fact001463"
      unitRef="USD">2839038</us-gaap:Goodwill>
    <us-gaap:NotesPayable
      contextRef="AsOf2022-04-20_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="0"
      id="Fact001465"
      unitRef="USD">900000</us-gaap:NotesPayable>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-04-202022-04-20_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="INF"
      id="Fact001467"
      unitRef="Shares">186048</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="From2020-01-012020-12-31_custom_CloudburstSecurityLLCMember"
      decimals="0"
      id="Fact001469"
      unitRef="USD">1400000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2020-01-012020-12-31_custom_CloudburstSecurityLLCMember"
      decimals="0"
      id="Fact001471"
      unitRef="USD">1400000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="AsOf2020-12-31_custom_CloudburstSecurityLLCMember"
      decimals="0"
      id="Fact001473"
      unitRef="USD">1439038</us-gaap:Goodwill>
    <us-gaap:RestrictedInvestments
      contextRef="AsOf2020-12-31_custom_SLGInnovationIncMember"
      decimals="-5"
      id="Fact001475"
      unitRef="USD">1400000</us-gaap:RestrictedInvestments>
    <us-gaap:DepositsAssets
      contextRef="AsOf2024-12-31_custom_SLGInnovationIncMember_srt_MaximumMember"
      decimals="-5"
      id="Fact001477"
      unitRef="USD">2000000.0</us-gaap:DepositsAssets>
    <us-gaap:DepositsAssets
      contextRef="AsOf2023-04-29_custom_SLGInnovationIncMember"
      decimals="-5"
      id="Fact001479"
      unitRef="USD">2000000.0</us-gaap:DepositsAssets>
    <us-gaap:AccountsPayableOtherCurrent
      contextRef="AsOf2023-04-29_custom_SLGInnovationIncMember"
      decimals="-5"
      id="Fact001481"
      unitRef="USD">2100000</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2023-04-292023-04-29_custom_SLGInnovationIncMember"
      decimals="INF"
      id="Fact001483"
      unitRef="Shares">33212</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:DepositsAssets
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember"
      decimals="-5"
      id="Fact001485"
      unitRef="USD">2000000.0</us-gaap:DepositsAssets>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2025-03-312025-03-31_custom_SLGInnovationIncMember"
      decimals="INF"
      id="Fact001487"
      unitRef="Shares">33609</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember"
      decimals="INF"
      id="Fact001489"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2025-03-312025-03-31_custom_SLGInnovationIncMember_us-gaap_SeriesEPreferredStockMember"
      decimals="INF"
      id="Fact001491"
      unitRef="Shares">51</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact001493"
      unitRef="USD">10000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember"
      decimals="INF"
      id="Fact001495"
      unitRef="USDPShares">1.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:GainLossOnSaleOfAccountsReceivable
      contextRef="From2025-03-312025-03-31_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact001497"
      unitRef="USD">10814147</us-gaap:GainLossOnSaleOfAccountsReceivable>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2025-03-312025-03-31_custom_SLGInnovationIncMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001499"
      unitRef="Shares">16667</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="From2025-03-312025-03-31_custom_SLGInnovationIncMember"
      decimals="-5"
      id="Fact001501"
      unitRef="USD">3100000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:Cash
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact001503"
      unitRef="USD">34983</us-gaap:Cash>
    <us-gaap:Liabilities
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember"
      decimals="-5"
      id="Fact001505"
      unitRef="USD">10200000</us-gaap:Liabilities>
    <us-gaap:MinorityInterest
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember"
      decimals="-5"
      id="Fact001507"
      unitRef="USD">3500000</us-gaap:MinorityInterest>
    <us-gaap:Assets
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember"
      decimals="-5"
      id="Fact001509"
      unitRef="USD">7100000</us-gaap:Assets>
    <us-gaap:Goodwill
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember"
      decimals="-5"
      id="Fact001511"
      unitRef="USD">14300000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="From2025-01-012025-12-31" id="Fact001513">&lt;p id="xdx_893_eus-gaap--ScheduleOfGoodwillTextBlock_zm4whnGPzP6j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zvJQ6B9tMTzh" style="display: none"&gt;SCHEDULE OF GOODWILL&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20251231_zxWuwRXfrZr" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20241231_zjGpks9PwLLi" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    9: Details of Goodwill&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--Goodwill_iI_hus-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember_zAoJ2c2206Y8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Axxum&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,153,266&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,153,266&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--Goodwill_iI_hus-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember_zE20WOOwi607" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cloudburst&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,439,038&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,439,038&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--Goodwill_iI_hus-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zGXhNEhuhsi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;SLG&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,250,204&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1522"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--Goodwill_iI_z81amJyFEStc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,842,508&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,592,304&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="AsOf2025-12-31_custom_AxxumTechnologiesLLCMember"
      decimals="0"
      id="Fact001515"
      unitRef="USD">5153266</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2024-12-31_custom_AxxumTechnologiesLLCMember"
      decimals="0"
      id="Fact001516"
      unitRef="USD">5153266</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2025-12-31_custom_CloudburstSecurityLLCMember"
      decimals="0"
      id="Fact001518"
      unitRef="USD">1439038</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2024-12-31_custom_CloudburstSecurityLLCMember"
      decimals="0"
      id="Fact001519"
      unitRef="USD">1439038</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact001521"
      unitRef="USD">14250204</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001524"
      unitRef="USD">20842508</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001525"
      unitRef="USD">6592304</us-gaap:Goodwill>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2025-01-012025-12-31" id="Fact001527">&lt;p id="xdx_803_eus-gaap--DebtDisclosureTextBlock_zvRvS6TwCNd3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82B_z77ODWXqI4Hg"&gt;BANK
                                            LOANS&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Revolving
Line of Credit&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 22, 2017, Axxum procured from Main Street Bank a revolving line of credit with a maximum of up to $&lt;span id="xdx_901_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember_zeyefpr1T4ld" title="Line of credit facility, maximum borrowing capacity"&gt;1,000,000&lt;/span&gt; (&#x201c;Revolving
Line of Credit&#x201d;), subject to certain restrictions based on available collateral pledged to the bank in the form of accounts and
trade receivables owed by the Company&#x2019;s customers. This Revolving Line of Credit is available for &lt;span id="xdx_903_eus-gaap--DebtInstrumentTerm_dc_c20171122__20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember_z9eYslHvut5i" title="Debt instrument term"&gt;one year&lt;/span&gt;, at which point it may
be renewed by Axxum. Axxum incurred origination and closing costs for this line of credit in the amount of $&lt;span id="xdx_908_eus-gaap--LineOfCredit_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember_zUoYid61737f" title="Long-term line of credit"&gt;10,000&lt;/span&gt;, which Axxum has recognized
a prepaid expense that will amortize over &lt;span id="xdx_909_eus-gaap--DebtInstrumentTerm_dc_c20171122__20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember_zjnKGCCk0c8d" title="Debt instrument term"&gt;one year&lt;/span&gt; as interest expense. The stated rate of interest of the Revolving Line of Credit is
the prime rate plus &lt;span id="xdx_90D_ecustom--DebtInstrumentBasisSpreadOnVariableRate_dp_uPure_c20171122__20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember_zYwQ9mkuXVGd" title="Long-term line of credit"&gt;100&lt;/span&gt; basis points, which at the time of the loan, was &lt;span id="xdx_90F_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20171122__20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember_zZfUbjbztBRk" title="Line of credit facility, interest rate during period"&gt;4.50&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 18, 2019, Axxum, Cloudburst, and the Company collectively renewed the Revolving Line of Credit with a maximum aggregate principal
sum of $&lt;span id="xdx_90C_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20190418__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember_zaAPD7qHIreh" title="Line of credit facility, maximum borrowing capacity"&gt;2,000,000&lt;/span&gt; with Main Street Bank. The stated rate of interest of the Revolving Line of Credit increased to &lt;span id="xdx_908_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20190418__20190418__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember_zBCc57k1t7c" title="Line of credit facility, interest rate during period"&gt;5.75&lt;/span&gt;% at the time of
the renewal.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 29, 2020 and again on June 30, 2021, the Company amended the Revolving Line of Credit with an extension of the maturity date to
March 31, 2024. The stated rate of interest of the Revolving Line of Credit decreased to &lt;span id="xdx_909_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20200629__20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember_z86FFtZo9FOf" title="Line of credit facility, interest rate during period"&gt;5.25&lt;/span&gt;% at the time of the first amendment and
an additional &lt;span id="xdx_906_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20210630__20210630__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember_zTZ3EJGON9Sd" title="Line of credit facility, interest rate during period"&gt;5&lt;/span&gt;% default interest on the second amendment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025, the stated rate of interest of the Revolving Line of Credit was &lt;span id="xdx_908_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20250101__20251231__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember_zWFBMa4sQe42" title="Line of credit facility, interest rate during period"&gt;8.50&lt;/span&gt;%. The outstanding balance of the Revolving
Line of Credit was $&lt;span id="xdx_908_eus-gaap--LineOfCredit_iI_c20251231_zCWLeG7JL4Kd" title="Long-term line of credit"&gt;2,933,396&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--LineOfCredit_iI_c20241231_zcPM1XBhfEta" title="Long-term line of credit"&gt;3,249,067&lt;/span&gt;, respectively, as of December 31, 2025 and 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Loan
and Security Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 22, 2017, concurrent with the above-mentioned Revolving Line of Credit, Axxum procured a bank term loan from Main Street Bank
in the amount of $&lt;span id="xdx_906_eus-gaap--LineOfCredit_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zmGJG3ZNQ1Gb" title="Line of credit"&gt;5,250,000&lt;/span&gt; with an expiration of December 31, 2024 (the &#x201c;Loan and Security Agreement&#x201d;). The Loan and Security
Agreement is subject to a monthly repayment of principal in the amount of $&lt;span id="xdx_90C_eus-gaap--RepaymentsOfLinesOfCredit_c20171122__20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_z424zbtp39vf" title="Repayments of revolving line of credit"&gt;109,375&lt;/span&gt;. The loan carries a stated adjustable interest rate
of the prime rate plus &lt;span id="xdx_900_ecustom--DebtInstrumentBasisSpreadOnVariableRate_dp_uPure_c20171122__20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zoxJvECNkWz" title="Long-term line of credit"&gt;200&lt;/span&gt; basis points, which, at the time of the loan, was &lt;span id="xdx_900_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20171122__20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zfvWlQHf1muk" title="Line of credit facility, interest rate during period"&gt;5.50&lt;/span&gt;%. Axxum incurred closing and origination costs totaling
$&lt;span id="xdx_90D_ecustom--OriginationCosts_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zXYLzI8NLfgi" title="Origination costs"&gt;211,729&lt;/span&gt;. The imputed interest rate after giving effect for the closing and origination costs was &lt;span id="xdx_90F_ecustom--ImputedInterestRateOnOriginationCosts_pid_dp_uPure_c20171122__20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zQ5wGXtUrAN1" title="Imputed interest rate on origination costs"&gt;7.82&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the Loan and Security Agreement, Axxum is subject to the following affirmative loan covenants: (i) on or after December 31, 2017 but
prior to June 30, 2018, minimum tangible net worth (net liability) of $&lt;span id="xdx_901_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterDecember312017ButPriorToJune302018Member_zEidpsI1eQtl" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;2,250,000&lt;/span&gt;; on or after June 30, 2018 but prior to June 30, 2019,
minimum tangible net worth (net liability) of $&lt;span id="xdx_90A_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterJune302018ButPriorToJune302019Member_ziXmbn1hJKCl" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;1,250,000&lt;/span&gt;; on or after June 30, 2019 but prior to December 31, 2019, minimum tangible
net worth (net liability) of $&lt;span id="xdx_903_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterJune302019ButPriorToDecember312019Member_zx7IFStgu7s7" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;950,000&lt;/span&gt;; on or after December 31, 2019 but prior to June 30, 2020, minimum tangible net worth (net asset)
of $&lt;span id="xdx_905_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterDecember312019ButPriorToJune302020Member_z1U7IplxdKMb" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;1,750,000&lt;/span&gt;; on or after June 30, 2020 but prior to December 31, 2020, minimum tangible net worth (net asset) of $&lt;span id="xdx_90F_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterJune302020ButPriorToDecember312020Member_zID4rz5Rande" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;2,500,000&lt;/span&gt;; on or
after December 31, 2020 but prior to June 30, 2021, minimum tangible net worth (net asset) of $&lt;span id="xdx_90B_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterDecember312020ButPriorToJune302021Member_zsG7AWM2ZWO2" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;3,000,000&lt;/span&gt;; on or after June 30, 2021 but
prior to December 31, 2021, minimum tangible net worth (net asset) of $&lt;span id="xdx_903_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterJune302021ButPriorToDecember312021Member_zicP1djW5L3e" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;3,500,000&lt;/span&gt;; on or after December 31, 2021, minimum tangible net
worth (net asset) of $&lt;span id="xdx_909_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterDecember312021Member_zZDev4QN62P1" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;5,000,000&lt;/span&gt;, (ii) interest coverage ratios must be greater than &lt;span id="xdx_904_ecustom--DebtInstrumentCovenantInterestCoverageRatioMinimum_iI_uPure_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zZAppnePGMBi" title="Debt instrument, covenant, interest coverage ratio"&gt;1.25&lt;/span&gt;-to-1, measured on quarterly basis, using a rolling
four-quarter basis, beginning with the fiscal quarter ending December 31, 2017, (iii) the Company and Axxum must achieve minimum consolidated
earnings before tax interest, tax, depreciation and amortization of (&#x201c;EBITDA&#x201d;) greater than $&lt;span id="xdx_907_ecustom--DebtInstrumentCovenantEBITDAMinimum_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zl8ofVaJ5ty5" title="Debt instrument, covenant, EBITDA"&gt;300,000&lt;/span&gt; per quarter, and (iv)
annual capital expenditures must be less than $&lt;span id="xdx_908_ecustom--DebtInstrumentCovenantAnnualCapitalExpendituresMaximum_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zqTjohOayuMe" title="Debt instrument, covenant, annual capital expenditures"&gt;50,000&lt;/span&gt;. Management conferred with the bank regarding the covenants and determined that
the Company was in compliance after giving effect to clarification in the definitions and formulas set forth by the bank in regard to
the calculation of the above covenants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 18, 2019, Axxum, Cloudburst, and the Company collectively amended the Loan and Security Agreement, including the addition of Cloudburst
as a borrower. The stated interest rate increased to &lt;span id="xdx_903_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20190418__20190418__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zckoAkaASvO1" title="Line of credit facility, interest rate during period"&gt;6.75&lt;/span&gt;% and the loan covenants remained the same.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 29, 2020, the Company amended and restated the Loan and Security Agreement (&#x201c;Amended and Restated Loan and Security Agreement&#x201d;)
by extending the maturity date to March 22, 2024 with a monthly repayment of principal in the amount of $&lt;span id="xdx_909_eus-gaap--RepaymentsOfLinesOfCredit_c20200629__20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zEptFzncLlj8" title="Repayments of revolving line of credit"&gt;62,500&lt;/span&gt; on or after June 22,
2020. The stated interest rate decreased to &lt;span id="xdx_904_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20200629__20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zUK5IXFAr6K4" title="Line of credit facility, interest rate during period"&gt;6.25&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the Amended and Restated Loan and Security Agreement, the loan covenants were replaced as follows: (i) on or after June 30, 2020 but
prior to December 31, 2020, minimum tangible net worth (net liability) of $&lt;span id="xdx_90B_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterJune302020ButPriorToDecember312020Member_zKusOjKd37Be" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;2,750,000&lt;/span&gt;; on or after December 31, 2020 but prior to June
30, 2021, minimum tangible net worth (net liability) of $&lt;span id="xdx_901_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterDecember312020ButPriorToJune302021Member_zD82oCEdq3Ke" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;2,250,000&lt;/span&gt;; on or after June 30, 2021 but prior to December 31, 2021, minimum
tangible net worth (net liability) of $&lt;span id="xdx_906_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterJune302021ButPriorToDecember312021Member_z53tf62wJSgf" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;1,750,000&lt;/span&gt;; on or after December 31, 2021, but prior to June 30, 2022, minimum tangible net worth
(net liability) of $&lt;span id="xdx_90A_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterDecember312021ButPriorToJune302022Member_zIpcEgpO9hCl" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;1,250,000&lt;/span&gt;; on or after June 30, 2022 but prior to December 31, 2022, minimum tangible net worth (net asset) of $&lt;span id="xdx_908_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterJune302022ButPriorToDecember312022Member_zzdo0crzdrZ5" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;500,000&lt;/span&gt;;
on or after December 31, 2022, but prior to June 30, 2023, minimum tangible net worth (net asset) of $&lt;span id="xdx_909_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterDecember312022ButPriorToJune302023Member_zrT2Ktt3kp12" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;1,250,000&lt;/span&gt;; on or after June 30,
2023 but prior to December 31, 2023, minimum tangible net worth (net asset) of $&lt;span id="xdx_90F_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterJune302023ButPriorToDecember312023Member_zBNYGJ5b20Yl" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;2,000,000&lt;/span&gt;; on or after December 31, 2023, minimum tangible
net worth (net asset) of $&lt;span id="xdx_903_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterDecember312023Member_zUXMfwooPGnd" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;2,500,000&lt;/span&gt;, (ii) interest coverage ratios must be greater than 1.20-to-1, measured on quarterly basis, using
a rolling four-quarter basis, beginning with the fiscal quarter ending June 30, 2020 (iii) the Company must achieve minimum consolidated
EBITDA greater than $&lt;span id="xdx_90B_ecustom--DebtInstrumentCovenantEBITDAMinimum_iI_c20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zMOpqQlrjAZd" title="Debt instrument, covenant, EBITDA"&gt;300,000&lt;/span&gt; per quarter, and (iv) annual capital expenditures must be less than $&lt;span id="xdx_905_ecustom--DebtInstrumentCovenantAnnualCapitalExpendituresMaximum_iI_c20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zPOf7QYIYNDg" title="Debt instrument, covenant, annual capital expenditures"&gt;50,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 1, 2025, the Company fully paid off the Loan and Security Agreement. The Company has categorized balances due within one operating
period as current and those payments due after one operating period as long-term. As of December 31, 2024, the Company recorded bank
loan-current portion of $&lt;span id="xdx_909_ecustom--BankLoanCurrent_iI_c20241231__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_z5X2cr4hszUl" title="Bank loan current"&gt;774,095&lt;/span&gt;, net of debt discount of $&lt;span id="xdx_90B_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_c20241231__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_ziq2aLcXfJz2" title="Debt instrument, unamortized discount, current"&gt;1,097&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Pledge
Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 22, 2017, concurrent with Axxum&#x2019;s procurement of the above-mentioned Revolving Line of Credit and Loan and Security Agreement,
Axxum entered into a pledge agreement (the &#x201c;Pledge Agreement&#x201d;). The following pledges of collateral and credit enhancement
were made by Axxum and the Company as the sole member of Axxum: (i) the Company equity ownership in Axxum and (ii) all of Axxum&#x2019;s
assets, such as accounts, instruments, equipment, fixtures, deposit accounts, letter of credit rights, and any other assets. All future
debt is subordinated to the bank term loan until the term loan is repaid in full. Personal guarantees have also been made by Emmit McHenry,
Kurt McHenry, and Alvin McCoy III, as officers and stockholders of the Company in support of the term loan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 18, 2019, Axxum, Cloudburst, and the Company collectively amended the Pledge Agreement, including the addition of Cloudburst as
a pledgor. The following pledges of collateral and credit enhancement were made by Axxum, Cloudburst, and the Company: (i) all of the
equity of Axxum, Cloudburst and each other subsidiary of the Company then owned or hereafter acquired by the Company and (ii) all rights
to which the owner of the pledged equity then or may thereafter become entitled by virtue of owning such pledged equity and being a member
of Axxum, Cloudburst, and each other subsidiary of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember"
      decimals="0"
      id="Fact001529"
      unitRef="USD">1000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2017-11-222017-11-22_custom_RevolvingLineOfCreditMember"
      id="Fact001531">P1Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCredit
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember"
      decimals="0"
      id="Fact001533"
      unitRef="USD">10000</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2017-11-222017-11-22_custom_RevolvingLineOfCreditMember"
      id="Fact001535">P1Y</us-gaap:DebtInstrumentTerm>
    <CYCU:DebtInstrumentBasisSpreadOnVariableRate
      contextRef="From2017-11-222017-11-22_custom_RevolvingLineOfCreditMember"
      decimals="INF"
      id="Fact001537"
      unitRef="Pure">1</CYCU:DebtInstrumentBasisSpreadOnVariableRate>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="From2017-11-222017-11-22_custom_RevolvingLineOfCreditMember"
      decimals="INF"
      id="Fact001539"
      unitRef="Pure">0.0450</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2019-04-18_custom_RevolvingLineOfCreditMember"
      decimals="0"
      id="Fact001541"
      unitRef="USD">2000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="From2019-04-182019-04-18_custom_RevolvingLineOfCreditMember"
      decimals="INF"
      id="Fact001543"
      unitRef="Pure">0.0575</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="From2020-06-292020-06-29_custom_RevolvingLineOfCreditMember"
      decimals="INF"
      id="Fact001545"
      unitRef="Pure">0.0525</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="From2021-06-302021-06-30_custom_RevolvingLineOfCreditMember"
      decimals="INF"
      id="Fact001547"
      unitRef="Pure">0.05</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="From2025-01-012025-12-31_custom_RevolvingLineOfCreditMember"
      decimals="INF"
      id="Fact001549"
      unitRef="Pure">0.0850</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCredit
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001551"
      unitRef="USD">2933396</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001553"
      unitRef="USD">3249067</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="0"
      id="Fact001555"
      unitRef="USD">5250000</us-gaap:LineOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="From2017-11-222017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="0"
      id="Fact001557"
      unitRef="USD">109375</us-gaap:RepaymentsOfLinesOfCredit>
    <CYCU:DebtInstrumentBasisSpreadOnVariableRate
      contextRef="From2017-11-222017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="INF"
      id="Fact001559"
      unitRef="Pure">2</CYCU:DebtInstrumentBasisSpreadOnVariableRate>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="From2017-11-222017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="INF"
      id="Fact001561"
      unitRef="Pure">0.0550</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <CYCU:OriginationCosts
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="0"
      id="Fact001563"
      unitRef="USD">211729</CYCU:OriginationCosts>
    <CYCU:ImputedInterestRateOnOriginationCosts
      contextRef="From2017-11-222017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="INF"
      id="Fact001565"
      unitRef="Pure">0.0782</CYCU:ImputedInterestRateOnOriginationCosts>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312017ButPriorToJune302018Member"
      decimals="0"
      id="Fact001567"
      unitRef="USD">2250000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302018ButPriorToJune302019Member"
      decimals="0"
      id="Fact001569"
      unitRef="USD">1250000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302019ButPriorToDecember312019Member"
      decimals="0"
      id="Fact001571"
      unitRef="USD">950000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312019ButPriorToJune302020Member"
      decimals="0"
      id="Fact001573"
      unitRef="USD">1750000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302020ButPriorToDecember312020Member"
      decimals="0"
      id="Fact001575"
      unitRef="USD">2500000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312020ButPriorToJune302021Member"
      decimals="0"
      id="Fact001577"
      unitRef="USD">3000000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302021ButPriorToDecember312021Member"
      decimals="0"
      id="Fact001579"
      unitRef="USD">3500000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312021Member"
      decimals="0"
      id="Fact001581"
      unitRef="USD">5000000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantInterestCoverageRatioMinimum
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="INF"
      id="Fact001583"
      unitRef="Pure">1.25</CYCU:DebtInstrumentCovenantInterestCoverageRatioMinimum>
    <CYCU:DebtInstrumentCovenantEBITDAMinimum
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="0"
      id="Fact001585"
      unitRef="USD">300000</CYCU:DebtInstrumentCovenantEBITDAMinimum>
    <CYCU:DebtInstrumentCovenantAnnualCapitalExpendituresMaximum
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="0"
      id="Fact001587"
      unitRef="USD">50000</CYCU:DebtInstrumentCovenantAnnualCapitalExpendituresMaximum>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="From2019-04-182019-04-18_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="INF"
      id="Fact001589"
      unitRef="Pure">0.0675</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="From2020-06-292020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="0"
      id="Fact001591"
      unitRef="USD">62500</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="From2020-06-292020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="INF"
      id="Fact001593"
      unitRef="Pure">0.0625</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302020ButPriorToDecember312020Member"
      decimals="0"
      id="Fact001595"
      unitRef="USD">2750000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312020ButPriorToJune302021Member"
      decimals="0"
      id="Fact001597"
      unitRef="USD">2250000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302021ButPriorToDecember312021Member"
      decimals="0"
      id="Fact001599"
      unitRef="USD">1750000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312021ButPriorToJune302022Member"
      decimals="0"
      id="Fact001601"
      unitRef="USD">1250000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302022ButPriorToDecember312022Member"
      decimals="0"
      id="Fact001603"
      unitRef="USD">500000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312022ButPriorToJune302023Member"
      decimals="0"
      id="Fact001605"
      unitRef="USD">1250000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302023ButPriorToDecember312023Member"
      decimals="0"
      id="Fact001607"
      unitRef="USD">2000000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312023Member"
      decimals="0"
      id="Fact001609"
      unitRef="USD">2500000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantEBITDAMinimum
      contextRef="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="0"
      id="Fact001611"
      unitRef="USD">300000</CYCU:DebtInstrumentCovenantEBITDAMinimum>
    <CYCU:DebtInstrumentCovenantAnnualCapitalExpendituresMaximum
      contextRef="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="0"
      id="Fact001613"
      unitRef="USD">50000</CYCU:DebtInstrumentCovenantAnnualCapitalExpendituresMaximum>
    <CYCU:BankLoanCurrent
      contextRef="AsOf2024-12-31_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="0"
      id="Fact001615"
      unitRef="USD">774095</CYCU:BankLoanCurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent
      contextRef="AsOf2024-12-31_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="0"
      id="Fact001617"
      unitRef="USD">1097</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <CYCU:LoansPayableTextBlock contextRef="From2025-01-012025-12-31" id="Fact001619">&lt;p id="xdx_80E_ecustom--LoansPayableTextBlock_zZF44MljSFii" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_827_zF2WlpybxE2l"&gt;LOANS
                                            PAYABLE&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_89D_ecustom--ScheduleOfLoansPayableAndAdvancesTableTextBlock_zZ6d0naRURa1" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BF_z7VSfKNTrdyh" style="display: none"&gt;SCHEDULE OF LOANS PAYABLE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20251231_zARzhpUfPx8g" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20241231_zCvjg53rNjUj" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    11: Details of Loans Payable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--LoanPayable_iI_zhlyPGb16QT" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loan payable - Cycurion&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;405,314&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;405,314&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--LoanPayable_iI_hdei--LegalEntityAxis__custom--SLGInnovationIncMember_zLKO5ZWJno59" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loan payable - SLG&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;264,379&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1627"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--EconomicInjuryDisasterLoan_iI_z6hdMv7vIEw9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Economic injury disaster loan - Cycurion&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--EconomicInjuryDisasterLoan_iI_hdei--LegalEntityAxis__custom--SLGInnovationIncMember_zOSAwjISd4g8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Economic injury disaster
    loan - SLG&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1633"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LoansPayable_iI_zI2edcheooV3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total loans payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;969,693&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;555,314&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LoansPayableCurrent_iI_zjiIks2MsvHj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: Current portion
    of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;669,693&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;408,516&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LongTermLoansPayable_iTI_z7NyqgacI0pd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Long-term
    debt&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;300,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;146,798&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zWxtbHY7Zebg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Loan
payable - Cycurion&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 20, 2023, the Company entered into a receivable purchase agreement (the &#x201c;RPA Loan&#x201d;) for cash received of $&lt;span id="xdx_903_eus-gaap--ProceedsFromConstructionLoansPayable_pn5n6_c20230320__20230320_z5YcQG0Cv9G9" title="Proceeds from construction loans payable"&gt;0.3&lt;/span&gt; million,
with a specified interest rate of &lt;span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230320_zuA6p3nS5hvd" title="Debt interest rate"&gt;8.00&lt;/span&gt;%, due January 20, 2024. The RPA Loan requires weekly payments of $&lt;span id="xdx_901_eus-gaap--PaymentsOfLoanCosts_c20230320__20230320_z3lFl091dMG8" title="Payments of loan costs"&gt;15,302&lt;/span&gt;, until $&lt;span id="xdx_903_ecustom--PaymentsOfRepaidCost_pn5n6_c20230320__20230320_zG3gDXvGh8Dc" title="Payments of repaid cost."&gt;0.5&lt;/span&gt; million is
repaid. As of both December 31, 2025 and 2024, the loan balance is $&lt;span id="xdx_90A_ecustom--LoanPayable_iI_pn5n6_c20251231_z1QoDUKBgtKl" title="Loan payable"&gt;&lt;span id="xdx_906_ecustom--LoanPayable_iI_pn5n6_c20241231_zitTaeZYHaYj" title="Loan payable"&gt;0.4&lt;/span&gt;&lt;/span&gt; million. The loan is in default and management is working to
settle the debt.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;EIDL
Loan - Cycurion&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 16, 2020, the Company executed the standard loan documents required for securing loans (the &#x201c;EIDL Loan - Cycurion&#x201d;)
offered by the U.S. Small Business Administration (the &#x201c;SBA&#x201d;) under its Economic Injury Disaster Loan (&#x201c;EIDL&#x201d;)
assistance program in light of the impact of the COVID-19 pandemic on the Company&#x2019;s business. The principal amount of the EIDL
Loan - Cycurion is $&lt;span id="xdx_90E_eus-gaap--ProceedsFromNotesPayable_c20200716__20200716__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zjs6oQ3Y11Ye" title="Proceeds from notes payable"&gt;150,000&lt;/span&gt;, with proceeds to be used for working capital purposes. Interest accrues at the rate of &lt;span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200716_zGr0wFs9Ekpl" title="Debt interest rate"&gt;3.75&lt;/span&gt;% per annum and
will accrue from the date of the EIDL Loan - Cycurion. Installment payments, including principal and interest, are due monthly beginning
July 16, 2021 in the amount of $&lt;span id="xdx_905_eus-gaap--DebtInstrumentPeriodicPayment_c20200716__20200716__us-gaap--DebtInstrumentAxis__custom--EIDLLoanMember_zMY7XLxAdKmf" title="Debt instrument, periodic payment"&gt;731&lt;/span&gt;. The balance of principal and interest is payable &lt;span id="xdx_907_eus-gaap--DebtInstrumentTerm_dtY_c20200716__20200716__us-gaap--DebtInstrumentAxis__custom--EIDLLoanMember_zAoBc3qHkwoc" title="Debt instrument term"&gt;30&lt;/span&gt; years from the date of the EIDL Loan - Cycurion.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;EIDL
Loan - SLG&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 30, 2020, the Company executed the standard loan documents required for securing loans (the &#x201c;EIDL Loan - SLG&#x201d;)
offered by the SBA under its EIDL assistance program in light of the impact of the COVID-19 pandemic on the Company&#x2019;s business.
The principal amount of the EIDL Loan - SLG is $&lt;span id="xdx_908_eus-gaap--ProceedsFromNotesPayable_c20200930__20200930__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zD5A8qun049b" title="Proceeds from notes payable"&gt;150,000&lt;/span&gt;, with the proceeds to be used for working capital purposes. Interest accrues
at the rate of &lt;span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200930__us-gaap--DebtInstrumentAxis__custom--EIDLLoanMember__dei--LegalEntityAxis__custom--SLGInnovationIncMember_zuTfPEx8te14" title="Debt interest rate"&gt;3.75&lt;/span&gt;% per annum and will accrue from the date of the EIDL Loan - SLG. Installment payments, including principal and interest,
are due monthly beginning January 1, 2023 in the amount of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPayment_c20200930__20200930__us-gaap--DebtInstrumentAxis__custom--EIDLLoanMember__dei--LegalEntityAxis__custom--SLGInnovationIncMember_z73qgCtdvS87" title="Debt instrument, periodic payment"&gt;731&lt;/span&gt;. The balance of principal and interest is payable &lt;span id="xdx_904_eus-gaap--DebtInstrumentTerm_dtY_c20200930__20200930__us-gaap--DebtInstrumentAxis__custom--EIDLLoanMember__dei--LegalEntityAxis__custom--SLGInnovationIncMember_z7YtaoNOLI3j" title="Debt instrument term"&gt;30&lt;/span&gt; years from the date
of the EIDL Loan - SLG.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Loan
Payable - SLG&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
2022 and 2023, the Company entered into non-recourse agreements with a lender to sell future cash receipts. Under the agreement, the
Company was required to make daily payments. The terms were renegotiated to monthly payments in 2023. As of December 31, 2025, the balance
on the loan is $&lt;span id="xdx_902_ecustom--LoanPayable_iI_c20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__dei--LegalEntityAxis__custom--SLGInnovationIncMember_zOnZ7HQPRHuj" title="Loan payable"&gt;264,379&lt;/span&gt;. The loan is in default and management is working to settle the debt.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



</CYCU:LoansPayableTextBlock>
    <CYCU:ScheduleOfLoansPayableAndAdvancesTableTextBlock contextRef="From2025-01-012025-12-31" id="Fact001621">&lt;p id="xdx_89D_ecustom--ScheduleOfLoansPayableAndAdvancesTableTextBlock_zZ6d0naRURa1" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BF_z7VSfKNTrdyh" style="display: none"&gt;SCHEDULE OF LOANS PAYABLE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20251231_zARzhpUfPx8g" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20241231_zCvjg53rNjUj" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    11: Details of Loans Payable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--LoanPayable_iI_zhlyPGb16QT" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loan payable - Cycurion&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;405,314&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;405,314&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--LoanPayable_iI_hdei--LegalEntityAxis__custom--SLGInnovationIncMember_zLKO5ZWJno59" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loan payable - SLG&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;264,379&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1627"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--EconomicInjuryDisasterLoan_iI_z6hdMv7vIEw9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Economic injury disaster loan - Cycurion&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--EconomicInjuryDisasterLoan_iI_hdei--LegalEntityAxis__custom--SLGInnovationIncMember_zOSAwjISd4g8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Economic injury disaster
    loan - SLG&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1633"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LoansPayable_iI_zI2edcheooV3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total loans payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;969,693&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;555,314&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LoansPayableCurrent_iI_zjiIks2MsvHj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: Current portion
    of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;669,693&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;408,516&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LongTermLoansPayable_iTI_z7NyqgacI0pd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Long-term
    debt&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;300,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;146,798&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</CYCU:ScheduleOfLoansPayableAndAdvancesTableTextBlock>
    <CYCU:LoanPayable
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001623"
      unitRef="USD">405314</CYCU:LoanPayable>
    <CYCU:LoanPayable
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001624"
      unitRef="USD">405314</CYCU:LoanPayable>
    <CYCU:LoanPayable
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember71576953"
      decimals="0"
      id="Fact001626"
      unitRef="USD">264379</CYCU:LoanPayable>
    <CYCU:EconomicInjuryDisasterLoan
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001629"
      unitRef="USD">150000</CYCU:EconomicInjuryDisasterLoan>
    <CYCU:EconomicInjuryDisasterLoan
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001630"
      unitRef="USD">150000</CYCU:EconomicInjuryDisasterLoan>
    <CYCU:EconomicInjuryDisasterLoan
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember71576953"
      decimals="0"
      id="Fact001632"
      unitRef="USD">150000</CYCU:EconomicInjuryDisasterLoan>
    <us-gaap:LoansPayable
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001635"
      unitRef="USD">969693</us-gaap:LoansPayable>
    <us-gaap:LoansPayable
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001636"
      unitRef="USD">555314</us-gaap:LoansPayable>
    <us-gaap:LoansPayableCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001638"
      unitRef="USD">669693</us-gaap:LoansPayableCurrent>
    <us-gaap:LoansPayableCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001639"
      unitRef="USD">408516</us-gaap:LoansPayableCurrent>
    <us-gaap:LongTermLoansPayable
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001641"
      unitRef="USD">300000</us-gaap:LongTermLoansPayable>
    <us-gaap:LongTermLoansPayable
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001642"
      unitRef="USD">146798</us-gaap:LongTermLoansPayable>
    <us-gaap:ProceedsFromConstructionLoansPayable
      contextRef="From2023-03-202023-03-20"
      decimals="-5"
      id="Fact001644"
      unitRef="USD">300000</us-gaap:ProceedsFromConstructionLoansPayable>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-03-20"
      decimals="INF"
      id="Fact001646"
      unitRef="Pure">0.0800</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:PaymentsOfLoanCosts
      contextRef="From2023-03-202023-03-20"
      decimals="0"
      id="Fact001648"
      unitRef="USD">15302</us-gaap:PaymentsOfLoanCosts>
    <CYCU:PaymentsOfRepaidCost
      contextRef="From2023-03-202023-03-20"
      decimals="-5"
      id="Fact001650"
      unitRef="USD">500000</CYCU:PaymentsOfRepaidCost>
    <CYCU:LoanPayable
      contextRef="AsOf2025-12-31"
      decimals="-5"
      id="Fact001652"
      unitRef="USD">400000</CYCU:LoanPayable>
    <CYCU:LoanPayable
      contextRef="AsOf2024-12-31"
      decimals="-5"
      id="Fact001654"
      unitRef="USD">400000</CYCU:LoanPayable>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2020-07-162020-07-16_custom_PromissoryNoteMember"
      decimals="0"
      id="Fact001656"
      unitRef="USD">150000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2020-07-16"
      decimals="INF"
      id="Fact001658"
      unitRef="Pure">0.0375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2020-07-162020-07-16_custom_EIDLLoanMember"
      decimals="0"
      id="Fact001660"
      unitRef="USD">731</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2020-07-162020-07-16_custom_EIDLLoanMember"
      id="Fact001662">P30Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2020-09-302020-09-30_custom_PromissoryNoteMember"
      decimals="0"
      id="Fact001664"
      unitRef="USD">150000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2020-09-30_custom_EIDLLoanMember_custom_SLGInnovationIncMember"
      decimals="INF"
      id="Fact001666"
      unitRef="Pure">0.0375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2020-09-302020-09-30_custom_EIDLLoanMember_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact001668"
      unitRef="USD">731</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2020-09-302020-09-30_custom_EIDLLoanMember_custom_SLGInnovationIncMember"
      id="Fact001670">P30Y</us-gaap:DebtInstrumentTerm>
    <CYCU:LoanPayable
      contextRef="AsOf2025-12-31_custom_PromissoryNoteMember_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact001672"
      unitRef="USD">264379</CYCU:LoanPayable>
    <CYCU:ConvertibleNotesDisclosureTextBlock contextRef="From2025-01-012025-12-31" id="Fact001674">&lt;p id="xdx_80F_ecustom--ConvertibleNotesDisclosureTextBlock_zwXH52X9RFX1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_821_zQkoXehsOzXe"&gt;CONVERTIBLE
                                            NOTES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_897_eus-gaap--ConvertibleDebtTableTextBlock_z7zKRujJPvM2" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BC_zHEazWhsmsha" style="display: none"&gt;SCHEDULE OF CONVERTIBLE NOTES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="19" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    12: Details of Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Principal
    Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unamortized
    Discount and &lt;br/&gt;Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Convertible
    Notes Carrying &lt;br/&gt;Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Maturity
    &lt;br/&gt;(Calendar Year)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DebtInstrumentFaceAmount_iS_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zS0ODmYs0dV9" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1678"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iS_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zEVGhxgACXM5" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1680"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ConvertibleNotesPayable_iS_c20250101__20250331_z7GP58mOslLi" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1682"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 35%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--DebtInstrumentFaceAmountIssued_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zN6kpUIWOvuj" style="width: 9%; text-align: right" title="Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;440,217&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--DeferredFinanceCostGross_iN_di_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z6z13DfFcY8a" style="width: 9%; text-align: right" title="Unamortized Discount and Issuance Costs Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(53,717&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ConvertibleNotesPayableIssuance_c20250101__20250331_zE8WgHhDrjM5" style="width: 9%; text-align: right" title="Convertible Notes Carrying balance - Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;386,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--DebtWeightedAverageInterestRateIssuance_iI_pid_dp_uPure_c20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zW2DrzAhqBu6" style="width: 9%; text-align: right" title="Weighted Average Interest Rate Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AmortizationOfDebtPremium_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zHjS8hZwWYDc" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1692"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AmortizationOfDebtDiscountPremium_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zqbysVcnDujl" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs , Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,476&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ConvertibleNotesPayableAmortizationOfDebtDiscountPremium_c20250101__20250331_zpcbgvziGlMg" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,476&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentFaceAmount_iS_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zxZq3WCgMut1" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;440,217&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zT1T1OKl3575" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(49,241&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ConvertibleNotesPayable_iS_c20250401__20250630_zuYIIOxibOZd" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;390,976&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zO2JJme4Lwz8" style="text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--DebtInstrumentFaceAmountIssued_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zTu3S76r3uU3" style="text-align: right" title="Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,050,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--DeferredFinanceCostGross_iN_di_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zawapJvZiNsk" style="text-align: right" title="Unamortized Discount and Issuance Costs Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(60,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ConvertibleNotesPayableIssuance_c20250401__20250630_zhtojjFrTsHc" style="text-align: right" title="Convertible Notes Carrying balance - Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,990,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--DebtWeightedAverageInterestRateIssuance_iI_pid_dp_uPure_c20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z1CaAF8Q8mHa" style="text-align: right" title="Weighted Average Interest Rate Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Conversion to equity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--DebtInstrumentFaceAmountConversionToEquity_iN_di_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zYmgW6Pasgef" style="text-align: right" title="Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,490,217&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ConversionOfStockAmountConverted1_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zRWcAlC00qB8" style="text-align: right" title="Unamortized Discount and Issuance Costs, Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;82,465&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ConvertibleNotesPayableConversionToEquity_iN_di_c20250401__20250630_zCdEgc1X0GI9" style="text-align: right" title="Convertible Notes Carrying balance - Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,407,752&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--DebtWeightedAverageInterestRateConversionToEquity_iI_pid_dp_uPure_c20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zKkTx618Ngsk" style="text-align: right" title="Weighted Average Interest Rate Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AmortizationOfDebtPremium_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zdkuT2t3OqBe" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1722"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AmortizationOfDebtDiscountPremium_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zSHu0CTuvVni" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs , Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,776&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ConvertibleNotesPayableAmortizationOfDebtDiscountPremium_c20250401__20250630_zTVJaDVtnbjb" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,776&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentFaceAmount_iS_c20250701__20250930__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zQaiawuHtnF5" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1728"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20250701__20250930__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zB3tFoJ4QC5f" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1730"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConvertibleNotesPayable_iS_c20250701__20250930_zriL1g9rF3Oe" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1732"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--DebtInstrumentFaceAmountIssued_c20250701__20250930__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zlXvaaw41wJd" style="border-bottom: Black 1pt solid; text-align: right" title="Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1734"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--DeferredFinanceCostGross_c20250701__20250930__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zqM6stsZdHj9" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1736"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ConvertibleNotesPayableIssuance_c20250701__20250930_zE3nmRcxJ2C4" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1738"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DebtInstrumentFaceAmount_iS_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zgbruJZ2a2dc" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1740"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iS_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zjYM3zR5l7ui" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1742"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ConvertibleNotesPayable_iS_c20251001__20251231_zb25pkdxnEU3" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1744"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--DebtInstrumentFaceAmountIssued_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z1bvGtnmK6Zk" style="border-bottom: Black 1pt solid; text-align: right" title="Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,897&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--DeferredFinanceCostGross_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zo53T45wgEWd" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1748"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ConvertibleNotesPayableIssuance_c20251001__20251231_z9KBnJmj6YTg" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,897&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--DebtWeightedAverageInterestRateIssuance_iI_pid_dp_uPure_c20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z9CbvNuUO4k7" style="text-align: right" title="Weighted Average Interest Rate Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DebtInstrumentFaceAmount_iE_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zzlJgUiBOdIc" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal value ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,897&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iE_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zOFSbop7Tqq" style="border-bottom: Black 2.5pt double; text-align: right" title="Unamortized Discount and Issuance Costs ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1756"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ConvertibleNotesPayable_iE_c20251001__20251231_zTiJhSQt1f06" style="border-bottom: Black 2.5pt double; text-align: right" title="Convertible Notes Carrying Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,897&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AE_zPPgTAdGyYk3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the first quarter of 2025, the Company issued convertible notes in the amount of &lt;span id="xdx_907_ecustom--DebtInstrumentFaceAmountIssued_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z6LBo6LnyAr1" title="Debt instrument, face amount issued"&gt;440,217&lt;/span&gt; for proceeds of &lt;span id="xdx_908_eus-gaap--ProceedsFromConvertibleDebt_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zVmnGm7v5Mfe" title="Proceeds from convertible notes payable"&gt;386,500&lt;/span&gt; to three unaffiliated
investors. The notes had a &lt;span id="xdx_90B_eus-gaap--DebtInstrumentTerm_dc_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z2bviExRyVTa" title="Debt instrument term"&gt;one year&lt;/span&gt; term and carried an annual interest rate of &lt;span id="xdx_901_ecustom--DebtWeightedAverageInterestRateIssuance_iI_pid_dp_uPure_c20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zTD5G1438Tve" title="Debt weighted average interest rate issuance"&gt;18.0&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the second quarter of 2025, the Company issued convertible notes in the amount of &lt;span id="xdx_90D_ecustom--DebtInstrumentFaceAmountIssued_pn5n6_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableOneMember_zYVQt5SGnF3d" title="Debt instrument, face amount issued"&gt;2.1&lt;/span&gt; million for proceeds of &lt;span id="xdx_907_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zJ39Yao7x7Yg" title="Proceeds from convertible notes payable"&gt;2.0&lt;/span&gt; million. All convertible
notes were fully converted to Series G Convertible Preferred Stock. See Note 17 &#x2013; Equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the fourth quarter, the Company issued convertible notes in the amount of $&lt;span id="xdx_90C_ecustom--DebtInstrumentFaceAmountIssued_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_znG75wbBU4pf" title="Debt instrument, face amount issued"&gt;192,897&lt;/span&gt; to one investor, Yield Point LLC. These notes were
issued in connection with the repayments of two promissory notes. No cash was received or paid by the Company. This convertible note
carries an annual interest rate of &lt;span id="xdx_907_ecustom--DebtWeightedAverageInterestRateIssuance_iI_pid_dp_uPure_c20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z6xgsC3ffTG1" title="Debt weighted average interest rate issuance"&gt;12.0&lt;/span&gt;% and has a &lt;span id="xdx_90F_eus-gaap--DebtInstrumentTerm_dc_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zgnFfa8VPLQ" title="Debt instrument term"&gt;one year&lt;/span&gt; term.&lt;/span&gt;&lt;/p&gt;

</CYCU:ConvertibleNotesDisclosureTextBlock>
    <us-gaap:ConvertibleDebtTableTextBlock contextRef="From2025-01-012025-12-31" id="Fact001676">&lt;p id="xdx_897_eus-gaap--ConvertibleDebtTableTextBlock_z7zKRujJPvM2" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BC_zHEazWhsmsha" style="display: none"&gt;SCHEDULE OF CONVERTIBLE NOTES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="19" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    12: Details of Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Principal
    Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unamortized
    Discount and &lt;br/&gt;Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Convertible
    Notes Carrying &lt;br/&gt;Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Maturity
    &lt;br/&gt;(Calendar Year)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DebtInstrumentFaceAmount_iS_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zS0ODmYs0dV9" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1678"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iS_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zEVGhxgACXM5" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1680"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ConvertibleNotesPayable_iS_c20250101__20250331_z7GP58mOslLi" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1682"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 35%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--DebtInstrumentFaceAmountIssued_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zN6kpUIWOvuj" style="width: 9%; text-align: right" title="Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;440,217&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--DeferredFinanceCostGross_iN_di_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z6z13DfFcY8a" style="width: 9%; text-align: right" title="Unamortized Discount and Issuance Costs Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(53,717&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ConvertibleNotesPayableIssuance_c20250101__20250331_zE8WgHhDrjM5" style="width: 9%; text-align: right" title="Convertible Notes Carrying balance - Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;386,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--DebtWeightedAverageInterestRateIssuance_iI_pid_dp_uPure_c20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zW2DrzAhqBu6" style="width: 9%; text-align: right" title="Weighted Average Interest Rate Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AmortizationOfDebtPremium_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zHjS8hZwWYDc" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1692"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AmortizationOfDebtDiscountPremium_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zqbysVcnDujl" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs , Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,476&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ConvertibleNotesPayableAmortizationOfDebtDiscountPremium_c20250101__20250331_zpcbgvziGlMg" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,476&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentFaceAmount_iS_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zxZq3WCgMut1" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;440,217&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zT1T1OKl3575" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(49,241&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ConvertibleNotesPayable_iS_c20250401__20250630_zuYIIOxibOZd" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;390,976&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zO2JJme4Lwz8" style="text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--DebtInstrumentFaceAmountIssued_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zTu3S76r3uU3" style="text-align: right" title="Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,050,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--DeferredFinanceCostGross_iN_di_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zawapJvZiNsk" style="text-align: right" title="Unamortized Discount and Issuance Costs Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(60,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ConvertibleNotesPayableIssuance_c20250401__20250630_zhtojjFrTsHc" style="text-align: right" title="Convertible Notes Carrying balance - Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,990,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--DebtWeightedAverageInterestRateIssuance_iI_pid_dp_uPure_c20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z1CaAF8Q8mHa" style="text-align: right" title="Weighted Average Interest Rate Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Conversion to equity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--DebtInstrumentFaceAmountConversionToEquity_iN_di_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zYmgW6Pasgef" style="text-align: right" title="Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,490,217&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ConversionOfStockAmountConverted1_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zRWcAlC00qB8" style="text-align: right" title="Unamortized Discount and Issuance Costs, Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;82,465&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ConvertibleNotesPayableConversionToEquity_iN_di_c20250401__20250630_zCdEgc1X0GI9" style="text-align: right" title="Convertible Notes Carrying balance - Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,407,752&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--DebtWeightedAverageInterestRateConversionToEquity_iI_pid_dp_uPure_c20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zKkTx618Ngsk" style="text-align: right" title="Weighted Average Interest Rate Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AmortizationOfDebtPremium_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zdkuT2t3OqBe" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1722"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AmortizationOfDebtDiscountPremium_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zSHu0CTuvVni" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs , Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,776&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ConvertibleNotesPayableAmortizationOfDebtDiscountPremium_c20250401__20250630_zTVJaDVtnbjb" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,776&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentFaceAmount_iS_c20250701__20250930__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zQaiawuHtnF5" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1728"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20250701__20250930__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zB3tFoJ4QC5f" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1730"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConvertibleNotesPayable_iS_c20250701__20250930_zriL1g9rF3Oe" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1732"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--DebtInstrumentFaceAmountIssued_c20250701__20250930__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zlXvaaw41wJd" style="border-bottom: Black 1pt solid; text-align: right" title="Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1734"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--DeferredFinanceCostGross_c20250701__20250930__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zqM6stsZdHj9" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1736"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ConvertibleNotesPayableIssuance_c20250701__20250930_zE3nmRcxJ2C4" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1738"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DebtInstrumentFaceAmount_iS_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zgbruJZ2a2dc" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1740"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iS_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zjYM3zR5l7ui" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1742"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ConvertibleNotesPayable_iS_c20251001__20251231_zb25pkdxnEU3" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1744"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--DebtInstrumentFaceAmountIssued_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z1bvGtnmK6Zk" style="border-bottom: Black 1pt solid; text-align: right" title="Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,897&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--DeferredFinanceCostGross_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zo53T45wgEWd" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1748"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ConvertibleNotesPayableIssuance_c20251001__20251231_z9KBnJmj6YTg" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,897&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--DebtWeightedAverageInterestRateIssuance_iI_pid_dp_uPure_c20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z9CbvNuUO4k7" style="text-align: right" title="Weighted Average Interest Rate Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DebtInstrumentFaceAmount_iE_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zzlJgUiBOdIc" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal value ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,897&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iE_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zOFSbop7Tqq" style="border-bottom: Black 2.5pt double; text-align: right" title="Unamortized Discount and Issuance Costs ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1756"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ConvertibleNotesPayable_iE_c20251001__20251231_zTiJhSQt1f06" style="border-bottom: Black 2.5pt double; text-align: right" title="Convertible Notes Carrying Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,897&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ConvertibleDebtTableTextBlock>
    <CYCU:DebtInstrumentFaceAmountIssued
      contextRef="From2025-01-012025-03-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact001684"
      unitRef="USD">440217</CYCU:DebtInstrumentFaceAmountIssued>
    <CYCU:DeferredFinanceCostGross
      contextRef="From2025-01-012025-03-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact001686"
      unitRef="USD">53717</CYCU:DeferredFinanceCostGross>
    <CYCU:ConvertibleNotesPayableIssuance
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact001688"
      unitRef="USD">386500</CYCU:ConvertibleNotesPayableIssuance>
    <CYCU:DebtWeightedAverageInterestRateIssuance
      contextRef="AsOf2025-03-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      id="Fact001690"
      unitRef="Pure">0.180</CYCU:DebtWeightedAverageInterestRateIssuance>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2025-01-012025-03-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact001694"
      unitRef="USD">4476</us-gaap:AmortizationOfDebtDiscountPremium>
    <CYCU:ConvertibleNotesPayableAmortizationOfDebtDiscountPremium
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact001696"
      unitRef="USD">4476</CYCU:ConvertibleNotesPayableAmortizationOfDebtDiscountPremium>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-03-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact001698"
      unitRef="USD">440217</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2025-03-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact001700"
      unitRef="USD">49241</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact001702"
      unitRef="USD">390976</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="AsOf2025-03-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      id="Fact001704"
      unitRef="Pure">0.180</us-gaap:DebtWeightedAverageInterestRate>
    <CYCU:DebtInstrumentFaceAmountIssued
      contextRef="From2025-04-012025-06-30_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact001706"
      unitRef="USD">2050000</CYCU:DebtInstrumentFaceAmountIssued>
    <CYCU:DeferredFinanceCostGross
      contextRef="From2025-04-012025-06-30_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact001708"
      unitRef="USD">60000</CYCU:DeferredFinanceCostGross>
    <CYCU:ConvertibleNotesPayableIssuance
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact001710"
      unitRef="USD">1990000</CYCU:ConvertibleNotesPayableIssuance>
    <CYCU:DebtWeightedAverageInterestRateIssuance
      contextRef="AsOf2025-06-30_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      id="Fact001712"
      unitRef="Pure">0.151</CYCU:DebtWeightedAverageInterestRateIssuance>
    <CYCU:DebtInstrumentFaceAmountConversionToEquity
      contextRef="From2025-04-012025-06-30_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact001714"
      unitRef="USD">2490217</CYCU:DebtInstrumentFaceAmountConversionToEquity>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="From2025-04-012025-06-30_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact001716"
      unitRef="USD">82465</us-gaap:ConversionOfStockAmountConverted1>
    <CYCU:ConvertibleNotesPayableConversionToEquity
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact001718"
      unitRef="USD">2407752</CYCU:ConvertibleNotesPayableConversionToEquity>
    <CYCU:DebtWeightedAverageInterestRateConversionToEquity
      contextRef="AsOf2025-06-30_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      id="Fact001720"
      unitRef="Pure">0.180</CYCU:DebtWeightedAverageInterestRateConversionToEquity>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2025-04-012025-06-30_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact001724"
      unitRef="USD">26776</us-gaap:AmortizationOfDebtDiscountPremium>
    <CYCU:ConvertibleNotesPayableAmortizationOfDebtDiscountPremium
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact001726"
      unitRef="USD">26776</CYCU:ConvertibleNotesPayableAmortizationOfDebtDiscountPremium>
    <CYCU:DebtInstrumentFaceAmountIssued
      contextRef="From2025-10-012025-12-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact001746"
      unitRef="USD">192897</CYCU:DebtInstrumentFaceAmountIssued>
    <CYCU:ConvertibleNotesPayableIssuance
      contextRef="From2025-10-012025-12-31"
      decimals="0"
      id="Fact001750"
      unitRef="USD">192897</CYCU:ConvertibleNotesPayableIssuance>
    <CYCU:DebtWeightedAverageInterestRateIssuance
      contextRef="AsOf2025-12-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      id="Fact001752"
      unitRef="Pure">0.120</CYCU:DebtWeightedAverageInterestRateIssuance>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact001754"
      unitRef="USD">192897</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001758"
      unitRef="USD">192897</us-gaap:ConvertibleNotesPayable>
    <CYCU:DebtInstrumentFaceAmountIssued
      contextRef="From2025-01-012025-03-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact001760"
      unitRef="USD">440217</CYCU:DebtInstrumentFaceAmountIssued>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2025-01-012025-03-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact001762"
      unitRef="USD">386500</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2025-01-012025-03-31_us-gaap_ConvertibleNotesPayableMember"
      id="Fact001764">P1Y</us-gaap:DebtInstrumentTerm>
    <CYCU:DebtWeightedAverageInterestRateIssuance
      contextRef="AsOf2025-03-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      id="Fact001766"
      unitRef="Pure">0.180</CYCU:DebtWeightedAverageInterestRateIssuance>
    <CYCU:DebtInstrumentFaceAmountIssued
      contextRef="From2025-04-012025-06-30_custom_ConvertibleNotesPayableOneMember"
      decimals="-5"
      id="Fact001768"
      unitRef="USD">2100000</CYCU:DebtInstrumentFaceAmountIssued>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2025-04-012025-06-30_us-gaap_ConvertibleNotesPayableMember"
      decimals="-5"
      id="Fact001770"
      unitRef="USD">2000000.0</us-gaap:ProceedsFromConvertibleDebt>
    <CYCU:DebtInstrumentFaceAmountIssued
      contextRef="From2025-10-012025-12-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact001772"
      unitRef="USD">192897</CYCU:DebtInstrumentFaceAmountIssued>
    <CYCU:DebtWeightedAverageInterestRateIssuance
      contextRef="AsOf2025-12-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      id="Fact001774"
      unitRef="Pure">0.120</CYCU:DebtWeightedAverageInterestRateIssuance>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2025-10-012025-12-31_us-gaap_ConvertibleNotesPayableMember"
      id="Fact001776">P1Y</us-gaap:DebtInstrumentTerm>
    <CYCU:PromissoryNotesDisclosureTextBlock contextRef="From2025-01-012025-12-31" id="Fact001778">&lt;p id="xdx_802_ecustom--PromissoryNotesDisclosureTextBlock_zpGKkhh9cQ9i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82C_zOszvzF68Rs6"&gt;PROMISSORY
                                            NOTES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_89E_ecustom--ScheduleOfPromissoryNotesTableTextBlock_zEWeviLa8tki" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B9_zk9JbGajQHk5" style="display: none"&gt;SCHEDULE OF PROMISSORY NOTES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    13.1: Details of Promissory Notes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Principal
    Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unamortized
    Discount and Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Convertible
    Notes Carrying Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
                                            Average&lt;/span&gt;&lt;/p&gt; &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
                                            Rate &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DebtInstrumentFaceAmount_iS_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z0WoE0P7MCQj" style="width: 12%; text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,498,369&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zCmvIZ2hFA25" style="width: 12%; text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(11,380&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NotesPayable_iS_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zMlF97BPg9hb" style="width: 12%; text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,486,989&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20241231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zQ9k0BlL9Wf3" style="width: 12%; text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16.6&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ProceedsFromNotesPayable_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zE70OtjIVpF3" style="text-align: right" title="Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;690,558&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--UnamortizedDiscountAndIssuanceCostsIssuance_iN_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zJVkm4iCYI5" style="text-align: right" title="Unamortized Discount and Issuance Costs Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(77,358&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ConvertibleNotesPayableIssuance_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zTUPMSx0O4v6" style="text-align: right" title="Convertible Notes Carrying balance - Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;613,200&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--DebtWeightedAverageInterestRateIssuance_iI_pid_dp_uPure_c20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zwgJ0VtZPar6" style="text-align: right" title="Weighted Average Interest Rate Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Repayment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RepaymentsOfNotesPayable_iN_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zG6BJrLLv5dj" style="text-align: right" title="Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(20,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--UnamortizedDiscountAndIssuanceCostsRepayment_iN_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zefZ2853EJla" style="text-align: right" title="Unamortized Discount and Issuance Costs Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1800"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ConvertibleNotesCarryingBalanceRepayment_iN_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zilEK9xU9QZf" style="text-align: right" title="Convertible Notes Carrying balance - Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(20,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--DebtWeightedAverageInterestRateRepayment_iI_pid_dp_uPure_c20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zgUmUh79A1hl" style="text-align: right" title="Weighted Average Interest Rate Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;35.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AdjustmentForAmortization_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zm1PKRAAOuFa" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36,667&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AmortizationOfDebtDiscountPremium_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z8gHSNGscrG7" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,297&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AmortizationOfIssuanceOfConvertibleNotesPayable_iN_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zpE2MRuReIOg" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;57,964&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DebtInstrumentFaceAmount_iS_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zfPoH6njYqW5" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,205,594&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zXBxWimm0Gqf" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(67,441&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NotesPayable_iS_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zdnYAfB18l4l" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,138,153&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zaRnAcCDpRTb" style="text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15.8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Conversion to equity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--DebtInstrumentFaceAmountConversionToEquity_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zVt9dyRwTCXb" style="text-align: right" title="Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(456,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ConversionOfStockAmountConverted1_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zqAvhpOQtbhk" style="text-align: right" title="Unamortized Discount and Issuance Costs Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1822"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ConvertibleNotesPayableConversionToEquity_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z5VPSfrTOe0k" style="text-align: right" title="Convertible Notes Carrying balance - Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(456,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--DebtWeightedAverageInterestRateConversionToEquity_iI_pid_dp_uPure_c20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z4mSMRPQoMRk" style="text-align: right" title="Weighted Average Interest Rate Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Repayment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RepaymentsOfNotesPayable_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zeEJ5XJIvrGe" style="text-align: right" title="Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(50,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--UnamortizedDiscountAndIssuanceCostsRepayment_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zFOOFi7krwOc" style="text-align: right" title="Unamortized Discount and Issuance Costs Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1830"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ConvertibleNotesCarryingBalanceRepayment_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zUrG9sED9RRd" style="text-align: right" title="Convertible Notes Carrying balance - Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(50,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--DebtWeightedAverageInterestRateRepayment_iI_pid_dp_uPure_c20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zOX0MdN0pIBd" style="text-align: right" title="Weighted Average Interest Rate Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AdjustmentForAmortization_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zIk8C4f9Dd7j" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1836"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AmortizationOfDebtDiscountPremium_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zkcIZX9NrThi" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,973&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--AmortizationOfIssuanceOfConvertibleNotesPayable_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z1sByrYrkKzj" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,973&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DebtInstrumentFaceAmount_iS_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zor0XCdwf9t9" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,699,094&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zf5UMxdfkTZf" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(29,468&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NotesPayable_iS_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zug3Qg5jtsM4" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,669,626&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_znyLOBkBV0b6" style="text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Repayment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RepaymentsOfNotesPayable_iN_di_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_ztMDEekbLZQ3" style="text-align: right" title="Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(31,579&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--UnamortizedDiscountAndIssuanceCostsRepayment_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z7kJHzlcsfKh" style="text-align: right" title="Unamortized Discount and Issuance Costs Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1852"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ConvertibleNotesCarryingBalanceRepayment_iN_di_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zEO2saxp273j" style="text-align: right" title="Convertible Notes Carrying balance - Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(31,579&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--DebtWeightedAverageInterestRateRepayment_iI_pid_dp_uPure_c20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z9edW2eM5G2" style="text-align: right" title="Weighted Average Interest Rate Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AdjustmentForAmortization_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zDY1eM5Dus5e" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1858"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AmortizationOfDebtDiscountPremium_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zpcVXVLVQutb" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,616&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AmortizationOfIssuanceOfConvertibleNotesPayable_iN_di_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z8wic4zA56Ab" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,616&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DebtInstrumentFaceAmount_iS_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zD3E5nQnSbwa" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,667,515&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zr7xX7iolLH6" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(8,852&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NotesPayable_iS_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zfTOjpWrzrh5" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,658,663&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z3tSch0tDi33" style="text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Conversion to a convertible
    note&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--PrincipalValueConversionToAConvertibleNote_iN_di_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zPUKGKOquPY8" style="text-align: right" title="Conversion to a convertible note"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(166,666&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--UnamortizedDiscountAndIssuanceCostsConversionToAConvertibleNote_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z1D5qeyyYArj" style="text-align: right" title="Unamortized Discount and Issuance Costs Conversion to a convertible note"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1874"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ConvertibleNotesCarryingBalanceConversionToAConvertibleNote_iN_di_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z12NMp0GS2U6" style="text-align: right" title="Convertible Notes Carrying balance - Conversion to a convertible note"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(166,666&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--DebtWeightedAverageInterestRateConversionToAConvertibleNote_iI_pid_dp_uPure_c20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zzoCH6DpN3y" style="text-align: right" title="Weighted Average Interest Rate Conversion to a convertible note"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AdjustmentForAmortization_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zRkDbriozSH2" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1880"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AmortizationOfDebtDiscountPremium_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zvzHzHlSNbtk" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,665&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--AmortizationOfIssuanceOfConvertibleNotesPayable_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zPrOqFbXkz8d" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,665&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DebtInstrumentFaceAmount_iE_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zipeRuJs7YTg" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal value ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,500,849&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNE_di_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zsWo2wkzqrG2" style="border-bottom: Black 2.5pt double; text-align: right" title="Unamortized Discount and Issuance Costs ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,187&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NotesPayable_iE_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z9gKIWXZ4053" style="border-bottom: Black 2.5pt double; text-align: right" title="Convertible Notes Carrying Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,499,662&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zjE1WZEtgFDf" style="text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zIRDiNqUNvGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;



&lt;p id="xdx_89A_ecustom--ScheduleOfLoansPayableTableTextBlock_zArqclBY9fgi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_z4OxkdMuPyh5" style="display: none"&gt;SCHEDULE OF LOANS PAYABLE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20251231_zqVEYOP0BIh2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20241231_zQ5L1ziinIb3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    Rate&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Calendar
    Year)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="15" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    13.2: Details of Loans Payable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
                                            Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Maturity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    Rate&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Calendar
    Year)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesOneMember_zOQWMppLZBW7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Note issued in 2017&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesOneMember_zc7GC1cz8Pmi" style="width: 12%; text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 14%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesTwoMember_zML8AWV5y6Q4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Note issued in 2020&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;300,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;300,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesTwoMember_z4DW4fidXdw2" style="text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesThreeMember_z4SWAcUsPgo1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Note issued in 2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;400,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;400,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesThreeMember_zmd9h1YHwU71" style="text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021 - 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesFourMember_zIx2bpkWQwZk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Notes issued in 2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;611,111&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,067,611&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesFourMember_zA5xnh0MTrJb" style="text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesFiveMember_zhLb0NQBpGHg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Notes issued in 2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;319,180&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;480,758&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesFiveMember_zcNWNNDULyaf" style="text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesSixMember_zG1YKhpv9t2f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Notes issued in 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;620,558&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1922"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesSixMember_zd0yl70hyfma" style="text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025 -2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zUzbz0gk5Kqk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Funded
    loans payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,500,849&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,498,369&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zh6O8B7lYW44" style="text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNI_di_zoZJJ8e5uxWa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: Unamortized debt-issuance
    costs and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,187&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(11,380&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--NotesPayableCurrent_iI_zwnJ16FzlrN" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    loans payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,499,662&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,486,989&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AB_zdXbiWbMOWLh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</CYCU:PromissoryNotesDisclosureTextBlock>
    <CYCU:ScheduleOfPromissoryNotesTableTextBlock contextRef="From2025-01-012025-12-31" id="Fact001780">&lt;p id="xdx_89E_ecustom--ScheduleOfPromissoryNotesTableTextBlock_zEWeviLa8tki" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B9_zk9JbGajQHk5" style="display: none"&gt;SCHEDULE OF PROMISSORY NOTES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    13.1: Details of Promissory Notes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Principal
    Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unamortized
    Discount and Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Convertible
    Notes Carrying Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
                                            Average&lt;/span&gt;&lt;/p&gt; &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
                                            Rate &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DebtInstrumentFaceAmount_iS_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z0WoE0P7MCQj" style="width: 12%; text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,498,369&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zCmvIZ2hFA25" style="width: 12%; text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(11,380&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NotesPayable_iS_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zMlF97BPg9hb" style="width: 12%; text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,486,989&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20241231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zQ9k0BlL9Wf3" style="width: 12%; text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16.6&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ProceedsFromNotesPayable_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zE70OtjIVpF3" style="text-align: right" title="Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;690,558&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--UnamortizedDiscountAndIssuanceCostsIssuance_iN_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zJVkm4iCYI5" style="text-align: right" title="Unamortized Discount and Issuance Costs Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(77,358&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ConvertibleNotesPayableIssuance_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zTUPMSx0O4v6" style="text-align: right" title="Convertible Notes Carrying balance - Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;613,200&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--DebtWeightedAverageInterestRateIssuance_iI_pid_dp_uPure_c20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zwgJ0VtZPar6" style="text-align: right" title="Weighted Average Interest Rate Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Repayment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RepaymentsOfNotesPayable_iN_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zG6BJrLLv5dj" style="text-align: right" title="Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(20,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--UnamortizedDiscountAndIssuanceCostsRepayment_iN_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zefZ2853EJla" style="text-align: right" title="Unamortized Discount and Issuance Costs Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1800"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ConvertibleNotesCarryingBalanceRepayment_iN_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zilEK9xU9QZf" style="text-align: right" title="Convertible Notes Carrying balance - Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(20,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--DebtWeightedAverageInterestRateRepayment_iI_pid_dp_uPure_c20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zgUmUh79A1hl" style="text-align: right" title="Weighted Average Interest Rate Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;35.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AdjustmentForAmortization_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zm1PKRAAOuFa" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36,667&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AmortizationOfDebtDiscountPremium_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z8gHSNGscrG7" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,297&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AmortizationOfIssuanceOfConvertibleNotesPayable_iN_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zpE2MRuReIOg" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;57,964&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DebtInstrumentFaceAmount_iS_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zfPoH6njYqW5" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,205,594&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zXBxWimm0Gqf" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(67,441&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NotesPayable_iS_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zdnYAfB18l4l" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,138,153&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zaRnAcCDpRTb" style="text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15.8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Conversion to equity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--DebtInstrumentFaceAmountConversionToEquity_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zVt9dyRwTCXb" style="text-align: right" title="Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(456,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ConversionOfStockAmountConverted1_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zqAvhpOQtbhk" style="text-align: right" title="Unamortized Discount and Issuance Costs Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1822"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ConvertibleNotesPayableConversionToEquity_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z5VPSfrTOe0k" style="text-align: right" title="Convertible Notes Carrying balance - Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(456,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--DebtWeightedAverageInterestRateConversionToEquity_iI_pid_dp_uPure_c20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z4mSMRPQoMRk" style="text-align: right" title="Weighted Average Interest Rate Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Repayment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RepaymentsOfNotesPayable_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zeEJ5XJIvrGe" style="text-align: right" title="Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(50,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--UnamortizedDiscountAndIssuanceCostsRepayment_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zFOOFi7krwOc" style="text-align: right" title="Unamortized Discount and Issuance Costs Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1830"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ConvertibleNotesCarryingBalanceRepayment_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zUrG9sED9RRd" style="text-align: right" title="Convertible Notes Carrying balance - Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(50,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--DebtWeightedAverageInterestRateRepayment_iI_pid_dp_uPure_c20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zOX0MdN0pIBd" style="text-align: right" title="Weighted Average Interest Rate Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AdjustmentForAmortization_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zIk8C4f9Dd7j" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1836"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AmortizationOfDebtDiscountPremium_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zkcIZX9NrThi" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,973&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--AmortizationOfIssuanceOfConvertibleNotesPayable_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z1sByrYrkKzj" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,973&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DebtInstrumentFaceAmount_iS_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zor0XCdwf9t9" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,699,094&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zf5UMxdfkTZf" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(29,468&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NotesPayable_iS_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zug3Qg5jtsM4" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,669,626&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_znyLOBkBV0b6" style="text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Repayment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RepaymentsOfNotesPayable_iN_di_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_ztMDEekbLZQ3" style="text-align: right" title="Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(31,579&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--UnamortizedDiscountAndIssuanceCostsRepayment_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z7kJHzlcsfKh" style="text-align: right" title="Unamortized Discount and Issuance Costs Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1852"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ConvertibleNotesCarryingBalanceRepayment_iN_di_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zEO2saxp273j" style="text-align: right" title="Convertible Notes Carrying balance - Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(31,579&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--DebtWeightedAverageInterestRateRepayment_iI_pid_dp_uPure_c20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z9edW2eM5G2" style="text-align: right" title="Weighted Average Interest Rate Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AdjustmentForAmortization_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zDY1eM5Dus5e" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1858"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AmortizationOfDebtDiscountPremium_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zpcVXVLVQutb" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,616&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AmortizationOfIssuanceOfConvertibleNotesPayable_iN_di_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z8wic4zA56Ab" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,616&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DebtInstrumentFaceAmount_iS_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zD3E5nQnSbwa" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,667,515&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zr7xX7iolLH6" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(8,852&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NotesPayable_iS_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zfTOjpWrzrh5" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,658,663&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z3tSch0tDi33" style="text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Conversion to a convertible
    note&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--PrincipalValueConversionToAConvertibleNote_iN_di_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zPUKGKOquPY8" style="text-align: right" title="Conversion to a convertible note"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(166,666&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--UnamortizedDiscountAndIssuanceCostsConversionToAConvertibleNote_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z1D5qeyyYArj" style="text-align: right" title="Unamortized Discount and Issuance Costs Conversion to a convertible note"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1874"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ConvertibleNotesCarryingBalanceConversionToAConvertibleNote_iN_di_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z12NMp0GS2U6" style="text-align: right" title="Convertible Notes Carrying balance - Conversion to a convertible note"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(166,666&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--DebtWeightedAverageInterestRateConversionToAConvertibleNote_iI_pid_dp_uPure_c20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zzoCH6DpN3y" style="text-align: right" title="Weighted Average Interest Rate Conversion to a convertible note"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AdjustmentForAmortization_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zRkDbriozSH2" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1880"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AmortizationOfDebtDiscountPremium_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zvzHzHlSNbtk" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,665&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--AmortizationOfIssuanceOfConvertibleNotesPayable_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zPrOqFbXkz8d" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,665&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DebtInstrumentFaceAmount_iE_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zipeRuJs7YTg" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal value ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,500,849&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNE_di_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zsWo2wkzqrG2" style="border-bottom: Black 2.5pt double; text-align: right" title="Unamortized Discount and Issuance Costs ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,187&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NotesPayable_iE_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z9gKIWXZ4053" style="border-bottom: Black 2.5pt double; text-align: right" title="Convertible Notes Carrying Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,499,662&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zjE1WZEtgFDf" style="text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</CYCU:ScheduleOfPromissoryNotesTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-12-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001782"
      unitRef="USD">2498369</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2024-12-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001784"
      unitRef="USD">11380</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-12-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001786"
      unitRef="USD">2486989</us-gaap:NotesPayable>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="AsOf2024-12-31_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact001788"
      unitRef="Pure">0.166</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2025-01-012025-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001790"
      unitRef="USD">690558</us-gaap:ProceedsFromNotesPayable>
    <CYCU:UnamortizedDiscountAndIssuanceCostsIssuance
      contextRef="From2025-01-012025-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001792"
      unitRef="USD">77358</CYCU:UnamortizedDiscountAndIssuanceCostsIssuance>
    <CYCU:ConvertibleNotesPayableIssuance
      contextRef="From2025-01-012025-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001794"
      unitRef="USD">613200</CYCU:ConvertibleNotesPayableIssuance>
    <CYCU:DebtWeightedAverageInterestRateIssuance
      contextRef="AsOf2025-03-31_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact001796"
      unitRef="Pure">0.135</CYCU:DebtWeightedAverageInterestRateIssuance>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2025-01-012025-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001798"
      unitRef="USD">20000</us-gaap:RepaymentsOfNotesPayable>
    <CYCU:ConvertibleNotesCarryingBalanceRepayment
      contextRef="From2025-01-012025-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001802"
      unitRef="USD">20000</CYCU:ConvertibleNotesCarryingBalanceRepayment>
    <CYCU:DebtWeightedAverageInterestRateRepayment
      contextRef="AsOf2025-03-31_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact001804"
      unitRef="Pure">0.350</CYCU:DebtWeightedAverageInterestRateRepayment>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2025-01-012025-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001806"
      unitRef="USD">36667</us-gaap:AdjustmentForAmortization>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2025-01-012025-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001808"
      unitRef="USD">21297</us-gaap:AmortizationOfDebtDiscountPremium>
    <CYCU:AmortizationOfIssuanceOfConvertibleNotesPayable
      contextRef="From2025-01-012025-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001810"
      unitRef="USD">-57964</CYCU:AmortizationOfIssuanceOfConvertibleNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001812"
      unitRef="USD">3205594</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2025-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001814"
      unitRef="USD">67441</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:NotesPayable
      contextRef="AsOf2025-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001816"
      unitRef="USD">3138153</us-gaap:NotesPayable>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="AsOf2025-03-31_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact001818"
      unitRef="Pure">0.158</us-gaap:DebtWeightedAverageInterestRate>
    <CYCU:DebtInstrumentFaceAmountConversionToEquity
      contextRef="From2025-04-012025-06-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001820"
      unitRef="USD">456500</CYCU:DebtInstrumentFaceAmountConversionToEquity>
    <CYCU:ConvertibleNotesPayableConversionToEquity
      contextRef="From2025-04-012025-06-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001824"
      unitRef="USD">456500</CYCU:ConvertibleNotesPayableConversionToEquity>
    <CYCU:DebtWeightedAverageInterestRateConversionToEquity
      contextRef="AsOf2025-06-30_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact001826"
      unitRef="Pure">0.240</CYCU:DebtWeightedAverageInterestRateConversionToEquity>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2025-04-012025-06-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001828"
      unitRef="USD">50000</us-gaap:RepaymentsOfNotesPayable>
    <CYCU:ConvertibleNotesCarryingBalanceRepayment
      contextRef="From2025-04-012025-06-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001832"
      unitRef="USD">50000</CYCU:ConvertibleNotesCarryingBalanceRepayment>
    <CYCU:DebtWeightedAverageInterestRateRepayment
      contextRef="AsOf2025-06-30_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact001834"
      unitRef="Pure">0.240</CYCU:DebtWeightedAverageInterestRateRepayment>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2025-04-012025-06-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001838"
      unitRef="USD">37973</us-gaap:AmortizationOfDebtDiscountPremium>
    <CYCU:AmortizationOfIssuanceOfConvertibleNotesPayable
      contextRef="From2025-04-012025-06-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001840"
      unitRef="USD">-37973</CYCU:AmortizationOfIssuanceOfConvertibleNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-06-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001842"
      unitRef="USD">2699094</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2025-06-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001844"
      unitRef="USD">29468</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:NotesPayable
      contextRef="AsOf2025-06-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001846"
      unitRef="USD">2669626</us-gaap:NotesPayable>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="AsOf2025-06-30_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact001848"
      unitRef="Pure">0.143</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2025-07-012025-09-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001850"
      unitRef="USD">31579</us-gaap:RepaymentsOfNotesPayable>
    <CYCU:ConvertibleNotesCarryingBalanceRepayment
      contextRef="From2025-07-012025-09-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001854"
      unitRef="USD">31579</CYCU:ConvertibleNotesCarryingBalanceRepayment>
    <CYCU:DebtWeightedAverageInterestRateRepayment
      contextRef="AsOf2025-09-30_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact001856"
      unitRef="Pure">0.120</CYCU:DebtWeightedAverageInterestRateRepayment>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2025-07-012025-09-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001860"
      unitRef="USD">20616</us-gaap:AmortizationOfDebtDiscountPremium>
    <CYCU:AmortizationOfIssuanceOfConvertibleNotesPayable
      contextRef="From2025-07-012025-09-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001862"
      unitRef="USD">-20616</CYCU:AmortizationOfIssuanceOfConvertibleNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-09-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001864"
      unitRef="USD">2667515</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2025-09-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001866"
      unitRef="USD">8852</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:NotesPayable
      contextRef="AsOf2025-09-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001868"
      unitRef="USD">2658663</us-gaap:NotesPayable>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="AsOf2025-09-30_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact001870"
      unitRef="Pure">0.143</us-gaap:DebtWeightedAverageInterestRate>
    <CYCU:PrincipalValueConversionToAConvertibleNote
      contextRef="From2025-10-012025-12-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001872"
      unitRef="USD">166666</CYCU:PrincipalValueConversionToAConvertibleNote>
    <CYCU:ConvertibleNotesCarryingBalanceConversionToAConvertibleNote
      contextRef="From2025-10-012025-12-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001876"
      unitRef="USD">166666</CYCU:ConvertibleNotesCarryingBalanceConversionToAConvertibleNote>
    <CYCU:DebtWeightedAverageInterestRateConversionToAConvertibleNote
      contextRef="AsOf2025-09-30_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact001878"
      unitRef="Pure">0.100</CYCU:DebtWeightedAverageInterestRateConversionToAConvertibleNote>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2025-10-012025-12-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001882"
      unitRef="USD">7665</us-gaap:AmortizationOfDebtDiscountPremium>
    <CYCU:AmortizationOfIssuanceOfConvertibleNotesPayable
      contextRef="From2025-10-012025-12-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001884"
      unitRef="USD">7665</CYCU:AmortizationOfIssuanceOfConvertibleNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001886"
      unitRef="USD">2500849</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2025-12-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001888"
      unitRef="USD">1187</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:NotesPayable
      contextRef="AsOf2025-12-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001890"
      unitRef="USD">2499662</us-gaap:NotesPayable>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="AsOf2025-12-31_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact001892"
      unitRef="Pure">0.143</us-gaap:DebtWeightedAverageInterestRate>
    <CYCU:ScheduleOfLoansPayableTableTextBlock contextRef="From2025-01-012025-12-31" id="Fact001894">&lt;p id="xdx_89A_ecustom--ScheduleOfLoansPayableTableTextBlock_zArqclBY9fgi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_z4OxkdMuPyh5" style="display: none"&gt;SCHEDULE OF LOANS PAYABLE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20251231_zqVEYOP0BIh2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20241231_zQ5L1ziinIb3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    Rate&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Calendar
    Year)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="15" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
    13.2: Details of Loans Payable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
                                            Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Maturity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    Rate&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Calendar
    Year)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesOneMember_zOQWMppLZBW7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Note issued in 2017&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesOneMember_zc7GC1cz8Pmi" style="width: 12%; text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 14%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesTwoMember_zML8AWV5y6Q4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Note issued in 2020&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;300,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;300,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesTwoMember_z4DW4fidXdw2" style="text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesThreeMember_z4SWAcUsPgo1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Note issued in 2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;400,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;400,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesThreeMember_zmd9h1YHwU71" style="text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021 - 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesFourMember_zIx2bpkWQwZk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Notes issued in 2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;611,111&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,067,611&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesFourMember_zA5xnh0MTrJb" style="text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesFiveMember_zhLb0NQBpGHg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Notes issued in 2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;319,180&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;480,758&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesFiveMember_zcNWNNDULyaf" style="text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesSixMember_zG1YKhpv9t2f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Notes issued in 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;620,558&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1922"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesSixMember_zd0yl70hyfma" style="text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025 -2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zUzbz0gk5Kqk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Funded
    loans payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,500,849&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,498,369&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zh6O8B7lYW44" style="text-align: right" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNI_di_zoZJJ8e5uxWa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: Unamortized debt-issuance
    costs and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,187&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(11,380&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--NotesPayableCurrent_iI_zwnJ16FzlrN" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    loans payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,499,662&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,486,989&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</CYCU:ScheduleOfLoansPayableTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_custom_PromissoryNotesOneMember"
      decimals="0"
      id="Fact001896"
      unitRef="USD">250000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-12-31_custom_PromissoryNotesOneMember"
      decimals="0"
      id="Fact001897"
      unitRef="USD">250000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2025-12-31_custom_PromissoryNotesOneMember"
      decimals="INF"
      id="Fact001899"
      unitRef="Pure">0.040</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_custom_PromissoryNotesTwoMember"
      decimals="0"
      id="Fact001901"
      unitRef="USD">300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-12-31_custom_PromissoryNotesTwoMember"
      decimals="0"
      id="Fact001902"
      unitRef="USD">300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2025-12-31_custom_PromissoryNotesTwoMember"
      decimals="INF"
      id="Fact001904"
      unitRef="Pure">0.240</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_custom_PromissoryNotesThreeMember"
      decimals="0"
      id="Fact001906"
      unitRef="USD">400000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-12-31_custom_PromissoryNotesThreeMember"
      decimals="0"
      id="Fact001907"
      unitRef="USD">400000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2025-12-31_custom_PromissoryNotesThreeMember"
      decimals="INF"
      id="Fact001909"
      unitRef="Pure">0.240</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_custom_PromissoryNotesFourMember"
      decimals="0"
      id="Fact001911"
      unitRef="USD">611111</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-12-31_custom_PromissoryNotesFourMember"
      decimals="0"
      id="Fact001912"
      unitRef="USD">1067611</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2025-12-31_custom_PromissoryNotesFourMember"
      decimals="INF"
      id="Fact001914"
      unitRef="Pure">0.240</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_custom_PromissoryNotesFiveMember"
      decimals="0"
      id="Fact001916"
      unitRef="USD">319180</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-12-31_custom_PromissoryNotesFiveMember"
      decimals="0"
      id="Fact001917"
      unitRef="USD">480758</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2025-12-31_custom_PromissoryNotesFiveMember"
      decimals="INF"
      id="Fact001919"
      unitRef="Pure">0.107</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_custom_PromissoryNotesSixMember"
      decimals="0"
      id="Fact001921"
      unitRef="USD">620558</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2025-12-31_custom_PromissoryNotesSixMember"
      decimals="INF"
      id="Fact001924"
      unitRef="Pure">0.120</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001926"
      unitRef="USD">2500849</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-12-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact001927"
      unitRef="USD">2498369</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2025-12-31_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact001929"
      unitRef="Pure">0.173</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001931"
      unitRef="USD">1187</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001932"
      unitRef="USD">11380</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001934"
      unitRef="USD">2499662</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001935"
      unitRef="USD">2486989</us-gaap:NotesPayableCurrent>
    <us-gaap:SubordinatedBorrowingsDisclosureTextBlock contextRef="From2025-01-012025-12-31" id="Fact001937">&lt;p id="xdx_80E_eus-gaap--SubordinatedBorrowingsDisclosureTextBlock_zdmZxbjeSNx9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_825_zgGeBHbskcH5"&gt;SUBORDINATED
                                            CONVERTIBLE PROMISSORY NOTES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 22, 2022, the Company issued subordinated convertible promissory notes with principal value of $&lt;span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20220322__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SixInvestorsMember_zsles6pfmKL1" title="Principal amount"&gt;526,315&lt;/span&gt; to six investors. While
subordinate to bank lender the notes are secured by The Company&#x2019;s assets. The Company issued to an independent director a $&lt;span id="xdx_90A_eus-gaap--ConvertibleDebt_iI_c20220322_zceDMQieiYze" title="Convertible debt"&gt;236,842&lt;/span&gt;
subordinated convertible note. The Company issued to an otherwise unaffiliated investors of subordinated convertible notes in principal
amounts of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20220322__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThreeInvestorsMember_zO2T3X7Se547" title="Principal amount"&gt;52,631&lt;/span&gt; to three investors, $&lt;span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20220322__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FifthInvestorMember_zXec2oD0MLal" title="Principal amount"&gt;105,263&lt;/span&gt; to a fifth investor and $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20220322__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SixthInvestorMember_zJEATYurdiI5" title="Principal amount"&gt;26,315&lt;/span&gt; to a sixth investor. The notes carry annual interest
rate of &lt;span id="xdx_907_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20220322_zHE0nYzs5Ujh" title="Debt instrument, interest rate, effective percentage"&gt;8&lt;/span&gt;% that commenced upon funding date through the date of repayment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 22, 2022, the Company issued to three otherwise unaffiliated investors $&lt;span id="xdx_902_eus-gaap--ConvertibleNotesPayable_iI_c20221122__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThreeUnaffiliatedInvestorsMember_zbENIMYdrdBc" title="Convertible notes payable"&gt;2,777,778&lt;/span&gt; in promissory notes, &lt;span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20221122__20221122_zbAX76FvHC96" title="Debt conversion, converted instrument, shares issued"&gt;13,134&lt;/span&gt; shares of Common
Stock and &lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221122_zfYHgAKf7G35" title="Number of warrants or rights outstanding"&gt;32,819&lt;/span&gt; warrants for $&lt;span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfDebt_c20221122__20221122__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThreeUnaffiliatedInvestorsMember_zAhi4sVAr1E5" title="Gross proceeds"&gt;2,500,000&lt;/span&gt; in gross proceeds.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company entered into the Merger Agreement with Western and Merger Sub, on November 21, 2022, as amended. As a result of the Business
Combination, Cycurion raised $&lt;span id="xdx_90A_eus-gaap--ConvertibleDebt_iI_c20221121__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NineUnaffiliatedInvestorsMember__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationAgreementMember_zyYE9kKBf68e" title="Convertible debt"&gt;3,333,335&lt;/span&gt; of debt capital on November 21, 2022, from nine unaffiliated investors who were issued for convertibles
notes, warrants and shares of Common Stock. The convertible notes had a maturity date of November 21, 2023, and an interest rate of &lt;span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20221121_zetlRMgVpZU6" title="Debt instrument, interest rate, effective percentage"&gt;8&lt;/span&gt;%.
They were also issued to convert to equity upon completion of the Business Combination between Cycurion and Western.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the first quarter of 2025, the Company issued shares of preferred stock and warrants in exchange of the outstanding convertible promissory
notes which had an aggregate principal amount of $&lt;span id="xdx_90F_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_c20250101__20250331__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationAgreementMember_z0UYaYtiaKW5" title="Aggregate principal amount"&gt;3,333,335&lt;/span&gt; and accrued interest of $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20250101__20250331__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationAgreementMember_z9n18IpBIrXc" title="Accrued interest"&gt;299,259&lt;/span&gt;. As a part of this conversion, the Company
issued &lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20250101__20250331__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zBxfWcnYqbfa" title="Stock issued during period, shares, conversion of convertible securities"&gt;222,222&lt;/span&gt; shares of Series D Convertible Preferred Stock and &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20250101__20250331__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SevenUnaffiliatedInvestorsMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDWarrantsMember_zY7AzwVy7ci5" title="Stock issued during period, shares, conversion of convertible securities"&gt;242,424&lt;/span&gt; Series D warrants to seven unaffiliated note holders. As a
result, the Company recorded gain on settlement of debt of $&lt;span id="xdx_90F_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20250101__20250331__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationAgreementMember_ztVKpa0OyKvf" title="Gain on debt settlement, net"&gt;299,259&lt;/span&gt;, which is presented on the consolidated statements of operations
and the consolidated statements of cash flows within &#x2018;Gain on debt settlement, net&#x2019;.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubordinatedBorrowingsDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-03-22_custom_SixInvestorsMember"
      decimals="0"
      id="Fact001939"
      unitRef="USD">526315</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2022-03-22"
      decimals="0"
      id="Fact001941"
      unitRef="USD">236842</us-gaap:ConvertibleDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-03-22_custom_ThreeInvestorsMember"
      decimals="0"
      id="Fact001943"
      unitRef="USD">52631</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-03-22_custom_FifthInvestorMember"
      decimals="0"
      id="Fact001945"
      unitRef="USD">105263</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-03-22_custom_SixthInvestorMember"
      decimals="0"
      id="Fact001947"
      unitRef="USD">26315</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2022-03-22"
      decimals="INF"
      id="Fact001949"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2022-11-22_custom_ThreeUnaffiliatedInvestorsMember"
      decimals="0"
      id="Fact001951"
      unitRef="USD">2777778</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2022-11-222022-11-22"
      decimals="INF"
      id="Fact001953"
      unitRef="Shares">13134</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-11-22"
      decimals="INF"
      id="Fact001955"
      unitRef="Shares">32819</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2022-11-222022-11-22_custom_ThreeUnaffiliatedInvestorsMember"
      decimals="0"
      id="Fact001957"
      unitRef="USD">2500000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2022-11-21_custom_NineUnaffiliatedInvestorsMember_custom_BusinessCombinationAgreementMember"
      decimals="0"
      id="Fact001959"
      unitRef="USD">3333335</us-gaap:ConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2022-11-21"
      decimals="INF"
      id="Fact001961"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2025-01-012025-03-31_custom_BusinessCombinationAgreementMember"
      decimals="0"
      id="Fact001963"
      unitRef="USD">3333335</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2025-01-012025-03-31_custom_BusinessCombinationAgreementMember"
      decimals="0"
      id="Fact001965"
      unitRef="USD">299259</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2025-01-012025-03-31_custom_BusinessCombinationAgreementMember_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact001967"
      unitRef="Shares">222222</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2025-01-012025-03-31_custom_BusinessCombinationAgreementMember_custom_SevenUnaffiliatedInvestorsMember_custom_SeriesDWarrantsMember"
      decimals="INF"
      id="Fact001969"
      unitRef="Shares">242424</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2025-01-012025-03-31_custom_BusinessCombinationAgreementMember"
      decimals="0"
      id="Fact001971"
      unitRef="USD">299259</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <CYCU:FactoringLiabilityDisclosureTextBlock contextRef="From2025-01-012025-12-31" id="Fact001973">&lt;p id="xdx_801_ecustom--FactoringLiabilityDisclosureTextBlock_zqeJ1ThGv3fl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82B_zRBXbTOrblAb"&gt;FACTORING
                                            LIABILITY&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 12, 2022, the Company entered into agreement with a lender, whereby the lender would loan proceeds against certain accounts receivable
up to &lt;span id="xdx_902_ecustom--PercentageOfAccountsReceivableCoveredByFactor_iI_pid_dp_uPure_c20220712_zM3tEBY4ssgf" title="Percentage of accounts receivable covered by factor"&gt;90&lt;/span&gt;% of the total value of the invoice, which is paid to the Company in the form of a cash advance. A factoring cost of &lt;span id="xdx_908_ecustom--FactoringCommissionPercentageForThirtyDays_iI_pid_dp_uPure_c20220712_zVPVvEmsODIk" title="Factoring commission percentage for thirty days"&gt;1.5&lt;/span&gt;% is
applied for days 1-30 after the loan is funded, and an additional &lt;span id="xdx_908_ecustom--PercentageOfAdditionalFactoringFeeForEveryTenDaysAfterThirtyDays_iI_pid_dp_uPure_c20220712_zbW8HFqMw1w8" title="Percentage of additional factoring fee for every ten days after thirty days"&gt;0.5&lt;/span&gt;% fee charge is applied for each additional 10 days period thereafter.
The maximum facility is $&lt;span id="xdx_90A_ecustom--MaximumLimitOfFactoring_iI_pn5n6_c20220712_zRkK4rsqudWg" title="Maximum limit of factoring"&gt;3.0&lt;/span&gt; million.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accordingly,
pursuant to ASC 860-20-55-24, the Company recognized a factoring liability to the lenders until the accounts receivables are collected.
As of December 31, 2025 the factoring liability was $&lt;span id="xdx_904_ecustom--FactoringLiability_iI_pn5n6_c20251231_zIe01eZf2m71" title="Factoring liability"&gt;1.5&lt;/span&gt; million. As of December 31, 2024, there was &lt;span id="xdx_90A_ecustom--FactoringLiability_iI_doxL_c20241231_z6vjyzyYTlK8" title="Factoring liability::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1985"&gt;no&lt;/span&gt;&lt;/span&gt; factoring liability recorded.&lt;/span&gt;&lt;/p&gt;
</CYCU:FactoringLiabilityDisclosureTextBlock>
    <CYCU:PercentageOfAccountsReceivableCoveredByFactor
      contextRef="AsOf2022-07-12"
      decimals="INF"
      id="Fact001975"
      unitRef="Pure">0.90</CYCU:PercentageOfAccountsReceivableCoveredByFactor>
    <CYCU:FactoringCommissionPercentageForThirtyDays
      contextRef="AsOf2022-07-12"
      decimals="INF"
      id="Fact001977"
      unitRef="Pure">0.015</CYCU:FactoringCommissionPercentageForThirtyDays>
    <CYCU:PercentageOfAdditionalFactoringFeeForEveryTenDaysAfterThirtyDays
      contextRef="AsOf2022-07-12"
      decimals="INF"
      id="Fact001979"
      unitRef="Pure">0.005</CYCU:PercentageOfAdditionalFactoringFeeForEveryTenDaysAfterThirtyDays>
    <CYCU:MaximumLimitOfFactoring
      contextRef="AsOf2022-07-12"
      decimals="-5"
      id="Fact001981"
      unitRef="USD">3000000.0</CYCU:MaximumLimitOfFactoring>
    <CYCU:FactoringLiability
      contextRef="AsOf2025-12-31"
      decimals="-5"
      id="Fact001983"
      unitRef="USD">1500000</CYCU:FactoringLiability>
    <us-gaap:PreferredStockTextBlock contextRef="From2025-01-012025-12-31" id="Fact001987">&lt;p id="xdx_802_eus-gaap--PreferredStockTextBlock_z37if2Qdmo9a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_826_zWLMAWinNw81"&gt;SERIES
                                            A CONVERTIBLE PREFERRED STOCK&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2024, the Company has authorized &lt;span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOneConvertiblePreferredStockMember_zAWf3X3glzy8" title="Preferred stock, shares authorized"&gt;16,667&lt;/span&gt; shares of Series A Convertible Preferred Stock with a par value of $&lt;span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOneConvertiblePreferredStockMember_z2Dkl2Hrfqik" title="Preferred stock, par value"&gt;0.001&lt;/span&gt; per
share. The Series A Convertible Preferred Stock had voting rights on an as-if-converted to Common Stock basis. The holders were entitled
to a &lt;span id="xdx_90C_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOneConvertiblePreferredStockMember_zxSmryXnKC2c" title="Preferred stock, dividend rate, percentage"&gt;12&lt;/span&gt;% dividend and convert at any time into shares of Common Stock at a ratio of 1 to &lt;span id="xdx_908_eus-gaap--PreferredStockConvertibleConversionRatio_iI_uPure_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOneConvertiblePreferredStockMember_z4tV9ICl7wQh" title="Preferred stock, convertible, conversion ratio"&gt;25.6938&lt;/span&gt; shares of Common Stock, subject to adjustment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
a part of the Business Combination with Western, the Company issued &lt;span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20240214__us-gaap--StatementClassOfStockAxis__custom--SeriesAOneConvertiblePreferredStockMember__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zYez5kPzqEr3" title="Preferred stock, shares authorized"&gt;106,816&lt;/span&gt; shares of Series A Convertible Preferred Stock, par value
$&lt;span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240214__us-gaap--StatementClassOfStockAxis__custom--SeriesAOneConvertiblePreferredStockMember__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z2Yj1JE8kRE4" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt; per share, in connection with the conversion and settlement of previously outstanding securities mentioned above. Refer to Note
17 for the characteristic of newly issued Series A Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:PreferredStockTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-12-31_custom_SeriesAOneConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001989"
      unitRef="Shares">16667</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31_custom_SeriesAOneConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001991"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="From2024-01-012024-12-31_custom_SeriesAOneConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001993"
      unitRef="Pure">0.12</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="AsOf2024-12-31_custom_SeriesAOneConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001995"
      unitRef="Pure">25.6938</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-02-14_custom_SeriesAOneConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact001997"
      unitRef="Shares">106816</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-02-14_custom_SeriesAOneConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact001999"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2025-01-012025-12-31" id="Fact002001">&lt;p id="xdx_800_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zOBSUhe0yq92" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82F_zD4cZcTJdK5h"&gt;EQUITY&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Preferred
Stock&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has authorized &lt;span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_c20251231_zM5qq6RXUfIi" title="Preferred stock, shares authorized"&gt;20,000,000&lt;/span&gt; shares of preferred stock, par value of $&lt;span id="xdx_909_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20251231_zDYL3YQPw35i" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt; per share, issuable from time to time in one or more
series.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Second Amended and Restated Certificate of Incorporation authorizes the board of directors to establish one or more series of preferred
stock. Unless required by law or by any stock exchange, and subject to the terms of the Second Amended and Restated Certificate of Incorporation,
the authorized shares of preferred stock will be available for issuance without further action by holders of Common Stock. The board
of directors is able to determine, with respect to any series of preferred stock, designations, powers, preferences and relative, participating,
optional or other rights, if any, and the qualifications, limitations, or restrictions thereof, if any.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company could issue a series of preferred stock that could, depending on the terms of the series, impede or discourage an acquisition
attempt or other transaction that some, or a majority, of the stockholders might believe to be in their best interests or in which the
stockholders might receive a premium over the market price of the Common Stock. Additionally, the issuance of preferred stock may adversely
affect the rights of stockholders by restricting dividends on the Common Stock, diluting the voting power of the Common Stock or subordinating
the rights of stockholders to distributions upon a liquidation, dissolution or winding up, or other event. As a result of these or other
factors, the issuance of preferred stock could have an adverse impact on the market price of our Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Mezzanine
Equity&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025 and 2024, there are &lt;span id="xdx_907_eus-gaap--TemporaryEquitySharesIssued_iI_dc_c20251231__us-gaap--StatementClassOfStockAxis__custom--CommonClassSubjectToRedemptionMember_zpljsGePhfPl" title="Common stock subject to possible redemption, shares issued"&gt;zero&lt;/span&gt; and &lt;span id="xdx_904_eus-gaap--TemporaryEquitySharesIssued_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--CommonClassSubjectToRedemptionMember_zBLToUoNz2c4" title="Common stock subject to possible redemption, shares issued"&gt;5,796&lt;/span&gt; shares of Common Stock subject to possible redemption, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Stockholders&#x2019;
Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Series
A Convertible Preferred Stock&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has authorized &lt;span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_z3mGN9WkSwu5" title="Preferred stock, authorized"&gt;110,000&lt;/span&gt; shares of Series A Convertible Preferred Stock, par value $&lt;span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zpSPRBw4Awqg" title="Preferred stock, par value per share"&gt;0.0001&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Voting
Rights:&lt;/span&gt; The holders of Cycurion&#x2019;s Series A Convertible Preferred Stock have voting rights on an as-if-converted-to-common-stock
basis and as required by law (including without limitation, the Delaware General Corporation Law (the &#x201c;DGCL&#x201d;) and as expressly
provided in the Certificate of Designation of Preferences, Rights and Limitations for our Series A Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Dividend
Rights:&lt;/span&gt; Holders of shares of our Series A Convertible Preferred Stock shall be entitled to receive dividends at the rate of twelve
percent (&lt;span id="xdx_908_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zUQ4NYL0njV5" title="Preferred stock, dividend rate"&gt;12&lt;/span&gt;%) per annum of the per-share stated value ($&lt;span id="xdx_900_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zWrknbtNPsh6" title="Dividends payable, amount per share"&gt;1.45&lt;/span&gt; per share). The dividends shall be paid payable quarterly in arrears in
shares of Common Stock, calculated for each dividend payment on an as-if-converted-to-Common-Stock basis. No other dividends shall be
paid on shares of Series A Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Conversion
Rights:&lt;/span&gt; &lt;span id="xdx_90D_eus-gaap--PreferredStockConversionBasis_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zSgmK1wfhXri" title="Preferred stock conversion description"&gt;Shares of Cycurion&#x2019;s Series A Convertible Preferred Stock shall be convertible, at any time and from time to time at
the option of the holder thereof, into shares of Common Stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion
ratio of &lt;span id="xdx_909_eus-gaap--PreferredStockConvertibleConversionRatio_iI_pid_dc_uPure_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_z0YHbskeOSNl" title="Preferred stock, convertible, conversion ratio"&gt;one&lt;/span&gt; share of Series A Convertible Preferred Stock-for-one share of Common Stock, subject to adjustment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Liquidation
Preference:&lt;/span&gt; Holders of shares of Cycurion&#x2019;s Series A Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up
of Cycurion, whether voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, of Cycurion
an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon, for each share of Series A Convertible Preferred
Stock before any distribution or payment shall be made to the holders of Common Stock, and, if the assets of Cycurion shall be insufficient
to pay in full such amounts, then the entire assets to be distributed to the holders of shares of Series A Convertible Preferred Stock
shall be ratably distributed among them in accordance with the respective amounts that would have been payable on such shares if all
amounts payable thereon had been paid in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Protective
Provisions:&lt;/span&gt; As long as any shares of Series A Convertible Preferred Stock are outstanding, Cycurion shall not, without the affirmative
vote of the holders of a majority of the then-outstanding shares of Series A Convertible Preferred Stock, (a) alter or change adversely
the powers, preferences, or rights given to the holders of Series A Convertible Preferred Stock or alter or amend the Certificate of
Designation of Preferences, Rights and Limitations for Cycurion&#x2019;s Series A Convertible Preferred Stock, (b) amend its certificate
of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series A Convertible
Preferred Stock, (c) increase the number of authorized shares of Series A Convertible Preferred Stock, or (d) enter into any agreement
with respect to any of the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
part of the Business Combination with Western during the year ended December 31, 2025, the Company issued to unaffiliated investors a
total of &lt;span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--WesternAcquisitionVenturesCorpMember_zo6FGGI2Ur35" title="Preferred stock, shares issued"&gt;106,816&lt;/span&gt; preferred shares, which were converted into Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of both December 31, 2025 and 2024, there were &lt;span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_dc_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zwnUJRXea4Lc" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_dc_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zWUrIH5vVYVb" title="Preferred stock, shares outstanding"&gt;&lt;span id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_dc_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zwycuiMMbAli" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_dc_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zaEY9bLbJvb3" title="Preferred stock, shares outstanding"&gt;zero&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; shares of Series A Convertible Preferred Stock issued and outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Series
B Convertible Preferred Stock&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has authorized &lt;span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zwIZdXkr3Xe4" title="Preferred stock, authorized"&gt;3,000&lt;/span&gt; shares of Series B Convertible Preferred Stock, par value $&lt;span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zOJRXuZquMPf" title="Preferred stock, par value per share"&gt;0.0001&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Voting
Rights:&lt;/span&gt; Holders of shares of Cycurion&#x2019;s Series B Convertible Preferred Stock shall not have any voting rights except as required
by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation of Preferences, Rights and
Limitations for our Series B Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Dividend
Rights:&lt;/span&gt; Holders of our Series B Convertible Preferred Stock shall be entitled to receive dividends (on an as-if-converted-to-Common-Stock
basis) to and in the same form as dividends actually paid on shares of Common Stock when, as, and if such dividends are paid on shares
of Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Conversion
Rights:&lt;/span&gt; &lt;span id="xdx_90D_eus-gaap--ConversionOfStockDescription_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zyVRWCPGPY79" title="Conversion of stock, description"&gt;Shares of our Series B Convertible Preferred Stock shall be convertible, at any time and from time to time at the option
of the holder thereof, into Common Stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of &lt;span id="xdx_900_eus-gaap--PreferredStockConvertibleConversionRatio_iI_pid_dc_uPure_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zaYIw2yO9UKi" title="Preferred stock, convertible, conversion ratio"&gt;one&lt;/span&gt; share
of Series B Convertible Preferred Stock-for-one share of Common Stock, subject to adjustment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Liquidation
Preference:&lt;/span&gt; Holders of shares of our Series B Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up, whether
voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, an amount equal to the Stated Value,
plus any accrued and unpaid dividends thereon, for each share of Series B Convertible Preferred Stock before any distribution or payment
shall be made to the holders of Common Stock, and, if our assets are insufficient to pay in full such amounts, then the entire assets
to be distributed to the holders of shares of Series B Convertible Preferred Stock shall be ratably distributed among them in accordance
with the respective amounts that would have been payable on such shares if all amounts payable thereon had been paid in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Protective
Provisions:&lt;/span&gt; As long as any shares of Series B Convertible Preferred Stock are outstanding, we will not, without the affirmative vote
of the holders of a majority of the then-outstanding shares of Series B Convertible Preferred Stock, (a) alter or change adversely the
powers, preferences, or rights given to the holders of Series B Convertible Preferred Stock or alter or amend the Certificate of Designation
of Preferences, Rights and Limitations for our Series B Convertible Preferred Stock, (b) amend our certificate of incorporation or other
charter documents in any manner that adversely affects any rights of the holders of shares of Series B Convertible Preferred Stock, (c)
increase the number of authorized shares of Series B Convertible Preferred Stock, or (d) enter into any agreement with respect to any
of the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
part of the Business Combination with Western during the first quarter of 2025, the Company issued to unaffiliated investors a total
of &lt;span id="xdx_90B_eus-gaap--PreferredStockSharesIssued_iI_c20250331__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--WesternAcquisitionVenturesCorpMember_zHIFxcIC9Qe4" title="Preferred stock, shares issued"&gt;3,000&lt;/span&gt; preferred shares of Series B Convertible Preferred Stock in exchange of existing &lt;span id="xdx_903_eus-gaap--PreferredStockSharesIssued_iI_c20250331__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--WesternAcquisitionVenturesCorpMember_zp6JBA2X81u1" title="Preferred stock, shares issued"&gt;3,000&lt;/span&gt; Series B Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December 31, 2025, a total of &lt;span id="xdx_903_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember_zJG0c4SpQ3tc" title="Number of Preferred stock converted"&gt;2,999&lt;/span&gt; Series B Convertible Preferred Stock were converted into &lt;span id="xdx_908_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zAOETLFNav9b" title="Number of common shares issuable upon conversion"&gt;199,955&lt;/span&gt; shares of Common
Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025 and 2024, there were &lt;span id="xdx_902_eus-gaap--PreferredStockSharesIssued_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zeKcrL5BjZYk" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zam87XvihK4d" title="Preferred stock, shares outstanding"&gt;1&lt;/span&gt;&lt;/span&gt; and &lt;span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zsSPmJCNIoi2" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_z9XOw7gVUxs9" title="Preferred stock, shares outstanding"&gt;3,000&lt;/span&gt;&lt;/span&gt; shares of Series B Convertible Preferred Stock issued and outstanding, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
C Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has authorized &lt;span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zF6oMf1vJIga"&gt;5,000&lt;/span&gt; shares of Series C Convertible Preferred Stock, par value $&lt;span id="xdx_909_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zdPO5flvOBH1" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Voting
Rights:&lt;/span&gt; The holders of our Series C Convertible Preferred Stock have voting rights on an as-if-converted-to-Common-Stock basis, as
required by law, and as expressly provided in its Certificate of Designation, as follows. As long as any shares of our Series C Convertible
Preferred Stock are outstanding, we shall not, without the affirmative vote of the holders of a majority of the then-outstanding shares
of our Series C Convertible Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to our Series C Convertible
Preferred Stock or alter or amend its Certificate of Designation, (b) amend our Certificate of Incorporation or other charter documents
in any manner that adversely affects any rights of the holders of our Series C Convertible Preferred Stock, (c) increase the number of
authorized shares of our Series C Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Dividend
Rights:&lt;/span&gt; We shall pay dividends on our Series C Convertible Preferred Stock at the rate of &lt;span id="xdx_906_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zNgTJ1cN7cE6" title="Preferred stock, convertible, conversion ratio"&gt;12&lt;/span&gt;% per annum of the per-share Stated Value
($&lt;span id="xdx_908_eus-gaap--DividendsPayableAmountPerShare_iI_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zGzP1kuNtAjb" title="Dividends payable, amount per share"&gt;82.46&lt;/span&gt; per share). The dividends are payable quarterly in arrears not in cash, but in shares of our Common Stock, calculated for each
dividend payment on an as-if-converted-to-Common-Stock basis. No other dividends are payable on shares of our Series C Convertible Preferred
Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Conversion
Rights:&lt;/span&gt; &lt;span id="xdx_908_eus-gaap--DebtConversionDescription_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_za7YXmPo8K5d" title="Debt conversion, description"&gt;The shares of our Series C Convertible Preferred Stock may be converted into shares of our Common Stock at a ratio of approximately
&lt;span id="xdx_905_eus-gaap--PreferredStockConvertibleConversionRatio_iI_pid_uPure_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zMVsCW24lHud" title="Preferred stock, convertible, conversion ratio"&gt;20&lt;/span&gt; shares of Common Stock for every one share of our Series C Convertible Preferred Stock, or an aggregate of &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zHJARBe9UxLh" title="Stock issued during period, shares, conversion of convertible securities"&gt;99,077&lt;/span&gt; shares of our Common
Stock, assuming full conversion. In connection with conversions, each holder of our Series C Convertible Preferred Stock is subject to
a &#x201c;beneficial ownership limitation&#x201d; of 4.99% of the number of shares of our Common Stock outstanding immediately after giving
effect to that conversion, which limitation may be increased by the holder to not more than 9.99% on 61 days&#x2019; advanced notice to
us.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Liquidation
Preference:&lt;/span&gt; Our Series C Convertible Preferred Stock has a liquidation preference in an amount equal to its per-share Stated Value
($&lt;span id="xdx_901_eus-gaap--PreferredStockLiquidationPreference_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_z3AZtWa8MxO1" title="Preferred stock, liquidation preference per share"&gt;82.46&lt;/span&gt; per share), plus any accrued and unpaid dividends thereon, for each share of our Series C Convertible Preferred Stock before
we can make any distribution or payment to the holders of our Common Stock. If our assets are insufficient to pay in full such liquidation
preference, then our entire assets are to be distributed to the holders of our Series C Convertible Preferred Stock, ratably distributed
among them in accordance with the respective amounts that would be payable on such shares if all amounts payable thereon were paid in
full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Protective
Provisions:&lt;/span&gt; As long as any shares of Series C Convertible Preferred Stock are outstanding, we will not, without the affirmative vote
of the holders of a majority of the then-outstanding shares of Series C Convertible Preferred Stock, (a) alter or change adversely the
powers, preferences, or rights given to the holders of Series C Convertible Preferred Stock or alter or amend the Certificate of Designation
of Preferences, Rights and Limitations for our Series C Convertible Preferred Stock, (b) amend our certificate of incorporation or other
charter documents in any manner that adversely affects any rights of the holders of shares of Series C Convertible Preferred Stock, (c)
increase the number of authorized shares of Series C Convertible Preferred Stock, or (d) enter into any agreement with respect to any
of the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
part of the Business Combination with Western during year ended December 31, 2025, the Company issued a total of &lt;span id="xdx_909_eus-gaap--PreferredStockSharesIssued_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember_zRuLp9lutZ2g" title="Preferred stock, shares issued"&gt;4,851&lt;/span&gt; shares of Series
C Convertible Preferred Stock in exchange of existing &lt;span id="xdx_90F_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_z3PIslLh9VIl" title="Number of common shares issuable upon conversion"&gt;1,356,586&lt;/span&gt; shares of Cycurion Common Stock and &lt;span id="xdx_907_eus-gaap--SharesIssued_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zGhnsurmCW4c" title="Shares issued"&gt;406,969&lt;/span&gt; Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025 and 2024, there were &lt;span id="xdx_909_eus-gaap--PreferredStockSharesIssued_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_z0MeOvnDtipb" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zUovNOnrsNKl" title="Preferred stock, shares outstanding"&gt;&lt;span id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zzmlECQuuuyd" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zH4xzVTRZJdg" title="Preferred stock, shares outstanding"&gt;4,851&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; shares of Series C Convertible Preferred Stock issued and outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
D Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has authorized &lt;span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zLqChVkqGmz"&gt;6,666,700&lt;/span&gt; shares of Series D Convertible Preferred Stock, par value $&lt;span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_z5Mf4y1WPOI8" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting
Rights&lt;/i&gt;: Holders of shares of Cycurion&#x2019;s Series D Convertible Preferred Stock shall not have any voting rights except as required
by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation of Preferences, Rights and
Limitations for Cycurion&#x2019;s Series D Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividend
Rights&lt;/i&gt;: Holders of shares of Cycurion&#x2019;s Series D Convertible Preferred Stock shall be entitled to receive, and Cycurion shall
pay, dividends on shares of Series D Convertible Preferred Stock (on an as-if-converted-to-Common-Stock basis) to and in the same form
as dividends actually paid on shares of Common Stock when, as, and if such dividends are paid on shares of Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion
Rights&lt;/i&gt;: &lt;span id="xdx_90F_eus-gaap--DebtConversionDescription_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zpp5OkQAoWE6" title="Debt conversion, description"&gt;Shares of Cycurion&#x2019;s Series D Convertible Preferred Stock shall be convertible, at any time and from time to time at
the option of the holder thereof, into shares of Common Stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion
ratio of &lt;span id="xdx_90B_eus-gaap--PreferredStockConvertibleConversionRatio_iI_pid_dc_uPure_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zgxbgUO3bY12" title="Preferred stock, convertible, conversion ratio"&gt;one&lt;/span&gt; share of Series D Convertible Preferred Stock-for-one share of Common Stock, subject to adjustment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation
Preference&lt;/i&gt;: Holders of shares of Cycurion&#x2019;s Series D Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up
of Cycurion, whether voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, of Cycurion
an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon, for each share of Series D Convertible Preferred
Stock before any distribution or payment shall be made to the holders of Common Stock, and, if the assets of Cycurion shall be insufficient
to pay in full such amounts, then the entire assets to be distributed to the holders of shares of Series D Convertible Preferred Stock
shall be ratably distributed among them in accordance with the respective amounts that would have been payable on such shares if all
amounts payable thereon had been paid in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Protective
Provisions&lt;/i&gt;: As long as any shares of Series D Convertible Preferred Stock are outstanding, Cycurion shall not, without the affirmative
vote of the holders of a majority of the then-outstanding shares of Series D Convertible Preferred Stock, (a) alter or change adversely
the powers, preferences, or rights given to the holders of Series D Convertible Preferred Stock or alter or amend the Certificate of
Designation of Preferences, Rights and Limitations for Cycurion&#x2019;s Series D Convertible Preferred Stock, (b) amend its certificate
of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series D Convertible
Preferred Stock, (c) increase the number of authorized shares of Series D Convertible Preferred Stock, or (d) enter into any agreement
with respect to any of the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
part of the Business Combination with Western, during the first quarter of calendar year 2025, the Company issued to unaffiliated investors
a total of &lt;span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_c20250331__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--WesternAcquisitionVenturesCorpMember_zLNDXqZ9aW5l" title="Preferred stock, shares issued"&gt;6,666,666&lt;/span&gt; preferred shares of Series D Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December 31, 2025, a total of &lt;span id="xdx_908_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember_zpTyEkIi1lhi" title="Number of Preferred stock converted"&gt;6,516,666&lt;/span&gt; shares of Series D Convertible Preferred Stock were converted into &lt;span id="xdx_90D_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zXmkMKAZvd4b" title="Number of common shares issuable upon conversion"&gt;217,220&lt;/span&gt; shares
of Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025 and 2024, there were &lt;span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_z59J3earn1zj" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_z3b01zifj81c" title="Preferred stock, shares outstanding"&gt;150,000&lt;/span&gt;&lt;/span&gt; and &lt;span id="xdx_902_eus-gaap--PreferredStockSharesIssued_iI_dc_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zfChpLYH8Ayk" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_dc_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_z2N2j8mUN6tk" title="Preferred stock, shares outstanding"&gt;zero&lt;/span&gt;&lt;/span&gt; shares of Series D Convertible Preferred Stock issued and outstanding, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
E Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has authorized &lt;span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zi5AVzQcjyS7" title="Preferred stock, shares authorized"&gt;100&lt;/span&gt; shares of Series E Convertible Preferred Stock, par value $&lt;span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zKDKgr0Mqmq" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting
Rights&lt;/i&gt;: Holders of shares of Cycurion&#x2019;s Series E Convertible Preferred Stock shall have voting rights on an as-if-converted-to-Common
Stock basis and as required by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation
of Preferences, Rights and Limitations for Cycurion&#x2019;s Series E Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividend
Rights&lt;/i&gt;: Holders of shares of Cycurion&#x2019;s Series E Convertible Preferred Stock shall be entitled to receive, and Cycurion shall
pay, dividends on shares of Series E Convertible Preferred Stock (on an as-if-converted-to-Common-Stock basis) to and in the same form
as dividends actually paid on shares of Common Stock when, as, and if such dividends are paid on shares of Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion
Rights&lt;/i&gt;: &lt;span id="xdx_90E_eus-gaap--ConversionOfStockDescription_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zL31Y1KBFPI1" title="Conversion of stock, description"&gt;Shares of Cycurion&#x2019;s Series E Convertible Preferred Stock shall be convertible, at any time and from time to time at
the option of the holder thereof, into shares of Common Stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion
ratio of &lt;span id="xdx_906_eus-gaap--PreferredStockConvertibleConversionRatio_iI_pid_dc_uPure_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_z5nLZCKQoWB5" title="Preferred stock, convertible, conversion ratio"&gt;one&lt;/span&gt; share of Series E Convertible Preferred Stock-for-one share of Common Stock, subject to adjustment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation
Preference&lt;/i&gt;: Holders of shares of Cycurion&#x2019;s Series E Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up
of Cycurion, whether voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, of Cycurion
an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon, for each share of Series E Convertible Preferred
Stock before any distribution or payment shall be made to the holders of Common Stock, and, if the assets of Cycurion shall be insufficient
to pay in full such amounts, then the entire assets to be distributed to the holders of shares of Series E Convertible Preferred Stock
shall be ratably distributed among them in accordance with the respective amounts that would have been payable on such shares if all
amounts payable thereon had been paid in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Protective
Provisions&lt;/i&gt;: As long as any shares of Series E Convertible Preferred Stock are outstanding, Cycurion shall not, without the affirmative
vote of the holders of a majority of the then-outstanding shares of Series E Convertible Preferred Stock, (a) alter or change adversely
the powers, preferences, or rights given to the holders of Series E Convertible Preferred Stock or alter or amend the Certificate of
Designation of Preferences, Rights and Limitations for Cycurion&#x2019;s Series E Convertible Preferred Stock, (b) amend its certificate
of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series E Convertible
Preferred Stock, (c) increase the number of authorized shares of Series E Convertible Preferred Stock, or (d) enter into any agreement
with respect to any of the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
part of the Management Services Agreement and a Release agreement with Ed Burns, the Company issued to the majority shareholder a total
of &lt;span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zoHDT0m6YaXh" title="Preferred stock, shares issued"&gt;51&lt;/span&gt; preferred shares of Series E Convertible Preferred Stock as consideration for the transaction during the year ended December 31,
2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
F Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has authorized &lt;span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zK5TCPrc5uKg" title="Preferred stock, shares authorized"&gt;10,000&lt;/span&gt; shares of Series F Convertible Preferred Stock, par value $&lt;span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zWEorrHCfPEj" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting
Rights&lt;/i&gt;: Holders of shares of our Series F Convertible Preferred Stock shall have voting rights on an as-if-converted-to-common-stock
basis and as required by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation of
Preferences, Rights and Limitations for our Series F Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividend
Rights&lt;/i&gt;: Holders of shares of our Series F Convertible Preferred Stock shall be entitled to receive, and we shall pay, dividends on
shares of our Series F Convertible Preferred Stock at the rate of twelve percent (&lt;span id="xdx_909_eus-gaap--PreferredStockConvertibleConversionRatio_iI_pid_dp_uPure_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_zJNd1qZZoq5" title="Preferred stock, convertible, conversion ratio"&gt;12&lt;/span&gt;%) per annum of the $&lt;span id="xdx_908_eus-gaap--DividendsPayableAmountPerShare_iI_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_zL1PqgpBWipg" title="Dividends payable, amount per share"&gt;0.0001&lt;/span&gt; per-share Stated Value
of the Series F Convertible Preferred Stock. The dividends shall be paid payable quarterly in arrears in shares of Common Stock, calculated
for each dividend payment on an as-if-converted-to-common-stock basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion
Rights&lt;/i&gt;: &lt;span id="xdx_907_eus-gaap--ConversionOfStockDescription_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_zixlhbQTEnDj" title="Conversion of stock, description"&gt;Shares of our Series F Convertible Preferred Stock shall be convertible, at any time and from time to time at the option
of the holder thereof, into shares of Common Stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of
one share of Series F Convertible Preferred Stock-for-&lt;span id="xdx_90C_eus-gaap--PreferredStockConvertibleConversionRatio_iI_pid_uPure_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zkUZpftiD2v5" title="Preferred stock, convertible, conversion ratio"&gt;1,000&lt;/span&gt; shares of Common Stock, subject to adjustment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation
Preference&lt;/i&gt;: Holders of shares of our Series F Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up, whether
voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, an amount equal to the Stated Value,
plus any accrued and unpaid dividends thereon, for each share Series F Convertible Preferred Stock before any distribution or payment
shall be made to the holders of Common Stock, and, if the assets shall be insufficient to pay in full such amounts, then the entire assets
to be distributed to the holders of shares of our Series F Convertible Preferred Stock shall be ratably distributed among them in accordance
with the respective amounts that would have been payable on such shares if all amounts payable thereon had been paid in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Protective
Provisions&lt;/i&gt;: As long as any shares of Series F Convertible Preferred Stock are outstanding, we shall not, without the affirmative
vote of the holders of a majority of the then-outstanding shares of Series F Convertible Preferred Stock, (a) alter or change adversely
the powers, preferences, or rights given to the holders of Series F Convertible Preferred Stock or alter or amend the Certificate of
Designation of Preferences, Rights and Limitations for our Series F Convertible Preferred Stock, (b) amend its certificate of incorporation
or other charter documents in any manner that adversely affects any rights of the holders of shares of Series F Convertible Preferred
Stock, (c) increase the number of authorized shares of Series F Convertible Preferred Stock, or (d) enter into any agreement with respect
to any of the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
G Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has designated &lt;span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zwKrZp5rGGSe" title="Preferred stock, shares authorized"&gt;10,000&lt;/span&gt; shares of Series G Convertible Preferred Stock, par value $&lt;span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zeEPIKZnBvB4" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting
Rights&lt;/i&gt;: Holders of shares of Series G Convertible Preferred Stock shall have voting rights on an as-if-converted-to-Common-Stock
basis and as required by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation of
Preferences, Rights and Limitations for our Series G Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividend
Rights&lt;/i&gt;: Holders of shares of our Series G Convertible Preferred Stock shall be entitled to receive, and we shall pay, dividends on
shares of our Series G Convertible Preferred Stock at the rate of twelve percent (&lt;span id="xdx_905_eus-gaap--PreferredStockConvertibleConversionRatio_iI_pid_dp_uPure_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zbA43kvsY1Q4" title="Preferred stock, convertible, conversion ratio"&gt;12&lt;/span&gt;%) per annum of the $&lt;span id="xdx_900_eus-gaap--DividendsPayableAmountPerShare_iI_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zbM0PP64AX3l" title="Dividends payable, amount per share"&gt;0.0001&lt;/span&gt; per-share Stated Value
of the Series G Convertible Preferred Stock. The dividends shall be paid payable quarterly in arrears in shares of Common Stock, calculated
for each dividend payment on an as-if-converted-to-Common-Stock basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion
Rights&lt;/i&gt;: &lt;span id="xdx_90C_eus-gaap--ConversionOfStockDescription_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zl9BYRGIrdQa" title="Conversion of stock, description"&gt;Shares of our Series G Convertible Preferred Stock shall be convertible, at any time and from time to time at the option
of the holder thereof, into shares of Common Stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of
&lt;span id="xdx_903_eus-gaap--PreferredStockConvertibleConversionRatio_iI_pid_dc_uPure_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_z7SR5DTHvyG6" title="Preferred stock, convertible, conversion ratio"&gt;one&lt;/span&gt; share of Series G Convertible Preferred Stock-for-1,000 shares of Common Stock, subject to adjustment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation
Preference&lt;/i&gt;: Holders of shares of our Series G Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up, whether
voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, an amount equal to the Stated Value,
plus any accrued and unpaid dividends thereon, for each share Series G Convertible Preferred Stock before any distribution or payment
shall be made to the holders of Common Stock, and, if the assets shall be insufficient to pay in full such amounts, then the entire assets
to be distributed to the holders of shares of our Series G Convertible Preferred Stock shall be ratably distributed among them in accordance
with the respective amounts that would have been payable on such shares if all amounts payable thereon had been paid in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Protective
Provisions&lt;/i&gt;: As long as any shares of Series G Convertible Preferred Stock are outstanding, we shall not, without the affirmative
vote of the holders of a majority of the then-outstanding shares of Series G Convertible Preferred Stock, (a) alter or change adversely
the powers, preferences, or rights given to the holders of Series G Convertible Preferred Stock or alter or amend the Certificate of
Designation of Preferences, Rights and Limitations for our Series G Convertible Preferred Stock, (b) amend its certificate of incorporation
or other charter documents in any manner that adversely affects any rights of the holders of shares of Series G Convertible Preferred
Stock, (c) increase the number of authorized shares of Series G Convertible Preferred Stock, or (d) enter into any agreement with respect
to any of the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Series
G Convertible Preferred Stock Activity&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cycurion
has engaged in a strategic recapitalization to strengthen its balance sheet and support growth initiatives. The Company entered into
agreements with certain investors to exchange $&lt;span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentAmount1_pn5n6_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zJ71oLwTqWad" title="Debt conversion, converted instrument, amount"&gt;3.2&lt;/span&gt; million aggregate principal amount of convertible indebtedness for an aggregate of
&lt;span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_z4itVryJUxzd" title="Debt conversion, converted instrument, shares issued"&gt;3,133&lt;/span&gt; shares of Series G Convertible Preferred Stock. These transactions convert a substantial portion of Cycurion&#x2019;s debt into
preferred equity, which provides additional capital to support business growth. For more information, please see &#x201c;Exchange Agreements
and Registration Rights Agreements&#x201d; below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Exchange
Agreements and Registration Rights Agreements&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 12, 2025, the Company entered into an exchange agreement with Alpha Capital Anstalt (the &#x201c;Alpha Capital Anstalt Exchange
Agreement&#x201d;) and a registration rights agreement. Pursuant to the Alpha Capital Anstalt Exchange Agreement, the parties intended
to effect a voluntary security exchange transaction whereby Alpha Capital Anstalt will exchange $&lt;span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--AlphaCapitalAnstaltMember_z8OxTWRkl2D5" title="Debt conversion, converted instrument, amount"&gt;366,050&lt;/span&gt; in debt for an aggregate of
&lt;span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--AlphaCapitalAnstaltMember_zQeibhKuxjJ5" title="Debt conversion, converted instrument, shares issued"&gt;366&lt;/span&gt; shares of Series G Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 12, 2025, the Company entered into an exchange agreement with M2B Funding Corp. (the &#x201c;M2B Funding Corp. Exchange Agreement&#x201d;)
and a registration rights agreement. Pursuant to the M2B Funding Corp. Exchange Agreement, the parties intended to effect a voluntary
security exchange transaction whereby M2B Funding Corp. will exchange $&lt;span id="xdx_900_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--M2BFundingCorpMember_zTfbrXJ4kUna" title="Debt conversion, converted instrument, amount"&gt;672,077&lt;/span&gt; in debt for an aggregate of &lt;span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--M2BFundingCorpMember_zR6OS38Ljtvl" title="Debt conversion, converted instrument, shares issued"&gt;672&lt;/span&gt; shares of Series G Convertible
Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 12, 2025, the Company entered into an exchange agreement with ADI Funding (the &#x201c;ADI Funding Exchange Agreement&#x201d;) and
a registration rights agreement. Pursuant to the ADI Funding Exchange Agreement, the parties intended to effect a voluntary security
exchange transaction whereby ADI Funding will exchange $&lt;span id="xdx_900_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--AdiFundingMember_zW1vTz9I3Ecf" title="Debt conversion, converted instrument, amount"&gt;347,730&lt;/span&gt; in debt for an aggregate of &lt;span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--AdiFundingMember_zFfMPdje3sme" title="Debt conversion, converted instrument, shares issued"&gt;348&lt;/span&gt; shares of Series G Convertible Preferred
Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 12, 2025, the Company entered into an exchange agreement with Deltennium (the &#x201c;Deltennium Exchange Agreement&#x201d;) and
a registration rights agreement. Pursuant to the Deltennium Exchange Agreement, the parties intended to effect a voluntary security exchange
transaction whereby Deltennium will exchange $&lt;span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--DeltenniumMember_z8UC0bK9k9Lc" title="Debt conversion, converted instrument, amount"&gt;617,667&lt;/span&gt; in debt for an aggregate of &lt;span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--DeltenniumMember_zbyw2nz4y1sa" title="Debt conversion, converted instrument, shares issued"&gt;618&lt;/span&gt; shares of Series G Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 12, 2025, the Company entered into an exchange agreement with Osher Capital (the &#x201c;Osher Capital Exchange Agreement&#x201d;)
and a registration rights agreement. Pursuant to the Osher Capital Exchange Agreement, the parties intended to effect a voluntary security
exchange transaction whereby Osher Capital will exchange $&lt;span id="xdx_906_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--OsherCapitalMember_zaVxaubkAtW8" title="Debt conversion, converted instrument, amount"&gt;103,800&lt;/span&gt; in debt for an aggregate of &lt;span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--OsherCapitalMember_zHsIWuXPusse" title="Debt conversion, converted instrument, shares issued"&gt;104&lt;/span&gt; shares of Series G Convertible Preferred
Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 12, 2025, the Company entered into an exchange agreement with Lexi London (the &#x201c;Lexi London Exchange Agreement&#x201d;) and
a registration rights agreement. Pursuant to the Lexi London Exchange Agreement, the parties intended to effect a voluntary security
exchange transaction whereby Lexi London will exchange $&lt;span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--LexiLondonMember_zFD5G2tFqMoc" title="Debt conversion, converted instrument, amount"&gt;769,000&lt;/span&gt; in debt for an aggregate of &lt;span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--LexiLondonMember_zZAzha9nbkg3" title="Debt conversion, converted instrument, shares issued"&gt;769&lt;/span&gt; shares of Series G Convertible Preferred
Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 12, 2025, the Company entered into an exchange agreement with ILE Associates (the &#x201c;ILE Associates Exchange Agreement&#x201d;)
and a registration rights agreement. Pursuant to the ILE Associates Exchange Agreement, the parties intended to effect a voluntary security
exchange transaction whereby ILE Associates will exchange $&lt;span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--IleAssociatesMember_z4mnbmlXX1fb" title="Debt conversion, converted instrument, amount"&gt;256,333&lt;/span&gt; in debt for an aggregate of &lt;span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--IleAssociatesMember_zUqKiQdipn4k" title="Debt conversion, converted instrument, shares issued"&gt;256&lt;/span&gt; shares of Series G Convertible Preferred
Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025 and 2024, there were &lt;span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zI5tbI5VaEDh" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_904_eus-gaap--PreferredStockSharesOutstanding_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zkcnN9S5lczf" title="Preferred stock, shares outstanding"&gt;143&lt;/span&gt;&lt;/span&gt; and &lt;span id="xdx_90A_eus-gaap--PreferredStockSharesIssued_iI_dc_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zIpLYg4xF2N7" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_dc_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zcwJE2ZM83Wh" title="Preferred stock, shares outstanding"&gt;zero&lt;/span&gt;&lt;/span&gt; shares of Series G Convertible Preferred Stock issued and outstanding, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Common
Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has authorized &lt;span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20251231_zChPICTpnvge" title="Common stock, shares authorized"&gt;300,000,000&lt;/span&gt; shares of Common Stock, par value of $&lt;span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20251231_zFaJUN9Kw0de" title="Common stock, par value"&gt;0.0001&lt;/span&gt; per share. Each share of Common Stock entitles the holder
to one vote, in person or proxy, on any matter on which an action of the stockholders of the Company is sought.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesABandDConvertiblePreferredStockMember_z3bUHOEGWV49" title="Common stock issued on conversion"&gt;578,863&lt;/span&gt;
shares for conversion of Series A, B and D Convertible Preferred Stock&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__custom--WarrantABandDMember_zMImfZwJimae" title="Common stock issued on conversion"&gt;258,464&lt;/span&gt;
shares for exercise of other warrants, Warrant A, B and D for $&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__custom--WarrantABandDMember_z2bLFYoejzI5" title="Common stock issued on conversion, value"&gt;3,309,921&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--NonrecurringAdjustmentAxis__us-gaap--AcquisitionRelatedCostsMember_z7Z6r2HAyaM" title="Common stock issued on conversion"&gt;25,000&lt;/span&gt;
shares valued at $&lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--NonrecurringAdjustmentAxis__us-gaap--AcquisitionRelatedCostsMember_zph85wYf1W44" title="Common stock issued on conversion, value"&gt;9,000,000&lt;/span&gt; for business acquisition costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--NonrecurringAdjustmentAxis__custom--SettlementOfDebtMember_zyMF1gOd1s6i" title="Common stock issued on conversion"&gt;10,894&lt;/span&gt;
shares valued at $&lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--NonrecurringAdjustmentAxis__custom--SettlementOfDebtMember_z8f66Uv1XH69" title="Common stock issued on conversion, value"&gt;1,193,634&lt;/span&gt; for a settlement of debt of $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentRepaidPrincipal_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--NonrecurringAdjustmentAxis__custom--SettlementOfDebtMember_zTIJDRTu0NFk" title="Amount of debt repaid"&gt;2,925,803&lt;/span&gt;, as a result, the Company recorded loss on settlement of debt of $&lt;span id="xdx_902_eus-gaap--GainsLossesOnExtinguishmentOfDebt_iN_di_c20250101__20251231__us-gaap--NonrecurringAdjustmentAxis__custom--SettlementOfDebtMember_zVgM9Flf8NKj" title="Loss on debt repaid"&gt;2,174,075&lt;/span&gt;,
which is presented on the consolidated statements of operations and the consolidated statements of cash flows within &#x2018;gain on debt
settlement, net&#x2019;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_z9h6z4aPfMXh" title="Common stock issued on conversion"&gt;330,869&lt;/span&gt;
shares valued at $&lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zYqXp7nSvrm9" title="Common stock issued on conversion, value"&gt;5,916,777&lt;/span&gt; for an employment agreement&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationMember_z4RmxjoT8HQ1" title="Common stock issued on conversion"&gt;33,609&lt;/span&gt;
shares valued at $&lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationMember_zXnbDB0cF7G4" title="Common stock issued on conversion, value"&gt;764,020&lt;/span&gt; for consideration in the Management Services Agreement and a Release agreement with Ed Burns&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockRedemptionMember_z6qqoJB00Cq" title="Common stock issued on conversion"&gt;2,633&lt;/span&gt;
shares for a release of Common Stock subject to redemption&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025 and 2024, there were &lt;span id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_pid_c20251231_z8ITVFEL0N9g" title="Common stock, shares issued"&gt;&lt;span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20251231_zEvZRjz3Aaak" title="Common stock, shares outstanding"&gt;3,642,501&lt;/span&gt;&lt;/span&gt; and &lt;span id="xdx_901_eus-gaap--CommonStockSharesIssued_iI_pid_c20241231_zJelsbo8sWJh" title="Common stock, shares issued"&gt;&lt;span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20241231_zXZIJoI8QRw8" title="Common stock, shares outstanding"&gt;391,373&lt;/span&gt;&lt;/span&gt; shares of Common Stock issued and outstanding, respectively. The &lt;span id="xdx_901_eus-gaap--SharesOutstanding_iI_pid_c20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationMember_zfPVWCD5KTF8" title="Shares outstanding"&gt;3,642,501&lt;/span&gt;
shares of Common Stock include &lt;span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_pid_c20251231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationMember_zBLG74RRx565" title="Shares issued"&gt;33,609&lt;/span&gt; shares of Common Stock to be issued to SLG and under certain equity plans.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zlnP6RJvAXQ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B5_zav9Zu71IhP6" style="display: none"&gt;SCHEDULE OF WARRANTS ACTIVITY&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="13" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Table 17.1: Details of Warrants&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Number of Warrants&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average Exercise Price&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average Life (years)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%"&gt;Outstanding warrants, December 31, 2024&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z5koWpXKxzdk" style="width: 14%; text-align: right" title="Number of Warrants, outstanding, beginning balance"&gt;315,028&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zANxz2XwRlS6" style="width: 14%; text-align: right" title="Weighted Average Exercise Price, beginning balance"&gt;20.64&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zgSc51nfH70b" style="width: 14%; text-align: right" title="Weighted Average Life (years), outstanding"&gt;3.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdrVIXQoK6th" style="text-align: right" title="Number of Warrants, granted"&gt;869,992&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zgK3DoCypH99" style="text-align: right" title="Weighted Average Exercise Price, granted"&gt;164.96&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms_dtY_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zS2lbpIrazQj" style="text-align: right" title="Weighted Average Life (years), granted"&gt;4.7&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Replacement of old warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NumberOfWarrantsReplacementOfOldWarrants_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zmx8YvOu9nSh" style="text-align: right" title="Number of Warrants, replacement of old warrants"&gt;(315,028&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageReplacementDateFairValue_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zBXNl9udLpsl" style="text-align: right" title="Weighted Average Exercise Price, replacement of old warrants"&gt;20.64&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsReplacementWeightedAverageRemainingContractualTerms_dtY_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zbJbga5B6MD" style="text-align: right" title="Weighted Average Life (years), replacement of old warrants"&gt;2.9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;Exercised&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zUzTzaAWd5X2" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, exercised"&gt;(234,831&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQPVrBM9yDok" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, exercised"&gt;14.27&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms_dtY_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zYa0Zn9oaDDf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Life (years), exercised"&gt;4.3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Outstanding warrants, March 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zOL5SSfzw9zj" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, outstanding, beginning balance"&gt;635,161&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zbuWKnZHLht3" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, beginning balance"&gt;220.67&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zWl7cTaUk2b3" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Life (years), outstanding"&gt;4.7&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Issued - Prefunded (equity line)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NumberOfWarrantsPrefundedEquityLine_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zzxZsjCsBH3h" style="text-align: right" title="Number of Warrants, prefunded (equity line)"&gt;150,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedPrefundedWarrantInPeriodWeightedAverageGrantDateFairValue_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z2ydQ2vjNMv2" style="text-align: right" title="Weighted Average Exercise Price, issued - prefunded (equity line)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2259"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedPrefundedWarrantWeightedAverageRemainingContractualTerms_dtY_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zc6rC0TnmJm4" style="text-align: right" title="Weighted Average Life (years), issued - prefunded (equity line)"&gt;1.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Exercised - Prefunded (equity line)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--NumberOfWarrantsExercisedPrefundedEquityLine_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zl89sD5eAj56" style="text-align: right" title="Number of Warrants, exercised - prefunded (equity line)"&gt;(83,333&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantInPeriodWeightedAverageGrantDateFairValue_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zyLuN4OlJUI7" style="text-align: right" title="Weighted Average Exercise Price, exercised - prefunded (equity line)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2265"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantWeightedAverageRemainingContractualTerms_dtY_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zFzzYECkWiY6" style="text-align: right" title="Weighted Average Life (years), exercised - prefunded (equity line)"&gt;1.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zjGQlDNjl9B9" style="text-align: right" title="Number of Warrants, exercised"&gt;(23,633&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zSW0wYOpIjM6" style="text-align: right" title="Weighted Average Exercise Price, exercised"&gt;15.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms_dtY_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpEOCmIoPkR1" style="text-align: right" title="Weighted Average Life (years), exercised"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Outstanding warrants, June 30, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zDi2VSWE0lub" style="text-align: right" title="Number of Warrants, outstanding, beginning balance"&gt;678,195&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zJtKLhcevsPa" style="text-align: right" title="Weighted Average Exercise Price, beginning balance"&gt;206.15&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztWAPt6V8wJb" style="text-align: right" title="Weighted Average Life (years), outstanding"&gt;4.8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt; text-align: left"&gt;Exercised - Prefunded (equity line)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NumberOfWarrantsExercisedPrefundedEquityLine_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z9BvOj2JikBf" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, exercised - prefunded (equity line)"&gt;(66,667&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantInPeriodWeightedAverageGrantDateFairValue_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zeMgbypFFdE5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, exercised - prefunded (equity line)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2283"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantWeightedAverageRemainingContractualTerms_dtY_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZRt4wPn8zGj" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Life (years), exercised - prefunded (equity line)"&gt;1.0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Outstanding warrants, September 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zXKzlQ10hms5" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, outstanding, beginning balance"&gt;611,528&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4p8IgQEMWn5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, beginning balance"&gt;228.62&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMb3B8fquovd" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Life (years), outstanding"&gt;4.8&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Issued - Prefunded (Armistice-Prefunded)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--NumberOfWarrantsIssuedPrefunded_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zj8dukPoEu8b" style="text-align: right" title="Number of Warrants, prefunded (equity line)"&gt;1,670,720&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--WeightedAverageExercisePriceIssuedPrefunded_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zoq3xlowRpv4" style="text-align: right" title="Weighted Average Exercise Price, issued - prefunded (Armistice-Prefunded)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2295"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageLifeYearsIssuedPrefunded_dtY_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZPqslvgomEk" style="text-align: right" title="Weighted Average Life (years), exercised - prefunded (Armistice-Prefunded)"&gt;1.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt; text-align: left"&gt;Issued (Armistice)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NumberOfWarrantsIssued_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4dcV4AyHh98" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, issued (Armistice)"&gt;3,341,439&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedWarrantInPeriodWeightedAverageGrantDateFairValue_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zcJ7nHHWAjA8" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, issued"&gt;3.62&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--WeightedAverageLifeYearsIssued_dtY_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z8nfRsIqCtVh" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Life (years), issued (Armistice)"&gt;5.0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding warrants, December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdgCGOqGQJoe" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Warrants, outstanding, ending balance"&gt;5,623,687&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z50DvSGYPq9l" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, ending balance"&gt;27.01&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zKrxFJa5CGKf" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Life (years), issued (Armistice)"&gt;5.0&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Exercisable warrants, December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber_iE_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNWAMlrUclti" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Warrants, exercisable"&gt;5,623,687&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iE_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zvQnGdv7qtUh" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, exercisable"&gt;27.01&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerms_dtY_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zyjibkTbnm14" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Life (years), exercisable"&gt;5.0&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zM8mNQgVROV6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has accounted for the issuance of Common Stock and warrants issued for cash proceeds in the private placements as equity instruments.
Management believes that the warrants are indexed to and are settled in the Company&#x2019;s own Common Stock; therefore, they should
be accounted for as permanent equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Public
Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025 and 2024, there were &lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zTJqbp93GHl7" title="Class of warrant or right, outstanding"&gt;&lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20241231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zKfz86IP7Ozf" title="Class of warrant or right, outstanding"&gt;383,333&lt;/span&gt;&lt;/span&gt; public warrants (&#x201c;Public Warrants&#x201d;) outstanding. The Company accounts for
the Public Warrants as equity instruments. The Public Warrants will become exercisable on the later of (a) &lt;span id="xdx_909_ecustom--ClassOfWarrantOrRightExercisablePeriodThresholdTradingDays_iI_dtD_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__srt--RangeAxis__srt--MinimumMember_zUJeOY8IG4Zj" title="Threshold trading days for redemption of public warrants"&gt;30&lt;/span&gt; days after the completion
of a Business Combination or (b) &lt;span id="xdx_90D_ecustom--ClassOfWarrantOrRightExercisablePeriodThresholdTradingDays_iI_dtM_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__srt--RangeAxis__srt--MaximumMember_ztz4tnegAFr5" title="Threshold trading days for redemption of public warrants"&gt;12&lt;/span&gt; months from the closing of the initial public offering. No warrants will be exercisable for cash
unless the Company has an effective and current registration statement covering the shares of Common Stock issuable upon exercise of
the warrants and a current prospectus relating to such shares of Common Stock. Notwithstanding the foregoing, if a registration statement
covering the shares of Common Stock issuable upon exercise of the Public Warrants is not effective within a specified period following
the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and
during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless
basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If neither
that exemption nor another exemption is available, holders will not be able to exercise their warrants on a cashless basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Public Warrants will expire on February 14, 2030, &lt;span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_znRkz4cbGJE9" title="Warrants and rights outstanding, term"&gt;five years&lt;/span&gt; after the completion of the Business Combination with Cycurion or earlier
upon redemption or liquidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Once
the Public Warrants become exercisable, the Company may redeem the Public Warrants:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in
whole and not in part&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;at
a price of $&lt;span id="xdx_90D_ecustom--ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_iI_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zLDMkCHhcppl" title="Redemption price per public warrant"&gt;0.30&lt;/span&gt; per Public Warrant;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;upon
not less than &lt;span id="xdx_905_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantOrRightMinimumThresholdWrittenNoticePeriod_i01_dtD_c20250101__20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z3YIs0MwwKP7" title="Minimum threshold written notice period for redemption of public warrants"&gt;30&lt;/span&gt; days&#x2019; prior written notice of redemption;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if,
and only if, the reported last sale price of the shares of Common Stock equals or exceeds $&lt;span id="xdx_90E_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_iI_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zz9f08LaJlel" title="Stock price trigger for redemption of public warrants per share"&gt;18.00&lt;/span&gt; per share (as adjusted for stock splits,
stock dividends, reorganizations and recapitalizations), for any &lt;span id="xdx_901_ecustom--ClassOfWarrantOrRightExercisablePeriodThresholdTradingDays_iI_dtD_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zVe6W5pFHRua" title="Threshold trading days for redemption of public warrants"&gt;20&lt;/span&gt; trading days within a &lt;span id="xdx_905_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantOrRightThresholdConsecutiveTradingDays_dtD_c20250101__20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z5TwZLL2RQNd" title="Threshold consecutive trading days for redemption of public warrants"&gt;30&lt;/span&gt; trading day period commencing at any time
after the Public Warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders;
and&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if,
and only if, there is a current registration statement in effect with respect to the shares of Common Stock underlying the Public Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
and when the Public Warrants become redeemable, we may not exercise our redemption right if the issuance of shares of Common Stock upon
exercise of the Public Warrants is not exempt from registration or qualification under applicable state blue sky laws or we are unable
to effect such registration or qualification. We will use our best efforts to register or qualify such shares of Common Stock under the
blue-sky laws of those states in which such Public Warrants were offered by us in the offering.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
we call the Public Warrants for redemption, as described above, we will have the option to require any holder that wishes to exercise
its Public Warrant to do so on a &#x201c;cashless basis.&#x201d; If we take advantage of this option, all holders of Public Warrants would
pay the exercise price by surrendering their Public Warrants for the number of shares of Common Stock equal to the quotient obtained
by dividing (x) the product of the number of shares of Common Stock underlying the Public Warrants, multiplied by the difference between
the exercise price of the Public Warrants and the &#x201c;fair market value&#x201d; (defined below) by (y) the fair market value. The &#x201c;fair
market value&#x201d; for this purpose means the average reported last sale price of the Common Stock for the ten&lt;span id="xdx_90F_ecustom--ClassOfWarrantOrRightFairValueMeasurementMeasurementPeriod_dtD_c20250101__20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zzTvY619hUD7" style="display: none" title="Fair value measurement, lookback period"&gt;10&lt;/span&gt; trading days ending on
the third trading day prior to the date on which the notice of redemption is sent to the holders of Public Warrants. If our management
takes advantage of this option, the notice of redemption will contain the information necessary to calculate the number of shares of
Common Stock to be received upon exercise of the Public Warrants, including the &#x201c;fair market value&#x201d; in such case. Requiring
a cashless exercise in this manner will reduce the number of shares to be issued and thereby lessen the dilutive effect of a Public Warrant
redemption. We believe this feature is an attractive option to us if we do not need the cash from the exercise of the Public Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;PIPE
Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 11, 2022, concurrently with the completion of the Business Combination, pursuant to the PIPE Subscription Agreement, dated January
11, 2022 (as the same may be amended from time to time, the &#x201c;PIPE Subscription Agreement&#x201d;) for an aggregate purchase price
of $&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220111__20220111__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeSubscriptionAgreementMember_z0BhD2gKYjkj" title="Common stock issued for exercise of warrants"&gt;3,760,000&lt;/span&gt;, Western issued an aggregate of &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220111__20220111__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeSubscriptionAgreementMember_zMeSzluf7fU7" title="Common stock issued for exercise of warrants, shares"&gt;12,533&lt;/span&gt; shares of Common Stock issued in a private placement (the &#x201c;PIPE Financing&#x201d;)
pursuant to that certain PIPE Subscription Agreement and &lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220111__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeWarrantsMember_zxEG5UPVpjXl" title="Class of warrant or right, number of securities called by warrants or rights, shares"&gt;12,533&lt;/span&gt; shares of Common Stock issuable upon the exercise of certain warrants
(the &#x201c;PIPE Warrants&#x201d;) issued in the PIPE Financing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
outstanding whole PIPE Warrant and public warrant (&#x201c;Public Warrant&#x201d;) issued in connection with the initial public offering
of Western represents the right to purchase &lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_dc_c20220111__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeWarrantsMember_zxlyJHREzLnc" title="Class of warrant or right, number of securities called by each warrant or right, shares"&gt;one&lt;/span&gt; share of Common Stock at a price of $&lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220111__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeWarrantsMember_zuoGKH24Lh2h" title="Class of warrant or right, exercise price of warrants or rights"&gt;11.50&lt;/span&gt; per share, subject to adjustment, at any time
commencing &lt;span id="xdx_906_ecustom--WarrantsAndRightsExerciseStartDelayPeriod_iI_dtD_c20220111__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeWarrantsMember_zHaK8e26QpIc" title="Warrants and rights, exercise start delay period"&gt;30&lt;/span&gt; days after the Business Combination with Western and ending &lt;span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20220111__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeWarrantsMember_zNnYIOcLbDle" title="Warrants and rights outstanding, term"&gt;five years&lt;/span&gt; after the Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
PIPE Warrants, as well as any warrants underlying additional units issued to the Western Acquisition Ventures Sponsor, LLC (the &#x201c;Sponsor&#x201d;)
or our officers, directors or their affiliates in payment of working capital loans, are identical to the Public Warrants except that
the PIPE Warrants (i) will be exercisable for cash or on a cashless basis, at the holder&#x2019;s option, and (ii) will not be redeemable
by us, in each case so long as they are still held by the Sponsor or its permitted transferees.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025 and 2024, there were &lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20251231__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeWarrantsMember_zLbOWMuxuY7c" title="Class of warrant or right, outstanding"&gt;&lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20241231__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeWarrantsMember_zdtBXkwWq99j" title="Class of warrant or right, outstanding"&gt;12,533&lt;/span&gt;&lt;/span&gt; PIPE Warrants outstanding. The Company accounts for the Private Placement Warrants as
equity instruments. The PIPE Warrants sold in the private placement are identical to the Public Warrants underlying the Units sold in
the initial public offering, except that such warrants, and the shares of Common Stock issuable upon the exercise of such warrants, will
not be transferable, assignable, or salable until after February 14, 2025, the date of completion of a Business Combination, subject
to certain limited exceptions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, if we, at any time while the Public Warrants or PIPE Warrants are outstanding and unexpired, pay a dividend or make a distribution
in cash, securities or other assets to the holders of Common Stock on account of such shares of Common Stock (or other shares of our
capital stock into which the Public Warrants or PIPE Warrants are convertible), other than (a) as described above, (b) certain ordinary
cash dividends, (c) to satisfy the redemption rights of the holders of Common Stock in connection with a proposed initial business combination,
(d) to satisfy the redemption rights of the holders of Common Stock in connection with a stockholder vote to amend our amended and restated
certificate of incorporation (i) to modify the substance or timing of our obligation to allow redemption in connection with our initial
business combination or certain amendments to our charter prior thereto or to redeem &lt;span id="xdx_90A_ecustom--CommonStockRedemptionRightsUponDelayInBusinessCombinationClosingPercentage_iI_pid_dp_uPure_c20220111__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeWarrantsMember_z4uwejgxqgOd" title="Common stock, redemption rights upon delay in business combination closing, percentage"&gt;100&lt;/span&gt;% of our Common Stock if we do not complete our
initial business combination within &lt;span id="xdx_904_ecustom--CommonStockRedemptionRightsBusinessCombinationClosingPeriod_dtM_c20220111__20220111__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeWarrantsMember__srt--RangeAxis__srt--MinimumMember_zU5knbgfFCUi" title="Common stock, redemption rights, business combination closing period"&gt;12&lt;/span&gt; months from the closing of this offering (or up to &lt;span id="xdx_905_ecustom--CommonStockRedemptionRightsBusinessCombinationClosingPeriod_dtM_c20220111__20220111__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeWarrantsMember__srt--RangeAxis__srt--MaximumMember_zhoVWlBqu1d8" title="Common stock, redemption rights, business combination closing period"&gt;18&lt;/span&gt; months from the closing of the offering
at the election of the Company subject to satisfaction of certain conditions or as extended by our stockholders in accordance with our
amended and restated certificate of incorporation) or (ii) with respect to any other provision relating to stockholders&#x2019; rights
or pre-initial business combination activity, or (e) in connection with the redemption of our public shares upon our failure to complete
our initial business combination, then the Public Warrants and PIPE Warrants exercise price will be decreased, effective immediately
after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid on
each share of Common Stock in respect of such event.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the number of outstanding shares of Common Stock is decreased by a consolidation, combination, reverse stock split or reclassification
of shares of Common Stock or other similar event, then, on the effective date of such consolidation, combination, reverse stock split,
reclassification or similar event, the number of shares of Common Stock issuable on exercise of each Public Warrant and PIPE Warrant
will be decreased in proportion to such decrease in outstanding shares of Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
case of any reclassification or reorganization of the outstanding shares of Common Stock (other than those described above or that solely
affects the par value of such shares of Common Stock), or in the case of any merger or consolidation of us with or into another corporation
(other than a consolidation or merger in which we are the continuing corporation and that does not result in any reclassification or
reorganization of our outstanding shares of Common Stock), or in the case of any sale or conveyance to another corporation or entity
of the assets or other property of ours as an entirety or substantially as an entirety in connection with which we are dissolved, the
holders of the Public Warrants and PIPE Warrants will thereafter have the right to purchase and receive, upon the basis and upon the
terms and conditions specified in the Public Warrants and PIPE Warrants and in lieu of the shares of Common Stock immediately theretofore
purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities
or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following
any such sale or transfer, that the holder of the Public Warrants or PIPE Warrants (as applicable) would have received if such holder
had exercised their Public Warrants or PIPE Warrant (as applicable) immediately prior to such event.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Public Warrants and PIPE Warrants are issued in registered form under a warrant agreement between Equiniti Trust Company, LLC, as warrant
agent, and us. The warrant agreement provides that the terms of the Public Warrants and PIPE Warrants may be amended without the consent
of any holder to cure any ambiguity or correct any mistake, or defective provision, but requires the approval by the holders of at least
a majority of the then outstanding Public Warrants to make any change that adversely affects the interests of the registered holders
of Public Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
A Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 17, 2017, the Company had issued &lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20171117__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zCVX41Zjjhkj" title="Class of warrant or right, number of securities called by warrants or rights"&gt;44,445&lt;/span&gt; Series A Warrants at exercise price of $&lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20171117__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_z89dpN9iSVE5" title="Class of warrant or right, exercise price of warrants"&gt;13.50&lt;/span&gt; with an expiration date of November 22,
2025. As part of the Business Combination with Western, during the first quarter of 2025, the Company issued to unaffiliated investors
a total of &lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_z2EBMp0tsph3" title="Warrants issued"&gt;22,696&lt;/span&gt; Series A Warrants in exchange of existing &lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZXIGBX0qAOe" title="Warrants issued"&gt;44,445&lt;/span&gt; Series A Warrants having expiry on February 19, 2029 and exercise
price of $&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zo7boHtq69sd" title="Exercise price of warrants"&gt;9.59121&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Series
B Warrants&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 1, 2023, the Company issued &lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20230801__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesBWarrantsMember_zNbjYutGbLh6" title="Class of warrant or right, number of securities called by warrants or rights"&gt;133,333&lt;/span&gt; Series B Warrants with an exercise price of $&lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230801__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesBWarrantsMember_zGgCCVpS0Up9" title="Class of warrant or right, exercise price of warrants"&gt;15.00&lt;/span&gt; with an expiration date of August 1, 2028.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 12, 2024, the Company issued &lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240412__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesBWarrantsMember_zcKC0r20mlYc" title="Class of warrant or right, number of securities called by warrants or rights"&gt;66,667&lt;/span&gt; Series B Warrants with an exercise price of $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240412__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesBWarrantsMember_zoAu4pVEewp5" title="Class of warrant or right, exercise price of warrants"&gt;15.00&lt;/span&gt; with an expiration date of April 12, 2029.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
part of the Business Combination with Western, during the year ended December 31, 2025, the Company issued to unaffiliated investors
a total of &lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesBWarrantsMember_zXLLsR9y2eDf" title="Class of warrant or right, number of securities called by warrants or rights"&gt;200,000&lt;/span&gt; Series B Warrants in exchange of existing &lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesBWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z0QUhY0qBlgj" title="Warrants issued"&gt;200,000&lt;/span&gt; Series B Warrants having and expiration date of February 19, 2030
and an exercise price of $&lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesBWarrantsMember_zRwAULHOd2W9" title="Exercise price of warrants"&gt;15.00&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Series
D Warrants&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 22, 2022, the Company issued &lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220322__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesDWarrantsMember__us-gaap--LongtermDebtTypeAxis__custom--SubordinatedConvertiblePromissoryNoteMember_zp4diAz21nRi" title="Warrants issued"&gt;6,564&lt;/span&gt; Series D Warrants with a subordinated convertible promissory note at an exercise price of $&lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220322__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesDWarrantsMember__us-gaap--LongtermDebtTypeAxis__custom--SubordinatedConvertiblePromissoryNoteMember_zGjv9BUIxee8" title="Exercise price of warrants"&gt;42.30&lt;/span&gt;
and an expiration date of September 22, 2027.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 22, 2022, the Company had issued &lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221122__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesDWarrantsMember__us-gaap--LongtermDebtTypeAxis__custom--SubordinatedConvertiblePromissoryNoteOneMember_zKHc3hgbtgz8" title="Warrants issued"&gt;32,819&lt;/span&gt; warrants with subordinated convertible promissory note at an exercise price of $&lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221122__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesDWarrantsMember__us-gaap--LongtermDebtTypeAxis__custom--SubordinatedConvertiblePromissoryNoteOneMember_zi26QoUkmrhf" title="Exercise price of warrants"&gt;42.30&lt;/span&gt;
and an expiration date of April 21, 2028.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
part of the Business Combination with Western, during the year ended December 31, 2025, the Company issued to unaffiliated investors
a total of &lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesDWarrantsMember_zuHJQhKANt8b" title="Class of warrant or right, number of securities called by warrants or rights"&gt;242,424&lt;/span&gt; Series D Warrants in exchange of existing &lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesDWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zcspWJWngDe" title="Class of warrant or right, number of securities called by warrants or rights"&gt;39,382&lt;/span&gt; Series D Warrants having an exercise price of $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesDWarrantsMember_zhTKccsdjq12" title="Class of warrant or right, exercise price of warrants"&gt;15.00&lt;/span&gt; and an expiration
date of February 19, 2029.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Armistice
Pre-Funded Warrant and Armistice Warrant&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 4, 2025, Cycurion entered into a securities purchase agreement (the &#x201c;Armistice Purchase Agreement&#x201d;) with a single
institutional accredited investor, Armistice Capital Master Fund Ltd. (&#x201c;Armistice&#x201d;), pursuant to which we issued and sold
to Armistice in a private placement (i) pre-funded warrants (the &#x201c;Armistice Pre-Funded Warrants&#x201d;) to purchase up to an aggregate
of &lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250412__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrantSharesMember_zMHIYazpB5Rg" title="Class of warrant or right, number of securities called by warrants or rights"&gt;1,657,460&lt;/span&gt; shares of Common Stock (the &#x201c;Pre-Funded Warrant Shares&#x201d;), and (ii) warrants (the &#x201c;Armistice Warrants&#x201d;)
to purchase up to an aggregate of &lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250412__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantSharesMember_zrmfggWMOkjh" title="Class of warrant or right, number of securities called by warrants or rights"&gt;3,314,920&lt;/span&gt; shares of Common Stock (the &#x201c;Warrant Shares&#x201d;). The exercise of the Warrants and
the issuance of the Warrant Shares upon exercise thereof is subject to stockholder approval (&#x201c;Stockholder Approval&#x201d;). Stockholder
Approval was received at the special general meeting of stockholders on March 19, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
Armistice Pre-Funded Warrant was sold at an offering price of $&lt;span id="xdx_90A_ecustom--ClassOfWarrantOrRightOfferingPrice_iI_pid_c20251205__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrantSharesMember_zQdyL9MsSz21" title="Class of warrant or right, offering price"&gt;3.62&lt;/span&gt;. Each Armistice Warrant has an exercise price of $&lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20251205__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantSharesMember__srt--CounterpartyNameAxis__custom--ArmisticeCapitalMasterFundLtdMember_zQ5Banz5eD51" title="Class of warrant or right, exercise price of warrants or rights"&gt;3.62&lt;/span&gt;. The Private
Placement closed (the &#x201c;Closing&#x201d;) on December 5, 2025 (the &#x201c;Closing Date&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 5, 2025, Cycurion entered into the Armistice Pre-Funded Warrant with Armistice that is exercisable for up to &lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20251205__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrantSharesMember__srt--CounterpartyNameAxis__custom--ArmisticeCapitalMasterFundLtdMember_zrogjUVmwzV3" title="Warrants shares"&gt;1,657,460&lt;/span&gt; shares
of Common Stock. Each Armistice Pre-Funded Warrant has an exercise price equal to $&lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20251205__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrantSharesMember__srt--CounterpartyNameAxis__custom--ArmisticeCapitalMasterFundLtdMember_zsphK6LoeYAf" title="Class of warrant or right, exercise price of warrants or rights"&gt;0.0001&lt;/span&gt; per share. The Armistice Pre-Funded Warrants
are exercisable at any time after their original issuance and will not expire until exercised in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 5, 2025, Cycurion entered into the Armistice Warrant with Armistice that has an exercise price equal to $&lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20251205__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantSharesMember__srt--CounterpartyNameAxis__custom--ArmisticeCapitalMasterFundLtdMember_zpzXHIq6zEbd" title="Class of warrant or right, exercise price of warrants or rights"&gt;3.62&lt;/span&gt; per share. The
Armistice Warrants will be exercisable immediately following receipt of Stockholder Approval for the issuance of the Armistice Warrants
and the Warrant Shares and have an exercise price of $&lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20251205__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantSharesMember__srt--CounterpartyNameAxis__custom--ArmisticeCapitalMasterFundLtdMember_zJ7FfVVkBfQ6" title="Class of warrant or right, exercise price of warrants or rights"&gt;3.62&lt;/span&gt; per share, subject to adjustment for customary events such as stock splits
and fundamental transactions. The Armistice Warrants will expire &lt;span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20251205__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantSharesMember__srt--CounterpartyNameAxis__custom--ArmisticeCapitalMasterFundLtdMember_zQEtSkiKahk1" title="Warrants and rights outstanding, term"&gt;five years&lt;/span&gt; from their initial exercise date. At any time following the
initial exercise date of the Armistice Warrants, the Armistice Warrants can be exercised on a cashless basis if there is no effective
registration statement registering, or no current prospectus available for, the resale of the Warrant Shares. The exercise price and
number of shares of Common Stock issuable upon exercise of the Armistice Warrant and Armistice Pre-Funded Warrant are subject to appropriate
adjustment in the event of stock dividends, stock splits, reorganizations or similar events.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Armistice Pre-Funded Warrants and the Armistice Warrants issued in the Armistice private placement provide that a holder of Armistice
Pre-Funded Warrants or Armistice Warrants, as applicable, will not have the right to exercise any portion of its Armistice Pre-Funded
Warrants or Armistice Warrants if such holder, together with its affiliates, and any other party whose holdings would be aggregated with
those of the holder for purposes of Section 13(d) or Section 16 of the Exchange Act would beneficially own in excess of 9.99% for the
Armistice Pre-Funded Warrants and 4.99% for the Armistice Warrants of the number of shares of Common Stock outstanding immediately after
giving effect to such exercise (the &#x201c;Beneficial Ownership Limitation&#x201d;); provided, however, that the holder may increase or
decrease the Beneficial Ownership Limitation by giving notice to the Company, with any such increase not taking effect until the sixty-first
day after such notice is delivered to the Company but not to any percentage in excess of 9.99%. The Warrants may be exercised on a cashless
basis if a registration statement registering Warrant Shares is not effective. The Armistice Pre-Funded Warrants may be exercised on
a cashless basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subject
to applicable laws, an Armistice Warrant and Armistice Pre-Funded Warrant may be transferred at the option of the holder upon surrender
of the applicable warrant to us together with the appropriate instruments of transfer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
is no trading market available for the Armistice Warrants or the Armistice Pre-Funded Warrants on any securities exchange or nationally
recognized trading system. We do not intend to list the Armistice Warrants or the Armistice Pre-Funded Warrants on any securities exchange
or nationally recognized trading system.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
the event of a fundamental transaction, as described in the Armistice Warrants and Armistice Pre-Funded Warrants and generally including
any reorganization, recapitalization or reclassification of our Common Stock, the sale, transfer or other disposition of all or substantially
all of our properties or assets, our consolidation or merger with or into another person, the acquisition of more than &lt;span id="xdx_905_ecustom--CommonStockOwnershipChangeInControlThresholdPercentage_iI_pid_dp_uPure_c20251205__srt--CounterpartyNameAxis__custom--ArmisticeCapitalMasterFundLtdMember_zzUGziPjjE" title="Common stock ownership, change in control threshold percentage"&gt;50&lt;/span&gt;% of our outstanding
Common Stock, or any person or group becoming the beneficial owner of &lt;span id="xdx_908_ecustom--VotingPowerChangeInControlThresholdPercentage_iI_pid_dp_uPure_c20251205__srt--CounterpartyNameAxis__custom--ArmisticeCapitalMasterFundLtdMember_zxow9gNX40Sa" title="Voting power, change in control threshold percentage"&gt;50&lt;/span&gt;% of the voting power represented by our outstanding Common Stock,
the holders of the Armistice Warrants and Armistice Pre-Funded Warrants will be entitled to receive upon exercise of the Armistice Warrants
and Armistice Pre-Funded Warrants the kind and amount of securities, cash or other property that the holders would have received had
they exercised the Armistice Warrants and Armistice Pre-Funded Warrants immediately prior to such fundamental transaction. In addition,
in certain circumstances, upon a fundamental transaction, the holder will have the right to require us to repurchase its Armistice Warrants
at the Black Scholes Value; provided, however, that, if the fundamental transaction is not within our control, including not approved
by our Board of Directors, then the holder shall only be entitled to receive the same type or form of consideration (and in the same
proportion), at the Black Scholes Value of the unexercised portion of the Warrant, that is being offered and paid to the holders of Common
Stock in connection with the fundamental transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the terms of the Armistice Purchase Agreement, the Company is prohibited from entering into any agreement to issue or announcing the
issuance or proposed issuance of any shares of Common Stock or securities convertible or exercisable into Common Stock for a period commencing
on December 4, 2025 and expiring &lt;span id="xdx_908_ecustom--ClassOfWarrantOrRightIssuanceRestrictionPeriod_iI_dtD_c20251204__srt--CounterpartyNameAxis__custom--ArmisticeCapitalMasterFundLtdMember_zwgw6fnxzDl2" title="Class of warrant or right, issuance restriction period"&gt;90&lt;/span&gt; days from the Effective Date (as defined in the Armistice Purchase Agreement). Furthermore, the Company
is also prohibited from entering into any agreement to issue Common Stock or Common Stock Equivalents (as defined in the Armistice Purchase
Agreement) involving a Variable Rate Transaction (as defined in the Armistice Purchase Agreement), subject to certain exceptions, for
a period commencing on December 4, 2025 and expiring &lt;span id="xdx_903_ecustom--ClassOfWarrantOrRightIssuanceRestrictionPeriod_iI_dtD_c20251204__srt--CounterpartyNameAxis__custom--ArmisticeCapitalMasterFundLtdMember_zzMh5kftgByc" title="Class of warrant or right, issuance restriction period"&gt;90&lt;/span&gt; days from such Effective Date. The Effective Date is defined in the Armistice
Purchase Agreement as the earliest of the date that (a) the initial registration statement has been declared effective by the SEC, (b)
all of the Pre-Funded Warrant Shares and Warrant Shares have been sold pursuant to Rule 144 or may be sold pursuant to Rule 144 without
the requirement for the Company to be in compliance with the current public information required under Rule 144 and without volume or
manner-of-sale restrictions, (c) following the one year anniversary of the Closing provided that a holder of Pre-Funded Warrant Shares
or Warrant Shares is not an affiliate of the Company, or (d) all of the Pre-Funded Warrant Shares and Warrant Shares may be sold pursuant
to an exemption from registration under the Securities Act without volume or manner-of-sale restrictions and Company counsel has delivered
to such holders a standing written opinion that resales may then be made by such holders of the Pre-Funded Warrant Shares and Warrant
Shares pursuant to such exemption which opinion shall be in form and substance reasonably acceptable to such holders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Armistice Purchase Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing,
indemnification obligations of the Company, including for liabilities arising under the Securities Act, other obligations of the parties
and termination provisions. The representations, warranties and covenants contained in the Armistice Purchase Agreement were made only
for the purposes of such agreements and as of the specific dates, were solely for the benefit of the parties to such agreement and may
be subject to limitations agreed upon by the contracting parties.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Yield
Point NY LLC Pre-Funded Warrant&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 7, 2025, Cycurion entered into an equity purchase agreement (the &#x201c;Equity Purchase Agreement&#x201d;) with Yield Point NY LLC
(the &#x201c;Yield Point&#x201d;) relating to up to &lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250407__srt--CounterpartyNameAxis__custom--YieldPointNYLLCMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrantMember_zu0geNfGsotf" title="Class of warrant or right, number of securities called by warrants or rights"&gt;4,500,000&lt;/span&gt; shares of Common Stock issuable to Yield Point upon exercise of a pre-funded
warrant (&#x201c;Yield Point Pre-Funded Warrant&#x201d;) issued as its commitment fee (&#x201c;Commitment Fee&#x201d;) under the Equity Purchase
Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Yield Point Pre-Funded Warrant was offered for the Commitment Fee in connection with the Equity Purchase Agreement for shares of Common
Stock, and provides that the holder may not exercise any portion of the Yield Point Pre-Funded Warrant to the extent that immediately
prior to or after giving effect to such exercise the holder would own more than 4.99%, which ownership cap may be increased by the holder
up to 9.99% upon 61 days&#x2019; prior notice. The exercise price for each share of Common Stock underlying the Yield Point Pre-Funded
Warrant is $&lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250407__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantMember__srt--CounterpartyNameAxis__custom--YieldPointNYLLCMember_zNw9UAiGPk23" title="Warrants exercise price"&gt;0.0001&lt;/span&gt;. The Yield Point Pre-Funded Warrant is immediately exercisable upon issuance and may be exercised at any time until
the Yield Point Pre-Funded Warrant is exercised in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
holder of the Yield Point Pre-Funded Warrant may not exercise any portion of the warrants or Yield Point Pre-Funded Warrant, as applicable,
to the extent that the holder would own more than 4.99% (or, at the holder&#x2019;s option upon issuance, 9.99%) of our outstanding Common
Stock immediately after exercise, as such percentage ownership is determined in accordance with the terms of the Yield Point Pre-Funded
Warrant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
lieu of making the cash payment otherwise contemplated to be made to us upon exercise of the Yield Point Pre-Funded Warrant in payment
of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the net number
of shares of our Common Stock determined according to a formula set forth in the Yield Point Pre-Funded Warrant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Seward
&amp;amp; Kissel LLP Pre-Funded Warrant&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 14, 2025, Cycurion entered into pre-funded warrant with Seward &amp;amp; Kissel LLP that is exercisable for approximately $&lt;span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstanding_iI_pn5n6_c20250214__srt--CounterpartyNameAxis__custom--SewardAndKisselLLPMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrantMember_zvOrl9CPX84f" title="Warrants exercisable"&gt;1.3&lt;/span&gt; million
in shares of Common Stock, or up to &lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250214__srt--CounterpartyNameAxis__custom--SewardAndKisselLLPMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrantMember_zoGs6hFpLrk" title="Class of warrant or right, number of securities called by warrants or rights"&gt;83,333&lt;/span&gt; shares of Common Stock (the &#x201c;Seward &amp;amp; Kissel Pre-Funded Warrant&#x201d;); provided
that once the net proceeds from the sale of the shares equals the $&lt;span id="xdx_90F_eus-gaap--LegalFees_pn5n6_c20250214__20250214__srt--CounterpartyNameAxis__custom--SewardAndKisselLLPMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrantMember_ziAWACUUCwng" title="Legal fees"&gt;1.3&lt;/span&gt; million in legal fees and expenses (the &#x201c;Legal Fees&#x201d;),
the remaining shares of Common Stock, including such Common Stock exercisable under the Seward &amp;amp; Kissel Pre-Funded Warrant, shall
be returned to Cycurion.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Seward &amp;amp; Kissel Pre-Funded Warrant provides that the holder may not exercise any portion of the Seward &amp;amp; Kissel Pre-Funded Warrant
to the extent that immediately prior to or after giving effect to such exercise the holder would own more than 4.99% upon 61 days&#x2019;
prior notice. The exercise price for each share of Common Stock underlying the Seward &amp;amp; Kissel Pre-Funded Warrant is $&lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250214__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantMember__srt--CounterpartyNameAxis__custom--SewardAndKisselLLPMember_zE0zdWED6Re9" title="Warrants exercise price"&gt;0.0001&lt;/span&gt;. The
Seward &amp;amp; Kissel Pre-Funded Warrant is immediately exercisable upon issuance and may be exercised at any time until the Seward &amp;amp;
Kissel Pre-Funded Warrant is exercised in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Seward
&amp;amp; Kissel LLP may not exercise any portion of the warrants or Seward &amp;amp; Kissel Pre-Funded Warrant, as applicable, to the extent
that the holder would own more than 4.99% of our outstanding Common Stock immediately after exercise, as such percentage ownership is
determined in accordance with the terms of the Seward &amp;amp; Kissel Pre-Funded Warrant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
lieu of making the cash payment otherwise contemplated to be made to us upon exercise of the Seward &amp;amp; Kissel Pre-Funded Warrant in
payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the
net number of shares of our Common Stock determined according to a formula set forth in the Seward &amp;amp; Kissel Pre-Funded Warrant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Other
Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 8, 2022, the Company issued &lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220308__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zuZAA60Nnd2d" title="Warrants issued"&gt;17,636&lt;/span&gt; warrants to the originators of $&lt;span id="xdx_903_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_c20220308__20220308__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z3AEKBZjsxn" title="Warrants issued to the originators of investor notes"&gt;700,000&lt;/span&gt; of investor notes at exercise price of $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220308__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z5aiQ1icl2w" title="Exercise price of warrants"&gt;0.92&lt;/span&gt;, which
all were exercised in 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
part of the Business Combination with Western, during the year ended December 31, 2025, the Company issued to unaffiliated investors
a total of &lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsMember_zXR180rHbLN2" title="Warrants issued"&gt;9,006&lt;/span&gt; warrants in exchange of existing &lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHtdfpIa6xEe" title="Warrants issued"&gt;17,636&lt;/span&gt; warrants having an expiration date of February 19, 2029 and an exercise price
of $&lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsMember_zwRoAWKsixb2" title="Exercise price of warrants"&gt;9.59121&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Common
Stock Subject to Possible Redemption&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its Common Stock subject to possible redemption in accordance with the guidance in ASC 480. Shares of Common Stock
subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable
Common Stock (including Common Stock that features redemption rights that are either within the control of the holder or subject to redemption
upon the occurrence of uncertain events not solely within the Company&#x2019;s control) is classified as temporary equity. At all other
times, Common Stock is classified as stockholders&#x2019; equity. The Company&#x2019;s shares of Common Stock sold in the initial public
offering of Western feature certain redemption rights that are considered to be outside of the Company&#x2019;s control and subject to
occurrence of uncertain future events.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--TemporaryEquityTableTextBlock_z9JjxzJjbAyd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B3_zWVCS6SwF8nb" style="display: none"&gt;SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Table 17.2: Details of Common Stock Subject to Possible Redemption&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Number of Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Common Stock subject to possible redemption as of December 31, 2024&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--TemporaryEquitySharesIssued_iS_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zQN3tTchE7Kb" style="width: 16%; text-align: right" title="Common stock subject to possible redemption shares, beginning balance"&gt;5,796&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zh6p9elsrzch" style="width: 16%; text-align: right" title="Common stock subject to possible redemption, beginning balance"&gt;1,917,309&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt"&gt;Redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--TemporaryEquityRedemptionShares_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zBNWaqHy2HBc" style="text-align: right" title="Redemption, shares"&gt;(3,163&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--TemporaryEquityRedemption_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zzvV6KwNGJY7" style="text-align: right" title="Redemption"&gt;(1,001,216&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Release of Common Stock subject to redemption&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--TemporaryEquityReleaseOfCommonStockSubjectToRedemptionShares_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_z9RCeH05Aodb" style="border-bottom: Black 1pt solid; text-align: right" title="Release of common stock subject to redemption, shares"&gt;(2,633&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--TemporaryEquityReleaseOfCommonStockSubjectToRedemption_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zECjVvoEoD41" style="border-bottom: Black 1pt solid; text-align: right" title="Release of common stock subject to redemption"&gt;(916,093&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Common Stock subject to possible redemption as of December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--TemporaryEquitySharesIssued_iE_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_z1bsxofHtg39" style="border-bottom: Black 2.5pt double; text-align: right" title="Common stock subject to possible redemption shares, ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2465"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zYVmk7phKSfh" style="border-bottom: Black 2.5pt double; text-align: right" title="Common stock subject to possible redemption, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2467"&gt;-&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AA_zI3MRCFtnSb5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact002003"
      unitRef="Shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact002005"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2025-12-31_custom_CommonClassSubjectToRedemptionMember71580718"
      decimals="INF"
      id="Fact002007"
      unitRef="Shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2024-12-31_custom_CommonClassSubjectToRedemptionMember71580718"
      decimals="INF"
      id="Fact002009"
      unitRef="Shares">5796</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002011"
      unitRef="Shares">110000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002013"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="From2025-01-012025-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002015"
      unitRef="Pure">0.12</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002017"
      unitRef="USDPShares">1.45</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:PreferredStockConversionBasis
      contextRef="From2025-01-012025-12-31_custom_SeriesAConvertiblePreferredStockMember"
      id="Fact002019">Shares of Cycurion&#x2019;s Series A Convertible Preferred Stock shall be convertible, at any time and from time to time at
the option of the holder thereof, into shares of Common Stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion
ratio of one share of Series A Convertible Preferred Stock-for-one share of Common Stock, subject to adjustment.</us-gaap:PreferredStockConversionBasis>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002021"
      unitRef="Pure">1</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PrivatePlacementMember_custom_WesternAcquisitionVenturesCorpMember"
      decimals="INF"
      id="Fact002023"
      unitRef="Shares">106816</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002025"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002027"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002029"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002031"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002033"
      unitRef="Shares">3000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002035"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:ConversionOfStockDescription
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesBPreferredStockMember"
      id="Fact002037">Shares of our Series B Convertible Preferred Stock shall be convertible, at any time and from time to time at the option
of the holder thereof, into Common Stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of one share
of Series B Convertible Preferred Stock-for-one share of Common Stock, subject to adjustment.</us-gaap:ConversionOfStockDescription>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002039"
      unitRef="Pure">1</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-03-31_custom_SeriesBConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember"
      decimals="INF"
      id="Fact002041"
      unitRef="Shares">3000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-03-31_custom_SeriesBConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember"
      decimals="INF"
      id="Fact002043"
      unitRef="Shares">3000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-01-012025-12-31_custom_SeriesBConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember"
      decimals="INF"
      id="Fact002045"
      unitRef="Shares">2999</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002047"
      unitRef="Shares">199955</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002049"
      unitRef="Shares">1</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002051"
      unitRef="Shares">1</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002053"
      unitRef="Shares">3000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002055"
      unitRef="Shares">3000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002056"
      unitRef="Shares">5000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002058"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact002060"
      unitRef="Pure">0.12</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="AsOf2025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact002062"
      unitRef="USDPShares">82.46</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DebtConversionDescription
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesCPreferredStockMember"
      id="Fact002064">The shares of our Series C Convertible Preferred Stock may be converted into shares of our Common Stock at a ratio of approximately
20 shares of Common Stock for every one share of our Series C Convertible Preferred Stock, or an aggregate of 99,077 shares of our Common
Stock, assuming full conversion. In connection with conversions, each holder of our Series C Convertible Preferred Stock is subject to
a &#x201c;beneficial ownership limitation&#x201d; of 4.99% of the number of shares of our Common Stock outstanding immediately after giving
effect to that conversion, which limitation may be increased by the holder to not more than 9.99% on 61 days&#x2019; advanced notice to
us.</us-gaap:DebtConversionDescription>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="AsOf2025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact002066"
      unitRef="Pure">20</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact002068"
      unitRef="Shares">99077</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="AsOf2025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact002070"
      unitRef="USDPShares">82.46</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember"
      decimals="INF"
      id="Fact002072"
      unitRef="Shares">4851</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002074"
      unitRef="Shares">1356586</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:SharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002076"
      unitRef="Shares">406969</us-gaap:SharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002078"
      unitRef="Shares">4851</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002080"
      unitRef="Shares">4851</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002082"
      unitRef="Shares">4851</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002084"
      unitRef="Shares">4851</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002085"
      unitRef="Shares">6666700</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002087"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:DebtConversionDescription
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesDPreferredStockMember"
      id="Fact002089">Shares of Cycurion&#x2019;s Series D Convertible Preferred Stock shall be convertible, at any time and from time to time at
the option of the holder thereof, into shares of Common Stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion
ratio of one share of Series D Convertible Preferred Stock-for-one share of Common Stock, subject to adjustment.</us-gaap:DebtConversionDescription>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002091"
      unitRef="Pure">1</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-03-31_custom_SeriesDConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember"
      decimals="INF"
      id="Fact002093"
      unitRef="Shares">6666666</us-gaap:PreferredStockSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-01-012025-12-31_custom_SeriesDConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember"
      decimals="INF"
      id="Fact002095"
      unitRef="Shares">6516666</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002097"
      unitRef="Shares">217220</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002099"
      unitRef="Shares">150000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002101"
      unitRef="Shares">150000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002103"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002105"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002107"
      unitRef="Shares">100</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002109"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:ConversionOfStockDescription
      contextRef="From2025-01-012025-12-31_custom_SeriesDConvertiblePreferredStockMember"
      id="Fact002111">Shares of Cycurion&#x2019;s Series E Convertible Preferred Stock shall be convertible, at any time and from time to time at
the option of the holder thereof, into shares of Common Stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion
ratio of one share of Series E Convertible Preferred Stock-for-one share of Common Stock, subject to adjustment.</us-gaap:ConversionOfStockDescription>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002113"
      unitRef="Pure">1</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002115"
      unitRef="Shares">51</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002117"
      unitRef="Shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002119"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="AsOf2025-12-31_us-gaap_SeriesFPreferredStockMember"
      decimals="INF"
      id="Fact002121"
      unitRef="Pure">0.12</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="AsOf2025-12-31_us-gaap_SeriesFPreferredStockMember"
      decimals="INF"
      id="Fact002123"
      unitRef="USDPShares">0.0001</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:ConversionOfStockDescription
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesFPreferredStockMember"
      id="Fact002125">Shares of our Series F Convertible Preferred Stock shall be convertible, at any time and from time to time at the option
of the holder thereof, into shares of Common Stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of
one share of Series F Convertible Preferred Stock-for-1,000 shares of Common Stock, subject to adjustment.</us-gaap:ConversionOfStockDescription>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="AsOf2025-12-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002127"
      unitRef="Pure">1000</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002129"
      unitRef="Shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002131"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="AsOf2025-12-31_us-gaap_SeriesGPreferredStockMember"
      decimals="INF"
      id="Fact002133"
      unitRef="Pure">0.12</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="AsOf2025-12-31_us-gaap_SeriesGPreferredStockMember"
      decimals="INF"
      id="Fact002135"
      unitRef="USDPShares">0.0001</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:ConversionOfStockDescription
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesGPreferredStockMember"
      id="Fact002137">Shares of our Series G Convertible Preferred Stock shall be convertible, at any time and from time to time at the option
of the holder thereof, into shares of Common Stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of
one share of Series G Convertible Preferred Stock-for-1,000 shares of Common Stock, subject to adjustment.</us-gaap:ConversionOfStockDescription>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="AsOf2025-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002139"
      unitRef="Pure">1</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2025-01-012025-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="-5"
      id="Fact002141"
      unitRef="USD">3200000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2025-01-012025-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002143"
      unitRef="Shares">3133</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_AlphaCapitalAnstaltMember"
      decimals="0"
      id="Fact002145"
      unitRef="USD">366050</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_AlphaCapitalAnstaltMember"
      decimals="INF"
      id="Fact002147"
      unitRef="Shares">366</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_M2BFundingCorpMember"
      decimals="0"
      id="Fact002149"
      unitRef="USD">672077</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_M2BFundingCorpMember"
      decimals="INF"
      id="Fact002151"
      unitRef="Shares">672</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_AdiFundingMember"
      decimals="0"
      id="Fact002153"
      unitRef="USD">347730</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_AdiFundingMember"
      decimals="INF"
      id="Fact002155"
      unitRef="Shares">348</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_DeltenniumMember"
      decimals="0"
      id="Fact002157"
      unitRef="USD">617667</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_DeltenniumMember"
      decimals="INF"
      id="Fact002159"
      unitRef="Shares">618</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_OsherCapitalMember"
      decimals="0"
      id="Fact002161"
      unitRef="USD">103800</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_OsherCapitalMember"
      decimals="INF"
      id="Fact002163"
      unitRef="Shares">104</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_LexiLondonMember"
      decimals="0"
      id="Fact002165"
      unitRef="USD">769000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_LexiLondonMember"
      decimals="INF"
      id="Fact002167"
      unitRef="Shares">769</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_IleAssociatesMember"
      decimals="0"
      id="Fact002169"
      unitRef="USD">256333</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_IleAssociatesMember"
      decimals="INF"
      id="Fact002171"
      unitRef="Shares">256</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002173"
      unitRef="Shares">143</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002175"
      unitRef="Shares">143</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002177"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002179"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact002181"
      unitRef="Shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact002183"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_SeriesABandDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002185"
      unitRef="Shares">578863</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_WarrantABandDMember"
      decimals="INF"
      id="Fact002187"
      unitRef="Shares">258464</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_WarrantABandDMember"
      decimals="0"
      id="Fact002189"
      unitRef="USD">3309921</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember_us-gaap_AcquisitionRelatedCostsMember"
      decimals="INF"
      id="Fact002191"
      unitRef="Shares">25000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember_us-gaap_AcquisitionRelatedCostsMember"
      decimals="0"
      id="Fact002193"
      unitRef="USD">9000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_SettlementOfDebtMember"
      decimals="INF"
      id="Fact002195"
      unitRef="Shares">10894</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_SettlementOfDebtMember"
      decimals="0"
      id="Fact002197"
      unitRef="USD">1193634</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:DebtInstrumentRepaidPrincipal
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_SettlementOfDebtMember"
      decimals="0"
      id="Fact002199"
      unitRef="USD">2925803</us-gaap:DebtInstrumentRepaidPrincipal>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2025-01-012025-12-31_custom_SettlementOfDebtMember"
      decimals="0"
      id="Fact002201"
      unitRef="USD">-2174075</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_EmploymentAgreementMember"
      decimals="INF"
      id="Fact002203"
      unitRef="Shares">330869</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_EmploymentAgreementMember"
      decimals="0"
      id="Fact002205"
      unitRef="USD">5916777</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_SLGInnovationMember"
      decimals="INF"
      id="Fact002207"
      unitRef="Shares">33609</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_SLGInnovationMember"
      decimals="0"
      id="Fact002209"
      unitRef="USD">764020</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-01-012025-12-31_custom_CommonStockRedemptionMember"
      decimals="INF"
      id="Fact002211"
      unitRef="Shares">2633</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact002213"
      unitRef="Shares">3642501</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact002215"
      unitRef="Shares">3642501</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact002217"
      unitRef="Shares">391373</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact002219"
      unitRef="Shares">391373</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_custom_SLGInnovationMember"
      decimals="INF"
      id="Fact002221"
      unitRef="Shares">3642501</us-gaap:SharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SLGInnovationMember"
      decimals="INF"
      id="Fact002223"
      unitRef="Shares">33609</us-gaap:CommonStockSharesIssued>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2025-01-012025-12-31" id="Fact002225">&lt;p id="xdx_893_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zlnP6RJvAXQ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B5_zav9Zu71IhP6" style="display: none"&gt;SCHEDULE OF WARRANTS ACTIVITY&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="13" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Table 17.1: Details of Warrants&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Number of Warrants&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average Exercise Price&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average Life (years)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%"&gt;Outstanding warrants, December 31, 2024&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z5koWpXKxzdk" style="width: 14%; text-align: right" title="Number of Warrants, outstanding, beginning balance"&gt;315,028&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zANxz2XwRlS6" style="width: 14%; text-align: right" title="Weighted Average Exercise Price, beginning balance"&gt;20.64&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zgSc51nfH70b" style="width: 14%; text-align: right" title="Weighted Average Life (years), outstanding"&gt;3.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdrVIXQoK6th" style="text-align: right" title="Number of Warrants, granted"&gt;869,992&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zgK3DoCypH99" style="text-align: right" title="Weighted Average Exercise Price, granted"&gt;164.96&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms_dtY_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zS2lbpIrazQj" style="text-align: right" title="Weighted Average Life (years), granted"&gt;4.7&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Replacement of old warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NumberOfWarrantsReplacementOfOldWarrants_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zmx8YvOu9nSh" style="text-align: right" title="Number of Warrants, replacement of old warrants"&gt;(315,028&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageReplacementDateFairValue_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zBXNl9udLpsl" style="text-align: right" title="Weighted Average Exercise Price, replacement of old warrants"&gt;20.64&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsReplacementWeightedAverageRemainingContractualTerms_dtY_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zbJbga5B6MD" style="text-align: right" title="Weighted Average Life (years), replacement of old warrants"&gt;2.9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;Exercised&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zUzTzaAWd5X2" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, exercised"&gt;(234,831&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQPVrBM9yDok" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, exercised"&gt;14.27&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms_dtY_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zYa0Zn9oaDDf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Life (years), exercised"&gt;4.3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Outstanding warrants, March 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zOL5SSfzw9zj" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, outstanding, beginning balance"&gt;635,161&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zbuWKnZHLht3" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, beginning balance"&gt;220.67&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zWl7cTaUk2b3" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Life (years), outstanding"&gt;4.7&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Issued - Prefunded (equity line)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NumberOfWarrantsPrefundedEquityLine_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zzxZsjCsBH3h" style="text-align: right" title="Number of Warrants, prefunded (equity line)"&gt;150,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedPrefundedWarrantInPeriodWeightedAverageGrantDateFairValue_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z2ydQ2vjNMv2" style="text-align: right" title="Weighted Average Exercise Price, issued - prefunded (equity line)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2259"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedPrefundedWarrantWeightedAverageRemainingContractualTerms_dtY_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zc6rC0TnmJm4" style="text-align: right" title="Weighted Average Life (years), issued - prefunded (equity line)"&gt;1.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Exercised - Prefunded (equity line)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--NumberOfWarrantsExercisedPrefundedEquityLine_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zl89sD5eAj56" style="text-align: right" title="Number of Warrants, exercised - prefunded (equity line)"&gt;(83,333&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantInPeriodWeightedAverageGrantDateFairValue_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zyLuN4OlJUI7" style="text-align: right" title="Weighted Average Exercise Price, exercised - prefunded (equity line)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2265"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantWeightedAverageRemainingContractualTerms_dtY_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zFzzYECkWiY6" style="text-align: right" title="Weighted Average Life (years), exercised - prefunded (equity line)"&gt;1.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zjGQlDNjl9B9" style="text-align: right" title="Number of Warrants, exercised"&gt;(23,633&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zSW0wYOpIjM6" style="text-align: right" title="Weighted Average Exercise Price, exercised"&gt;15.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms_dtY_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpEOCmIoPkR1" style="text-align: right" title="Weighted Average Life (years), exercised"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Outstanding warrants, June 30, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zDi2VSWE0lub" style="text-align: right" title="Number of Warrants, outstanding, beginning balance"&gt;678,195&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zJtKLhcevsPa" style="text-align: right" title="Weighted Average Exercise Price, beginning balance"&gt;206.15&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztWAPt6V8wJb" style="text-align: right" title="Weighted Average Life (years), outstanding"&gt;4.8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt; text-align: left"&gt;Exercised - Prefunded (equity line)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NumberOfWarrantsExercisedPrefundedEquityLine_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z9BvOj2JikBf" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, exercised - prefunded (equity line)"&gt;(66,667&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantInPeriodWeightedAverageGrantDateFairValue_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zeMgbypFFdE5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, exercised - prefunded (equity line)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2283"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantWeightedAverageRemainingContractualTerms_dtY_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZRt4wPn8zGj" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Life (years), exercised - prefunded (equity line)"&gt;1.0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Outstanding warrants, September 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zXKzlQ10hms5" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, outstanding, beginning balance"&gt;611,528&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4p8IgQEMWn5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, beginning balance"&gt;228.62&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMb3B8fquovd" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Life (years), outstanding"&gt;4.8&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Issued - Prefunded (Armistice-Prefunded)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--NumberOfWarrantsIssuedPrefunded_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zj8dukPoEu8b" style="text-align: right" title="Number of Warrants, prefunded (equity line)"&gt;1,670,720&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--WeightedAverageExercisePriceIssuedPrefunded_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zoq3xlowRpv4" style="text-align: right" title="Weighted Average Exercise Price, issued - prefunded (Armistice-Prefunded)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2295"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageLifeYearsIssuedPrefunded_dtY_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZPqslvgomEk" style="text-align: right" title="Weighted Average Life (years), exercised - prefunded (Armistice-Prefunded)"&gt;1.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt; text-align: left"&gt;Issued (Armistice)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NumberOfWarrantsIssued_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4dcV4AyHh98" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, issued (Armistice)"&gt;3,341,439&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedWarrantInPeriodWeightedAverageGrantDateFairValue_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zcJ7nHHWAjA8" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, issued"&gt;3.62&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--WeightedAverageLifeYearsIssued_dtY_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z8nfRsIqCtVh" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Life (years), issued (Armistice)"&gt;5.0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding warrants, December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdgCGOqGQJoe" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Warrants, outstanding, ending balance"&gt;5,623,687&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z50DvSGYPq9l" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, ending balance"&gt;27.01&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zKrxFJa5CGKf" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Life (years), issued (Armistice)"&gt;5.0&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Exercisable warrants, December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber_iE_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNWAMlrUclti" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Warrants, exercisable"&gt;5,623,687&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iE_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zvQnGdv7qtUh" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, exercisable"&gt;27.01&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerms_dtY_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zyjibkTbnm14" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Life (years), exercisable"&gt;5.0&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2024-12-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002227"
      unitRef="Shares">315028</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2024-12-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002229"
      unitRef="USDPShares">20.64</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="From2024-01-012024-12-31_us-gaap_WarrantMember"
      id="Fact002231">P3Y</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2025-01-012025-03-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002233"
      unitRef="Shares">869992</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2025-01-012025-03-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002235"
      unitRef="USDPShares">164.96</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms
      contextRef="From2025-01-012025-03-31_us-gaap_WarrantMember"
      id="Fact002237">P4Y8M12D</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms>
    <CYCU:NumberOfWarrantsReplacementOfOldWarrants
      contextRef="From2025-01-012025-03-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002239"
      unitRef="Shares">-315028</CYCU:NumberOfWarrantsReplacementOfOldWarrants>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageReplacementDateFairValue
      contextRef="From2025-01-012025-03-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002241"
      unitRef="USDPShares">20.64</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageReplacementDateFairValue>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsReplacementWeightedAverageRemainingContractualTerms
      contextRef="From2025-01-012025-03-31_us-gaap_WarrantMember"
      id="Fact002243">P2Y10M24D</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsReplacementWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="From2025-01-012025-03-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002245"
      unitRef="Shares">-234831</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2025-01-012025-03-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002247"
      unitRef="USDPShares">14.27</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageGrantDateFairValue>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms
      contextRef="From2025-01-012025-03-31_us-gaap_WarrantMember"
      id="Fact002249">P4Y3M18D</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2025-03-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002251"
      unitRef="Shares">635161</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2025-03-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002253"
      unitRef="USDPShares">220.67</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="From2025-01-012025-03-31_us-gaap_WarrantMember"
      id="Fact002255">P4Y8M12D</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <CYCU:NumberOfWarrantsPrefundedEquityLine
      contextRef="From2025-04-012025-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002257"
      unitRef="Shares">150000</CYCU:NumberOfWarrantsPrefundedEquityLine>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedPrefundedWarrantWeightedAverageRemainingContractualTerms
      contextRef="From2025-04-012025-06-30_us-gaap_WarrantMember"
      id="Fact002261">P1Y</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedPrefundedWarrantWeightedAverageRemainingContractualTerms>
    <CYCU:NumberOfWarrantsExercisedPrefundedEquityLine
      contextRef="From2025-04-012025-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002263"
      unitRef="Shares">-83333</CYCU:NumberOfWarrantsExercisedPrefundedEquityLine>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantWeightedAverageRemainingContractualTerms
      contextRef="From2025-04-012025-06-30_us-gaap_WarrantMember"
      id="Fact002267">P1Y</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="From2025-04-012025-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002269"
      unitRef="Shares">-23633</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2025-04-012025-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002271"
      unitRef="USDPShares">15.00</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageGrantDateFairValue>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms
      contextRef="From2025-04-012025-06-30_us-gaap_WarrantMember"
      id="Fact002273">P5Y</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2025-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002275"
      unitRef="Shares">678195</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2025-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002277"
      unitRef="USDPShares">206.15</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="From2025-04-012025-06-30_us-gaap_WarrantMember"
      id="Fact002279">P4Y9M18D</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <CYCU:NumberOfWarrantsExercisedPrefundedEquityLine
      contextRef="From2025-07-012025-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002281"
      unitRef="Shares">-66667</CYCU:NumberOfWarrantsExercisedPrefundedEquityLine>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantWeightedAverageRemainingContractualTerms
      contextRef="From2025-07-012025-09-30_us-gaap_WarrantMember"
      id="Fact002285">P1Y</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2025-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002287"
      unitRef="Shares">611528</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2025-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002289"
      unitRef="USDPShares">228.62</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="From2025-07-012025-09-30_us-gaap_WarrantMember"
      id="Fact002291">P4Y9M18D</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <CYCU:NumberOfWarrantsIssuedPrefunded
      contextRef="From2025-10-012025-12-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002293"
      unitRef="Shares">1670720</CYCU:NumberOfWarrantsIssuedPrefunded>
    <CYCU:WeightedAverageLifeYearsIssuedPrefunded
      contextRef="From2025-10-012025-12-31_us-gaap_WarrantMember"
      id="Fact002297">P1Y</CYCU:WeightedAverageLifeYearsIssuedPrefunded>
    <CYCU:NumberOfWarrantsIssued
      contextRef="From2025-10-012025-12-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002299"
      unitRef="Shares">3341439</CYCU:NumberOfWarrantsIssued>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedWarrantInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2025-10-012025-12-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002301"
      unitRef="USDPShares">3.62</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedWarrantInPeriodWeightedAverageGrantDateFairValue>
    <CYCU:WeightedAverageLifeYearsIssued
      contextRef="From2025-10-012025-12-31_us-gaap_WarrantMember"
      id="Fact002303">P5Y</CYCU:WeightedAverageLifeYearsIssued>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2025-12-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002305"
      unitRef="Shares">5623687</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2025-12-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002307"
      unitRef="USDPShares">27.01</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="From2025-10-012025-12-31_us-gaap_WarrantMember"
      id="Fact002309">P5Y</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber
      contextRef="AsOf2025-12-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002311"
      unitRef="Shares">5623687</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2025-12-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002313"
      unitRef="USDPShares">27.01</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerms
      contextRef="From2025-10-012025-12-31_us-gaap_WarrantMember"
      id="Fact002315">P5Y</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-12-31_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact002317"
      unitRef="Shares">383333</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-12-31_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact002319"
      unitRef="Shares">383333</us-gaap:ClassOfWarrantOrRightOutstanding>
    <CYCU:ClassOfWarrantOrRightExercisablePeriodThresholdTradingDays
      contextRef="AsOf2025-12-31_custom_PublicWarrantsMember_srt_MinimumMember"
      id="Fact002321">P30D</CYCU:ClassOfWarrantOrRightExercisablePeriodThresholdTradingDays>
    <CYCU:ClassOfWarrantOrRightExercisablePeriodThresholdTradingDays
      contextRef="AsOf2025-12-31_custom_PublicWarrantsMember_srt_MaximumMember"
      id="Fact002323">P12M</CYCU:ClassOfWarrantOrRightExercisablePeriodThresholdTradingDays>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2025-12-31_custom_PublicWarrantsMember"
      id="Fact002325">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <CYCU:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights
      contextRef="AsOf2025-12-31_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact002327"
      unitRef="USDPShares">0.30</CYCU:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights>
    <CYCU:ClassOfWarrantOrRightRedemptionOfWarrantOrRightMinimumThresholdWrittenNoticePeriod
      contextRef="From2025-01-012025-12-31_custom_PublicWarrantsMember"
      id="Fact002329">P30D</CYCU:ClassOfWarrantOrRightRedemptionOfWarrantOrRightMinimumThresholdWrittenNoticePeriod>
    <CYCU:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="AsOf2025-12-31_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact002331"
      unitRef="USDPShares">18.00</CYCU:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <CYCU:ClassOfWarrantOrRightExercisablePeriodThresholdTradingDays
      contextRef="AsOf2025-12-31_custom_PublicWarrantsMember"
      id="Fact002333">P20D</CYCU:ClassOfWarrantOrRightExercisablePeriodThresholdTradingDays>
    <CYCU:ClassOfWarrantOrRightRedemptionOfWarrantOrRightThresholdConsecutiveTradingDays
      contextRef="From2025-01-012025-12-31_custom_PublicWarrantsMember"
      id="Fact002335">P30D</CYCU:ClassOfWarrantOrRightRedemptionOfWarrantOrRightThresholdConsecutiveTradingDays>
    <CYCU:ClassOfWarrantOrRightFairValueMeasurementMeasurementPeriod
      contextRef="From2025-01-012025-12-31_custom_PublicWarrantsMember"
      id="Fact002337">P10D</CYCU:ClassOfWarrantOrRightFairValueMeasurementMeasurementPeriod>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-112022-01-11_custom_PipeSubscriptionAgreementMember"
      decimals="0"
      id="Fact002339"
      unitRef="USD">3760000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-01-112022-01-11_custom_PipeSubscriptionAgreementMember"
      decimals="INF"
      id="Fact002341"
      unitRef="Shares">12533</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-01-11_custom_PipeWarrantsMember"
      decimals="INF"
      id="Fact002343"
      unitRef="Shares">12533</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="AsOf2022-01-11_custom_PipeWarrantsMember"
      decimals="INF"
      id="Fact002345"
      unitRef="Shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-01-11_custom_PipeWarrantsMember"
      decimals="INF"
      id="Fact002347"
      unitRef="USDPShares">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <CYCU:WarrantsAndRightsExerciseStartDelayPeriod
      contextRef="AsOf2022-01-11_custom_PipeWarrantsMember"
      id="Fact002349">P30D</CYCU:WarrantsAndRightsExerciseStartDelayPeriod>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2022-01-11_custom_PipeWarrantsMember"
      id="Fact002351">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-12-31_custom_PipeWarrantsMember"
      decimals="INF"
      id="Fact002353"
      unitRef="Shares">12533</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-12-31_custom_PipeWarrantsMember"
      decimals="INF"
      id="Fact002355"
      unitRef="Shares">12533</us-gaap:ClassOfWarrantOrRightOutstanding>
    <CYCU:CommonStockRedemptionRightsUponDelayInBusinessCombinationClosingPercentage
      contextRef="AsOf2022-01-11_custom_PipeWarrantsMember"
      decimals="INF"
      id="Fact002357"
      unitRef="Pure">1</CYCU:CommonStockRedemptionRightsUponDelayInBusinessCombinationClosingPercentage>
    <CYCU:CommonStockRedemptionRightsBusinessCombinationClosingPeriod
      contextRef="From2022-01-112022-01-11_custom_PipeWarrantsMember_srt_MinimumMember"
      id="Fact002359">P12M</CYCU:CommonStockRedemptionRightsBusinessCombinationClosingPeriod>
    <CYCU:CommonStockRedemptionRightsBusinessCombinationClosingPeriod
      contextRef="From2022-01-112022-01-11_custom_PipeWarrantsMember_srt_MaximumMember"
      id="Fact002361">P18M</CYCU:CommonStockRedemptionRightsBusinessCombinationClosingPeriod>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2017-11-17_custom_SeriesAWarrantsMember"
      decimals="INF"
      id="Fact002363"
      unitRef="Shares">44445</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2017-11-17_custom_SeriesAWarrantsMember"
      decimals="INF"
      id="Fact002365"
      unitRef="USDPShares">13.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-03-31_custom_SeriesAWarrantsMember"
      decimals="INF"
      id="Fact002367"
      unitRef="Shares">22696</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-03-31_custom_SeriesAWarrantsMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002369"
      unitRef="Shares">44445</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-03-31_custom_SeriesAWarrantsMember"
      decimals="INF"
      id="Fact002371"
      unitRef="USDPShares">9.59121</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2023-08-01_custom_SeriesBWarrantsMember"
      decimals="INF"
      id="Fact002373"
      unitRef="Shares">133333</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-08-01_custom_SeriesBWarrantsMember"
      decimals="INF"
      id="Fact002375"
      unitRef="USDPShares">15.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-04-12_custom_SeriesBWarrantsMember"
      decimals="INF"
      id="Fact002377"
      unitRef="Shares">66667</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-04-12_custom_SeriesBWarrantsMember"
      decimals="INF"
      id="Fact002379"
      unitRef="USDPShares">15.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-12-31_custom_SeriesBWarrantsMember"
      decimals="INF"
      id="Fact002381"
      unitRef="Shares">200000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-12-31_custom_SeriesBWarrantsMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002383"
      unitRef="Shares">200000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-12-31_custom_SeriesBWarrantsMember"
      decimals="INF"
      id="Fact002385"
      unitRef="USDPShares">15.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-03-22_custom_SeriesDWarrantsMember_custom_SubordinatedConvertiblePromissoryNoteMember"
      decimals="INF"
      id="Fact002387"
      unitRef="Shares">6564</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-03-22_custom_SeriesDWarrantsMember_custom_SubordinatedConvertiblePromissoryNoteMember"
      decimals="INF"
      id="Fact002389"
      unitRef="USDPShares">42.30</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-11-22_custom_SeriesDWarrantsMember_custom_SubordinatedConvertiblePromissoryNoteOneMember"
      decimals="INF"
      id="Fact002391"
      unitRef="Shares">32819</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-11-22_custom_SeriesDWarrantsMember_custom_SubordinatedConvertiblePromissoryNoteOneMember"
      decimals="INF"
      id="Fact002393"
      unitRef="USDPShares">42.30</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-12-31_custom_SeriesDWarrantsMember"
      decimals="INF"
      id="Fact002395"
      unitRef="Shares">242424</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-12-31_custom_SeriesDWarrantsMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002397"
      unitRef="Shares">39382</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-03-31_custom_SeriesDWarrantsMember"
      decimals="INF"
      id="Fact002399"
      unitRef="USDPShares">15.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-04-12_custom_PreFundedWarrantSharesMember"
      decimals="INF"
      id="Fact002401"
      unitRef="Shares">1657460</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-04-12_custom_WarrantSharesMember"
      decimals="INF"
      id="Fact002403"
      unitRef="Shares">3314920</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <CYCU:ClassOfWarrantOrRightOfferingPrice
      contextRef="AsOf2025-12-05_custom_PreFundedWarrantSharesMember"
      decimals="INF"
      id="Fact002405"
      unitRef="USDPShares">3.62</CYCU:ClassOfWarrantOrRightOfferingPrice>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-12-05_custom_WarrantSharesMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="INF"
      id="Fact002407"
      unitRef="USDPShares">3.62</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-12-05_custom_PreFundedWarrantSharesMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="INF"
      id="Fact002409"
      unitRef="Shares">1657460</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-12-05_custom_PreFundedWarrantSharesMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="INF"
      id="Fact002411"
      unitRef="USDPShares">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-12-05_custom_WarrantSharesMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="INF"
      id="Fact002413"
      unitRef="USDPShares">3.62</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-12-05_custom_WarrantSharesMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="INF"
      id="Fact002415"
      unitRef="USDPShares">3.62</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2025-12-05_custom_WarrantSharesMember_custom_ArmisticeCapitalMasterFundLtdMember"
      id="Fact002417">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <CYCU:CommonStockOwnershipChangeInControlThresholdPercentage
      contextRef="AsOf2025-12-05_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="INF"
      id="Fact002419"
      unitRef="Pure">0.50</CYCU:CommonStockOwnershipChangeInControlThresholdPercentage>
    <CYCU:VotingPowerChangeInControlThresholdPercentage
      contextRef="AsOf2025-12-05_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="INF"
      id="Fact002421"
      unitRef="Pure">0.50</CYCU:VotingPowerChangeInControlThresholdPercentage>
    <CYCU:ClassOfWarrantOrRightIssuanceRestrictionPeriod
      contextRef="AsOf2025-12-04_custom_ArmisticeCapitalMasterFundLtdMember"
      id="Fact002423">P90D</CYCU:ClassOfWarrantOrRightIssuanceRestrictionPeriod>
    <CYCU:ClassOfWarrantOrRightIssuanceRestrictionPeriod
      contextRef="AsOf2025-12-04_custom_ArmisticeCapitalMasterFundLtdMember"
      id="Fact002425">P90D</CYCU:ClassOfWarrantOrRightIssuanceRestrictionPeriod>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-04-07_custom_YieldPointNYLLCMember_custom_PreFundedWarrantMember"
      decimals="INF"
      id="Fact002427"
      unitRef="Shares">4500000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-04-07_custom_PreFundedWarrantMember_custom_YieldPointNYLLCMember"
      decimals="INF"
      id="Fact002429"
      unitRef="USDPShares">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2025-02-14_custom_SewardAndKisselLLPMember_custom_PreFundedWarrantMember"
      decimals="-5"
      id="Fact002431"
      unitRef="USD">1300000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-02-14_custom_SewardAndKisselLLPMember_custom_PreFundedWarrantMember"
      decimals="INF"
      id="Fact002433"
      unitRef="Shares">83333</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:LegalFees
      contextRef="From2025-02-142025-02-14_custom_SewardAndKisselLLPMember_custom_PreFundedWarrantMember"
      decimals="-5"
      id="Fact002435"
      unitRef="USD">1300000</us-gaap:LegalFees>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-02-14_custom_PreFundedWarrantMember_custom_SewardAndKisselLLPMember"
      decimals="INF"
      id="Fact002437"
      unitRef="USDPShares">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-03-08_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002439"
      unitRef="Shares">17636</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-03-082022-03-08_us-gaap_WarrantMember"
      decimals="0"
      id="Fact002441"
      unitRef="USD">700000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-03-08_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002443"
      unitRef="USDPShares">0.92</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-12-31_custom_WarrantsMember"
      decimals="INF"
      id="Fact002445"
      unitRef="Shares">9006</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-12-31_custom_WarrantsMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002447"
      unitRef="Shares">17636</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-12-31_custom_WarrantsMember"
      decimals="INF"
      id="Fact002449"
      unitRef="USDPShares">9.59121</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:TemporaryEquityTableTextBlock contextRef="From2025-01-012025-12-31" id="Fact002451">&lt;p id="xdx_891_eus-gaap--TemporaryEquityTableTextBlock_z9JjxzJjbAyd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B3_zWVCS6SwF8nb" style="display: none"&gt;SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Table 17.2: Details of Common Stock Subject to Possible Redemption&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Number of Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Common Stock subject to possible redemption as of December 31, 2024&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--TemporaryEquitySharesIssued_iS_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zQN3tTchE7Kb" style="width: 16%; text-align: right" title="Common stock subject to possible redemption shares, beginning balance"&gt;5,796&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zh6p9elsrzch" style="width: 16%; text-align: right" title="Common stock subject to possible redemption, beginning balance"&gt;1,917,309&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt"&gt;Redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--TemporaryEquityRedemptionShares_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zBNWaqHy2HBc" style="text-align: right" title="Redemption, shares"&gt;(3,163&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--TemporaryEquityRedemption_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zzvV6KwNGJY7" style="text-align: right" title="Redemption"&gt;(1,001,216&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Release of Common Stock subject to redemption&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--TemporaryEquityReleaseOfCommonStockSubjectToRedemptionShares_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_z9RCeH05Aodb" style="border-bottom: Black 1pt solid; text-align: right" title="Release of common stock subject to redemption, shares"&gt;(2,633&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--TemporaryEquityReleaseOfCommonStockSubjectToRedemption_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zECjVvoEoD41" style="border-bottom: Black 1pt solid; text-align: right" title="Release of common stock subject to redemption"&gt;(916,093&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Common Stock subject to possible redemption as of December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--TemporaryEquitySharesIssued_iE_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_z1bsxofHtg39" style="border-bottom: Black 2.5pt double; text-align: right" title="Common stock subject to possible redemption shares, ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2465"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zYVmk7phKSfh" style="border-bottom: Black 2.5pt double; text-align: right" title="Common stock subject to possible redemption, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2467"&gt;-&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2024-12-31_custom_CommonClassSubjectToRedemptionMember"
      decimals="INF"
      id="Fact002453"
      unitRef="Shares">5796</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2024-12-31_custom_CommonClassSubjectToRedemptionMember"
      decimals="0"
      id="Fact002455"
      unitRef="USD">1917309</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <CYCU:TemporaryEquityRedemptionShares
      contextRef="From2025-01-012025-12-31_custom_CommonClassSubjectToRedemptionMember"
      decimals="INF"
      id="Fact002457"
      unitRef="Shares">-3163</CYCU:TemporaryEquityRedemptionShares>
    <CYCU:TemporaryEquityRedemption
      contextRef="From2025-01-012025-12-31_custom_CommonClassSubjectToRedemptionMember"
      decimals="0"
      id="Fact002459"
      unitRef="USD">-1001216</CYCU:TemporaryEquityRedemption>
    <CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemptionShares
      contextRef="From2025-01-012025-12-31_custom_CommonClassSubjectToRedemptionMember"
      decimals="INF"
      id="Fact002461"
      unitRef="Shares">-2633</CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemptionShares>
    <CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemption
      contextRef="From2025-01-012025-12-31_custom_CommonClassSubjectToRedemptionMember"
      decimals="0"
      id="Fact002463"
      unitRef="USD">-916093</CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemption>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2025-01-012025-12-31" id="Fact002469">&lt;p id="xdx_809_eus-gaap--ConcentrationRiskDisclosureTextBlock_zjzM27quxKh4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_827_zCGJPj3ssgG5"&gt;CONCENTRATIONS,
                                            RISKS AND UNCERTAINTIES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Credit
risk&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s primary bank deposits are located in the United States. Those deposits are provided protection under FDIC insurance up
to maximum of $&lt;span id="xdx_90E_eus-gaap--CashFDICInsuredAmount_iI_c20251231__srt--RangeAxis__srt--MaximumMember_zqDkgNjnn5hd" title="FDIC amount"&gt;250,000&lt;/span&gt;. Any deposits in excess of the aforementioned maximum are at risk of loss if those banks become insolvent. The
Company is subject to risk borne from credit extended to customers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Interest
risk&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is subject to interest rate risk when its loans become due and require refinancing or if the prime rate adjusts, as the Company&#x2019;s
loans are based on adjustable interest rates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Inflation
risk&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
monitors changes in prices levels. Historically, inflation has not materially impacted the Company&#x2019;s financial statements; however,
significant increases in the cost of labor that cannot be passed on to the Company&#x2019;s customers could adversely impact the Company&#x2019;s
results of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Concentration
risks&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zynUCoTwkMab" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B9_zqX5H5TeQhu9" style="display: none"&gt;SCHEDULE OF CONCENTRATION RISKS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Table 18.1: Revenue Concentration by Customer - Based on % of Revenue&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Customer&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: center"&gt;A&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20250101__20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerAMember_zLaiavQvEZR4" style="width: 11%; text-align: right" title="Revenue"&gt;4,576,315&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerAMember_z1Wk06V9t1ig" title="Revenue, percentage"&gt;30.2&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_c20240101__20241231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerAMember_zHZ7XdSnHG2d" style="width: 11%; text-align: right" title="Revenue"&gt;3,584,564&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240101__20241231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerAMember_z88JkJdt53q3" title="Revenue, percentage"&gt;20.2&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;B&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20250101__20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerBMember_zNNXTSbJhws7" style="text-align: right" title="Revenue"&gt;2,504,836&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerBMember_zMmPLlIYs3o8" title="Revenue, percentage"&gt;16.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20240101__20241231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerBMember_z8a38qMN4rr6" style="text-align: right" title="Revenue"&gt;2,167,024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240101__20241231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerBMember_z8VM9s0Si1pk" title="Revenue, percentage"&gt;12.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;C&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20250101__20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerCMember_zGt0QYjjaYR4" style="text-align: right" title="Revenue"&gt;1,300,680&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerCMember_zc7cv31cavX" title="Revenue, percentage"&gt;8.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20240101__20241231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerCMember_z1IK1uoVA6n6" style="text-align: right" title="Revenue"&gt;2,652,925&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240101__20241231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerCMember_zQFICY4ArXUl" title="Revenue, percentage"&gt;14.9&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;D&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20250101__20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerDMember_zSmWPJMW4Vg5" style="text-align: right" title="Revenue"&gt;1,378,738&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerDMember_zTRbDgzV2xKj" title="Revenue, percentage"&gt;9.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20240101__20241231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerDMember_zgzttgi0Fx72" style="text-align: right" title="Revenue"&gt;2,934,031&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240101__20241231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerDMember_zYLcdQdKlEp8" title="Revenue, percentage"&gt;16.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Table 18.2: Accounts Receivable Concentration by Customer - Based on % of Accounts Receivable, Net&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Customer&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: center"&gt;1&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccountsReceivableNet_iI_c20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zKFvEN6CeH1g" style="width: 16%; text-align: right" title="Accounts receivable"&gt;768,954&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zUU4UMZXTUR8" title="Accounts receivable, percentage"&gt;29&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AccountsReceivableNet_iI_c20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zpSJF2syUBf7" style="text-align: right" title="Accounts receivable"&gt;479,151&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zSPHkIpM6tDk" title="Accounts receivable, percentage"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;3&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AccountsReceivableNet_iI_c20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zrmy3V4ygeR7" style="text-align: right" title="Accounts receivable"&gt;373,236&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zEqWZHpmo8y9" title="Concentration risk, percentage"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zBqLUGlgIcf6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prior
to the Management Services Agreement and a Release agreement with Ed Burns of SLG on March 31, 2025, the Company had combined all SLG
customers as one customer for purposes of customer concentration disclosures due to the nature of the relationship. Once the acquisition
was complete, the Company has re-evaluated this disclosure to break out all SLG customers individually, therefore the amounts reported
above are not comparable to the first quarter of 2025 amounts previously reported. As of December 31, 2024, no individual customer accounts
receivable balances were 10% or greater than the total accounts receivable balance.&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:CashFDICInsuredAmount
      contextRef="AsOf2025-12-31_srt_MaximumMember"
      decimals="0"
      id="Fact002471"
      unitRef="USD">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock contextRef="From2025-01-012025-12-31" id="Fact002473">&lt;p id="xdx_89D_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zynUCoTwkMab" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B9_zqX5H5TeQhu9" style="display: none"&gt;SCHEDULE OF CONCENTRATION RISKS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Table 18.1: Revenue Concentration by Customer - Based on % of Revenue&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Customer&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: center"&gt;A&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20250101__20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerAMember_zLaiavQvEZR4" style="width: 11%; text-align: right" title="Revenue"&gt;4,576,315&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerAMember_z1Wk06V9t1ig" title="Revenue, percentage"&gt;30.2&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_c20240101__20241231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerAMember_zHZ7XdSnHG2d" style="width: 11%; text-align: right" title="Revenue"&gt;3,584,564&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240101__20241231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerAMember_z88JkJdt53q3" title="Revenue, percentage"&gt;20.2&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;B&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20250101__20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerBMember_zNNXTSbJhws7" style="text-align: right" title="Revenue"&gt;2,504,836&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerBMember_zMmPLlIYs3o8" title="Revenue, percentage"&gt;16.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20240101__20241231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerBMember_z8a38qMN4rr6" style="text-align: right" title="Revenue"&gt;2,167,024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240101__20241231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerBMember_z8VM9s0Si1pk" title="Revenue, percentage"&gt;12.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;C&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20250101__20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerCMember_zGt0QYjjaYR4" style="text-align: right" title="Revenue"&gt;1,300,680&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerCMember_zc7cv31cavX" title="Revenue, percentage"&gt;8.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20240101__20241231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerCMember_z1IK1uoVA6n6" style="text-align: right" title="Revenue"&gt;2,652,925&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240101__20241231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerCMember_zQFICY4ArXUl" title="Revenue, percentage"&gt;14.9&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;D&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20250101__20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerDMember_zSmWPJMW4Vg5" style="text-align: right" title="Revenue"&gt;1,378,738&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerDMember_zTRbDgzV2xKj" title="Revenue, percentage"&gt;9.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20240101__20241231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerDMember_zgzttgi0Fx72" style="text-align: right" title="Revenue"&gt;2,934,031&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240101__20241231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerDMember_zYLcdQdKlEp8" title="Revenue, percentage"&gt;16.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Table 18.2: Accounts Receivable Concentration by Customer - Based on % of Accounts Receivable, Net&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Customer&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: center"&gt;1&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccountsReceivableNet_iI_c20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zKFvEN6CeH1g" style="width: 16%; text-align: right" title="Accounts receivable"&gt;768,954&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zUU4UMZXTUR8" title="Accounts receivable, percentage"&gt;29&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AccountsReceivableNet_iI_c20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zpSJF2syUBf7" style="text-align: right" title="Accounts receivable"&gt;479,151&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zSPHkIpM6tDk" title="Accounts receivable, percentage"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;3&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AccountsReceivableNet_iI_c20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zrmy3V4ygeR7" style="text-align: right" title="Accounts receivable"&gt;373,236&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20251231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zEqWZHpmo8y9" title="Concentration risk, percentage"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:Revenues
      contextRef="From2025-01-012025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerAMember"
      decimals="0"
      id="Fact002475"
      unitRef="USD">4576315</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-01-012025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerAMember"
      decimals="INF"
      id="Fact002477"
      unitRef="Pure">0.302</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="From2024-01-012024-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerAMember"
      decimals="0"
      id="Fact002479"
      unitRef="USD">3584564</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-01-012024-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerAMember"
      decimals="INF"
      id="Fact002481"
      unitRef="Pure">0.202</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="From2025-01-012025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerBMember"
      decimals="0"
      id="Fact002483"
      unitRef="USD">2504836</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-01-012025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerBMember"
      decimals="INF"
      id="Fact002485"
      unitRef="Pure">0.166</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="From2024-01-012024-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerBMember"
      decimals="0"
      id="Fact002487"
      unitRef="USD">2167024</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-01-012024-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerBMember"
      decimals="INF"
      id="Fact002489"
      unitRef="Pure">0.122</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="From2025-01-012025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerCMember"
      decimals="0"
      id="Fact002491"
      unitRef="USD">1300680</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-01-012025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerCMember"
      decimals="INF"
      id="Fact002493"
      unitRef="Pure">0.086</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="From2024-01-012024-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerCMember"
      decimals="0"
      id="Fact002495"
      unitRef="USD">2652925</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-01-012024-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerCMember"
      decimals="INF"
      id="Fact002497"
      unitRef="Pure">0.149</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="From2025-01-012025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerDMember"
      decimals="0"
      id="Fact002499"
      unitRef="USD">1378738</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-01-012025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerDMember"
      decimals="INF"
      id="Fact002501"
      unitRef="Pure">0.091</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="From2024-01-012024-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerDMember"
      decimals="0"
      id="Fact002503"
      unitRef="USD">2934031</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-01-012024-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerDMember"
      decimals="INF"
      id="Fact002505"
      unitRef="Pure">0.165</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember"
      decimals="0"
      id="Fact002507"
      unitRef="USD">768954</us-gaap:AccountsReceivableNet>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-01-012025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember"
      decimals="INF"
      id="Fact002509"
      unitRef="Pure">0.29</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember"
      decimals="0"
      id="Fact002511"
      unitRef="USD">479151</us-gaap:AccountsReceivableNet>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-01-012025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember"
      decimals="INF"
      id="Fact002513"
      unitRef="Pure">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember"
      decimals="0"
      id="Fact002515"
      unitRef="USD">373236</us-gaap:AccountsReceivableNet>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-01-012025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember"
      decimals="INF"
      id="Fact002517"
      unitRef="Pure">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2025-01-012025-12-31" id="Fact002519">&lt;p id="xdx_809_eus-gaap--FairValueDisclosuresTextBlock_zlKnEeknMdX4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82F_z9EdMfXvHR1f"&gt;FAIR
                                            VALUE DISCLOSURES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company estimates the fair value of its debt by discounting the future cash flows of each instrument using estimated market rates of
debt instruments with similar maturities and credit profiles. These inputs are classified as Level 3 within the fair value hierarchy.
As of December 31, 2025 and 2024, the carrying value reported in the consolidated balance sheet for the Company&#x2019;s notes payable
approximated its fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
were no assets or liabilities recorded at fair value on a recurring basis as of December 31, 2025. As of December 31, 2024, the Company
had recorded liabilities at fair value on a recurring basis for subordinated convertible promissory notes and Series A Convertible Preferred
Stock and equity warrants at fair value on a recurring basis. The subordinated convertible promissory notes carry an interest rate that
is indicative of the Company&#x2019;s overall borrowing cost and the length of time until maturity is not expected to significantly impact
their value. The convertible preferred stock, which is akin to debt, has been discounted to its presented carrying value in accordance
with the debt discounts and redemption premiums recognized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Assets
and liabilities that are measured at fair value on a non-recurring basis include intangible assets and goodwill. These items are recognized
at fair value when they are considered to be impaired.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
were no fair value adjustments for assets and liabilities measured on a non-recurring basis. The Company discloses fair value information
about financial instruments for which it is practicable to estimate that value.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zXXSR4joCKY9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_zkWB0f24OmM7" style="display: none"&gt;SCHEDULE OF FINANCIAL INSTRUMENTS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zsDMt29HTDOe" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z6wywibGQyYe" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zJKYS7jZbxf6" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20241231_zlLXQdPwvU98" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Table 19: Fair Value Hierarchy - 2024&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; text-align: center"&gt;As of December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--LiabilitiesFairValueDisclosureAbstract_iB_z5bNEu4Vp0lj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisSubordinatedDebtObligations_i01I_maLFVDzUKK_zKAJHtj7Hcvh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 40%; text-align: left"&gt;Subordinated convertible promissory notes&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2528"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2529"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;5,490,324&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;5,490,324&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ConvertiblePreferredStockLiabilityFairValueDisclosure_i01I_maLFVDzUKK_zTSTHmTEacNe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Series A Convertible Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2533"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2534"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,294,117&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,294,117&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LiabilitiesFairValueDisclosure_iTI_mtLFVDzUKK_zSUKwjnuLjHc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2538"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2539"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,784,441&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,784,441&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--EquityFairValueDisclosureAbstract_iB_zWuLSRP20Av7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Equity:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--WarrantsAndRightsOutstanding_i01I_maEFVDzOHo_z2QBuvVqr7jl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2548"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2549"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,687,074&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,687,074&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--EquityFairValueDisclosure_iTI_mtEFVDzOHo_z0CROVrxKsai" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"&gt;Total equity&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2553"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2554"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,687,074&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,687,074&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zQk3jHhogDLe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="From2025-01-012025-12-31" id="Fact002521">&lt;p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zXXSR4joCKY9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_zkWB0f24OmM7" style="display: none"&gt;SCHEDULE OF FINANCIAL INSTRUMENTS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zsDMt29HTDOe" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z6wywibGQyYe" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zJKYS7jZbxf6" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20241231_zlLXQdPwvU98" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Table 19: Fair Value Hierarchy - 2024&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; text-align: center"&gt;As of December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--LiabilitiesFairValueDisclosureAbstract_iB_z5bNEu4Vp0lj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisSubordinatedDebtObligations_i01I_maLFVDzUKK_zKAJHtj7Hcvh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 40%; text-align: left"&gt;Subordinated convertible promissory notes&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2528"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2529"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;5,490,324&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;5,490,324&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ConvertiblePreferredStockLiabilityFairValueDisclosure_i01I_maLFVDzUKK_zTSTHmTEacNe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Series A Convertible Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2533"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2534"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,294,117&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,294,117&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LiabilitiesFairValueDisclosure_iTI_mtLFVDzUKK_zSUKwjnuLjHc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2538"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2539"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,784,441&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,784,441&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--EquityFairValueDisclosureAbstract_iB_zWuLSRP20Av7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Equity:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--WarrantsAndRightsOutstanding_i01I_maEFVDzOHo_z2QBuvVqr7jl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2548"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2549"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,687,074&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,687,074&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--EquityFairValueDisclosure_iTI_mtEFVDzOHo_z0CROVrxKsai" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"&gt;Total equity&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2553"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2554"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,687,074&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,687,074&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisSubordinatedDebtObligations
      contextRef="AsOf2024-12-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact002530"
      unitRef="USD">5490324</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisSubordinatedDebtObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisSubordinatedDebtObligations
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact002531"
      unitRef="USD">5490324</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisSubordinatedDebtObligations>
    <CYCU:ConvertiblePreferredStockLiabilityFairValueDisclosure
      contextRef="AsOf2024-12-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact002535"
      unitRef="USD">1294117</CYCU:ConvertiblePreferredStockLiabilityFairValueDisclosure>
    <CYCU:ConvertiblePreferredStockLiabilityFairValueDisclosure
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact002536"
      unitRef="USD">1294117</CYCU:ConvertiblePreferredStockLiabilityFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-12-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact002540"
      unitRef="USD">6784441</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact002541"
      unitRef="USD">6784441</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-12-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact002550"
      unitRef="USD">2687074</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact002551"
      unitRef="USD">2687074</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:EquityFairValueDisclosure
      contextRef="AsOf2024-12-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact002555"
      unitRef="USD">2687074</us-gaap:EquityFairValueDisclosure>
    <us-gaap:EquityFairValueDisclosure
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact002556"
      unitRef="USD">2687074</us-gaap:EquityFairValueDisclosure>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2025-01-012025-12-31" id="Fact002558">&lt;p id="xdx_802_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zsO8pWfLpVL" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_826_z5VWqhtqFita"&gt;RELATED
                                            PARTY TRANSACTIONS&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Promissory
Note &#x2013; Related Party&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 20, 2024, the Company entered into a promissory note with Western Acquisition Ventures Sponsor, LLC (the &#x201c;Sponsor&#x201d;)
for $&lt;span id="xdx_90F_ecustom--MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_c20240920__20240920__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorPromissoryNoteMember_zvUdbUiM3fA7"&gt;230,000&lt;/span&gt;, pursuant to which the Company can borrow up to an aggregate cash amount of $&lt;span id="xdx_90B_ecustom--MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_c20240920__20240920__us-gaap--RelatedPartyTransactionAxis__custom--SponsorPromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z7IDyAH8wnNg" title="Maximum borrowing capacity of related party promissory note"&gt;230,000&lt;/span&gt;. The Promissory Note, with an interest
rate of &lt;span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20240920__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorPromissoryNoteMember_zd3u93SnRj3f" title="Debt interest rate"&gt;10&lt;/span&gt;% per annum is payable upon the sooner of the consummation of the Business Combination with Cycurion. During the year ended
December 31, 2024, the Company borrowed the full $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorPromissoryNoteMember_zckV3f5DXO97" title="Principal amount"&gt;255,556&lt;/span&gt;, with a discount of $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorPromissoryNoteMember_zNTjoTsFQSfc" title="Debt discount"&gt;25,556&lt;/span&gt;, resulting in net proceeds of $&lt;span id="xdx_903_eus-gaap--ProceedsFromNotesPayable_c20240101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorPromissoryNoteMember_zsp2FqqLqqu4" title="Proceeds from notes payable"&gt;230,000&lt;/span&gt;. The Company
amortized the discount of &lt;span id="xdx_90F_eus-gaap--AmortizationOfDebtDiscountPremium_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorPromissoryNoteMember_zmc7O8xMFDgh" title="Debt discount"&gt;25,556&lt;/span&gt; fully in 2025. Additionally, the company has an accrued interest balance of $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorPromissoryNoteMember_zL0SRV47rXgb" title="Accrued interest"&gt;32,867&lt;/span&gt; related to these
notes as of December 31, 2025. These notes are presented with other promissory notes on the balance sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Personal
guarantees were entered by Emmit McHenry, Kurt McHenry, and Alvin McCoy III, as officers and stockholders of the Company in support of
the Main Street Bank Loan and Security Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Axxum
purchased an AT&amp;amp;T contract relationship from Archura, LLC, a company owned by Emmit McHenry and Kurt McHenry at the end of 2018.
The contract relationship includes &lt;span id="xdx_907_ecustom--PurchaseObligationNumberOfPurchaseOrders_iI_dc_uInteger_c20251231_zoaeUd8OiiW5" title="Purchase orders"&gt;five&lt;/span&gt; purchase orders to deliver networking services to AT&amp;amp;T and its clients. The total sales of
these &lt;span id="xdx_90A_ecustom--PurchaseObligationNumberOfPurchaseOrders_iI_dc_uInteger_c20251231_zyjg8HSXTyvb" title="Purchase orders"&gt;five&lt;/span&gt; purchase orders were $&lt;span id="xdx_904_eus-gaap--PurchaseObligation_iI_c20251231_zo9Fjeu1NX0j" title="Purchase obligation"&gt;99,653&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--PurchaseObligation_iI_c20241231_zN0FKwtnkf12" title="Purchase obligation"&gt;119,279&lt;/span&gt; for the years ended December 31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Loans
Payable - Related Parties&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zb70P3gJuzWg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B5_znQDqG9Hxb0g" style="display: none"&gt;SCHEDULE OF RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Table 20: Details of Loans Payable - Related Party&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average Interest Rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Maturity (Calendar Year)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Loans issued to directors in 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DebtInstrumentFaceAmount_iI_c20251231__srt--TitleOfIndividualAxis__custom--TwoDirectorMember_zl23iuefiz7h" style="width: 11%; text-align: right" title="Debt amount face value"&gt;103,400&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DebtInstrumentFaceAmount_iI_c20241231__srt--TitleOfIndividualAxis__custom--TwoDirectorMember_zXjV5S6CpLSb" style="width: 11%; text-align: right" title="Principal amount"&gt;130,900&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20251231__srt--TitleOfIndividualAxis__custom--TwoDirectorMember_zYaznmLyBQe1" style="width: 11%; text-align: right" title="Debt interest rate"&gt;24.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--DebtMaturityYear_pid_c20250101__20251231__srt--TitleOfIndividualAxis__custom--TwoDirectorMember_z5jef8eFTvH7" style="width: 11%; text-align: right" title="Debt maturity year"&gt;2023&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;Loan to a director issued in 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DebtInstrumentFaceAmount_iI_c20251231__srt--TitleOfIndividualAxis__srt--DirectorMember_zrnpyS5Jbvz8" style="border-bottom: Black 1pt solid; text-align: right" title="Debt amount face value"&gt;20,250&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentFaceAmount_iI_c20241231__srt--TitleOfIndividualAxis__srt--DirectorMember_ziTaHuS723M" style="border-bottom: Black 1pt solid; text-align: right" title="Debt amount face value"&gt;20,250&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20251231__srt--TitleOfIndividualAxis__srt--DirectorMember_zuKx3E1sPPu4" style="padding-bottom: 1pt; text-align: right" title="Debt interest rate"&gt;24.0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--DebtMaturityYear_pid_c20250101__20251231__srt--TitleOfIndividualAxis__srt--DirectorMember_zPbX5Zp5XGM2" style="padding-bottom: 1pt; text-align: right" title="Debt maturity year"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 10pt; text-align: left"&gt;Funded loans payable - related party principal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DebtInstrumentFaceAmount_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zGyhR8HYoi16" style="border-bottom: Black 1pt solid; text-align: right" title="Debt amount face value"&gt;123,650&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentFaceAmount_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zeWdkABTFsrc" style="border-bottom: Black 1pt solid; text-align: right" title="Principal amount"&gt;151,150&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;Less: Unamortized debt-issuance costs and discounts&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z16MpzeaThIb" style="border-bottom: Black 1pt solid; text-align: right" title="Debt unamortized discount and issuance costs"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2605"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zbC9FINsD41d" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Unamortized debt-issuance costs and discounts"&gt;(3,062&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 10pt; text-align: left"&gt;Loans payable - related party - current&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LoansPayable_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zekP1As6ZWLh" style="border-bottom: Black 2.5pt double; text-align: right" title="Debt amount net of unamortized discount and issuance costs"&gt;123,650&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LoansPayable_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zYb87jxzJWK8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total loans payable"&gt;148,088&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zwb0DfNHZ9sl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December 31, 2025, the Company recorded amortization of debt discount of $&lt;span id="xdx_90E_eus-gaap--AmortizationOfDebtDiscountPremium_c20250101__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zCWuXpm4Pd0c" title="Amortization of debt discount"&gt;3,062&lt;/span&gt;, compared to &lt;span id="xdx_907_eus-gaap--AmortizationOfDebtDiscountPremium_dc_c20240101__20241231__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_z5PJpK1QzxEh" title="Amortization of debt discount"&gt;zero&lt;/span&gt; U.S. dollars for the
year ended December 31, 2024. It is also noted that the paydown in 2025 resulted in the total loans being only to one director as of
December 31, 2025.&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <CYCU:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote
      contextRef="From2024-09-202024-09-20_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember"
      decimals="0"
      id="Fact002559"
      unitRef="USD">230000</CYCU:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote>
    <CYCU:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote
      contextRef="From2024-09-202024-09-20_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember"
      decimals="0"
      id="Fact002561"
      unitRef="USD">230000</CYCU:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-09-20_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember"
      decimals="INF"
      id="Fact002563"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-12-31_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember"
      decimals="0"
      id="Fact002565"
      unitRef="USD">255556</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2024-12-31_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember"
      decimals="0"
      id="Fact002567"
      unitRef="USD">25556</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2024-01-012024-12-31_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember"
      decimals="0"
      id="Fact002569"
      unitRef="USD">230000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2025-01-012025-12-31_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember"
      decimals="0"
      id="Fact002571"
      unitRef="USD">25556</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2025-01-012025-12-31_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember"
      decimals="0"
      id="Fact002573"
      unitRef="USD">32867</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <CYCU:PurchaseObligationNumberOfPurchaseOrders
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact002575"
      unitRef="Integer">5</CYCU:PurchaseObligationNumberOfPurchaseOrders>
    <CYCU:PurchaseObligationNumberOfPurchaseOrders
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact002577"
      unitRef="Integer">5</CYCU:PurchaseObligationNumberOfPurchaseOrders>
    <us-gaap:PurchaseObligation
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002579"
      unitRef="USD">99653</us-gaap:PurchaseObligation>
    <us-gaap:PurchaseObligation
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact002581"
      unitRef="USD">119279</us-gaap:PurchaseObligation>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="From2025-01-012025-12-31" id="Fact002583">&lt;p id="xdx_89A_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zb70P3gJuzWg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B5_znQDqG9Hxb0g" style="display: none"&gt;SCHEDULE OF RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Table 20: Details of Loans Payable - Related Party&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average Interest Rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Maturity (Calendar Year)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Loans issued to directors in 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DebtInstrumentFaceAmount_iI_c20251231__srt--TitleOfIndividualAxis__custom--TwoDirectorMember_zl23iuefiz7h" style="width: 11%; text-align: right" title="Debt amount face value"&gt;103,400&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DebtInstrumentFaceAmount_iI_c20241231__srt--TitleOfIndividualAxis__custom--TwoDirectorMember_zXjV5S6CpLSb" style="width: 11%; text-align: right" title="Principal amount"&gt;130,900&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20251231__srt--TitleOfIndividualAxis__custom--TwoDirectorMember_zYaznmLyBQe1" style="width: 11%; text-align: right" title="Debt interest rate"&gt;24.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--DebtMaturityYear_pid_c20250101__20251231__srt--TitleOfIndividualAxis__custom--TwoDirectorMember_z5jef8eFTvH7" style="width: 11%; text-align: right" title="Debt maturity year"&gt;2023&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;Loan to a director issued in 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DebtInstrumentFaceAmount_iI_c20251231__srt--TitleOfIndividualAxis__srt--DirectorMember_zrnpyS5Jbvz8" style="border-bottom: Black 1pt solid; text-align: right" title="Debt amount face value"&gt;20,250&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentFaceAmount_iI_c20241231__srt--TitleOfIndividualAxis__srt--DirectorMember_ziTaHuS723M" style="border-bottom: Black 1pt solid; text-align: right" title="Debt amount face value"&gt;20,250&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20251231__srt--TitleOfIndividualAxis__srt--DirectorMember_zuKx3E1sPPu4" style="padding-bottom: 1pt; text-align: right" title="Debt interest rate"&gt;24.0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--DebtMaturityYear_pid_c20250101__20251231__srt--TitleOfIndividualAxis__srt--DirectorMember_zPbX5Zp5XGM2" style="padding-bottom: 1pt; text-align: right" title="Debt maturity year"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 10pt; text-align: left"&gt;Funded loans payable - related party principal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DebtInstrumentFaceAmount_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zGyhR8HYoi16" style="border-bottom: Black 1pt solid; text-align: right" title="Debt amount face value"&gt;123,650&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentFaceAmount_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zeWdkABTFsrc" style="border-bottom: Black 1pt solid; text-align: right" title="Principal amount"&gt;151,150&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;Less: Unamortized debt-issuance costs and discounts&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z16MpzeaThIb" style="border-bottom: Black 1pt solid; text-align: right" title="Debt unamortized discount and issuance costs"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2605"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zbC9FINsD41d" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Unamortized debt-issuance costs and discounts"&gt;(3,062&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 10pt; text-align: left"&gt;Loans payable - related party - current&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LoansPayable_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zekP1As6ZWLh" style="border-bottom: Black 2.5pt double; text-align: right" title="Debt amount net of unamortized discount and issuance costs"&gt;123,650&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LoansPayable_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zYb87jxzJWK8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total loans payable"&gt;148,088&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_custom_TwoDirectorMember"
      decimals="0"
      id="Fact002585"
      unitRef="USD">103400</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-12-31_custom_TwoDirectorMember"
      decimals="0"
      id="Fact002587"
      unitRef="USD">130900</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2025-12-31_custom_TwoDirectorMember"
      decimals="INF"
      id="Fact002589"
      unitRef="Pure">0.240</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <CYCU:DebtMaturityYear
      contextRef="From2025-01-012025-12-31_custom_TwoDirectorMember"
      id="Fact002591">2023</CYCU:DebtMaturityYear>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_srt_DirectorMember"
      decimals="0"
      id="Fact002593"
      unitRef="USD">20250</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-12-31_srt_DirectorMember"
      decimals="0"
      id="Fact002595"
      unitRef="USD">20250</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2025-12-31_srt_DirectorMember"
      decimals="INF"
      id="Fact002597"
      unitRef="Pure">0.240</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <CYCU:DebtMaturityYear
      contextRef="From2025-01-012025-12-31_srt_DirectorMember"
      id="Fact002599">2025</CYCU:DebtMaturityYear>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002601"
      unitRef="USD">123650</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002603"
      unitRef="USD">151150</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2024-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002607"
      unitRef="USD">-3062</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LoansPayable
      contextRef="AsOf2025-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002609"
      unitRef="USD">123650</us-gaap:LoansPayable>
    <us-gaap:LoansPayable
      contextRef="AsOf2024-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002611"
      unitRef="USD">148088</us-gaap:LoansPayable>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2025-01-012025-12-31_custom_PromissoryNoteMember"
      decimals="0"
      id="Fact002613"
      unitRef="USD">3062</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2024-01-012024-12-31_custom_PromissoryNoteMember"
      decimals="0"
      id="Fact002615"
      unitRef="USD">0</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2025-01-012025-12-31" id="Fact002617">&lt;p id="xdx_80D_eus-gaap--EarningsPerShareTextBlock_zOq6M7Y1ILga" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;21.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82D_zqREZHYfWScd"&gt;EARNINGS
                                            PER SHARE&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ziygobkBR8Uk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_zDwqY66INkMa" style="display: none"&gt;SCHEDULE OF COMPONENTS OF BASIC AND DILUTED EARNINGS PER SHARE&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="display: none"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20250101__20251231_ztQjEjUCjfR2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20240101__20241231_zPeSH7aKZ7Pk" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Table 21.1: Details of Basic and Dilutive (Loss)/Earnings Per Share&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; font-weight: bold"&gt;Basic net (loss)/income per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_iB_z1HeVmHBq2Lb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold"&gt;Numerator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--ProfitLoss_maNILATzrTM_zZLyvdAYfG0j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; width: 60%; text-align: left"&gt;Net (loss)/income including non-controlling interests&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;(24,059,084&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,229,601&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_msNILATzrTM_zOSK4rCo3fef" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt"&gt;Less: Net loss attributable to non-controlling interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(393,376&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2628"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_mtNILATzrTM_z9dhB17Vglp1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"&gt;Net (loss)/income attributable to Common Stockholders - basic&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(23,665,708&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,229,601&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasicAbstract_iB_zRsyOAaqcVN9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold"&gt;Denominator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_z5K8b1CJ7wah" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; padding-bottom: 1pt"&gt;Weighted average shares outstanding - basic&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,760,310&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;282,437&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pid_zP1DGckQc4l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 2.5pt"&gt;Basic net (loss)/income per share attributable to Common Stockholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(13.44&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4.35&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; font-weight: bold"&gt;Diluted net (loss)/income per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_iB_zPb2Qvznlwd6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold"&gt;Numerator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_maNILATzrtv_zNwjhhovuned" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Net (loss)/income attributable to Common Stockholders - basic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(23,665,708&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,229,601&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--InterestOnConvertibleDebtNetOfTax_maNILATzrtv_zY3i8JvWDoH5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt"&gt;Add back interest for subordinated convertible promissory note&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;43,333&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;276,667&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_iT_mtNILATzrtv_zSInNDpj84Q4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"&gt;Net (loss)/income attributable to Common Stockholders - diluted&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(23,622,375&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,506,268&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_iB_zdHzQWBOkoZ8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold"&gt;Denominator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_zns8mxchfYFa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt"&gt;Weighted average shares outstanding - basic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,760,310&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;282,437&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DilutiveSecuritiesAbstract_iB_pid_zgCyWOZSJX59" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Weighted-average effect of potentially dilutive securities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_zwbJEDPZk3tb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Conversion of subordinated convertible promissory note&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,333&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;58,347&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zPbIWYw3sNq2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Conversion of Series A Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2666"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;70,203&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zF2GKsmwF0xh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Conversion of Series B Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2669"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;175,182&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zYicmYj1WTS4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Conversion of Series C Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2672"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,212&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zFpr9mBXGcc7" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Conversion of Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2675"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,212&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--IncrementalCommonSharesAttributableToDilutiveEffectOfExerciseOfInvestorAndPlacementAgentWarrants_zvzdjj8dIfM3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt"&gt;Exercise of investor and placement agent warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2678"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;317,548&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_iT_pid_zY6dmQCw8rF5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; padding-bottom: 1pt"&gt;Weighted average shares outstanding - diluted&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,763,643&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;904,929&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--IncomeLossFromContinuingOperationsPerDilutedShare_pid_zATSsaac4lSh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 2.5pt"&gt;Dilutive net (loss)/income per share attributable to Common Stockholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(13.39&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1.66&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_z2Q5sbi1HFek" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p id="xdx_89E_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zIbgnohzwOqk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B4_ziSg7QQEG5D4" style="display: none"&gt;SCHEDULE OF DILUTIVE EFFECT OF SECURITIES EXCLUDED FROM DILUTIVE EPS DUE TO ANTI-DILUTIVE EFFECT&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="display: none"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20250101__20251231_zC66guBQtGZ3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240101__20241231_z1r0VkR6eSq3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Table 21.2: Details of Potentially Dilutive Effect of Securities Excluded from Dilutive EPS due to Anti-Dilutive Effect&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertiblePreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zL1lPfc5PrCd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Conversion of Series A Convertible Preferred Stock&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;92,332&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2690"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertiblePreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zO0le1NCVfR4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Conversion of Series B Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2693"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertiblePreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_z5I5Bbd1PtWh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion of Series C Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,202&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2696"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertiblePreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zLXDoSsCjlj2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Conversion of Series D Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,092&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2699"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertiblePreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zNi8umvfilz2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion of Series E Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2702"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zG5xUcO8Hmif" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Exercise of investor and placement agent warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;922,845&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;317,548&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zCUBouDx3Qc4" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Antidilutive securities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;922,845&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;317,548&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A3_zJ5wfr3R1TUe" style="display: none; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;
</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2025-01-012025-12-31" id="Fact002619">&lt;p id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ziygobkBR8Uk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_zDwqY66INkMa" style="display: none"&gt;SCHEDULE OF COMPONENTS OF BASIC AND DILUTED EARNINGS PER SHARE&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="display: none"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20250101__20251231_ztQjEjUCjfR2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20240101__20241231_zPeSH7aKZ7Pk" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Table 21.1: Details of Basic and Dilutive (Loss)/Earnings Per Share&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; font-weight: bold"&gt;Basic net (loss)/income per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_iB_z1HeVmHBq2Lb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold"&gt;Numerator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--ProfitLoss_maNILATzrTM_zZLyvdAYfG0j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; width: 60%; text-align: left"&gt;Net (loss)/income including non-controlling interests&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;(24,059,084&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,229,601&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_msNILATzrTM_zOSK4rCo3fef" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt"&gt;Less: Net loss attributable to non-controlling interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(393,376&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2628"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_mtNILATzrTM_z9dhB17Vglp1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"&gt;Net (loss)/income attributable to Common Stockholders - basic&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(23,665,708&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,229,601&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasicAbstract_iB_zRsyOAaqcVN9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold"&gt;Denominator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_z5K8b1CJ7wah" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; padding-bottom: 1pt"&gt;Weighted average shares outstanding - basic&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,760,310&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;282,437&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pid_zP1DGckQc4l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 2.5pt"&gt;Basic net (loss)/income per share attributable to Common Stockholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(13.44&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4.35&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; font-weight: bold"&gt;Diluted net (loss)/income per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_iB_zPb2Qvznlwd6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold"&gt;Numerator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_maNILATzrtv_zNwjhhovuned" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Net (loss)/income attributable to Common Stockholders - basic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(23,665,708&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,229,601&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--InterestOnConvertibleDebtNetOfTax_maNILATzrtv_zY3i8JvWDoH5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt"&gt;Add back interest for subordinated convertible promissory note&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;43,333&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;276,667&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_iT_mtNILATzrtv_zSInNDpj84Q4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"&gt;Net (loss)/income attributable to Common Stockholders - diluted&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(23,622,375&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,506,268&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_iB_zdHzQWBOkoZ8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold"&gt;Denominator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_zns8mxchfYFa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt"&gt;Weighted average shares outstanding - basic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,760,310&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;282,437&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DilutiveSecuritiesAbstract_iB_pid_zgCyWOZSJX59" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Weighted-average effect of potentially dilutive securities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_zwbJEDPZk3tb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Conversion of subordinated convertible promissory note&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,333&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;58,347&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zPbIWYw3sNq2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Conversion of Series A Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2666"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;70,203&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zF2GKsmwF0xh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Conversion of Series B Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2669"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;175,182&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zYicmYj1WTS4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Conversion of Series C Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2672"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,212&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zFpr9mBXGcc7" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Conversion of Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2675"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,212&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--IncrementalCommonSharesAttributableToDilutiveEffectOfExerciseOfInvestorAndPlacementAgentWarrants_zvzdjj8dIfM3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt"&gt;Exercise of investor and placement agent warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2678"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;317,548&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_iT_pid_zY6dmQCw8rF5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; padding-bottom: 1pt"&gt;Weighted average shares outstanding - diluted&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,763,643&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;904,929&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--IncomeLossFromContinuingOperationsPerDilutedShare_pid_zATSsaac4lSh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 2.5pt"&gt;Dilutive net (loss)/income per share attributable to Common Stockholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(13.39&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1.66&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact002624"
      unitRef="USD">-24059084</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact002625"
      unitRef="USD">1229601</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact002627"
      unitRef="USD">-393376</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact002630"
      unitRef="USD">-23665708</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact002631"
      unitRef="USD">1229601</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-01-012025-12-31"
      decimals="INF"
      id="Fact002636"
      unitRef="Shares">1760310</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact002637"
      unitRef="Shares">282437</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2025-01-012025-12-31"
      decimals="INF"
      id="Fact002639"
      unitRef="USDPShares">-13.44</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact002640"
      unitRef="USDPShares">4.35</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact002645"
      unitRef="USD">-23665708</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact002646"
      unitRef="USD">1229601</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact002648"
      unitRef="USD">43333</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact002649"
      unitRef="USD">276667</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact002651"
      unitRef="USD">-23622375</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact002652"
      unitRef="USD">1506268</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-01-012025-12-31"
      decimals="INF"
      id="Fact002657"
      unitRef="Shares">1760310</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact002658"
      unitRef="Shares">282437</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="From2025-01-012025-12-31"
      decimals="INF"
      id="Fact002663"
      unitRef="Shares">3333</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact002664"
      unitRef="Shares">58347</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2024-01-012024-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002667"
      unitRef="Shares">70203</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2024-01-012024-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002670"
      unitRef="Shares">175182</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2024-01-012024-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002673"
      unitRef="Shares">1212</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2024-01-012024-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002676"
      unitRef="Shares">1212</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <CYCU:IncrementalCommonSharesAttributableToDilutiveEffectOfExerciseOfInvestorAndPlacementAgentWarrants
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact002679"
      unitRef="Shares">317548</CYCU:IncrementalCommonSharesAttributableToDilutiveEffectOfExerciseOfInvestorAndPlacementAgentWarrants>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2025-01-012025-12-31"
      decimals="INF"
      id="Fact002681"
      unitRef="Shares">1763643</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact002682"
      unitRef="Shares">904929</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="From2025-01-012025-12-31"
      decimals="INF"
      id="Fact002684"
      unitRef="USDPShares">-13.39</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact002685"
      unitRef="USDPShares">1.66</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2025-01-012025-12-31" id="Fact002687">&lt;p id="xdx_89E_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zIbgnohzwOqk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B4_ziSg7QQEG5D4" style="display: none"&gt;SCHEDULE OF DILUTIVE EFFECT OF SECURITIES EXCLUDED FROM DILUTIVE EPS DUE TO ANTI-DILUTIVE EFFECT&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="display: none"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20250101__20251231_zC66guBQtGZ3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240101__20241231_z1r0VkR6eSq3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Table 21.2: Details of Potentially Dilutive Effect of Securities Excluded from Dilutive EPS due to Anti-Dilutive Effect&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertiblePreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zL1lPfc5PrCd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Conversion of Series A Convertible Preferred Stock&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;92,332&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2690"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertiblePreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zO0le1NCVfR4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Conversion of Series B Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2693"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertiblePreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_z5I5Bbd1PtWh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion of Series C Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,202&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2696"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertiblePreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zLXDoSsCjlj2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Conversion of Series D Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,092&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2699"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertiblePreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zNi8umvfilz2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion of Series E Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2702"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zG5xUcO8Hmif" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Exercise of investor and placement agent warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;922,845&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;317,548&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zCUBouDx3Qc4" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Antidilutive securities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;922,845&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;317,548&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2025-01-012025-12-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002689"
      unitRef="Shares">92332</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2025-01-012025-12-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002692"
      unitRef="Shares">28090</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2025-01-012025-12-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002695"
      unitRef="Shares">1202</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2025-01-012025-12-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002698"
      unitRef="Shares">10092</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2025-01-012025-12-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002701"
      unitRef="Shares">2</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2025-01-012025-12-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002704"
      unitRef="Shares">922845</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-012024-12-31_us-gaap_WarrantMember71589000"
      decimals="INF"
      id="Fact002705"
      unitRef="Shares">317548</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2025-01-012025-12-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002707"
      unitRef="Shares">922845</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-012024-12-31_us-gaap_WarrantMember71589000"
      decimals="INF"
      id="Fact002708"
      unitRef="Shares">317548</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2025-01-012025-12-31" id="Fact002710">&lt;p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zCmQAfy56ke9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_820_zK8bzwflkBB8"&gt;COMMITMENTS
                                            AND CONTINGENCIES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Legal
Proceedings&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
time to time, the Company may be a party to litigation or claims arising in the ordinary course of business, including those relating
to employment matters, relationships with clients and contractors, intellectual property disputes, and other business matters. These
legal proceedings seek various remedies, including claims for monetary damages in varying amounts, none of which are considered material,
or are unspecified as to amount. Although the outcome of any such matter is inherently uncertain and may be materially adverse, based
on current information, management believes that the outcome of such known matters will not have a material adverse effect on the Company&#x2019;s
financial condition and results of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that there are any litigation or claims that would have a material adverse effect on the business, or the consolidated
financial statements of the Company as of December 31, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Registration
Rights&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
holders of Founder Shares, Private Placement Units, and units that may be issued upon conversion of working capital loans, if any, are
entitled to registration rights pursuant to a registration rights agreement that was signed on the date of the IPO. These holders will
be entitled to certain demand and &#x201c;piggyback&#x201d; registration rights. However, the registration rights agreement provides that
the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the
applicable lock-up period for the securities to be registered. The Company will bear the expenses incurred in connection with the filing
of any such registration statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Business
Combination Marketing Agreement&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company entered into a business combination marketing agreement on January 11, 2022 (the &#x201c;Business Combination Marketing Agreement&#x201d;)
with A.G.P. whereby A.G.P. is to act as an advisor in connection with a Business Combination to assist the Company in holding meetings
with its stockholders to discuss the potential Business Combination and the target business&#x2019; attributes, introduce the Company
to potential investors that are interested in purchasing the Company&#x2019;s securities in connection with a Business Combination, assist
the Company in obtaining stockholders&#x2019; approval for a Business Combination, and assist the Company with its press releases and
public filings in connection with a Business Combination. The Company was to pay A.G.P. a fee for such marketing services upon the consummation
of a Business Combination in an amount equal to &lt;span id="xdx_90A_ecustom--DebtInstrumentAmortizationPercentage_pid_dp_uPure_c20220111__20220111_zvMSRKr9MIqc" title="Debt amortization percentage"&gt;4.5&lt;/span&gt;% of the gross proceeds of the IPO, or $&lt;span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220111__20220111_zScRRODFimlj" title="Proceds from issuance of equity"&gt;5,175,000&lt;/span&gt; in the aggregate (exclusive of any
applicable finders&#x2019; fees that might become payable). The Business Combination Marketing Agreement will be terminated upon entry
into the A.G.P. Advisory Agreement (defined below).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Advisory
Agreement with A.G.P.&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A.G.P.
was a financial advisor to both Western in connection with the Business Combination transaction. Upon the completion of the Business
Combination, A.G.P.: (i) received a cash fee of $&lt;span id="xdx_900_eus-gaap--PaymentsForFees_c20220111__20220111_zWGbx63t0Qmd" title="Other fees"&gt;500,000&lt;/span&gt; shares of Common Stock and warrants to purchase &lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220111_zQBRDHbD1w76" title="Warrants"&gt;16,667 &lt;/span&gt;shares of Common Stock
at an exercise price of $&lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220111_zUTRtnGiIr2j" title="Exercise price"&gt;150.00&lt;/span&gt; per share. Pursuant to the advisory agreement (the &#x201c;A.G.P. Advisory Agreement&#x201d;), Western
shall pay A.G.P. a total transaction fee equal to $&lt;span id="xdx_904_ecustom--TransactionFee_iI_c20220111_zJVKglBwVK63" title="Transaction fee"&gt;2,500,000&lt;/span&gt; (the &#x201c;Transaction Fee&#x201d;) upon the closing of the Business Combination.
The Transaction Fee will be payable in the form of preferred shares of Cycurion that are convertible into &lt;span id="xdx_901_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20220111_zGDMiSQxBwkc" title="Preferred stock convertible shares"&gt;16,667&lt;/span&gt; shares of Common Stock
(such preferred shares or the Common Stock into which they convert, the &#x201c;Transaction Fee Shares&#x201d;), for a price per share
of Common Stock equal to $&lt;span id="xdx_902_eus-gaap--SharePrice_iI_c20220111_zMBEDQEvLDy1" title="Share price"&gt;5.00&lt;/span&gt;. A portion of the Transaction Fee Shares shall be subject to forfeiture and return to the Company for
cancellation once A.G.P. converts and sells Transaction Fee Shares generating sales proceeds (excluding commissions) of $&lt;span id="xdx_90C_eus-gaap--ProceedsFromSalesOfAssetsInvestingActivities_c20220111__20220111_zi2crVkDxdti" title="Proceeds from generating sales"&gt;2,500,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Transaction Fee Shares shall be subject to a lock-up ending on the earlier of (i) the date on which &lt;span id="xdx_90F_ecustom--AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock_pid_dp_uPure_c20220111__20220111__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember__us-gaap--GainContingenciesByNatureAxis__custom--TransactionFeeMember_zYbZH6Suyas5" title="Conversion percentage"&gt;75&lt;/span&gt;%
of the outstanding Series B Convertible Preferred Stock is converted into shares of the combined Company&#x2019;s Common Stock and
(ii) &lt;span style="display: none"&gt;&lt;/span&gt;&lt;span id="xdx_901_ecustom--AdvisoryAgreementLockUpTerminationPeriod_dc_c20220111__20220111__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember__us-gaap--GainContingenciesByNatureAxis__custom--TransactionFeeMember_zPHbDTsHOXe" title="Lock-up termination period"&gt;three
months&lt;/span&gt; from February 14, 2025, which was the closing date of the de-SPAC (the &#x201c;Lock-Up Termination Date&#x201d;). After
the Lock-Up Termination Date, A.G.P. may convert the Transaction Fee Shares and sell them subject to a leak-out provision that
limits A.G.P.&#x2019;s sales of Transaction Fee Shares on any given date to &lt;span id="xdx_902_ecustom--AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock_pid_dp_uPure_c20220111__20220111__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember__srt--RangeAxis__srt--MinimumMember__us-gaap--GainContingenciesByNatureAxis__custom--TransactionFeeMember_zLaKrsQc7a06" title="Conversion percentage"&gt;10&lt;/span&gt;%
of the cumulative trading volume of the Common Stock for such date (including pre-market, market and post-market trading) as
reported by Bloomberg, LP. This restriction shall remain in effect beginning on the Lock-Up Termination Date and ending on the date
on which &lt;span id="xdx_90A_eus-gaap--LongTermDebtPercentageBearingFixedInterestRate_iI_pid_dp_uPure_c20220111__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember__us-gaap--GainContingenciesByNatureAxis__custom--TransactionFeeMember_zmWPke8k2P3b" title="Conversion percentage"&gt;100&lt;/span&gt;%
of the Series B Convertible Preferred Stock outstanding as of the closing is converted into shares of our Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
parties amended the Advisory Agreement (the &#x201c;Amended A.G.P. Advisory Agreement&#x201d;), pursuant to which Western shall pay A.G.P.
the Transaction Fee in the form of preferred shares of Cycurion that are convertible into &lt;span id="xdx_905_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20220111__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember_zHoCoyuXmRbk" title="Convertible shares issuable"&gt;166,667&lt;/span&gt; shares of Common Stock (such preferred
shares or the Common Stock into which they convert, the &#x201c;Amended Transaction Fee Shares&#x201d;), for a price per share of Common
Stock of $&lt;span id="xdx_909_eus-gaap--PreferredStockConvertibleConversionPrice_iI_pid_c20220111__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember_zhNkGnxBlOub" title="Conversion price"&gt;0.50&lt;/span&gt;. A portion of the Amended Transaction Fee Shares shall be subject to forfeiture and return to the Company for cancellation
once A.G.P. converts and sells Transaction Fee Shares generating sales proceeds (excluding commissions) of $&lt;span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220111__20220111__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember_zCG2XEVjoI1j" title="Transaction fee shares generating sales proceeds"&gt;2,500,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Amended Transaction Fee Shares shall be subject to a lock-up ending on the earlier of (i) the date on which &lt;span id="xdx_90E_ecustom--AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock_pid_dp_uPure_c20220111__20220111__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember__us-gaap--GainContingenciesByNatureAxis__custom--AmendedTransactionFeeMember_zR0lkD25Fc07" title="Conversion percentage"&gt;75&lt;/span&gt;% of the outstanding Series
B Convertible Preferred Stock is converted into shares of the Combined Company&#x2019;s Common Stock and (ii) &lt;span id="xdx_908_ecustom--AdvisoryAgreementSharesLockUpEndingPeriodFromClosingDate_dc_c20220111__20220111__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember__us-gaap--GainContingenciesByNatureAxis__custom--AmendedTransactionFeeMember_zN6gcZzIwkn3" title="Advisory agreement lock-up ending period from closing date"&gt;six months&lt;/span&gt; from the Lock-Up
Termination Date. After the Lock-Up Termination Date, A.G.P. may convert the Amended Transaction Fee Shares and sell them subject to
a leak-out provision that limits A.G.P.&#x2019;s sales of Amended Transaction Fee Shares on any given date to &lt;span id="xdx_901_ecustom--AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock_pid_dp_uPure_c20220111__20220111__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember__srt--RangeAxis__srt--MinimumMember__us-gaap--GainContingenciesByNatureAxis__custom--AmendedTransactionFeeMember_zbYSatMITDWj" title="Conversion percentage"&gt;10&lt;/span&gt;% of the cumulative trading
volume of the Common Stock for such date (including pre-market, market and post-market trading) as reported by Bloomberg, LP. This restriction
shall remain in effect beginning on the Lock-Up Termination Date and ending on the date on which &lt;span id="xdx_907_eus-gaap--LongTermDebtPercentageBearingFixedInterestRate_iI_pid_dp_uPure_c20220111__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember__us-gaap--GainContingenciesByNatureAxis__custom--AmendedTransactionFeeMember_zs5PQjmPUcZf" title="Converted percentage"&gt;100&lt;/span&gt;% of the Series B Convertible Preferred
Stock outstanding as of the closing is converted into shares of our Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
the execution of the A.G.P. Advisory Agreement, the Business Combination Marketing Agreement, dated January 11, 2022, between Western
and A.G.P. in which Western and Cycurion Sub caused the combined company to issue to A.G.P. &lt;span id="xdx_907_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20220111__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember_zy2ynavRLpL7" title="Shares reserve for future issuance"&gt;8,333&lt;/span&gt; shares of Common Stock of the combined
company in full satisfaction of the fees, was terminated, and such shares of Common Stock extinguished in their entirety.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Agreements
with Seward &amp;amp; Kissel LLP&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 27, 2024, we entered into a revised engagement letter (the &#x201c;Revised Engagement Letter&#x201d;) with Seward &amp;amp; Kissel
LLP (&#x201c;Seward &amp;amp; Kissel&#x201d;), pursuant to which Western and Cycurion agreed to pay approximately $&lt;span id="xdx_909_eus-gaap--LegalFees_pn5n6_c20241127__20241127__dei--LegalEntityAxis__custom--SewardAndKisselLLPMember_zj9e7lw4cfDg" title="Legal fees"&gt;1.3&lt;/span&gt; million of its outstanding
legal fees and expenses (&#x201c;Legal Fees&#x201d;) in shares of Common Stock in connection with the Business Combination. Following the
closing of the Business Combination on February 14, 2025 and in connection with the Revised Engagement Letter, we issued to Seward &amp;amp;
Kissel &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241127__20241127__dei--LegalEntityAxis__custom--SewardAndKisselLLPMember_zoGKDgVBbmpi" title="Number of shares issued"&gt;8,333&lt;/span&gt; shares of Common Stock and a pre-funded warrant that is exercisable for approximately $&lt;span id="xdx_907_eus-gaap--WarrantsAndRightsOutstanding_iI_pn5n6_c20241127__dei--LegalEntityAxis__custom--SewardAndKisselLLPMember_zc9FBBRsRHdf" title="Warrants exercisable"&gt;1.3&lt;/span&gt; million in shares of Common Stock
(the &#x201c;Seward &amp;amp; Kissel Pre-Funded Warrant&#x201d;); provided that once the net proceeds from the sale of the shares equals the
Legal Fees, the remaining shares of Common Stock, including such Common Stock exercisable under the Seward &amp;amp; Kissel Pre-Funded Warrant,
shall be returned to the Cycurion. We plan to enter into an exchange agreement with Seward &amp;amp; Kissel to exchange the Seward &amp;amp;
Kissel Pre-Funded Warrant for a convertible promissory note that is convertible into such number of shares equal to the Legal Fees.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 14, 2025, Cycurion entered into pre-funded warrant with Seward &amp;amp; Kissel Pre-Funded Warrant that is exercisable for approximately
$&lt;span id="xdx_901_eus-gaap--WarrantsAndRightsOutstanding_iI_pn5n6_c20250214__dei--LegalEntityAxis__custom--SewardAndKisselLLPMember_zBshojEXXrd9" title="Warrants exercisable"&gt;1.3&lt;/span&gt; million in shares of Common Stock, or up to &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250214__20250214__dei--LegalEntityAxis__custom--SewardAndKisselLLPMember_zoZJHhuUQtQb" title="Stock issued"&gt;83,333&lt;/span&gt; shares of Common Stock; provided that once the net proceeds from the sale of
the shares equals the $&lt;span id="xdx_900_eus-gaap--LegalFees_pn5n6_c20250214__20250214__dei--LegalEntityAxis__custom--SewardAndKisselLLPMember_zhFOaIljvRN" title="Legal fees"&gt;1.3&lt;/span&gt; million in Legal, the remaining shares of Common Stock, including such Common Stock exercisable under the
Seward &amp;amp; Kissel Pre-Funded Warrant, shall be returned to Cycurion.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Seward &amp;amp; Kissel Pre-Funded Warrant provides that the holder may not exercise any portion of the Seward &amp;amp; Kissel Pre-Funded Warrant
to the extent that immediately prior to or after giving effect to such exercise the holder would own more than 4.99% upon 61 days&#x2019;
prior notice. The exercise price for each share of Common Stock underlying the Seward &amp;amp; Kissel Pre-Funded Warrant is $&lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250214__dei--LegalEntityAxis__custom--SewardAndKisselLLPMember__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantMember_zYggtmX29Vjf" title="Warrants exercise price"&gt;0.0030&lt;/span&gt;. The
Seward &amp;amp; Kissel Pre-Funded Warrant is immediately exercisable upon issuance and may be exercised at any time until the Seward &amp;amp;
Kissel Pre-Funded Warrant is exercised in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Seward
&amp;amp; Kissel LLP may not exercise any portion of the warrants or Seward &amp;amp; Kissel Pre-Funded Warrant, as applicable, to the extent
that the holder would own more than 4.99% of our outstanding Common Stock immediately after exercise, as such percentage ownership is
determined in accordance with the terms of the Seward &amp;amp; Kissel Pre-Funded Warrant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
lieu of making the cash payment otherwise contemplated to be made to us upon exercise of the Seward &amp;amp; Kissel Pre-Funded Warrant in
payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the
net number of shares of our Common Stock determined according to a formula set forth in the Seward &amp;amp; Kissel Pre-Funded Warrant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Agreement
with Baker &amp;amp; Hostetler LLP&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
2023, Western agreed to pay approximately $&lt;span id="xdx_903_eus-gaap--OtherCommitment_iI_c20231231__dei--LegalEntityAxis__custom--BakerHostetlerLlpMember_z4uL2wvhTNki" title="Payment obligation"&gt;788,030&lt;/span&gt; of its obligations to its counsel, Baker Hostetler LLP, in shares of Common Stock
following the Business Combination, which will be issued at a price per share equal to $&lt;span id="xdx_90F_eus-gaap--SharePrice_iI_c20231231__dei--LegalEntityAxis__custom--BakerHostetlerLlpMember_zCgkUDBR9UTg" title="Share price"&gt;10.00&lt;/span&gt;, or &lt;span id="xdx_906_eus-gaap--SharesIssued_iI_c20231231__dei--LegalEntityAxis__custom--BakerHostetlerLlpMember_ziFwSCWPW2Ng" title="Share issued"&gt;2,627&lt;/span&gt; shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Equity
Line of Credit&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Equity
Purchase Agreement&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 7, 2025 (the &#x201c;Execution Date&#x201d;), we entered into the Equity Purchase Agreement with Yield Point NYC LLC (&#x201c;Yield
Point&#x201d;). Under the Equity Purchase Agreement, we have the right, but not the obligation, to direct Yield Point to purchase up to
$&lt;span id="xdx_90A_ecustom--MaximumCommitmentAmount_iI_pn6n6_c20250407__us-gaap--TypeOfArrangementAxis__custom--EquityPurchaseAgreementMember_z8l8MTGKa4df" title="Maximum commitment amount"&gt;60.0&lt;/span&gt; million (the &#x201c;Maximum Commitment Amount&#x201d;) in shares of our Common Stock upon satisfaction of certain terms and conditions
contained in the Equity Purchase Agreement, including, without limitation, an effective registration statement filed with the SEC registering
the resale of the shares of Put Stock (defined below) and the shares of Commitment Stock (defined below) and additional shares to be
sold to Yield Point from time to time under the Equity Purchase Agreement. The term of the Equity Purchase Agreement began on the Execution
Date and ends on the earlier of (i) the date on which Yield Point shall have purchased shares of Common Stock issued, or that we shall
be entitled to issue, per any applicable Put Notice (defined below) in accordance with the terms and conditions of the Equity Purchase
Agreement (the &#x201c;Put Stock&#x201d;) equal to the Maximum Commitment Amount, (ii) the date that is twelve (&lt;span id="xdx_900_ecustom--EquityPurchaseAgreementMaximumTerm_iI_dtM_c20250407__us-gaap--TypeOfArrangementAxis__custom--EquityPurchaseAgreementMember_zSZIWdKlKuh2" title="Maximum commitment period"&gt;12&lt;/span&gt;) months from the date
the registration statement is declared effective, (iii) written notice of termination by us to Yield Point (which shall not occur at
any time that Yield Point holds any of the shares of Put Stock), or (iv) written notice of termination by Yield Point to us pursuant
to (the &#x201c;Commitment Period&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the Commitment Period, we may direct Yield Point to purchase shares of Put Stock by delivering a notice (a &#x201c;Put Notice&#x201d;)
to Yield Point. We shall, in our sole discretion, select the number of shares of Put Stock requested in each Put Notice. However, such
amount may not exceed the Maximum Put Amount (as defined in the Equity Purchase Agreement). The purchase price to be paid by Yield Point
for the shares of Put Stock will be ninety percent (&lt;span id="xdx_90A_ecustom--EquityOfferingPricePerSharePercentageOfClosingPrice_iI_pid_dp_uPure_c20250407__us-gaap--TypeOfArrangementAxis__custom--EquityPurchaseAgreementMember_zxtcDlrpkhM6" title="Percentage of closing price"&gt;90&lt;/span&gt;%) of the lowest trade of the Common Stock on the Principal Market during the Valuation
Period (as defined in the Equity Purchase Agreement).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
consideration for Yield Point&#x2019;s execution and delivery of, and performance under the Equity Purchase Agreement, on the Execution
Date, we, in our discretion, either were to (i) pay to Yield Point in cash $&lt;span id="xdx_90A_eus-gaap--Cash_iI_pn5n6_c20250407__us-gaap--TypeOfArrangementAxis__custom--EquityPurchaseAgreementMember_zyA19dlsGYM" title="Cash"&gt;1.8&lt;/span&gt; million (&#x201c;Commitment Cash&#x201d;) or (ii) issue
the Yield Point Pre-Funded Warrant (as defined below) to Yield Point in a form acceptable to Yield Point in its sole discretion and having
an exercise price per share of $&lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250407__us-gaap--TypeOfArrangementAxis__custom--EquityPurchaseAgreementMember_z5Z7zOp9kFAf" title="Warrants exercise price"&gt;0.0030&lt;/span&gt;, for Yield Point&#x2019;s purchase of shares of Common Stock (the &#x201c;Commitment Stock&#x201d;)
having a value of $&lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn5n6_c20250407__20250407__us-gaap--TypeOfArrangementAxis__custom--EquityPurchaseAgreementMember_zZOC483eOu8k" title="Common stock issued for exercise of warrants"&gt;1.8&lt;/span&gt; million based on closing price of the Common Stock on April 6, 2025. We chose to issue the Pre-Funded Warrant.
All of the shares of Commitment Stock were fully earned as of the Execution Date, and the issuance of the shares of Commitment Stock
is not contingent upon any other event or condition, including, without limitation, the effectiveness of the Initial Registration Statement
(defined below) or our submission of a Put Notice to Yield Point and irrespective of any termination of the Equity Purchase Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with the Equity Purchase Agreement, a registration statement on Form S-1 (the &#x201c;Initial Registration Statement&#x201d;)
covering only the resale of the shares of Put Stock and Commitment Stock was filed with the SEC on May 7, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Pre-Funded
Warrant&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
pre-funded warrant with Yield Point (the &#x201c;Yield Point Pre-Funded Warrant&#x201d;) certifies that, for value received, Yield Point
is entitled to be issued up to &lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20250407__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantMember_zfo6vs0nNmIe" title="Warrants"&gt;150,000&lt;/span&gt; shares of Common Stock as its commitment fee (&#x201c;Commitment Fee&#x201d;) and has an initial
exercise price of $&lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250407__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantMember_zPDKdQaEEvaf" title="Warrants exercise price"&gt;0.003&lt;/span&gt; per share. The Yield Point Pre-Funded Warrant was offered for the Commitment Fee in connection with the Equity
Purchase Agreement for shares of Common Stock, and provides that the holder may not exercise any portion of the Yield Point Pre-Funded
Warrant to the extent that immediately prior to or after giving effect to such exercise the holder would own more than 4.99%, which ownership
cap may be increased by the holder up to 9.99% upon 61 days&#x2019; prior notice. The exercise price for each share of Common Stock underlying
the Yield Point Pre-Funded Warrant is $&lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250407__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantMember_zqWn73dh5EKi" title="Warrants exercise price"&gt;0.003&lt;/span&gt;. The Yield Point Pre-Funded Warrant is immediately exercisable upon issuance and may be
exercised at any time until the Yield Point Pre-Funded Warrant is exercised in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
holder of the Yield Point Pre-Funded Warrant may not exercise any portion of the warrants or Yield Point Pre-Funded Warrant, as applicable,
to the extent that the holder would own more than 4.99% (or, at the holder&#x2019;s option upon issuance, 9.99%) of our outstanding Common
Stock immediately after exercise, as such percentage ownership is determined in accordance with the terms of the Yield Point Pre-Funded
Warrant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
lieu of making the cash payment otherwise contemplated to be made to us upon exercise of the Yield Point Pre-Funded Warrant in payment
of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the net number
of shares of our Common Stock determined according to a formula set forth in the Yield Point Pre-Funded Warrant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December 31, 2025, &lt;span id="xdx_902_ecustom--NumberOfWarrantsExercised_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMbkylEEpGJ6" title="Number of warrants, exercised"&gt;150,000&lt;/span&gt; of these shares have been exercised, therefore as of December 31, 2025, all Yield Point Pre-Funded
Warrants have been exercised.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Registration
Rights Agreement&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 7, 2025 (the &#x201c;RRA Execution Date&#x201d;), in connection with the Equity Purchase Agreement, we entered into a registration
rights agreement with Yield Point (the &#x201c;Registration Rights Agreement&#x201d;), pursuant to which we shall, by May 7, 2025, file
with the SEC the Initial Registration Statement covering the maximum number of (i) shares of Commitment Stock, (ii) shares of Put Stock,
which have been, or which may, from time to time be issued, including without limitation all of the shares of Common Stock which have
been issued or will be issued to Yield Point under the Equity Purchase Agreement (without regard to any limitation or restriction on
purchases), and (iii) any and all shares of capital stock issued or issuable with respect to the Put Stock, Commitment Stock, and the
Equity Purchase Agreement as a result of any stock split, combination, stock dividend, recapitalization, exchange, or similar event,
or otherwise, without regard to any limitation on purchases under the Equity Purchase Agreement (the &#x201c;Registrable Securities&#x201d;),
as shall be permitted to be included thereon in accordance with applicable SEC rules, regulations, and interpretations so as to permit
the resale of the Registrable Securities by Yield Point, including, but not limited to, under Rule 415 at then-prevailing market prices
(and not fixed prices). The Initial Registration Statement shall register only Registrable Securities. The Initial Registration Statement
and any amendment thereto was declared effective by the SEC in May 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Non-Redemption
Agreement&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 6, 2024, the Company, Western Acquisition Ventures Sponsor, LLC (the &#x201c;Sponsor&#x201d;) and RiverNorth SPAC Arbitrage Fund,
LP (the &#x201c;RiverNorth&#x201d;) entered into a non-redemption agreement (the &#x201c;Non-Redemption Agreement&#x201d;) whereby the Sponsor
plans to transfer to RiverNorth &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesOther_c20240806__20240806__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorPromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--NonRedemptionAgreementMember_zxKQASEdjBk3" title="Stock issued during period"&gt;167&lt;/span&gt; shares each month over the next three months for agreeing not to redeem the &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20240806__20240806__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorPromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--NonRedemptionAgreementMember_zzJJWMSVV1yg" title="Common stock issued for business combination costs"&gt;3,327&lt;/span&gt; that it currently
holds prior to the business combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 9, 2024, the Company, the Sponsor and RiverNorth entered into an extended Non-Redemption Agreement whereby the Sponsor plans
to transfer to RiverNorth &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesOther_c20241009__20241009__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorPromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--NonRedemptionAgreementMember_zMl7YL2S2fja" title="Stock issued during period"&gt;167&lt;/span&gt; shares each month over the next three months for agreeing not to redeem the &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20241009__20241009__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorPromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--NonRedemptionAgreementMember_zGgq2KDZq2gk" title="Common stock issued for business combination costs"&gt;3,327&lt;/span&gt; that it currently holds
prior to the business combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Employment
Agreements&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 27, 2023, we entered into an employment agreement with James P. McCormick whereby the Company agreed to pay a total of $&lt;span id="xdx_903_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20231227__20231227_zfYcEfovBKXb" title="Compensation expense"&gt;125,000&lt;/span&gt;
of total compensation annually, including $&lt;span id="xdx_90C_eus-gaap--Cash_iI_c20231227_zttDHAaEIS33" title="Cash"&gt;40,000&lt;/span&gt; in cash and $&lt;span id="xdx_90D_eus-gaap--PaymentsOfStockIssuanceCosts_c20231227__20231227_zHvdx61G26Hf" title="Payment of stock"&gt;85,000&lt;/span&gt; in stock payment. On October 30, 2024, we entered into an amendment
to the employment agreement with James P. McCormick whereby the Company agreed to pay total compensation of $&lt;span id="xdx_908_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20241030__20241030_z7p66eTLr7lf" title="Compensation expense"&gt;200,000&lt;/span&gt;, including $&lt;span id="xdx_900_eus-gaap--Cash_iI_c20241030_zhkA0XIsrXHc" title="Cash"&gt;40,000&lt;/span&gt;
in cash at the closing of the Business Combination and the remaining $&lt;span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_c20241030__20241030_z7nFPkgU7lBk" title="Cash proceeds"&gt;160,000&lt;/span&gt; in cash from the proceeds that the Company receives from
any capital raising transaction following the closing of the Business Combination, including the proceeds from an equity line of credit
to be entered into by and among the Company, Cycurion and the investors named therein; provided that the Company shall only be obligated
to apply up to &lt;span id="xdx_90B_eus-gaap--DebtInstrumentRedemptionPricePercentage_pid_dp_uPure_c20241030__20241030_zCi7j9ij0Fm7" title="Proceeds percentage"&gt;15&lt;/span&gt;% of the proceeds from each capital raise until Mr. McCormick&#x2019;s compensation of $&lt;span id="xdx_904_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20241030__20241030_zqnrq61ko7Z5" title="Compensation expense"&gt;200,000&lt;/span&gt; has been paid in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 1, 2024, Cycurion and L. Kevin Kelly, Chief Executive Officer, entered into an employment agreement on a &lt;span id="xdx_900_ecustom--EmploymentAgreementTerm_dtY_c20241201__20241201__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zKRhp9QOzxEj" style="display: none" title="Employment agreement period"&gt;2&lt;/span&gt;two-year term, commencing
on December 1, 2024 and ending on December 1, 2026. During the employment period, Mr. Kelly will receive an annual base salary of $&lt;span id="xdx_90B_eus-gaap--SalariesAndWages_c20241201__20241201__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zjEFoe6kE0a4" title="Salaries and wages"&gt;325,000&lt;/span&gt;,
and equity compensation of $&lt;span id="xdx_90D_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20241201__20241201__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zPt9nTJyg5B5" title="Equity compensation"&gt;500,000&lt;/span&gt; of Company Common Stock in the first year of the employment agreement, payable quarterly. Mr. Kelly
is eligible for a performance bonus based on the Company&#x2019;s results. The targeted performance bonus is $&lt;span id="xdx_90B_ecustom--PerformanceBonus_c20241201__20241201__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zlp9Ghbc845" title="Performance bonus"&gt;325,000&lt;/span&gt; for year-one, and
the performance bonus will increase for subsequent years based on future financial and non-financial results&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 1, 2025, Cycurion and Alvin McCoy, III, Chief Financial Officer, entered into an employment agreement on a &lt;span id="xdx_908_ecustom--EmploymentAgreementTerm_dtY_c20250101__20250101__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zLkIluTIkJuc" style="display: none" title="Employment agreement period"&gt;2&lt;/span&gt;two-year term, commencing
on January 1, 2025 and ending on December 31, 2026. During the employment period, Mr. McCoy, III will receive an annual base salary of
$&lt;span id="xdx_90D_eus-gaap--SalariesAndWages_c20250101__20250101__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zi1KUawYQ2T7" title="Salaries and wages"&gt;325,000&lt;/span&gt; and equity compensation of $&lt;span id="xdx_903_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20250101__20250101__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zjhu02gLBIMk" title="Equity compensation"&gt;500,000&lt;/span&gt; of Company stock in the first year of the employment agreement, payable quarterly. Mr. McCoy,
III is eligible for a performance bonus based on the Company&#x2019;s performance. The targeted performance bonus is $&lt;span id="xdx_900_ecustom--PerformanceBonus_c20250101__20250101__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zgZqo74GC0N6" title="Performance bonus"&gt;325,000&lt;/span&gt; for year-one,
and the performance bonus will increase for subsequent years based on future financial and non-financial results.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Retention
Packages&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 16, 2025, the Board of Directors approved a retention package for L. Kevin Kelly, Chief Executive Officer, and Alvin McCoy III,
Chief Financial Officer, and issued each officer &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250616__20250616__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zyJwD6MtqDni" title="Stock issued"&gt;&lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250616__20250616__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zP8XXIMhgDd7" title="Stock issued during period shares new issues"&gt;100,000&lt;/span&gt;&lt;/span&gt; shares of Common Stock under the Company&#x2019;s 2025 Equity Incentive Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Inflation
Reduction Act of 2022)&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 16, 2022, the Inflation Reduction Act of 2022 (the &#x201c;IR Act&#x201d;) was signed into federal law. The IR Act provides for,
among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and
certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed
on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally
1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise
tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value
of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the
Treasury (the &#x201c;Treasury&#x201d;) has been given authority to provide regulations and other guidance to carry out and prevent the
abuse or avoidance of the excise tax.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Any
redemption or other repurchase that occurs after December 31, 2022, in connection with a business combination, extension vote or otherwise,
may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a business
combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions
and repurchases in connection with the business combination, extension or otherwise, (ii) the structure of a business combination, (iii)
the nature and amount of any &#x201c;PIPE&#x201d; or other equity issuances in connection with a business combination (or otherwise issued
not in connection with a business combination but issued within the same taxable year of a business combination) and (iv) the content
of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the
redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction
in the cash available on hand to complete a business combination and in the Company&#x2019;s ability to complete a business combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025 and 2024, the Company&#x2019;s stockholders have redeemed a total of &lt;span id="xdx_900_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zorWy8MLW3x1" title="Stockholders redeemed shares"&gt;380,701&lt;/span&gt; and &lt;span id="xdx_909_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZuXg7LS7mbl" title="Stockholders redeemed shares"&gt;377,537&lt;/span&gt; shares of Common Stock resulting
in $&lt;span id="xdx_90A_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn5n6_c20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqlsu7olmXA9" title="Excise tax liabilty"&gt;1.2&lt;/span&gt; million and $&lt;span id="xdx_901_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn5n6_c20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKrv9agYO26b" title="Excise tax liabilty"&gt;1.2&lt;/span&gt; million of excise tax liability, calculated as 1% of the value of the shares redeemed, respectively&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <CYCU:DebtInstrumentAmortizationPercentage
      contextRef="From2022-01-112022-01-11"
      decimals="INF"
      id="Fact002712"
      unitRef="Pure">0.045</CYCU:DebtInstrumentAmortizationPercentage>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2022-01-112022-01-11"
      decimals="0"
      id="Fact002714"
      unitRef="USD">5175000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:PaymentsForFees
      contextRef="From2022-01-112022-01-11"
      decimals="0"
      id="Fact002716"
      unitRef="USD">500000</us-gaap:PaymentsForFees>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-01-11"
      decimals="INF"
      id="Fact002718"
      unitRef="Shares">16667</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-01-11"
      decimals="INF"
      id="Fact002720"
      unitRef="USDPShares">150.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <CYCU:TransactionFee
      contextRef="AsOf2022-01-11"
      decimals="0"
      id="Fact002722"
      unitRef="USD">2500000</CYCU:TransactionFee>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2022-01-11"
      decimals="INF"
      id="Fact002724"
      unitRef="Shares">16667</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:SharePrice
      contextRef="AsOf2022-01-11"
      decimals="INF"
      id="Fact002726"
      unitRef="USDPShares">5.00</us-gaap:SharePrice>
    <us-gaap:ProceedsFromSalesOfAssetsInvestingActivities
      contextRef="From2022-01-112022-01-11"
      decimals="0"
      id="Fact002728"
      unitRef="USD">2500000</us-gaap:ProceedsFromSalesOfAssetsInvestingActivities>
    <CYCU:AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock
      contextRef="From2022-01-112022-01-11_custom_AllianceGlobalPartnersMember_custom_TransactionFeeMember"
      decimals="INF"
      id="Fact002730"
      unitRef="Pure">0.75</CYCU:AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock>
    <CYCU:AdvisoryAgreementLockUpTerminationPeriod
      contextRef="From2022-01-112022-01-11_custom_AllianceGlobalPartnersMember_custom_TransactionFeeMember"
      id="Fact002732">P3M</CYCU:AdvisoryAgreementLockUpTerminationPeriod>
    <CYCU:AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock
      contextRef="From2022-01-112022-01-11_custom_AllianceGlobalPartnersMember_srt_MinimumMember_custom_TransactionFeeMember"
      decimals="INF"
      id="Fact002734"
      unitRef="Pure">0.10</CYCU:AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate
      contextRef="AsOf2022-01-11_custom_AllianceGlobalPartnersMember_custom_TransactionFeeMember"
      decimals="INF"
      id="Fact002736"
      unitRef="Pure">1</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2022-01-11_custom_AllianceGlobalPartnersMember"
      decimals="INF"
      id="Fact002738"
      unitRef="Shares">166667</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="AsOf2022-01-11_custom_AllianceGlobalPartnersMember"
      decimals="INF"
      id="Fact002740"
      unitRef="USDPShares">0.50</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2022-01-112022-01-11_custom_AllianceGlobalPartnersMember"
      decimals="0"
      id="Fact002742"
      unitRef="USD">2500000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <CYCU:AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock
      contextRef="From2022-01-112022-01-11_custom_AllianceGlobalPartnersMember_custom_AmendedTransactionFeeMember"
      decimals="INF"
      id="Fact002744"
      unitRef="Pure">0.75</CYCU:AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock>
    <CYCU:AdvisoryAgreementSharesLockUpEndingPeriodFromClosingDate
      contextRef="From2022-01-112022-01-11_custom_AllianceGlobalPartnersMember_custom_AmendedTransactionFeeMember"
      id="Fact002746">P6M</CYCU:AdvisoryAgreementSharesLockUpEndingPeriodFromClosingDate>
    <CYCU:AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock
      contextRef="From2022-01-112022-01-11_custom_AllianceGlobalPartnersMember_srt_MinimumMember_custom_AmendedTransactionFeeMember"
      decimals="INF"
      id="Fact002748"
      unitRef="Pure">0.10</CYCU:AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate
      contextRef="AsOf2022-01-11_custom_AllianceGlobalPartnersMember_custom_AmendedTransactionFeeMember"
      decimals="INF"
      id="Fact002750"
      unitRef="Pure">1</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2022-01-11_custom_AllianceGlobalPartnersMember"
      decimals="INF"
      id="Fact002752"
      unitRef="Shares">8333</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:LegalFees
      contextRef="From2024-11-272024-11-27_custom_SewardAndKisselLLPMember"
      decimals="-5"
      id="Fact002754"
      unitRef="USD">1300000</us-gaap:LegalFees>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-11-272024-11-27_custom_SewardAndKisselLLPMember"
      decimals="INF"
      id="Fact002756"
      unitRef="Shares">8333</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-11-27_custom_SewardAndKisselLLPMember"
      decimals="-5"
      id="Fact002758"
      unitRef="USD">1300000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2025-02-14_custom_SewardAndKisselLLPMember"
      decimals="-5"
      id="Fact002760"
      unitRef="USD">1300000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-02-142025-02-14_custom_SewardAndKisselLLPMember"
      decimals="INF"
      id="Fact002762"
      unitRef="Shares">83333</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:LegalFees
      contextRef="From2025-02-142025-02-14_custom_SewardAndKisselLLPMember"
      decimals="-5"
      id="Fact002764"
      unitRef="USD">1300000</us-gaap:LegalFees>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-02-14_custom_SewardAndKisselLLPMember_custom_PreFundedWarrantMember71589796"
      decimals="INF"
      id="Fact002766"
      unitRef="USDPShares">0.0030</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:OtherCommitment
      contextRef="AsOf2023-12-31_custom_BakerHostetlerLlpMember"
      decimals="0"
      id="Fact002768"
      unitRef="USD">788030</us-gaap:OtherCommitment>
    <us-gaap:SharePrice
      contextRef="AsOf2023-12-31_custom_BakerHostetlerLlpMember"
      decimals="INF"
      id="Fact002770"
      unitRef="USDPShares">10.00</us-gaap:SharePrice>
    <us-gaap:SharesIssued
      contextRef="AsOf2023-12-31_custom_BakerHostetlerLlpMember"
      decimals="INF"
      id="Fact002772"
      unitRef="Shares">2627</us-gaap:SharesIssued>
    <CYCU:MaximumCommitmentAmount
      contextRef="AsOf2025-04-07_custom_EquityPurchaseAgreementMember"
      decimals="-6"
      id="Fact002774"
      unitRef="USD">60000000.0</CYCU:MaximumCommitmentAmount>
    <CYCU:EquityPurchaseAgreementMaximumTerm
      contextRef="AsOf2025-04-07_custom_EquityPurchaseAgreementMember"
      id="Fact002776">P12M</CYCU:EquityPurchaseAgreementMaximumTerm>
    <CYCU:EquityOfferingPricePerSharePercentageOfClosingPrice
      contextRef="AsOf2025-04-07_custom_EquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact002778"
      unitRef="Pure">0.90</CYCU:EquityOfferingPricePerSharePercentageOfClosingPrice>
    <us-gaap:Cash
      contextRef="AsOf2025-04-07_custom_EquityPurchaseAgreementMember"
      decimals="-5"
      id="Fact002780"
      unitRef="USD">1800000</us-gaap:Cash>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-04-07_custom_EquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact002782"
      unitRef="USDPShares">0.0030</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-04-072025-04-07_custom_EquityPurchaseAgreementMember"
      decimals="-5"
      id="Fact002784"
      unitRef="USD">1800000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-04-07_custom_PreFundedWarrantMember"
      decimals="INF"
      id="Fact002786"
      unitRef="Shares">150000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-04-07_custom_PreFundedWarrantMember"
      decimals="INF"
      id="Fact002788"
      unitRef="USDPShares">0.003</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-04-07_custom_PreFundedWarrantMember"
      decimals="INF"
      id="Fact002790"
      unitRef="USDPShares">0.003</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <CYCU:NumberOfWarrantsExercised
      contextRef="From2025-01-012025-12-31_us-gaap_WarrantMember71590187"
      decimals="INF"
      id="Fact002792"
      unitRef="Shares">150000</CYCU:NumberOfWarrantsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2024-08-062024-08-06_custom_SponsorPromissoryNoteMember_custom_NonRedemptionAgreementMember"
      decimals="INF"
      id="Fact002794"
      unitRef="Shares">167</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2024-08-062024-08-06_custom_SponsorPromissoryNoteMember_custom_NonRedemptionAgreementMember"
      decimals="INF"
      id="Fact002796"
      unitRef="Shares">3327</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2024-10-092024-10-09_custom_SponsorPromissoryNoteMember_custom_NonRedemptionAgreementMember"
      decimals="INF"
      id="Fact002798"
      unitRef="Shares">167</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2024-10-092024-10-09_custom_SponsorPromissoryNoteMember_custom_NonRedemptionAgreementMember"
      decimals="INF"
      id="Fact002800"
      unitRef="Shares">3327</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="From2023-12-272023-12-27"
      decimals="0"
      id="Fact002802"
      unitRef="USD">125000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:Cash
      contextRef="AsOf2023-12-27"
      decimals="0"
      id="Fact002804"
      unitRef="USD">40000</us-gaap:Cash>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2023-12-272023-12-27"
      decimals="0"
      id="Fact002806"
      unitRef="USD">85000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="From2024-10-302024-10-30"
      decimals="0"
      id="Fact002808"
      unitRef="USD">200000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:Cash
      contextRef="AsOf2024-10-30"
      decimals="0"
      id="Fact002810"
      unitRef="USD">40000</us-gaap:Cash>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="From2024-10-302024-10-30"
      decimals="0"
      id="Fact002812"
      unitRef="USD">160000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="From2024-10-302024-10-30"
      decimals="INF"
      id="Fact002814"
      unitRef="Pure">0.15</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="From2024-10-302024-10-30"
      decimals="0"
      id="Fact002816"
      unitRef="USD">200000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <CYCU:EmploymentAgreementTerm
      contextRef="From2024-12-012024-12-01_srt_ChiefExecutiveOfficerMember_custom_EmploymentAgreementMember"
      id="Fact002818">P2Y</CYCU:EmploymentAgreementTerm>
    <us-gaap:SalariesAndWages
      contextRef="From2024-12-012024-12-01_srt_ChiefExecutiveOfficerMember_custom_EmploymentAgreementMember"
      decimals="0"
      id="Fact002820"
      unitRef="USD">325000</us-gaap:SalariesAndWages>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="From2024-12-012024-12-01_srt_ChiefExecutiveOfficerMember_custom_EmploymentAgreementMember"
      decimals="0"
      id="Fact002822"
      unitRef="USD">500000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <CYCU:PerformanceBonus
      contextRef="From2024-12-012024-12-01_srt_ChiefExecutiveOfficerMember_custom_EmploymentAgreementMember"
      decimals="0"
      id="Fact002824"
      unitRef="USD">325000</CYCU:PerformanceBonus>
    <CYCU:EmploymentAgreementTerm
      contextRef="From2025-01-012025-01-01_srt_ChiefExecutiveOfficerMember_custom_EmploymentAgreementMember"
      id="Fact002826">P2Y</CYCU:EmploymentAgreementTerm>
    <us-gaap:SalariesAndWages
      contextRef="From2025-01-012025-01-01_srt_ChiefExecutiveOfficerMember_custom_EmploymentAgreementMember"
      decimals="0"
      id="Fact002828"
      unitRef="USD">325000</us-gaap:SalariesAndWages>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="From2025-01-012025-01-01_srt_ChiefExecutiveOfficerMember_custom_EmploymentAgreementMember"
      decimals="0"
      id="Fact002830"
      unitRef="USD">500000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <CYCU:PerformanceBonus
      contextRef="From2025-01-012025-01-01_srt_ChiefExecutiveOfficerMember_custom_EmploymentAgreementMember"
      decimals="0"
      id="Fact002832"
      unitRef="USD">325000</CYCU:PerformanceBonus>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-06-162025-06-16_custom_EquityIncentivePlanMember_srt_ChiefExecutiveOfficerMember"
      decimals="INF"
      id="Fact002834"
      unitRef="Shares">100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-06-162025-06-16_custom_EquityIncentivePlanMember_srt_ChiefFinancialOfficerMember"
      decimals="INF"
      id="Fact002836"
      unitRef="Shares">100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002838"
      unitRef="Shares">380701</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002840"
      unitRef="Shares">377537</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="AsOf2025-12-31_us-gaap_CommonStockMember"
      decimals="-5"
      id="Fact002842"
      unitRef="USD">1200000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="-5"
      id="Fact002844"
      unitRef="USD">1200000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2025-01-012025-12-31" id="Fact002846">&lt;p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_zTBypoR5dLDf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;23.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_829_zcSOEqW9LsY7"&gt;SUBSEQUENT
                                            EVENTS&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluates subsequent events that have occurred after the balance sheet date but before the financial statements are issued which
is up to and through March 31, 2026. There are two types of subsequent events: (i) recognized, or those that provide additional evidence
with respect to conditions that existed at the date of the balance sheet, including the estimates inherent in the process of preparing
consolidated financial statements, and (ii) nonrecognized, or those that provide evidence with respect to conditions that did not exist
at the date of the balance sheet but arose subsequent to that date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 22, 2026, the Company announced that it has entered into a Memorandum of Understanding to acquire the video-solutions division
of Kustom Entertainment, Inc., a pioneer in mobile video surveillance technologies, including body-worn cameras, in-car video systems,
and digital evidence management solutions for law enforcement, public safety, and commercial sectors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 3, 2026, the Company announce that Litchfield Hills Research has initiated coverage on Cycurion.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 11, 2026, the Company announced a strategic business reorganization that will streamline operations, enhance organizational
agility, and position the Company for long-term growth.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 19, 2026, the Company held a special meeting of stockholders (the &#x201c;Special Meeting&#x201d;) to vote on the proposals identified
in the proxy statement filed with the SEC and mailed to stockholders on February 2, 2026. As of the record date on January 21, 2026,
there were a total of &lt;span id="xdx_907_eus-gaap--SharesIssued_iI_c20260319__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zEcnqI8EOWLk" title="Shares issued"&gt;5,148,411&lt;/span&gt; shares of Voting Stock (as defined below) issued and outstanding, consisting of &lt;span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20260319__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zDSnSx30bANl" title="Common Stock, Shares, Outstanding"&gt;4,188,187&lt;/span&gt; shares of Common
Stock, par value $&lt;span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20260319__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zRaCxrlHcfE9" title="Common stock, par value per share"&gt;0.0001&lt;/span&gt; per share (the &#x201c;Common Stock&#x201d;), and &lt;span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_c20260319__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zhaDvnupS885" title="Preferred Stock, Shares, Outstanding"&gt;960,224&lt;/span&gt; shares of preferred stock, par value $&lt;span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20260319__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zzTbsrVjLGTf" title="Preferred stock, par value per share"&gt;0.0001&lt;/span&gt; per share,
having voting rights on as as-if-converted-to- Common Stock basis (the &#x201c;Preferred Voting Stock&#x201d;, and together with the Common
Stock, the &#x201c;Voting Stock&#x201d;), each of which is entitled to &lt;span id="xdx_906_ecustom--CommonStockVotesPerShare_iI_dc_uVote_c20260319__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpQraNqMiU0b" title="Common stock, votes per share"&gt;one&lt;/span&gt; vote. A total of &lt;span id="xdx_90A_ecustom--VotingStockSharesRepresented_iI_c20260319__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zbgf5VmMXyvc" title="Voting stock, shares represented"&gt;2,611,518&lt;/span&gt; shares of the Company&#x2019;s Voting
Stock were represented at the Special Meeting either in person or by proxy. At the Special Meeting, the Company&#x2019;s stockholders
voted on the following matters and approved the proposal to approve, pursuant to Nasdaq Listing Rule 5635(d), the issuance of up to an
aggregate of &lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20260319__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zlFE2WvWDwsi" title="Class of warrant or right, number of securities called by warrants or rights"&gt;3,314,920&lt;/span&gt; shares of Common Stock upon the exercise of certain Common Stock purchase warrants issued in connection with our
private placement that closed on December 5, 2025, that may be equal to or exceed &lt;span id="xdx_90D_ecustom--CommonStockThresholdPercentageOfSharesOutstanding_iI_pid_c20260319__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zoKja1xhK0Y6" title="Voting stock, shares represented"&gt;20&lt;/span&gt;% of our outstanding shares of Common Stock immediately
prior to such offering.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 17, 2026, the Company issued a press release in response to an unauthorized press release.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 25, 2026, the Company announced two new contract awards which are expected to generate approximately $&lt;span id="xdx_901_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn4n6_c20260325__20260325__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z3ak5Tbw9yZ7" title="Net revenues"&gt;1.35&lt;/span&gt; million in combined
revenue in 2026, including $&lt;span id="xdx_900_ecustom--RevenueFromContractWithCustomerExcludingAssessedTaxAnnualRecurringRevenue_pn2n6_c20260325__20260325__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zB1J6Eu47aGb" title="Annual recurring revenue"&gt;1.165&lt;/span&gt; million in new annual recurring revenue. The awards include a multi-year engagement with a large healthcare
government agency and an expanded relationship with the National Association of County and City Health Officials.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SharesIssued
      contextRef="AsOf2026-03-19_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002848"
      unitRef="Shares">5148411</us-gaap:SharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2026-03-19_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002850"
      unitRef="Shares">4188187</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-19_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002852"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-03-19_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002854"
      unitRef="Shares">960224</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-19_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002856"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <CYCU:CommonStockVotesPerShare
      contextRef="AsOf2026-03-19_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002858"
      unitRef="Vote">1</CYCU:CommonStockVotesPerShare>
    <CYCU:VotingStockSharesRepresented
      contextRef="AsOf2026-03-19_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002860"
      unitRef="Shares">2611518</CYCU:VotingStockSharesRepresented>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2026-03-19_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002862"
      unitRef="Shares">3314920</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <CYCU:CommonStockThresholdPercentageOfSharesOutstanding
      contextRef="AsOf2026-03-19_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002864"
      unitRef="Pure">20</CYCU:CommonStockThresholdPercentageOfSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2026-03-252026-03-25_srt_ScenarioForecastMember"
      decimals="-4"
      id="Fact002866"
      unitRef="USD">1350000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <CYCU:RevenueFromContractWithCustomerExcludingAssessedTaxAnnualRecurringRevenue
      contextRef="From2026-03-252026-03-25_srt_ScenarioForecastMember"
      decimals="-2"
      id="Fact002868"
      unitRef="USD">1165000</CYCU:RevenueFromContractWithCustomerExcludingAssessedTaxAnnualRecurringRevenue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002873"
      unitRef="USD">2028718</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002874"
      unitRef="USD">5255235</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002876"
      unitRef="USD">3336047</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002877"
      unitRef="USD">2687479</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002879"
      unitRef="USD">106934</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002880"
      unitRef="USD">60133</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002882"
      unitRef="USD">5471699</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002883"
      unitRef="USD">8002847</us-gaap:AssetsCurrent>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002885"
      unitRef="USD">4735981</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002886"
      unitRef="USD">4606981</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:Goodwill
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002888"
      unitRef="USD">21238450</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002889"
      unitRef="USD">20842508</us-gaap:Goodwill>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002891"
      unitRef="USD">25974431</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002892"
      unitRef="USD">25449489</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002894"
      unitRef="USD">31446130</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002895"
      unitRef="USD">33452336</us-gaap:Assets>
    <us-gaap:LinesOfCreditCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002903"
      unitRef="USD">2725546</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LinesOfCreditCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002904"
      unitRef="USD">2933396</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LoansPayableCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002906"
      unitRef="USD">669693</us-gaap:LoansPayableCurrent>
    <us-gaap:LoansPayableCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002907"
      unitRef="USD">669693</us-gaap:LoansPayableCurrent>
    <CYCU:FactoringLiability
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002909"
      unitRef="USD">1566887</CYCU:FactoringLiability>
    <CYCU:FactoringLiability
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002910"
      unitRef="USD">1511678</CYCU:FactoringLiability>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002912"
      unitRef="USD">192897</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002913"
      unitRef="USD">192897</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:OtherNotesPayable
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002915"
      unitRef="USD">2500849</us-gaap:OtherNotesPayable>
    <us-gaap:OtherNotesPayable
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002916"
      unitRef="USD">2499662</us-gaap:OtherNotesPayable>
    <CYCU:LoansPayableRelatedParties
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002918"
      unitRef="USD">123650</CYCU:LoansPayableRelatedParties>
    <CYCU:LoansPayableRelatedParties
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002919"
      unitRef="USD">123650</CYCU:LoansPayableRelatedParties>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002921"
      unitRef="USD">1441596</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002922"
      unitRef="USD">1314772</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002924"
      unitRef="USD">4283045</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002925"
      unitRef="USD">4228337</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002927"
      unitRef="USD">1306906</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002928"
      unitRef="USD">919825</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002930"
      unitRef="USD">1486041</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002931"
      unitRef="USD">1347787</us-gaap:InterestPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002933"
      unitRef="USD">1167173</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002934"
      unitRef="USD">1167173</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002936"
      unitRef="USD">17464283</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002937"
      unitRef="USD">16908870</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermLoansPayable
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002939"
      unitRef="USD">300000</us-gaap:LongTermLoansPayable>
    <us-gaap:LongTermLoansPayable
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002940"
      unitRef="USD">300000</us-gaap:LongTermLoansPayable>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002942"
      unitRef="USD">300000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002943"
      unitRef="USD">300000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002945"
      unitRef="USD">17764283</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact002946"
      unitRef="USD">17208870</us-gaap:Liabilities>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact002957"
      unitRef="Shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact002959"
      unitRef="Shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002964"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002966"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-03-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002968"
      unitRef="Shares">110000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002970"
      unitRef="Shares">110000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2026-03-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002972"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-03-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002974"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002976"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002978"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002983"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002985"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-03-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002987"
      unitRef="Shares">3000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002989"
      unitRef="Shares">3000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2026-03-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002991"
      unitRef="Shares">1</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-03-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002993"
      unitRef="Shares">1</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002995"
      unitRef="Shares">1</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002997"
      unitRef="Shares">1</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003002"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003004"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-03-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003006"
      unitRef="Shares">5000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003008"
      unitRef="Shares">5000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2026-03-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003010"
      unitRef="Shares">2547</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-03-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003012"
      unitRef="Shares">2547</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003014"
      unitRef="Shares">4851</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003016"
      unitRef="Shares">4851</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003021"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003023"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-03-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003025"
      unitRef="Shares">6666700</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003027"
      unitRef="Shares">6666700</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2026-03-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003029"
      unitRef="Shares">150000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-03-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003031"
      unitRef="Shares">150000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003033"
      unitRef="Shares">150000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003035"
      unitRef="Shares">150000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2026-03-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="0"
      id="Fact003018"
      unitRef="USD">15</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="0"
      id="Fact003019"
      unitRef="USD">15</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003040"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003042"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-03-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003044"
      unitRef="Shares">100</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003046"
      unitRef="Shares">100</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2026-03-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003048"
      unitRef="Shares">51</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-03-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003050"
      unitRef="Shares">51</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003052"
      unitRef="Shares">51</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003054"
      unitRef="Shares">51</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003059"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003061"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-03-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003063"
      unitRef="Shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003065"
      unitRef="Shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2026-03-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003067"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-03-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003069"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003071"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003073"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003078"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003080"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-03-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003082"
      unitRef="Shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003084"
      unitRef="Shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2026-03-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003086"
      unitRef="Shares">143</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-03-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003088"
      unitRef="Shares">143</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003090"
      unitRef="Shares">143</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003092"
      unitRef="Shares">143</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact003100"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact003102"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact003104"
      unitRef="Shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact003106"
      unitRef="Shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact003108"
      unitRef="Shares">5510021</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact003110"
      unitRef="Shares">5510021</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact003112"
      unitRef="Shares">3642501</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact003114"
      unitRef="Shares">3642501</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact003097"
      unitRef="USD">551</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact003098"
      unitRef="USD">364</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact003116"
      unitRef="USD">46979742</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact003117"
      unitRef="USD">46979762</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact003119"
      unitRef="USD">-29007543</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact003120"
      unitRef="USD">-26879081</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact003122"
      unitRef="USD">17972765</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact003123"
      unitRef="USD">20101060</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact003125"
      unitRef="USD">-4290918</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact003126"
      unitRef="USD">-3857594</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact003128"
      unitRef="USD">13681847</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact003129"
      unitRef="USD">16243466</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact003131"
      unitRef="USD">31446130</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact003132"
      unitRef="USD">33452336</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003134"
      unitRef="USD">3268620</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003135"
      unitRef="USD">3870050</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003137"
      unitRef="USD">2580262</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003138"
      unitRef="USD">3192287</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003140"
      unitRef="USD">688358</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003141"
      unitRef="USD">677763</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003146"
      unitRef="USD">2743695</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003147"
      unitRef="USD">337374</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003149"
      unitRef="USD">315833</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003153"
      unitRef="USD">10437894</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:OperatingExpenses
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003155"
      unitRef="USD">3059528</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003156"
      unitRef="USD">10775268</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003158"
      unitRef="USD">-2371170</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003159"
      unitRef="USD">-10097505</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeNonoperating
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003164"
      unitRef="USD">14236</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003167"
      unitRef="USD">204852</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003168"
      unitRef="USD">178890</us-gaap:InterestExpenseNonoperating>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003171"
      unitRef="USD">141653</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003174"
      unitRef="USD">-113744</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003176"
      unitRef="USD">-190616</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003177"
      unitRef="USD">-150981</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003179"
      unitRef="USD">-2561786</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003180"
      unitRef="USD">-10248486</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003185"
      unitRef="USD">-2561786</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003186"
      unitRef="USD">-10248486</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003188"
      unitRef="USD">-433324</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003191"
      unitRef="USD">-2128462</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003192"
      unitRef="USD">-10248486</us-gaap:NetIncomeLoss>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003194"
      unitRef="USD">-2128462</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003195"
      unitRef="USD">-10248486</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2026-01-01to2026-03-31"
      decimals="INF"
      id="Fact003200"
      unitRef="USDPShares">-0.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-01-012025-03-31"
      decimals="INF"
      id="Fact003201"
      unitRef="USDPShares">-15.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2026-01-01to2026-03-31"
      decimals="INF"
      id="Fact003203"
      unitRef="USDPShares">-0.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-01-012025-03-31"
      decimals="INF"
      id="Fact003204"
      unitRef="USDPShares">-7.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2026-01-01to2026-03-31"
      decimals="INF"
      id="Fact003209"
      unitRef="Shares">4561976</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-01-012025-03-31"
      decimals="INF"
      id="Fact003210"
      unitRef="Shares">658218</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2026-01-01to2026-03-31"
      decimals="INF"
      id="Fact003212"
      unitRef="Shares">4561976</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-01-012025-03-31"
      decimals="INF"
      id="Fact003213"
      unitRef="Shares">1383507</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact003228"
      unitRef="Shares">5796</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact003230"
      unitRef="USD">1917309</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact003234"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact003236"
      unitRef="Shares">4851</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact003238"
      unitRef="Shares">150000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact003218"
      unitRef="USD">15</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact003240"
      unitRef="Shares">51</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact003242"
      unitRef="Shares">143</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003244"
      unitRef="Shares">3642501</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003221"
      unitRef="USD">364</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003222"
      unitRef="USD">46979762</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact003223"
      unitRef="USD">-26879081</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact003224"
      unitRef="USD">20101060</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact003225"
      unitRef="USD">-3857594</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact003226"
      unitRef="USD">16243466</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2026-01-012026-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003259"
      unitRef="Shares">1670719</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2026-01-012026-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003252"
      unitRef="USD">167</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2026-01-012026-03-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact003255"
      unitRef="USD">167</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003257"
      unitRef="USD">167</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2026-01-012026-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact003274"
      unitRef="Shares">-2304</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2026-01-012026-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003276"
      unitRef="Shares">196801</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2026-01-012026-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003267"
      unitRef="USD">20</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2026-01-012026-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003268"
      unitRef="USD">-20</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-012026-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact003286"
      unitRef="USD">-2128462</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-012026-03-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact003287"
      unitRef="USD">-2128462</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-012026-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact003288"
      unitRef="USD">-433324</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003289"
      unitRef="USD">-2561786</us-gaap:ProfitLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact003304"
      unitRef="Shares">5796</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact003306"
      unitRef="USD">1917309</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2026-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact003310"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2026-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact003312"
      unitRef="Shares">2547</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2026-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact003314"
      unitRef="Shares">150000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2026-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact003294"
      unitRef="USD">15</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2026-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact003316"
      unitRef="Shares">51</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2026-03-31_custom_SeriesGConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact003318"
      unitRef="Shares">143</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2026-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003320"
      unitRef="Shares">5510021</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2026-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003297"
      unitRef="USD">551</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2026-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003298"
      unitRef="USD">46979742</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2026-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact003299"
      unitRef="USD">-29007543</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2026-03-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact003300"
      unitRef="USD">17972765</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2026-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact003301"
      unitRef="USD">-4290918</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact003302"
      unitRef="USD">13681847</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact003335"
      unitRef="Shares">5796</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact003337"
      unitRef="USD">1917309</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact003341"
      unitRef="Shares">3000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact003343"
      unitRef="Shares">4851</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003351"
      unitRef="Shares">391373</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003328"
      unitRef="USD">38</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003329"
      unitRef="USD">6671081</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact003330"
      unitRef="USD">-3203361</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact003331"
      unitRef="USD">3467758</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact003333"
      unitRef="USD">3467758</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <CYCU:TemporaryEquityRedeemedShares
      contextRef="From2025-01-012025-03-31"
      decimals="INF"
      id="Fact003366"
      unitRef="Shares">-3163</CYCU:TemporaryEquityRedeemedShares>
    <CYCU:TemporaryEquityRedeemedValue
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003368"
      unitRef="USD">-1001216</CYCU:TemporaryEquityRedeemedValue>
    <CYCU:TemporaryEquitySharesReleaseOfCommonStockSubjectToRedemption
      contextRef="From2025-01-012025-03-31"
      decimals="INF"
      id="Fact003383"
      unitRef="Shares">-2633</CYCU:TemporaryEquitySharesReleaseOfCommonStockSubjectToRedemption>
    <CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemption
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003385"
      unitRef="USD">-916093</CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemption>
    <CYCU:StockIssuedDuringPeriodSharesReleaseOfCommonStockSubjectToRedemption
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003387"
      unitRef="Shares">2654</CYCU:StockIssuedDuringPeriodSharesReleaseOfCommonStockSubjectToRedemption>
    <CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemptionValue
      contextRef="From2025-01-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003377"
      unitRef="USD">916093</CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemptionValue>
    <CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemptionValue
      contextRef="From2025-01-012025-03-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact003379"
      unitRef="USD">916093</CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemptionValue>
    <CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemptionValue
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003381"
      unitRef="USD">916093</CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemptionValue>
    <CYCU:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesLiability
      contextRef="From2025-01-012025-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact003402"
      unitRef="Shares">106816</CYCU:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesLiability>
    <CYCU:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesLiability
      contextRef="From2025-01-012025-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact003389"
      unitRef="USD">11</CYCU:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesLiability>
    <CYCU:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesLiability
      contextRef="From2025-01-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003396"
      unitRef="USD">1391165</CYCU:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesLiability>
    <CYCU:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesLiability
      contextRef="From2025-01-012025-03-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact003398"
      unitRef="USD">1391176</CYCU:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesLiability>
    <CYCU:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesLiability
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003400"
      unitRef="USD">1391176</CYCU:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesLiability>
    <CYCU:StockIssuedDuringPeriodSharesPreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact003417"
      unitRef="Shares">6666666</CYCU:StockIssuedDuringPeriodSharesPreferredStockInExchangeOfConvertibleNotes>
    <CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact003407"
      unitRef="USD">667</CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes>
    <CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003411"
      unitRef="USD">3332668</CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes>
    <CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-03-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact003413"
      unitRef="USD">3333335</CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes>
    <CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003415"
      unitRef="USD">3333335</CYCU:StockIssuedDuringPeriodValuePreferredStockInExchangeOfConvertibleNotes>
    <CYCU:StockIssuedDuringPeriodSharesCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact003432"
      unitRef="Shares">-2999</CYCU:StockIssuedDuringPeriodSharesCommonStockIssuedForConversionOfConvertiblePreferredStock>
    <CYCU:StockIssuedDuringPeriodSharesCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact003434"
      unitRef="Shares">-6516666</CYCU:StockIssuedDuringPeriodSharesCommonStockIssuedForConversionOfConvertiblePreferredStock>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact003422"
      unitRef="USD">-652</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock>
    <CYCU:StockIssuedDuringPeriodSharesCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember_custom_SeriesBConvertiblePreferredStockAndSeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003436"
      unitRef="Shares">420515</CYCU:StockIssuedDuringPeriodSharesCommonStockIssuedForConversionOfConvertiblePreferredStock>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003425"
      unitRef="USD">42</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock
      contextRef="From2025-01-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003426"
      unitRef="USD">610</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfConvertiblePreferredStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003451"
      unitRef="Shares">236709</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003444"
      unitRef="USD">24</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003445"
      unitRef="USD">3309897</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-03-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact003447"
      unitRef="USD">3309921</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003449"
      unitRef="USD">3309921</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003466"
      unitRef="Shares">25200</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003459"
      unitRef="USD">3</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2025-01-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003460"
      unitRef="USD">8999997</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2025-01-012025-03-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact003462"
      unitRef="USD">9000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003464"
      unitRef="USD">9000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <CYCU:StockIssuedDuringPeriodSharesCommonStockIssuedForSettlementOfLiability
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003481"
      unitRef="Shares">2648</CYCU:StockIssuedDuringPeriodSharesCommonStockIssuedForSettlementOfLiability>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability
      contextRef="From2025-01-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003475"
      unitRef="USD">945636</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability
      contextRef="From2025-01-012025-03-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact003477"
      unitRef="USD">945636</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003479"
      unitRef="USD">945636</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfLiability>
    <CYCU:StockIssuedDuringPeriodSharesCommonStockIssuedForEmploymentAgreement
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003496"
      unitRef="Shares">16800</CYCU:StockIssuedDuringPeriodSharesCommonStockIssuedForEmploymentAgreement>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003489"
      unitRef="USD">2</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement
      contextRef="From2025-01-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003490"
      unitRef="USD">249998</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement
      contextRef="From2025-01-012025-03-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact003492"
      unitRef="USD">250000</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement>
    <CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003494"
      unitRef="USD">250000</CYCU:StockIssuedDuringPeriodValueCommonStockIssuedForEmploymentAgreement>
    <CYCU:StockIssuedDuringPeriodSharesAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact003511"
      unitRef="Shares">51</CYCU:StockIssuedDuringPeriodSharesAcquisitionOfSubsidiary>
    <CYCU:StockIssuedDuringPeriodSharesAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003513"
      unitRef="Shares">17074</CYCU:StockIssuedDuringPeriodSharesAcquisitionOfSubsidiary>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003504"
      unitRef="USD">2</CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003505"
      unitRef="USD">509069</CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-03-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact003507"
      unitRef="USD">509071</CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary>
    <CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003509"
      unitRef="USD">509071</CYCU:StockIssuedDuringPeriodValueAcquisitionOfSubsidiary>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2025-01-012025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact003523"
      unitRef="USD">10012</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2025-01-012025-03-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact003524"
      unitRef="USD">10012</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2025-01-012025-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact003525"
      unitRef="USD">3464218</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003526"
      unitRef="USD">3474230</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-012025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact003536"
      unitRef="USD">-10248486</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-012025-03-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact003537"
      unitRef="USD">-10248486</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003539"
      unitRef="USD">-10248486</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact003558"
      unitRef="Shares">106816</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-03-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact003541"
      unitRef="USD">11</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-03-31_custom_SeriesBConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact003560"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-03-31_custom_SeriesCConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact003562"
      unitRef="Shares">4851</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact003564"
      unitRef="Shares">150000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-03-31_custom_SeriesDConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact003544"
      unitRef="USD">15</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-03-31_custom_SeriesEConvertiblePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact003566"
      unitRef="Shares">51</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003570"
      unitRef="Shares">1112973</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003547"
      unitRef="USD">111</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003548"
      unitRef="USD">26326214</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact003549"
      unitRef="USD">-13461859</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-03-31_us-gaap_ParentMember"
      decimals="0"
      id="Fact003550"
      unitRef="USD">12864492</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact003551"
      unitRef="USD">-3464218</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact003552"
      unitRef="USD">9400274</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003575"
      unitRef="USD">-2561786</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003576"
      unitRef="USD">-10248486</us-gaap:ProfitLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003581"
      unitRef="USD">315833</us-gaap:ShareBasedCompensation>
    <CYCU:ShareBasedPaymentArrangementBusinessCombinationRelatedNoncashExpense
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003585"
      unitRef="USD">9250000</CYCU:ShareBasedPaymentArrangementBusinessCombinationRelatedNoncashExpense>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003587"
      unitRef="USD">1187</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003588"
      unitRef="USD">64850</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:Depreciation
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003591"
      unitRef="USD">1709</us-gaap:Depreciation>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003594"
      unitRef="USD">8333</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003597"
      unitRef="USD">141653</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003600"
      unitRef="USD">100000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003605"
      unitRef="USD">648568</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003606"
      unitRef="USD">1300686</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003608"
      unitRef="USD">46801</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003609"
      unitRef="USD">11415</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003611"
      unitRef="USD">-184201</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003612"
      unitRef="USD">-286114</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003614"
      unitRef="USD">96248</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003615"
      unitRef="USD">37673</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003617"
      unitRef="USD">138254</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003618"
      unitRef="USD">-219320</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003620"
      unitRef="USD">-2889834</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003621"
      unitRef="USD">-2745109</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003627"
      unitRef="USD">34983</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003629"
      unitRef="USD">129000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003630"
      unitRef="USD">70000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <CYCU:CashWithdrawnFromTrustAccountInConnectionWithRedemption
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003633"
      unitRef="USD">1001216</CYCU:CashWithdrawnFromTrustAccountInConnectionWithRedemption>
    <CYCU:ReleaseOfTrustAccountToCompanysBankAccount
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003636"
      unitRef="USD">833324</CYCU:ReleaseOfTrustAccountToCompanysBankAccount>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003638"
      unitRef="USD">-129000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003639"
      unitRef="USD">1799523</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003644"
      unitRef="USD">167</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003645"
      unitRef="USD">3309921</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003648"
      unitRef="USD">1001216</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003650"
      unitRef="USD">207850</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003651"
      unitRef="USD">9300</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfBankDebt
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003654"
      unitRef="USD">5114</us-gaap:RepaymentsOfBankDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003657"
      unitRef="USD">386500</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2025-01-012025-03-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact003660"
      unitRef="USD">513200</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2025-01-012025-03-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact003663"
      unitRef="USD">20000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003665"
      unitRef="USD">-207683</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003666"
      unitRef="USD">3173991</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003668"
      unitRef="USD">-3226517</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003669"
      unitRef="USD">2228405</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact003671"
      unitRef="USD">5255235</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact003672"
      unitRef="USD">40790</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact003674"
      unitRef="USD">2028718</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact003675"
      unitRef="USD">2269195</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact003677">&lt;p id="xdx_807_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zf6TslQtTDfg" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.
&lt;span id="xdx_829_ztTDK1oUM1Nd"&gt;ORGANIZATION AND DESCRIPTION OF BUSINESS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cycurion,
Inc. (f/k/a KAE Holdings, Inc.; f/k/a Cyber Secure Solutions, Inc.)(the &#x201c;Company&#x201d;, &#x201c;Cycurion&#x201d;, &#x201c;we&#x201d;,
&#x201c;us&#x201d; or &#x201c;our&#x201d;) was incorporated on October&#160;12, 2017, in the state of Delaware. Through its subsidiaries,
the Company provides premier information technology security solutions. The Company continually strives to deliver top-notch services
in the areas of risk management, cybersecurity, information assurance, systems engineering and help desk solutions. The Company is headquartered
in McLean, Virginia. On July 14, 2020, the Company changed its corporate name from KAE Holdings, Inc. to Cyber Secure Solutions, Inc.,
and, on February 24, 2021, to Cycurion, Inc.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has &lt;span id="xdx_90A_ecustom--NumberOfWhollyOwnedSubsidiariesFirstTier_pid_dc_uSubsidiary_c20260101__20260331_zz59iRU0npzl" title="Number of first tier wholly owned subsidiaries"&gt;two&lt;/span&gt; first-tier wholly-owned subsidiaries, Cycurion Sub, Inc. (formerly Cycurion, Inc., until February 14, 2025) and Cycurion
Crypto Inc., a Delaware corporation formed in July 2025, and &lt;span id="xdx_909_ecustom--NumberOfWhollyOwnedSubsidiariesSecondTier_pid_dc_uSubsidiary_c20260101__20260331_zi9R1G4VFao3" title="Number of second tier wholly owned subsidiaries"&gt;three&lt;/span&gt; indirectly wholly-owned second-tier subsidiaries: (i) Axxum Technologies
LLC (&#x201c;Axxum&#x201d;), a Virginia limited liability company formed in December 2006, (ii) Cloudburst Security LLC (&#x201c;Cloudburst&#x201d;),
a Virginia limited liability company formed in January 2007, and (iii) Cycurion Innovation, Inc., a Delaware corporation formed in September
2021 (&#x201c;Cycurion Innovation&#x201d;), in connection with our acquisition of assets from Sabres Security Ltd. (&#x201c;Sabres&#x201d;),
a leading Israeli-based cybersecurity provider.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Business
Combination&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 14, 2025, the Company completed the business combination and transactions (the &#x201c;Business Combination&#x201d;) as set
forth in an Agreement and Plan of Merger, dated November 21, 2022, as amended on April 26, 2024, December 31, 2024 and
February&#160;13,&#160;2025 (the &#x201c;Merger Agreement&#x201d;), by and among Western Acquisition Ventures Corp.
(&#x201c;Western&#x201d;), Western Acquisition Merger Inc., a Delaware corporation and a wholly-owned subsidiary of Western
(&#x201c;Merger Sub&#x201d;), and Cycurion Sub, Inc., a Delaware corporation formerly known as Cycurion, Inc. (&#x201c;Cycurion
Sub&#x201d;). As contemplated by the Merger Agreement, Merger Sub merged with and into Cycurion Sub with Cycurion Sub as surviving
the merger as a wholly-owned subsidiary of Western. In addition, in connection with the consummation of the Business Combination,
Western was renamed &#x201c;Cycurion, Inc.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
a result of the Business Combination, each common share of Cycurion Sub was cancelled and converted into shares of Company common stock,
on the terms set forth in the Merger Agreement. Pursuant to the terms of the Merger Agreement, the aggregate number of shares of Company
common stock that was delivered as consideration in the Business Combination was capped at &lt;span id="xdx_903_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember_zPb7pDVJmQvf" title="Number of preferred stock converted"&gt;500,000&lt;/span&gt; shares. Concurrently with the completion
of the Business Combination, the Company issued an aggregate of &lt;span id="xdx_90A_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z67gcy7gNnh7" title="Number of preferred stock converted"&gt;218,102&lt;/span&gt; shares of common stock, &lt;span id="xdx_90C_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zEwGcqfwxUi2" title="Number of preferred stock converted"&gt;106,816&lt;/span&gt; shares of Series A convertible
preferred stock (&#x201c;Series A Convertible Preferred Stock&#x201d;), &lt;span id="xdx_907_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zbNwtcDy87cf" title="Number of preferred stock converted"&gt;3,000&lt;/span&gt; shares of Series B convertible preferred stock (&#x201c;Series
B Convertible Preferred Stock&#x201d;), &lt;span id="xdx_908_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zNjntX1r3d8l" title="Number of preferred stock converted"&gt;4,851&lt;/span&gt; shares of Series C convertible preferred stock (&#x201c;Series C Convertible Preferred Stock&#x201d;),
&lt;span id="xdx_908_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zahxoF6ef2cb" title="Number of preferred stock converted"&gt;6,666,666&lt;/span&gt; shares of Series D convertible preferred stock (&#x201c;Series D Convertible Preferred Stock&#x201d;), &lt;span id="xdx_906_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_z4TaRvXu0B9g" title="Number of preferred stock converted"&gt;22,696&lt;/span&gt; Series A warrants,
&lt;span id="xdx_90A_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zvL5sxd9FRP4" title="Number of preferred stock converted"&gt;200,000&lt;/span&gt; Series B warrants, &lt;span id="xdx_901_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDWarrantsMember_zlf1b4bi4cK7" title="Number of preferred stock converted"&gt;242,424&lt;/span&gt; Series D warrants , &lt;span id="xdx_90B_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--StatementEquityComponentsAxis__custom--CommonStockWarrantMember_zDZ9HV59O7sc" title="Number of preferred stock converted"&gt;9,006&lt;/span&gt; common stock warrants, &lt;span id="xdx_907_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--StatementEquityComponentsAxis__custom--SeriesDPrivatePlacementMember_z70Syi8M7sm2" title="Number of preferred stock converted"&gt;15,760&lt;/span&gt; shares of common stock issued in connection
with the Series D private placement, &lt;span id="xdx_908_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--AllianceGlobalPartnersMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztpgrGl8MFoh" title="Number of preferred stock converted"&gt;16,667&lt;/span&gt; shares of common stock issued to A.G.P./Alliance Global Partners (&#x201c;A.G.P.&#x201d;),
&lt;span id="xdx_90E_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--SewardAndKisselLLPMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zh8lhHQRLrOl" title="Number of preferred stock converted"&gt;8,333 &lt;/span&gt;shares of common stock issued to Seward &amp;amp; Kissel LLP and &lt;span id="xdx_903_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250214__20250214__us-gaap--BusinessAcquisitionAxis__custom--BakerAndHostetlerLLPMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjWHtytbIwe7" title="Number of preferred stock converted"&gt;2,627&lt;/span&gt; shares of common stock issued to Baker &amp;amp; Hostetler LLP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Business Combination has been accounted for as a reverse recapitalization in accordance with accounting principles generally accepted
in the United States of America (&#x201c;U.S. GAAP&#x201d;) because Cycurion is the operating company and has been determined to be the
accounting acquirer under Financial Accounting Standards Board&#x2019;s Accounting Standards Codification Topic 805, Business Combinations
(&#x201c;ASC 805&#x201d;), while Western is a blank check company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the reverse recapitalization model, the Business Combination was treated as Cycurion issuing equity for the net assets of Western, with
no goodwill or intangible assets recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;While
Western was the legal acquirer in the Business Combination, because Cycurion Sub, prior to the Business Combination, was deemed the accounting
acquirer, the historical financial statements of Cycurion Sub became the historical financial statements of the combined company upon
the consummation of the Business Combination. As a result, the financial statements reflect (i) the historical operating results of Cycurion
Sub prior to the Business Combination; (ii) the combined results of Western and Cycurion Sub following the closing of the Business Combination;
(iii) the assets and liabilities of Cycurion Sub at their historical cost; and (iv) Cycurion&#x2019;s equity structure for all periods
presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with the applicable guidance, the equity structure has been retroactively restated in all comparative periods up to the closing
date, of the Business Combination to reflect the number of shares of the Company&#x2019;s common stock issued to Cycurion Sub common stockholders
in connection with the Business Combination. As such, the shares and corresponding capital amounts and earnings per share related to
Cycurion Sub prior to the Business Combination have been retroactively restated as shares reflecting the exchange ratio established in
the Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Going
Concern&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying financial statements have been prepared in conformity with U.S. GAAP, which contemplates continuation of the Company on
a going concern basis. The going concern basis assumes that assets are realized, and liabilities are settled in the ordinary course of
business at amounts disclosed in the financial statements. As of March&#160;31, 2026, there was substantial doubt regarding the Company&#x2019;s
ability to continue as a going concern, as the Company had a net working capital deficit and an accumulated deficit resulting from substantial
losses incurred during the three months ended March&#160;31, 2026 and from prior periods. The Company&#x2019;s ability to continue as
a going concern depends upon its ability to market and sell its products to generate positive operating cash flows. As of March&#160;31,
2026, the Company had an accumulated deficit of $&lt;span id="xdx_902_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn5n6_di_c20260331_zv5dEMxHTZSl" title="Accumulated deficit"&gt;29.0&lt;/span&gt;&#160;million and a working capital deficit of $&lt;span id="xdx_90E_ecustom--WorkingCapitalDeficit_iI_c20260331_zCxUAfdFTRL5" title="Working capital deficit"&gt;12.0&lt;/span&gt;&#160;million. In addition,
the Company had a net cash outflow of $&lt;span id="xdx_901_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn5n6_di_c20260101__20260331_zAbzpubfC3ob" title="Net cash used in operating activities"&gt;2.9&lt;/span&gt;&#160;million from operating activities during the three months ended March&#160;31, 2026.
These circumstances continued to give rise to substantial doubt as to whether the Company will be able to continue as a going concern
and did not alleviate the doubt outstanding from 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management&#x2019;s
plan is to continue improving operations to generate positive cash flows and register shares of its common stock in order to undertake
a public offering to raise additional capital. Management believes that the valuation and liquidity brought by a public offering of its
securities will allow holders of convertibles notes, and convertible preferred stockholders the mechanism to convert their securities
into common stock that will reduce the Company&#x2019;s overall leverage and debt service requirement. If the Company is not able to continue
generating positive operating cash flows, and raise additional capital, there is the risk that the Company may become insolvent.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Emerging
Growth Company&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an emerging growth company as defined in Section 102(b)(1) of the Jumpstart Our Business Start-ups Act of 2012 (the &#x201c;JOBS
Act&#x201d;) which exempts emerging growth companies from being required to comply with new or revised financial accounting standards
until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a
class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards.
The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies, but any such an election to opt out is irrevocable. The Company has elected not to opt out
of such extended transition period, which means that when a standard is issued or revised, and it has different application dates for
public or private companies. The Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;This
may make comparison of the Company&#x2019;s financial statements with another public company that is neither an emerging growth company
nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential
differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Nasdaq
Communications&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 21, 2025, the Company announced that we received formal notification on August 19, 2025 and August&#160;20,&#160;2025 from the
Nasdaq Stock Market (&#x201c;Nasdaq&#x201d;) regarding its previous deficiencies. On August 19, 2025, Nasdaq determined that we comply
with Nasdaq Listing Rule 5450(b)(1)(A), which requires a minimum of $10,000,000 in stockholders&#x2019; equity (&#x201c;Equity Rule&#x201d;),
based on our Form 10-Q for the period ended June 30, 2025, evidencing stockholders&#x2019; equity of $&lt;span id="xdx_90A_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iI_c20250630_zLsdHnt96bT4" title="Stockholders' equity"&gt;10,448,853&lt;/span&gt;. Reference is made to
the April 11, 2025 notification for failure to maintain a minimum market value of listed securities of $50,000,000 over the previous
30 consecutive business days as set forth in Listing Rule 5450(b)(2)(A) (&#x201c;MVLS Rule&#x201d;). As we are in compliance with the Equity
Rule, Nasdaq notified us that the matter regarding the MVLS Rule is now closed. Additionally, on August 20, 2025, we received formal
notification from Nasdaq, determining that for the last 10 consecutive business days, from August 5, 2025 to August 18, 2025, our market
value of publicly held shares (&#x201c;MVPHS&#x201d;) has been $5,000,000 or greater set forth in Nasdaq Listing Rule 5450(b)(1)(C) (&#x201c;MVPHS
Rule&#x201d;), and that we have regained compliance with the MVPHS Rule.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 14, 2025, we received written notice from the staff of Nasdaq Listing Qualifications (the &#x201c;Staff&#x201d;) that it has determined
to commence proceedings to delist our common stock from the Nasdaq Global Market. As previously announced in a Current Report filed with
the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;), on April 15, 2025, the Staff notified the Company on April 9, 2025
that, for the prior 30 consecutive business days, the closing bid price of our common stock had been below the minimum of $1.00 per share
required for continued listing on The Nasdaq Global Market under Nasdaq Listing Rule 5550(a)(2) (the &#x201c;Bid Price Rule&#x201d;). The
notification letter stated that we would be afforded 180 calendar days, or until October 6, 2025, to regain compliance. The Company did
not regain compliance with the Bid Price Rule by October 6, 2025, and the listed security was subject to delisting from The Nasdaq Global
Market.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 20, 2025, the Company submitted its request to the Nasdaq Global Market to appeal the Staff&#x2019;s determination to a Hearings
Panel (the &#x201c;Panel&#x201d;) pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series, which stayed the suspension
of the Company&#x2019;s securities and the filing of a Form 25-NSE with the SEC that would remove the Company&#x2019;s shares of common
stock from listing and registration on The Nasdaq Stock Market. The Company&#x2019;s hearing was scheduled for November 20, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 11, 2025, the Company announced that it received a letter Nasdaq stating that Nasdaq has determined that the Company has regained
compliance with Nasdaq&#x2019;s Bid Price Rule requirement under Listing Rule 5450(a)(1). The Company is now in compliance with Nasdaq
Global Market&#x2019;s listing requirements. Additionally, Nasdaq confirmed that the previously scheduled hearing before the Panel on
November 20, 2025 has been canceled. The Company&#x2019;s securities will continue to be listed and traded on The Nasdaq Stock Market
without interruption and no further communication from Nasdaq has been received as of the date of this filing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Reverse
Stock Split&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 27, 2025, the Company announced a one-for-thirty reverse stock split of the Company&#x2019;s shares of common stock, par value
$&lt;span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20251027_zDtaUfdN9MSh" title="Common stock, par value per share"&gt;0.0001&lt;/span&gt; per share (the &#x201c;Reverse Stock Split&#x201d;) that took effect with the commencement of business on October 27, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company effected the Reverse Stock Split by filing the Second Amendment to the Second Amended and Restated Certificate of Incorporation
with the Secretary of State of the State of Delaware. The Company&#x2019;s shares of common stock began trading on a split-adjusted basis
on The Nasdaq Global Market, when the market opened on October 27, 2025, under the existing trading symbol &#x201c;CYCU&#x201d; and new
CUSIP number 95758L305.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
a result of the Reverse Stock Split, every thirty of the Company&#x2019;s issued shares of common stock was combined into one issued share
of common stock, without any change to the par value per share and without any change in the total number of authorized shares of common
stock. The number of outstanding shares of common stock was reduced from approximately &lt;span id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_iI_c20251026_znXHirLRPXB1" title="Common stock,shares outstanding"&gt;86,533,435&lt;/span&gt; shares to approximately &lt;span id="xdx_907_eus-gaap--CommonStockSharesOutstanding_iI_c20251027_znR7WHYie9Yl" title="Common stock,shares outstanding"&gt;2,884,447&lt;/span&gt; shares.
All disclosures affected in this Annual Report on Form 10-K, including share counts and warrant counts have been retroactively adjusted
to give effect to the Reverse Stock Split.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;No
fractional shares were issued in connection with the Reverse Stock Split. Stockholders who otherwise held a fraction of a share of common
stock of the Company will receive a cash payment (without interest and subject to withholding taxes, as applicable) in lieu thereof at
a price equal to that fraction of a share to which the stockholder would otherwise be entitled, multiplied by the closing price of the
Company&#x2019;s shares on The Nasdaq Global Market on the trading day immediately preceding the effective date of the Reverse Stock Split.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <CYCU:NumberOfWhollyOwnedSubsidiariesFirstTier
      contextRef="From2026-01-01to2026-03-31"
      decimals="INF"
      id="Fact003679"
      unitRef="Subsidiary">2</CYCU:NumberOfWhollyOwnedSubsidiariesFirstTier>
    <CYCU:NumberOfWhollyOwnedSubsidiariesSecondTier
      contextRef="From2026-01-01to2026-03-31"
      decimals="INF"
      id="Fact003681"
      unitRef="Subsidiary">3</CYCU:NumberOfWhollyOwnedSubsidiariesSecondTier>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember"
      decimals="INF"
      id="Fact003683"
      unitRef="Shares">500000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003685"
      unitRef="Shares">218102</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact003687"
      unitRef="Shares">106816</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact003689"
      unitRef="Shares">3000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact003691"
      unitRef="Shares">4851</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact003693"
      unitRef="Shares">6666666</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_custom_SeriesAWarrantsMember"
      decimals="INF"
      id="Fact003695"
      unitRef="Shares">22696</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_custom_SeriesBWarrantsMember"
      decimals="INF"
      id="Fact003697"
      unitRef="Shares">200000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_custom_SeriesDWarrantsMember"
      decimals="INF"
      id="Fact003699"
      unitRef="Shares">242424</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_custom_CommonStockWarrantMember71571109"
      decimals="INF"
      id="Fact003701"
      unitRef="Shares">9006</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_WesternAcquisitionVenturesCorpMember_custom_SeriesDPrivatePlacementMember71571109"
      decimals="INF"
      id="Fact003703"
      unitRef="Shares">15760</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_AllianceGlobalPartnersMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003705"
      unitRef="Shares">16667</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_SewardAndKisselLLPMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003707"
      unitRef="Shares">8333</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-02-142025-02-14_custom_BakerAndHostetlerLLPMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003709"
      unitRef="Shares">2627</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2026-03-31"
      decimals="-5"
      id="Fact003711"
      unitRef="USD">-29000000.0</us-gaap:RetainedEarningsAccumulatedDeficit>
    <CYCU:WorkingCapitalDeficit
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact003713"
      unitRef="USD">12.0</CYCU:WorkingCapitalDeficit>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2026-01-01to2026-03-31"
      decimals="-5"
      id="Fact003715"
      unitRef="USD">-2900000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact003717"
      unitRef="USD">10448853</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-10-27"
      decimals="INF"
      id="Fact003719"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-10-26"
      decimals="INF"
      id="Fact003721"
      unitRef="Shares">86533435</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-10-27"
      decimals="INF"
      id="Fact003723"
      unitRef="Shares">2884447</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact003725">&lt;p id="xdx_803_eus-gaap--SignificantAccountingPoliciesTextBlock_zaA5EBocdJ0f" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.
&lt;span id="xdx_82F_zOchiA5z3Zeb"&gt;SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_ecustom--BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_zfM0OF4zc2s1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zbc2NYa1p40e"&gt;Basis
of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. GAAP, and the rules and regulations
of the SEC.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
unaudited consolidated financial statements include the accounts of Cycurion, Inc. (f/k/a KAE Holdings, Inc.; f/k/a Cyber Secure Solutions,
Inc.) and its wholly owned subsidiaries: Cycurion Sub, Inc., Axxum Technologies LLC (&#x201c;Axxum&#x201d;), Cloudburst Security LLC (&#x201c;Cloudburst&#x201d;),
and Cycurion Innovation, Inc. The unaudited consolidated financial statements also include the accounts of SLG Innovation Inc. (&#x201c;SLG&#x201d;)
as a result of the master service agreement entered into between the Cycurion and SLG. The Company has determined that the SLG master
service agreement constitutes a business combination as defined by ASC 805, Business Combinations (&#x201c;ASC 805&#x201d;). ASC 805 establishes
principles and requirements as to how the acquirer of a business recognizes and measures in its financial statements the identifiable
assets acquired, the liabilities assumed and any non-controlling interest in the acquiree. The assets acquired and liabilities assumed
were recognized provisionally in the accompanying consolidated balance sheets at their estimated fair values as of March 31, 2025, and
adjusted to final fair value amounts as of March 31, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 14, 2025, the Company completed its Business Combination with Western a special purpose acquisition company, whereby Western
merged with and into the Company, with the Company surviving the merger. The Business Combination was accounted for as a reverse recapitalization
in accordance with U.S. GAAP, with Cycurion Sub, Inc. treated as the accounting acquirer. Accordingly, the consolidated financial statements
for periods prior to the Business Combination reflect the historical results of Cycurion Sub, Inc., and the equity structure has been
retroactively recast to reflect the number of shares of the Company&#x2019;s common stock issued in connection with the Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
significant intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zoiCMO9GxQpe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Basis
of Presentation for Interim Periods&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
information and disclosures normally included for the annual financial statements to be prepared in accordance with U.S. GAAP have been
condensed or omitted for the interim periods presented. We believe that the unaudited interim consolidated financial statements include
all adjustments (which are normal and recurring in nature) necessary to present fairly our financial position and the results of operations
and cash flows for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
results of operations for the interim periods presented are not necessarily indicative of results that may be expected for the year or
future periods. The financial statements should be read in conjunction with our audited consolidated financial statements and the accompanying
notes contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025. We have continued to follow the accounting
policies set forth in those financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--UseOfEstimates_zv5JbWkOGZI3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_z0TjSG8P6Yw8"&gt;Use
of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Preparing
consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of revenue, expenses, assets and liabilities, and disclosure of contingent assets and liabilities. The Company regularly
assesses these estimates; however, actual results could differ from those estimates. We base our estimates on historical experience,
currently available information, and various other assumptions that we believe are reasonable under the circumstances.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
evaluates these estimates and assumptions on an ongoing basis, including those relating to revenue recognition on cost estimation on
certain contracts, allowance for credit losses, certain assumptions related to share-based compensation, valuation and impairment of
intangible assets and goodwill, and contingencies. Actual results could differ from those estimates. The impact of changes in estimates
is recorded in the period in which they become known.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zgop9Ba7iVe7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_z18ZiW3ut93i"&gt;Reclassifications&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
amounts have been reclassified to improve the clarity and comparability of the financial statements. These reclassifications had no impact
on previously reported total assets, liabilities, equity, net (loss)/income, or cash flows for any periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zCyRDnR3rXMg" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zyv22UFpXRX9"&gt;Recent
Accounting Pronouncements - Adopted&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, the FASB issued ASU 2023-07, &#x201c;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,&#x201d;
which requires public entities, including entities with a single reportable segment, to disclose on an annual and interim basis significant
segment expenses that are regularly provided to the CODM and included within each reported measure of segment profit or loss. The Company
adopted this standard for its fiscal year ended December 31, 2025, and has applied the required disclosures on a retrospective basis
for all periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
July 2025, the FASB issued ASU No. 2025-05, Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses for Accounts
Receivable and Contract Assets. The amendments in this update provide a practical expedient permitting an entity to assume that conditions
at the balance sheet date remain unchanged over the life of the asset when estimating expected credit losses for current classified accounts
receivable and contract assets. The Company adopted this standard for its fiscal year ended December 31, 2026, and has applied the required
disclosures on a retrospective basis for all periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Recent
Accounting Pronouncements - Not Yet Adopted&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2024, the FASB issued ASU 2024-03, &#x201c;Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation
Disclosures (Subtopic 220-40),&#x201d; which requires public entities to disclose, on both an annual and interim basis, additional information
about certain expense categories in tabular form. The standard is effective for fiscal years beginning after December 15, 2026, and for
interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating
the impact of this standard on its disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
early 2025, the FASB issued ASU 2025-03, &#x201c;Business Combinations (Topic 805): Determining the Accounting Acquirer When a VIE Is
Acquired,&#x201d; which provides clarifying guidance to help entities identify the accounting acquirer in a business combination when
the entity being acquired is a VIE. The Company is currently evaluating the impact of this standard on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
September 2025, the FASB issued ASU No. 2025-06, Intangibles&#x2014;Goodwill and Other&#x2014;Internal-Use Software (Subtopic 350-40):
Targeted Improvements to the Accounting for Internal-Use Software. The ASU simplifies the capitalization guidance by removing all references
to prescriptive and sequential software development stages (referred to as &#x201c;project stages&#x201d;) throughout ASC 350-40. The ASU
is effective for annual periods beginning after December 15, 2027, and interim periods within those fiscal years. Adoption of this ASU
can be applied prospectively for reporting periods after its effective date; or follow a modified transition approach that is based on
the status of the respective projects and whether software costs were capitalized before the date of adoption; or retrospectively to
any or all prior periods presented in the consolidated financial statements. Early adoption is permitted. We are currently evaluating
the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2025, the FASB issued ASU No. 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business
Entities. The ASU establishes authoritative guidance in GAAP about accounting for government grants received by business entities, clarifies
the appropriate accounting, in an effort to reduce diversity in practice, and increase consistency of application across business entities.
The ASU is effective for annual reporting periods beginning after December 15, 2028, and interim reporting periods within those annual
reporting periods. Adoption of this ASU can be applied a modified prospective approach, a modified retrospective approach, or a retrospective
approach. Early adoption is permitted. We are currently evaluating the provisions of this ASU and do not expect this ASU to have a material
impact on our consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2025, the FASB issued ASU No. 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements. The ASU clarifies interim disclosure
requirements and the applicability of Topic 270. The objective of the amendments is to provide further clarity about the current interim
disclosure requirements. The ASU is effective for interim reporting periods within annual reporting periods beginning after December
15, 2027. Adoption of this ASU can be applied either a prospective or a retrospective approach. Early adoption is permitted. We are currently
evaluating the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2025, the FASB issued ASU No. 2025-12, Codification Improvements. The ASU addresses thirty-three items, representing the changes
to the Codification that (1) clarify, (2) correct errors, or (3) make minor improvements. Generally, the amendments in this Update are
not intended to result in significant changes for most entities. The ASU is effective for interim reporting periods within annual reporting
periods beginning after December 15, 2026. The adoption method of this ASU may vary, on an issue-by-issue basis. Early adoption is permitted.
We are currently evaluating the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial
statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has reviewed all other recently issued accounting pronouncements and does not believe that any such pronouncements will have
a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85F_z9X7HPFpvCkh" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
</us-gaap:SignificantAccountingPoliciesTextBlock>
    <CYCU:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact003727">&lt;p id="xdx_84F_ecustom--BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_zfM0OF4zc2s1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zbc2NYa1p40e"&gt;Basis
of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. GAAP, and the rules and regulations
of the SEC.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
unaudited consolidated financial statements include the accounts of Cycurion, Inc. (f/k/a KAE Holdings, Inc.; f/k/a Cyber Secure Solutions,
Inc.) and its wholly owned subsidiaries: Cycurion Sub, Inc., Axxum Technologies LLC (&#x201c;Axxum&#x201d;), Cloudburst Security LLC (&#x201c;Cloudburst&#x201d;),
and Cycurion Innovation, Inc. The unaudited consolidated financial statements also include the accounts of SLG Innovation Inc. (&#x201c;SLG&#x201d;)
as a result of the master service agreement entered into between the Cycurion and SLG. The Company has determined that the SLG master
service agreement constitutes a business combination as defined by ASC 805, Business Combinations (&#x201c;ASC 805&#x201d;). ASC 805 establishes
principles and requirements as to how the acquirer of a business recognizes and measures in its financial statements the identifiable
assets acquired, the liabilities assumed and any non-controlling interest in the acquiree. The assets acquired and liabilities assumed
were recognized provisionally in the accompanying consolidated balance sheets at their estimated fair values as of March 31, 2025, and
adjusted to final fair value amounts as of March 31, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 14, 2025, the Company completed its Business Combination with Western a special purpose acquisition company, whereby Western
merged with and into the Company, with the Company surviving the merger. The Business Combination was accounted for as a reverse recapitalization
in accordance with U.S. GAAP, with Cycurion Sub, Inc. treated as the accounting acquirer. Accordingly, the consolidated financial statements
for periods prior to the Business Combination reflect the historical results of Cycurion Sub, Inc., and the equity structure has been
retroactively recast to reflect the number of shares of the Company&#x2019;s common stock issued in connection with the Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
significant intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</CYCU:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact003729">&lt;p id="xdx_841_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zoiCMO9GxQpe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Basis
of Presentation for Interim Periods&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
information and disclosures normally included for the annual financial statements to be prepared in accordance with U.S. GAAP have been
condensed or omitted for the interim periods presented. We believe that the unaudited interim consolidated financial statements include
all adjustments (which are normal and recurring in nature) necessary to present fairly our financial position and the results of operations
and cash flows for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
results of operations for the interim periods presented are not necessarily indicative of results that may be expected for the year or
future periods. The financial statements should be read in conjunction with our audited consolidated financial statements and the accompanying
notes contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025. We have continued to follow the accounting
policies set forth in those financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2026-01-01to2026-03-31" id="Fact003731">&lt;p id="xdx_84C_eus-gaap--UseOfEstimates_zv5JbWkOGZI3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_z0TjSG8P6Yw8"&gt;Use
of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Preparing
consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of revenue, expenses, assets and liabilities, and disclosure of contingent assets and liabilities. The Company regularly
assesses these estimates; however, actual results could differ from those estimates. We base our estimates on historical experience,
currently available information, and various other assumptions that we believe are reasonable under the circumstances.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
evaluates these estimates and assumptions on an ongoing basis, including those relating to revenue recognition on cost estimation on
certain contracts, allowance for credit losses, certain assumptions related to share-based compensation, valuation and impairment of
intangible assets and goodwill, and contingencies. Actual results could differ from those estimates. The impact of changes in estimates
is recorded in the period in which they become known.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2026-01-01to2026-03-31" id="Fact003733">&lt;p id="xdx_84C_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zgop9Ba7iVe7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_z18ZiW3ut93i"&gt;Reclassifications&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
amounts have been reclassified to improve the clarity and comparability of the financial statements. These reclassifications had no impact
on previously reported total assets, liabilities, equity, net (loss)/income, or cash flows for any periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact003735">&lt;p id="xdx_84D_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zCyRDnR3rXMg" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zyv22UFpXRX9"&gt;Recent
Accounting Pronouncements - Adopted&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, the FASB issued ASU 2023-07, &#x201c;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,&#x201d;
which requires public entities, including entities with a single reportable segment, to disclose on an annual and interim basis significant
segment expenses that are regularly provided to the CODM and included within each reported measure of segment profit or loss. The Company
adopted this standard for its fiscal year ended December 31, 2025, and has applied the required disclosures on a retrospective basis
for all periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
July 2025, the FASB issued ASU No. 2025-05, Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses for Accounts
Receivable and Contract Assets. The amendments in this update provide a practical expedient permitting an entity to assume that conditions
at the balance sheet date remain unchanged over the life of the asset when estimating expected credit losses for current classified accounts
receivable and contract assets. The Company adopted this standard for its fiscal year ended December 31, 2026, and has applied the required
disclosures on a retrospective basis for all periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Recent
Accounting Pronouncements - Not Yet Adopted&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2024, the FASB issued ASU 2024-03, &#x201c;Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation
Disclosures (Subtopic 220-40),&#x201d; which requires public entities to disclose, on both an annual and interim basis, additional information
about certain expense categories in tabular form. The standard is effective for fiscal years beginning after December 15, 2026, and for
interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating
the impact of this standard on its disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
early 2025, the FASB issued ASU 2025-03, &#x201c;Business Combinations (Topic 805): Determining the Accounting Acquirer When a VIE Is
Acquired,&#x201d; which provides clarifying guidance to help entities identify the accounting acquirer in a business combination when
the entity being acquired is a VIE. The Company is currently evaluating the impact of this standard on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
September 2025, the FASB issued ASU No. 2025-06, Intangibles&#x2014;Goodwill and Other&#x2014;Internal-Use Software (Subtopic 350-40):
Targeted Improvements to the Accounting for Internal-Use Software. The ASU simplifies the capitalization guidance by removing all references
to prescriptive and sequential software development stages (referred to as &#x201c;project stages&#x201d;) throughout ASC 350-40. The ASU
is effective for annual periods beginning after December 15, 2027, and interim periods within those fiscal years. Adoption of this ASU
can be applied prospectively for reporting periods after its effective date; or follow a modified transition approach that is based on
the status of the respective projects and whether software costs were capitalized before the date of adoption; or retrospectively to
any or all prior periods presented in the consolidated financial statements. Early adoption is permitted. We are currently evaluating
the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2025, the FASB issued ASU No. 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business
Entities. The ASU establishes authoritative guidance in GAAP about accounting for government grants received by business entities, clarifies
the appropriate accounting, in an effort to reduce diversity in practice, and increase consistency of application across business entities.
The ASU is effective for annual reporting periods beginning after December 15, 2028, and interim reporting periods within those annual
reporting periods. Adoption of this ASU can be applied a modified prospective approach, a modified retrospective approach, or a retrospective
approach. Early adoption is permitted. We are currently evaluating the provisions of this ASU and do not expect this ASU to have a material
impact on our consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2025, the FASB issued ASU No. 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements. The ASU clarifies interim disclosure
requirements and the applicability of Topic 270. The objective of the amendments is to provide further clarity about the current interim
disclosure requirements. The ASU is effective for interim reporting periods within annual reporting periods beginning after December
15, 2027. Adoption of this ASU can be applied either a prospective or a retrospective approach. Early adoption is permitted. We are currently
evaluating the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2025, the FASB issued ASU No. 2025-12, Codification Improvements. The ASU addresses thirty-three items, representing the changes
to the Codification that (1) clarify, (2) correct errors, or (3) make minor improvements. Generally, the amendments in this Update are
not intended to result in significant changes for most entities. The ASU is effective for interim reporting periods within annual reporting
periods beginning after December 15, 2026. The adoption method of this ASU may vary, on an issue-by-issue basis. Early adoption is permitted.
We are currently evaluating the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial
statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has reviewed all other recently issued accounting pronouncements and does not believe that any such pronouncements will have
a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact003737">&lt;p id="xdx_80B_eus-gaap--RevenueFromContractWithCustomerTextBlock_zNkv4MTLXZWb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.
&lt;span id="xdx_822_zz27XBKxLrtj"&gt;REVENUE RECOGNITION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Advisory
Consulting&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company enters into service agreements with customers that will set forth the responsibilities of both parties, including the type of
service to be delivered, the timing of the delivery of those services, and the associated price per unit for such services. The unit
of measure in the agreement is typically hours. The advisory consulting services represent a single performance obligation, as they constitute
a series of distinct hourly services that are substantially the same and transferred to the customer over time. The revenue from advisory
service agreement will also set forth the timing of payments by the customers which is typically between &lt;span id="xdx_906_ecustom--CustomerPaymentTermDays_dtD_c20260101__20260331__srt--RangeAxis__srt--MinimumMember_zEY78flAHAhc" title="Revenue recognition, expected term"&gt;60&lt;/span&gt; and &lt;span id="xdx_90A_ecustom--CustomerPaymentTermDays_dtD_c20260101__20260331__srt--RangeAxis__srt--MaximumMember_zDUOFS6MsJI7" title="Revenue recognition, expected term"&gt;90&lt;/span&gt; days from the date
that an invoice is issued to the customer. As a practical matter, the Company continuously delivers service to customers, and the customer
receives benefits from those services over time. The revenue advisory consulting is recognized over time as services are rendered, based
on contractual hourly rates, and when the Company has received the aforementioned acknowledgement from its customers that service has
been rendered related to hours accumulated over period of time, such as a week, or two weeks, or a month, which is determined on a customer-by-customer
basis. The Company&#x2019;s contracts do not include terms for returns, or warranties, or guarantees, or rebates, or discounts on the
services rendered. The Company also enters into annual contracts with customers to provide ongoing advisory and consulting services.
Services are delivered continuously over the contract term and customers are billed periodically. The annual service contract represents
a single performance obligation because the services are a series of distinct, substantially similar acts that are inseparable and transferred
over time. Revenue is recognized over time straight-line over the contract term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Managed
Security Service Practice (MSSP)&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
has determined that its managed security service practice is a bundle of cybersecurity software tools, and expert 24x7x365
monitoring and breach resolution service that is accounted for as a single performance obligation that is delivered over time which
is typically a month. The components of the bundle have individual commercial value. However, management believes assigning
stand-alone value to each component is impractical because each component would not be able to be fully implemented or utilized if
not packaged with the other components. Therefore, management believes the MSSP can only be sold as a bundle package over time. At
the time that the Company recognizes revenue, it is has either already received funds in advance from its customer or it is
reasonably assured that it will collect funds from its customer. In the event that funds that are received in advance, they are
accounted for as contract liabilities in the deferred revenue account until the Company fulfills the performance obligation. A
majority of the Company&#x2019;s contracts call for the Company to first deliver service and collect fees thereafter. The Company
typically receives payment for these contracts within &lt;span id="xdx_90D_ecustom--RevenueFromContractWithCustomerPaymentPeriod_dtD_c20260101__20260331__srt--RangeAxis__srt--MinimumMember_zoXK59poDaTj" style="display: none" title="Payment received for contracts, term"&gt;30&lt;/span&gt;
thirty to &lt;span id="xdx_909_ecustom--RevenueFromContractWithCustomerPaymentPeriod_dc_c20260101__20260331__srt--RangeAxis__srt--MaximumMember_z6YPYcFH4j01" title="Payment received for contracts, term"&gt;ninety
days&lt;/span&gt; of delivery of service. The Company does not sell monitoring time, security software-tools, and breach resolution as
stand-alone services, as the customer would not receive the benefits of these items if they were not sold as an integrated package.
The cybersecurity needs to monitor the customer cybersecurity environment regularly, stay up to date on cyberthreats and solutions,
maintain its software tools, and then address threats identified, or rectify situations when customer environments have been
breached. It is not practical or viable to sell these components separately, as customers expect comprehensive solutions. While the
components are separately identifiable, management does not believe they could market the components individually. The
Company&#x2019;s management does not believe their customers can benefit from the individual components alone, and there are not
readily available resources in the market that can be obtained to make those components viable. The continuous monitoring allows the
Company to identify and either neutralize and or rectify breaches by having up to the minute first-hand information, and the tools
allow the Company to implement solutions rapidly. The absence of the components would render the solutions and service offering
significantly devalued and non-competitive in the marketplace.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company believes MSSP meets the criteria to combine the goods and services under a single performance obligation. The Company believes
combined integrated solution is delivered continuously over a period of time. In accordance with the terms of the contract between the
Company and its customers, the Company receives prepayments in advance from its customers, and recognizes those payments to revenues
over a period of time, which is typically each month.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Managed
Service Provider (MSP)&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s managed service provider (MSP) service offering is the provision of IT infrastructure support to customers,
specifically in the areas of desktop support, on-site troubleshooting, and cloud-based network infrastructure troubleshooting. This
service is accounted for as a single performance obligation that is delivered over time, which is typically a month; At the time
that the Company recognizes revenue, it either already received funds in advance from its customer, or it is reasonably assured that
it will collect funds from its customer. In the event that funds that are received in advance, they are accounted for as contract
liabilities in the deferred revenue account until the Company fulfills the performance obligation. A majority of the Company&#x2019;s
contracts call for the Company to first deliver service and collect fees thereafter. The Company typically receives payment for
these contracts within &lt;span id="xdx_902_ecustom--RevenueFromContractWithCustomerPaymentPeriod_dtD_c20260101__20260331__srt--RangeAxis__srt--MinimumMember_zlS2HOkm3Quf" style="display: none" title="Payment received for contracts, term"&gt;30&lt;/span&gt; thirty to &lt;span id="xdx_906_ecustom--RevenueFromContractWithCustomerPaymentPeriod_dc_c20260101__20260331__srt--RangeAxis__srt--MaximumMember_zCBE8AUFrnkg" title="Payment received for contracts, term"&gt;ninety days&lt;/span&gt; of delivery of service.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;MSP
requires the integration of tools and labor in order for a customer to receive any benefit from the services provided. The Company refers
to the guidance in ASC 606-10-25-19 to provide an analysis regarding this accounting recognition of this integrated service. Under MSP,
the customer cannot receive any benefit purely from labor or individual software tools as a stand-alone service. The tools that the Company
deploys require engineers to decipher results and develop solutions to problems during the service period covered in a contract.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;While
components can be separately identified, they must be used in conjunction with each other to serve the Company&#x2019;s customers. The
Company must continuously make available support engineers to customers whenever they need support and troubleshooting. The service includes
remote resolution of issues or going onsite to customer locations to solve problems. The Company&#x2019;s contracts with customers require
the Company to have these resources available during the length of the contract. Therefore, these services are continuously delivered
as a service over time. Accordingly, the Company recognizes revenue for such MSP contracts on a monthly basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Software
as a service (SaaS)&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
has determined that its software as a service is a suite of cybersecurity tools that are delivered either remotely or on customer premises.
The service is delivered on a monthly basis. The cybersecurity tools are typically sold as a package. However, the individual components
of the suite of tools can either be sold individually or bundled together. Nevertheless, if they are sold individually, or as a bundle,
they are all delivered over time. Accordingly, the Company recognizes revenue over time, which is typically monthly; At the time that
the Company recognizes revenue it has either already received funds in advance from its customer, or it is reasonably assured that it
will collect funds from its customer. In the event that funds that are received in advance, they are accounted for as contract liabilities
in the deferred revenue account until the Company fulfills the performance obligation. A majority of the Company&#x2019;s contracts call
for the Company to first deliver service and collect fees thereafter. The Company typically receives payment for these contracts within
&lt;span id="xdx_902_ecustom--RevenueFromContractWithCustomerPaymentPeriod_dtD_c20260101__20260331__srt--RangeAxis__srt--MinimumMember_zWrBZjsTjPoe" style="display: none" title="Payment received for contracts, term"&gt;30&lt;/span&gt; thirty to &lt;span id="xdx_905_ecustom--RevenueFromContractWithCustomerPaymentPeriod_dc_c20260101__20260331__srt--RangeAxis__srt--MaximumMember_zba5HI3jqO54" title="Payment received for contracts, term"&gt;ninety days&lt;/span&gt; of delivery of service.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s SaaS is delivered continuously over time. It is a subscription service where the Company provisions a suite of security
software tools to its customers accessed via the internet that allows the customers to protect themselves from cyber-attacks using multiple
tools within the suite. This subscription service is recognized to revenue monthly.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--DisaggregationOfRevenueTableTextBlock_zUWYfgrnOMCg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B4_zMKA2GvklXU3" style="display: none"&gt;SCHEDULE OF DISAGGREGATED REVENUES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
3: Disaggregated Revenue&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20260101__20260331_zxOlbREVfeE7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20250101__20250331_z0zHIPTn6Pf8" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hcustom--ProductAndServiceAxis__custom--AdvisoryConsultingMember_zVr6myBAvQlk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Advisory consulting&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,244,770&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,835,414&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hcustom--ProductAndServiceAxis__custom--ManagedSecurityServicePracticeMember_zLfjXHSErfS5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Managed security service practice (MSSP)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;31,513&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hcustom--ProductAndServiceAxis__custom--SoftwareAsAServiceMember_zNYaaxwOArV1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Software as a service
    (Saas)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,350&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,123&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_znGpOf6BFlJe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,268,620&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,870,050&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zmKucWygT2lb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <CYCU:CustomerPaymentTermDays
      contextRef="From2026-01-012026-03-31_srt_MinimumMember"
      id="Fact003739">P60D</CYCU:CustomerPaymentTermDays>
    <CYCU:CustomerPaymentTermDays
      contextRef="From2026-01-012026-03-31_srt_MaximumMember"
      id="Fact003741">P90D</CYCU:CustomerPaymentTermDays>
    <CYCU:RevenueFromContractWithCustomerPaymentPeriod
      contextRef="From2026-01-012026-03-31_srt_MinimumMember"
      id="Fact003743">P30D</CYCU:RevenueFromContractWithCustomerPaymentPeriod>
    <CYCU:RevenueFromContractWithCustomerPaymentPeriod
      contextRef="From2026-01-012026-03-31_srt_MaximumMember"
      id="Fact003745">P90D</CYCU:RevenueFromContractWithCustomerPaymentPeriod>
    <CYCU:RevenueFromContractWithCustomerPaymentPeriod
      contextRef="From2026-01-012026-03-31_srt_MinimumMember"
      id="Fact003747">P30D</CYCU:RevenueFromContractWithCustomerPaymentPeriod>
    <CYCU:RevenueFromContractWithCustomerPaymentPeriod
      contextRef="From2026-01-012026-03-31_srt_MaximumMember"
      id="Fact003749">P90D</CYCU:RevenueFromContractWithCustomerPaymentPeriod>
    <CYCU:RevenueFromContractWithCustomerPaymentPeriod
      contextRef="From2026-01-012026-03-31_srt_MinimumMember"
      id="Fact003751">P30D</CYCU:RevenueFromContractWithCustomerPaymentPeriod>
    <CYCU:RevenueFromContractWithCustomerPaymentPeriod
      contextRef="From2026-01-012026-03-31_srt_MaximumMember"
      id="Fact003753">P90D</CYCU:RevenueFromContractWithCustomerPaymentPeriod>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact003755">&lt;p id="xdx_898_eus-gaap--DisaggregationOfRevenueTableTextBlock_zUWYfgrnOMCg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B4_zMKA2GvklXU3" style="display: none"&gt;SCHEDULE OF DISAGGREGATED REVENUES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
3: Disaggregated Revenue&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20260101__20260331_zxOlbREVfeE7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20250101__20250331_z0zHIPTn6Pf8" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hcustom--ProductAndServiceAxis__custom--AdvisoryConsultingMember_zVr6myBAvQlk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Advisory consulting&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,244,770&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,835,414&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hcustom--ProductAndServiceAxis__custom--ManagedSecurityServicePracticeMember_zLfjXHSErfS5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Managed security service practice (MSSP)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;31,513&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hcustom--ProductAndServiceAxis__custom--SoftwareAsAServiceMember_zNYaaxwOArV1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Software as a service
    (Saas)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,350&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,123&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_znGpOf6BFlJe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,268,620&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,870,050&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2026-01-012026-03-31_custom_AdvisoryConsultingMember"
      decimals="0"
      id="Fact003757"
      unitRef="USD">3244770</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2025-01-012025-03-31_custom_AdvisoryConsultingMember"
      decimals="0"
      id="Fact003758"
      unitRef="USD">3835414</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2026-01-012026-03-31_custom_ManagedSecurityServicePracticeMember"
      decimals="0"
      id="Fact003760"
      unitRef="USD">22500</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2025-01-012025-03-31_custom_ManagedSecurityServicePracticeMember"
      decimals="0"
      id="Fact003761"
      unitRef="USD">31513</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2026-01-012026-03-31_custom_SoftwareAsAServiceMember"
      decimals="0"
      id="Fact003763"
      unitRef="USD">1350</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2025-01-012025-03-31_custom_SoftwareAsAServiceMember"
      decimals="0"
      id="Fact003764"
      unitRef="USD">3123</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003766"
      unitRef="USD">3268620</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003767"
      unitRef="USD">3870050</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact003769">&lt;p id="xdx_800_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zyP11uIquc2a" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.
&lt;span id="xdx_829_zh7FfizJQ53"&gt;ACCOUNTS RECEIVABLE, NET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p id="xdx_893_eus-gaap--AccountsReceivableAllowanceForCreditLossTableTextBlock_z7i5o3XdRRHi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B9_zfszPnTgh6W4" style="display: none"&gt;SCHEDULE OF ACCOUNTS RECEIVABLES, NET&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Table
4: Details of Accounts Receivable, Net&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20260331_z1A3iMc5m2re" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;March
    31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20251231_zMxeHu7iR3W" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AccountsReceivableGrossCurrent_iI_hus-gaap--AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis__custom--BilledAccountsReceivableMember_zl5xO6cZW2c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Billed accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,156,076&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,518,937&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccountsReceivableGrossCurrent_iI_hus-gaap--AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis__custom--BilledAccountsReceivableFactoredMember_z8XULKPWTR17" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Billed accounts receivable - factored&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,649,354&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,591,240&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AccountsReceivableGrossCurrent_iI_hus-gaap--AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis__us-gaap--UnbilledRevenuesMember_zTv7O387pYLj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unbilled accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3779"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;45,325&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AccountsReceivableGrossCurrent_iI_hus-gaap--AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis__us-gaap--UnbilledRevenuesMember_zAW3gSPIFpki" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3782"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;45,325&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_di_zqh2X5SgPMrd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(469,383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(468,023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccountsReceivableNetCurrent_iTI_zCHBctwryf68" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts
    receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,336,047&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,687,479&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AE_znNp0bUyUCm9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the three months ended March&#160;31, 2026, the Company recorded $&lt;span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_c20260101__20260331_zlt8uaOoRbXh" title="Provision for credit losses"&gt;1,360&lt;/span&gt; for provisions for credit losses, compared to &lt;span id="xdx_90E_eus-gaap--AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_dc_c20250101__20250331_zdIGIpvOmfk2" title="Provision for credit losses"&gt;zero&lt;/span&gt; U.S. dollars
for the three months ended March&#160;31, 2025. During both the three months ended March&#160;31, 2026 and 2025, the Company has &lt;span id="xdx_905_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_do_c20260101__20260331_zH64lNJRHby1" title="Write-off of outstanding receivables"&gt;&lt;span id="xdx_903_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_do_c20250101__20250331_z2kVdYt1FZid" title="Write-off of outstanding receivables"&gt;no&lt;/span&gt;&lt;/span&gt; write-offs
of any outstanding receivables.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact003771">&lt;p id="xdx_893_eus-gaap--AccountsReceivableAllowanceForCreditLossTableTextBlock_z7i5o3XdRRHi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B9_zfszPnTgh6W4" style="display: none"&gt;SCHEDULE OF ACCOUNTS RECEIVABLES, NET&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Table
4: Details of Accounts Receivable, Net&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20260331_z1A3iMc5m2re" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;March
    31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20251231_zMxeHu7iR3W" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AccountsReceivableGrossCurrent_iI_hus-gaap--AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis__custom--BilledAccountsReceivableMember_zl5xO6cZW2c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Billed accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,156,076&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,518,937&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccountsReceivableGrossCurrent_iI_hus-gaap--AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis__custom--BilledAccountsReceivableFactoredMember_z8XULKPWTR17" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Billed accounts receivable - factored&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,649,354&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,591,240&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AccountsReceivableGrossCurrent_iI_hus-gaap--AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis__us-gaap--UnbilledRevenuesMember_zTv7O387pYLj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unbilled accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3779"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;45,325&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AccountsReceivableGrossCurrent_iI_hus-gaap--AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis__us-gaap--UnbilledRevenuesMember_zAW3gSPIFpki" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3782"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;45,325&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_di_zqh2X5SgPMrd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(469,383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(468,023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccountsReceivableNetCurrent_iTI_zCHBctwryf68" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts
    receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,336,047&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,687,479&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="AsOf2026-03-31_custom_BilledAccountsReceivableMember"
      decimals="0"
      id="Fact003773"
      unitRef="USD">2156076</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="AsOf2025-12-31_custom_BilledAccountsReceivableMember"
      decimals="0"
      id="Fact003774"
      unitRef="USD">1518937</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="AsOf2026-03-31_custom_BilledAccountsReceivableFactoredMember"
      decimals="0"
      id="Fact003776"
      unitRef="USD">1649354</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="AsOf2025-12-31_custom_BilledAccountsReceivableFactoredMember"
      decimals="0"
      id="Fact003777"
      unitRef="USD">1591240</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="AsOf2025-12-31_us-gaap_UnbilledRevenuesMember"
      decimals="0"
      id="Fact003780"
      unitRef="USD">45325</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="AsOf2025-12-31_us-gaap_UnbilledRevenuesMember"
      decimals="0"
      id="Fact003783"
      unitRef="USD">45325</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact003785"
      unitRef="USD">469383</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact003786"
      unitRef="USD">468023</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact003788"
      unitRef="USD">3336047</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact003789"
      unitRef="USD">2687479</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003791"
      unitRef="USD">1360</us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease>
    <us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003793"
      unitRef="USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003795"
      unitRef="USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003797"
      unitRef="USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact003799">&lt;p id="xdx_80E_eus-gaap--ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_zWXv1bWmxTv7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.
&lt;span id="xdx_822_zUX9OjUztHb6"&gt;SOFTWARE DEVELOPMENT COSTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
2024, the Company reclassified software development costs from property and equipment to software development costs. The Company continues
to incur costs to develop new modules, functionalities, and integrations on the previously purchased SaaS platform in order to develop
a new product with differentiated offering. As of March&#160;31, 2026, the SaaS platform is still in the development stage and is not
ready for external sales. &lt;span id="xdx_90D_eus-gaap--AdjustmentForAmortization_do_c20260101__20260331_ztLkTj3B3dri" title="Amortization"&gt;&lt;span id="xdx_90C_eus-gaap--AdjustmentForAmortization_do_c20250101__20250331_z0gORioUGbp5" title="Amortization"&gt;No&lt;/span&gt;&lt;/span&gt; amortization has been recorded during the three months ended March&#160;31, 2026 and 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_ecustom--ScheduleOfSoftwareDevelopmentCostsTableTextBlock_zQsQcVcvzXu3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_zIePXqDi8901" style="display: none"&gt;SCHEDULE OF SOFTWARE DEVELOPMENT COSTS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
5: Capitalized Software Development Costs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20260101__20260331_zHiGWuayQ2h6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20250101__20250331_zfBHhF4bW3Wi" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--CapitalizedComputerSoftwarePeriodIncreaseDecrease_znvx5Fet92bi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Capitalized software development
    costs&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;129,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;70,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AC_zJlTKOodnU93" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;
</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003801"
      unitRef="USD">0</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003803"
      unitRef="USD">0</us-gaap:AdjustmentForAmortization>
    <CYCU:ScheduleOfSoftwareDevelopmentCostsTableTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact003805">&lt;p id="xdx_89E_ecustom--ScheduleOfSoftwareDevelopmentCostsTableTextBlock_zQsQcVcvzXu3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_zIePXqDi8901" style="display: none"&gt;SCHEDULE OF SOFTWARE DEVELOPMENT COSTS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
5: Capitalized Software Development Costs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20260101__20260331_zHiGWuayQ2h6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20250101__20250331_zfBHhF4bW3Wi" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--CapitalizedComputerSoftwarePeriodIncreaseDecrease_znvx5Fet92bi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Capitalized software development
    costs&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;129,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;70,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</CYCU:ScheduleOfSoftwareDevelopmentCostsTableTextBlock>
    <us-gaap:CapitalizedComputerSoftwarePeriodIncreaseDecrease
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact003807"
      unitRef="USD">129000</us-gaap:CapitalizedComputerSoftwarePeriodIncreaseDecrease>
    <us-gaap:CapitalizedComputerSoftwarePeriodIncreaseDecrease
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact003808"
      unitRef="USD">70000</us-gaap:CapitalizedComputerSoftwarePeriodIncreaseDecrease>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact003810">&lt;p id="xdx_800_eus-gaap--BusinessCombinationDisclosureTextBlock_zgK4QbleuZJd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6.
&lt;span id="xdx_82D_zVHztP3IYfg6"&gt;BUSINESS COMBINATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;SLG
Innovation, Inc.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SLG
is a technology services firm with operations and client contracts deemed to be strategically complementary to the Company&#x2019;s existing
business and long-term growth objectives. As of December&#160;31, 2020, the Company had initiated discussions regarding the potential
acquisition of SLG and had advanced a non-refundable deposit of $&lt;span id="xdx_901_eus-gaap--DepositsAssets_iI_c20201231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zAIfCE2YiVe" title="Deposits assets"&gt;1,401,923&lt;/span&gt; for cash advances, loans, capitalized transaction costs and
accounts receivable arising from prior business dealings with SLG. On May 13, 2021, the Company entered into an agreement to acquire
substantially all of SLG&#x2019;s assets and certain liabilities, which included a termination right exercisable at the Company&#x2019;s
sole discretion prior to December 31, 2021. This agreement was subsequently amended to limit the acquisition to certain specified assets,
primarily identifiable sales contracts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December&#160;31, 2024, the refundable deposit had increased to $&lt;span id="xdx_90A_eus-gaap--Deposits_iI_c20241231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zXDVLT4sp51a" title="Deposits"&gt;2,000,000&lt;/span&gt;, comprising $&lt;span id="xdx_904_eus-gaap--DepositsAssets_iI_c20241231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zM86tlXsG74l" title="Deposits assets"&gt;561,808&lt;/span&gt; in cash advances and loans, $&lt;span id="xdx_908_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_c20241231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zhllCu45lk1a" title="Net assets acquired"&gt;20,000&lt;/span&gt;
in due diligence costs, and $&lt;span id="xdx_901_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_c20241231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_z60uJAB5GxZ1" title="Accounts receivable"&gt;1,418,192&lt;/span&gt; in accounts receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April&#160;29, 2023, the Company and SLG executed a unidirectional letter of intent (&#x201c;SLG LOI&#x201d;), which bound SLG to the transaction
but did not obligate the Company. The SLG LOI provided that, unless terminated by the Company on or before April 30, 2024, the Company
would proceed to acquire SLG or substantially all of its assets and liabilities through a structure to be finalized. The agreed-upon
valuation included the $&lt;span id="xdx_903_eus-gaap--DepositsAssets_iI_c20230429__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zg2qR185dfd9" title="Non-refundable deposits"&gt;2,000,000&lt;/span&gt; receivable, $&lt;span id="xdx_903_eus-gaap--AccountsPayableOtherCurrent_iI_c20230429__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zyE0ZjB8ceT6" title="Accounts payable, other current"&gt;2,136,445&lt;/span&gt; in SLG payables to RCR Technology Corporation (excluding payables incurred within
&lt;span id="xdx_904_ecustom--BusinessCombinationExcludingPayablesIncurredPriorToClosingPeriod_dtD_c20230429__20230429__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zYOatPgqLAGa" title="Business combination, excluding payables incurred prior to closing, period"&gt;90&lt;/span&gt; days prior to closing), and &lt;span id="xdx_902_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20230429__20230429__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zpxzyHfA3eMk" title="Number of preferred stock converted"&gt;33,212&lt;/span&gt; shares of the Company&#x2019;s capital stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the potential SLG transaction, the Company entered into a separate unidirectional letter of intent with RCR (&#x201c;RCR
LOI&#x201d;) on April 29, 2023, under which the Company would acquire SLG&#x2019;s payables owed to RCR, subject to the closing of the
potential SLG transaction. Consideration for the RCR transaction was to be settled in the form of shares of common stock of the Company,
as specified in the RCR LOI.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
transaction contemplated by the SLG LOI did not close and the Company does not expect that it will close. In lieu of such transaction,
and consistent with the economic and business relationship between SLG and the Company for more than the past two years, on March 31,
2025, the Company and SLG entered into a Management Services Agreement (the &#x201c;MSA&#x201d;), pursuant to which SLG memorialized its
formal engagement of the Company to provide the Management Services (as defined in the MSA) on the terms and subject to the conditions
set forth therein. The parties agreed that the Company would continue to retain sole and absolute discretion to select its employees
and/or independent contractors who would perform and support the Management Services; provided that the compensation paid to any such
persons shall not exceed the compensation that would have been paid to a comparable, unaffiliated third party on a commercial, arms-length
basis. SLG agreed to cooperate in good faith with the Company in furtherance of its continued performance of the Management Services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Management Services to be provided by the Company, SLG agreed to pay a fee equal to SLG&#x2019;s &#x201c;operational
cash flow&#x201d; (whether or not the inbound funds included were recognized as revenue under U.S. GAAP and whether or not the outbound
funds were recognized as expenses under U.S. GAAP during the relevant reporting period). For purposes of the MSA, &#x201c;operational
cash flow&#x201d; means (i) all cash and cash-equivalencies received by, or on behalf of, SLG from any source for any reason during any
reporting period &lt;i&gt;&lt;span style="text-decoration: underline"&gt;minus&lt;/span&gt;&lt;/i&gt; (ii) all payments made by, or on behalf of, SLG, all in connection with SLG&#x2019;s business as
historically operated and as managed by the Company in accordance with the provisions of the MSA. If SLG&#x2019;s operational cash flow
during any reporting period is negative, then the Company reserves the right (in its sole and absolute discretion) to advance funds to
SLG in an amount not to exceed such negative cash flow during such period with an interest rate to be determined on a case-by-case basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the execution and delivery of the MSA, the Company and Ed Burns entered into a Release Agreement (the &#x201c;Burns Release
Agreement&#x201d;), pursuant to which the Company acknowledged that it has provided and will continue to provide certain services to SLG
as a subcontractor and Mr. Burns agreed to release certain claims that he had, has, or may have against the Company or SLG in relation
to the terms and conditions of the MSA, the transactions contemplated thereby, or the manner in which the Company and SLG became parties
to the MSA, as well as the relationship between the Company and SLG prior to the date of the MSA and the Company issued to Mr. Burns
&lt;span id="xdx_901_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zc2q9qYO1VGg" title="Common stock, authorized"&gt;33,609&lt;/span&gt; shares of common stock and &lt;span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_pid_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zvCisyEo9qSl" title="Preferred stock, shares issued"&gt;51&lt;/span&gt; shares of Series E Convertible Preferred Stock with a face value of $&lt;span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_z7GhVQs1sy09" title="Principal amount"&gt;10,000&lt;/span&gt; and conversion price
of $&lt;span id="xdx_908_eus-gaap--PreferredStockConvertibleConversionPrice_iI_pid_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zY3RImG82Mw8" title="Conversion price"&gt;1.00&lt;/span&gt;. The Company offered a substantially equivalent release agreement to the owner of &lt;span id="xdx_904_ecustom--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestPercentage_iI_pid_dp_uPure_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zLodSTDgocK1" title="Business combination, noncontrolling interest, percentage"&gt;49&lt;/span&gt;% of the equity of SLG with a percentage-equivalent
contingent issuance of common stock and Series E Convertible Preferred Stock. As of the date of this quarterly report, such other release
has not been accepted or executed and delivered.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 31, 2025, the company entered into a Management Services Agreement and a Release agreement (the &#x201c;Agreement&#x201d;) to gain
control of SLG as a VIE. The total purchase consideration for the VIE contractual relationship of SLG consisted primarily of:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)
prepaid deposit of $&lt;span id="xdx_907_eus-gaap--PaymentsForDeposits_c20250331__20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zzOLx6wSE6Pl" title="Principal amount"&gt;2,000,000&lt;/span&gt;;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)
&lt;span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zsccqhwRMtO1" title="Common stock, shares authorized"&gt;33,609&lt;/span&gt; shares of common stock having par value of $&lt;span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zGwMb0zF7nha" title="Common stock, par value"&gt;0.0001&lt;/span&gt; per share;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c)
&lt;span id="xdx_903_eus-gaap--PreferredStockSharesIssued_iI_pid_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zXbtS9l6QhIa" title="Preferred stock, shares issued"&gt;51&lt;/span&gt; shares of Series E Convertible Preferred Stock with a face value of $&lt;span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_z2zOelLg6am1" title="Principal amount"&gt;10,000&lt;/span&gt; and conversion price of $&lt;span id="xdx_90B_eus-gaap--PreferredStockConvertibleConversionPrice_iI_pid_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zI0sPf7ZUcO1" title="Conversion price"&gt;1.00&lt;/span&gt;; and&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d)
$&lt;span id="xdx_909_eus-gaap--IncreaseDecreaseInAccountsAndNotesReceivable_c20250331__20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zBLu0pgcEfCg" title="Accounts receivable"&gt;10,814,147&lt;/span&gt; of accounts receivable in Cycurion owing from SLG&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has determined that the SLG transaction constitutes a business combination as defined by ASC 805, Business Combinations (&#x201c;ASC
805&#x201d;). ASC 805 establishes principles and requirements as to how the acquirer of a business recognizes and measures in its financial
statements the identifiable assets acquired, the liabilities assumed and any non-controlling interest in the acquiree. The assets acquired
and liabilities assumed were recognized provisionally in the accompanying consolidated balance sheets at their estimated fair values
as of March 31, 2025, and subsequently adjusted through March 31, 2026. Under U.S. GAAP, the measurement period shall not exceed one
year from the acquisition date and the Company has finalized these amounts as of March 31, 2026. The results of operations for SLG are
included in the consolidated results of Cycurion, Inc. starting April 1, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
6: SLG Valuation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zQqKkr8IBEKl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B9_zdwrvbh30VUg" style="display: none"&gt;SCHEDULE OF FAIR VALUE OF CONSIDERATION TRANSFERRED ASSETS ACQUIRED LIABILITIES ASSUMED&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--InitialAllocationOfAssetsAndLiabilitiesMember_zu0RG2scPho2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Initial
    Allocation of Assets and Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AdjustmentsMember_z53GaS3XNVk3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EstimatedAllocationOfAssetAandLiabilitiesMember_zm7ZyPrKArJi" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Final
    Allocation of Assets and Liabilities as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash
    consideration:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 40%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PaymentsToAcquireBusinessesGross_c20260101__20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--InitialAllocationOfAssetsAndLiabilitiesMember_zleVbMCre0Ld" style="width: 16%; text-align: right" title="Cash consideration"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PaymentsToAcquireBusinessesGross_c20260101__20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AdjustmentsMember_z9NJfgfTuqHg" style="width: 16%; text-align: right" title="Cash consideration"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3858"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PaymentsToAcquireBusinessesGross_c20260101__20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EstimatedAllocationOfAssetAandLiabilitiesMember_zQ7aoIc4p1kl" style="width: 16%; text-align: right" title="Cash consideration"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less:
    cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--BusinessCombinationRecognizedCashAcquired_iN_di_c20260101__20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--InitialAllocationOfAssetsAndLiabilitiesMember_zIcvO3DcylU6" style="border-bottom: Black 1pt solid; text-align: right" title="Less: cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(34,983&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--BusinessCombinationRecognizedCashAcquired_iN_di_c20260101__20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AdjustmentsMember_zL30PWVTIUIi" style="border-bottom: Black 1pt solid; text-align: right" title="Less: cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3864"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--BusinessCombinationRecognizedCashAcquired_iN_di_c20260101__20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EstimatedAllocationOfAssetAandLiabilitiesMember_zfSNs2ujKgWi" style="border-bottom: Black 1pt solid; text-align: right" title="Less: cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(34,983&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash consideration, net
    of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_c20260101__20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--InitialAllocationOfAssetsAndLiabilitiesMember_zL2KODey8Li9" style="text-align: right" title="Cash consideration, net of cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,965,017&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_c20260101__20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AdjustmentsMember_zjA1jvQC5ud4" style="text-align: right" title="Cash consideration, net of cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3870"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_c20260101__20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EstimatedAllocationOfAssetAandLiabilitiesMember_zEskGy5y7f7k" style="text-align: right" title="Cash consideration, net of cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,965,017&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Noncash consideration:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_iI_hus-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztiNsSULGqx9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common stock &lt;span id="xdx_F45_zF9iWYY30Ouf"&gt;(1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;254,071&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,071&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;504,142&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_iI_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zaO6SNfadLyj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Series E Convertible Preferred
    Stock &lt;span id="xdx_F48_zF0BMdhd5Tqk"&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;255,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3879"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;255,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--BusinessCombinationNonCashConsiderationOnAccountsReceivable_zB5iVwQ8wg39" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts
    receivable in Cycurion owing from SLG &lt;span id="xdx_F43_zxMarJbQx9p9"&gt;(3)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,814,147&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3883"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,814,147&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--BusinessCombinationNonCashConsiderationTransferred_iI_zcHo0IqwC1P8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Noncash
    consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,323,218&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,071&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,573,289&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--BusinessCombinationConsiderationTransferred_iI_zG5kyAbXhxM1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,288,235&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,071&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,538,306&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Assets
    acquired:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_zSNz4BAva6Bl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,066,581&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3895"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,066,581&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_zxDB725DaRxj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    identified assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,066,581&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3899"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,066,581&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-decoration: underline; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liabilities
    assumed:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_zjfsu1L6EAu2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,317,052&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;222,313&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,539,365&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiability_iI_zogAMsApB0Oe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,650&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;54,209&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;64,859&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--PayrollLiability_iI_ziez8i1WWH86" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Payroll liability&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;40,642&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;173,629&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;214,271&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesFactoringLiability_iI_zqdXlxFGWiD8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Factoring liability&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,176,922&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3915"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,176,922&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_iI_zBLK4eb5aFX" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Due to related parties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3919"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable_iI_zrmWwGfQDTZ8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loans payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;625,222&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3923"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;625,222&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_iI_zUkkOE9VHFI7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liabilities
    to Cycurion&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,982,908&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3927"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,982,908&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_zeGXnJJPfpx" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    identified liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,171,396&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;450,151&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,621,547&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iNI_di_zqdpvq0NMb2b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net identifiable liabilities
    assumed&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,104,815&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(450,151&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,554,966&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--BusinessCombinationEliminationOfInterCompanyBalances_iI_zc6yw6LsipNa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Elimination of inter-company
    balances&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,982,908&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3939"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,982,908&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_iNI_di_zYw2h0hanSwc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,464,218&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3943"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,464,218&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--Goodwill_iI_zYTtK4NFeZwi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,945,924&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;700,222&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,646,146&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_zi3J7gGu0Ize" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,288,235&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,071&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,538,306&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F05_zBjwVJLHsTs5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1D_zU3lVCqTN6zh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents the
fair value of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSERFVUxFIE9GIEZBSVIgVkFMVUUgT0YgQ09OU0lERVJBVElPTiBUUkFOU0ZFUlJFRCBBU1NFVFMgQUNRVUlSRUQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90E_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250331__20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_z2l9FX7jcTOj" title="Number of preferred stock converted"&gt;33,609&lt;/span&gt; common stock issued in the SLG transaction based on the quoted stock price on the date of issuance.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F04_z53GQQLKrwZ4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F18_zcupARr5Hmvh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents the
fair value of the Series E Convertible Preferred Stock as is converted to common stock based on the quoted price common stock on the
date of issuance.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F02_zymkA50gbP74" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F10_zfSzQh2qMzpf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents the
fair value of the accounts receivable in Cycurion owing from SLG.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair value of the
noncontrolling interest based on NCI&#x2019;s &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSERFVUxFIE9GIEZBSVIgVkFMVUUgT0YgQ09OU0lERVJBVElPTiBUUkFOU0ZFUlJFRCBBU1NFVFMgQUNRVUlSRUQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_909_ecustom--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestPercentage_iI_pid_dp_uPure_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zW9pUrakqBlk" title="Noncontrolling interest percentage"&gt;49&lt;/span&gt;% interest in the net assets acquired.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Goodwill is calculated
as Total Consideration paid less the net assets acquired.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A9_zWLfgDFHpWh8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:DepositsAssets
      contextRef="AsOf2020-12-31_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact003812"
      unitRef="USD">1401923</us-gaap:DepositsAssets>
    <us-gaap:Deposits
      contextRef="AsOf2024-12-31_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact003814"
      unitRef="USD">2000000</us-gaap:Deposits>
    <us-gaap:DepositsAssets
      contextRef="AsOf2024-12-31_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact003816"
      unitRef="USD">561808</us-gaap:DepositsAssets>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="AsOf2024-12-31_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact003818"
      unitRef="USD">20000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="AsOf2024-12-31_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact003820"
      unitRef="USD">1418192</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:DepositsAssets
      contextRef="AsOf2023-04-29_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact003822"
      unitRef="USD">2000000</us-gaap:DepositsAssets>
    <us-gaap:AccountsPayableOtherCurrent
      contextRef="AsOf2023-04-29_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact003824"
      unitRef="USD">2136445</us-gaap:AccountsPayableOtherCurrent>
    <CYCU:BusinessCombinationExcludingPayablesIncurredPriorToClosingPeriod
      contextRef="From2023-04-292023-04-29_custom_SLGInnovationIncMember"
      id="Fact003826">P90D</CYCU:BusinessCombinationExcludingPayablesIncurredPriorToClosingPeriod>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2023-04-292023-04-29_custom_SLGInnovationIncMember"
      decimals="INF"
      id="Fact003828"
      unitRef="Shares">33212</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember"
      decimals="INF"
      id="Fact003830"
      unitRef="Shares">33609</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember_us-gaap_SeriesEPreferredStockMember"
      decimals="INF"
      id="Fact003832"
      unitRef="Shares">51</us-gaap:PreferredStockSharesIssued>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember_us-gaap_SeriesEPreferredStockMember"
      decimals="0"
      id="Fact003834"
      unitRef="USD">10000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember_us-gaap_SeriesEPreferredStockMember"
      decimals="INF"
      id="Fact003836"
      unitRef="USDPShares">1.00</us-gaap:PreferredStockConvertibleConversionPrice>
    <CYCU:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestPercentage
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember_us-gaap_SeriesEPreferredStockMember"
      decimals="INF"
      id="Fact003838"
      unitRef="Pure">0.49</CYCU:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestPercentage>
    <us-gaap:PaymentsForDeposits
      contextRef="From2025-03-312025-03-31_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact003840"
      unitRef="USD">2000000</us-gaap:PaymentsForDeposits>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember"
      decimals="INF"
      id="Fact003842"
      unitRef="Shares">33609</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember"
      decimals="INF"
      id="Fact003844"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember_us-gaap_SeriesEPreferredStockMember"
      decimals="INF"
      id="Fact003846"
      unitRef="Shares">51</us-gaap:PreferredStockSharesIssued>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember_us-gaap_SeriesEPreferredStockMember"
      decimals="0"
      id="Fact003848"
      unitRef="USD">10000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember_us-gaap_SeriesEPreferredStockMember"
      decimals="INF"
      id="Fact003850"
      unitRef="USDPShares">1.00</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable
      contextRef="From2025-03-312025-03-31_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact003852"
      unitRef="USD">10814147</us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact003854">&lt;p id="xdx_891_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zQqKkr8IBEKl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B9_zdwrvbh30VUg" style="display: none"&gt;SCHEDULE OF FAIR VALUE OF CONSIDERATION TRANSFERRED ASSETS ACQUIRED LIABILITIES ASSUMED&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--InitialAllocationOfAssetsAndLiabilitiesMember_zu0RG2scPho2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Initial
    Allocation of Assets and Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AdjustmentsMember_z53GaS3XNVk3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EstimatedAllocationOfAssetAandLiabilitiesMember_zm7ZyPrKArJi" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Final
    Allocation of Assets and Liabilities as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash
    consideration:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 40%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PaymentsToAcquireBusinessesGross_c20260101__20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--InitialAllocationOfAssetsAndLiabilitiesMember_zleVbMCre0Ld" style="width: 16%; text-align: right" title="Cash consideration"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PaymentsToAcquireBusinessesGross_c20260101__20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AdjustmentsMember_z9NJfgfTuqHg" style="width: 16%; text-align: right" title="Cash consideration"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3858"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PaymentsToAcquireBusinessesGross_c20260101__20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EstimatedAllocationOfAssetAandLiabilitiesMember_zQ7aoIc4p1kl" style="width: 16%; text-align: right" title="Cash consideration"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less:
    cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--BusinessCombinationRecognizedCashAcquired_iN_di_c20260101__20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--InitialAllocationOfAssetsAndLiabilitiesMember_zIcvO3DcylU6" style="border-bottom: Black 1pt solid; text-align: right" title="Less: cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(34,983&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--BusinessCombinationRecognizedCashAcquired_iN_di_c20260101__20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AdjustmentsMember_zL30PWVTIUIi" style="border-bottom: Black 1pt solid; text-align: right" title="Less: cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3864"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--BusinessCombinationRecognizedCashAcquired_iN_di_c20260101__20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EstimatedAllocationOfAssetAandLiabilitiesMember_zfSNs2ujKgWi" style="border-bottom: Black 1pt solid; text-align: right" title="Less: cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(34,983&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash consideration, net
    of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_c20260101__20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--InitialAllocationOfAssetsAndLiabilitiesMember_zL2KODey8Li9" style="text-align: right" title="Cash consideration, net of cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,965,017&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_c20260101__20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AdjustmentsMember_zjA1jvQC5ud4" style="text-align: right" title="Cash consideration, net of cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3870"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_c20260101__20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EstimatedAllocationOfAssetAandLiabilitiesMember_zEskGy5y7f7k" style="text-align: right" title="Cash consideration, net of cash acquired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,965,017&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Noncash consideration:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_iI_hus-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztiNsSULGqx9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common stock &lt;span id="xdx_F45_zF9iWYY30Ouf"&gt;(1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;254,071&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,071&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;504,142&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_iI_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zaO6SNfadLyj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Series E Convertible Preferred
    Stock &lt;span id="xdx_F48_zF0BMdhd5Tqk"&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;255,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3879"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;255,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--BusinessCombinationNonCashConsiderationOnAccountsReceivable_zB5iVwQ8wg39" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts
    receivable in Cycurion owing from SLG &lt;span id="xdx_F43_zxMarJbQx9p9"&gt;(3)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,814,147&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3883"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,814,147&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--BusinessCombinationNonCashConsiderationTransferred_iI_zcHo0IqwC1P8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Noncash
    consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,323,218&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,071&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,573,289&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--BusinessCombinationConsiderationTransferred_iI_zG5kyAbXhxM1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,288,235&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,071&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,538,306&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Assets
    acquired:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_zSNz4BAva6Bl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,066,581&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3895"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,066,581&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_zxDB725DaRxj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    identified assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,066,581&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3899"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,066,581&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-decoration: underline; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liabilities
    assumed:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_zjfsu1L6EAu2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,317,052&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;222,313&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,539,365&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiability_iI_zogAMsApB0Oe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,650&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;54,209&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;64,859&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--PayrollLiability_iI_ziez8i1WWH86" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Payroll liability&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;40,642&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;173,629&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;214,271&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesFactoringLiability_iI_zqdXlxFGWiD8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Factoring liability&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,176,922&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3915"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,176,922&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_iI_zBLK4eb5aFX" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Due to related parties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3919"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable_iI_zrmWwGfQDTZ8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loans payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;625,222&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3923"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;625,222&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_iI_zUkkOE9VHFI7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liabilities
    to Cycurion&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,982,908&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3927"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,982,908&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_zeGXnJJPfpx" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    identified liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,171,396&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;450,151&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,621,547&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iNI_di_zqdpvq0NMb2b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net identifiable liabilities
    assumed&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,104,815&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(450,151&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,554,966&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--BusinessCombinationEliminationOfInterCompanyBalances_iI_zc6yw6LsipNa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Elimination of inter-company
    balances&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,982,908&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3939"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,982,908&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_iNI_di_zYw2h0hanSwc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,464,218&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3943"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,464,218&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--Goodwill_iI_zYTtK4NFeZwi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,945,924&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;700,222&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,646,146&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_zi3J7gGu0Ize" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,288,235&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,071&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,538,306&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F05_zBjwVJLHsTs5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1D_zU3lVCqTN6zh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents the
fair value of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSERFVUxFIE9GIEZBSVIgVkFMVUUgT0YgQ09OU0lERVJBVElPTiBUUkFOU0ZFUlJFRCBBU1NFVFMgQUNRVUlSRUQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90E_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250331__20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_z2l9FX7jcTOj" title="Number of preferred stock converted"&gt;33,609&lt;/span&gt; common stock issued in the SLG transaction based on the quoted stock price on the date of issuance.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F04_z53GQQLKrwZ4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F18_zcupARr5Hmvh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents the
fair value of the Series E Convertible Preferred Stock as is converted to common stock based on the quoted price common stock on the
date of issuance.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F02_zymkA50gbP74" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F10_zfSzQh2qMzpf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents the
fair value of the accounts receivable in Cycurion owing from SLG.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair value of the
noncontrolling interest based on NCI&#x2019;s &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSERFVUxFIE9GIEZBSVIgVkFMVUUgT0YgQ09OU0lERVJBVElPTiBUUkFOU0ZFUlJFRCBBU1NFVFMgQUNRVUlSRUQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_909_ecustom--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestPercentage_iI_pid_dp_uPure_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zW9pUrakqBlk" title="Noncontrolling interest percentage"&gt;49&lt;/span&gt;% interest in the net assets acquired.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Goodwill is calculated
as Total Consideration paid less the net assets acquired.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="From2026-01-012026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact003856"
      unitRef="USD">2000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="From2026-01-012026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact003860"
      unitRef="USD">2000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <CYCU:BusinessCombinationRecognizedCashAcquired
      contextRef="From2026-01-012026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact003862"
      unitRef="USD">34983</CYCU:BusinessCombinationRecognizedCashAcquired>
    <CYCU:BusinessCombinationRecognizedCashAcquired
      contextRef="From2026-01-012026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact003866"
      unitRef="USD">34983</CYCU:BusinessCombinationRecognizedCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="From2026-01-012026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact003868"
      unitRef="USD">1965017</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="From2026-01-012026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact003872"
      unitRef="USD">1965017</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003874"
      unitRef="USD">254071</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003875"
      unitRef="USD">250071</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003876"
      unitRef="USD">504142</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember_us-gaap_SeriesEPreferredStockMember"
      decimals="0"
      id="Fact003878"
      unitRef="USD">255000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember_us-gaap_SeriesEPreferredStockMember"
      decimals="0"
      id="Fact003880"
      unitRef="USD">255000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <CYCU:BusinessCombinationNonCashConsiderationOnAccountsReceivable
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact003882"
      unitRef="USD">10814147</CYCU:BusinessCombinationNonCashConsiderationOnAccountsReceivable>
    <CYCU:BusinessCombinationNonCashConsiderationOnAccountsReceivable
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact003884"
      unitRef="USD">10814147</CYCU:BusinessCombinationNonCashConsiderationOnAccountsReceivable>
    <CYCU:BusinessCombinationNonCashConsiderationTransferred
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact003886"
      unitRef="USD">11323218</CYCU:BusinessCombinationNonCashConsiderationTransferred>
    <CYCU:BusinessCombinationNonCashConsiderationTransferred
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      decimals="0"
      id="Fact003887"
      unitRef="USD">250071</CYCU:BusinessCombinationNonCashConsiderationTransferred>
    <CYCU:BusinessCombinationNonCashConsiderationTransferred
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact003888"
      unitRef="USD">11573289</CYCU:BusinessCombinationNonCashConsiderationTransferred>
    <CYCU:BusinessCombinationConsiderationTransferred
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact003890"
      unitRef="USD">13288235</CYCU:BusinessCombinationConsiderationTransferred>
    <CYCU:BusinessCombinationConsiderationTransferred
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      decimals="0"
      id="Fact003891"
      unitRef="USD">250071</CYCU:BusinessCombinationConsiderationTransferred>
    <CYCU:BusinessCombinationConsiderationTransferred
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact003892"
      unitRef="USD">13538306</CYCU:BusinessCombinationConsiderationTransferred>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact003894"
      unitRef="USD">3066581</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact003896"
      unitRef="USD">3066581</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact003898"
      unitRef="USD">3066581</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact003900"
      unitRef="USD">3066581</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact003902"
      unitRef="USD">4317052</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      decimals="0"
      id="Fact003903"
      unitRef="USD">222313</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact003904"
      unitRef="USD">4539365</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiability
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact003906"
      unitRef="USD">10650</CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiability>
    <CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiability
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      decimals="0"
      id="Fact003907"
      unitRef="USD">54209</CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiability>
    <CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiability
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact003908"
      unitRef="USD">64859</CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiability>
    <CYCU:PayrollLiability
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact003910"
      unitRef="USD">40642</CYCU:PayrollLiability>
    <CYCU:PayrollLiability
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      decimals="0"
      id="Fact003911"
      unitRef="USD">173629</CYCU:PayrollLiability>
    <CYCU:PayrollLiability
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact003912"
      unitRef="USD">214271</CYCU:PayrollLiability>
    <CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesFactoringLiability
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact003914"
      unitRef="USD">2176922</CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesFactoringLiability>
    <CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesFactoringLiability
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact003916"
      unitRef="USD">2176922</CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesFactoringLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact003918"
      unitRef="USD">18000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact003920"
      unitRef="USD">18000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact003922"
      unitRef="USD">625222</CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable>
    <CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact003924"
      unitRef="USD">625222</CYCU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact003926"
      unitRef="USD">2982908</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact003928"
      unitRef="USD">2982908</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact003930"
      unitRef="USD">10171396</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      decimals="0"
      id="Fact003931"
      unitRef="USD">450151</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact003932"
      unitRef="USD">10621547</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact003934"
      unitRef="USD">7104815</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      decimals="0"
      id="Fact003935"
      unitRef="USD">450151</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact003936"
      unitRef="USD">7554966</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <CYCU:BusinessCombinationEliminationOfInterCompanyBalances
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact003938"
      unitRef="USD">2982908</CYCU:BusinessCombinationEliminationOfInterCompanyBalances>
    <CYCU:BusinessCombinationEliminationOfInterCompanyBalances
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact003940"
      unitRef="USD">2982908</CYCU:BusinessCombinationEliminationOfInterCompanyBalances>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact003942"
      unitRef="USD">3464218</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact003944"
      unitRef="USD">3464218</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:Goodwill
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact003946"
      unitRef="USD">13945924</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      decimals="0"
      id="Fact003947"
      unitRef="USD">700222</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact003948"
      unitRef="USD">14646146</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_InitialAllocationOfAssetsAndLiabilitiesMember"
      decimals="0"
      id="Fact003950"
      unitRef="USD">13288235</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_AdjustmentsMember"
      decimals="0"
      id="Fact003951"
      unitRef="USD">250071</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember_custom_EstimatedAllocationOfAssetAandLiabilitiesMember"
      decimals="0"
      id="Fact003952"
      unitRef="USD">13538306</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-03-312025-03-31_custom_SLGInnovationIncMember"
      decimals="INF"
      id="Fact003955"
      unitRef="Shares">33609</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <CYCU:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestPercentage
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember"
      decimals="INF"
      id="Fact003959"
      unitRef="Pure">0.49</CYCU:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestPercentage>
    <us-gaap:GoodwillDisclosureTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact003961">&lt;p id="xdx_800_eus-gaap--GoodwillDisclosureTextBlock_zqOkTnBfpZq4" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.
&lt;span id="xdx_82D_zzLejxtUGEWf"&gt;GOODWILL&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Acquisition
of Axxum Technologies, LLC.&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November&#160;22, 2017, the Company entered into a share transfer agreement with Axxum and the two prior members of Axxum to purchase
&lt;span id="xdx_903_eus-gaap--EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_iI_pid_dp_uPure_c20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember_zSXk0JSqNb1b" title="Equity interest percentage"&gt;100&lt;/span&gt;% of the members&#x2019; equity interest in the Company in exchange for $&lt;span id="xdx_90D_eus-gaap--Cash_iI_c20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember_zhdgVqzBb4ue" title="Cash"&gt;6,500,000&lt;/span&gt; in cash and $&lt;span id="xdx_90F_eus-gaap--ConvertibleSubordinatedDebt_iI_c20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember_zdCdBCorNfU7" title="Convertible subordinated debt"&gt;500,000&lt;/span&gt; in two subordinated convertible
promissory notes for $&lt;span id="xdx_904_eus-gaap--ConvertibleSubordinatedDebt_iI_c20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember__srt--TitleOfIndividualAxis__custom--TwoMember_zc6yRMJzDcwg" title="Convertible subordinated debt"&gt;250,000&lt;/span&gt; each, payable to the two members of Axxum. Accordingly, Axxum became a wholly-owned subsidiary of the Company.
The Company assessed the carrying value of Axxum&#x2019;s assets and liabilities at the date of acquisition and determined that the carrying
value of those accounts approximated fair value. The difference between the purchase price paid for the acquisition of Axxum and the
net asset value derived from the assets and liabilities of Axxum at the date of acquisition has been recognized as goodwill. Accordingly,
the purchase costs of $&lt;span id="xdx_906_eus-gaap--CashAcquiredInExcessOfPaymentsToAcquireBusiness_c20171122__20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember_zKKXx5klk7Vc" title="Cash acquired in excess of payments to acquire business"&gt;6,500,000&lt;/span&gt; in cash, $&lt;span id="xdx_90C_eus-gaap--NotesPayable_iI_c20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember_z9jcsC9Gt49e" title="Promissory notes"&gt;500,000&lt;/span&gt; in promissory notes, and $&lt;span id="xdx_908_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_c20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember_zmyIUjyfSWX9" title="Net assets acquired"&gt;140,005&lt;/span&gt; in capitalized transaction costs, less $&lt;span id="xdx_90A_ecustom--AdjustmentInWorkingCapital_iI_c20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember_zegSbNR1bWla" title="Adjustment in working capital"&gt;573,150&lt;/span&gt;
in adjustment in working capital that is recoverable from sellers resulted in a total purchase cost of $&lt;span id="xdx_902_eus-gaap--BusinessCombinationConsiderationTransferred1_c20171122__20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember_zqJbLeZegQ1g" title="Adjustment in working capital"&gt;6,566,855&lt;/span&gt;. The net asset value
of Axxum at the date of acquisition was $&lt;span id="xdx_905_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_c20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember_z8VvffFJKmv2" title="Business combination, recognized asset acquired to liability assumed, excess (less), and goodwill"&gt;1,413,589&lt;/span&gt;. Accordingly, the Company recognized $&lt;span id="xdx_903_eus-gaap--Goodwill_iI_c20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember_zrAUPbajcuM4" title="Goodwill"&gt;5,153,266&lt;/span&gt; in goodwill related to the acquisition
of Axxum.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Acquisition
of Cloudburst Security, LLC.&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 3, 2019, the Company entered into a membership interest purchase agreement with Cloudburst and its two equity holders to
purchase &lt;span id="xdx_903_eus-gaap--EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_iI_pid_dp_uPure_c20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_zgrf2YPCs5Xf" title="Equity interest percentage"&gt;100&lt;/span&gt;% of the issued and outstanding units in exchange for $&lt;span id="xdx_90F_eus-gaap--Cash_iI_c20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_zbAkNtTR4D2b" title="Cash"&gt;500,000&lt;/span&gt; in cash; $&lt;span id="xdx_902_eus-gaap--NotesPayable_iI_c20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember__srt--TitleOfIndividualAxis__custom--OneEquityHolderMember_ztA53P8YTwJc" title="Promissory notes"&gt;540,000&lt;/span&gt; for a promissory note to one equity
holder and $&lt;span id="xdx_905_eus-gaap--NotesPayable_iI_c20171122__us-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementMember__srt--TitleOfIndividualAxis__custom--TwoEquityHolderMember_znuyOu57EUsh" title="Promissory notes"&gt;360,000&lt;/span&gt; to the other; and &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20190403__20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--OneEquityHolderMember_zYnVH9pgdwa3" title="Stock issued"&gt;111,628&lt;/span&gt; and &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20190403__20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--TwoEquityHolderMember_zMm5FNOTNdh" title="Stock issued"&gt;74,420&lt;/span&gt; shares of the Company&#x2019;s common stock to the two equity holders,
respectively, on a post-split basis. Accordingly, Cloudburst became a wholly-owned subsidiary of the Company. The Company assessed
the carrying value of Cloudburst&#x2019;s assets and liabilities at the date of acquisition and determined that the carrying value of
those accounts approximated fair value; the difference between the purchase price paid for the acquisition of Cloudburst and the net
asset value derived from the assets and liabilities of Cloudburst at the date of acquisition has been recognized as goodwill. The
purchase costs of $&lt;span id="xdx_90E_eus-gaap--CashAcquiredInExcessOfPaymentsToAcquireBusiness_c20190403__20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_z88yPzb3U4Eg" title="Cash acquired in excess of payments to acquire business"&gt;500,000&lt;/span&gt; in cash, $&lt;span id="xdx_90A_eus-gaap--NotesPayable_iI_c20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_zNBTIYXspHp3" title="Promissory notes"&gt;900,000&lt;/span&gt; in promissory notes, $&lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20190403__20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_zx412Ndiy97h" title="Number of shares issued, value"&gt;300,000&lt;/span&gt; in &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20190403__20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_zF3LtzQHfszk" title="Stock issued (in shares)"&gt;186,048&lt;/span&gt; shares of the Company&#x2019;s common stock,
$&lt;span id="xdx_90E_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_z6SQywxpeGke" title="Business combination, contingent consideration, asset"&gt;1,400,000&lt;/span&gt; in contingent earnout, $&lt;span id="xdx_908_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_c20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_zIaMgPHeSER7" title="Net assets acquired"&gt;62,305&lt;/span&gt; in capitalized transaction costs, resulted in a total purchase cost of $&lt;span id="xdx_900_eus-gaap--BusinessCombinationConsiderationTransferred1_c20190403__20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_zxjLkPdr813d" title="Total consideration"&gt;3,162,305&lt;/span&gt;. The net
asset value of Cloudburst at the date of acquisition was $&lt;span id="xdx_907_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_c20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_zowHMWBayhn7" title="Business combination, recognized asset acquired to liability assumed, excess (less), and goodwill"&gt;323,267&lt;/span&gt;. Accordingly, the Company recognized $&lt;span id="xdx_906_eus-gaap--Goodwill_iI_c20190403__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_zowQirbK6Jj9" title="Goodwill"&gt;2,839,038&lt;/span&gt; in goodwill
related to the acquisition of Cloudburst. On April&#160;20, 2022, the holders of the (i) $&lt;span id="xdx_909_eus-gaap--NotesPayable_iI_c20220420__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_zlXGrUDbHTJh" title="Promissory notes"&gt;900,000&lt;/span&gt; promissory notes and (ii) &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220420__20220420__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember__us-gaap--TypeOfArrangementAxis__custom--MembershipInterestPurchaseAgreementMember_zBSN2TKDuDhg" title="Stock issued (in shares)"&gt;186,048&lt;/span&gt;
shares of the Company&#x2019;s common stock tendered them to the Company for cancellation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Relevant
factors to the Company&#x2019;s assessment of the carrying value of goodwill for both business combinations in accordance to the fair
value hierarchy under the category of level 3 are as follows: estimation of the growth rate of future incoming and outgoing cash flows,
certain elements that comprise the appropriate weighted average cost of capital, such as the equity of potential market participants
for comparability analysis, and the Company&#x2019;s sensitivity to outside factors that would lead to variation in the aforementioned
cash flows and weighted average cost of capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s management reviewed the performance of Cloudburst and its manager during the year ended December 31, 2020 and
determined that Cloudburst had not met the performance targets set forth at the time of acquisition. As a result, the manager of
Cloudburst was dismissed. Management of the Company performed a quantitative analysis of the carrying value of the subsidiary and
its related goodwill by preparing a future discounted cash flow analysis, which included variables such as expectations on future
cash flows, calculation of the cost of capital, and the probability of capturing certain contracts under the framework of Cloudburst
being a federal government approved service provider, and determined that the fair value as of December&#160;31, 2020 was lower than
the carrying value that was previously established at the point of acquisition; accordingly, during the year ended December&#160;31,
2020, the Company determined that the contingent earnout should be de-recognized, and written off in its entirety in the amount of
$&lt;span id="xdx_900_eus-gaap--GoodwillWrittenOffRelatedToSaleOfBusinessUnit_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember_zS8sbBBgppaj" title="Goodwill, written off related to sale of business unit"&gt;1,400,000&lt;/span&gt; to the Company&#x2019;s result of operations, and, as a result of the above assessment, the Company recognized an
impairment of goodwill in the amount of $&lt;span id="xdx_90B_eus-gaap--GoodwillImpairmentLoss_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember_z0jdgx4j8XD9" title="Goodwill impairment"&gt;1,400,000&lt;/span&gt; that was also recognized to the Company&#x2019;s results of operations. The
Company&#x2019;s ending goodwill related to the acquisition of Cloudburst after recognizing impairment was $&lt;span id="xdx_909_eus-gaap--Goodwill_iI_c20201231__us-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember_zLt6Kt7lZi3k" title="Goodwill"&gt;1,439,038&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;SLG
Innovation Inc. Master Service Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company initiated discussions to acquire SLG in late 2020, advancing an initial non-refundable deposit of $&lt;span id="xdx_909_eus-gaap--RestrictedInvestments_iI_pn5n6_c20201231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zQrcBNiNNWU8" title="Restricted investments"&gt;1.4&lt;/span&gt; million for loans,
capitalized transaction costs, and accounts receivable. By December&#160;31, 2024, this deposit had increased to $&lt;span id="xdx_90C_eus-gaap--DepositsAssets_iI_pn5n6_c20241231__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__srt--RangeAxis__srt--MaximumMember_zUMtSgfjMUP5" title="Non-refundable deposits"&gt;2.0&lt;/span&gt;&#160;million.
On May 13, 2021, the Company entered into an agreement to acquire substantially all of SLG&#x2019;s assets and certain
liabilities, later amended to focus on specific sales contracts. A unidirectional letter of intent (LOI) was executed on
April 29, 2023, binding SLG to the transaction while allowing the Company the option to proceed. The LOI contemplated a
structure involving the $&lt;span id="xdx_900_eus-gaap--DepositsAssets_iI_pn5n6_c20230429__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_z7dzkPSHsB8b" title="Deposits assets"&gt;2.0&lt;/span&gt; million receivable, $&lt;span id="xdx_904_eus-gaap--AccountsPayableOtherCurrent_iI_pn5n6_c20230429__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zDAhM3Oew3Bc" title="Accounts payable, other, current"&gt;2.1&lt;/span&gt; million in SLG payables to RCR Technology Corporation, and &lt;span id="xdx_903_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20230429__20230429__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zvWsNejrrjAi" title="Number of preferred stock converted"&gt;33,212&lt;/span&gt; shares of
the Company&#x2019;s capital stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March&#160;31, 2025, the Company finalized the MSA and Burns Release Agreement for SLG. The total purchase consideration included the
$&lt;span id="xdx_906_eus-gaap--DepositsAssets_iI_pn5n6_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zojp8Z7sURnj" title="Non-refundable deposits"&gt;2.0&lt;/span&gt; million prepaid deposit, &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20250331__20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zBt2HMMrtU28" title="Common stock issued for business combination costs"&gt;33,609&lt;/span&gt; shares of common stock (par value $&lt;span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zdRMkbdHm3e7" title="Common stock, par value"&gt;0.0001&lt;/span&gt;), &lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20250331__20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zYiMNBcdx3e6" title="Common stock issued for business combination costs"&gt;51&lt;/span&gt; shares of Series E Convertible Preferred Stock (face
value $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zRClO4ofBsP8" title="Principal amount"&gt;10,000&lt;/span&gt; each, conversion price $&lt;span id="xdx_900_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zDHL9u9JXMh3" title="Conversion price"&gt;1.00&lt;/span&gt;) and $&lt;span id="xdx_90B_eus-gaap--GainLossOnSaleOfAccountsReceivable_c20250331__20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zdVxrIxYzqCh" title="Accounts receivable"&gt;10,814,147&lt;/span&gt; of accounts receivable in Cycurion owing from SLG. Additionally, the Company
issued &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20250331__20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zB56L2kh0hC8" title="Share based compensation shares"&gt;16,667&lt;/span&gt; shares of common stock to assume SLG&#x2019;s share-based payment obligations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
transaction was accounted for as a business combination under ASC 805. As of the transaction date, the fair value of assets acquired
totaled $&lt;span id="xdx_903_eus-gaap--FairValueOfAssetsAcquired_pn5n6_c20250331__20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationMember_zr4MayHFtk0d" title="Fair value of assets acquired"&gt;3.1&lt;/span&gt;&#160;million, excluding cash of $&lt;span id="xdx_904_eus-gaap--Cash_iI_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationMember_znQNKMRMnsTj" title="Cash"&gt;34,983&lt;/span&gt; that was netted against cash consideration paid. Liabilities assumed amounted to
$&lt;span id="xdx_90A_eus-gaap--Liabilities_iI_pn5n6_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationMember_z6k71BElEbTh" title="Liabilities"&gt;10.6&lt;/span&gt;&#160;million, including accounts payable, accrued liabilities, payroll liabilities and loans. After recognizing a non-controlling
interest of $&lt;span id="xdx_90F_eus-gaap--MinorityInterest_iI_pn5n6_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationMember_zssWY45qHQQc" title="Non-controlling interest"&gt;3.5&lt;/span&gt;&#160;million, the net assets acquired were negative $&lt;span id="xdx_909_eus-gaap--Assets_iI_pn5n6_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationMember_zYKKLxBUNDJ6" title="Assets"&gt;7.6&lt;/span&gt;&#160;million. The total consideration transferred exceeded
the net assets acquired, resulting in the recognition of goodwill amounting to $&lt;span id="xdx_90F_eus-gaap--Goodwill_iI_pn5n6_c20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationMember_z1ZNPolPXrg5" title="Goodwill"&gt;14.6&lt;/span&gt;&#160;million. This goodwill reflects the strategic
value of SLG&#x2019;s operations, expected synergies, and future growth potential.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
7: Details of Goodwill&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfGoodwillTextBlock_zBW0nundeVu6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BC_zzMjvtB4i4Qj" style="display: none"&gt;SCHEDULE OF GOODWILL&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20260331_zwDYvZx3xYA2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;March
    31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20251231_zcxIicfC5jN8" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--Goodwill_iI_hus-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember_zw9KLwe2kGl8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Axxum&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,153,266&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,153,266&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--Goodwill_iI_hus-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember_zOVfpKZ48nJ4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cloudburst&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,439,038&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,439,038&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--Goodwill_iI_hus-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_z2DoUlu7fRVi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;SLG&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,646,146&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,250,204&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--Goodwill_iI_zv20QC0xGKXl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,238,450&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,842,508&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AB_z3dItYJPSc12" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee
      contextRef="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember"
      decimals="INF"
      id="Fact003963"
      unitRef="Pure">1</us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee>
    <us-gaap:Cash
      contextRef="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember"
      decimals="0"
      id="Fact003965"
      unitRef="USD">6500000</us-gaap:Cash>
    <us-gaap:ConvertibleSubordinatedDebt
      contextRef="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember"
      decimals="0"
      id="Fact003967"
      unitRef="USD">500000</us-gaap:ConvertibleSubordinatedDebt>
    <us-gaap:ConvertibleSubordinatedDebt
      contextRef="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember_custom_TwoMember"
      decimals="0"
      id="Fact003969"
      unitRef="USD">250000</us-gaap:ConvertibleSubordinatedDebt>
    <us-gaap:CashAcquiredInExcessOfPaymentsToAcquireBusiness
      contextRef="From2017-11-222017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember"
      decimals="0"
      id="Fact003971"
      unitRef="USD">6500000</us-gaap:CashAcquiredInExcessOfPaymentsToAcquireBusiness>
    <us-gaap:NotesPayable
      contextRef="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember"
      decimals="0"
      id="Fact003973"
      unitRef="USD">500000</us-gaap:NotesPayable>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember"
      decimals="0"
      id="Fact003975"
      unitRef="USD">140005</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <CYCU:AdjustmentInWorkingCapital
      contextRef="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember"
      decimals="0"
      id="Fact003977"
      unitRef="USD">573150</CYCU:AdjustmentInWorkingCapital>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2017-11-222017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember"
      decimals="0"
      id="Fact003979"
      unitRef="USD">6566855</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember"
      decimals="0"
      id="Fact003981"
      unitRef="USD">1413589</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember"
      decimals="0"
      id="Fact003983"
      unitRef="USD">5153266</us-gaap:Goodwill>
    <us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee
      contextRef="AsOf2019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="INF"
      id="Fact003985"
      unitRef="Pure">1</us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee>
    <us-gaap:Cash
      contextRef="AsOf2019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="0"
      id="Fact003987"
      unitRef="USD">500000</us-gaap:Cash>
    <us-gaap:NotesPayable
      contextRef="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember_custom_OneEquityHolderMember"
      decimals="0"
      id="Fact003989"
      unitRef="USD">540000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2017-11-22_custom_AxxumTechnologiesLLCMember_custom_ShareTransferAgreementMember_custom_TwoEquityHolderMember"
      decimals="0"
      id="Fact003991"
      unitRef="USD">360000</us-gaap:NotesPayable>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2019-04-032019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember_custom_OneEquityHolderMember"
      decimals="INF"
      id="Fact003993"
      unitRef="Shares">111628</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2019-04-032019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember_custom_TwoEquityHolderMember"
      decimals="INF"
      id="Fact003995"
      unitRef="Shares">74420</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CashAcquiredInExcessOfPaymentsToAcquireBusiness
      contextRef="From2019-04-032019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="0"
      id="Fact003997"
      unitRef="USD">500000</us-gaap:CashAcquiredInExcessOfPaymentsToAcquireBusiness>
    <us-gaap:NotesPayable
      contextRef="AsOf2019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="0"
      id="Fact003999"
      unitRef="USD">900000</us-gaap:NotesPayable>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2019-04-032019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="0"
      id="Fact004001"
      unitRef="USD">300000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2019-04-032019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="INF"
      id="Fact004003"
      unitRef="Shares">186048</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:BusinessCombinationContingentConsiderationAsset
      contextRef="AsOf2019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="0"
      id="Fact004005"
      unitRef="USD">1400000</us-gaap:BusinessCombinationContingentConsiderationAsset>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="AsOf2019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="0"
      id="Fact004007"
      unitRef="USD">62305</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2019-04-032019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="0"
      id="Fact004009"
      unitRef="USD">3162305</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="AsOf2019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="0"
      id="Fact004011"
      unitRef="USD">323267</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="AsOf2019-04-03_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="0"
      id="Fact004013"
      unitRef="USD">2839038</us-gaap:Goodwill>
    <us-gaap:NotesPayable
      contextRef="AsOf2022-04-20_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="0"
      id="Fact004015"
      unitRef="USD">900000</us-gaap:NotesPayable>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-04-202022-04-20_custom_CloudburstSecurityLLCMember_custom_MembershipInterestPurchaseAgreementMember"
      decimals="INF"
      id="Fact004017"
      unitRef="Shares">186048</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="From2020-01-012020-12-31_custom_CloudburstSecurityLLCMember"
      decimals="0"
      id="Fact004019"
      unitRef="USD">1400000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2020-01-012020-12-31_custom_CloudburstSecurityLLCMember"
      decimals="0"
      id="Fact004021"
      unitRef="USD">1400000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="AsOf2020-12-31_custom_CloudburstSecurityLLCMember"
      decimals="0"
      id="Fact004023"
      unitRef="USD">1439038</us-gaap:Goodwill>
    <us-gaap:RestrictedInvestments
      contextRef="AsOf2020-12-31_custom_SLGInnovationIncMember"
      decimals="-5"
      id="Fact004025"
      unitRef="USD">1400000</us-gaap:RestrictedInvestments>
    <us-gaap:DepositsAssets
      contextRef="AsOf2024-12-31_custom_SLGInnovationIncMember_srt_MaximumMember"
      decimals="-5"
      id="Fact004027"
      unitRef="USD">2000000.0</us-gaap:DepositsAssets>
    <us-gaap:DepositsAssets
      contextRef="AsOf2023-04-29_custom_SLGInnovationIncMember"
      decimals="-5"
      id="Fact004029"
      unitRef="USD">2000000.0</us-gaap:DepositsAssets>
    <us-gaap:AccountsPayableOtherCurrent
      contextRef="AsOf2023-04-29_custom_SLGInnovationIncMember"
      decimals="-5"
      id="Fact004031"
      unitRef="USD">2100000</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2023-04-292023-04-29_custom_SLGInnovationIncMember"
      decimals="INF"
      id="Fact004033"
      unitRef="Shares">33212</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:DepositsAssets
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember"
      decimals="-5"
      id="Fact004035"
      unitRef="USD">2000000.0</us-gaap:DepositsAssets>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2025-03-312025-03-31_custom_SLGInnovationIncMember"
      decimals="INF"
      id="Fact004037"
      unitRef="Shares">33609</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember"
      decimals="INF"
      id="Fact004039"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2025-03-312025-03-31_custom_SLGInnovationIncMember_us-gaap_SeriesEPreferredStockMember"
      decimals="INF"
      id="Fact004041"
      unitRef="Shares">51</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact004043"
      unitRef="USD">10000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2025-03-31_custom_SLGInnovationIncMember"
      decimals="INF"
      id="Fact004045"
      unitRef="USDPShares">1.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:GainLossOnSaleOfAccountsReceivable
      contextRef="From2025-03-312025-03-31_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact004047"
      unitRef="USD">10814147</us-gaap:GainLossOnSaleOfAccountsReceivable>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2025-03-312025-03-31_custom_SLGInnovationIncMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact004049"
      unitRef="Shares">16667</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="From2025-03-312025-03-31_custom_SLGInnovationMember"
      decimals="-5"
      id="Fact004051"
      unitRef="USD">3100000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:Cash
      contextRef="AsOf2025-03-31_custom_SLGInnovationMember"
      decimals="0"
      id="Fact004053"
      unitRef="USD">34983</us-gaap:Cash>
    <us-gaap:Liabilities
      contextRef="AsOf2025-03-31_custom_SLGInnovationMember"
      decimals="-5"
      id="Fact004055"
      unitRef="USD">10600000</us-gaap:Liabilities>
    <us-gaap:MinorityInterest
      contextRef="AsOf2025-03-31_custom_SLGInnovationMember"
      decimals="-5"
      id="Fact004057"
      unitRef="USD">3500000</us-gaap:MinorityInterest>
    <us-gaap:Assets
      contextRef="AsOf2025-03-31_custom_SLGInnovationMember"
      decimals="-5"
      id="Fact004059"
      unitRef="USD">7600000</us-gaap:Assets>
    <us-gaap:Goodwill
      contextRef="AsOf2025-03-31_custom_SLGInnovationMember"
      decimals="-5"
      id="Fact004061"
      unitRef="USD">14600000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact004063">&lt;p id="xdx_893_eus-gaap--ScheduleOfGoodwillTextBlock_zBW0nundeVu6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BC_zzMjvtB4i4Qj" style="display: none"&gt;SCHEDULE OF GOODWILL&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20260331_zwDYvZx3xYA2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;March
    31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20251231_zcxIicfC5jN8" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--Goodwill_iI_hus-gaap--BusinessAcquisitionAxis__custom--AxxumTechnologiesLLCMember_zw9KLwe2kGl8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Axxum&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,153,266&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,153,266&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--Goodwill_iI_hus-gaap--BusinessAcquisitionAxis__custom--CloudburstSecurityLLCMember_zOVfpKZ48nJ4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cloudburst&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,439,038&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,439,038&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--Goodwill_iI_hus-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_z2DoUlu7fRVi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;SLG&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,646,146&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,250,204&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--Goodwill_iI_zv20QC0xGKXl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,238,450&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,842,508&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="AsOf2026-03-31_custom_AxxumTechnologiesLLCMember"
      decimals="0"
      id="Fact004065"
      unitRef="USD">5153266</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2025-12-31_custom_AxxumTechnologiesLLCMember"
      decimals="0"
      id="Fact004066"
      unitRef="USD">5153266</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2026-03-31_custom_CloudburstSecurityLLCMember"
      decimals="0"
      id="Fact004068"
      unitRef="USD">1439038</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2025-12-31_custom_CloudburstSecurityLLCMember"
      decimals="0"
      id="Fact004069"
      unitRef="USD">1439038</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact004071"
      unitRef="USD">14646146</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact004072"
      unitRef="USD">14250204</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact004074"
      unitRef="USD">21238450</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact004075"
      unitRef="USD">20842508</us-gaap:Goodwill>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact004077">&lt;p id="xdx_803_eus-gaap--DebtDisclosureTextBlock_zxSpZXfppoV4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8.
&lt;span id="xdx_82B_zF8qHmqkMu0b"&gt;BANK LOANS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Revolving
Line of Credit&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 22, 2017, Axxum procured from Main Street Bank a revolving line of credit with a maximum of up to $&lt;span id="xdx_90D_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn5n6_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember_zDdZMLx3SkW8" title="Line of credit facility, maximum borrowing capacity"&gt;1.0&lt;/span&gt; million
(&#x201c;Revolving Line of Credit&#x201d;), subject to certain restrictions based on available collateral pledged to the bank in the
form of accounts and trade receivables owed by the Company&#x2019;s customers. This Revolving Line of Credit is available for &lt;span id="xdx_903_eus-gaap--DebtInstrumentTerm_dc_c20171122__20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember_zgkUOYZHv88a" title="Debt instrument term"&gt;one
year&lt;/span&gt;, at which point it may be renewed by Axxum. Axxum incurred origination and closing costs for this line of credit in the amount
of $&lt;span id="xdx_908_eus-gaap--LineOfCredit_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember_zT0UyPyS7z15" title="Long-term line of credit"&gt;10,000&lt;/span&gt;, which Axxum has recognized a prepaid expense that will amortize over &lt;span id="xdx_909_eus-gaap--DebtInstrumentTerm_dc_c20171122__20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember_zJDNFxiWxSri" title="Debt instrument term"&gt;one year&lt;/span&gt; as interest expense. The stated rate of
interest of the Revolving Line of Credit is the prime rate plus &lt;span id="xdx_900_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20171122__20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember_zcpTx99g1hz7" title="Long-term line of credit"&gt;100&lt;/span&gt; basis points, which at the time of the loan, was
&lt;span id="xdx_90F_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20171122__20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember_zYGu3hDH5yN9" title="Line of credit facility, interest rate during period"&gt;4.50&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 18, 2019, Axxum, Cloudburst, and the Company collectively renewed the Revolving Line of Credit with a maximum aggregate
principal sum of $&lt;span id="xdx_90B_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn5n6_c20190418__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember_z8PopmR0BGIk" title="Line of credit facility, maximum borrowing capacity"&gt;2.0&lt;/span&gt; million with Main Street Bank. The stated rate of interest of the Revolving Line of Credit increased to &lt;span id="xdx_908_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20190418__20190418__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember_z8dEipoei7Jg" title="Line of credit facility, interest rate during period"&gt;5.75&lt;/span&gt;%
at the time of the renewal.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June&#160;29, 2020 and again on June&#160;30, 2021, the Company amended the Revolving Line of Credit with an extension of the maturity
date to March 31, 2024. The stated rate of interest of the Revolving Line of Credit decreased to &lt;span id="xdx_909_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20200629__20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember_znqE0pGggQdh" title="Line of credit facility, interest rate during period"&gt;5.25&lt;/span&gt;% at the time of the first amendment
and an additional &lt;span id="xdx_906_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20210630__20210630__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember_zBkBdhMMGpuj" title="Line of credit facility, interest rate during period"&gt;5&lt;/span&gt;% default interest on the second amendment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March&#160;31, 2026, the stated rate of interest of the Revolving Line of Credit was &lt;span id="xdx_900_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20260101__20260331__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember_z2FUAixs2U58" title="Line of credit facility, interest rate during period"&gt;7.75&lt;/span&gt;%. The outstanding balance of the
Revolving Line of Credit was $&lt;span id="xdx_902_eus-gaap--LineOfCredit_iI_pn5n6_c20260331_zqRmNic05Ojk" title="Long-term line of credit"&gt;2.7&lt;/span&gt;&#160;million and $&lt;span id="xdx_90B_eus-gaap--LineOfCredit_iI_pn5n6_c20251231_ziRJecUDVUve" title="Long-term line of credit"&gt;2.9&lt;/span&gt;&#160;million, as of March 31, 2026 and December&#160;31, 2025,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Loan
and Security Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 22, 2017, concurrent with the above-mentioned Revolving Line of Credit, Axxum procured a bank term loan from Main Street Bank
in the amount of $&lt;span id="xdx_906_eus-gaap--LineOfCredit_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zXuZN5dgUhTb" title="Line of credit"&gt;5,250,000&lt;/span&gt; with an expiration of December 31, 2024 (the &#x201c;Loan and Security Agreement&#x201d;). The Loan and Security
Agreement is subject to a monthly repayment of principal in the amount of $&lt;span id="xdx_90C_eus-gaap--RepaymentsOfLinesOfCredit_c20171122__20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zWIFLBpwkepe" title="Repayments of revolving line of credit"&gt;109,375&lt;/span&gt;. The loan carries a stated adjustable interest rate
of the prime rate plus &lt;span id="xdx_904_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20171122__20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zTCvZRIPPuPl" title="Long-term line of credit"&gt;200&lt;/span&gt; basis points, which, at the time of the loan, was &lt;span id="xdx_900_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20171122__20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_z4dA1W2OT2m1" title="Line of credit facility, interest rate during period"&gt;5.50&lt;/span&gt;%. Axxum incurred closing and origination costs totaling
$&lt;span id="xdx_90D_ecustom--OriginationCosts_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zjK7LGIwYPK4" title="Origination costs"&gt;211,729&lt;/span&gt;. The imputed interest rate after giving effect for the closing and origination costs was &lt;span id="xdx_90F_ecustom--ImputedInterestRateOnOriginationCosts_pid_dp_uPure_c20171122__20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zzvkmGYyXoG4" title="Imputed interest rate on origination costs"&gt;7.82&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the Loan and Security Agreement, Axxum is subject to the following affirmative loan covenants: (i) on or after December 31, 2017 but
prior to June 30, 2018, minimum tangible net worth (net liability) of $&lt;span id="xdx_901_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterDecember312017ButPriorToJune302018Member_zHGzPMKjWuZf" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;2,250,000&lt;/span&gt;; on or after June 30, 2018 but prior to June 30, 2019,
minimum tangible net worth (net liability) of $&lt;span id="xdx_90A_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterJune302018ButPriorToJune302019Member_z0RrsQPpanl3" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;1,250,000&lt;/span&gt;; on or after June 30, 2019 but prior to December 31, 2019, minimum tangible
net worth (net liability) of $&lt;span id="xdx_903_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterJune302019ButPriorToDecember312019Member_zb9aCcON8SVh" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;950,000&lt;/span&gt;; on or after December 31, 2019 but prior to June 30, 2020, minimum tangible net worth (net asset)
of $&lt;span id="xdx_905_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterDecember312019ButPriorToJune302020Member_zVpYPJhcsRD6" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;1,750,000&lt;/span&gt;; on or after June 30, 2020 but prior to December 31, 2020, minimum tangible net worth (net asset) of $&lt;span id="xdx_90F_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterJune302020ButPriorToDecember312020Member_zNq4Z6hFWI44" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;2,500,000&lt;/span&gt;; on or
after December 31, 2020 but prior to June 30, 2021, minimum tangible net worth (net asset) of $&lt;span id="xdx_90B_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterDecember312020ButPriorToJune302021Member_z66hJJK0YRM" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;3,000,000&lt;/span&gt;; on or after June 30, 2021 but
prior to December 31, 2021, minimum tangible net worth (net asset) of $&lt;span id="xdx_903_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterJune302021ButPriorToDecember312021Member_zS43flote08g" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;3,500,000&lt;/span&gt;; on or after December 31, 2021, minimum tangible net
worth (net asset) of $&lt;span id="xdx_909_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterDecember312021Member_z2S7UGAdAL56" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;5,000,000&lt;/span&gt;, (ii) interest coverage ratios must be greater than &lt;span id="xdx_90F_ecustom--DebtInstrumentCovenantInterestCoverageRatioMinimum_iI_uPure_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zzsZgxbyJn66" title="Debt instrument, covenant, interest coverage ratio"&gt;1.25-to-1&lt;/span&gt;, measured on quarterly basis, using a rolling
four-quarter basis, beginning with the fiscal quarter ending December 31, 2017, (iii) the Company and Axxum must achieve minimum consolidated
earnings before tax interest, tax, depreciation and amortization of (&#x201c;EBITDA&#x201d;) greater than $&lt;span id="xdx_907_ecustom--DebtInstrumentCovenantEBITDAMinimum_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zp5LGNYUZf2" title="Debt instrument, covenant, EBITDA"&gt;300,000&lt;/span&gt; per quarter, and (iv)
annual capital expenditures must be less than $&lt;span id="xdx_908_ecustom--DebtInstrumentCovenantAnnualCapitalExpendituresMaximum_iI_c20171122__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_z2tIHKbBGQw" title="Debt instrument, covenant, annual capital expenditures"&gt;50,000&lt;/span&gt;. Management conferred with the bank regarding the covenants and determined that
the Company was in compliance after giving effect to clarification in the definitions and formulas set forth by the bank in regard to
the calculation of the above covenants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April&#160;18, 2019, Axxum, Cloudburst, and the Company collectively amended the Loan and Security Agreement, including the addition
of Cloudburst as a borrower. The stated interest rate increased to &lt;span id="xdx_903_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20190418__20190418__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zJoj3SN4TW49" title="Line of credit facility, interest rate during period"&gt;6.75&lt;/span&gt;% and the loan covenants remained the same.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June&#160;29, 2020, the Company amended and restated the Loan and Security Agreement (&#x201c;Amended and Restated Loan and Security Agreement&#x201d;)
by extending the maturity date to March 22, 2024 with a monthly repayment of principal in the amount of $&lt;span id="xdx_909_eus-gaap--RepaymentsOfLinesOfCredit_c20200629__20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zPSL9eVQitMd" title="Repayments of revolving line of credit"&gt;62,500&lt;/span&gt; on or after June 22,
2020. The stated interest rate decreased to &lt;span id="xdx_904_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20200629__20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zN9fJUcT21d3" title="Line of credit facility, interest rate during period"&gt;6.25&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the Amended and Restated Loan and Security Agreement, the loan covenants were replaced as follows: (i) on or after June 30, 2020 but
prior to December 31, 2020, minimum tangible net worth (net liability) of $&lt;span id="xdx_90B_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterJune302020ButPriorToDecember312020Member_z17i4VPGOqKg" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;2,750,000&lt;/span&gt;; on or after December 31, 2020 but prior to June
30, 2021, minimum tangible net worth (net liability) of $&lt;span id="xdx_901_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterDecember312020ButPriorToJune302021Member_zXElG79atCE2" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;2,250,000&lt;/span&gt;; on or after June 30, 2021 but prior to December 31, 2021, minimum
tangible net worth (net liability) of $&lt;span id="xdx_906_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterJune302021ButPriorToDecember312021Member_zpMUiFW7aOmc" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;1,750,000&lt;/span&gt;; on or after December 31, 2021, but prior to June 30, 2022, minimum tangible net worth
(net liability) of $&lt;span id="xdx_90A_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterDecember312021ButPriorToJune302022Member_z8EWwGH4w4If" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;1,250,000&lt;/span&gt;; on or after June 30, 2022 but prior to December 31, 2022, minimum tangible net worth (net asset) of $&lt;span id="xdx_908_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterJune302022ButPriorToDecember312022Member_ztg7fW7KrSkh" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;500,000&lt;/span&gt;;
on or after December 31, 2022, but prior to June 30, 2023, minimum tangible net worth (net asset) of $&lt;span id="xdx_909_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterDecember312022ButPriorToJune302023Member_zxhqJj5Wjpak" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;1,250,000&lt;/span&gt;; on or after June 30,
2023 but prior to December 31, 2023, minimum tangible net worth (net asset) of $&lt;span id="xdx_90F_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterJune302023ButPriorToDecember312023Member_zNwlJpmDxYS5" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;2,000,000&lt;/span&gt;; on or after December 31, 2023, minimum tangible
net worth (net asset) of $&lt;span id="xdx_903_ecustom--DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability_iI_c20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__us-gaap--TaxPeriodAxis__custom--OnOrAfterDecember312023Member_zWXvej6hXJid" title="Debt instrument, covenant, minimum tangible net worth, net liability"&gt;2,500,000&lt;/span&gt;, (ii) interest coverage ratios must be greater than 1.20-to-1, measured on quarterly basis, using
a rolling four-quarter basis, beginning with the fiscal quarter ending June 30, 2020 (iii) the Company must achieve minimum consolidated
EBITDA greater than $&lt;span id="xdx_90B_ecustom--DebtInstrumentCovenantEBITDAMinimum_iI_c20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zjjXZCz44gnl" title="Debt instrument, covenant, EBITDA"&gt;300,000&lt;/span&gt; per quarter, and (iv) annual capital expenditures must be less than $&lt;span id="xdx_905_ecustom--DebtInstrumentCovenantAnnualCapitalExpendituresMaximum_iI_c20200629__us-gaap--CreditFacilityAxis__custom--RevolvingLineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember_zdyiEZhwkN4" title="Debt instrument, covenant, annual capital expenditures"&gt;50,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October&#160;1, 2025, the Company fully paid off the Loan and Security Agreement. The Company has categorized balances due within one
operating period as current and those payments due after one operating period as long-term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Pledge
Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 22, 2017, concurrent with Axxum&#x2019;s procurement of the above-mentioned Revolving Line of Credit and Loan and Security Agreement,
Axxum entered into a pledge agreement (the &#x201c;Pledge Agreement&#x201d;). The following pledges of collateral and credit enhancement
were made by Axxum and the Company as the sole member of Axxum: (i) the Company equity ownership in Axxum and (ii) all of Axxum&#x2019;s
assets, such as accounts, instruments, equipment, fixtures, deposit accounts, letter of credit rights, and any other assets. All future
debt is subordinated to the bank term loan until the term loan is repaid in full. Personal guarantees have also been made by Emmit McHenry,
Kurt McHenry, and Alvin McCoy III, as officers and stockholders of the Company in support of the term loan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 18, 2019, Axxum, Cloudburst, and the Company collectively amended the Pledge Agreement, including the addition of Cloudburst as
a pledgor. The following pledges of collateral and credit enhancement were made by Axxum, Cloudburst, and the Company: (i) all of the
equity of Axxum, Cloudburst and each other subsidiary of the Company then owned or hereafter acquired by the Company and (ii) all rights
to which the owner of the pledged equity then or may thereafter become entitled by virtue of owning such pledged equity and being a member
of Axxum, Cloudburst and each other subsidiary of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember"
      decimals="-5"
      id="Fact004079"
      unitRef="USD">1000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2017-11-222017-11-22_custom_RevolvingLineOfCreditMember"
      id="Fact004081">P1Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCredit
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember"
      decimals="0"
      id="Fact004083"
      unitRef="USD">10000</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2017-11-222017-11-22_custom_RevolvingLineOfCreditMember"
      id="Fact004085">P1Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="From2017-11-222017-11-22_custom_RevolvingLineOfCreditMember"
      decimals="INF"
      id="Fact004087"
      unitRef="Pure">1</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="From2017-11-222017-11-22_custom_RevolvingLineOfCreditMember"
      decimals="INF"
      id="Fact004089"
      unitRef="Pure">0.0450</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2019-04-18_custom_RevolvingLineOfCreditMember"
      decimals="-5"
      id="Fact004091"
      unitRef="USD">2000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="From2019-04-182019-04-18_custom_RevolvingLineOfCreditMember"
      decimals="INF"
      id="Fact004093"
      unitRef="Pure">0.0575</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="From2020-06-292020-06-29_custom_RevolvingLineOfCreditMember"
      decimals="INF"
      id="Fact004095"
      unitRef="Pure">0.0525</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="From2021-06-302021-06-30_custom_RevolvingLineOfCreditMember"
      decimals="INF"
      id="Fact004097"
      unitRef="Pure">0.05</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="From2026-01-012026-03-31_custom_RevolvingLineOfCreditMember"
      decimals="INF"
      id="Fact004099"
      unitRef="Pure">0.0775</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCredit
      contextRef="AsOf2026-03-31"
      decimals="-5"
      id="Fact004101"
      unitRef="USD">2700000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="AsOf2025-12-31"
      decimals="-5"
      id="Fact004103"
      unitRef="USD">2900000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="0"
      id="Fact004105"
      unitRef="USD">5250000</us-gaap:LineOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="From2017-11-222017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="0"
      id="Fact004107"
      unitRef="USD">109375</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="From2017-11-222017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="INF"
      id="Fact004109"
      unitRef="Pure">2</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="From2017-11-222017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="INF"
      id="Fact004111"
      unitRef="Pure">0.0550</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <CYCU:OriginationCosts
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="0"
      id="Fact004113"
      unitRef="USD">211729</CYCU:OriginationCosts>
    <CYCU:ImputedInterestRateOnOriginationCosts
      contextRef="From2017-11-222017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="INF"
      id="Fact004115"
      unitRef="Pure">0.0782</CYCU:ImputedInterestRateOnOriginationCosts>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312017ButPriorToJune302018Member"
      decimals="0"
      id="Fact004117"
      unitRef="USD">2250000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302018ButPriorToJune302019Member"
      decimals="0"
      id="Fact004119"
      unitRef="USD">1250000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302019ButPriorToDecember312019Member"
      decimals="0"
      id="Fact004121"
      unitRef="USD">950000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312019ButPriorToJune302020Member"
      decimals="0"
      id="Fact004123"
      unitRef="USD">1750000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302020ButPriorToDecember312020Member"
      decimals="0"
      id="Fact004125"
      unitRef="USD">2500000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312020ButPriorToJune302021Member"
      decimals="0"
      id="Fact004127"
      unitRef="USD">3000000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302021ButPriorToDecember312021Member"
      decimals="0"
      id="Fact004129"
      unitRef="USD">3500000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312021Member"
      decimals="0"
      id="Fact004131"
      unitRef="USD">5000000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantInterestCoverageRatioMinimum
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="INF"
      id="Fact004133"
      unitRef="Pure">1.25</CYCU:DebtInstrumentCovenantInterestCoverageRatioMinimum>
    <CYCU:DebtInstrumentCovenantEBITDAMinimum
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="0"
      id="Fact004135"
      unitRef="USD">300000</CYCU:DebtInstrumentCovenantEBITDAMinimum>
    <CYCU:DebtInstrumentCovenantAnnualCapitalExpendituresMaximum
      contextRef="AsOf2017-11-22_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="0"
      id="Fact004137"
      unitRef="USD">50000</CYCU:DebtInstrumentCovenantAnnualCapitalExpendituresMaximum>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="From2019-04-182019-04-18_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="INF"
      id="Fact004139"
      unitRef="Pure">0.0675</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="From2020-06-292020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="0"
      id="Fact004141"
      unitRef="USD">62500</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="From2020-06-292020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="INF"
      id="Fact004143"
      unitRef="Pure">0.0625</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302020ButPriorToDecember312020Member"
      decimals="0"
      id="Fact004145"
      unitRef="USD">2750000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312020ButPriorToJune302021Member"
      decimals="0"
      id="Fact004147"
      unitRef="USD">2250000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302021ButPriorToDecember312021Member"
      decimals="0"
      id="Fact004149"
      unitRef="USD">1750000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312021ButPriorToJune302022Member"
      decimals="0"
      id="Fact004151"
      unitRef="USD">1250000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302022ButPriorToDecember312022Member"
      decimals="0"
      id="Fact004153"
      unitRef="USD">500000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312022ButPriorToJune302023Member"
      decimals="0"
      id="Fact004155"
      unitRef="USD">1250000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterJune302023ButPriorToDecember312023Member"
      decimals="0"
      id="Fact004157"
      unitRef="USD">2000000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability
      contextRef="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember_custom_OnOrAfterDecember312023Member"
      decimals="0"
      id="Fact004159"
      unitRef="USD">2500000</CYCU:DebtInstrumentCovenantMinimumTangibleNetWorthNetLiability>
    <CYCU:DebtInstrumentCovenantEBITDAMinimum
      contextRef="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="0"
      id="Fact004161"
      unitRef="USD">300000</CYCU:DebtInstrumentCovenantEBITDAMinimum>
    <CYCU:DebtInstrumentCovenantAnnualCapitalExpendituresMaximum
      contextRef="AsOf2020-06-29_custom_RevolvingLineOfCreditMember_custom_LoanAndSecurityAgreementMember"
      decimals="0"
      id="Fact004163"
      unitRef="USD">50000</CYCU:DebtInstrumentCovenantAnnualCapitalExpendituresMaximum>
    <CYCU:LoansPayableTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact004165">&lt;p id="xdx_80E_ecustom--LoansPayableTextBlock_zCn0L2zBTcq1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9.
&lt;span id="xdx_822_zp3V9omJvKjl"&gt;LOANS PAYABLE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Table
9: Details of Loans Payable&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;p id="xdx_895_ecustom--ScheduleOfLoansPayableAndAdvancesTableTextBlock_znoi4U1fDM95" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BF_zj1Smfel7r83" style="display: none"&gt;SCHEDULE OF LOANS PAYABLE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20260331_zWKneeO9pDVa" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;March
    31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20251231_zbsS55lwqGG3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--LoanPayable_iI_hdei--LegalEntityAxis__custom--CycurionMember_zM9e4s5o2Dfk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loan payable - Cycurion&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;405,314&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;405,314&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--LoanPayable_iI_hdei--LegalEntityAxis__custom--SLGInnovationIncMember_zXF6jQZlOHt7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loan payable - SLG&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;264,379&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;264,379&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--EconomicInjuryDisasterLoan_iI_hdei--LegalEntityAxis__custom--CycurionMember_zjpnAFt5GSd8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Economic injury disaster loan - Cycurion&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--EconomicInjuryDisasterLoan_iI_hdei--LegalEntityAxis__custom--SLGInnovationIncMember_zkKHa0vjv2I8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Economic injury disaster
    loan - SLG&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LoansPayable_iI_ziviAyd1H4W1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total loans payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;969,693&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;969,693&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--LoansPayableCurrent_iI_zYfXBxWQxqP5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: Current portion
    of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;669,693&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;669,693&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--LongTermLoansPayable_iTI_zsVzAHJ03CNf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Long-term
    debt&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;300,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;300,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zIodDw6Xniq6" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Loan
payable - Cycurion&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March&#160;20, 2023, the Company entered into a receivable purchase agreement (the &#x201c;RPA Loan&#x201d;) for cash received of $&lt;span id="xdx_903_eus-gaap--ProceedsFromConstructionLoansPayable_pn5n6_c20230320__20230320_zbIjnIVnER02" title="Proceeds from construction loans payable"&gt;0.3&lt;/span&gt;&#160;million,
with a specified interest rate of &lt;span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230320_z8KUP5IYG7a8" title="Debt interest rate"&gt;8.00&lt;/span&gt;%, due January&#160;20, 2024. The RPA Loan requires weekly payments of $&lt;span id="xdx_901_eus-gaap--PaymentsOfLoanCosts_c20230320__20230320_zgwpykmX4Rdk" title="Payments of loan costs"&gt;15,302&lt;/span&gt;, until $&lt;span id="xdx_903_ecustom--PaymentsOfRepaidCost_pn5n6_c20230320__20230320_zL9ybXGv6T75" title="Payments of repaid cost."&gt;0.5&lt;/span&gt;&#160;million
is repaid. As of both March&#160;31, 2026 and December&#160;31, 2025, the loan balance is $&lt;span id="xdx_900_ecustom--LoanPayable_iI_pn5n6_c20260331_zJhyGIxi5kYh" title="Loan payable"&gt;&lt;span id="xdx_90D_ecustom--LoanPayable_iI_pn5n6_c20251231_zPW61wB4X4nj" title="Loan payable"&gt;0.4&lt;/span&gt;&lt;/span&gt; million. The loan is in default and management
is working to settle the debt.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;EIDL
Loan - Cycurion&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July&#160;16, 2020, the Company executed the standard loan documents required for securing loans (the &#x201c;EIDL Loan - Cycurion&#x201d;)
offered by the U.S. Small Business Administration (the &#x201c;SBA&#x201d;) under its Economic Injury Disaster Loan (&#x201c;EIDL&#x201d;)
assistance program in light of the impact of the COVID-19 pandemic on the Company&#x2019;s business. The principal amount of the EIDL
Loan - Cycurion is $&lt;span id="xdx_90E_eus-gaap--ProceedsFromNotesPayable_c20200716__20200716__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zBweAB2zCuB9" title="Proceeds from notes payable"&gt;150,000&lt;/span&gt;, with proceeds to be used for working capital purposes. Interest accrues at the rate of &lt;span id="xdx_901_eus-gaap--ShortTermDebtPercentageBearingFixedInterestRate_iI_pid_dp_uPure_c20200716_zpBYplRqv8Z6" title="Debt interest rate"&gt;3.75&lt;/span&gt;% per annum and
will accrue from the date of the EIDL Loan - Cycurion. Installment payments, including principal and interest, are due monthly beginning
July&#160;16,&#160;2021 in the amount of $&lt;span id="xdx_905_eus-gaap--DebtInstrumentPeriodicPayment_c20200716__20200716__us-gaap--DebtInstrumentAxis__custom--EIDLLoanMember_zQ3ajcfK62Dh" title="Debt instrument, periodic payment"&gt;731&lt;/span&gt;. The balance of principal and interest is payable &lt;span id="xdx_907_eus-gaap--DebtInstrumentTerm_dtY_c20200716__20200716__us-gaap--DebtInstrumentAxis__custom--EIDLLoanMember_zaYTos1fWdA9" title="Debt instrument term"&gt;30&lt;/span&gt; years from the date of the EIDL Loan
- Cycurion.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;EIDL
Loan - SLG&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September&#160;30, 2020, the Company executed the standard loan documents required for securing loans (the &#x201c;EIDL Loan - SLG&#x201d;)
offered by the SBA under its EIDL assistance program in light of the impact of the COVID-19 pandemic on the Company&#x2019;s business.
The principal amount of the EIDL Loan - SLG is $&lt;span id="xdx_909_eus-gaap--ProceedsFromNotesPayable_c20200930__20200930__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__dei--LegalEntityAxis__custom--SLGInnovationIncMember_z3rXnwPlpLLf" title="Proceeds from notes payable"&gt;150,000&lt;/span&gt;, with the proceeds to be used for working capital purposes. Interest accrues
at the rate of &lt;span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200930__us-gaap--DebtInstrumentAxis__custom--EIDLLoanMember__dei--LegalEntityAxis__custom--SLGInnovationIncMember_zPPxUFuJ5Hec" title="Debt interest rate"&gt;3.75&lt;/span&gt;% per annum and will accrue from the date of the EIDL Loan - SLG. Installment payments, including principal and interest,
are due monthly beginning January 1, 2023 in the amount of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPayment_c20200930__20200930__us-gaap--DebtInstrumentAxis__custom--EIDLLoanMember__dei--LegalEntityAxis__custom--SLGInnovationIncMember_zSoPz1mcoZd1" title="Debt instrument, periodic payment"&gt;731&lt;/span&gt;. The balance of principal and interest is payable &lt;span id="xdx_904_eus-gaap--DebtInstrumentTerm_dtY_c20200930__20200930__us-gaap--DebtInstrumentAxis__custom--EIDLLoanMember__dei--LegalEntityAxis__custom--SLGInnovationIncMember_zBIuStM2jLg7" title="Debt instrument term"&gt;30&lt;/span&gt; years from the date
of the EIDL Loan - SLG.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Loan
Payable - SLG&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
2022 and 2023, the Company entered into non-recourse agreements with a lender to sell future cash receipts. Under the agreement, the
Company was required to make daily payments. The terms were renegotiated to monthly payments in 2023. As of March&#160;31, 2026, the
balance on the loan is $&lt;span id="xdx_909_ecustom--LoanPayable_iI_c20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__dei--LegalEntityAxis__custom--SLGInnovationIncMember_z3Yaf7mn33tf" title="Loan payable"&gt;264,379&lt;/span&gt;. The loan is in default and management is working to settle the debt.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
</CYCU:LoansPayableTextBlock>
    <CYCU:ScheduleOfLoansPayableAndAdvancesTableTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact004167">&lt;p id="xdx_895_ecustom--ScheduleOfLoansPayableAndAdvancesTableTextBlock_znoi4U1fDM95" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BF_zj1Smfel7r83" style="display: none"&gt;SCHEDULE OF LOANS PAYABLE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20260331_zWKneeO9pDVa" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;March
    31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20251231_zbsS55lwqGG3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--LoanPayable_iI_hdei--LegalEntityAxis__custom--CycurionMember_zM9e4s5o2Dfk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loan payable - Cycurion&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;405,314&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;405,314&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--LoanPayable_iI_hdei--LegalEntityAxis__custom--SLGInnovationIncMember_zXF6jQZlOHt7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loan payable - SLG&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;264,379&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;264,379&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--EconomicInjuryDisasterLoan_iI_hdei--LegalEntityAxis__custom--CycurionMember_zjpnAFt5GSd8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Economic injury disaster loan - Cycurion&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--EconomicInjuryDisasterLoan_iI_hdei--LegalEntityAxis__custom--SLGInnovationIncMember_zkKHa0vjv2I8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Economic injury disaster
    loan - SLG&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LoansPayable_iI_ziviAyd1H4W1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total loans payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;969,693&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;969,693&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--LoansPayableCurrent_iI_zYfXBxWQxqP5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: Current portion
    of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;669,693&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;669,693&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--LongTermLoansPayable_iTI_zsVzAHJ03CNf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Long-term
    debt&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;300,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;300,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</CYCU:ScheduleOfLoansPayableAndAdvancesTableTextBlock>
    <CYCU:LoanPayable
      contextRef="AsOf2026-03-31_custom_CycurionMember"
      decimals="0"
      id="Fact004169"
      unitRef="USD">405314</CYCU:LoanPayable>
    <CYCU:LoanPayable
      contextRef="AsOf2025-12-31_custom_CycurionMember"
      decimals="0"
      id="Fact004170"
      unitRef="USD">405314</CYCU:LoanPayable>
    <CYCU:LoanPayable
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember71577093"
      decimals="0"
      id="Fact004172"
      unitRef="USD">264379</CYCU:LoanPayable>
    <CYCU:LoanPayable
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember71576953"
      decimals="0"
      id="Fact004173"
      unitRef="USD">264379</CYCU:LoanPayable>
    <CYCU:EconomicInjuryDisasterLoan
      contextRef="AsOf2026-03-31_custom_CycurionMember"
      decimals="0"
      id="Fact004175"
      unitRef="USD">150000</CYCU:EconomicInjuryDisasterLoan>
    <CYCU:EconomicInjuryDisasterLoan
      contextRef="AsOf2025-12-31_custom_CycurionMember"
      decimals="0"
      id="Fact004176"
      unitRef="USD">150000</CYCU:EconomicInjuryDisasterLoan>
    <CYCU:EconomicInjuryDisasterLoan
      contextRef="AsOf2026-03-31_custom_SLGInnovationIncMember71577093"
      decimals="0"
      id="Fact004178"
      unitRef="USD">150000</CYCU:EconomicInjuryDisasterLoan>
    <CYCU:EconomicInjuryDisasterLoan
      contextRef="AsOf2025-12-31_custom_SLGInnovationIncMember71576953"
      decimals="0"
      id="Fact004179"
      unitRef="USD">150000</CYCU:EconomicInjuryDisasterLoan>
    <us-gaap:LoansPayable
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact004181"
      unitRef="USD">969693</us-gaap:LoansPayable>
    <us-gaap:LoansPayable
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact004182"
      unitRef="USD">969693</us-gaap:LoansPayable>
    <us-gaap:LoansPayableCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact004184"
      unitRef="USD">669693</us-gaap:LoansPayableCurrent>
    <us-gaap:LoansPayableCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact004185"
      unitRef="USD">669693</us-gaap:LoansPayableCurrent>
    <us-gaap:LongTermLoansPayable
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact004187"
      unitRef="USD">300000</us-gaap:LongTermLoansPayable>
    <us-gaap:LongTermLoansPayable
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact004188"
      unitRef="USD">300000</us-gaap:LongTermLoansPayable>
    <us-gaap:ProceedsFromConstructionLoansPayable
      contextRef="From2023-03-202023-03-20"
      decimals="-5"
      id="Fact004190"
      unitRef="USD">300000</us-gaap:ProceedsFromConstructionLoansPayable>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-03-20"
      decimals="INF"
      id="Fact004192"
      unitRef="Pure">0.0800</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:PaymentsOfLoanCosts
      contextRef="From2023-03-202023-03-20"
      decimals="0"
      id="Fact004194"
      unitRef="USD">15302</us-gaap:PaymentsOfLoanCosts>
    <CYCU:PaymentsOfRepaidCost
      contextRef="From2023-03-202023-03-20"
      decimals="-5"
      id="Fact004196"
      unitRef="USD">500000</CYCU:PaymentsOfRepaidCost>
    <CYCU:LoanPayable
      contextRef="AsOf2026-03-31"
      decimals="-5"
      id="Fact004198"
      unitRef="USD">400000</CYCU:LoanPayable>
    <CYCU:LoanPayable
      contextRef="AsOf2025-12-31"
      decimals="-5"
      id="Fact004200"
      unitRef="USD">400000</CYCU:LoanPayable>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2020-07-162020-07-16_custom_PromissoryNoteMember"
      decimals="0"
      id="Fact004202"
      unitRef="USD">150000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ShortTermDebtPercentageBearingFixedInterestRate
      contextRef="AsOf2020-07-16"
      decimals="INF"
      id="Fact004204"
      unitRef="Pure">0.0375</us-gaap:ShortTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2020-07-162020-07-16_custom_EIDLLoanMember"
      decimals="0"
      id="Fact004206"
      unitRef="USD">731</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2020-07-162020-07-16_custom_EIDLLoanMember"
      id="Fact004208">P30Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2020-09-302020-09-30_custom_PromissoryNoteMember_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact004210"
      unitRef="USD">150000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2020-09-30_custom_EIDLLoanMember_custom_SLGInnovationIncMember"
      decimals="INF"
      id="Fact004212"
      unitRef="Pure">0.0375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2020-09-302020-09-30_custom_EIDLLoanMember_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact004214"
      unitRef="USD">731</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2020-09-302020-09-30_custom_EIDLLoanMember_custom_SLGInnovationIncMember"
      id="Fact004216">P30Y</us-gaap:DebtInstrumentTerm>
    <CYCU:LoanPayable
      contextRef="AsOf2026-03-31_custom_PromissoryNoteMember_custom_SLGInnovationIncMember"
      decimals="0"
      id="Fact004218"
      unitRef="USD">264379</CYCU:LoanPayable>
    <CYCU:ConvertibleNotesDisclosureTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact004220">&lt;p id="xdx_80F_ecustom--ConvertibleNotesDisclosureTextBlock_zBIBnzwRI8Sd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10.
&lt;span id="xdx_82E_z17FUTMv3408"&gt;CONVERTIBLE NOTES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ConvertibleDebtTableTextBlock_zuEuuK7xzDrd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B2_zaOfj8KdwPM7" style="display: none"&gt;SCHEDULE OF CONVERTIBLE NOTES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Table
10: Details of Convertible Notes&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Principal
    Value&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unamortized
    Discount and&lt;br/&gt; Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Convertible
    Notes Carrying&lt;br/&gt; Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Maturity&lt;br/&gt;
    (Calendar Year)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DebtInstrumentFaceAmount_iS_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z5v1gNOmfM01" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4224"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iS_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zq8Mm7J58Q33" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4226"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ConvertibleNotesPayable_iS_c20250101__20250331_zIo4yi5U5jrb" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4228"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 32%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--DebtInstrumentFaceAmountIssued_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zHHSa5oBDHA5" style="width: 10%; text-align: right" title="Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;440,217&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--DeferredFinanceCostGross_iN_di_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zNnflUaCACK9" style="width: 10%; text-align: right" title="Unamortized Discount and Issuance Costs Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(53,717&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ConvertibleNotesPayableIssuance_c20250101__20250331_zPn6CFz6ruMd" style="width: 10%; text-align: right" title="Convertible Notes Carrying balance - Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;386,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--DebtWeightedAverageInterestRateIssuance_iI_pid_dp_uPure_c20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zKlzZZBrICJ4" style="width: 10%; text-align: center" title="Weighted Average Interest Rate Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18.0%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AmortizationOfDebtPremium_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zKV3SPV5a8A4" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4238"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AmortizationOfDebtDiscountPremium_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z8aT0Avxx6Bi" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs , Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,476&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ConvertibleNotesPayableAmortizationOfDebtDiscountPremium_c20250101__20250331_z72bi4cGFBc5" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,476&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentFaceAmount_iS_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zWMqhGw70qXc" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;440,217&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zCRNEVyC3iP7" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(49,241&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ConvertibleNotesPayable_iS_c20250401__20250630_zOXqolq3sio3" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;390,976&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zU9WhxmBvcx1" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18.0%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--DebtInstrumentFaceAmountIssued_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zqDEILaUkKca" style="text-align: right" title="Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,050,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--DeferredFinanceCostGross_iN_di_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zGzMh2cGsno2" style="text-align: right" title="Unamortized Discount and Issuance Costs Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(60,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ConvertibleNotesPayableIssuance_c20250401__20250630_ztx8X0Cw6k0c" style="text-align: right" title="Convertible Notes Carrying balance - Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,990,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--DebtWeightedAverageInterestRateIssuance_iI_pid_dp_uPure_c20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zf3HYrTqrDUg" style="text-align: center" title="Weighted Average Interest Rate Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15.1%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Conversion to equity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--DebtInstrumentFaceAmountConversionToEquity_iN_di_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zXpjeFdoMet6" style="text-align: right" title="Principal Value, Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,490,217&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ConversionOfStockAmountConverted1_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zFK1qhqtNeY5" style="text-align: right" title="Unamortized Discount and Issuance Costs , Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;82,465&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ConvertibleNotesPayableConversionToEquity_iN_di_c20250401__20250630_zH5Z74vLbrB4" style="text-align: right" title="Convertible Notes Carrying balance - Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,407,752&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--DebtWeightedAverageInterestRateConversionToEquity_iI_pid_dp_uPure_c20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zOpO1DfN1aRg" style="text-align: center" title="Weighted Average Interest Rate Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18.0%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AmortizationOfDebtPremium_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zzphqIlS1Goh" style="border-bottom: Black 1pt solid; text-align: right" title="Principal Value, Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4268"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AmortizationOfDebtDiscountPremium_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z3U3n1W8oPz5" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs , Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,776&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ConvertibleNotesPayableAmortizationOfDebtDiscountPremium_c20250401__20250630_zZFfEXKm5HFi" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,776&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentFaceAmount_iS_c20250701__20250930__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zJM1MXHxiqx3" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4274"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20250701__20250930__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_ziCKGDnm2dXe" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4276"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConvertibleNotesPayable_iS_c20250701__20250930_zpFR5d3DImF7" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4278"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--DebtInstrumentFaceAmountIssued_c20250701__20250930__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zdiLSwCbQnGh" style="border-bottom: Black 1pt solid; text-align: right" title="Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4280"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--DeferredFinanceCostGross_c20250701__20250930__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zOUI0eD6izF3" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4282"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ConvertibleNotesPayableIssuance_c20250701__20250930_z3Wt1Kv9wXJ1" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4284"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DebtInstrumentFaceAmount_iS_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_ztKUH7KutT98" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4286"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iS_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zG0b31MHoHTh" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4288"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ConvertibleNotesPayable_iS_c20251001__20251231_zjEJdn0Ukbe2" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4290"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--DebtInstrumentFaceAmountIssued_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zF9UkRV8RDD2" style="border-bottom: Black 1pt solid; text-align: right" title="Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,897&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--DeferredFinanceCostGross_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zlnuCOKTINO9" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4294"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ConvertibleNotesPayableIssuance_c20251001__20251231_z8KPvfhnCO" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,897&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--DebtWeightedAverageInterestRateIssuance_iI_pid_dp_uPure_c20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zZ3o4kCdfDa8" style="text-align: center" title="Weighted Average Interest Rate Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.0%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DebtInstrumentFaceAmount_iS_c20260101__20260331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z2xFCp94gq5d" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,897&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iS_c20260101__20260331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_ziAsaEUyLQf3" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4302"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ConvertibleNotesPayable_iS_c20260101__20260331_z9YCBcZYOIsl" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,897&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zLfqfL52TIkj" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.0%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--DebtInstrumentFaceAmountIssued_c20260101__20260331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z3rhyeBdpNra" style="border-bottom: Black 1pt solid; text-align: right" title="Principal Value, Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4308"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--DeferredFinanceCostGross_c20260101__20260331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zyxfduwnGzUl" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4310"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ConvertibleNotesPayableIssuance_c20260101__20260331_zuOFZxXp9Gj9" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4312"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DebtInstrumentFaceAmount_iE_c20260101__20260331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z82w7k8vzec" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal value ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,897&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iE_c20260101__20260331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zZanfUwkdvDj" style="border-bottom: Black 2.5pt double; text-align: right" title="Unamortized Discount and Issuance Costs ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4316"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ConvertibleNotesPayable_iE_c20260101__20260331_zBWU6zgZhuah" style="border-bottom: Black 2.5pt double; text-align: right" title="Convertible Notes Carrying Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,897&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20260331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zNIeF6Lh9xS" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.0%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A9_zGeB8brJmcJi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the first quarter of 2025, the Company issued convertible notes in the amount of $&lt;span id="xdx_907_ecustom--DebtInstrumentFaceAmountIssued_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zwS2sObdonCl" title="Debt instrument, face amount issued"&gt;440,217&lt;/span&gt; for proceeds of $&lt;span id="xdx_908_eus-gaap--ProceedsFromConvertibleDebt_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zeaem5B5s2K8" title="Proceeds from convertible notes payable"&gt;386,500&lt;/span&gt; to &lt;span id="xdx_90D_ecustom--DebtInstrumentNumberOfInvestors_iI_dc_uInteger_c20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zngfC1h4DL25" title="Debt Instrument, number of investors"&gt;three&lt;/span&gt; unaffiliated
investors. The notes had a &lt;span id="xdx_90B_eus-gaap--DebtInstrumentTerm_dc_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zDTjjmbinyk3" title="Debt instrument term"&gt;one year&lt;/span&gt; term and carried an annual interest rate of &lt;span id="xdx_901_ecustom--DebtWeightedAverageInterestRateIssuance_iI_pid_dp_uPure_c20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zk3EtWjAVui4" title="Debt weighted average interest rate issuance"&gt;18.0&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the second quarter of 2025, the Company issued convertible notes in the amount of $&lt;span id="xdx_90D_ecustom--DebtInstrumentFaceAmountIssued_pn5n6_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableOneMember_zK1BNGIqvy5e" title="Debt instrument, face amount issued"&gt;2.1&lt;/span&gt; million for proceeds of $&lt;span id="xdx_907_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zXIvtq4BqU39" title="Proceeds from convertible notes payable"&gt;2.0&lt;/span&gt;&#160;million. All
convertible notes were fully converted to Series G Convertible Preferred Stock. See Note 15 &#x2013; Equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the fourth quarter of 2025, the Company issued convertible notes in the amount of $&lt;span id="xdx_90C_ecustom--DebtInstrumentFaceAmountIssued_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zElOhtlS88cd" title="Debt instrument, face amount issued"&gt;192,897&lt;/span&gt; to &lt;span id="xdx_907_ecustom--DebtInstrumentNumberOfInvestors_iI_dc_uInteger_c20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_ze6CyrYZP8We" title="Debt Instrument, number of investors"&gt;one&lt;/span&gt; investor, Yield Point LLC. These notes
were issued in connection with the repayments of &lt;span id="xdx_900_ecustom--NumberOfPromissoryNotesRepaid_iI_dc_uInteger_c20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z2fH3F7s0JAa" title="Number of promissory notes repaid"&gt;two&lt;/span&gt; promissory notes. No cash was received or paid by the Company. This convertible
note carries an annual interest rate of &lt;span id="xdx_907_ecustom--DebtWeightedAverageInterestRateIssuance_iI_pid_dp_uPure_c20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zvyJTWqlRPHf" title="Debt weighted average interest rate issuance"&gt;12.0&lt;/span&gt;% and has a &lt;span id="xdx_90F_eus-gaap--DebtInstrumentTerm_dc_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z2WE4IyIqIla" title="Debt instrument term"&gt;one year&lt;/span&gt; term.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
</CYCU:ConvertibleNotesDisclosureTextBlock>
    <us-gaap:ConvertibleDebtTableTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact004222">&lt;p id="xdx_897_eus-gaap--ConvertibleDebtTableTextBlock_zuEuuK7xzDrd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B2_zaOfj8KdwPM7" style="display: none"&gt;SCHEDULE OF CONVERTIBLE NOTES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Table
10: Details of Convertible Notes&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Principal
    Value&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unamortized
    Discount and&lt;br/&gt; Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Convertible
    Notes Carrying&lt;br/&gt; Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Maturity&lt;br/&gt;
    (Calendar Year)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DebtInstrumentFaceAmount_iS_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z5v1gNOmfM01" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4224"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iS_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zq8Mm7J58Q33" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4226"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ConvertibleNotesPayable_iS_c20250101__20250331_zIo4yi5U5jrb" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4228"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 32%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--DebtInstrumentFaceAmountIssued_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zHHSa5oBDHA5" style="width: 10%; text-align: right" title="Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;440,217&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--DeferredFinanceCostGross_iN_di_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zNnflUaCACK9" style="width: 10%; text-align: right" title="Unamortized Discount and Issuance Costs Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(53,717&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ConvertibleNotesPayableIssuance_c20250101__20250331_zPn6CFz6ruMd" style="width: 10%; text-align: right" title="Convertible Notes Carrying balance - Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;386,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--DebtWeightedAverageInterestRateIssuance_iI_pid_dp_uPure_c20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zKlzZZBrICJ4" style="width: 10%; text-align: center" title="Weighted Average Interest Rate Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18.0%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AmortizationOfDebtPremium_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zKV3SPV5a8A4" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4238"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AmortizationOfDebtDiscountPremium_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z8aT0Avxx6Bi" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs , Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,476&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ConvertibleNotesPayableAmortizationOfDebtDiscountPremium_c20250101__20250331_z72bi4cGFBc5" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,476&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentFaceAmount_iS_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zWMqhGw70qXc" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;440,217&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zCRNEVyC3iP7" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(49,241&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ConvertibleNotesPayable_iS_c20250401__20250630_zOXqolq3sio3" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;390,976&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zU9WhxmBvcx1" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18.0%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--DebtInstrumentFaceAmountIssued_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zqDEILaUkKca" style="text-align: right" title="Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,050,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--DeferredFinanceCostGross_iN_di_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zGzMh2cGsno2" style="text-align: right" title="Unamortized Discount and Issuance Costs Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(60,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ConvertibleNotesPayableIssuance_c20250401__20250630_ztx8X0Cw6k0c" style="text-align: right" title="Convertible Notes Carrying balance - Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,990,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--DebtWeightedAverageInterestRateIssuance_iI_pid_dp_uPure_c20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zf3HYrTqrDUg" style="text-align: center" title="Weighted Average Interest Rate Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15.1%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Conversion to equity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--DebtInstrumentFaceAmountConversionToEquity_iN_di_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zXpjeFdoMet6" style="text-align: right" title="Principal Value, Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,490,217&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ConversionOfStockAmountConverted1_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zFK1qhqtNeY5" style="text-align: right" title="Unamortized Discount and Issuance Costs , Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;82,465&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ConvertibleNotesPayableConversionToEquity_iN_di_c20250401__20250630_zH5Z74vLbrB4" style="text-align: right" title="Convertible Notes Carrying balance - Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,407,752&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--DebtWeightedAverageInterestRateConversionToEquity_iI_pid_dp_uPure_c20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zOpO1DfN1aRg" style="text-align: center" title="Weighted Average Interest Rate Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18.0%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AmortizationOfDebtPremium_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zzphqIlS1Goh" style="border-bottom: Black 1pt solid; text-align: right" title="Principal Value, Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4268"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AmortizationOfDebtDiscountPremium_c20250401__20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z3U3n1W8oPz5" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs , Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,776&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ConvertibleNotesPayableAmortizationOfDebtDiscountPremium_c20250401__20250630_zZFfEXKm5HFi" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,776&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentFaceAmount_iS_c20250701__20250930__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zJM1MXHxiqx3" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4274"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20250701__20250930__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_ziCKGDnm2dXe" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4276"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConvertibleNotesPayable_iS_c20250701__20250930_zpFR5d3DImF7" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4278"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--DebtInstrumentFaceAmountIssued_c20250701__20250930__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zdiLSwCbQnGh" style="border-bottom: Black 1pt solid; text-align: right" title="Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4280"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--DeferredFinanceCostGross_c20250701__20250930__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zOUI0eD6izF3" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4282"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ConvertibleNotesPayableIssuance_c20250701__20250930_z3Wt1Kv9wXJ1" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4284"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DebtInstrumentFaceAmount_iS_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_ztKUH7KutT98" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4286"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iS_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zG0b31MHoHTh" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4288"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ConvertibleNotesPayable_iS_c20251001__20251231_zjEJdn0Ukbe2" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4290"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--DebtInstrumentFaceAmountIssued_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zF9UkRV8RDD2" style="border-bottom: Black 1pt solid; text-align: right" title="Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,897&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--DeferredFinanceCostGross_c20251001__20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zlnuCOKTINO9" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4294"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ConvertibleNotesPayableIssuance_c20251001__20251231_z8KPvfhnCO" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,897&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--DebtWeightedAverageInterestRateIssuance_iI_pid_dp_uPure_c20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zZ3o4kCdfDa8" style="text-align: center" title="Weighted Average Interest Rate Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.0%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DebtInstrumentFaceAmount_iS_c20260101__20260331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z2xFCp94gq5d" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,897&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iS_c20260101__20260331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_ziAsaEUyLQf3" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4302"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ConvertibleNotesPayable_iS_c20260101__20260331_z9YCBcZYOIsl" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,897&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zLfqfL52TIkj" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.0%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--DebtInstrumentFaceAmountIssued_c20260101__20260331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z3rhyeBdpNra" style="border-bottom: Black 1pt solid; text-align: right" title="Principal Value, Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4308"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--DeferredFinanceCostGross_c20260101__20260331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zyxfduwnGzUl" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4310"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ConvertibleNotesPayableIssuance_c20260101__20260331_zuOFZxXp9Gj9" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4312"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DebtInstrumentFaceAmount_iE_c20260101__20260331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z82w7k8vzec" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal value ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,897&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iE_c20260101__20260331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zZanfUwkdvDj" style="border-bottom: Black 2.5pt double; text-align: right" title="Unamortized Discount and Issuance Costs ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4316"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ConvertibleNotesPayable_iE_c20260101__20260331_zBWU6zgZhuah" style="border-bottom: Black 2.5pt double; text-align: right" title="Convertible Notes Carrying Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,897&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20260331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zNIeF6Lh9xS" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.0%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ConvertibleDebtTableTextBlock>
    <CYCU:DebtInstrumentFaceAmountIssued
      contextRef="From2025-01-012025-03-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact004230"
      unitRef="USD">440217</CYCU:DebtInstrumentFaceAmountIssued>
    <CYCU:DeferredFinanceCostGross
      contextRef="From2025-01-012025-03-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact004232"
      unitRef="USD">53717</CYCU:DeferredFinanceCostGross>
    <CYCU:ConvertibleNotesPayableIssuance
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact004234"
      unitRef="USD">386500</CYCU:ConvertibleNotesPayableIssuance>
    <CYCU:DebtWeightedAverageInterestRateIssuance
      contextRef="AsOf2025-03-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      id="Fact004236"
      unitRef="Pure">0.180</CYCU:DebtWeightedAverageInterestRateIssuance>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2025-01-012025-03-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact004240"
      unitRef="USD">4476</us-gaap:AmortizationOfDebtDiscountPremium>
    <CYCU:ConvertibleNotesPayableAmortizationOfDebtDiscountPremium
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact004242"
      unitRef="USD">4476</CYCU:ConvertibleNotesPayableAmortizationOfDebtDiscountPremium>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-03-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact004244"
      unitRef="USD">440217</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2025-03-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact004246"
      unitRef="USD">49241</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact004248"
      unitRef="USD">390976</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="AsOf2025-03-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      id="Fact004250"
      unitRef="Pure">0.180</us-gaap:DebtWeightedAverageInterestRate>
    <CYCU:DebtInstrumentFaceAmountIssued
      contextRef="From2025-04-012025-06-30_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact004252"
      unitRef="USD">2050000</CYCU:DebtInstrumentFaceAmountIssued>
    <CYCU:DeferredFinanceCostGross
      contextRef="From2025-04-012025-06-30_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact004254"
      unitRef="USD">60000</CYCU:DeferredFinanceCostGross>
    <CYCU:ConvertibleNotesPayableIssuance
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact004256"
      unitRef="USD">1990000</CYCU:ConvertibleNotesPayableIssuance>
    <CYCU:DebtWeightedAverageInterestRateIssuance
      contextRef="AsOf2025-06-30_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      id="Fact004258"
      unitRef="Pure">0.151</CYCU:DebtWeightedAverageInterestRateIssuance>
    <CYCU:DebtInstrumentFaceAmountConversionToEquity
      contextRef="From2025-04-012025-06-30_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact004260"
      unitRef="USD">2490217</CYCU:DebtInstrumentFaceAmountConversionToEquity>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="From2025-04-012025-06-30_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact004262"
      unitRef="USD">82465</us-gaap:ConversionOfStockAmountConverted1>
    <CYCU:ConvertibleNotesPayableConversionToEquity
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact004264"
      unitRef="USD">2407752</CYCU:ConvertibleNotesPayableConversionToEquity>
    <CYCU:DebtWeightedAverageInterestRateConversionToEquity
      contextRef="AsOf2025-06-30_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      id="Fact004266"
      unitRef="Pure">0.180</CYCU:DebtWeightedAverageInterestRateConversionToEquity>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2025-04-012025-06-30_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact004270"
      unitRef="USD">26776</us-gaap:AmortizationOfDebtDiscountPremium>
    <CYCU:ConvertibleNotesPayableAmortizationOfDebtDiscountPremium
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact004272"
      unitRef="USD">26776</CYCU:ConvertibleNotesPayableAmortizationOfDebtDiscountPremium>
    <CYCU:DebtInstrumentFaceAmountIssued
      contextRef="From2025-10-012025-12-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact004292"
      unitRef="USD">192897</CYCU:DebtInstrumentFaceAmountIssued>
    <CYCU:ConvertibleNotesPayableIssuance
      contextRef="From2025-10-012025-12-31"
      decimals="0"
      id="Fact004296"
      unitRef="USD">192897</CYCU:ConvertibleNotesPayableIssuance>
    <CYCU:DebtWeightedAverageInterestRateIssuance
      contextRef="AsOf2025-12-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      id="Fact004298"
      unitRef="Pure">0.120</CYCU:DebtWeightedAverageInterestRateIssuance>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact004300"
      unitRef="USD">192897</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact004304"
      unitRef="USD">192897</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="AsOf2025-12-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      id="Fact004306"
      unitRef="Pure">0.120</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2026-03-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact004314"
      unitRef="USD">192897</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact004318"
      unitRef="USD">192897</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="AsOf2026-03-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      id="Fact004320"
      unitRef="Pure">0.120</us-gaap:DebtWeightedAverageInterestRate>
    <CYCU:DebtInstrumentFaceAmountIssued
      contextRef="From2025-01-012025-03-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact004322"
      unitRef="USD">440217</CYCU:DebtInstrumentFaceAmountIssued>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2025-01-012025-03-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact004324"
      unitRef="USD">386500</us-gaap:ProceedsFromConvertibleDebt>
    <CYCU:DebtInstrumentNumberOfInvestors
      contextRef="AsOf2025-03-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      id="Fact004326"
      unitRef="Integer">3</CYCU:DebtInstrumentNumberOfInvestors>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2025-01-012025-03-31_us-gaap_ConvertibleNotesPayableMember"
      id="Fact004328">P1Y</us-gaap:DebtInstrumentTerm>
    <CYCU:DebtWeightedAverageInterestRateIssuance
      contextRef="AsOf2025-03-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      id="Fact004330"
      unitRef="Pure">0.180</CYCU:DebtWeightedAverageInterestRateIssuance>
    <CYCU:DebtInstrumentFaceAmountIssued
      contextRef="From2025-04-012025-06-30_custom_ConvertibleNotesPayableOneMember"
      decimals="-5"
      id="Fact004332"
      unitRef="USD">2100000</CYCU:DebtInstrumentFaceAmountIssued>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2025-04-012025-06-30_us-gaap_ConvertibleNotesPayableMember"
      decimals="-5"
      id="Fact004334"
      unitRef="USD">2000000.0</us-gaap:ProceedsFromConvertibleDebt>
    <CYCU:DebtInstrumentFaceAmountIssued
      contextRef="From2025-10-012025-12-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="0"
      id="Fact004336"
      unitRef="USD">192897</CYCU:DebtInstrumentFaceAmountIssued>
    <CYCU:DebtInstrumentNumberOfInvestors
      contextRef="AsOf2025-12-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      id="Fact004338"
      unitRef="Integer">1</CYCU:DebtInstrumentNumberOfInvestors>
    <CYCU:NumberOfPromissoryNotesRepaid
      contextRef="AsOf2025-12-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      id="Fact004340"
      unitRef="Integer">2</CYCU:NumberOfPromissoryNotesRepaid>
    <CYCU:DebtWeightedAverageInterestRateIssuance
      contextRef="AsOf2025-12-31_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      id="Fact004342"
      unitRef="Pure">0.120</CYCU:DebtWeightedAverageInterestRateIssuance>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2025-10-012025-12-31_us-gaap_ConvertibleNotesPayableMember"
      id="Fact004344">P1Y</us-gaap:DebtInstrumentTerm>
    <CYCU:PromissoryNotesDisclosureTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact004346">&lt;p id="xdx_80A_ecustom--PromissoryNotesDisclosureTextBlock_zLKQHF99ggGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11.
&lt;span id="xdx_82F_zcoAwhFwmcnc"&gt;PROMISSORY NOTES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_ecustom--ScheduleOfPromissoryNotesTableTextBlock_zGy9Q87kAxlb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_zofDxxA1GvOd" style="display: none"&gt;SCHEDULE OF PROMISSORY NOTES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
11.1: Details of Promissory Notes&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;






&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Principal
    Value&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unamortized
    Discount and Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Convertible
    Notes Carrying Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 38%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentFaceAmount_iS_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zHprm2VcEHpk" style="width: 12%; text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,498,369&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zgyurOomdZ37" style="width: 12%; text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(11,380&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NotesPayable_iS_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zpXmpgxrM2Jj" style="width: 12%; text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,486,989&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20241231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zOzAXAbR9jra" style="width: 12%; text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16.6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ProceedsFromNotesPayable_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z8Iw8PC6C6ki" style="text-align: right" title="Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;690,558&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--UnamortizedDiscountAndIssuanceCostsIssuance_iN_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zb1PHuNuGLFc" style="text-align: right" title="Unamortized Discount and Issuance Costs Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(77,358&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ConvertibleNotesPayableIssuance_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zmBBg5sBZEI4" style="text-align: right" title="Convertible Notes Carrying balance - Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;613,200&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--DebtWeightedAverageInterestRateIssuance_iI_pid_dp_uPure_c20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_ziFJi5gAACub" style="text-align: center" title="Weighted Average Interest Rate Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Repayment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RepaymentsOfNotesPayable_iN_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zkiUx5FsbXde" style="text-align: right" title="Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(20,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--UnamortizedDiscountAndIssuanceCostsRepayment_iN_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zIPrbpmnfA74" style="text-align: right" title="Unamortized Discount and Issuance Costs Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4368"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ConvertibleNotesCarryingBalanceRepayment_iN_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_ztRfcQ5wQtk4" style="text-align: right" title="Convertible Notes Carrying balance - Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(20,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--DebtWeightedAverageInterestRateRepayment_iI_pid_dp_uPure_c20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zRIQjqRyUfO4" style="text-align: center" title="Weighted Average Interest Rate Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;35.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AdjustmentForAmortization_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z0KhGqpHNOe" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36,667&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AmortizationOfDebtDiscountPremium_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zmYtwTdt9NQj" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,297&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AmortizationOfIssuanceOfConvertibleNotesPayable_iN_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zsJ1heVzaUI" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;57,964&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentFaceAmount_iS_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zEulMlqHJjH4" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,205,594&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zSHRVqO0KzE5" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(67,441&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NotesPayable_iS_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zK1zDRGPIcXc" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,138,153&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zGDqOs6Jamuh" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15.8%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Conversion to equity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--DebtInstrumentFaceAmountConversionToEquity_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z7MMkwsFRac7" style="text-align: right" title="Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(456,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ConversionOfStockAmountConverted1_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zKGCHMtTWdof" style="text-align: right" title="Unamortized Discount and Issuance Costs Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4390"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ConvertibleNotesPayableConversionToEquity_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zhOMwyPHIJZ6" style="text-align: right" title="Convertible Notes Carrying balance - Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(456,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--DebtWeightedAverageInterestRateConversionToEquity_iI_pid_dp_uPure_c20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zkyuNYM6iyVg" style="text-align: center" title="Weighted Average Interest Rate Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Repayment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RepaymentsOfNotesPayable_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zOjsIGAfTb1j" style="text-align: right" title="Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(50,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--UnamortizedDiscountAndIssuanceCostsRepayment_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z7whZkdwiRAc" style="text-align: right" title="Unamortized Discount and Issuance Costs Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4398"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ConvertibleNotesCarryingBalanceRepayment_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zVX9P6RlXQxk" style="text-align: right" title="Convertible Notes Carrying balance - Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(50,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--DebtWeightedAverageInterestRateRepayment_iI_pid_dp_uPure_c20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zcLhIRZVFfTa" style="text-align: center" title="Weighted Average Interest Rate Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AdjustmentForAmortization_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zAQPWNvO0I06" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4404"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AmortizationOfDebtDiscountPremium_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zfCQgeJgOmPg" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,973&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--AmortizationOfIssuanceOfConvertibleNotesPayable_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zNnqbR3kGSo2" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,973&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DebtInstrumentFaceAmount_iS_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z0dLEEfvLkU9" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,699,094&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zPz9bocb0lr6" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(29,468&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NotesPayable_iS_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zWCuwevILtT6" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,669,626&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zEh1wASj9x0e" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14.3%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Repayment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RepaymentsOfNotesPayable_iN_di_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zZZIgikPgoqi" style="text-align: right" title="Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(31,579&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--UnamortizedDiscountAndIssuanceCostsRepayment_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zbpCpANa4BP3" style="text-align: right" title="Unamortized Discount and Issuance Costs Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4420"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ConvertibleNotesCarryingBalanceRepayment_iN_di_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zVnCSNV0FkFj" style="text-align: right" title="Convertible Notes Carrying balance - Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(31,579&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--DebtWeightedAverageInterestRateRepayment_iI_pid_dp_uPure_c20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zFYIGPrbLc47" style="text-align: center" title="Weighted Average Interest Rate Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AdjustmentForAmortization_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_za7cpMvDid09" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4426"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AmortizationOfDebtDiscountPremium_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zw5jj0uEroZi" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,616&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AmortizationOfIssuanceOfConvertibleNotesPayable_iN_di_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zQNyZpdmyxsc" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,616&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DebtInstrumentFaceAmount_iS_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zIChp7FAg2K5" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,667,515&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_znxxLJMuwJcf" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(8,852&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NotesPayable_iS_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zMe5knLeI9Fe" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,658,663&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zkXWSP6VHIZ" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14.3%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Conversion to a convertible
    note&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PrincipalValueConversionToAConvertibleNote_iN_di_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zT55v9jpd8Xi" style="text-align: right" title="Conversion to a convertible note"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(166,666&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--UnamortizedDiscountAndIssuanceCostsConversionToAConvertibleNote_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zVh426xppiZc" style="text-align: right" title="Unamortized Discount and Issuance Costs Conversion to a convertible note"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4442"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ConvertibleNotesCarryingBalanceConversionToAConvertibleNote_iN_di_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zBluYqKteFJ3" style="text-align: right" title="Convertible Notes Carrying balance - Conversion to a convertible note"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(166,666&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--DebtWeightedAverageInterestRateConversionToAConvertibleNote_iI_pid_dp_uPure_c20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z0paONdoPFLj" style="text-align: center" title="Weighted Average Interest Rate Conversion to a convertible note"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AdjustmentForAmortization_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zyNHnOOLNuV" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4448"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AmortizationOfDebtDiscountPremium_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zKK7JB0uinxh" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,665&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AmortizationOfIssuanceOfConvertibleNotesPayable_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zwE0tSkPtDAd" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,665&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DebtInstrumentFaceAmount_iS_c20260101__20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z6y5NC6Qdw8g" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,500,849&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20260101__20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_ziMnHtsSCgCa" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,187&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NotesPayable_iS_c20260101__20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zBTVEMqxEpCk" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,499,662&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zZU7ESucrCIk" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14.3%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AdjustmentForAmortization_c20260101__20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zzJUVvKik4mg" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4462"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AmortizationOfDebtDiscountPremium_c20260101__20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z4VHyQDiK1Ai" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,187&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AmortizationOfIssuanceOfConvertibleNotesPayable_c20260101__20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z7R7TsLtAnN6" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,187&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DebtInstrumentFaceAmount_iE_c20260101__20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zBKksT1qZw85" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal value ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,500,849&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNE_di_c20260101__20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zEsEa5DBXFEj" style="border-bottom: Black 2.5pt double; text-align: right" title="Unamortized Discount and Issuance Costs ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4470"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NotesPayable_iE_c20260101__20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zmXw9M59jKg8" style="border-bottom: Black 2.5pt double; text-align: right" title="Convertible Notes Carrying Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,500,849&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z2tedeJDfxZc" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14.3%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A0_zerA4gaaFvz3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_ecustom--ScheduleOfLoansPayableTableTextBlock_z8RkO1x72xi9" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B6_zn7jp4uxZJz4" style="display: none"&gt;SCHEDULE OF LOANS PAYABLE&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Table
11.2: Details of Loans Payable&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20260331_zfzVDav8Dxo2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;March
    31,&lt;br/&gt; 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20251231_zgDkW8prCvkk" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;br/&gt; 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Maturity&lt;br/&gt;
    (Calendar Year)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesOneMember_zqRKursiRVnf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Note issued in 2017&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesOneMember_zdRew7mIUSy6" style="width: 12%; text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.0%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesTwoMember_zBCEwqxchJNi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Note issued in 2020&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;300,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;300,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesTwoMember_zE6NWE4SlPn" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24.0%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesThreeMember_zAiqj6oQRay4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Note issued in 2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;400,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;400,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesThreeMember_znqMPbRgnHyb" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24.0%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021 - 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesFourMember_zjEDPVxFXvGj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Notes issued in 2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;611,111&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;611,111&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesFourMember_zMDisRThfZl6" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24.0%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesFiveMember_z58Y7NszDOV3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Notes issued in 2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;319,180&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;319,180&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesFiveMember_zdpr1qEZ6f6g" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.7%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesSixMember_zdYg11IKKyAc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Notes issued in 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;620,558&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;620,558&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesSixMember_zW9J68sofHP6" style="text-align: center; padding-bottom: 1pt" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.0%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025 -2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zqYEA3Dq2zIh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Funded
    loans payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,500,849&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,500,849&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z4niwGSoOKG5" style="text-align: center; padding-bottom: 1pt" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17.3%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNI_di_zy4nXecyM3Rf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: Unamortized debt-issuance
    costs and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4513"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,187&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--NotesPayableCurrent_iI_zzXJCN49YDSc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    loans payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,500,849&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,499,662&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A3_zln9L0crzCmb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
</CYCU:PromissoryNotesDisclosureTextBlock>
    <CYCU:ScheduleOfPromissoryNotesTableTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact004348">&lt;p id="xdx_89E_ecustom--ScheduleOfPromissoryNotesTableTextBlock_zGy9Q87kAxlb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_zofDxxA1GvOd" style="display: none"&gt;SCHEDULE OF PROMISSORY NOTES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
11.1: Details of Promissory Notes&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;






&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Principal
    Value&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unamortized
    Discount and Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Convertible
    Notes Carrying Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 38%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentFaceAmount_iS_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zHprm2VcEHpk" style="width: 12%; text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,498,369&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zgyurOomdZ37" style="width: 12%; text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(11,380&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NotesPayable_iS_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zpXmpgxrM2Jj" style="width: 12%; text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,486,989&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20241231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zOzAXAbR9jra" style="width: 12%; text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16.6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ProceedsFromNotesPayable_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z8Iw8PC6C6ki" style="text-align: right" title="Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;690,558&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--UnamortizedDiscountAndIssuanceCostsIssuance_iN_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zb1PHuNuGLFc" style="text-align: right" title="Unamortized Discount and Issuance Costs Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(77,358&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ConvertibleNotesPayableIssuance_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zmBBg5sBZEI4" style="text-align: right" title="Convertible Notes Carrying balance - Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;613,200&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--DebtWeightedAverageInterestRateIssuance_iI_pid_dp_uPure_c20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_ziFJi5gAACub" style="text-align: center" title="Weighted Average Interest Rate Issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Repayment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RepaymentsOfNotesPayable_iN_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zkiUx5FsbXde" style="text-align: right" title="Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(20,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--UnamortizedDiscountAndIssuanceCostsRepayment_iN_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zIPrbpmnfA74" style="text-align: right" title="Unamortized Discount and Issuance Costs Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4368"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ConvertibleNotesCarryingBalanceRepayment_iN_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_ztRfcQ5wQtk4" style="text-align: right" title="Convertible Notes Carrying balance - Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(20,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--DebtWeightedAverageInterestRateRepayment_iI_pid_dp_uPure_c20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zRIQjqRyUfO4" style="text-align: center" title="Weighted Average Interest Rate Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;35.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AdjustmentForAmortization_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z0KhGqpHNOe" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36,667&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AmortizationOfDebtDiscountPremium_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zmYtwTdt9NQj" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,297&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AmortizationOfIssuanceOfConvertibleNotesPayable_iN_di_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zsJ1heVzaUI" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;57,964&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentFaceAmount_iS_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zEulMlqHJjH4" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,205,594&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zSHRVqO0KzE5" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(67,441&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NotesPayable_iS_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zK1zDRGPIcXc" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,138,153&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zGDqOs6Jamuh" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15.8%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Conversion to equity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--DebtInstrumentFaceAmountConversionToEquity_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z7MMkwsFRac7" style="text-align: right" title="Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(456,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ConversionOfStockAmountConverted1_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zKGCHMtTWdof" style="text-align: right" title="Unamortized Discount and Issuance Costs Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4390"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ConvertibleNotesPayableConversionToEquity_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zhOMwyPHIJZ6" style="text-align: right" title="Convertible Notes Carrying balance - Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(456,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--DebtWeightedAverageInterestRateConversionToEquity_iI_pid_dp_uPure_c20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zkyuNYM6iyVg" style="text-align: center" title="Weighted Average Interest Rate Conversion to equity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Repayment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RepaymentsOfNotesPayable_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zOjsIGAfTb1j" style="text-align: right" title="Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(50,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--UnamortizedDiscountAndIssuanceCostsRepayment_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z7whZkdwiRAc" style="text-align: right" title="Unamortized Discount and Issuance Costs Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4398"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ConvertibleNotesCarryingBalanceRepayment_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zVX9P6RlXQxk" style="text-align: right" title="Convertible Notes Carrying balance - Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(50,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--DebtWeightedAverageInterestRateRepayment_iI_pid_dp_uPure_c20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zcLhIRZVFfTa" style="text-align: center" title="Weighted Average Interest Rate Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AdjustmentForAmortization_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zAQPWNvO0I06" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4404"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AmortizationOfDebtDiscountPremium_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zfCQgeJgOmPg" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,973&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--AmortizationOfIssuanceOfConvertibleNotesPayable_iN_di_c20250401__20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zNnqbR3kGSo2" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,973&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DebtInstrumentFaceAmount_iS_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z0dLEEfvLkU9" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,699,094&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zPz9bocb0lr6" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(29,468&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NotesPayable_iS_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zWCuwevILtT6" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,669,626&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zEh1wASj9x0e" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14.3%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Repayment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RepaymentsOfNotesPayable_iN_di_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zZZIgikPgoqi" style="text-align: right" title="Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(31,579&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--UnamortizedDiscountAndIssuanceCostsRepayment_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zbpCpANa4BP3" style="text-align: right" title="Unamortized Discount and Issuance Costs Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4420"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ConvertibleNotesCarryingBalanceRepayment_iN_di_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zVnCSNV0FkFj" style="text-align: right" title="Convertible Notes Carrying balance - Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(31,579&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--DebtWeightedAverageInterestRateRepayment_iI_pid_dp_uPure_c20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zFYIGPrbLc47" style="text-align: center" title="Weighted Average Interest Rate Repayment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AdjustmentForAmortization_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_za7cpMvDid09" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4426"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AmortizationOfDebtDiscountPremium_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zw5jj0uEroZi" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,616&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AmortizationOfIssuanceOfConvertibleNotesPayable_iN_di_c20250701__20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zQNyZpdmyxsc" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,616&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DebtInstrumentFaceAmount_iS_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zIChp7FAg2K5" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,667,515&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_znxxLJMuwJcf" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(8,852&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NotesPayable_iS_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zMe5knLeI9Fe" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,658,663&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zkXWSP6VHIZ" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14.3%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Conversion to a convertible
    note&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PrincipalValueConversionToAConvertibleNote_iN_di_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zT55v9jpd8Xi" style="text-align: right" title="Conversion to a convertible note"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(166,666&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--UnamortizedDiscountAndIssuanceCostsConversionToAConvertibleNote_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zVh426xppiZc" style="text-align: right" title="Unamortized Discount and Issuance Costs Conversion to a convertible note"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4442"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ConvertibleNotesCarryingBalanceConversionToAConvertibleNote_iN_di_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zBluYqKteFJ3" style="text-align: right" title="Convertible Notes Carrying balance - Conversion to a convertible note"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(166,666&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--DebtWeightedAverageInterestRateConversionToAConvertibleNote_iI_pid_dp_uPure_c20250930__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z0paONdoPFLj" style="text-align: center" title="Weighted Average Interest Rate Conversion to a convertible note"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AdjustmentForAmortization_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zyNHnOOLNuV" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4448"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AmortizationOfDebtDiscountPremium_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zKK7JB0uinxh" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,665&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AmortizationOfIssuanceOfConvertibleNotesPayable_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zwE0tSkPtDAd" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,665&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DebtInstrumentFaceAmount_iS_c20260101__20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z6y5NC6Qdw8g" style="text-align: right" title="Principal value beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,500,849&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNS_di_c20260101__20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_ziMnHtsSCgCa" style="text-align: right" title="Unamortized Discount and Issuance Costs beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,187&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NotesPayable_iS_c20260101__20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zBTVEMqxEpCk" style="text-align: right" title="Convertible Notes Carrying Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,499,662&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zZU7ESucrCIk" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14.3%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AdjustmentForAmortization_c20260101__20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zzJUVvKik4mg" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4462"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AmortizationOfDebtDiscountPremium_c20260101__20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z4VHyQDiK1Ai" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized Discount and Issuance Costs Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,187&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AmortizationOfIssuanceOfConvertibleNotesPayable_c20260101__20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z7R7TsLtAnN6" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Carrying balance - Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,187&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DebtInstrumentFaceAmount_iE_c20260101__20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zBKksT1qZw85" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal value ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,500,849&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNE_di_c20260101__20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zEsEa5DBXFEj" style="border-bottom: Black 2.5pt double; text-align: right" title="Unamortized Discount and Issuance Costs ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4470"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NotesPayable_iE_c20260101__20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zmXw9M59jKg8" style="border-bottom: Black 2.5pt double; text-align: right" title="Convertible Notes Carrying Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,500,849&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z2tedeJDfxZc" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14.3%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</CYCU:ScheduleOfPromissoryNotesTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-12-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004350"
      unitRef="USD">2498369</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2024-12-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004352"
      unitRef="USD">11380</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-12-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004354"
      unitRef="USD">2486989</us-gaap:NotesPayable>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="AsOf2024-12-31_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact004356"
      unitRef="Pure">0.166</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2025-01-012025-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004358"
      unitRef="USD">690558</us-gaap:ProceedsFromNotesPayable>
    <CYCU:UnamortizedDiscountAndIssuanceCostsIssuance
      contextRef="From2025-01-012025-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004360"
      unitRef="USD">77358</CYCU:UnamortizedDiscountAndIssuanceCostsIssuance>
    <CYCU:ConvertibleNotesPayableIssuance
      contextRef="From2025-01-012025-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004362"
      unitRef="USD">613200</CYCU:ConvertibleNotesPayableIssuance>
    <CYCU:DebtWeightedAverageInterestRateIssuance
      contextRef="AsOf2025-03-31_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact004364"
      unitRef="Pure">0.135</CYCU:DebtWeightedAverageInterestRateIssuance>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2025-01-012025-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004366"
      unitRef="USD">20000</us-gaap:RepaymentsOfNotesPayable>
    <CYCU:ConvertibleNotesCarryingBalanceRepayment
      contextRef="From2025-01-012025-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004370"
      unitRef="USD">20000</CYCU:ConvertibleNotesCarryingBalanceRepayment>
    <CYCU:DebtWeightedAverageInterestRateRepayment
      contextRef="AsOf2025-03-31_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact004372"
      unitRef="Pure">0.350</CYCU:DebtWeightedAverageInterestRateRepayment>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2025-01-012025-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004374"
      unitRef="USD">36667</us-gaap:AdjustmentForAmortization>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2025-01-012025-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004376"
      unitRef="USD">21297</us-gaap:AmortizationOfDebtDiscountPremium>
    <CYCU:AmortizationOfIssuanceOfConvertibleNotesPayable
      contextRef="From2025-01-012025-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004378"
      unitRef="USD">-57964</CYCU:AmortizationOfIssuanceOfConvertibleNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004380"
      unitRef="USD">3205594</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2025-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004382"
      unitRef="USD">67441</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:NotesPayable
      contextRef="AsOf2025-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004384"
      unitRef="USD">3138153</us-gaap:NotesPayable>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="AsOf2025-03-31_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact004386"
      unitRef="Pure">0.158</us-gaap:DebtWeightedAverageInterestRate>
    <CYCU:DebtInstrumentFaceAmountConversionToEquity
      contextRef="From2025-04-012025-06-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004388"
      unitRef="USD">456500</CYCU:DebtInstrumentFaceAmountConversionToEquity>
    <CYCU:ConvertibleNotesPayableConversionToEquity
      contextRef="From2025-04-012025-06-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004392"
      unitRef="USD">456500</CYCU:ConvertibleNotesPayableConversionToEquity>
    <CYCU:DebtWeightedAverageInterestRateConversionToEquity
      contextRef="AsOf2025-06-30_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact004394"
      unitRef="Pure">0.240</CYCU:DebtWeightedAverageInterestRateConversionToEquity>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2025-04-012025-06-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004396"
      unitRef="USD">50000</us-gaap:RepaymentsOfNotesPayable>
    <CYCU:ConvertibleNotesCarryingBalanceRepayment
      contextRef="From2025-04-012025-06-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004400"
      unitRef="USD">50000</CYCU:ConvertibleNotesCarryingBalanceRepayment>
    <CYCU:DebtWeightedAverageInterestRateRepayment
      contextRef="AsOf2025-06-30_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact004402"
      unitRef="Pure">0.240</CYCU:DebtWeightedAverageInterestRateRepayment>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2025-04-012025-06-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004406"
      unitRef="USD">37973</us-gaap:AmortizationOfDebtDiscountPremium>
    <CYCU:AmortizationOfIssuanceOfConvertibleNotesPayable
      contextRef="From2025-04-012025-06-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004408"
      unitRef="USD">-37973</CYCU:AmortizationOfIssuanceOfConvertibleNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-06-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004410"
      unitRef="USD">2699094</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2025-06-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004412"
      unitRef="USD">29468</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:NotesPayable
      contextRef="AsOf2025-06-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004414"
      unitRef="USD">2669626</us-gaap:NotesPayable>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="AsOf2025-06-30_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact004416"
      unitRef="Pure">0.143</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2025-07-012025-09-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004418"
      unitRef="USD">31579</us-gaap:RepaymentsOfNotesPayable>
    <CYCU:ConvertibleNotesCarryingBalanceRepayment
      contextRef="From2025-07-012025-09-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004422"
      unitRef="USD">31579</CYCU:ConvertibleNotesCarryingBalanceRepayment>
    <CYCU:DebtWeightedAverageInterestRateRepayment
      contextRef="AsOf2025-09-30_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact004424"
      unitRef="Pure">0.120</CYCU:DebtWeightedAverageInterestRateRepayment>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2025-07-012025-09-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004428"
      unitRef="USD">20616</us-gaap:AmortizationOfDebtDiscountPremium>
    <CYCU:AmortizationOfIssuanceOfConvertibleNotesPayable
      contextRef="From2025-07-012025-09-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004430"
      unitRef="USD">-20616</CYCU:AmortizationOfIssuanceOfConvertibleNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-09-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004432"
      unitRef="USD">2667515</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2025-09-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004434"
      unitRef="USD">8852</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:NotesPayable
      contextRef="AsOf2025-09-30_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004436"
      unitRef="USD">2658663</us-gaap:NotesPayable>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="AsOf2025-09-30_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact004438"
      unitRef="Pure">0.143</us-gaap:DebtWeightedAverageInterestRate>
    <CYCU:PrincipalValueConversionToAConvertibleNote
      contextRef="From2025-10-012025-12-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004440"
      unitRef="USD">166666</CYCU:PrincipalValueConversionToAConvertibleNote>
    <CYCU:ConvertibleNotesCarryingBalanceConversionToAConvertibleNote
      contextRef="From2025-10-012025-12-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004444"
      unitRef="USD">166666</CYCU:ConvertibleNotesCarryingBalanceConversionToAConvertibleNote>
    <CYCU:DebtWeightedAverageInterestRateConversionToAConvertibleNote
      contextRef="AsOf2025-09-30_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact004446"
      unitRef="Pure">0.100</CYCU:DebtWeightedAverageInterestRateConversionToAConvertibleNote>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2025-10-012025-12-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004450"
      unitRef="USD">7665</us-gaap:AmortizationOfDebtDiscountPremium>
    <CYCU:AmortizationOfIssuanceOfConvertibleNotesPayable
      contextRef="From2025-10-012025-12-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004452"
      unitRef="USD">7665</CYCU:AmortizationOfIssuanceOfConvertibleNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004454"
      unitRef="USD">2500849</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2025-12-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004456"
      unitRef="USD">1187</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:NotesPayable
      contextRef="AsOf2025-12-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004458"
      unitRef="USD">2499662</us-gaap:NotesPayable>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="AsOf2025-12-31_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact004460"
      unitRef="Pure">0.143</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2026-01-012026-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004464"
      unitRef="USD">1187</us-gaap:AmortizationOfDebtDiscountPremium>
    <CYCU:AmortizationOfIssuanceOfConvertibleNotesPayable
      contextRef="From2026-01-012026-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004466"
      unitRef="USD">1187</CYCU:AmortizationOfIssuanceOfConvertibleNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2026-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004468"
      unitRef="USD">2500849</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:NotesPayable
      contextRef="AsOf2026-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004472"
      unitRef="USD">2500849</us-gaap:NotesPayable>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="AsOf2026-03-31_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact004474"
      unitRef="Pure">0.143</us-gaap:DebtWeightedAverageInterestRate>
    <CYCU:ScheduleOfLoansPayableTableTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact004476">&lt;p id="xdx_89A_ecustom--ScheduleOfLoansPayableTableTextBlock_z8RkO1x72xi9" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B6_zn7jp4uxZJz4" style="display: none"&gt;SCHEDULE OF LOANS PAYABLE&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Table
11.2: Details of Loans Payable&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20260331_zfzVDav8Dxo2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;March
    31,&lt;br/&gt; 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20251231_zgDkW8prCvkk" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;br/&gt; 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Maturity&lt;br/&gt;
    (Calendar Year)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesOneMember_zqRKursiRVnf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Note issued in 2017&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesOneMember_zdRew7mIUSy6" style="width: 12%; text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.0%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesTwoMember_zBCEwqxchJNi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Note issued in 2020&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;300,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;300,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesTwoMember_zE6NWE4SlPn" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24.0%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesThreeMember_zAiqj6oQRay4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Note issued in 2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;400,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;400,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesThreeMember_znqMPbRgnHyb" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24.0%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021 - 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesFourMember_zjEDPVxFXvGj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Notes issued in 2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;611,111&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;611,111&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesFourMember_zMDisRThfZl6" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24.0%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesFiveMember_z58Y7NszDOV3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Notes issued in 2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;319,180&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;319,180&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesFiveMember_zdpr1qEZ6f6g" style="text-align: center" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.7%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesSixMember_zdYg11IKKyAc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Notes issued in 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;620,558&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;620,558&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesSixMember_zW9J68sofHP6" style="text-align: center; padding-bottom: 1pt" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.0%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025 -2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zqYEA3Dq2zIh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Funded
    loans payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,500,849&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,500,849&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z4niwGSoOKG5" style="text-align: center; padding-bottom: 1pt" title="Weighted Average Interest Rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17.3%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iNI_di_zy4nXecyM3Rf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: Unamortized debt-issuance
    costs and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4513"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,187&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--NotesPayableCurrent_iI_zzXJCN49YDSc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    loans payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,500,849&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,499,662&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</CYCU:ScheduleOfLoansPayableTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2026-03-31_custom_PromissoryNotesOneMember"
      decimals="0"
      id="Fact004478"
      unitRef="USD">250000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_custom_PromissoryNotesOneMember"
      decimals="0"
      id="Fact004479"
      unitRef="USD">250000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2026-03-31_custom_PromissoryNotesOneMember"
      decimals="INF"
      id="Fact004481"
      unitRef="Pure">0.040</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2026-03-31_custom_PromissoryNotesTwoMember"
      decimals="0"
      id="Fact004483"
      unitRef="USD">300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_custom_PromissoryNotesTwoMember"
      decimals="0"
      id="Fact004484"
      unitRef="USD">300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2026-03-31_custom_PromissoryNotesTwoMember"
      decimals="INF"
      id="Fact004486"
      unitRef="Pure">0.240</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2026-03-31_custom_PromissoryNotesThreeMember"
      decimals="0"
      id="Fact004488"
      unitRef="USD">400000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_custom_PromissoryNotesThreeMember"
      decimals="0"
      id="Fact004489"
      unitRef="USD">400000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2026-03-31_custom_PromissoryNotesThreeMember"
      decimals="INF"
      id="Fact004491"
      unitRef="Pure">0.240</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2026-03-31_custom_PromissoryNotesFourMember"
      decimals="0"
      id="Fact004493"
      unitRef="USD">611111</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_custom_PromissoryNotesFourMember"
      decimals="0"
      id="Fact004494"
      unitRef="USD">611111</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2026-03-31_custom_PromissoryNotesFourMember"
      decimals="INF"
      id="Fact004496"
      unitRef="Pure">0.240</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2026-03-31_custom_PromissoryNotesFiveMember"
      decimals="0"
      id="Fact004498"
      unitRef="USD">319180</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_custom_PromissoryNotesFiveMember"
      decimals="0"
      id="Fact004499"
      unitRef="USD">319180</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2026-03-31_custom_PromissoryNotesFiveMember"
      decimals="INF"
      id="Fact004501"
      unitRef="Pure">0.107</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2026-03-31_custom_PromissoryNotesSixMember"
      decimals="0"
      id="Fact004503"
      unitRef="USD">620558</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_custom_PromissoryNotesSixMember"
      decimals="0"
      id="Fact004504"
      unitRef="USD">620558</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2026-03-31_custom_PromissoryNotesSixMember"
      decimals="INF"
      id="Fact004506"
      unitRef="Pure">0.120</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2026-03-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004508"
      unitRef="USD">2500849</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_custom_PromissoryNotesMember"
      decimals="0"
      id="Fact004509"
      unitRef="USD">2500849</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2026-03-31_custom_PromissoryNotesMember"
      decimals="INF"
      id="Fact004511"
      unitRef="Pure">0.173</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact004514"
      unitRef="USD">1187</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact004516"
      unitRef="USD">2500849</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact004517"
      unitRef="USD">2499662</us-gaap:NotesPayableCurrent>
    <us-gaap:SubordinatedBorrowingsDisclosureTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact004519">&lt;p id="xdx_80E_eus-gaap--SubordinatedBorrowingsDisclosureTextBlock_zXKaSkvDRlU7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12.
&lt;span id="xdx_821_zRlShrD6lLO7"&gt;SUBORDINATED CONVERTIBLE PROMISSORY NOTES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March&#160;22, 2022, the Company issued subordinated convertible promissory notes with principal value of $&lt;span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20220322__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SixInvestorsMember_zxHLz0BSc5L9" title="Principal amount"&gt;526,315&lt;/span&gt; to six investors.
While subordinate to bank lender the notes are secured by The Company&#x2019;s assets. The Company issued to an independent director a
$&lt;span id="xdx_90A_eus-gaap--ConvertibleDebt_iI_c20220322_zq60rdkPFkZh" title="Convertible debt"&gt;236,842&lt;/span&gt; subordinated convertible note. The Company issued to an otherwise unaffiliated investors of subordinated convertible notes in
principal amounts of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20220322__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThreeInvestorsMember_zHlptyCQkypf" title="Principal amount"&gt;52,631&lt;/span&gt; to three investors, $&lt;span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20220322__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FifthInvestorMember_zYK5zuiWauq3" title="Principal amount"&gt;105,263&lt;/span&gt; to a fifth investor and $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20220322__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SixthInvestorMember_z3pmxEutEuq" title="Principal amount"&gt;26,315&lt;/span&gt; to a sixth investor. The notes carry annual
interest rate of &lt;span id="xdx_907_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20220322_zv1gThZ8nye3" title="Debt instrument, interest rate, effective percentage"&gt;8&lt;/span&gt;% that commenced upon funding date through the date of repayment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November&#160;22, 2022, the Company issued to three otherwise unaffiliated investors $&lt;span id="xdx_902_eus-gaap--ConvertibleNotesPayable_iI_c20221122__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThreeUnaffiliatedInvestorsMember_zqYF640dRRyk" title="Convertible notes payable"&gt;2,777,778&lt;/span&gt; in promissory notes, &lt;span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20221122__20221122_zgN25Al9MZB5" title="Debt conversion, converted instrument, shares issued"&gt;13,134&lt;/span&gt; shares of
common stock and &lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221122_zSi7RVTpHGY8" title="Number of warrants or rights outstanding"&gt;32,819&lt;/span&gt; warrants for $&lt;span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfDebt_c20221122__20221122__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThreeUnaffiliatedInvestorsMember_zqmQzaNGrPC3" title="Gross proceeds"&gt;2,500,000&lt;/span&gt; in gross proceeds.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company entered into the Merger Agreement with Western and Merger Sub, on November&#160;21, 2022, as amended. As a result of the Business
Combination, Cycurion raised $&lt;span id="xdx_90A_eus-gaap--ConvertibleDebt_iI_c20221121__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NineUnaffiliatedInvestorsMember__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationAgreementMember_zBSvvX5Brd1b" title="Convertible debt"&gt;3,333,335&lt;/span&gt; of debt capital on November&#160;21, 2022, from nine unaffiliated investors who were issued for
convertibles notes, warrants and shares of common stock. The convertible notes had a maturity date of November&#160;21, 2023, and an
interest rate of &lt;span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20221121_zJvAL6xAjL6" title="Debt instrument, interest rate, effective percentage"&gt;8&lt;/span&gt;%. They were also issued to convert to equity upon completion of the Business Combination between Cycurion and Western.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the first quarter of 2025, the Company issued shares of preferred stock and warrants in exchange of the outstanding convertible promissory
notes which had an aggregate principal amount of $&lt;span id="xdx_90F_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_c20250101__20250331__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationAgreementMember_zTdLjCpKA8vk" title="Aggregate principal amount"&gt;3,333,335&lt;/span&gt; and accrued interest of $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20250101__20250331__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationAgreementMember_zeUYhNJwcfGb" title="Accrued interest"&gt;299,259&lt;/span&gt;. As a part of this conversion, the Company
issued &lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20250101__20250331__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_znxri5bxT1R1" title="Stock issued during period, shares, conversion of convertible securities"&gt;222,222&lt;/span&gt; shares of Series D Convertible Preferred Stock and &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20250101__20250331__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SevenUnaffiliatedInvestorsMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDWarrantsMember_zKKv07lPoIH3" title="Stock issued during period, shares, conversion of convertible securities"&gt;242,424&lt;/span&gt; Series D warrants to seven unaffiliated note holders. As a
result, the Company recorded gain on settlement of debt of $&lt;span id="xdx_90F_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20250101__20250331__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationAgreementMember_zZM2vAE96tP3" title="Gain on debt settlement, net"&gt;299,259&lt;/span&gt;, which is presented on the consolidated statements of operations
and the consolidated statements of cash flows within &#x2018;Gain on debt settlement, net&#x2019;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
</us-gaap:SubordinatedBorrowingsDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-03-22_custom_SixInvestorsMember"
      decimals="0"
      id="Fact004521"
      unitRef="USD">526315</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2022-03-22"
      decimals="0"
      id="Fact004523"
      unitRef="USD">236842</us-gaap:ConvertibleDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-03-22_custom_ThreeInvestorsMember"
      decimals="0"
      id="Fact004525"
      unitRef="USD">52631</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-03-22_custom_FifthInvestorMember"
      decimals="0"
      id="Fact004527"
      unitRef="USD">105263</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-03-22_custom_SixthInvestorMember"
      decimals="0"
      id="Fact004529"
      unitRef="USD">26315</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2022-03-22"
      decimals="INF"
      id="Fact004531"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2022-11-22_custom_ThreeUnaffiliatedInvestorsMember"
      decimals="0"
      id="Fact004533"
      unitRef="USD">2777778</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2022-11-222022-11-22"
      decimals="INF"
      id="Fact004535"
      unitRef="Shares">13134</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-11-22"
      decimals="INF"
      id="Fact004537"
      unitRef="Shares">32819</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2022-11-222022-11-22_custom_ThreeUnaffiliatedInvestorsMember"
      decimals="0"
      id="Fact004539"
      unitRef="USD">2500000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2022-11-21_custom_NineUnaffiliatedInvestorsMember_custom_BusinessCombinationAgreementMember"
      decimals="0"
      id="Fact004541"
      unitRef="USD">3333335</us-gaap:ConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2022-11-21"
      decimals="INF"
      id="Fact004543"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2025-01-012025-03-31_custom_BusinessCombinationAgreementMember"
      decimals="0"
      id="Fact004545"
      unitRef="USD">3333335</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2025-01-012025-03-31_custom_BusinessCombinationAgreementMember"
      decimals="0"
      id="Fact004547"
      unitRef="USD">299259</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2025-01-012025-03-31_custom_BusinessCombinationAgreementMember_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact004549"
      unitRef="Shares">222222</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2025-01-012025-03-31_custom_BusinessCombinationAgreementMember_custom_SevenUnaffiliatedInvestorsMember_custom_SeriesDWarrantsMember"
      decimals="INF"
      id="Fact004551"
      unitRef="Shares">242424</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2025-01-012025-03-31_custom_BusinessCombinationAgreementMember"
      decimals="0"
      id="Fact004553"
      unitRef="USD">299259</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <CYCU:FactoringLiabilityDisclosureTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact004555">&lt;p id="xdx_801_ecustom--FactoringLiabilityDisclosureTextBlock_zniXd7WJVuvk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13.
&lt;span id="xdx_822_zuzApqlkdFEd"&gt;FACTORING LIABILITY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 12, 2022, the Company entered into agreement with a lender, whereby the lender would loan proceeds against certain accounts
receivable up to &lt;span id="xdx_902_ecustom--PercentageOfAccountsReceivableCoveredByFactor_iI_pid_dp_uPure_c20220712_zi1iiXVHLvlg" title="Percentage of accounts receivable covered by factor"&gt;90&lt;/span&gt;% of the total value of the invoice, which is paid to the Company in the form of a cash advance. A factoring cost
of &lt;span id="xdx_908_ecustom--FactoringCommissionPercentageForThirtyDays_iI_pid_dp_uPure_c20220712_zaXUYsvPv9z7" title="Factoring commission percentage for thirty days"&gt;1.5&lt;/span&gt;% is applied for days 1-30 after the loan is funded, and an additional &lt;span id="xdx_908_ecustom--PercentageOfAdditionalFactoringFeeForEveryTenDaysAfterThirtyDays_iI_pid_dp_uPure_c20220712_zKFARshNAQf7" title="Percentage of additional factoring fee for every ten days after thirty days"&gt;0.5&lt;/span&gt;% fee charge is applied for each additional 10 days period
thereafter. The maximum facility is $&lt;span id="xdx_90A_ecustom--MaximumLimitOfFactoring_iI_pn5n6_c20220712_z7Hn0UmEe4Yk" title="Maximum limit of factoring"&gt;3.0&lt;/span&gt; million.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accordingly,
pursuant to ASC 860-20-55-24, the Company recognized a factoring liability to the lenders until the accounts receivables are collected.
As of March&#160;31, 2026 and December&#160;31, 2025 the factoring liability was $&lt;span id="xdx_901_ecustom--FactoringLiability_iI_pn5n6_c20260331_zg7b7W4ZftQ4" title="Factoring liability"&gt;1.6&lt;/span&gt;&#160;million and $&lt;span id="xdx_904_ecustom--FactoringLiability_iI_pn5n6_c20251231_zw1HXOCOUm1a" title="Factoring liability"&gt;1.5&lt;/span&gt;&#160;million, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
</CYCU:FactoringLiabilityDisclosureTextBlock>
    <CYCU:PercentageOfAccountsReceivableCoveredByFactor
      contextRef="AsOf2022-07-12"
      decimals="INF"
      id="Fact004557"
      unitRef="Pure">0.90</CYCU:PercentageOfAccountsReceivableCoveredByFactor>
    <CYCU:FactoringCommissionPercentageForThirtyDays
      contextRef="AsOf2022-07-12"
      decimals="INF"
      id="Fact004559"
      unitRef="Pure">0.015</CYCU:FactoringCommissionPercentageForThirtyDays>
    <CYCU:PercentageOfAdditionalFactoringFeeForEveryTenDaysAfterThirtyDays
      contextRef="AsOf2022-07-12"
      decimals="INF"
      id="Fact004561"
      unitRef="Pure">0.005</CYCU:PercentageOfAdditionalFactoringFeeForEveryTenDaysAfterThirtyDays>
    <CYCU:MaximumLimitOfFactoring
      contextRef="AsOf2022-07-12"
      decimals="-5"
      id="Fact004563"
      unitRef="USD">3000000.0</CYCU:MaximumLimitOfFactoring>
    <CYCU:FactoringLiability
      contextRef="AsOf2026-03-31"
      decimals="-5"
      id="Fact004565"
      unitRef="USD">1600000</CYCU:FactoringLiability>
    <CYCU:FactoringLiability
      contextRef="AsOf2025-12-31"
      decimals="-5"
      id="Fact004567"
      unitRef="USD">1500000</CYCU:FactoringLiability>
    <us-gaap:PreferredStockTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact004569">&lt;p id="xdx_802_eus-gaap--PreferredStockTextBlock_zmUVY3Jw4FDa" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14.
&lt;span id="xdx_82A_z90Q1524yXve"&gt;SERIES A CONVERTIBLE PREFERRED STOCK&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December&#160;31, 2024, the Company has authorized &lt;span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOneConvertiblePreferredStockMember_zg70mu5sGIW8" title="Preferred stock, shares authorized"&gt;16,667&lt;/span&gt; shares of Series A Convertible Preferred Stock with a par value of $&lt;span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOneConvertiblePreferredStockMember_zGcSoGRLs7og" title="Preferred stock, par value"&gt;0.001&lt;/span&gt;
per share. The Series A Convertible Preferred Stock had voting rights on an as-if-converted to common stock basis. The holders were entitled
to a &lt;span id="xdx_90A_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOneConvertiblePreferredStockMember_zhTnT2521Wi4" title="Preferred stock, dividend rate, percentage"&gt;12&lt;/span&gt;% dividend and convert at any time into shares of common stock at a ratio of 1 to &lt;span id="xdx_908_eus-gaap--PreferredStockConvertibleConversionRatio_iI_uPure_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOneConvertiblePreferredStockMember_zMRMtG49Hkwa" title="Preferred stock, convertible, conversion ratio"&gt;25.6938&lt;/span&gt; shares of common stock, subject to adjustment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
a part of the Business Combination with Western, the Company issued &lt;span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20250214__us-gaap--StatementClassOfStockAxis__custom--SeriesAOneConvertiblePreferredStockMember__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zYn5a2XElD84" title="Preferred stock, shares authorized"&gt;106,816&lt;/span&gt; shares of Series A Convertible Preferred Stock, par value
$&lt;span id="xdx_909_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20250214__us-gaap--StatementClassOfStockAxis__custom--SeriesAOneConvertiblePreferredStockMember__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zMbPVoLEVD1c" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt; per share, in connection with the conversion and settlement of previously outstanding securities mentioned above. Refer to Note
15 for the characteristic of newly issued Series A Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;
</us-gaap:PreferredStockTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-12-31_custom_SeriesAOneConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004571"
      unitRef="Shares">16667</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31_custom_SeriesAOneConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004573"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="From2024-01-012024-12-31_custom_SeriesAOneConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004575"
      unitRef="Pure">0.12</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="AsOf2024-12-31_custom_SeriesAOneConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004577"
      unitRef="Pure">25.6938</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-02-14_custom_SeriesAOneConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact004579"
      unitRef="Shares">106816</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-02-14_custom_SeriesAOneConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact004581"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact004583">&lt;p id="xdx_800_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zbYhqF2pSRub" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15.
&lt;span id="xdx_829_z8txAcSppsQd"&gt;EQUITY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Preferred
Stock&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has authorized &lt;span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_c20260331_zMohuYSSuswe" title="Preferred stock, shares authorized"&gt;20,000,000&lt;/span&gt; shares of preferred stock, par value of $&lt;span id="xdx_909_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20260331_zFT1b4YXC11g" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt; per share, issuable from time to time in one or more
series.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Second Amended and Restated Certificate of Incorporation authorizes the board of directors to establish one or more series of preferred
stock. Unless required by law or by any stock exchange, and subject to the terms of the Second Amended and Restated Certificate of Incorporation,
the authorized shares of preferred stock will be available for issuance without further action by holders of common stock. The board
of directors is able to determine, with respect to any series of preferred stock, designations, powers, preferences and relative, participating,
optional or other rights, if any, and the qualifications, limitations, or restrictions thereof, if any.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company could issue a series of preferred stock that could, depending on the terms of the series, impede or discourage an acquisition
attempt or other transaction that some, or a majority, of the stockholders might believe to be in their best interests or in which the
stockholders might receive a premium over the market price of the common stock. Additionally, the issuance of preferred stock may adversely
affect the rights of stockholders by restricting dividends on the common stock, diluting the voting power of the common stock or subordinating
the rights of stockholders to distributions upon a liquidation, dissolution or winding up, or other event. As a result of these or other
factors, the issuance of preferred stock could have an adverse impact on the market price of our common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Stockholders&#x2019;
Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Series
A Convertible Preferred Stock&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has authorized &lt;span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zZiui5NOv1T" title="Preferred stock, authorized"&gt;110,000&lt;/span&gt; shares of Series A Convertible Preferred Stock, par value $&lt;span id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zDvyaKBofLNi" title="Preferred stock, par value per share"&gt;0.0001&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Voting
Rights:&lt;/span&gt; The holders of Cycurion&#x2019;s Series A Convertible Preferred Stock have voting rights on an as-if-converted-to-common-stock
basis and as required by law (including without limitation, the Delaware General Corporation Law (the &#x201c;DGCL&#x201d;) and as expressly
provided in the Certificate of Designation of Preferences, Rights and Limitations for our Series A Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Dividend
Rights:&lt;/span&gt; Holders of shares of our Series A Convertible Preferred Stock shall be entitled to receive dividends at the rate of twelve
percent (&lt;span id="xdx_909_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zeA9ZisZ1WY8" title="Preferred stock, dividend rate"&gt;12&lt;/span&gt;%) per annum of the per-share stated value ($&lt;span id="xdx_90A_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zJi5wMFCuI2a" title="Dividends payable, amount per share"&gt;1.45&lt;/span&gt; per share). The dividends shall be paid payable quarterly in arrears in
shares of common stock, calculated for each dividend payment on an as-if-converted-to-Common-Stock basis. No other dividends shall be
paid on shares of Series A Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Conversion
Rights:&lt;/span&gt; &lt;span id="xdx_905_eus-gaap--PreferredStockConversionBasis_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zqXgQVH9uuAk" title="Preferred stock conversion description"&gt;Shares of Cycurion&#x2019;s Series A Convertible Preferred Stock shall be convertible, at any time and from time to time at
the option of the holder thereof, into shares of common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion
ratio of &lt;span id="xdx_900_eus-gaap--PreferredStockConvertibleConversionRatio_iI_pid_dc_uPure_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zJAfDPF8Wgm3" title="Preferred stock, convertible, conversion ratio"&gt;one&lt;/span&gt; share of Series A Convertible Preferred Stock-for-one share of common stock, subject to adjustment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Liquidation
Preference:&lt;/span&gt; Holders of shares of Cycurion&#x2019;s Series A Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up
of Cycurion, whether voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, of Cycurion
an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon, for each share of Series A Convertible Preferred
Stock before any distribution or payment shall be made to the holders of common stock, and, if the assets of Cycurion shall be insufficient
to pay in full such amounts, then the entire assets to be distributed to the holders of shares of Series A Convertible Preferred Stock
shall be ratably distributed among them in accordance with the respective amounts that would have been payable on such shares if all
amounts payable thereon had been paid in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Protective
Provisions:&lt;/span&gt; As long as any shares of Series A Convertible Preferred Stock are outstanding, Cycurion shall not, without the affirmative
vote of the holders of a majority of the then-outstanding shares of Series A Convertible Preferred Stock, (a) alter or change adversely
the powers, preferences, or rights given to the holders of Series A Convertible Preferred Stock or alter or amend the Certificate of
Designation of Preferences, Rights and Limitations for Cycurion&#x2019;s Series A Convertible Preferred Stock, (b) amend its certificate
of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series A Convertible
Preferred Stock, (c) increase the number of authorized shares of Series A Convertible Preferred Stock, or (d) enter into any agreement
with respect to any of the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
part of the Business Combination with Western during the year ended December&#160;31, 2025, the Company issued to unaffiliated investors
a total of &lt;span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--WesternAcquisitionVenturesCorpMember_zVbxSkQbLGZ8" title="Preferred stock, shares issued"&gt;106,816&lt;/span&gt; preferred shares, which were converted into common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of both March&#160;31, 2026 and December&#160;31, 2025, there were &lt;span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_dc_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zp0rbZsHaIBa" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_dc_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zwHVIPr7ftN" title="Preferred stock, shares outstanding"&gt;&lt;span id="xdx_909_eus-gaap--PreferredStockSharesIssued_iI_dc_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zliFxlCRmGOa" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_dc_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zWHzSMXt87aa" title="Preferred stock, shares outstanding"&gt;zero&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; shares of Series A Convertible Preferred Stock issued and outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Series
B Convertible Preferred Stock&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has authorized &lt;span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zoN6ky8EWsg5" title="Preferred stock, authorized"&gt;3,000&lt;/span&gt; shares of Series B Convertible Preferred Stock, par value $&lt;span id="xdx_909_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zlfY8SmisX39" title="Preferred stock, par value per share"&gt;0.0001&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Voting
Rights:&lt;/span&gt; Holders of shares of Cycurion&#x2019;s Series B Convertible Preferred Stock shall not have any voting rights except as required
by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation of Preferences, Rights and
Limitations for our Series B Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Dividend
Rights:&lt;/span&gt; Holders of our Series B Convertible Preferred Stock shall be entitled to receive dividends (on an as-if-converted-to-Common-Stock
basis) to and in the same form as dividends actually paid on shares of common stock when, as, and if such dividends are paid on shares
of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Conversion
Rights:&lt;/span&gt; &lt;span id="xdx_901_eus-gaap--ConversionOfStockDescription_c20260101__20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zfR68ctQFdba" title="Conversion of stock, description"&gt;Shares of our Series B Convertible Preferred Stock shall be convertible, at any time and from time to time at the option
of the holder thereof, into common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of &lt;span id="xdx_908_eus-gaap--PreferredStockConvertibleConversionRatio_iI_pid_dc_uPure_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zCms7cW9vI94" title="Preferred stock, convertible, conversion ratio"&gt;one&lt;/span&gt; share
of Series B Convertible Preferred Stock-for-one share of common stock, subject to adjustment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Liquidation
Preference:&lt;/span&gt; Holders of shares of our Series B Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up, whether
voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, an amount equal to the Stated Value,
plus any accrued and unpaid dividends thereon, for each share of Series B Convertible Preferred Stock before any distribution or payment
shall be made to the holders of common stock, and, if our assets are insufficient to pay in full such amounts, then the entire assets
to be distributed to the holders of shares of Series B Convertible Preferred Stock shall be ratably distributed among them in accordance
with the respective amounts that would have been payable on such shares if all amounts payable thereon had been paid in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Protective
Provisions:&lt;/span&gt; As long as any shares of Series B Convertible Preferred Stock are outstanding, we will not, without the affirmative vote
of the holders of a majority of the then-outstanding shares of Series B Convertible Preferred Stock, (a) alter or change adversely the
powers, preferences, or rights given to the holders of Series B Convertible Preferred Stock or alter or amend the Certificate of Designation
of Preferences, Rights and Limitations for our Series B Convertible Preferred Stock, (b) amend our certificate of incorporation or other
charter documents in any manner that adversely affects any rights of the holders of shares of Series B Convertible Preferred Stock, (c)
increase the number of authorized shares of Series B Convertible Preferred Stock, or (d) enter into any agreement with respect to any
of the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
part of the Business Combination with Western during the first quarter of 2025, the Company issued to unaffiliated investors a total
of &lt;span id="xdx_90B_eus-gaap--PreferredStockSharesIssued_iI_c20250331__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--WesternAcquisitionVenturesCorpMember_zSyeyBpeycEk" title="Preferred stock, shares issued"&gt;3,000&lt;/span&gt; preferred shares of Series B Convertible Preferred Stock in exchange of existing &lt;span id="xdx_903_eus-gaap--PreferredStockSharesIssued_iI_c20250331__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--WesternAcquisitionVenturesCorpMember_zGdZNwoT0Fnj" title="Preferred stock, shares issued"&gt;3,000&lt;/span&gt; Series B Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December&#160;31, 2025, a total of &lt;span id="xdx_90F_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember_zPkhtIjEZpV9" title="Number of Preferred stock converted"&gt;2,999&lt;/span&gt; Series B Convertible Preferred Stock were converted into &lt;span id="xdx_906_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zpmNynLS4xY8" title="Number of common shares issuable upon conversion"&gt;199,955&lt;/span&gt; shares of common
stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of both March&#160;31, 2026 and December&#160;31, 2025, there was &lt;span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zVVbGDRPRft8" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_z74vBngKoGCe" title="Preferred stock, shares outstanding"&gt;&lt;span id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_z7zlK9NMdUkc" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zXE2ui7C72ta" title="Preferred stock, shares outstanding"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; share of Series B Convertible Preferred Stock issued and outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
C Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has authorized &lt;span id="xdx_90D_eus-gaap--PreferredStockSharesAuthorized_iI_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zGRi0sNNc2Pa"&gt;5,000&lt;/span&gt; shares of Series C Convertible Preferred Stock, par value $&lt;span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zxPofPEnNhCl" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Voting
Rights:&lt;/span&gt; The holders of our Series C Convertible Preferred Stock have voting rights on an as-if-converted-to-Common-Stock basis, as
required by law, and as expressly provided in its Certificate of Designation, as follows. As long as any shares of our Series C Convertible
Preferred Stock are outstanding, we shall not, without the affirmative vote of the holders of a majority of the then-outstanding shares
of our Series C Convertible Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to our Series C Convertible
Preferred Stock or alter or amend its Certificate of Designation, (b) amend our Certificate of Incorporation or other charter documents
in any manner that adversely affects any rights of the holders of our Series C Convertible Preferred Stock, (c) increase the number of
authorized shares of our Series C Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Dividend
Rights:&lt;/span&gt; We shall pay dividends on our Series C Convertible Preferred Stock at the rate of &lt;span id="xdx_90D_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20260101__20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zJbX84Tq5mY4" title="Preferred stock, dividend rate, percentage"&gt;12&lt;/span&gt;% per annum of the per-share Stated Value
($&lt;span id="xdx_90D_eus-gaap--DividendsPayableAmountPerShare_iI_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zh9cD2MPpr27" title="Dividends payable, amount per share"&gt;82.46&lt;/span&gt; per share). The dividends are payable quarterly in arrears not in cash, but in shares of our common stock, calculated for each
dividend payment on an as-if-converted-to-Common-Stock basis. No other dividends are payable on shares of our Series C Convertible Preferred
Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Conversion
Rights:&lt;/span&gt; &lt;span id="xdx_90A_eus-gaap--DebtConversionDescription_c20260101__20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zPhN17wMBFMl" title="Debt conversion, description"&gt;The shares of our Series C Convertible Preferred Stock may be converted into shares of our common stock at a ratio of approximately
&lt;span id="xdx_90E_eus-gaap--PreferredStockConvertibleConversionRatio_iI_pid_uPure_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zbJPaidtKaZk" title="Preferred stock, convertible, conversion ratio"&gt;20&lt;/span&gt; shares of common stock for every one share of our Series C Convertible Preferred Stock, or an aggregate of &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20260101__20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zprjc2aH1ss9" title="Stock issued during period, shares, conversion of convertible securities"&gt;99,077&lt;/span&gt; shares of our common
stock, assuming full conversion. In connection with conversions, each holder of our Series C Convertible Preferred Stock is subject to
a &#x201c;beneficial ownership limitation&#x201d; of 4.99% of the number of shares of our common stock outstanding immediately after giving
effect to that conversion, which limitation may be increased by the holder to not more than 9.99% on 61 days&#x2019; advanced notice to
us.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Liquidation
Preference:&lt;/span&gt; Our Series C Convertible Preferred Stock has a liquidation preference in an amount equal to its per-share Stated Value
($&lt;span id="xdx_907_eus-gaap--PreferredStockLiquidationPreference_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zU1FWj5uH4sg" title="Preferred stock, liquidation preference per share"&gt;82.46&lt;/span&gt; per share), plus any accrued and unpaid dividends thereon, for each share of our Series C Convertible Preferred Stock before
we can make any distribution or payment to the holders of our common stock. If our assets are insufficient to pay in full such liquidation
preference, then our entire assets are to be distributed to the holders of our Series C Convertible Preferred Stock, ratably distributed
among them in accordance with the respective amounts that would be payable on such shares if all amounts payable thereon were paid in
full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Protective
Provisions:&lt;/span&gt; As long as any shares of Series C Convertible Preferred Stock are outstanding, we will not, without the affirmative vote
of the holders of a majority of the then-outstanding shares of Series C Convertible Preferred Stock, (a) alter or change adversely the
powers, preferences, or rights given to the holders of Series C Convertible Preferred Stock or alter or amend the Certificate of Designation
of Preferences, Rights and Limitations for our Series C Convertible Preferred Stock, (b) amend our certificate of incorporation or other
charter documents in any manner that adversely affects any rights of the holders of shares of Series C Convertible Preferred Stock, (c)
increase the number of authorized shares of Series C Convertible Preferred Stock, or (d) enter into any agreement with respect to any
of the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
part of the Business Combination with Western during year ended December 31, 2025, the Company issued a total of &lt;span id="xdx_909_eus-gaap--PreferredStockSharesIssued_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember_zVYiE6rQUBe3" title="Preferred stock, shares issued"&gt;4,851&lt;/span&gt; shares of Series
C Convertible Preferred Stock in exchange of existing &lt;span id="xdx_90F_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zJfaJ8904E07" title="Number of common shares issuable upon conversion"&gt;1,356,586&lt;/span&gt; shares of Cycurion common stock and &lt;span id="xdx_907_eus-gaap--SharesIssued_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zeWLpE6UGLh1" title="Shares issued"&gt;406,969&lt;/span&gt; Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2026 and December 31, 2025, there were &lt;span id="xdx_909_eus-gaap--PreferredStockSharesIssued_iI_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zXUti0yxpAh4" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zPpV7BYB7gY2" title="Preferred stock, shares outstanding"&gt;2,547&lt;/span&gt;&lt;/span&gt; and &lt;span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zLCLA738HcSc" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zdlG9uVTSHze" title="Preferred stock, shares outstanding"&gt;4,851&lt;/span&gt;&lt;/span&gt; shares of Series C Convertible Preferred Stock issued and outstanding,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
D Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has authorized &lt;span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zLvQl9neIC63"&gt;6,666,700&lt;/span&gt; shares of Series D Convertible Preferred Stock, par value $&lt;span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zin8Nj0ltTrg" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting
Rights&lt;/i&gt;: Holders of shares of Cycurion&#x2019;s Series D Convertible Preferred Stock shall not have any voting rights except as required
by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation of Preferences, Rights and
Limitations for Cycurion&#x2019;s Series D Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividend
Rights&lt;/i&gt;: Holders of shares of Cycurion&#x2019;s Series D Convertible Preferred Stock shall be entitled to receive, and Cycurion shall
pay, dividends on shares of Series D Convertible Preferred Stock (on an as-if-converted-to-Common-Stock basis) to and in the same form
as dividends actually paid on shares of common stock when, as, and if such dividends are paid on shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion
Rights&lt;/i&gt;: &lt;span id="xdx_90A_eus-gaap--DebtConversionDescription_c20260101__20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zyQFPhSbyyS7" title="Debt conversion, description"&gt;Shares of Cycurion&#x2019;s Series D Convertible Preferred Stock shall be convertible, at any time and from time to time at
the option of the holder thereof, into shares of common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion
ratio of &lt;span id="xdx_905_eus-gaap--PreferredStockConvertibleConversionRatio_iI_pid_dc_uPure_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zNlEIADl1N1a" title="Preferred stock, convertible, conversion ratio"&gt;one&lt;/span&gt; share of Series D Convertible Preferred Stock-for-one share of common stock, subject to adjustment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation
Preference&lt;/i&gt;: Holders of shares of Cycurion&#x2019;s Series D Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up
of Cycurion, whether voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, of Cycurion
an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon, for each share of Series D Convertible Preferred
Stock before any distribution or payment shall be made to the holders of common stock, and, if the assets of Cycurion shall be insufficient
to pay in full such amounts, then the entire assets to be distributed to the holders of shares of Series D Convertible Preferred Stock
shall be ratably distributed among them in accordance with the respective amounts that would have been payable on such shares if all
amounts payable thereon had been paid in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Protective
Provisions&lt;/i&gt;: As long as any shares of Series D Convertible Preferred Stock are outstanding, Cycurion shall not, without the affirmative
vote of the holders of a majority of the then-outstanding shares of Series D Convertible Preferred Stock, (a) alter or change adversely
the powers, preferences, or rights given to the holders of Series D Convertible Preferred Stock or alter or amend the Certificate of
Designation of Preferences, Rights and Limitations for Cycurion&#x2019;s Series D Convertible Preferred Stock, (b) amend its certificate
of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series D Convertible
Preferred Stock, (c) increase the number of authorized shares of Series D Convertible Preferred Stock, or (d) enter into any agreement
with respect to any of the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
part of the Business Combination with Western, during the first quarter of calendar year 2025, the Company issued to unaffiliated investors
a total of &lt;span id="xdx_902_eus-gaap--PreferredStockSharesIssued_iI_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--WesternAcquisitionVenturesCorpMember_zmdnOxwOegl2" title="Preferred stock, shares issued"&gt;6,666,666&lt;/span&gt; preferred shares of Series D Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December 31, 2025, a total of &lt;span id="xdx_908_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--BusinessAcquisitionAxis__custom--WesternAcquisitionVenturesCorpMember_za8fMU3SjYs2" title="Number of Preferred stock converted"&gt;6,516,666&lt;/span&gt; shares of Series D Convertible Preferred Stock were converted into &lt;span id="xdx_90D_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zwzzlb9bGaL1" title="Number of common shares issuable upon conversion"&gt;217,220&lt;/span&gt; shares
of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of both March 31, 2026 and December 31, 2025, there were &lt;span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zA7s4aFPPXDh" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zzkprYJ0cMKe" title="Preferred stock, shares outstanding"&gt;&lt;span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zSvC7u8KvS7l" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_904_eus-gaap--PreferredStockSharesOutstanding_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zq18h3cIkZR3" title="Preferred stock, shares outstanding"&gt;150,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; shares of Series D Convertible Preferred Stock issued and outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
E Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has authorized &lt;span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_z7d9QHBLCBi" title="Preferred stock, shares authorized"&gt;100&lt;/span&gt; shares of Series E Convertible Preferred Stock, par value $&lt;span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zTtQJFtYWO72" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting
Rights&lt;/i&gt;: Holders of shares of Cycurion&#x2019;s Series E Convertible Preferred Stock shall have voting rights on an as-if-converted-to-common
stock basis and as required by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation
of Preferences, Rights and Limitations for Cycurion&#x2019;s Series E Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividend
Rights&lt;/i&gt;: Holders of shares of Cycurion&#x2019;s Series E Convertible Preferred Stock shall be entitled to receive, and Cycurion shall
pay, dividends on shares of Series E Convertible Preferred Stock (on an as-if-converted-to-Common-Stock basis) to and in the same form
as dividends actually paid on shares of common stock when, as, and if such dividends are paid on shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion
Rights&lt;/i&gt;: &lt;span id="xdx_90B_eus-gaap--ConversionOfStockDescription_c20260101__20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zstVtICRKgh3" title="Conversion of stock, description"&gt;Shares of Cycurion&#x2019;s Series E Convertible Preferred Stock shall be convertible, at any time and from time to time at
the option of the holder thereof, into shares of common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion
ratio of &lt;span id="xdx_90A_eus-gaap--PreferredStockConvertibleConversionRatio_iI_pid_dc_uPure_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_z1QAqpXLd8p2" title="Preferred stock, convertible, conversion ratio"&gt;one&lt;/span&gt; share of Series E Convertible Preferred Stock-for-one share of common stock, subject to adjustment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation
Preference&lt;/i&gt;: Holders of shares of Cycurion&#x2019;s Series E Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up
of Cycurion, whether voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, of Cycurion
an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon, for each share of Series E Convertible Preferred
Stock before any distribution or payment shall be made to the holders of common stock, and, if the assets of Cycurion shall be insufficient
to pay in full such amounts, then the entire assets to be distributed to the holders of shares of Series E Convertible Preferred Stock
shall be ratably distributed among them in accordance with the respective amounts that would have been payable on such shares if all
amounts payable thereon had been paid in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Protective
Provisions&lt;/i&gt;: As long as any shares of Series E Convertible Preferred Stock are outstanding, Cycurion shall not, without the affirmative
vote of the holders of a majority of the then-outstanding shares of Series E Convertible Preferred Stock, (a) alter or change adversely
the powers, preferences, or rights given to the holders of Series E Convertible Preferred Stock or alter or amend the Certificate of
Designation of Preferences, Rights and Limitations for Cycurion&#x2019;s Series E Convertible Preferred Stock, (b) amend its certificate
of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series E Convertible
Preferred Stock, (c) increase the number of authorized shares of Series E Convertible Preferred Stock, or (d) enter into any agreement
with respect to any of the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
part of the Management Services Agreement and a Release agreement with Ed Burns, the Company issued to the majority shareholder a total
of &lt;span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zjFk5VDbBKY2" title="Preferred stock, shares issued"&gt;51&lt;/span&gt; preferred shares of Series E Convertible Preferred Stock as consideration for the transaction during the year ended December 31,
2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of both March 31, 2026 and December 31, 2025, there were &lt;span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zxURu8PfJJk5" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zrMcPvapsJae" title="Preferred stock, shares outstanding"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zdnjeQbsElgc" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_z1Uu2Yyocb39" title="Preferred stock, shares outstanding"&gt;51&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; shares of Series E Convertible Preferred Stock issued and outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
F Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has authorized &lt;span id="xdx_90D_eus-gaap--PreferredStockSharesAuthorized_iI_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zEXWJwywcOm9" title="Preferred stock, shares authorized"&gt;10,000&lt;/span&gt; shares of Series F Convertible Preferred Stock, par value $&lt;span id="xdx_909_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_z50iPtNqR2Kf" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting
Rights&lt;/i&gt;: Holders of shares of our Series F Convertible Preferred Stock shall have voting rights on an as-if-converted-to-common-stock
basis and as required by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation of
Preferences, Rights and Limitations for our Series F Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividend
Rights&lt;/i&gt;: Holders of shares of our Series F Convertible Preferred Stock shall be entitled to receive, and we shall pay, dividends on
shares of our Series F Convertible Preferred Stock at the rate of twelve percent (&lt;span id="xdx_904_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20260101__20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_zL1xXM7Qndue"&gt;12&lt;/span&gt;%) per annum of the $&lt;span id="xdx_90E_eus-gaap--DividendsPayableAmountPerShare_iI_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_zClrLe5zPQZk" title="Dividends payable, amount per share"&gt;0.0001&lt;/span&gt; per-share Stated Value
of the Series F Convertible Preferred Stock. The dividends shall be paid payable quarterly in arrears in shares of common stock, calculated
for each dividend payment on an as-if-converted-to-common-stock basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion
Rights&lt;/i&gt;: &lt;span id="xdx_905_eus-gaap--ConversionOfStockDescription_c20260101__20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_zvWrnVBkwMjl" title="Conversion of stock, description"&gt;Shares of our Series F Convertible Preferred Stock shall be convertible, at any time and from time to time at the option
of the holder thereof, into shares of common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of
one share of Series F Convertible Preferred Stock-for-&lt;span id="xdx_90D_eus-gaap--PreferredStockConvertibleConversionRatio_iI_uPure_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_z1FWXeg87xei" title="Preferred stock, convertible, conversion ratio"&gt;1,000&lt;/span&gt; shares of common stock, subject to adjustment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation
Preference&lt;/i&gt;: Holders of shares of our Series F Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up, whether
voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, an amount equal to the Stated Value,
plus any accrued and unpaid dividends thereon, for each share Series F Convertible Preferred Stock before any distribution or payment
shall be made to the holders of common stock, and, if the assets shall be insufficient to pay in full such amounts, then the entire assets
to be distributed to the holders of shares of our Series F Convertible Preferred Stock shall be ratably distributed among them in accordance
with the respective amounts that would have been payable on such shares if all amounts payable thereon had been paid in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Protective
Provisions&lt;/i&gt;: As long as any shares of Series F Convertible Preferred Stock are outstanding, we shall not, without the affirmative
vote of the holders of a majority of the then-outstanding shares of Series F Convertible Preferred Stock, (a) alter or change adversely
the powers, preferences, or rights given to the holders of Series F Convertible Preferred Stock or alter or amend the Certificate of
Designation of Preferences, Rights and Limitations for our Series F Convertible Preferred Stock, (b) amend its certificate of incorporation
or other charter documents in any manner that adversely affects any rights of the holders of shares of Series F Convertible Preferred
Stock, (c) increase the number of authorized shares of Series F Convertible Preferred Stock, or (d) enter into any agreement with respect
to any of the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of both March 31, 2026 and December 31, 2025, there were &lt;span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_dc_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zkDpTzL3zOt2" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_dc_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zpDJczww37uj" title="Preferred stock, shares outstanding"&gt;&lt;span id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_dc_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_z8ciOs8cI7bi" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_dc_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zakOrZCNc9Rf" title="Preferred stock, shares outstanding"&gt;zero&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; shares of Series F Convertible Preferred Stock issued and outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
G Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has designated &lt;span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zKK8PZmPYPJc" title="Preferred stock, shares authorized"&gt;10,000&lt;/span&gt; shares of Series G Convertible Preferred Stock, par value $&lt;span id="xdx_904_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zQBfEE1xQtmf" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting
Rights&lt;/i&gt;: Holders of shares of Series G Convertible Preferred Stock shall have voting rights on an as-if-converted-to-Common-Stock
basis and as required by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation of
Preferences, Rights and Limitations for our Series G Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividend
Rights&lt;/i&gt;: Holders of shares of our Series G Convertible Preferred Stock shall be entitled to receive, and we shall pay, dividends on
shares of our Series G Convertible Preferred Stock at the rate of twelve percent (&lt;span id="xdx_90F_eus-gaap--PreferredStockConvertibleConversionRatio_iI_pid_dp_uPure_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zpweMzxSvlc" title="Preferred stock, convertible, conversion ratio"&gt;12&lt;/span&gt;%) per annum of the $&lt;span id="xdx_908_eus-gaap--DividendsPayableAmountPerShare_iI_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zbZoVGuDhtxb" title="Dividends payable, amount per share"&gt;0.0001&lt;/span&gt; per-share Stated Value
of the Series G Convertible Preferred Stock. The dividends shall be paid payable quarterly in arrears in shares of common stock, calculated
for each dividend payment on an as-if-converted-to-Common-Stock basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion
Rights&lt;/i&gt;: &lt;span id="xdx_901_eus-gaap--ConversionOfStockDescription_c20260101__20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_z1eZ21SILQz7" title="Conversion of stock, description"&gt;Shares of our Series G Convertible Preferred Stock shall be convertible, at any time and from time to time at the option
of the holder thereof, into shares of common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of
one share of Series G Convertible Preferred Stock-for-&lt;span id="xdx_90B_eus-gaap--PreferredStockConvertibleConversionRatio_iI_uPure_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zCM74zm02D41" title="Preferred stock, convertible, conversion ratio"&gt;1,000&lt;/span&gt; shares of common stock, subject to adjustment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation
Preference&lt;/i&gt;: Holders of shares of our Series G Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up, whether
voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, an amount equal to the Stated Value,
plus any accrued and unpaid dividends thereon, for each share Series G Convertible Preferred Stock before any distribution or payment
shall be made to the holders of common stock, and, if the assets shall be insufficient to pay in full such amounts, then the entire assets
to be distributed to the holders of shares of our Series G Convertible Preferred Stock shall be ratably distributed among them in accordance
with the respective amounts that would have been payable on such shares if all amounts payable thereon had been paid in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Protective
Provisions&lt;/i&gt;: As long as any shares of Series G Convertible Preferred Stock are outstanding, we shall not, without the affirmative
vote of the holders of a majority of the then-outstanding shares of Series G Convertible Preferred Stock, (a) alter or change adversely
the powers, preferences, or rights given to the holders of Series G Convertible Preferred Stock or alter or amend the Certificate of
Designation of Preferences, Rights and Limitations for our Series G Convertible Preferred Stock, (b) amend its certificate of incorporation
or other charter documents in any manner that adversely affects any rights of the holders of shares of Series G Convertible Preferred
Stock, (c) increase the number of authorized shares of Series G Convertible Preferred Stock, or (d) enter into any agreement with respect
to any of the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of both March 31, 2026 and December 31, 2025, there were &lt;span id="xdx_90E_eus-gaap--PreferredStockSharesIssued_iI_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zoPIZ5UBvp8a" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_z51BprYZzYMh" title="Preferred stock, shares outstanding"&gt;&lt;span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zhoCHh53Zy8" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zYKevr7C9TEg" title="Preferred stock, shares outstanding"&gt;143&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; shares of Series G Convertible Preferred Stock issued and outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Series
G Convertible Preferred Stock Activity&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cycurion
has engaged in a strategic recapitalization to strengthen its balance sheet and support growth initiatives. The Company entered into
agreements with certain investors to exchange $&lt;span id="xdx_907_eus-gaap--DebtConversionConvertedInstrumentAmount1_pn5n6_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zBXnwgRreali" title="Debt conversion, converted instrument, amount"&gt;3.2&lt;/span&gt; million aggregate principal amount of convertible indebtedness for an aggregate of
&lt;span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zoVez83IN9M" title="Debt conversion, converted instrument, shares issued"&gt;3,133&lt;/span&gt; shares of Series G Convertible Preferred Stock. These transactions convert a substantial portion of Cycurion&#x2019;s debt into
preferred equity, which provides additional capital to support business growth. For more information, please see &#x201c;Exchange Agreements
and Registration Rights Agreements&#x201d; below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Exchange
Agreements and Registration Rights Agreements&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 12, 2025, the Company entered into an exchange agreement with Alpha Capital Anstalt (the &#x201c;Alpha Capital Anstalt Exchange
Agreement&#x201d;) and a registration rights agreement. Pursuant to the Alpha Capital Anstalt Exchange Agreement, the parties intended
to effect a voluntary security exchange transaction whereby Alpha Capital Anstalt will exchange $&lt;span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--AlphaCapitalAnstaltMember_zOIw5VxuaJZ4" title="Debt conversion, converted instrument, amount"&gt;366,050&lt;/span&gt; in debt for an aggregate of
&lt;span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--AlphaCapitalAnstaltMember_zifXE6Uu4Epf" title="Debt conversion, converted instrument, shares issued"&gt;366&lt;/span&gt; shares of Series G Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 12, 2025, the Company entered into an exchange agreement with M2B Funding Corp. (the &#x201c;M2B Funding Corp. Exchange Agreement&#x201d;)
and a registration rights agreement. Pursuant to the M2B Funding Corp. Exchange Agreement, the parties intended to effect a voluntary
security exchange transaction whereby M2B Funding Corp. will exchange $&lt;span id="xdx_900_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--M2BFundingCorpMember_zR4p2LVDFw94" title="Debt conversion, converted instrument, amount"&gt;672,077&lt;/span&gt; in debt for an aggregate of &lt;span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--M2BFundingCorpMember_zCY1taVV8gj8" title="Debt conversion, converted instrument, shares issued"&gt;672&lt;/span&gt; shares of Series G Convertible
Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 12, 2025, the Company entered into an exchange agreement with ADI Funding (the &#x201c;ADI Funding Exchange Agreement&#x201d;) and
a registration rights agreement. Pursuant to the ADI Funding Exchange Agreement, the parties intended to effect a voluntary security
exchange transaction whereby ADI Funding will exchange $&lt;span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--AdiFundingMember_zRPUdGjtrG79" title="Debt conversion, converted instrument, amount"&gt;347,730&lt;/span&gt; in debt for an aggregate of &lt;span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--AdiFundingMember_zvn7Ca1qNWd1" title="Debt conversion, converted instrument, shares issued"&gt;348&lt;/span&gt; shares of Series G Convertible Preferred
Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 12, 2025, the Company entered into an exchange agreement with Deltennium (the &#x201c;Deltennium Exchange Agreement&#x201d;) and
a registration rights agreement. Pursuant to the Deltennium Exchange Agreement, the parties intended to effect a voluntary security exchange
transaction whereby Deltennium will exchange $&lt;span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--DeltenniumMember_znNgRvjw8qI4" title="Debt conversion, converted instrument, amount"&gt;617,667&lt;/span&gt; in debt for an aggregate of &lt;span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--DeltenniumMember_zIHGistcs67d" title="Debt conversion, converted instrument, shares issued"&gt;618&lt;/span&gt; shares of Series G Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 12, 2025, the Company entered into an exchange agreement with Osher Capital (the &#x201c;Osher Capital Exchange Agreement&#x201d;)
and a registration rights agreement. Pursuant to the Osher Capital Exchange Agreement, the parties intended to effect a voluntary security
exchange transaction whereby Osher Capital will exchange $&lt;span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--OsherCapitalMember_z4dSBfOsw1q8" title="Debt conversion, converted instrument, amount"&gt;103,800&lt;/span&gt; in debt for an aggregate of &lt;span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--OsherCapitalMember_zyrvkMh5k0o4" title="Debt conversion, converted instrument, shares issued"&gt;104&lt;/span&gt; shares of Series G Convertible Preferred
Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 12, 2025, the Company entered into an exchange agreement with Lexi London (the &#x201c;Lexi London Exchange Agreement&#x201d;) and
a registration rights agreement. Pursuant to the Lexi London Exchange Agreement, the parties intended to effect a voluntary security
exchange transaction whereby Lexi London will exchange $&lt;span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--LexiLondonMember_zjwPtUPdhvVk" title="Debt conversion, converted instrument, amount"&gt;769,000&lt;/span&gt; in debt for an aggregate of &lt;span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--LexiLondonMember_z8dCMWEwOAk7" title="Debt conversion, converted instrument, shares issued"&gt;769&lt;/span&gt; shares of Series G Convertible Preferred
Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 12, 2025, the Company entered into an exchange agreement with ILE Associates (the &#x201c;ILE Associates Exchange Agreement&#x201d;)
and a registration rights agreement. Pursuant to the ILE Associates Exchange Agreement, the parties intended to effect a voluntary security
exchange transaction whereby ILE Associates will exchange $&lt;span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--IleAssociatesMember_zhxkfj8GdvN4" title="Debt conversion, converted instrument, amount"&gt;256,333&lt;/span&gt; in debt for an aggregate of &lt;span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20250812__20250812__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember__srt--CounterpartyNameAxis__custom--IleAssociatesMember_zAN7YxJ24z81" title="Debt conversion, converted instrument, shares issued"&gt;256&lt;/span&gt; shares of Series G Convertible Preferred
Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Common
Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has authorized &lt;span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20260331_zbGMOILBJj1i" title="Common stock, shares authorized"&gt;300,000,000&lt;/span&gt; shares of common stock, par value of $&lt;span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20260331_z8hm3WebMRYc" title="Common stock, par value"&gt;0.0001&lt;/span&gt; per share. Each share of common stock entitles the holder
to &lt;span id="xdx_909_ecustom--CommonStockVotesPerShare_iI_pid_dc_uVote_c20260331_zTYCy6n7RWH7" title="Common stock, votes per share"&gt;one&lt;/span&gt; vote, in person or proxy, on any matter on which an action of the stockholders of the Company is sought.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesABandDConvertiblePreferredStockMember_zrpi4jLOkvr3" title="Common stock issued on conversion"&gt;578,863&lt;/span&gt; shares
    for conversion of Series A, B and D Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__custom--WarrantABandDMember_zkuY82BF4Lw4" title="Common stock issued on conversion"&gt;258,464&lt;/span&gt; shares for exercise
    of other warrants, Warrant A, B and D for $&lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__custom--WarrantABandDMember_zOvkecgNMBh9" title="Common stock issued on conversion, value"&gt;3,309,921&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--NonrecurringAdjustmentAxis__us-gaap--AcquisitionRelatedCostsMember_zAleY1TcOnt3" title="Common stock issued on conversion"&gt;25,000&lt;/span&gt; shares valued at
    $&lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--NonrecurringAdjustmentAxis__us-gaap--AcquisitionRelatedCostsMember_zC5lN3AMWYvj" title="Common stock issued on conversion, value"&gt;9,000,000&lt;/span&gt; for business acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--NonrecurringAdjustmentAxis__custom--SettlementOfDebtMember_zz5CqcSDpYUe" title="Common stock issued on conversion"&gt;10,894&lt;/span&gt; shares valued at
    $&lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--NonrecurringAdjustmentAxis__custom--SettlementOfDebtMember_zUVVX7ZT03g8" title="Common stock issued on conversion, value"&gt;1,193,634&lt;/span&gt; for a settlement of debt of $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentRepaidPrincipal_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--NonrecurringAdjustmentAxis__custom--SettlementOfDebtMember_zMKJ1KvuWpug" title="Amount of debt repaid"&gt;2,925,803&lt;/span&gt;, as a result, the Company recorded loss on settlement of debt of $&lt;span id="xdx_90C_eus-gaap--GainsLossesOnExtinguishmentOfDebt_iN_di_c20260101__20260331__us-gaap--NonrecurringAdjustmentAxis__custom--SettlementOfDebtMember_z7pOqxjVgfeb" title="Loss on debt repaid"&gt;2,174,075&lt;/span&gt;, which
    is presented on the consolidated statements of operations and the consolidated statements of cash flows within &#x2018;gain on debt
    settlement, net&#x2019;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zdlxaNGCU3th" title="Common stock issued on conversion"&gt;330,869&lt;/span&gt; shares valued at
    $&lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zfOHjTJ5nHHf" title="Common stock issued on conversion, value"&gt;5,916,777&lt;/span&gt; for an employment agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationMember_zNFpRxog8R1b" title="Common stock issued on conversion"&gt;33,609&lt;/span&gt; shares valued at
    $&lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationMember_z72fdu0a4WUj" title="Common stock issued on conversion, value"&gt;764,020&lt;/span&gt; for consideration in the Management Services Agreement and a Release agreement with Ed Burns&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__custom--CommonStockRedemptionMember_zhdga7jpjOs6" title="Common stock issued on conversion"&gt;2,633&lt;/span&gt; shares for a release
    of common stock subject to redemption&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2026 and December 31, 2025, there were &lt;span id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_pid_c20260331_zGr0vZYQHMaa" title="Common stock, shares issued"&gt;&lt;span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20260331_zwDA5WMl9DIi" title="Common stock, shares outstanding"&gt;5,510,021&lt;/span&gt;&lt;/span&gt; and &lt;span id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_pid_c20251231_zf8v0e2V7xF6" title="Common stock, shares issued"&gt;&lt;span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20251231_zNmo6KYLhqL5" title="Common stock, shares outstanding"&gt;3,642,501&lt;/span&gt;&lt;/span&gt; shares of common stock issued and outstanding, respectively.
The &lt;span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationMember_z2NNf1DLvl41" title="Common stock, shares outstanding"&gt;5,510,021&lt;/span&gt; shares of common stock include &lt;span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20260331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationMember_zxcxGCrc1pC7" title="Common stock, shares issued"&gt;33,609&lt;/span&gt; shares of common stock to be issued to SLG and under certain equity plans.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
15.1: Details of Warrants&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z8RA9XWrkPxa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B8_zGR6skk3w0Ag" style="display: none"&gt;SCHEDULE OF WARRANTS ACTIVITY&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Number of Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average Life (years)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;Outstanding warrants, December 31, 2024&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6Lsb0OfLL11" style="width: 12%; text-align: right" title="Number of Warrants, outstanding, beginning balance"&gt;315,028&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zcyCBzKSjUMd" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, beginning balance"&gt;20.64&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zhjdaUAS3y7h" title="Weighted Average Life (years), outstanding"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zGcMya6TJao4" style="text-align: right" title="Number of Warrants, granted"&gt;869,992&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNduiL1CntG9" style="text-align: right" title="Weighted Average Exercise Price, granted"&gt;164.96&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms_dtY_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z3HM43653XP8" title="Weighted Average Life (years), granted"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Replacement of old warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NumberOfWarrantsReplacementOfOldWarrants_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zK0t2yVuD5ol" style="text-align: right" title="Number of Warrants, replacement of old warrants"&gt;(315,028&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageReplacementDateFairValue_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zJGBENT8TWQ5" style="text-align: right" title="Weighted Average Exercise Price, replacement of old warrants"&gt;20.64&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsReplacementWeightedAverageRemainingContractualTerms_dtY_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztBgiweu4no" title="Weighted Average Life (years), replacement of old warrants"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 10pt"&gt;Exercised&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zvFKVZCUSB54" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, exercised"&gt;(234,831&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zPJ107apVRGk" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, exercised"&gt;14.27&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms_dtY_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zjmQ36SORynl" title="Weighted Average Life (years), exercised"&gt;4.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Outstanding warrants, March 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zo9Q2Br3yqOk" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, outstanding, beginning balance"&gt;635,161&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z1HLif87z7Sc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, beginning balance"&gt;220.67&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zwcH99P7asEg" title="Weighted Average Life (years), outstanding"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Issued - Prefunded (equity line)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NumberOfWarrantsPrefundedEquityLine_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zl78q7pIswvk" style="text-align: right" title="Number of Warrants, prefunded (equity line)"&gt;150,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedPrefundedWarrantInPeriodWeightedAverageGrantDateFairValue_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ziblyyM9l40f" style="text-align: right" title="Weighted Average Exercise Price, issued - prefunded (equity line)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4854"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedPrefundedWarrantWeightedAverageRemainingContractualTerms_dtY_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zzkSTWbsu41f" title="Weighted Average Life (years), issued - prefunded (equity line)"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Exercised - Prefunded (equity line)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NumberOfWarrantsExercisedPrefundedEquityLine_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zKLoKBm25ec2" style="text-align: right" title="Number of Warrants, exercised - prefunded (equity line)"&gt;(83,333&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantInPeriodWeightedAverageGrantDateFairValue_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zYwwWX5be5H6" style="text-align: right" title="Weighted Average Exercise Price, exercised - prefunded (equity line)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4860"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantWeightedAverageRemainingContractualTerms_dtY_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zTZVabX7XH7g" title="Weighted Average Life (years), exercised - prefunded (equity line)"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zXAum2WcojF3" style="text-align: right" title="Number of Warrants, exercised"&gt;(23,633&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zYI0USIJL9P5" style="text-align: right" title="Weighted Average Exercise Price, exercised"&gt;15.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms_dtY_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMSqd9RdEz36" title="Weighted Average Life (years), granted"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Outstanding warrants, June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zhemVr632BG" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, outstanding, beginning balance"&gt;678,195&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0LO8X9Asrwf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, beginning balance"&gt;206.15&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zofIspokhOo5" title="Weighted Average Life (years), outstanding"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Exercised - Prefunded (equity line)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NumberOfWarrantsExercisedPrefundedEquityLine_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRhADXwsLr8b" style="text-align: right" title="Number of Warrants, exercised - prefunded (equity line)"&gt;(66,667&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantInPeriodWeightedAverageGrantDateFairValue_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxRQAbfStUo7" style="text-align: right" title="Weighted Average Exercise Price, exercised - prefunded (equity line)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4878"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantWeightedAverageRemainingContractualTerms_dtY_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zJUQEx54zzQc" title="Weighted Average Life (years), exercised - prefunded (equity line)"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Outstanding warrants, September 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0jitETr2Bm8" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, outstanding, beginning balance"&gt;611,528&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrz4Oz7LQ4P7" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, beginning balance"&gt;228.62&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6TKWH0XPFvf" title="Weighted Average Life (years), outstanding"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Issued - Prefunded (Armistice-Prefunded)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NumberOfWarrantsIssuedPrefunded_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zJqvdyFaoWp4" style="text-align: right" title="Number of Warrants, issued prefunded"&gt;1,670,720&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--WeightedAverageExercisePriceIssuedPrefunded_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZnQ69KMOM3j" style="text-align: right" title="Weighted Average Exercise Price, issued - prefunded"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4890"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--WeightedAverageLifeYearsIssuedPrefunded_dtY_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zBHpEwX9ZJG" title="Weighted Average Life (years), issued - prefunded"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Issued (Armistice)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--NumberOfWarrantsIssued_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6r77uxDNG01" style="text-align: right" title="Number of Warrants, issued"&gt;3,341,439&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedWarrantInPeriodWeightedAverageGrantDateFairValue_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zM6gzsKRBJ8d" style="text-align: right" title="Weighted Average Exercise Price, issued"&gt;3.62&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--WeightedAverageLifeYearsIssued_dtY_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zFCYuuZfkqu" title="Weighted Average Life (years), issued"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Outstanding warrants, December 31, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zYZRFbK2576g" style="text-align: right" title="Number of Warrants, outstanding, beginning balance"&gt;5,623,687&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zLuypRiSoMzg" style="text-align: right" title="Weighted Average Exercise Price, beginning balance"&gt;27.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zsEkcN13L581" title="Weighted Average Life (years), outstanding"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 10pt; text-align: left"&gt;Exercised - Prefunded (Armistice-Prefunded)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NumberOfWarrantsExercisedPrefunded_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zVaEwGVAs5X8" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, exercised - prefunded"&gt;(1,670,720&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--WeightedAverageExercisePriceExercisedPrefunded_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zS2yTeupHn8e" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, exercised - prefunded"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4908"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--WeightedAverageLifeYearsExercisedPrefundedArmisticePrefunded_dtY_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zUhIfGxWUXa3" title="Weighted Average Life (years), exercised - prefunded"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Outstanding warrants, March 31, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQwmj0jwxl47" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, outstanding, ending balance"&gt;3,952,967&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zcAN58pEdH18" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, ending balance"&gt;27.01&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0msCGuXzD83" title="Weighted Average Life (years), outstanding"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Exercisable warrants, March 31, 2026&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber_iE_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zGs0UTczN858" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Warrants, exercisable"&gt;3,952,967&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iE_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zCwMMEDUTzM1" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, exercisable"&gt;27.01&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerms_dtY_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zLcZF3F65rgg" title="Weighted Average Life (years), exercisable"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zt05aIbeywg8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has accounted for the issuance of common stock and warrants issued for cash proceeds in the private placements as equity instruments.
Management believes that the warrants are indexed to and are settled in the Company&#x2019;s own common stock; therefore, they should
be accounted for as permanent equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Public
Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of both March 31, 2026 and December 31, 2025, there were &lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zjzKVHBRzbs1" title="Class of warrant or right, outstanding"&gt;&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zayl7T0x3LVj" title="Class of warrant or right, outstanding"&gt;383,333&lt;/span&gt;&lt;/span&gt; public warrants (&#x201c;Public Warrants&#x201d;) outstanding. The Company
accounts for the Public Warrants as equity instruments. The Public Warrants will become exercisable on the later of (a) &lt;span id="xdx_90C_ecustom--ClassOfWarrantOrRightExercisablePeriodThresholdTradingDays_iI_dtD_c20260331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__srt--RangeAxis__srt--MinimumMember_zo3hy10RDsLh" title="Threshold trading days for redemption of public warrants"&gt;30&lt;/span&gt; days after
the completion of a Business Combination or (b) &lt;span id="xdx_907_ecustom--ClassOfWarrantOrRightExercisablePeriodThresholdTradingDays_iI_dtM_c20260331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__srt--RangeAxis__srt--MaximumMember_z3AWRIoggZXc" title="Threshold trading days for redemption of public warrants"&gt;12&lt;/span&gt; months from the closing of the initial public offering. No warrants will be exercisable
for cash unless the Company has an effective and current registration statement covering the shares of common stock issuable upon exercise
of the warrants and a current prospectus relating to such shares of common stock. Notwithstanding the foregoing, if a registration statement
covering the shares of common stock issuable upon exercise of the Public Warrants is not effective within a specified period following
the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and
during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless
basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If neither
that exemption nor another exemption is available, holders will not be able to exercise their warrants on a cashless basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Public Warrants will expire on February 14, 2030, &lt;span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20260331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zmBY7EPiGT5e" title="Warrants and rights outstanding, term"&gt;five years&lt;/span&gt; after the completion of the Business Combination with Cycurion or earlier
upon redemption or liquidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Once
the Public Warrants become exercisable, the Company may redeem the Public Warrants:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in whole and
    not in part&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;at a price of $&lt;span id="xdx_908_ecustom--ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_iI_c20260331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zI6INBF0fbGc" title="Redemption price per public warrant"&gt;0.30&lt;/span&gt; per
    Public Warrant;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;upon not less than &lt;span id="xdx_906_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantOrRightMinimumThresholdWrittenNoticePeriod_i01_dtD_c20260101__20260331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z5WQNDqf3Nzl" title="Minimum threshold written notice period for redemption of public warrants"&gt;30&lt;/span&gt; days&#x2019;
    prior written notice of redemption;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if, and only if, the reported
    last sale price of the shares of common stock equals or exceeds $&lt;span id="xdx_901_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_iI_c20260331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zJKY6y2CIVa7" title="Stock price trigger for redemption of public warrants per share"&gt;18.00&lt;/span&gt; per share (as adjusted for stock splits, stock dividends,
    reorganizations and recapitalizations), for any &lt;span id="xdx_90C_ecustom--ClassOfWarrantOrRightExercisablePeriodThresholdTradingDays_iI_dtD_c20260331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zBmbjfOnSOSh" title="Threshold trading days for redemption of public warrants"&gt;20&lt;/span&gt; trading days within a &lt;span id="xdx_901_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantOrRightThresholdConsecutiveTradingDays_dtD_c20260101__20260331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zq1qcVs9wLM8" title="Threshold consecutive trading days for redemption of public warrants"&gt;30&lt;/span&gt; trading day period commencing at any time after the Public
    Warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if, and only if, there
    is a current registration statement in effect with respect to the shares of common stock underlying the Public Warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
and when the Public Warrants become redeemable, we may not exercise our redemption right if the issuance of shares of common stock upon
exercise of the Public Warrants is not exempt from registration or qualification under applicable state blue sky laws or we are unable
to effect such registration or qualification. We will use our best efforts to register or qualify such shares of common stock under the
blue-sky laws of those states in which such Public Warrants were offered by us in the offering.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
we call the Public Warrants for redemption, as described above, we will have the option to require any holder that wishes to exercise
its Public Warrant to do so on a &#x201c;cashless basis.&#x201d; If we take advantage of this option, all holders of Public Warrants would
pay the exercise price by surrendering their Public Warrants for the number of shares of common stock equal to the quotient obtained
by dividing (x) the product of the number of shares of common stock underlying the Public Warrants, multiplied by the difference between
the exercise price of the Public Warrants and the &#x201c;fair market value&#x201d; (defined below) by (y) the fair market value. The &#x201c;fair
market value&#x201d; for this purpose means the average reported last sale price of the common stock for the ten trading days ending on
the third trading day prior to the date on which the notice of redemption is sent to the holders of Public Warrants. If our management
takes advantage of this option, the notice of redemption will contain the information necessary to calculate the number of shares of
common stock to be received upon exercise of the Public Warrants, including the &#x201c;fair market value&#x201d; in such case. Requiring
a cashless exercise in this manner will reduce the number of shares to be issued and thereby lessen the dilutive effect of a Public Warrant
redemption. We believe this feature is an attractive option to us if we do not need the cash from the exercise of the Public Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;PIPE
Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 11, 2022, concurrently with the completion of the Business Combination, pursuant to the PIPE Subscription Agreement, dated January
11, 2022 (as the same may be amended from time to time, the &#x201c;PIPE Subscription Agreement&#x201d;) for an aggregate purchase price
of $&lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220111__20220111__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeSubscriptionAgreementMember_zeCRJZHyQhxj" title="Common stock issued for exercise of warrants"&gt;3,760,000&lt;/span&gt;, Western issued an aggregate of &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220111__20220111__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeSubscriptionAgreementMember_z5LNgie7o0id" title="Common stock issued for exercise of warrants, shares"&gt;12,533&lt;/span&gt; shares of common stock issued in a private placement (the &#x201c;PIPE Financing&#x201d;)
pursuant to that certain PIPE Subscription Agreement and &lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220111__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeWarrantsMember_ziulSsfbeEzh" title="Class of warrant or right, number of securities called by warrants or rights, shares"&gt;12,533&lt;/span&gt; shares of common stock issuable upon the exercise of certain warrants
(the &#x201c;PIPE Warrants&#x201d;) issued in the PIPE Financing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
outstanding whole PIPE Warrant and public warrant (&#x201c;Public Warrant&#x201d;) issued in connection with the initial public offering
of Western represents the right to purchase &lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_dc_c20220111__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeWarrantsMember_zXsYjaCU0a8" title="Class of warrant or right, number of securities called by each warrant or right, shares"&gt;one&lt;/span&gt; share of common stock at a price of $&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220111__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeWarrantsMember_zqPUacebuGl9" title="Class of warrant or right, exercise price of warrants or rights"&gt;11.50&lt;/span&gt; per share, subject to adjustment, at any time
commencing &lt;span id="xdx_905_ecustom--WarrantsAndRightsExerciseStartDelayPeriod_iI_dtD_c20220111__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeWarrantsMember_zakn1X0EJzvj" title="Warrants and rights, exercise start delay period"&gt;30&lt;/span&gt; days after the Business Combination with Western and ending &lt;span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20220111__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeWarrantsMember_zaB2hvpv6j9g" title="Warrants and rights outstanding, term"&gt;five years&lt;/span&gt; after the Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
PIPE Warrants, as well as any warrants underlying additional units issued to the Western Acquisition Ventures Sponsor, LLC (the &#x201c;Sponsor&#x201d;)
or our officers, directors or their affiliates in payment of working capital loans, are identical to the Public Warrants except that
the PIPE Warrants (i) will be exercisable for cash or on a cashless basis, at the holder&#x2019;s option, and (ii) will not be redeemable
by us, in each case so long as they are still held by the Sponsor or its permitted transferees.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2026 and December 31, 2025, there were &lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260331__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeWarrantsMember_zO9i3EijB5hj" title="Class of warrant or right, outstanding"&gt;&lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20251231__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeWarrantsMember_zW7XVxoCNoZi" title="Class of warrant or right, outstanding"&gt;12,533&lt;/span&gt;&lt;/span&gt; PIPE Warrants outstanding. The Company accounts for the Private Placement
Warrants as equity instruments. The PIPE Warrants sold in the private placement are identical to the Public Warrants underlying the Units
sold in the initial public offering, except that such warrants, and the shares of common stock issuable upon the exercise of such warrants,
will not be transferable, assignable, or salable until after February 14, 2025, the date of completion of a Business Combination, subject
to certain limited exceptions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, if we, at any time while the Public Warrants or PIPE Warrants are outstanding and unexpired, pay a dividend or make a distribution
in cash, securities or other assets to the holders of common stock on account of such shares of common stock (or other shares of our
capital stock into which the Public Warrants or PIPE Warrants are convertible), other than (a) as described above, (b) certain ordinary
cash dividends, (c) to satisfy the redemption rights of the holders of common stock in connection with a proposed initial business combination,
(d) to satisfy the redemption rights of the holders of common stock in connection with a stockholder vote to amend our amended and restated
certificate of incorporation (i) to modify the substance or timing of our obligation to allow redemption in connection with our initial
business combination or certain amendments to our charter prior thereto or to redeem &lt;span id="xdx_906_ecustom--CommonStockRedemptionRightsUponDelayInBusinessCombinationClosingPercentage_iI_pid_dp_uPure_c20220111__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeWarrantsMember_zKctuNNffqBf" title="Common stock, redemption rights upon delay in business combination closing, percentage"&gt;100&lt;/span&gt;% of our common stock if we do not complete our
initial business combination within &lt;span id="xdx_904_ecustom--CommonStockRedemptionRightsBusinessCombinationClosingPeriod_dtM_c20220111__20220111__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeWarrantsMember__srt--RangeAxis__srt--MinimumMember_zlyqhu8XmoFl" title="Common stock, redemption rights, business combination closing period"&gt;12&lt;/span&gt; months from the closing of this offering (or up to &lt;span id="xdx_904_ecustom--CommonStockRedemptionRightsBusinessCombinationClosingPeriod_dtM_c20220111__20220111__us-gaap--SubsidiarySaleOfStockAxis__custom--PipeWarrantsMember__srt--RangeAxis__srt--MaximumMember_zQtq7X1deKh8" title="Common stock, redemption rights, business combination closing period"&gt;18&lt;/span&gt; months from the closing of the offering
at the election of the Company subject to satisfaction of certain conditions or as extended by our stockholders in accordance with our
amended and restated certificate of incorporation) or (ii) with respect to any other provision relating to stockholders&#x2019; rights
or pre-initial business combination activity, or (e) in connection with the redemption of our public shares upon our failure to complete
our initial business combination, then the Public Warrants and PIPE Warrants exercise price will be decreased, effective immediately
after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid on
each share of common stock in respect of such event.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the number of outstanding shares of common stock is decreased by a consolidation, combination, reverse stock split or reclassification
of shares of common stock or other similar event, then, on the effective date of such consolidation, combination, reverse stock split,
reclassification or similar event, the number of shares of common stock issuable on exercise of each Public Warrant and PIPE Warrant
will be decreased in proportion to such decrease in outstanding shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
case of any reclassification or reorganization of the outstanding shares of common stock (other than those described above or that solely
affects the par value of such shares of common stock), or in the case of any merger or consolidation of us with or into another corporation
(other than a consolidation or merger in which we are the continuing corporation and that does not result in any reclassification or
reorganization of our outstanding shares of common stock), or in the case of any sale or conveyance to another corporation or entity
of the assets or other property of ours as an entirety or substantially as an entirety in connection with which we are dissolved, the
holders of the Public Warrants and PIPE Warrants will thereafter have the right to purchase and receive, upon the basis and upon the
terms and conditions specified in the Public Warrants and PIPE Warrants and in lieu of the shares of common stock immediately theretofore
purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities
or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following
any such sale or transfer, that the holder of the Public Warrants or PIPE Warrants (as applicable) would have received if such holder
had exercised their Public Warrants or PIPE Warrant (as applicable) immediately prior to such event.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Public Warrants and PIPE Warrants are issued in registered form under a warrant agreement between Equiniti Trust Company, LLC, as warrant
agent, and us. The warrant agreement provides that the terms of the Public Warrants and PIPE Warrants may be amended without the consent
of any holder to cure any ambiguity or correct any mistake, or defective provision, but requires the approval by the holders of at least
a majority of the then outstanding Public Warrants to make any change that adversely affects the interests of the registered holders
of Public Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
A Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 17, 2017, the Company had issued &lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20171117__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zZ1sAvk24m23" title="Class of warrant or right, number of securities called by warrants or rights"&gt;44,445&lt;/span&gt; Series A Warrants at exercise price of $&lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20171117__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zCETWxfK2Rei" title="Class of warrant or right, exercise price of warrants"&gt;13.50&lt;/span&gt; with an expiration date of November 22,
2025. As part of the Business Combination with Western, during the first quarter of 2025, the Company issued to unaffiliated investors
a total of &lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zCJt7dgSqke1" title="Warrants issued"&gt;22,696&lt;/span&gt; Series A Warrants in exchange of existing &lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zRKvkABbmMcd" title="Warrants issued"&gt;44,445&lt;/span&gt; Series A Warrants having expiry on February 19, 2029 and exercise
price of $&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zci5IaYHCaDb" title="Exercise price of warrants"&gt;9.59121&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
B Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 1, 2023, the Company issued &lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20230801__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesBWarrantsMember_zSeyIHYBSaX9" title="Class of warrant or right, number of securities called by warrants or rights"&gt;133,333&lt;/span&gt; Series B Warrants with an exercise price of $&lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230801__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesBWarrantsMember_zgbvp35D5vt" title="Class of warrant or right, exercise price of warrants"&gt;15.00&lt;/span&gt; with an expiration date of August 1, 2028.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 12, 2024, the Company issued &lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240412__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesBWarrantsMember_zrZboOt4DXb2" title="Class of warrant or right, number of securities called by warrants or rights"&gt;66,667&lt;/span&gt; Series B Warrants with an exercise price of $&lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240412__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesBWarrantsMember_zWSepV8NGj19" title="Class of warrant or right, exercise price of warrants"&gt;15.00&lt;/span&gt; with an expiration date of April 12, 2029.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
part of the Business Combination with Western, during the year ended December 31, 2025, the Company issued to unaffiliated investors
a total of &lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesBWarrantsMember_zoofhpbumWqh" title="Class of warrant or right, number of securities called by warrants or rights"&gt;200,000&lt;/span&gt; Series B Warrants in exchange of existing &lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesBWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUrLpQJsC6Yj" title="Warrants issued"&gt;200,000&lt;/span&gt; Series B Warrants having and expiration date of February 19, 2030
and an exercise price of $&lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesBWarrantsMember_zDJvJ7YCPiQg" title="Exercise price of warrants"&gt;15.00&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
D Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 22, 2022, the Company issued &lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220322__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesDWarrantsMember__us-gaap--LongtermDebtTypeAxis__custom--SubordinatedConvertiblePromissoryNoteMember_zFVwxSUGvEYd" title="Warrants issued"&gt;6,564&lt;/span&gt; Series D Warrants with a subordinated convertible promissory note at an exercise price of $&lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220322__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesDWarrantsMember__us-gaap--LongtermDebtTypeAxis__custom--SubordinatedConvertiblePromissoryNoteMember_zEXDTmcedRkg" title="Exercise price of warrants"&gt;42.30&lt;/span&gt;
and an expiration date of September 22, 2027.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 22, 2022, the Company had issued &lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221122__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesDWarrantsMember__us-gaap--LongtermDebtTypeAxis__custom--SubordinatedConvertiblePromissoryNoteOneMember_zXbLE2lSnM2a" title="Warrants issued"&gt;32,819&lt;/span&gt; warrants with subordinated convertible promissory note at an exercise price of $&lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221122__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesDWarrantsMember__us-gaap--LongtermDebtTypeAxis__custom--SubordinatedConvertiblePromissoryNoteOneMember_z7EQyXZookif" title="Exercise price of warrants"&gt;42.30&lt;/span&gt;
and an expiration date of April 21, 2028.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
part of the Business Combination with Western, during the year ended December 31, 2025, the Company issued to unaffiliated investors
a total of &lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesDWarrantsMember_zk2Cdu1Rvma7" title="Class of warrant or right, number of securities called by warrants or rights"&gt;242,424&lt;/span&gt; Series D Warrants in exchange of existing &lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesDWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zPn4op7edtP8" title="Class of warrant or right, number of securities called by warrants or rights"&gt;39,382&lt;/span&gt; Series D Warrants having an exercise price of $&lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesDWarrantsMember_zIARMIvygi6g" title="Class of warrant or right, exercise price of warrants"&gt;15.00&lt;/span&gt; and an expiration
date of February 19, 2029.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Armistice
Pre-Funded Warrant and Armistice Warrant&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 4, 2025, Cycurion entered into a securities purchase agreement (the &#x201c;Armistice Purchase Agreement&#x201d;) with a single
institutional accredited investor, Armistice Capital Master Fund Ltd. (&#x201c;Armistice&#x201d;), pursuant to which we issued and sold
to Armistice in a private placement (i) pre-funded warrants (the &#x201c;Armistice Pre-Funded Warrants&#x201d;) to purchase up to an aggregate
of &lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20251204__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrantSharesMember_z9L5ZPwkWnqf" title="Class of warrant or right, number of securities called by warrants or rights"&gt;1,670,720&lt;/span&gt; shares of common stock (the &#x201c;Pre-Funded Warrant Shares&#x201d;), and (ii) warrants (the &#x201c;Armistice Warrants&#x201d;)
to purchase up to an aggregate of &lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20251204__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantSharesMember_zK6D16S9Qreh" title="Class of warrant or right, number of securities called by warrants or rights"&gt;3,341,439&lt;/span&gt; shares of common stock (the &#x201c;Warrant Shares&#x201d;). The exercise of the Warrants and
the issuance of the Warrant Shares upon exercise thereof is subject to stockholder approval (&#x201c;Stockholder Approval&#x201d;). Stockholder
Approval was received at the special general meeting of stockholders on March 19, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
Armistice Pre-Funded Warrant was sold at an offering price of $&lt;span id="xdx_90A_ecustom--ClassOfWarrantOrRightOfferingPrice_iI_pid_c20251205__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrantSharesMember_zuK695e0hiub" title="Class of warrant or right, offering price"&gt;3.62&lt;/span&gt;. Each Armistice Warrant has an exercise price of $&lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20251205__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantSharesMember__srt--CounterpartyNameAxis__custom--ArmisticeCapitalMasterFundLtdMember_zIfWb49mc0qi" title="Class of warrant or right, exercise price of warrants or rights"&gt;3.62&lt;/span&gt;. The Private
Placement closed (the &#x201c;Closing&#x201d;) on December 5, 2025 (the &#x201c;Closing Date&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 5, 2025, Cycurion entered into the Armistice Pre-Funded Warrant with Armistice that is exercisable for up to &lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20251205__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrantSharesMember__srt--CounterpartyNameAxis__custom--ArmisticeCapitalMasterFundLtdMember_zXCVGL2Afp7l" title="Warrants shares"&gt;1,657,460&lt;/span&gt; shares
of common stock. Each Armistice Pre-Funded Warrant has an exercise price equal to $&lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20251205__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrantSharesMember__srt--CounterpartyNameAxis__custom--ArmisticeCapitalMasterFundLtdMember_z2ESJVAbr44a" title="Class of warrant or right, exercise price of warrants or rights"&gt;0.0001&lt;/span&gt; per share. The Armistice Pre-Funded Warrants
were all exercised during the three months ended March 31, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 5, 2025, Cycurion entered into the Armistice Warrant with Armistice that has an exercise price equal to $&lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20251205__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantSharesMember__srt--CounterpartyNameAxis__custom--ArmisticeCapitalMasterFundLtdMember_zafsx9hvyOq4" title="Class of warrant or right, exercise price of warrants or rights"&gt;3.62&lt;/span&gt; per share. The
Armistice Warrants will be exercisable immediately following receipt of Stockholder Approval for the issuance of the Armistice Warrants
and the Warrant Shares and have an exercise price of $&lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20251205__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantSharesMember__srt--CounterpartyNameAxis__custom--ArmisticeCapitalMasterFundLtdMember_z1jnVoQb8253" title="Class of warrant or right, exercise price of warrants or rights"&gt;3.62&lt;/span&gt; per share, subject to adjustment for customary events such as stock splits
and fundamental transactions. The Armistice Warrants will expire &lt;span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_pid_dc_c20251205__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantSharesMember__srt--CounterpartyNameAxis__custom--ArmisticeCapitalMasterFundLtdMember_zHvpjfqU7KQ9" title="Warrants and rights outstanding, term"&gt;five years&lt;/span&gt; from their initial exercise date. At any time following the
initial exercise date of the Armistice Warrants, the Armistice Warrants can be exercised on a cashless basis if there is no effective
registration statement registering, or no current prospectus available for, the resale of the Warrant Shares. The exercise price and
number of shares of common stock issuable upon exercise of the Armistice Warrant and Armistice Pre-Funded Warrant are subject to appropriate
adjustment in the event of stock dividends, stock splits, reorganizations or similar events.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Armistice Pre-Funded Warrants and the Armistice Warrants issued in the Armistice private placement provide that a holder of Armistice
Pre-Funded Warrants or Armistice Warrants, as applicable, will not have the right to exercise any portion of its Armistice Pre-Funded
Warrants or Armistice Warrants if such holder, together with its affiliates, and any other party whose holdings would be aggregated with
those of the holder for purposes of Section 13(d) or Section 16 of the Exchange Act would beneficially own in excess of 9.99% for the
Armistice Pre-Funded Warrants and 4.99% for the Armistice Warrants of the number of shares of common stock outstanding immediately after
giving effect to such exercise (the &#x201c;Beneficial Ownership Limitation&#x201d;); provided, however, that the holder may increase or
decrease the Beneficial Ownership Limitation by giving notice to the Company, with any such increase not taking effect until the sixty-first
day after such notice is delivered to the Company but not to any percentage in excess of 9.99%. The Warrants may be exercised on a cashless
basis if a registration statement registering Warrant Shares is not effective. The Armistice Pre-Funded Warrants may be exercised on
a cashless basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subject
to applicable laws, an Armistice Warrant and Armistice Pre-Funded Warrant may be transferred at the option of the holder upon surrender
of the applicable warrant to us together with the appropriate instruments of transfer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
is no trading market available for the Armistice Warrants or the Armistice Pre-Funded Warrants on any securities exchange or nationally
recognized trading system. We do not intend to list the Armistice Warrants or the Armistice Pre-Funded Warrants on any securities exchange
or nationally recognized trading system.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
the event of a fundamental transaction, as described in the Armistice Warrants and Armistice Pre-Funded Warrants and generally including
any reorganization, recapitalization or reclassification of our common stock, the sale, transfer or other disposition of all or substantially
all of our properties or assets, our consolidation or merger with or into another person, the acquisition of more than &lt;span id="xdx_906_ecustom--CommonStockOwnershipChangeInControlThresholdPercentage_iI_pid_dp_uPure_c20251205__srt--CounterpartyNameAxis__custom--ArmisticeCapitalMasterFundLtdMember_zhCoAjs6reRe" title="Common stock ownership, change in control threshold percentage"&gt;50&lt;/span&gt;% of our outstanding
common stock, or any person or group becoming the beneficial owner of &lt;span id="xdx_90C_ecustom--VotingPowerChangeInControlThresholdPercentage_iI_pid_dp_uPure_c20251205__srt--CounterpartyNameAxis__custom--ArmisticeCapitalMasterFundLtdMember_zmqm16jXlsa4" title="Voting power, change in control threshold percentage"&gt;50&lt;/span&gt;% of the voting power represented by our outstanding common stock,
the holders of the Armistice Warrants and Armistice Pre-Funded Warrants will be entitled to receive upon exercise of the Armistice Warrants
and Armistice Pre-Funded Warrants the kind and amount of securities, cash or other property that the holders would have received had
they exercised the Armistice Warrants and Armistice Pre-Funded Warrants immediately prior to such fundamental transaction. In addition,
in certain circumstances, upon a fundamental transaction, the holder will have the right to require us to repurchase its Armistice Warrants
at the Black Scholes Value; provided, however, that, if the fundamental transaction is not within our control, including not approved
by our Board of Directors, then the holder shall only be entitled to receive the same type or form of consideration (and in the same
proportion), at the Black Scholes Value of the unexercised portion of the Warrant, that is being offered and paid to the holders of common
stock in connection with the fundamental transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the terms of the Armistice Purchase Agreement, the Company is prohibited from entering into any agreement to issue or announcing the
issuance or proposed issuance of any shares of common stock or securities convertible or exercisable into common stock for a period commencing
on December 4, 2025 and expiring &lt;span id="xdx_90B_ecustom--ClassOfWarrantOrRightIssuanceRestrictionPeriod_iI_dtD_c20251204__srt--CounterpartyNameAxis__custom--ArmisticeCapitalMasterFundLtdMember_zIiK7nEum0Rc" title="Class of warrant or right, issuance restriction period"&gt;90&lt;/span&gt; days from the Effective Date (as defined in the Armistice Purchase Agreement). Furthermore, the Company
is also prohibited from entering into any agreement to issue common stock or Common Stock Equivalents (as defined in the Armistice Purchase
Agreement) involving a Variable Rate Transaction (as defined in the Armistice Purchase Agreement), subject to certain exceptions, for
a period commencing on December 4, 2025 and expiring &lt;span id="xdx_907_ecustom--ClassOfWarrantOrRightIssuanceRestrictionPeriod_iI_dtD_c20251204__srt--CounterpartyNameAxis__custom--ArmisticeCapitalMasterFundLtdMember_zHHtuXBq0Gge" title="Class of warrant or right, issuance restriction period"&gt;90&lt;/span&gt; days from such Effective Date. The Effective Date is defined in the Armistice
Purchase Agreement as the earliest of the date that (a) the initial registration statement has been declared effective by the SEC, (b)
all of the Pre-Funded Warrant Shares and Warrant Shares have been sold pursuant to Rule 144 or may be sold pursuant to Rule 144 without
the requirement for the Company to be in compliance with the current public information required under Rule 144 and without volume or
manner-of-sale restrictions, (c) following the one year anniversary of the Closing provided that a holder of Pre-Funded Warrant Shares
or Warrant Shares is not an affiliate of the Company, or (d) all of the Pre-Funded Warrant Shares and Warrant Shares may be sold pursuant
to an exemption from registration under the Securities Act without volume or manner-of-sale restrictions and Company counsel has delivered
to such holders a standing written opinion that resales may then be made by such holders of the Pre-Funded Warrant Shares and Warrant
Shares pursuant to such exemption which opinion shall be in form and substance reasonably acceptable to such holders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Armistice Purchase Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing,
indemnification obligations of the Company, including for liabilities arising under the Securities Act, other obligations of the parties
and termination provisions. The representations, warranties and covenants contained in the Armistice Purchase Agreement were made only
for the purposes of such agreements and as of the specific dates, were solely for the benefit of the parties to such agreement and may
be subject to limitations agreed upon by the contracting parties.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Yield
Point NY LLC Pre-Funded Warrant&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 7, 2025, Cycurion entered into an equity purchase agreement (the &#x201c;Equity Purchase Agreement&#x201d;) with Yield Point NY LLC
(the &#x201c;Yield Point&#x201d;) relating to up to &lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250407__srt--CounterpartyNameAxis__custom--YieldPointNYLLCMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrantMember_zbRybUnO39fl" title="Class of warrant or right, number of securities called by warrants or rights"&gt;4,500,000&lt;/span&gt; shares of common stock issuable to Yield Point upon exercise of a pre-funded
warrant (&#x201c;Yield Point Pre-Funded Warrant&#x201d;) issued as its commitment fee (&#x201c;Commitment Fee&#x201d;) under the Equity Purchase
Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Yield Point Pre-Funded Warrant was offered for the Commitment Fee in connection with the Equity Purchase Agreement for shares of common
stock, and provides that the holder may not exercise any portion of the Yield Point Pre-Funded Warrant to the extent that immediately
prior to or after giving effect to such exercise the holder would own more than 4.99%, which ownership cap may be increased by the holder
up to 9.99% upon 61 days&#x2019; prior notice. The exercise price for each share of common stock underlying the Yield Point Pre-Funded
Warrant is $&lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250407__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantMember__srt--CounterpartyNameAxis__custom--YieldPointNYLLCMember_zu4Zv7L221n4" title="Warrants exercise price"&gt;0.0001&lt;/span&gt;. The Yield Point Pre-Funded Warrant is immediately exercisable upon issuance and may be exercised at any time until
the Yield Point Pre-Funded Warrant is exercised in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
holder of the Yield Point Pre-Funded Warrant may not exercise any portion of the warrants or Yield Point Pre-Funded Warrant, as applicable,
to the extent that the holder would own more than 4.99% (or, at the holder&#x2019;s option upon issuance, 9.99%) of our outstanding common
stock immediately after exercise, as such percentage ownership is determined in accordance with the terms of the Yield Point Pre-Funded
Warrant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
lieu of making the cash payment otherwise contemplated to be made to us upon exercise of the Yield Point Pre-Funded Warrant in payment
of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the net number
of shares of our common stock determined according to a formula set forth in the Yield Point Pre-Funded Warrant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Seward
&amp;amp; Kissel LLP Pre-Funded Warrant&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 14, 2025, Cycurion entered into pre-funded warrant with Seward &amp;amp; Kissel LLP that is exercisable for approximately $&lt;span id="xdx_904_eus-gaap--WarrantsAndRightsOutstanding_iI_pn5n6_c20250214__srt--CounterpartyNameAxis__custom--SewardAndKisselLLPMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrantMember_z9tz4xo066cf" title="Warrants exercisable"&gt;1.3&lt;/span&gt; million
in shares of common stock, or up to &lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250214__srt--CounterpartyNameAxis__custom--SewardAndKisselLLPMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrantMember_zwgaxAhzHbya" title="Class of warrant or right, number of securities called by warrants or rights"&gt;83,333&lt;/span&gt; shares of common stock (the &#x201c;Seward &amp;amp; Kissel Pre-Funded Warrant&#x201d;); provided
that once the net proceeds from the sale of the shares equals the $&lt;span id="xdx_908_eus-gaap--LegalFees_pn5n6_c20250214__20250214__srt--CounterpartyNameAxis__custom--SewardAndKisselLLPMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrantMember_zlxanZ7pWQ0d" title="Legal fees"&gt;1.3&lt;/span&gt; million in legal fees and expenses (the &#x201c;Legal Fees&#x201d;),
the remaining shares of common stock, including such common stock exercisable under the Seward &amp;amp; Kissel Pre-Funded Warrant, shall
be returned to Cycurion.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Seward &amp;amp; Kissel Pre-Funded Warrant provides that the holder may not exercise any portion of the Seward &amp;amp; Kissel Pre-Funded Warrant
to the extent that immediately prior to or after giving effect to such exercise the holder would own more than 4.99% upon 61 days&#x2019;
prior notice. The exercise price for each share of common stock underlying the Seward &amp;amp; Kissel Pre-Funded Warrant is $&lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250214__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantMember__srt--CounterpartyNameAxis__custom--SewardAndKisselLLPMember_zHCzcVLKhLY2" title="Warrants exercise price"&gt;0.0001&lt;/span&gt;. The
Seward &amp;amp; Kissel Pre-Funded Warrant is immediately exercisable upon issuance and may be exercised at any time until the Seward &amp;amp;
Kissel Pre-Funded Warrant is exercised in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Seward
&amp;amp; Kissel LLP may not exercise any portion of the warrants or Seward &amp;amp; Kissel Pre-Funded Warrant, as applicable, to the extent
that the holder would own more than 4.99% of our outstanding common stock immediately after exercise, as such percentage ownership is
determined in accordance with the terms of the Seward &amp;amp; Kissel Pre-Funded Warrant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
lieu of making the cash payment otherwise contemplated to be made to us upon exercise of the Seward &amp;amp; Kissel Pre-Funded Warrant in
payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the
net number of shares of our common stock determined according to a formula set forth in the Seward &amp;amp; Kissel Pre-Funded Warrant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Other
Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 8, 2022, the Company issued &lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220308__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxKSCDIMMVch" title="Warrants issued"&gt;17,636&lt;/span&gt; warrants to the originators of $&lt;span id="xdx_907_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_c20220308__20220308__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zoBsDaQZ7VTb" title="Warrants issued to the originators of investor notes"&gt;700,000&lt;/span&gt; of investor notes at exercise price of $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220308__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztMAyhaJK12b" title="Exercise price of warrants"&gt;0.92&lt;/span&gt;, which
all were exercised in 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
part of the Business Combination with Western, during the year ended December 31, 2025, the Company issued to unaffiliated investors
a total of &lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsMember_zcmANLB3drrk" title="Warrants issued"&gt;9,006&lt;/span&gt; warrants in exchange of existing &lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUBHTs7J5M22" title="Warrants issued"&gt;17,636&lt;/span&gt; warrants having an expiration date of February 19, 2029 and an exercise price
of $&lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20251231__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsMember_zsXC7k7Qfnm9" title="Exercise price of warrants"&gt;9.59121&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Common
Stock Subject to Possible Redemption&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC 480. Shares of common stock
subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable
common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption
upon the occurrence of uncertain events not solely within the Company&#x2019;s control) is classified as temporary equity. At all other
times, common stock is classified as stockholders&#x2019; equity. The Company&#x2019;s shares of common stock sold in the initial public
offering of Western feature certain redemption rights that are considered to be outside of the Company&#x2019;s control and subject to
occurrence of uncertain future events.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
15.2: Details of Common Stock Subject to Possible Redemption&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--TemporaryEquityTableTextBlock_ziPxtBtNYFG8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_zC4x0c78dg0k" style="display: none"&gt;SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Number of Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Common stock subject to possible redemption as of December 31, 2024&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--TemporaryEquitySharesIssued_iS_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zAO6jumgQv1a" style="width: 12%; text-align: right" title="Common stock subject to possible redemption shares, beginning balance"&gt;5,796&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_z5uYgoO47jZf" style="width: 12%; text-align: right" title="Common stock subject to possible redemption, beginning balance"&gt;1,917,309&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt"&gt;Redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--TemporaryEquityRedemptionShares_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zx0D9dXbkj1a" style="text-align: right" title="Redemption, shares"&gt;(3,163&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--TemporaryEquityRedemption_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zBZRwUKji34d" style="text-align: right" title="Redemption"&gt;(1,001,216&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 20pt; text-align: left"&gt;Release of common stock subject to redemption&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--TemporaryEquityReleaseOfCommonStockSubjectToRedemptionShares_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zeY0wcTEoxe6" style="border-bottom: Black 1pt solid; text-align: right" title="Release of common stock subject to redemption, shares"&gt;(2,633&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--TemporaryEquityReleaseOfCommonStockSubjectToRedemption_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zCzWs4nZiNIk" style="border-bottom: Black 1pt solid; text-align: right" title="Release of common stock subject to redemption"&gt;(916,093&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Common stock subject to possible redemption as of December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--TemporaryEquitySharesIssued_iE_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zhcWAnIl0nEd" style="border-bottom: Black 2.5pt double; text-align: right" title="Common stock subject to possible redemption shares, ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5070"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zyLS6N6iBND6" style="border-bottom: Black 2.5pt double; text-align: right" title="Common stock subject to possible redemption, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5072"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_z188Zs8M7Jpa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact004585"
      unitRef="Shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact004587"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-03-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004589"
      unitRef="Shares">110000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004591"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="From2026-01-012026-03-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004593"
      unitRef="Pure">0.12</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="AsOf2026-03-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004595"
      unitRef="USDPShares">1.45</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:PreferredStockConversionBasis
      contextRef="From2026-01-012026-03-31_custom_SeriesAConvertiblePreferredStockMember"
      id="Fact004597">Shares of Cycurion&#x2019;s Series A Convertible Preferred Stock shall be convertible, at any time and from time to time at
the option of the holder thereof, into shares of common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion
ratio of one share of Series A Convertible Preferred Stock-for-one share of common stock, subject to adjustment.</us-gaap:PreferredStockConversionBasis>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="AsOf2026-03-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004599"
      unitRef="Pure">1</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember_us-gaap_PrivatePlacementMember_custom_WesternAcquisitionVenturesCorpMember"
      decimals="INF"
      id="Fact004601"
      unitRef="Shares">106816</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2026-03-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004603"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-03-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004605"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004607"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004609"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-03-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004611"
      unitRef="Shares">3000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004613"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:ConversionOfStockDescription
      contextRef="From2026-01-012026-03-31_us-gaap_SeriesBPreferredStockMember"
      id="Fact004615">Shares of our Series B Convertible Preferred Stock shall be convertible, at any time and from time to time at the option
of the holder thereof, into common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of one share
of Series B Convertible Preferred Stock-for-one share of common stock, subject to adjustment.</us-gaap:ConversionOfStockDescription>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="AsOf2026-03-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004617"
      unitRef="Pure">1</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-03-31_custom_SeriesBConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember"
      decimals="INF"
      id="Fact004619"
      unitRef="Shares">3000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-03-31_custom_SeriesBConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember"
      decimals="INF"
      id="Fact004621"
      unitRef="Shares">3000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-01-012025-12-31_custom_SeriesBConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember"
      decimals="INF"
      id="Fact004623"
      unitRef="Shares">2999</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004625"
      unitRef="Shares">199955</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2026-03-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004627"
      unitRef="Shares">1</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-03-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004629"
      unitRef="Shares">1</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004631"
      unitRef="Shares">1</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004633"
      unitRef="Shares">1</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-03-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004634"
      unitRef="Shares">5000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004636"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="From2026-01-012026-03-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact004638"
      unitRef="Pure">0.12</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="AsOf2026-03-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact004640"
      unitRef="USDPShares">82.46</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DebtConversionDescription
      contextRef="From2026-01-012026-03-31_us-gaap_SeriesCPreferredStockMember"
      id="Fact004642">The shares of our Series C Convertible Preferred Stock may be converted into shares of our common stock at a ratio of approximately
20 shares of common stock for every one share of our Series C Convertible Preferred Stock, or an aggregate of 99,077 shares of our common
stock, assuming full conversion. In connection with conversions, each holder of our Series C Convertible Preferred Stock is subject to
a &#x201c;beneficial ownership limitation&#x201d; of 4.99% of the number of shares of our common stock outstanding immediately after giving
effect to that conversion, which limitation may be increased by the holder to not more than 9.99% on 61 days&#x2019; advanced notice to
us.</us-gaap:DebtConversionDescription>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="AsOf2026-03-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact004644"
      unitRef="Pure">20</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2026-01-012026-03-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact004646"
      unitRef="Shares">99077</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="AsOf2026-03-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact004648"
      unitRef="USDPShares">82.46</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember"
      decimals="INF"
      id="Fact004650"
      unitRef="Shares">4851</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004652"
      unitRef="Shares">1356586</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:SharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004654"
      unitRef="Shares">406969</us-gaap:SharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2026-03-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004656"
      unitRef="Shares">2547</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-03-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004658"
      unitRef="Shares">2547</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004660"
      unitRef="Shares">4851</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004662"
      unitRef="Shares">4851</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-03-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004663"
      unitRef="Shares">6666700</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004665"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:DebtConversionDescription
      contextRef="From2026-01-012026-03-31_us-gaap_SeriesDPreferredStockMember"
      id="Fact004667">Shares of Cycurion&#x2019;s Series D Convertible Preferred Stock shall be convertible, at any time and from time to time at
the option of the holder thereof, into shares of common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion
ratio of one share of Series D Convertible Preferred Stock-for-one share of common stock, subject to adjustment.</us-gaap:DebtConversionDescription>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="AsOf2026-03-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004669"
      unitRef="Pure">1</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2026-03-31_custom_SeriesDConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember"
      decimals="INF"
      id="Fact004671"
      unitRef="Shares">6666666</us-gaap:PreferredStockSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2025-01-012025-12-31_custom_SeriesDConvertiblePreferredStockMember_custom_WesternAcquisitionVenturesCorpMember"
      decimals="INF"
      id="Fact004673"
      unitRef="Shares">6516666</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004675"
      unitRef="Shares">217220</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2026-03-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004677"
      unitRef="Shares">150000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-03-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004679"
      unitRef="Shares">150000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004681"
      unitRef="Shares">150000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004683"
      unitRef="Shares">150000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-03-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004685"
      unitRef="Shares">100</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004687"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:ConversionOfStockDescription
      contextRef="From2026-01-012026-03-31_us-gaap_SeriesEPreferredStockMember"
      id="Fact004689">Shares of Cycurion&#x2019;s Series E Convertible Preferred Stock shall be convertible, at any time and from time to time at
the option of the holder thereof, into shares of common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion
ratio of one share of Series E Convertible Preferred Stock-for-one share of common stock, subject to adjustment.</us-gaap:ConversionOfStockDescription>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="AsOf2026-03-31_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004691"
      unitRef="Pure">1</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004693"
      unitRef="Shares">51</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2026-03-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004695"
      unitRef="Shares">51</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-03-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004697"
      unitRef="Shares">51</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004699"
      unitRef="Shares">51</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004701"
      unitRef="Shares">51</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-03-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004703"
      unitRef="Shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004705"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="From2026-01-012026-03-31_us-gaap_SeriesFPreferredStockMember"
      decimals="INF"
      id="Fact004706"
      unitRef="Pure">0.12</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="AsOf2026-03-31_us-gaap_SeriesFPreferredStockMember"
      decimals="INF"
      id="Fact004708"
      unitRef="USDPShares">0.0001</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:ConversionOfStockDescription
      contextRef="From2026-01-012026-03-31_us-gaap_SeriesFPreferredStockMember"
      id="Fact004710">Shares of our Series F Convertible Preferred Stock shall be convertible, at any time and from time to time at the option
of the holder thereof, into shares of common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of
one share of Series F Convertible Preferred Stock-for-1,000 shares of common stock, subject to adjustment.</us-gaap:ConversionOfStockDescription>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="AsOf2026-03-31_us-gaap_SeriesFPreferredStockMember"
      decimals="INF"
      id="Fact004712"
      unitRef="Pure">1000</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2026-03-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004714"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-03-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004716"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004718"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004720"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-03-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004722"
      unitRef="Shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004724"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="AsOf2026-03-31_us-gaap_SeriesGPreferredStockMember"
      decimals="INF"
      id="Fact004726"
      unitRef="Pure">0.12</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="AsOf2026-03-31_us-gaap_SeriesGPreferredStockMember"
      decimals="INF"
      id="Fact004728"
      unitRef="USDPShares">0.0001</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:ConversionOfStockDescription
      contextRef="From2026-01-012026-03-31_us-gaap_SeriesGPreferredStockMember"
      id="Fact004730">Shares of our Series G Convertible Preferred Stock shall be convertible, at any time and from time to time at the option
of the holder thereof, into shares of common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of
one share of Series G Convertible Preferred Stock-for-1,000 shares of common stock, subject to adjustment.</us-gaap:ConversionOfStockDescription>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="AsOf2026-03-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004732"
      unitRef="Pure">1000</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2026-03-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004734"
      unitRef="Shares">143</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-03-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004736"
      unitRef="Shares">143</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004738"
      unitRef="Shares">143</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004740"
      unitRef="Shares">143</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2026-01-012026-03-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="-5"
      id="Fact004742"
      unitRef="USD">3200000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2026-01-012026-03-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004744"
      unitRef="Shares">3133</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_AlphaCapitalAnstaltMember"
      decimals="0"
      id="Fact004746"
      unitRef="USD">366050</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_AlphaCapitalAnstaltMember"
      decimals="INF"
      id="Fact004748"
      unitRef="Shares">366</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_M2BFundingCorpMember"
      decimals="0"
      id="Fact004750"
      unitRef="USD">672077</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_M2BFundingCorpMember"
      decimals="INF"
      id="Fact004752"
      unitRef="Shares">672</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_AdiFundingMember"
      decimals="0"
      id="Fact004754"
      unitRef="USD">347730</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_AdiFundingMember"
      decimals="INF"
      id="Fact004756"
      unitRef="Shares">348</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_DeltenniumMember"
      decimals="0"
      id="Fact004758"
      unitRef="USD">617667</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_DeltenniumMember"
      decimals="INF"
      id="Fact004760"
      unitRef="Shares">618</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_OsherCapitalMember"
      decimals="0"
      id="Fact004762"
      unitRef="USD">103800</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_OsherCapitalMember"
      decimals="INF"
      id="Fact004764"
      unitRef="Shares">104</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_LexiLondonMember"
      decimals="0"
      id="Fact004766"
      unitRef="USD">769000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_LexiLondonMember"
      decimals="INF"
      id="Fact004768"
      unitRef="Shares">769</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_IleAssociatesMember"
      decimals="0"
      id="Fact004770"
      unitRef="USD">256333</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2025-08-122025-08-12_custom_SeriesGConvertiblePreferredStockMember_custom_IleAssociatesMember"
      decimals="INF"
      id="Fact004772"
      unitRef="Shares">256</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact004774"
      unitRef="Shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact004776"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <CYCU:CommonStockVotesPerShare
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact004778"
      unitRef="Vote">1</CYCU:CommonStockVotesPerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2026-01-012026-03-31_us-gaap_CommonStockMember_custom_SeriesABandDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact004780"
      unitRef="Shares">578863</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2026-01-012026-03-31_us-gaap_CommonStockMember_custom_WarrantABandDMember"
      decimals="INF"
      id="Fact004782"
      unitRef="Shares">258464</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2026-01-012026-03-31_us-gaap_CommonStockMember_custom_WarrantABandDMember"
      decimals="0"
      id="Fact004784"
      unitRef="USD">3309921</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2026-01-012026-03-31_us-gaap_CommonStockMember_us-gaap_AcquisitionRelatedCostsMember"
      decimals="INF"
      id="Fact004786"
      unitRef="Shares">25000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2026-01-012026-03-31_us-gaap_CommonStockMember_us-gaap_AcquisitionRelatedCostsMember"
      decimals="0"
      id="Fact004788"
      unitRef="USD">9000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2026-01-012026-03-31_us-gaap_CommonStockMember_custom_SettlementOfDebtMember"
      decimals="INF"
      id="Fact004790"
      unitRef="Shares">10894</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2026-01-012026-03-31_us-gaap_CommonStockMember_custom_SettlementOfDebtMember"
      decimals="0"
      id="Fact004792"
      unitRef="USD">1193634</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:DebtInstrumentRepaidPrincipal
      contextRef="From2026-01-012026-03-31_us-gaap_CommonStockMember_custom_SettlementOfDebtMember"
      decimals="0"
      id="Fact004794"
      unitRef="USD">2925803</us-gaap:DebtInstrumentRepaidPrincipal>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2026-01-012026-03-31_custom_SettlementOfDebtMember"
      decimals="0"
      id="Fact004796"
      unitRef="USD">-2174075</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2026-01-012026-03-31_us-gaap_CommonStockMember_custom_EmploymentAgreementMember"
      decimals="INF"
      id="Fact004798"
      unitRef="Shares">330869</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2026-01-012026-03-31_us-gaap_CommonStockMember_custom_EmploymentAgreementMember"
      decimals="0"
      id="Fact004800"
      unitRef="USD">5916777</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2026-01-012026-03-31_us-gaap_CommonStockMember_custom_SLGInnovationMember"
      decimals="INF"
      id="Fact004802"
      unitRef="Shares">33609</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2026-01-012026-03-31_us-gaap_CommonStockMember_custom_SLGInnovationMember"
      decimals="0"
      id="Fact004804"
      unitRef="USD">764020</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2026-01-012026-03-31_custom_CommonStockRedemptionMember"
      decimals="INF"
      id="Fact004806"
      unitRef="Shares">2633</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact004808"
      unitRef="Shares">5510021</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact004810"
      unitRef="Shares">5510021</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact004812"
      unitRef="Shares">3642501</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact004814"
      unitRef="Shares">3642501</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2026-03-31_custom_SLGInnovationMember"
      decimals="INF"
      id="Fact004816"
      unitRef="Shares">5510021</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2026-03-31_custom_SLGInnovationMember"
      decimals="INF"
      id="Fact004818"
      unitRef="Shares">33609</us-gaap:CommonStockSharesIssued>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact004820">&lt;p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z8RA9XWrkPxa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B8_zGR6skk3w0Ag" style="display: none"&gt;SCHEDULE OF WARRANTS ACTIVITY&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Number of Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average Life (years)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;Outstanding warrants, December 31, 2024&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6Lsb0OfLL11" style="width: 12%; text-align: right" title="Number of Warrants, outstanding, beginning balance"&gt;315,028&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zcyCBzKSjUMd" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, beginning balance"&gt;20.64&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zhjdaUAS3y7h" title="Weighted Average Life (years), outstanding"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zGcMya6TJao4" style="text-align: right" title="Number of Warrants, granted"&gt;869,992&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNduiL1CntG9" style="text-align: right" title="Weighted Average Exercise Price, granted"&gt;164.96&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms_dtY_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z3HM43653XP8" title="Weighted Average Life (years), granted"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Replacement of old warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NumberOfWarrantsReplacementOfOldWarrants_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zK0t2yVuD5ol" style="text-align: right" title="Number of Warrants, replacement of old warrants"&gt;(315,028&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageReplacementDateFairValue_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zJGBENT8TWQ5" style="text-align: right" title="Weighted Average Exercise Price, replacement of old warrants"&gt;20.64&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsReplacementWeightedAverageRemainingContractualTerms_dtY_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztBgiweu4no" title="Weighted Average Life (years), replacement of old warrants"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 10pt"&gt;Exercised&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zvFKVZCUSB54" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, exercised"&gt;(234,831&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zPJ107apVRGk" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, exercised"&gt;14.27&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms_dtY_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zjmQ36SORynl" title="Weighted Average Life (years), exercised"&gt;4.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Outstanding warrants, March 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zo9Q2Br3yqOk" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, outstanding, beginning balance"&gt;635,161&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z1HLif87z7Sc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, beginning balance"&gt;220.67&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zwcH99P7asEg" title="Weighted Average Life (years), outstanding"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Issued - Prefunded (equity line)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NumberOfWarrantsPrefundedEquityLine_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zl78q7pIswvk" style="text-align: right" title="Number of Warrants, prefunded (equity line)"&gt;150,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedPrefundedWarrantInPeriodWeightedAverageGrantDateFairValue_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ziblyyM9l40f" style="text-align: right" title="Weighted Average Exercise Price, issued - prefunded (equity line)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4854"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedPrefundedWarrantWeightedAverageRemainingContractualTerms_dtY_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zzkSTWbsu41f" title="Weighted Average Life (years), issued - prefunded (equity line)"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Exercised - Prefunded (equity line)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NumberOfWarrantsExercisedPrefundedEquityLine_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zKLoKBm25ec2" style="text-align: right" title="Number of Warrants, exercised - prefunded (equity line)"&gt;(83,333&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantInPeriodWeightedAverageGrantDateFairValue_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zYwwWX5be5H6" style="text-align: right" title="Weighted Average Exercise Price, exercised - prefunded (equity line)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4860"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantWeightedAverageRemainingContractualTerms_dtY_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zTZVabX7XH7g" title="Weighted Average Life (years), exercised - prefunded (equity line)"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zXAum2WcojF3" style="text-align: right" title="Number of Warrants, exercised"&gt;(23,633&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zYI0USIJL9P5" style="text-align: right" title="Weighted Average Exercise Price, exercised"&gt;15.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms_dtY_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMSqd9RdEz36" title="Weighted Average Life (years), granted"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Outstanding warrants, June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zhemVr632BG" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, outstanding, beginning balance"&gt;678,195&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0LO8X9Asrwf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, beginning balance"&gt;206.15&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zofIspokhOo5" title="Weighted Average Life (years), outstanding"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Exercised - Prefunded (equity line)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NumberOfWarrantsExercisedPrefundedEquityLine_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRhADXwsLr8b" style="text-align: right" title="Number of Warrants, exercised - prefunded (equity line)"&gt;(66,667&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantInPeriodWeightedAverageGrantDateFairValue_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxRQAbfStUo7" style="text-align: right" title="Weighted Average Exercise Price, exercised - prefunded (equity line)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4878"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantWeightedAverageRemainingContractualTerms_dtY_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zJUQEx54zzQc" title="Weighted Average Life (years), exercised - prefunded (equity line)"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Outstanding warrants, September 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0jitETr2Bm8" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, outstanding, beginning balance"&gt;611,528&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrz4Oz7LQ4P7" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, beginning balance"&gt;228.62&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6TKWH0XPFvf" title="Weighted Average Life (years), outstanding"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Issued - Prefunded (Armistice-Prefunded)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NumberOfWarrantsIssuedPrefunded_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zJqvdyFaoWp4" style="text-align: right" title="Number of Warrants, issued prefunded"&gt;1,670,720&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--WeightedAverageExercisePriceIssuedPrefunded_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZnQ69KMOM3j" style="text-align: right" title="Weighted Average Exercise Price, issued - prefunded"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4890"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--WeightedAverageLifeYearsIssuedPrefunded_dtY_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zBHpEwX9ZJG" title="Weighted Average Life (years), issued - prefunded"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Issued (Armistice)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--NumberOfWarrantsIssued_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6r77uxDNG01" style="text-align: right" title="Number of Warrants, issued"&gt;3,341,439&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedWarrantInPeriodWeightedAverageGrantDateFairValue_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zM6gzsKRBJ8d" style="text-align: right" title="Weighted Average Exercise Price, issued"&gt;3.62&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--WeightedAverageLifeYearsIssued_dtY_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zFCYuuZfkqu" title="Weighted Average Life (years), issued"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Outstanding warrants, December 31, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zYZRFbK2576g" style="text-align: right" title="Number of Warrants, outstanding, beginning balance"&gt;5,623,687&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zLuypRiSoMzg" style="text-align: right" title="Weighted Average Exercise Price, beginning balance"&gt;27.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zsEkcN13L581" title="Weighted Average Life (years), outstanding"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 10pt; text-align: left"&gt;Exercised - Prefunded (Armistice-Prefunded)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NumberOfWarrantsExercisedPrefunded_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zVaEwGVAs5X8" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, exercised - prefunded"&gt;(1,670,720&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--WeightedAverageExercisePriceExercisedPrefunded_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zS2yTeupHn8e" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, exercised - prefunded"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4908"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--WeightedAverageLifeYearsExercisedPrefundedArmisticePrefunded_dtY_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zUhIfGxWUXa3" title="Weighted Average Life (years), exercised - prefunded"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Outstanding warrants, March 31, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQwmj0jwxl47" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, outstanding, ending balance"&gt;3,952,967&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zcAN58pEdH18" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, ending balance"&gt;27.01&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0msCGuXzD83" title="Weighted Average Life (years), outstanding"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Exercisable warrants, March 31, 2026&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber_iE_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zGs0UTczN858" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Warrants, exercisable"&gt;3,952,967&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iE_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zCwMMEDUTzM1" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, exercisable"&gt;27.01&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerms_dtY_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zLcZF3F65rgg" title="Weighted Average Life (years), exercisable"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2024-12-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004822"
      unitRef="Shares">315028</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2024-12-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004824"
      unitRef="USDPShares">20.64</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="From2024-01-012024-12-31_us-gaap_WarrantMember"
      id="Fact004826">P3Y</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2025-01-012025-03-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004828"
      unitRef="Shares">869992</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2025-01-012025-03-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004830"
      unitRef="USDPShares">164.96</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms
      contextRef="From2025-01-012025-03-31_us-gaap_WarrantMember"
      id="Fact004832">P4Y8M12D</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms>
    <CYCU:NumberOfWarrantsReplacementOfOldWarrants
      contextRef="From2025-01-012025-03-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004834"
      unitRef="Shares">-315028</CYCU:NumberOfWarrantsReplacementOfOldWarrants>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageReplacementDateFairValue
      contextRef="From2025-01-012025-03-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004836"
      unitRef="USDPShares">20.64</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageReplacementDateFairValue>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsReplacementWeightedAverageRemainingContractualTerms
      contextRef="From2025-01-012025-03-31_us-gaap_WarrantMember"
      id="Fact004838">P2Y10M24D</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsReplacementWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="From2025-01-012025-03-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004840"
      unitRef="Shares">-234831</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2025-01-012025-03-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004842"
      unitRef="USDPShares">14.27</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageGrantDateFairValue>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms
      contextRef="From2025-01-012025-03-31_us-gaap_WarrantMember"
      id="Fact004844">P4Y3M18D</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2025-03-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004846"
      unitRef="Shares">635161</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2025-03-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004848"
      unitRef="USDPShares">220.67</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="From2025-01-012025-03-31_us-gaap_WarrantMember"
      id="Fact004850">P4Y8M12D</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <CYCU:NumberOfWarrantsPrefundedEquityLine
      contextRef="From2025-04-012025-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004852"
      unitRef="Shares">150000</CYCU:NumberOfWarrantsPrefundedEquityLine>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedPrefundedWarrantWeightedAverageRemainingContractualTerms
      contextRef="From2025-04-012025-06-30_us-gaap_WarrantMember"
      id="Fact004856">P1Y</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedPrefundedWarrantWeightedAverageRemainingContractualTerms>
    <CYCU:NumberOfWarrantsExercisedPrefundedEquityLine
      contextRef="From2025-04-012025-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004858"
      unitRef="Shares">-83333</CYCU:NumberOfWarrantsExercisedPrefundedEquityLine>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantWeightedAverageRemainingContractualTerms
      contextRef="From2025-04-012025-06-30_us-gaap_WarrantMember"
      id="Fact004862">P1Y</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="From2025-04-012025-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004864"
      unitRef="Shares">-23633</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2025-04-012025-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004866"
      unitRef="USDPShares">15.00</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageGrantDateFairValue>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms
      contextRef="From2025-04-012025-06-30_us-gaap_WarrantMember"
      id="Fact004868">P5Y</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2025-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004870"
      unitRef="Shares">678195</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2025-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004872"
      unitRef="USDPShares">206.15</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="From2025-04-012025-06-30_us-gaap_WarrantMember"
      id="Fact004874">P4Y9M18D</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <CYCU:NumberOfWarrantsExercisedPrefundedEquityLine
      contextRef="From2025-07-012025-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004876"
      unitRef="Shares">-66667</CYCU:NumberOfWarrantsExercisedPrefundedEquityLine>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantWeightedAverageRemainingContractualTerms
      contextRef="From2025-07-012025-09-30_us-gaap_WarrantMember"
      id="Fact004880">P1Y</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedPrefundedWarrantWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2025-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004882"
      unitRef="Shares">611528</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2025-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004884"
      unitRef="USDPShares">228.62</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="From2025-07-012025-09-30_us-gaap_WarrantMember"
      id="Fact004886">P4Y9M18D</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <CYCU:NumberOfWarrantsIssuedPrefunded
      contextRef="From2025-10-012025-12-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004888"
      unitRef="Shares">1670720</CYCU:NumberOfWarrantsIssuedPrefunded>
    <CYCU:WeightedAverageLifeYearsIssuedPrefunded
      contextRef="From2025-10-012025-12-31_us-gaap_WarrantMember"
      id="Fact004892">P1Y</CYCU:WeightedAverageLifeYearsIssuedPrefunded>
    <CYCU:NumberOfWarrantsIssued
      contextRef="From2025-10-012025-12-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004894"
      unitRef="Shares">3341439</CYCU:NumberOfWarrantsIssued>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedWarrantInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2025-07-012025-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004896"
      unitRef="USDPShares">3.62</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedWarrantInPeriodWeightedAverageGrantDateFairValue>
    <CYCU:WeightedAverageLifeYearsIssued
      contextRef="From2025-10-012025-12-31_us-gaap_WarrantMember"
      id="Fact004898">P5Y</CYCU:WeightedAverageLifeYearsIssued>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2025-12-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004900"
      unitRef="Shares">5623687</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2025-12-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004902"
      unitRef="USDPShares">27.01</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="From2025-10-012025-12-31_us-gaap_WarrantMember"
      id="Fact004904">P5Y</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <CYCU:NumberOfWarrantsExercisedPrefunded
      contextRef="From2026-01-012026-03-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004906"
      unitRef="Shares">-1670720</CYCU:NumberOfWarrantsExercisedPrefunded>
    <CYCU:WeightedAverageLifeYearsExercisedPrefundedArmisticePrefunded
      contextRef="From2026-01-012026-03-31_us-gaap_WarrantMember"
      id="Fact004910">P1Y</CYCU:WeightedAverageLifeYearsExercisedPrefundedArmisticePrefunded>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2026-03-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004912"
      unitRef="Shares">3952967</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2026-03-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004914"
      unitRef="USDPShares">27.01</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="From2026-01-012026-03-31_us-gaap_WarrantMember"
      id="Fact004916">P5Y</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber
      contextRef="AsOf2026-03-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004918"
      unitRef="Shares">3952967</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2026-03-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004920"
      unitRef="USDPShares">27.01</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice>
    <CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerms
      contextRef="From2026-01-012026-03-31_us-gaap_WarrantMember"
      id="Fact004922">P5Y</CYCU:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2026-03-31_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact004924"
      unitRef="Shares">383333</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-12-31_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact004926"
      unitRef="Shares">383333</us-gaap:ClassOfWarrantOrRightOutstanding>
    <CYCU:ClassOfWarrantOrRightExercisablePeriodThresholdTradingDays
      contextRef="AsOf2026-03-31_custom_PublicWarrantsMember_srt_MinimumMember"
      id="Fact004928">P30D</CYCU:ClassOfWarrantOrRightExercisablePeriodThresholdTradingDays>
    <CYCU:ClassOfWarrantOrRightExercisablePeriodThresholdTradingDays
      contextRef="AsOf2026-03-31_custom_PublicWarrantsMember_srt_MaximumMember"
      id="Fact004930">P12M</CYCU:ClassOfWarrantOrRightExercisablePeriodThresholdTradingDays>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2026-03-31_custom_PublicWarrantsMember"
      id="Fact004932">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <CYCU:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights
      contextRef="AsOf2026-03-31_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact004934"
      unitRef="USDPShares">0.30</CYCU:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights>
    <CYCU:ClassOfWarrantOrRightRedemptionOfWarrantOrRightMinimumThresholdWrittenNoticePeriod
      contextRef="From2026-01-012026-03-31_custom_PublicWarrantsMember"
      id="Fact004936">P30D</CYCU:ClassOfWarrantOrRightRedemptionOfWarrantOrRightMinimumThresholdWrittenNoticePeriod>
    <CYCU:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="AsOf2026-03-31_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact004938"
      unitRef="USDPShares">18.00</CYCU:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <CYCU:ClassOfWarrantOrRightExercisablePeriodThresholdTradingDays
      contextRef="AsOf2026-03-31_custom_PublicWarrantsMember"
      id="Fact004940">P20D</CYCU:ClassOfWarrantOrRightExercisablePeriodThresholdTradingDays>
    <CYCU:ClassOfWarrantOrRightRedemptionOfWarrantOrRightThresholdConsecutiveTradingDays
      contextRef="From2026-01-012026-03-31_custom_PublicWarrantsMember"
      id="Fact004942">P30D</CYCU:ClassOfWarrantOrRightRedemptionOfWarrantOrRightThresholdConsecutiveTradingDays>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-112022-01-11_custom_PipeSubscriptionAgreementMember"
      decimals="0"
      id="Fact004944"
      unitRef="USD">3760000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-01-112022-01-11_custom_PipeSubscriptionAgreementMember"
      decimals="INF"
      id="Fact004946"
      unitRef="Shares">12533</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-01-11_custom_PipeWarrantsMember"
      decimals="INF"
      id="Fact004948"
      unitRef="Shares">12533</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="AsOf2022-01-11_custom_PipeWarrantsMember"
      decimals="INF"
      id="Fact004950"
      unitRef="Shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-01-11_custom_PipeWarrantsMember"
      decimals="INF"
      id="Fact004952"
      unitRef="USDPShares">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <CYCU:WarrantsAndRightsExerciseStartDelayPeriod
      contextRef="AsOf2022-01-11_custom_PipeWarrantsMember"
      id="Fact004954">P30D</CYCU:WarrantsAndRightsExerciseStartDelayPeriod>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2022-01-11_custom_PipeWarrantsMember"
      id="Fact004956">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2026-03-31_custom_PipeWarrantsMember"
      decimals="INF"
      id="Fact004958"
      unitRef="Shares">12533</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-12-31_custom_PipeWarrantsMember"
      decimals="INF"
      id="Fact004960"
      unitRef="Shares">12533</us-gaap:ClassOfWarrantOrRightOutstanding>
    <CYCU:CommonStockRedemptionRightsUponDelayInBusinessCombinationClosingPercentage
      contextRef="AsOf2022-01-11_custom_PipeWarrantsMember"
      decimals="INF"
      id="Fact004962"
      unitRef="Pure">1</CYCU:CommonStockRedemptionRightsUponDelayInBusinessCombinationClosingPercentage>
    <CYCU:CommonStockRedemptionRightsBusinessCombinationClosingPeriod
      contextRef="From2022-01-112022-01-11_custom_PipeWarrantsMember_srt_MinimumMember"
      id="Fact004964">P12M</CYCU:CommonStockRedemptionRightsBusinessCombinationClosingPeriod>
    <CYCU:CommonStockRedemptionRightsBusinessCombinationClosingPeriod
      contextRef="From2022-01-112022-01-11_custom_PipeWarrantsMember_srt_MaximumMember"
      id="Fact004966">P18M</CYCU:CommonStockRedemptionRightsBusinessCombinationClosingPeriod>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2017-11-17_custom_SeriesAWarrantsMember"
      decimals="INF"
      id="Fact004968"
      unitRef="Shares">44445</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2017-11-17_custom_SeriesAWarrantsMember"
      decimals="INF"
      id="Fact004970"
      unitRef="USDPShares">13.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-03-31_custom_SeriesAWarrantsMember"
      decimals="INF"
      id="Fact004972"
      unitRef="Shares">22696</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-03-31_custom_SeriesAWarrantsMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact004974"
      unitRef="Shares">44445</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-03-31_custom_SeriesAWarrantsMember"
      decimals="INF"
      id="Fact004976"
      unitRef="USDPShares">9.59121</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2023-08-01_custom_SeriesBWarrantsMember"
      decimals="INF"
      id="Fact004978"
      unitRef="Shares">133333</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-08-01_custom_SeriesBWarrantsMember"
      decimals="INF"
      id="Fact004980"
      unitRef="USDPShares">15.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-04-12_custom_SeriesBWarrantsMember"
      decimals="INF"
      id="Fact004982"
      unitRef="Shares">66667</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-04-12_custom_SeriesBWarrantsMember"
      decimals="INF"
      id="Fact004984"
      unitRef="USDPShares">15.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-12-31_custom_SeriesBWarrantsMember"
      decimals="INF"
      id="Fact004986"
      unitRef="Shares">200000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-12-31_custom_SeriesBWarrantsMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact004988"
      unitRef="Shares">200000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-12-31_custom_SeriesBWarrantsMember"
      decimals="INF"
      id="Fact004990"
      unitRef="USDPShares">15.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-03-22_custom_SeriesDWarrantsMember_custom_SubordinatedConvertiblePromissoryNoteMember"
      decimals="INF"
      id="Fact004992"
      unitRef="Shares">6564</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-03-22_custom_SeriesDWarrantsMember_custom_SubordinatedConvertiblePromissoryNoteMember"
      decimals="INF"
      id="Fact004994"
      unitRef="USDPShares">42.30</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-11-22_custom_SeriesDWarrantsMember_custom_SubordinatedConvertiblePromissoryNoteOneMember"
      decimals="INF"
      id="Fact004996"
      unitRef="Shares">32819</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-11-22_custom_SeriesDWarrantsMember_custom_SubordinatedConvertiblePromissoryNoteOneMember"
      decimals="INF"
      id="Fact004998"
      unitRef="USDPShares">42.30</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-12-31_custom_SeriesDWarrantsMember"
      decimals="INF"
      id="Fact005000"
      unitRef="Shares">242424</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-12-31_custom_SeriesDWarrantsMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact005002"
      unitRef="Shares">39382</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-12-31_custom_SeriesDWarrantsMember"
      decimals="INF"
      id="Fact005004"
      unitRef="USDPShares">15.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-12-04_custom_PreFundedWarrantSharesMember"
      decimals="INF"
      id="Fact005006"
      unitRef="Shares">1670720</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-12-04_custom_WarrantSharesMember"
      decimals="INF"
      id="Fact005008"
      unitRef="Shares">3341439</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <CYCU:ClassOfWarrantOrRightOfferingPrice
      contextRef="AsOf2025-12-05_custom_PreFundedWarrantSharesMember"
      decimals="INF"
      id="Fact005010"
      unitRef="USDPShares">3.62</CYCU:ClassOfWarrantOrRightOfferingPrice>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-12-05_custom_WarrantSharesMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="INF"
      id="Fact005012"
      unitRef="USDPShares">3.62</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-12-05_custom_PreFundedWarrantSharesMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="INF"
      id="Fact005014"
      unitRef="Shares">1657460</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-12-05_custom_PreFundedWarrantSharesMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="INF"
      id="Fact005016"
      unitRef="USDPShares">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-12-05_custom_WarrantSharesMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="INF"
      id="Fact005018"
      unitRef="USDPShares">3.62</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-12-05_custom_WarrantSharesMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="INF"
      id="Fact005020"
      unitRef="USDPShares">3.62</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2025-12-05_custom_WarrantSharesMember_custom_ArmisticeCapitalMasterFundLtdMember"
      id="Fact005022">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <CYCU:CommonStockOwnershipChangeInControlThresholdPercentage
      contextRef="AsOf2025-12-05_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="INF"
      id="Fact005024"
      unitRef="Pure">0.50</CYCU:CommonStockOwnershipChangeInControlThresholdPercentage>
    <CYCU:VotingPowerChangeInControlThresholdPercentage
      contextRef="AsOf2025-12-05_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="INF"
      id="Fact005026"
      unitRef="Pure">0.50</CYCU:VotingPowerChangeInControlThresholdPercentage>
    <CYCU:ClassOfWarrantOrRightIssuanceRestrictionPeriod
      contextRef="AsOf2025-12-04_custom_ArmisticeCapitalMasterFundLtdMember"
      id="Fact005028">P90D</CYCU:ClassOfWarrantOrRightIssuanceRestrictionPeriod>
    <CYCU:ClassOfWarrantOrRightIssuanceRestrictionPeriod
      contextRef="AsOf2025-12-04_custom_ArmisticeCapitalMasterFundLtdMember"
      id="Fact005030">P90D</CYCU:ClassOfWarrantOrRightIssuanceRestrictionPeriod>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-04-07_custom_YieldPointNYLLCMember_custom_PreFundedWarrantMember"
      decimals="INF"
      id="Fact005032"
      unitRef="Shares">4500000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-04-07_custom_PreFundedWarrantMember_custom_YieldPointNYLLCMember"
      decimals="INF"
      id="Fact005034"
      unitRef="USDPShares">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2025-02-14_custom_SewardAndKisselLLPMember_custom_PreFundedWarrantMember"
      decimals="-5"
      id="Fact005036"
      unitRef="USD">1300000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-02-14_custom_SewardAndKisselLLPMember_custom_PreFundedWarrantMember"
      decimals="INF"
      id="Fact005038"
      unitRef="Shares">83333</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:LegalFees
      contextRef="From2025-02-142025-02-14_custom_SewardAndKisselLLPMember_custom_PreFundedWarrantMember"
      decimals="-5"
      id="Fact005040"
      unitRef="USD">1300000</us-gaap:LegalFees>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-02-14_custom_PreFundedWarrantMember_custom_SewardAndKisselLLPMember"
      decimals="INF"
      id="Fact005042"
      unitRef="USDPShares">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-03-08_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact005044"
      unitRef="Shares">17636</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-03-082022-03-08_us-gaap_WarrantMember"
      decimals="0"
      id="Fact005046"
      unitRef="USD">700000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-03-08_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact005048"
      unitRef="USDPShares">0.92</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-12-31_custom_WarrantsMember"
      decimals="INF"
      id="Fact005050"
      unitRef="Shares">9006</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-12-31_custom_WarrantsMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact005052"
      unitRef="Shares">17636</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-12-31_custom_WarrantsMember"
      decimals="INF"
      id="Fact005054"
      unitRef="USDPShares">9.59121</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:TemporaryEquityTableTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact005056">&lt;p id="xdx_891_eus-gaap--TemporaryEquityTableTextBlock_ziPxtBtNYFG8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_zC4x0c78dg0k" style="display: none"&gt;SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Number of Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Common stock subject to possible redemption as of December 31, 2024&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--TemporaryEquitySharesIssued_iS_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zAO6jumgQv1a" style="width: 12%; text-align: right" title="Common stock subject to possible redemption shares, beginning balance"&gt;5,796&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_z5uYgoO47jZf" style="width: 12%; text-align: right" title="Common stock subject to possible redemption, beginning balance"&gt;1,917,309&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt"&gt;Redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--TemporaryEquityRedemptionShares_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zx0D9dXbkj1a" style="text-align: right" title="Redemption, shares"&gt;(3,163&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--TemporaryEquityRedemption_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zBZRwUKji34d" style="text-align: right" title="Redemption"&gt;(1,001,216&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 20pt; text-align: left"&gt;Release of common stock subject to redemption&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--TemporaryEquityReleaseOfCommonStockSubjectToRedemptionShares_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zeY0wcTEoxe6" style="border-bottom: Black 1pt solid; text-align: right" title="Release of common stock subject to redemption, shares"&gt;(2,633&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--TemporaryEquityReleaseOfCommonStockSubjectToRedemption_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zCzWs4nZiNIk" style="border-bottom: Black 1pt solid; text-align: right" title="Release of common stock subject to redemption"&gt;(916,093&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Common stock subject to possible redemption as of December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--TemporaryEquitySharesIssued_iE_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zhcWAnIl0nEd" style="border-bottom: Black 2.5pt double; text-align: right" title="Common stock subject to possible redemption shares, ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5070"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--CommonClassSubjectToRedemptionMember_zyLS6N6iBND6" style="border-bottom: Black 2.5pt double; text-align: right" title="Common stock subject to possible redemption, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5072"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2024-12-31_custom_CommonClassSubjectToRedemptionMember"
      decimals="INF"
      id="Fact005058"
      unitRef="Shares">5796</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2024-12-31_custom_CommonClassSubjectToRedemptionMember"
      decimals="0"
      id="Fact005060"
      unitRef="USD">1917309</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <CYCU:TemporaryEquityRedemptionShares
      contextRef="From2025-01-012025-12-31_custom_CommonClassSubjectToRedemptionMember"
      decimals="INF"
      id="Fact005062"
      unitRef="Shares">-3163</CYCU:TemporaryEquityRedemptionShares>
    <CYCU:TemporaryEquityRedemption
      contextRef="From2025-01-012025-12-31_custom_CommonClassSubjectToRedemptionMember"
      decimals="0"
      id="Fact005064"
      unitRef="USD">-1001216</CYCU:TemporaryEquityRedemption>
    <CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemptionShares
      contextRef="From2025-01-012025-12-31_custom_CommonClassSubjectToRedemptionMember"
      decimals="INF"
      id="Fact005066"
      unitRef="Shares">-2633</CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemptionShares>
    <CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemption
      contextRef="From2025-01-012025-12-31_custom_CommonClassSubjectToRedemptionMember"
      decimals="0"
      id="Fact005068"
      unitRef="USD">-916093</CYCU:TemporaryEquityReleaseOfCommonStockSubjectToRedemption>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact005074">&lt;p id="xdx_80E_eus-gaap--ConcentrationRiskDisclosureTextBlock_zgVQCX45iNR5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16.
&lt;span id="xdx_821_z0uEwmf3g2Ba"&gt;CONCENTRATIONS, RISKS AND UNCERTAINTIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Credit
risk&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s primary bank deposits are located in the United States. Those deposits are provided protection under FDIC insurance up
to maximum of $&lt;span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_c20260331__srt--RangeAxis__srt--MaximumMember_zmpXRsMQybsg" title="FDIC amount"&gt;250,000&lt;/span&gt;. Any deposits in excess of the aforementioned maximum are at risk of loss if those banks become insolvent. The
Company is subject to risk borne from credit extended to customers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Interest
risk&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is subject to interest rate risk when its loans become due and require refinancing or if the prime rate adjusts, as the Company&#x2019;s
loans are based on adjustable interest rates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Inflation
risk&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
monitors changes in prices levels. Historically, inflation has not materially impacted the Company&#x2019;s financial statements; however,
significant increases in the cost of labor that cannot be passed on to the Company&#x2019;s customers could adversely impact the Company&#x2019;s
results of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Concentration
risks&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zRuGCOK1pVll" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B2_zRHwrpithK29" style="display: none"&gt;SCHEDULE
OF CONCENTRATION RISKS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
16.1: Revenue Concentration by Customer - Based on % of Revenue&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Three Months Ended March 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Customer&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: center; padding-left: 1pt"&gt;A&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_c20260101__20260331__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zsx7onO8tT1l" style="width: 10%; text-align: right" title="Revenue"&gt;1,105,481&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20260101__20260331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zT5OER7U38Wl" title="Revenue, percentage"&gt;33.8&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z2yrTJCY7yUe" style="width: 10%; text-align: right" title="Revenue"&gt;1,112,572&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zWM65BbYW64h" title="Revenue, percentage"&gt;28.7&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center; padding-left: 1pt"&gt;B&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_c20260101__20260331__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zaSk8KKnnWq1" style="text-align: right" title="Revenue"&gt;724,822&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20260101__20260331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zBZ0scaxs89e" title="Revenue, percentage"&gt;22.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zGcPzJEcCecb" style="text-align: right" title="Revenue"&gt;563,621&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_z3LN6r9vJoy" title="Revenue, percentage"&gt;14.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center; padding-left: 1pt"&gt;C&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20260101__20260331__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zG1Xl6UOE6fh" style="text-align: right" title="Revenue"&gt;315,240&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20260101__20260331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zPE0EiUXlHLg" title="Revenue, percentage"&gt;9.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zlnmtp71CZH3" style="text-align: right" title="Revenue"&gt;487,173&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zjPwb7y7tZ59" title="Revenue, percentage"&gt;12.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center; padding-left: 1pt"&gt;D&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20260101__20260331__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zf9SxTliRwCb" style="text-align: right" title="Revenue"&gt;229,893&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20260101__20260331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zTNajTFautba" title="Revenue, percentage"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zneuFEcJvI6b" style="text-align: right" title="Revenue"&gt;389,280&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zIoocwkWV8j9" title="Revenue, percentage"&gt;10.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
16.2: Accounts Receivable Concentration by Customer - Based on % of Accounts Receivable, Net&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;March 31, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Customer&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: center; padding-left: 1pt"&gt;1&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AccountsReceivableNet_iI_c20260331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zM12Lc6kxO8e" style="width: 10%; text-align: right" title="Accounts receivable"&gt;1,060,754&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20260101__20260331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zM3007Rjm6a4" title="Accounts receivable, percentage"&gt;31.8&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AccountsReceivableNet_iI_c20251231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zrgegvZ20pDg" style="width: 10%; text-align: right" title="Accounts receivable"&gt;768,954&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20251231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zpmRITGPrW4i" title="Accounts receivable, percentage"&gt;29&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center; padding-left: 1pt"&gt;2&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccountsReceivableNet_iI_c20260331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_znYZTA2JNx8i" style="text-align: right" title="Accounts receivable"&gt;724,821&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20260101__20260331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_z8ArCTuNCjI6" title="Accounts receivable, percentage"&gt;21.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AccountsReceivableNet_iI_c20251231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zvzC91hgExvg" style="text-align: right" title="Accounts receivable"&gt;479,151&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20251231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zmc8mAy4tsj7" title="Accounts receivable, percentage"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center; padding-left: 1pt"&gt;3&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccountsReceivableNet_iI_c20260331__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zoUHbP7Cneod" style="text-align: right" title="Accounts receivable"&gt;275,057&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20260101__20260331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zSTJceTcXXia" title="Accounts receivable, percentage"&gt;8.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccountsReceivableNet_iI_c20251231__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zn0TwXbMjlY1" style="text-align: right" title="Accounts receivable"&gt;373,236&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20251231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zwJMIWOVFg71" title="Accounts receivable, percentage"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zNW42TfLwGvg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prior
to the Management Services Agreement and a Release agreement with Ed Burns of SLG on March 31, 2025, the Company had combined all SLG
customers as one customer for purposes of customer concentration disclosures due to the nature of the relationship. Once the acquisition
was complete, the Company has re-evaluated this disclosure to break out all SLG customers individually, therefore the amounts reported
above are not comparable to the first quarter of 2025 amounts previously reported.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:CashFDICInsuredAmount
      contextRef="AsOf2026-03-31_srt_MaximumMember"
      decimals="0"
      id="Fact005076"
      unitRef="USD">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact005078">&lt;p id="xdx_893_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zRuGCOK1pVll" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B2_zRHwrpithK29" style="display: none"&gt;SCHEDULE
OF CONCENTRATION RISKS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
16.1: Revenue Concentration by Customer - Based on % of Revenue&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Three Months Ended March 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Customer&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: center; padding-left: 1pt"&gt;A&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_c20260101__20260331__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zsx7onO8tT1l" style="width: 10%; text-align: right" title="Revenue"&gt;1,105,481&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20260101__20260331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zT5OER7U38Wl" title="Revenue, percentage"&gt;33.8&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z2yrTJCY7yUe" style="width: 10%; text-align: right" title="Revenue"&gt;1,112,572&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zWM65BbYW64h" title="Revenue, percentage"&gt;28.7&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center; padding-left: 1pt"&gt;B&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_c20260101__20260331__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zaSk8KKnnWq1" style="text-align: right" title="Revenue"&gt;724,822&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20260101__20260331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zBZ0scaxs89e" title="Revenue, percentage"&gt;22.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zGcPzJEcCecb" style="text-align: right" title="Revenue"&gt;563,621&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_z3LN6r9vJoy" title="Revenue, percentage"&gt;14.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center; padding-left: 1pt"&gt;C&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20260101__20260331__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zG1Xl6UOE6fh" style="text-align: right" title="Revenue"&gt;315,240&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20260101__20260331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zPE0EiUXlHLg" title="Revenue, percentage"&gt;9.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zlnmtp71CZH3" style="text-align: right" title="Revenue"&gt;487,173&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zjPwb7y7tZ59" title="Revenue, percentage"&gt;12.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center; padding-left: 1pt"&gt;D&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20260101__20260331__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zf9SxTliRwCb" style="text-align: right" title="Revenue"&gt;229,893&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20260101__20260331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zTNajTFautba" title="Revenue, percentage"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zneuFEcJvI6b" style="text-align: right" title="Revenue"&gt;389,280&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zIoocwkWV8j9" title="Revenue, percentage"&gt;10.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
16.2: Accounts Receivable Concentration by Customer - Based on % of Accounts Receivable, Net&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;March 31, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Customer&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: center; padding-left: 1pt"&gt;1&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AccountsReceivableNet_iI_c20260331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zM12Lc6kxO8e" style="width: 10%; text-align: right" title="Accounts receivable"&gt;1,060,754&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20260101__20260331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zM3007Rjm6a4" title="Accounts receivable, percentage"&gt;31.8&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AccountsReceivableNet_iI_c20251231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zrgegvZ20pDg" style="width: 10%; text-align: right" title="Accounts receivable"&gt;768,954&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20251231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zpmRITGPrW4i" title="Accounts receivable, percentage"&gt;29&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center; padding-left: 1pt"&gt;2&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccountsReceivableNet_iI_c20260331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_znYZTA2JNx8i" style="text-align: right" title="Accounts receivable"&gt;724,821&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20260101__20260331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_z8ArCTuNCjI6" title="Accounts receivable, percentage"&gt;21.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AccountsReceivableNet_iI_c20251231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zvzC91hgExvg" style="text-align: right" title="Accounts receivable"&gt;479,151&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20251231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zmc8mAy4tsj7" title="Accounts receivable, percentage"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center; padding-left: 1pt"&gt;3&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccountsReceivableNet_iI_c20260331__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zoUHbP7Cneod" style="text-align: right" title="Accounts receivable"&gt;275,057&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20260101__20260331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zSTJceTcXXia" title="Accounts receivable, percentage"&gt;8.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccountsReceivableNet_iI_c20251231__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zn0TwXbMjlY1" style="text-align: right" title="Accounts receivable"&gt;373,236&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20250101__20251231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zwJMIWOVFg71" title="Accounts receivable, percentage"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:Revenues
      contextRef="From2026-01-012026-03-31_custom_CustomerAMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="0"
      id="Fact005080"
      unitRef="USD">1105481</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2026-01-012026-03-31_custom_CustomerAMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="INF"
      id="Fact005082"
      unitRef="Pure">0.338</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="From2025-01-012025-03-31_custom_CustomerAMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="0"
      id="Fact005084"
      unitRef="USD">1112572</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-01-012025-03-31_custom_CustomerAMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="INF"
      id="Fact005086"
      unitRef="Pure">0.287</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="From2026-01-012026-03-31_custom_CustomerBMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="0"
      id="Fact005088"
      unitRef="USD">724822</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2026-01-012026-03-31_custom_CustomerBMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="INF"
      id="Fact005090"
      unitRef="Pure">0.222</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="From2025-01-012025-03-31_custom_CustomerBMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="0"
      id="Fact005092"
      unitRef="USD">563621</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-01-012025-03-31_custom_CustomerBMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="INF"
      id="Fact005094"
      unitRef="Pure">0.146</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="From2026-01-012026-03-31_custom_CustomerCMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="0"
      id="Fact005096"
      unitRef="USD">315240</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2026-01-012026-03-31_custom_CustomerCMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="INF"
      id="Fact005098"
      unitRef="Pure">0.096</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="From2025-01-012025-03-31_custom_CustomerCMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="0"
      id="Fact005100"
      unitRef="USD">487173</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-01-012025-03-31_custom_CustomerCMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="INF"
      id="Fact005102"
      unitRef="Pure">0.126</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="From2026-01-012026-03-31_custom_CustomerDMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="0"
      id="Fact005104"
      unitRef="USD">229893</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2026-01-012026-03-31_custom_CustomerDMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="INF"
      id="Fact005106"
      unitRef="Pure">0.070</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="From2025-01-012025-03-31_custom_CustomerDMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="0"
      id="Fact005108"
      unitRef="USD">389280</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-01-012025-03-31_custom_CustomerDMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="INF"
      id="Fact005110"
      unitRef="Pure">0.101</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2026-03-31_custom_CustomerOneMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="0"
      id="Fact005112"
      unitRef="USD">1060754</us-gaap:AccountsReceivableNet>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2026-01-012026-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember"
      decimals="INF"
      id="Fact005114"
      unitRef="Pure">0.318</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember"
      decimals="0"
      id="Fact005116"
      unitRef="USD">768954</us-gaap:AccountsReceivableNet>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-01-012025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember"
      decimals="INF"
      id="Fact005118"
      unitRef="Pure">0.29</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2026-03-31_custom_CustomerTwoMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="0"
      id="Fact005120"
      unitRef="USD">724821</us-gaap:AccountsReceivableNet>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2026-01-012026-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerTwoMember"
      decimals="INF"
      id="Fact005122"
      unitRef="Pure">0.217</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember"
      decimals="0"
      id="Fact005124"
      unitRef="USD">479151</us-gaap:AccountsReceivableNet>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-01-012025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember"
      decimals="INF"
      id="Fact005126"
      unitRef="Pure">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2026-03-31_custom_CustomerThreeMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="0"
      id="Fact005128"
      unitRef="USD">275057</us-gaap:AccountsReceivableNet>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2026-01-012026-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerThreeMember"
      decimals="INF"
      id="Fact005130"
      unitRef="Pure">0.082</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember"
      decimals="0"
      id="Fact005132"
      unitRef="USD">373236</us-gaap:AccountsReceivableNet>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-01-012025-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember"
      decimals="INF"
      id="Fact005134"
      unitRef="Pure">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact005136">&lt;p id="xdx_802_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zSnLDuNYomqc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17.
&lt;span id="xdx_82E_zvn9E4FTWaT6"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Promissory
Note &#x2013; Related Party&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 20, 2024, the Company entered into a promissory note with Western Acquisition Ventures Sponsor, LLC (the &#x201c;Sponsor&#x201d;)
for $&lt;span id="xdx_90F_ecustom--MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_c20240920__20240920__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorPromissoryNoteMember_znJHtAtlMTS4"&gt;230,000&lt;/span&gt;, pursuant to which the Company can borrow up to an aggregate cash amount of $&lt;span id="xdx_908_ecustom--MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_c20240920__20240920__us-gaap--RelatedPartyTransactionAxis__custom--SponsorPromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zVZ5v6BZIBR4" title="Maximum borrowing capacity of related party promissory note"&gt;230,000&lt;/span&gt;. The Promissory Note, with an interest
rate of &lt;span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20240920__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorPromissoryNoteMember_zyP7TbWwABc9" title="Debt interest rate"&gt;10&lt;/span&gt;% per annum is payable upon the sooner of the consummation of the Business Combination with Cycurion. During the year ended
December 31, 2024, the Company borrowed the full $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorPromissoryNoteMember_z3wb95879zQg" title="Principal amount"&gt;255,556&lt;/span&gt;, with a discount of $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorPromissoryNoteMember_zOSUOAKYInV6" title="Debt discount"&gt;25,556&lt;/span&gt;, resulting in net proceeds of $&lt;span id="xdx_903_eus-gaap--ProceedsFromNotesPayable_c20240101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorPromissoryNoteMember_zOiFegdbGxkk" title="Proceeds from notes payable"&gt;230,000&lt;/span&gt;. The Company
amortized the discount of &lt;span id="xdx_909_eus-gaap--AmortizationOfDebtDiscountPremium_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorPromissoryNoteMember_z7RaX0vKor1e" title="Debt discount"&gt;25,556&lt;/span&gt; fully in 2025. As of both March 31, 2026 and December 31, 2025 the balance of these loans was $&lt;span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorPromissoryNoteMember_zmwWSQuPhsb1" title="Principal amount"&gt;&lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorPromissoryNoteMember_zf6ZAiEkOksl" title="Principal amount"&gt;133,334&lt;/span&gt;&lt;/span&gt;,
with accrued interest balances of $&lt;span id="xdx_90A_eus-gaap--InterestPayableCurrent_iI_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorPromissoryNoteMember_z6RKKfIiEsJ1" title="Accrued interest payable"&gt;20,482&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--InterestPayableCurrent_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorPromissoryNoteMember_zJ15r3mHfcUf" title="Accrued interest payable"&gt;17,148&lt;/span&gt;, respectively. These notes are presented with other promissory notes on the balance
sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Personal
guarantees were entered by Emmit McHenry, Kurt McHenry and Alvin McCoy III, as officers and stockholders of the Company in support of
the Main Street Bank Loan and Security Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Axxum
purchased an AT&amp;amp;T contract relationship from Archura, LLC, a company owned by Emmit McHenry and Kurt McHenry at the end of 2018.
The contract relationship includes &lt;span id="xdx_907_ecustom--PurchaseObligationNumberOfPurchaseOrders_iI_dc_uInteger_c20260331_zZGvutgD71dh" title="Purchase orders"&gt;five&lt;/span&gt; purchase orders to deliver networking services to AT&amp;amp;T and its clients. The total sales of
these &lt;span id="xdx_901_ecustom--PurchaseObligationNumberOfPurchaseOrders_iI_dc_uInteger_c20260331_zpFjpZMsCON5" title="Purchase orders"&gt;five&lt;/span&gt; purchase orders were $&lt;span id="xdx_90C_eus-gaap--PurchaseObligation_iI_c20260331_zYCkVI5qYCab" title="Purchase obligation"&gt;2,149&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--PurchaseObligation_iI_c20250331_zuQJ9hY78OZa" title="Purchase obligation"&gt;20,615&lt;/span&gt; for the three months ended March 31, 2026 and 2025, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Loans
Payable - Related Parties&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zmXGQJo89Pz5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BC_zpsdObDuB7Ke" style="display: none"&gt;SCHEDULE OF RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
17: Details of Loans Payable - Related Party&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;March 31, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average Interest Rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Maturity (Calendar Year)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 45%; text-align: left"&gt;Loans issued to a director in 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DebtInstrumentFaceAmount_iI_c20260331__srt--TitleOfIndividualAxis__custom--TwoDirectorMember_ziZVuHZG8Gid" style="width: 10%; text-align: right" title="Debt amount face value"&gt;103,400&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DebtInstrumentFaceAmount_iI_c20251231__srt--TitleOfIndividualAxis__custom--TwoDirectorMember_z7cnKS1zPGjk" style="width: 10%; text-align: right" title="Debt amount face value"&gt;103,400&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20260331__srt--TitleOfIndividualAxis__custom--TwoDirectorMember_zg8FRArJfGJ" style="width: 10%; text-align: right" title="Debt interest rate"&gt;24.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--DebtMaturityYear_pid_c20260101__20261231__srt--TitleOfIndividualAxis__custom--TwoDirectorMember_zsLZzBDidDn2" style="width: 10%; text-align: center" title="Debt maturity year"&gt;2023&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;Loan issued to a director in 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DebtInstrumentFaceAmount_iI_c20260331__srt--TitleOfIndividualAxis__srt--DirectorMember_zFOz5QWLIxji" style="border-bottom: Black 1pt solid; text-align: right" title="Debt amount face value"&gt;20,250&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DebtInstrumentFaceAmount_iI_c20251231__srt--TitleOfIndividualAxis__srt--DirectorMember_zcddUwfpLnPi" style="border-bottom: Black 1pt solid; text-align: right" title="Debt amount face value"&gt;20,250&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20260331__srt--TitleOfIndividualAxis__srt--DirectorMember_zTOecRZOqRyi" style="padding-bottom: 1pt; text-align: right" title="Debt interest rate"&gt;24.0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--DebtMaturityYear_pid_c20260101__20261231__srt--TitleOfIndividualAxis__srt--DirectorMember_ze3YynIac07k" style="padding-bottom: 1pt; text-align: center" title="Debt maturity year"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;Funded loans payable - related party principal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentFaceAmount_iI_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zUC5h6Smi2Mc" style="border-bottom: Black 1pt solid; text-align: right" title="Debt amount face value"&gt;123,650&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DebtInstrumentFaceAmount_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zUWxNKrOA0x9" style="border-bottom: Black 1pt solid; text-align: right" title="Debt amount face value"&gt;123,650&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Less: Unamortized debt-issuance costs and discounts&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iI_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zuP3VPrUjcCd" style="text-align: right" title="Debt unamortized discount and issuance costs"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5189"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zPPwXqUrqRF8" style="text-align: right" title="Debt unamortized discount and issuance costs"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5191"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Loans payable - related party - current&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LoansPayable_iI_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zY3IwINzesj5" style="border-bottom: Black 2.5pt double; text-align: right" title="Debt amount net of unamortized discount and issuance costs"&gt;123,650&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LoansPayable_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zgo2UdrTbWf7" style="border-bottom: Black 2.5pt double; text-align: right" title="Debt amount net of unamortized discount and issuance costs"&gt;123,650&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AE_zJRrf6B9lXBj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the three months ended March 31, 2025, the Company recorded amortization of debt discount of $&lt;span id="xdx_90D_eus-gaap--AmortizationOfDebtDiscountPremium_c20250101__20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_z2ADknOqN7d" title="Amortization of debt discount"&gt;1,313&lt;/span&gt;. As of December 31, 2025 the debt
discount was fully amortized, therefore there is &lt;span id="xdx_901_eus-gaap--AmortizationOfDebtDiscountPremium_c20260101__20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zyBoDjxuGNB6" title="Amortization of debt discount"&gt;no&lt;/span&gt; amortization for the three months ended March 31, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <CYCU:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote
      contextRef="From2024-09-202024-09-20_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember"
      decimals="0"
      id="Fact005137"
      unitRef="USD">230000</CYCU:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote>
    <CYCU:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote
      contextRef="From2024-09-202024-09-20_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember"
      decimals="0"
      id="Fact005139"
      unitRef="USD">230000</CYCU:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-09-20_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember"
      decimals="INF"
      id="Fact005141"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-12-31_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember"
      decimals="0"
      id="Fact005143"
      unitRef="USD">255556</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2024-12-31_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember"
      decimals="0"
      id="Fact005145"
      unitRef="USD">25556</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2024-01-012024-12-31_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember"
      decimals="0"
      id="Fact005147"
      unitRef="USD">230000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2025-01-012025-12-31_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember"
      decimals="0"
      id="Fact005149"
      unitRef="USD">25556</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2026-03-31_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember"
      decimals="0"
      id="Fact005151"
      unitRef="USD">133334</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember"
      decimals="0"
      id="Fact005153"
      unitRef="USD">133334</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2026-03-31_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember"
      decimals="0"
      id="Fact005155"
      unitRef="USD">20482</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2025-12-31_us-gaap_RelatedPartyMember_custom_SponsorPromissoryNoteMember"
      decimals="0"
      id="Fact005157"
      unitRef="USD">17148</us-gaap:InterestPayableCurrent>
    <CYCU:PurchaseObligationNumberOfPurchaseOrders
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact005159"
      unitRef="Integer">5</CYCU:PurchaseObligationNumberOfPurchaseOrders>
    <CYCU:PurchaseObligationNumberOfPurchaseOrders
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact005161"
      unitRef="Integer">5</CYCU:PurchaseObligationNumberOfPurchaseOrders>
    <us-gaap:PurchaseObligation
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact005163"
      unitRef="USD">2149</us-gaap:PurchaseObligation>
    <us-gaap:PurchaseObligation
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact005165"
      unitRef="USD">20615</us-gaap:PurchaseObligation>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact005167">&lt;p id="xdx_892_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zmXGQJo89Pz5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BC_zpsdObDuB7Ke" style="display: none"&gt;SCHEDULE OF RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
17: Details of Loans Payable - Related Party&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;March 31, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average Interest Rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Maturity (Calendar Year)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 45%; text-align: left"&gt;Loans issued to a director in 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DebtInstrumentFaceAmount_iI_c20260331__srt--TitleOfIndividualAxis__custom--TwoDirectorMember_ziZVuHZG8Gid" style="width: 10%; text-align: right" title="Debt amount face value"&gt;103,400&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DebtInstrumentFaceAmount_iI_c20251231__srt--TitleOfIndividualAxis__custom--TwoDirectorMember_z7cnKS1zPGjk" style="width: 10%; text-align: right" title="Debt amount face value"&gt;103,400&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20260331__srt--TitleOfIndividualAxis__custom--TwoDirectorMember_zg8FRArJfGJ" style="width: 10%; text-align: right" title="Debt interest rate"&gt;24.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--DebtMaturityYear_pid_c20260101__20261231__srt--TitleOfIndividualAxis__custom--TwoDirectorMember_zsLZzBDidDn2" style="width: 10%; text-align: center" title="Debt maturity year"&gt;2023&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;Loan issued to a director in 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DebtInstrumentFaceAmount_iI_c20260331__srt--TitleOfIndividualAxis__srt--DirectorMember_zFOz5QWLIxji" style="border-bottom: Black 1pt solid; text-align: right" title="Debt amount face value"&gt;20,250&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DebtInstrumentFaceAmount_iI_c20251231__srt--TitleOfIndividualAxis__srt--DirectorMember_zcddUwfpLnPi" style="border-bottom: Black 1pt solid; text-align: right" title="Debt amount face value"&gt;20,250&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20260331__srt--TitleOfIndividualAxis__srt--DirectorMember_zTOecRZOqRyi" style="padding-bottom: 1pt; text-align: right" title="Debt interest rate"&gt;24.0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--DebtMaturityYear_pid_c20260101__20261231__srt--TitleOfIndividualAxis__srt--DirectorMember_ze3YynIac07k" style="padding-bottom: 1pt; text-align: center" title="Debt maturity year"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;Funded loans payable - related party principal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentFaceAmount_iI_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zUC5h6Smi2Mc" style="border-bottom: Black 1pt solid; text-align: right" title="Debt amount face value"&gt;123,650&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DebtInstrumentFaceAmount_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zUWxNKrOA0x9" style="border-bottom: Black 1pt solid; text-align: right" title="Debt amount face value"&gt;123,650&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Less: Unamortized debt-issuance costs and discounts&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iI_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zuP3VPrUjcCd" style="text-align: right" title="Debt unamortized discount and issuance costs"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5189"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zPPwXqUrqRF8" style="text-align: right" title="Debt unamortized discount and issuance costs"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5191"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Loans payable - related party - current&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LoansPayable_iI_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zY3IwINzesj5" style="border-bottom: Black 2.5pt double; text-align: right" title="Debt amount net of unamortized discount and issuance costs"&gt;123,650&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LoansPayable_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zgo2UdrTbWf7" style="border-bottom: Black 2.5pt double; text-align: right" title="Debt amount net of unamortized discount and issuance costs"&gt;123,650&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2026-03-31_custom_TwoDirectorMember"
      decimals="0"
      id="Fact005169"
      unitRef="USD">103400</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_custom_TwoDirectorMember"
      decimals="0"
      id="Fact005171"
      unitRef="USD">103400</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2026-03-31_custom_TwoDirectorMember"
      decimals="INF"
      id="Fact005173"
      unitRef="Pure">0.240</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <CYCU:DebtMaturityYear
      contextRef="From2026-01-012026-12-31_custom_TwoDirectorMember"
      id="Fact005175">2023</CYCU:DebtMaturityYear>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2026-03-31_srt_DirectorMember"
      decimals="0"
      id="Fact005177"
      unitRef="USD">20250</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_srt_DirectorMember"
      decimals="0"
      id="Fact005179"
      unitRef="USD">20250</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2026-03-31_srt_DirectorMember"
      decimals="INF"
      id="Fact005181"
      unitRef="Pure">0.240</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <CYCU:DebtMaturityYear
      contextRef="From2026-01-012026-12-31_srt_DirectorMember"
      id="Fact005183">2025</CYCU:DebtMaturityYear>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2026-03-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact005185"
      unitRef="USD">123650</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact005187"
      unitRef="USD">123650</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LoansPayable
      contextRef="AsOf2026-03-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact005193"
      unitRef="USD">123650</us-gaap:LoansPayable>
    <us-gaap:LoansPayable
      contextRef="AsOf2025-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact005195"
      unitRef="USD">123650</us-gaap:LoansPayable>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2025-01-012025-03-31_custom_PromissoryNoteMember"
      decimals="0"
      id="Fact005197"
      unitRef="USD">1313</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact005201">&lt;p id="xdx_80E_eus-gaap--EarningsPerShareTextBlock_zu3uOGHEADOa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18.
&lt;span id="xdx_820_zH4hREDug9kc"&gt;EARNINGS PER SHARE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zC29CEkuJnLk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_zmot8J67f3F3" style="display: none"&gt;SCHEDULE OF COMPONENTS OF BASIC AND DILUTED EARNINGS PER SHARE&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
18.1: Details of Basic and Dilutive Loss Per Share&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20260101__20260331_zEvD2rTF6IVl" style="border-bottom: Black 1pt solid; text-align: center"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20250101__20250331_zMlZfNR6yFpc" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Three Months Ended March 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; font-weight: bold"&gt;Basic net loss per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_iB_zWMMieQIpQd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold"&gt;Numerator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--ProfitLoss_zWCr0oI7RYWl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; width: 64%; text-align: left"&gt;Net loss including non-controlling interests&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;(2,561,786&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;(10,248,486&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_z14kLvf7HOne" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 30pt; text-align: left"&gt;Less: Net loss attributable to non-controlling interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(433,324&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5212"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zWFa6VcLPAgd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 20pt; text-align: left"&gt;Net loss attributable to common stockholders - basic&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(2,128,462&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(10,248,486&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasicAbstract_iB_z8x6MrFpzi7l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold"&gt;Denominator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_zPhMbmQx4iIl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 20pt"&gt;Weighted average shares outstanding - basic&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,561,976&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;658,218&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pid_zrFvNfHNk2sh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 30pt; text-align: left"&gt;Basic net loss per share attributable to common stockholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(0.47&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(15.57&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; font-weight: bold"&gt;Diluted net loss per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_iB_zkpkASBg4EI8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold"&gt;Numerator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zcdUy2x4gDHh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Net loss attributable to common stockholders - basic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,128,462&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,248,486&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--InterestOnConvertibleDebtNetOfTax_zgBNYS0eTael" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Add back interest for subordinated convertible promissory note&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5232"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_zQHfLlmuAmQe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 20pt; text-align: left"&gt;Net loss attributable to common stockholders - diluted&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(2,128,462&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(10,243,486&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_iB_znwmQrW3nHIf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold"&gt;Denominator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_zIADyBW1oUK5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt"&gt;Weighted average shares outstanding - basic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,561,976&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;658,218&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DilutiveSecuritiesAbstract_iB_pid_z4V0XyU3n05f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Weighted-average effect of potentially dilutive securities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_zCQ3Z1t3Oiok" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Conversion of subordinated convertible promissory note&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5247"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,360&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zngWIKdQs56e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Conversion of Series A Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5250"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;77,860&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zZqAFYNwNmqd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Conversion of Series B Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5253"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;38&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zl2OchvGOJbc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Conversion of Series C Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5256"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,212&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zgfN16mhYNh3" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Conversion of Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5259"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,212&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--IncrementalCommonSharesAttributableToDilutiveEffectOfExerciseOfInvestorAndPlacementAgentWarrants_zc9FEglf19nk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 30pt; text-align: left"&gt;Exercise of investor and placement agent warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5262"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;640,243&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_iT_pid_zyMiz9UIvK34" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 40pt"&gt;Weighted average shares outstanding - diluted&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,561,976&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,383,507&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--IncomeLossFromContinuingOperationsPerDilutedShare_pid_zBDc2g0B57C" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 40pt; text-align: left"&gt;Dilutive net loss per share attributable to common stockholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(0.47&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(7.40&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zHs7vqDybwEl" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zZ7mzgY5Imq8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B3_zaAB6qQYIKNi" style="display: none"&gt;SCHEDULE OF DILUTIVE EFFECT OF SECURITIES EXCLUDED FROM DILUTIVE EPS DUE TO ANTI-DILUTIVE EFFECT&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
18.2: Details of Potentially Dilutive Effect of Securities Excluded from Dilutive EPS due to Anti-Dilutive Effect&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertiblePreferredStockMember_zgnCamkblNCj" style="border-bottom: Black 1pt solid; text-align: center"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertiblePreferredStockMember_zZgfBMv3UUDk" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Three Months Ended March 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zb3lbpeOdDF6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-left: 1pt"&gt;Conversion of Series B Convertible Preferred Stock&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,347&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl5274"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zoYG1jZIK5pi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 1pt"&gt;Conversion of Series C Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,202&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5277"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zMbZsJiSeBUa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 1pt"&gt;Conversion of Series D Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,092&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5280"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zX1vbt2wAha8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 1pt"&gt;Conversion of Series E Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5283"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zGKFWaF5llIj" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 1pt"&gt;Conversion  convertible preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5286"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A8_zq70yrsbBTD8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact005203">&lt;p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zC29CEkuJnLk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_zmot8J67f3F3" style="display: none"&gt;SCHEDULE OF COMPONENTS OF BASIC AND DILUTED EARNINGS PER SHARE&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
18.1: Details of Basic and Dilutive Loss Per Share&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20260101__20260331_zEvD2rTF6IVl" style="border-bottom: Black 1pt solid; text-align: center"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20250101__20250331_zMlZfNR6yFpc" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Three Months Ended March 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; font-weight: bold"&gt;Basic net loss per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_iB_zWMMieQIpQd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold"&gt;Numerator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--ProfitLoss_zWCr0oI7RYWl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; width: 64%; text-align: left"&gt;Net loss including non-controlling interests&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;(2,561,786&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;(10,248,486&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_z14kLvf7HOne" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 30pt; text-align: left"&gt;Less: Net loss attributable to non-controlling interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(433,324&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5212"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zWFa6VcLPAgd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 20pt; text-align: left"&gt;Net loss attributable to common stockholders - basic&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(2,128,462&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(10,248,486&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasicAbstract_iB_z8x6MrFpzi7l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold"&gt;Denominator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_zPhMbmQx4iIl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 20pt"&gt;Weighted average shares outstanding - basic&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,561,976&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;658,218&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pid_zrFvNfHNk2sh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 30pt; text-align: left"&gt;Basic net loss per share attributable to common stockholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(0.47&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(15.57&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: underline; font-weight: bold"&gt;Diluted net loss per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_iB_zkpkASBg4EI8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold"&gt;Numerator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zcdUy2x4gDHh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Net loss attributable to common stockholders - basic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,128,462&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,248,486&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--InterestOnConvertibleDebtNetOfTax_zgBNYS0eTael" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Add back interest for subordinated convertible promissory note&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5232"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_zQHfLlmuAmQe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 20pt; text-align: left"&gt;Net loss attributable to common stockholders - diluted&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(2,128,462&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(10,243,486&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_iB_znwmQrW3nHIf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold"&gt;Denominator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_zIADyBW1oUK5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt"&gt;Weighted average shares outstanding - basic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,561,976&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;658,218&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DilutiveSecuritiesAbstract_iB_pid_z4V0XyU3n05f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Weighted-average effect of potentially dilutive securities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_zCQ3Z1t3Oiok" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Conversion of subordinated convertible promissory note&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5247"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,360&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zngWIKdQs56e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Conversion of Series A Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5250"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;77,860&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zZqAFYNwNmqd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Conversion of Series B Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5253"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;38&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zl2OchvGOJbc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Conversion of Series C Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5256"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,212&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zgfN16mhYNh3" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Conversion of Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5259"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,212&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--IncrementalCommonSharesAttributableToDilutiveEffectOfExerciseOfInvestorAndPlacementAgentWarrants_zc9FEglf19nk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 30pt; text-align: left"&gt;Exercise of investor and placement agent warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5262"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;640,243&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_iT_pid_zyMiz9UIvK34" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 40pt"&gt;Weighted average shares outstanding - diluted&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,561,976&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,383,507&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--IncomeLossFromContinuingOperationsPerDilutedShare_pid_zBDc2g0B57C" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 40pt; text-align: left"&gt;Dilutive net loss per share attributable to common stockholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(0.47&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(7.40&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact005208"
      unitRef="USD">-2561786</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact005209"
      unitRef="USD">-10248486</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact005211"
      unitRef="USD">-433324</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact005214"
      unitRef="USD">-2128462</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact005215"
      unitRef="USD">-10248486</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2026-01-01to2026-03-31"
      decimals="INF"
      id="Fact005220"
      unitRef="Shares">4561976</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-01-012025-03-31"
      decimals="INF"
      id="Fact005221"
      unitRef="Shares">658218</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2026-01-01to2026-03-31"
      decimals="INF"
      id="Fact005223"
      unitRef="USDPShares">-0.47</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2025-01-012025-03-31"
      decimals="INF"
      id="Fact005224"
      unitRef="USDPShares">-15.57</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact005229"
      unitRef="USD">-2128462</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact005230"
      unitRef="USD">-10248486</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact005233"
      unitRef="USD">5000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact005235"
      unitRef="USD">-2128462</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact005236"
      unitRef="USD">-10243486</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2026-01-01to2026-03-31"
      decimals="INF"
      id="Fact005241"
      unitRef="Shares">4561976</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-01-012025-03-31"
      decimals="INF"
      id="Fact005242"
      unitRef="Shares">658218</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="From2025-01-012025-03-31"
      decimals="INF"
      id="Fact005248"
      unitRef="Shares">3360</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2025-01-012025-03-31_custom_SeriesAConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact005251"
      unitRef="Shares">77860</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2025-01-012025-03-31_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact005254"
      unitRef="Shares">38</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2025-01-012025-03-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact005257"
      unitRef="Shares">1212</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2025-01-012025-03-31_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact005260"
      unitRef="Shares">1212</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <CYCU:IncrementalCommonSharesAttributableToDilutiveEffectOfExerciseOfInvestorAndPlacementAgentWarrants
      contextRef="From2025-01-012025-03-31"
      decimals="INF"
      id="Fact005263"
      unitRef="Shares">640243</CYCU:IncrementalCommonSharesAttributableToDilutiveEffectOfExerciseOfInvestorAndPlacementAgentWarrants>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2026-01-01to2026-03-31"
      decimals="INF"
      id="Fact005265"
      unitRef="Shares">4561976</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2025-01-012025-03-31"
      decimals="INF"
      id="Fact005266"
      unitRef="Shares">1383507</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="From2026-01-01to2026-03-31"
      decimals="INF"
      id="Fact005268"
      unitRef="USDPShares">-0.47</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="From2025-01-012025-03-31"
      decimals="INF"
      id="Fact005269"
      unitRef="USDPShares">-7.40</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact005271">&lt;p id="xdx_894_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zZ7mzgY5Imq8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B3_zaAB6qQYIKNi" style="display: none"&gt;SCHEDULE OF DILUTIVE EFFECT OF SECURITIES EXCLUDED FROM DILUTIVE EPS DUE TO ANTI-DILUTIVE EFFECT&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
18.2: Details of Potentially Dilutive Effect of Securities Excluded from Dilutive EPS due to Anti-Dilutive Effect&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertiblePreferredStockMember_zgnCamkblNCj" style="border-bottom: Black 1pt solid; text-align: center"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertiblePreferredStockMember_zZgfBMv3UUDk" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Three Months Ended March 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zb3lbpeOdDF6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-left: 1pt"&gt;Conversion of Series B Convertible Preferred Stock&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,347&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl5274"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zoYG1jZIK5pi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 1pt"&gt;Conversion of Series C Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,202&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5277"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zMbZsJiSeBUa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 1pt"&gt;Conversion of Series D Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,092&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5280"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zX1vbt2wAha8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 1pt"&gt;Conversion of Series E Convertible Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5283"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zGKFWaF5llIj" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 1pt"&gt;Conversion  convertible preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5286"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2026-01-012026-03-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact005273"
      unitRef="Shares">1347</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2026-01-012026-03-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact005276"
      unitRef="Shares">1202</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2026-01-012026-03-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesDConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact005279"
      unitRef="Shares">10092</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2026-01-012026-03-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact005282"
      unitRef="Shares">51</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2026-01-012026-03-31_us-gaap_ConvertiblePreferredStockMember_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact005285"
      unitRef="Shares">51</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact005288">&lt;p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zOlDhKMWODoi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19.
&lt;span id="xdx_823_zdcPdHlJirta"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Legal
Proceedings&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
time to time, the Company may be a party to litigation or claims arising in the ordinary course of business, including those relating
to employment matters, relationships with clients and contractors, intellectual property disputes, and other business matters. These
legal proceedings seek various remedies, including claims for monetary damages in varying amounts, none of which are considered material,
or are unspecified as to amount. Although the outcome of any such matter is inherently uncertain and may be materially adverse, based
on current information, management believes that the outcome of such known matters will not have a material adverse effect on the Company&#x2019;s
financial condition and results of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that there are any litigation or claims that would have a material adverse effect on the business, or the consolidated
financial statements of the Company as of March 31, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Registration
Rights&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
holders of Founder Shares, Private Placement Units, and units that may be issued upon conversion of working capital loans, if any, are
entitled to registration rights pursuant to a registration rights agreement that was signed on the date of the IPO. These holders will
be entitled to certain demand and &#x201c;piggyback&#x201d; registration rights. However, the registration rights agreement provides that
the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the
applicable lock-up period for the securities to be registered. The Company will bear the expenses incurred in connection with the filing
of any such registration statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Business
Combination Marketing Agreement&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company entered into a business combination marketing agreement on January 11, 2022 (the &#x201c;Business Combination Marketing Agreement&#x201d;)
with A.G.P. whereby A.G.P. is to act as an advisor in connection with a Business Combination to assist the Company in holding meetings
with its stockholders to discuss the potential Business Combination and the target business&#x2019; attributes, introduce the Company
to potential investors that are interested in purchasing the Company&#x2019;s securities in connection with a Business Combination, assist
the Company in obtaining stockholders&#x2019; approval for a Business Combination, and assist the Company with its press releases and
public filings in connection with a Business Combination. The Company was to pay A.G.P. a fee for such marketing services upon the consummation
of a Business Combination in an amount equal to &lt;span id="xdx_90E_ecustom--DebtInstrumentAmortizationPercentage_pid_dp_uPure_c20220111__20220111_zptIh1Ts8gsa" title="Debt amortization percentage"&gt;4.5&lt;/span&gt;% of the gross proceeds of the IPO, or $&lt;span id="xdx_900_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220111__20220111_zY60NgeqrzXi" title="Proceds from issuance of equity"&gt;5,175,000&lt;/span&gt; in the aggregate (exclusive of any
applicable finders&#x2019; fees that might become payable). The Business Combination Marketing Agreement will be terminated upon entry
into the Advisory Agreement (defined below).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Advisory
Agreement with A.G.P.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A.G.P.
was a financial advisor to both Western in connection with the Business Combination transaction. Upon the completion of the Business
Combination, A.G.P.: (i) received a cash fee of $&lt;span id="xdx_905_eus-gaap--PaymentsForFees_c20220111__20220111_zlYhCKK2euWc" title="Cash fee"&gt;500,000&lt;/span&gt; shares of common stock and warrants to purchase &lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220111_z5DRfbLT43g3" title="Warrants"&gt;16,667&lt;/span&gt; shares of common stock
at an exercise price of $&lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220111_zL1MKGr4vRWi" title="Exercise price"&gt;150.00&lt;/span&gt; per share. Pursuant to the advisory agreement (the &#x201c;Advisory Agreement&#x201d;), Western shall pay
A.G.P. a total transaction fee equal to $&lt;span id="xdx_903_ecustom--TransactionFee_iI_c20220111_zDTV8EX3Roi8" title="Transaction fee"&gt;2,500,000&lt;/span&gt; (the &#x201c;Transaction Fee&#x201d;) upon the closing of the Business Combination.
The Transaction Fee will be payable in the form of preferred shares of Cycurion that are convertible into &lt;span id="xdx_90A_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20220111_zjMqHMl1ul6" title="Preferred stock convertible shares"&gt;16,667&lt;/span&gt; shares of common stock
(such preferred shares or the common stock into which they convert, the &#x201c;Transaction Fee Shares&#x201d;), for a price per share
of common stock equal to $&lt;span id="xdx_90D_eus-gaap--SharePrice_iI_c20220111_z2bEKPmsbLBg" title="Share price"&gt;5.00&lt;/span&gt;. A portion of the Transaction Fee Shares shall be subject to forfeiture and return to the Company for
cancellation once A.G.P. converts and sells Transaction Fee Shares generating sales proceeds (excluding commissions) of $&lt;span id="xdx_90D_eus-gaap--ProceedsFromSalesOfAssetsInvestingActivities_c20220111__20220111_zNEBdshkSHY3" title="Proceeds from generating sales"&gt;2,500,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Transaction Fee Shares shall be subject to a lock-up ending on the earlier of (i) the date on which &lt;span id="xdx_90D_ecustom--AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock_pid_dp_uPure_c20220111__20220111__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember__us-gaap--GainContingenciesByNatureAxis__custom--TransactionFeeMember_ztKFlBY1DO4d" title="Conversion percentage"&gt;75&lt;/span&gt;% of the outstanding Series B Convertible
Preferred Stock is converted into shares of the combined Company&#x2019;s common stock and (ii) &lt;span id="xdx_901_ecustom--AdvisoryAgreementSharesLockUpEndingPeriodFromClosingDate_dc_c20220111__20220111__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember__us-gaap--GainContingenciesByNatureAxis__custom--TransactionFeeMember_zFYyFN47m7y" title="Advisory agreement lock-up ending period from closing date"&gt;three months&lt;/span&gt; from February 14, 2025, which
was the closing date of the de-SPAC (the &#x201c;Lock-Up Termination Date&#x201d;). After the Lock-Up Termination Date, A.G.P. may convert
the Transaction Fee Shares and sell them subject to a leak-out provision that limits A.G.P.&#x2019;s sales of Transaction Fee Shares on
any given date to &lt;span id="xdx_905_ecustom--AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock_pid_dp_uPure_c20220111__20220111__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember__srt--RangeAxis__srt--MinimumMember__us-gaap--GainContingenciesByNatureAxis__custom--TransactionFeeMember_z7KImQ5KPPA5" title="Conversion percentage"&gt;10&lt;/span&gt;% of the cumulative trading volume of the common stock for such date (including pre-market, market and post-market
trading) as reported by Bloomberg, LP. This restriction shall remain in effect beginning on the Lock-Up Termination Date and ending on
the date on which &lt;span id="xdx_902_eus-gaap--LongTermDebtPercentageBearingFixedInterestRate_iI_pid_dp_uPure_c20220111__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember__us-gaap--GainContingenciesByNatureAxis__custom--TransactionFeeMember_zZ56Yb5l9Q42" title="Converted percentage"&gt;100&lt;/span&gt;% of the Series B Convertible Preferred Stock outstanding as of the closing is converted into shares of our common
stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
parties amended the Advisory Agreement (the &#x201c;Amended Advisory Agreement&#x201d;), pursuant to which Western shall pay A.G.P. the
Transaction Fee in the form of preferred shares of Cycurion that are convertible into &lt;span id="xdx_90A_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20260331__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember_zL3muBjIDYFf" title="Convertible shares issuable"&gt;166,667&lt;/span&gt; shares of common stock (such preferred
shares or the common stock into which they convert, the &#x201c;Amended Transaction Fee Shares&#x201d;), for a price per share of common
stock of $&lt;span id="xdx_905_eus-gaap--PreferredStockConvertibleConversionPrice_iI_c20260331__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember_zNAOoYYwEPx" title="Conversion price"&gt;0.50&lt;/span&gt;. A portion of the Amended Transaction Fee Shares shall be subject to forfeiture and return to the Company for cancellation
once A.G.P. converts and sells Transaction Fee Shares generating sales proceeds (excluding commissions) of $&lt;span id="xdx_905_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20260101__20260331__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember_zrxnGCHPvVX" title="Transaction fee shares generating sales proceeds"&gt;2,500,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Amended Transaction Fee Shares shall be subject to a lock-up ending on the earlier of (i) the date on which &lt;span id="xdx_906_ecustom--AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock_pid_dp_uPure_c20220111__20220111__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember__us-gaap--GainContingenciesByNatureAxis__custom--AmendedTransactionFeeMember_zGZI5OHuPkk5" title="Conversion percentage"&gt;75&lt;/span&gt;% of the outstanding Series
B Convertible Preferred Stock is converted into shares of the Combined Company&#x2019;s common stock and (ii) &lt;span id="xdx_906_ecustom--AdvisoryAgreementSharesLockUpEndingPeriodFromClosingDate_dc_c20220111__20220111__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember__us-gaap--GainContingenciesByNatureAxis__custom--AmendedTransactionFeeMember_zbyMDyc7X6mf" title="Advisory agreement lock-up ending period from closing date"&gt;six months&lt;/span&gt; from the Lock-Up
Termination Date. After the Lock-Up Termination Date, A.G.P. may convert the Amended Transaction Fee Shares and sell them subject to
a leak-out provision that limits A.G.P.&#x2019;s sales of Amended Transaction Fee Shares on any given date to &lt;span id="xdx_908_ecustom--AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock_pid_dp_uPure_c20220111__20220111__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember__srt--RangeAxis__srt--MinimumMember__us-gaap--GainContingenciesByNatureAxis__custom--AmendedTransactionFeeMember_zpPnToOBCVek" title="Conversion percentage"&gt;10&lt;/span&gt;% of the cumulative trading
volume of the common stock for such date (including pre-market, market and post-market trading) as reported by Bloomberg, LP. This restriction
shall remain in effect beginning on the Lock-Up Termination Date and ending on the date on which &lt;span id="xdx_905_eus-gaap--LongTermDebtPercentageBearingFixedInterestRate_iI_pid_dp_uPure_c20220111__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember__us-gaap--GainContingenciesByNatureAxis__custom--AmendedTransactionFeeMember_zU1kTFYdJBNj" title="Converted percentage"&gt;100&lt;/span&gt;% of the Series B Convertible Preferred
Stock outstanding as of the closing is converted into shares of our common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
the execution of the Advisory Agreement, the Business Combination Marketing Agreement, dated January 11, 2022, between Western and A.G.P.
in which Western and Cycurion Sub caused the combined company to issue to A.G.P. &lt;span id="xdx_902_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20220111__srt--CounterpartyNameAxis__custom--AllianceGlobalPartnersMember_zzQs2kYmlpTb" title="Shares reserve for future issuance"&gt;8,333&lt;/span&gt; shares of common stock of the combined company
in full satisfaction of the fees, was terminated, and such shares of common stock extinguished in their entirety.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Agreements
with Seward &amp;amp; Kissel LLP&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 27, 2024, we entered into a revised engagement letter (the &#x201c;Revised Engagement Letter&#x201d;) with Seward &amp;amp; Kissel
LLP (&#x201c;Seward &amp;amp; Kissel&#x201d;), pursuant to which Western and Cycurion agreed to pay approximately $&lt;span id="xdx_904_eus-gaap--LegalFees_pn5n6_c20241127__20241127__dei--LegalEntityAxis__custom--SewardAndKisselLLPMember_zqbSaviXze72" title="Legal fees"&gt;1.3&lt;/span&gt; million of its outstanding
legal fees and expenses (&#x201c;Legal Fees&#x201d;) in shares of common stock in connection with the Business Combination. Following the
closing of the Business Combination on February 14, 2025 and in connection with the Revised Engagement Letter, we issued to Seward &amp;amp;
Kissel &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241127__20241127__dei--LegalEntityAxis__custom--SewardAndKisselLLPMember_zn4ebBQARHJj" title="Number of shares issued"&gt;8,333&lt;/span&gt; shares of common stock and a pre-funded warrant that is exercisable for approximately $&lt;span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstanding_iI_pn5n6_c20241127__dei--LegalEntityAxis__custom--SewardAndKisselLLPMember_zd8IemM65H9k" title="Warrants exercisable"&gt;1.3&lt;/span&gt; million in shares of common stock
(the &#x201c;Seward &amp;amp; Kissel Pre-Funded Warrant&#x201d;); provided that once the net proceeds from the sale of the shares equals the
Legal Fees, the remaining shares of common stock, including such common stock exercisable under the Seward &amp;amp; Kissel Pre-Funded Warrant,
shall be returned to the Cycurion. We plan to enter into an exchange agreement with Seward &amp;amp; Kissel to exchange the Seward &amp;amp;
Kissel Pre-Funded Warrant for a convertible promissory note that is convertible into such number of shares equal to the Legal Fees.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 14, 2025, Cycurion entered into pre-funded warrant with Seward &amp;amp; Kissel Pre-Funded Warrant that is exercisable for approximately
$&lt;span id="xdx_901_eus-gaap--WarrantsAndRightsOutstanding_iI_pn5n6_c20250214__dei--LegalEntityAxis__custom--SewardAndKisselLLPMember_zRfi1BOkQ0qk" title="Warrants exercisable"&gt;1.3&lt;/span&gt; million in shares of common stock, or up to &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250214__20250214__dei--LegalEntityAxis__custom--SewardAndKisselLLPMember_z9taHlE3bZUf" title="Number of shares issued"&gt;83,333&lt;/span&gt; shares of common stock; provided that once the net proceeds from the sale of
the shares equals the $&lt;span id="xdx_90B_eus-gaap--LegalFees_pn5n6_c20250214__20250214__dei--LegalEntityAxis__custom--SewardAndKisselLLPMember_zC9X2NsDLG38" title="Legal fees"&gt;1.3&lt;/span&gt; million in Legal, the remaining shares of common stock, including such common stock exercisable under the
Seward &amp;amp; Kissel Pre-Funded Warrant, shall be returned to Cycurion.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Seward &amp;amp; Kissel Pre-Funded Warrant provides that the holder may not exercise any portion of the Seward &amp;amp; Kissel Pre-Funded Warrant
to the extent that immediately prior to or after giving effect to such exercise the holder would own more than 4.99% upon 61 days&#x2019;
prior notice. The exercise price for each share of common stock underlying the Seward &amp;amp; Kissel Pre-Funded Warrant is $&lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250214__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantMember__dei--LegalEntityAxis__custom--SewardAndKisselLLPMember_zHFnAM1MREQk" title="Warrants exercise price"&gt;0.0030&lt;/span&gt;. The
Seward &amp;amp; Kissel Pre-Funded Warrant is immediately exercisable upon issuance and may be exercised at any time until the Seward &amp;amp;
Kissel Pre-Funded Warrant is exercised in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Seward
&amp;amp; Kissel LLP may not exercise any portion of the warrants or Seward &amp;amp; Kissel Pre-Funded Warrant, as applicable, to the extent
that the holder would own more than 4.99% of our outstanding common stock immediately after exercise, as such percentage ownership is
determined in accordance with the terms of the Seward &amp;amp; Kissel Pre-Funded Warrant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
lieu of making the cash payment otherwise contemplated to be made to us upon exercise of the Seward &amp;amp; Kissel Pre-Funded Warrant in
payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the
net number of shares of our common stock determined according to a formula set forth in the Seward &amp;amp; Kissel Pre-Funded Warrant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Agreement
with Baker &amp;amp; Hostetler LLP&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
2023, Western agreed to pay approximately $&lt;span id="xdx_906_eus-gaap--OtherCommitment_iI_c20231231__dei--LegalEntityAxis__custom--BakerHostetlerLlpMember_zWn2L5nmLjx5" title="Payment obligation"&gt;788,030&lt;/span&gt; of its obligations to its counsel, Baker Hostetler LLP, in shares of common stock
following the Business Combination, which will be issued at a price per share equal to $&lt;span id="xdx_90F_eus-gaap--SharePrice_iI_c20231231__dei--LegalEntityAxis__custom--BakerHostetlerLlpMember_zz3Hrj3wMS9k" title="Share price"&gt;10.00&lt;/span&gt;, or &lt;span id="xdx_906_eus-gaap--SharesIssued_iI_c20231231__dei--LegalEntityAxis__custom--BakerHostetlerLlpMember_ztfq6O6c2Cj5" title="Share issued"&gt;2,627&lt;/span&gt; shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity
Line of Credit&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity
Purchase Agreement&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 7, 2025 (the &#x201c;Execution Date&#x201d;), we entered into the Equity Purchase Agreement with Yield Point NYC LLC (&#x201c;Yield
Point&#x201d;). Under the Equity Purchase Agreement, we have the right, but not the obligation, to direct Yield Point to purchase up to
$&lt;span id="xdx_90F_ecustom--EquityPurchaseAgreementMaximumCommitmentAmount_iI_pn5n6_c20250407__us-gaap--TypeOfArrangementAxis__custom--EquityPurchaseAgreementMember_zh4cxmAfkTOb" title="Maximum commitment amount"&gt;60.0&lt;/span&gt; million (the &#x201c;Maximum Commitment Amount&#x201d;) in shares of our common stock upon satisfaction of certain terms and conditions
contained in the Equity Purchase Agreement, including, without limitation, an effective registration statement filed with the SEC registering
the resale of the shares of Put Stock (defined below) and the shares of Commitment Stock (defined below) and additional shares to be
sold to Yield Point from time to time under the Equity Purchase Agreement. The term of the Equity Purchase Agreement began on the Execution
Date and ends on the earlier of (i) the date on which Yield Point shall have purchased shares of common stock issued, or that we shall
be entitled to issue, per any applicable Put Notice (defined below) in accordance with the terms and conditions of the Equity Purchase
Agreement (the &#x201c;Put Stock&#x201d;) equal to the Maximum Commitment Amount, (ii) the date that is twelve (&lt;span id="xdx_905_ecustom--EquityPurchaseAgreementMaximumTerm_iI_dtM_c20250407__us-gaap--TypeOfArrangementAxis__custom--EquityPurchaseAgreementMember_zTQ3CHbVxemb" title="Maximum commitment period"&gt;12&lt;/span&gt;) months from the date
the registration statement is declared effective, (iii) written notice of termination by us to Yield Point (which shall not occur at
any time that Yield Point holds any of the shares of Put Stock), or (iv) written notice of termination by Yield Point to us pursuant
to (the &#x201c;Commitment Period&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the Commitment Period, we may direct Yield Point to purchase shares of Put Stock by delivering a notice (a &#x201c;Put Notice&#x201d;)
to Yield Point. We shall, in our sole discretion, select the number of shares of Put Stock requested in each Put Notice. However, such
amount may not exceed the Maximum Put Amount (as defined in the Equity Purchase Agreement). The purchase price to be paid by Yield Point
for the shares of Put Stock will be ninety percent (&lt;span id="xdx_90D_ecustom--EquityOfferingPricePerSharePercentageOfClosingPrice_iI_pid_dp_c20250407__us-gaap--TypeOfArrangementAxis__custom--EquityPurchaseAgreementMember_zy9OzWdFKJZb" title="Percentage of closing price"&gt;90&lt;/span&gt;%) of the lowest trade of the common stock on the Principal Market during the Valuation
Period (as defined in the Equity Purchase Agreement).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
consideration for Yield Point&#x2019;s execution and delivery of, and performance under the Equity Purchase Agreement, on the Execution
Date, we, in our discretion, either were to (i) pay to Yield Point in cash $&lt;span id="xdx_902_eus-gaap--Cash_iI_pn5n6_c20250407__us-gaap--TypeOfArrangementAxis__custom--EquityPurchaseAgreementMember_z0gpeCD6qQk3" title="Cash"&gt;1.8&lt;/span&gt; million (&#x201c;Commitment Cash&#x201d;) or (ii) issue
the Yield Point Pre-Funded Warrant (as defined below) to Yield Point in a form acceptable to Yield Point in its sole discretion and having
an exercise price per share of $&lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250407__us-gaap--TypeOfArrangementAxis__custom--EquityPurchaseAgreementMember_zBYAlb0BESb2" title="Warrants exercise price"&gt;0.0030&lt;/span&gt;, for Yield Point&#x2019;s purchase of shares of common stock (the &#x201c;Commitment Stock&#x201d;)
having a value of $&lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn5n6_c20250407__20250407__us-gaap--TypeOfArrangementAxis__custom--EquityPurchaseAgreementMember_zN5iRGpgzVwd" title="Number of shares issued"&gt;1.8&lt;/span&gt; million based on closing price of the common stock on April 6, 2025. We chose to issue the Pre-Funded Warrant.
All of the shares of Commitment Stock were fully earned as of the Execution Date, and the issuance of the shares of Commitment Stock
is not contingent upon any other event or condition, including, without limitation, the effectiveness of the Initial Registration Statement
(defined below) or our submission of a Put Notice to Yield Point and irrespective of any termination of the Equity Purchase Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with the Equity Purchase Agreement, a registration statement on Form S-1 (the &#x201c;Initial Registration Statement&#x201d;)
covering only the resale of the shares of Put Stock and Commitment Stock was filed with the SEC on May 7, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pre-Funded
Warrant&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
pre-funded warrant with Yield Point (the &#x201c;Yield Point Pre-Funded Warrant&#x201d;) certifies that, for value received, Yield Point
is entitled to be issued up to &lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20250407__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantMember_zGPitTtOpJ68" title="Warrant issued"&gt;150,000&lt;/span&gt; shares of common stock as its commitment fee (&#x201c;Commitment Fee&#x201d;) and has an initial
exercise price of $&lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250407__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantMember_z4cBimqFjea4" title="Warrants exercise price"&gt;0.003&lt;/span&gt; per share. The Yield Point Pre-Funded Warrant was offered for the Commitment Fee in connection with the Equity
Purchase Agreement for shares of common stock, and provides that the holder may not exercise any portion of the Yield Point Pre-Funded
Warrant to the extent that immediately prior to or after giving effect to such exercise the holder would own more than 4.99%, which ownership
cap may be increased by the holder up to 9.99% upon 61 days&#x2019; prior notice. The exercise price for each share of common stock underlying
the Yield Point Pre-Funded Warrant is $&lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250407__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantMember_zmty6suH1Mn3" title="Warrants exercise price"&gt;0.003&lt;/span&gt;. The Yield Point Pre-Funded Warrant is immediately exercisable upon issuance and may be
exercised at any time until the Yield Point Pre-Funded Warrant is exercised in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
holder of the Yield Point Pre-Funded Warrant may not exercise any portion of the warrants or Yield Point Pre-Funded Warrant, as applicable,
to the extent that the holder would own more than 4.99% (or, at the holder&#x2019;s option upon issuance, 9.99%) of our outstanding common
stock immediately after exercise, as such percentage ownership is determined in accordance with the terms of the Yield Point Pre-Funded
Warrant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
lieu of making the cash payment otherwise contemplated to be made to us upon exercise of the Yield Point Pre-Funded Warrant in payment
of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the net number
of shares of our common stock determined according to a formula set forth in the Yield Point Pre-Funded Warrant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December 31, 2025, &lt;span id="xdx_901_ecustom--NumberOfWarrantsExercised_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zJJ2er9IhiA" title="Number of warrants, exercised - prefunded"&gt;150,000&lt;/span&gt; of these shares have been exercised, therefore as of December 31, 2025, all Yield Point Pre-Funded
Warrants have been exercised.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Registration
Rights Agreement&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 7, 2025 (the &#x201c;RRA Execution Date&#x201d;), in connection with the Equity Purchase Agreement, we entered into a registration
rights agreement with Yield Point (the &#x201c;Registration Rights Agreement&#x201d;), pursuant to which we shall, by May 7, 2025, file
with the SEC the Initial Registration Statement covering the maximum number of (i) shares of Commitment Stock, (ii) shares of Put Stock,
which have been, or which may, from time to time be issued, including without limitation all of the shares of common stock which have
been issued or will be issued to Yield Point under the Equity Purchase Agreement (without regard to any limitation or restriction on
purchases), and (iii) any and all shares of capital stock issued or issuable with respect to the Put Stock, Commitment Stock, and the
Equity Purchase Agreement as a result of any stock split, combination, stock dividend, recapitalization, exchange, or similar event,
or otherwise, without regard to any limitation on purchases under the Equity Purchase Agreement (the &#x201c;Registrable Securities&#x201d;),
as shall be permitted to be included thereon in accordance with applicable SEC rules, regulations, and interpretations so as to permit
the resale of the Registrable Securities by Yield Point, including, but not limited to, under Rule 415 at then-prevailing market prices
(and not fixed prices). The Initial Registration Statement shall register only Registrable Securities. The Initial Registration Statement
and any amendment thereto was declared effective by the SEC in May 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redemption
Agreement&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 6, 2024, the Company, Western Acquisition Ventures Sponsor, LLC (the &#x201c;Sponsor&#x201d;) and RiverNorth SPAC Arbitrage Fund,
LP (the &#x201c;RiverNorth&#x201d;) entered into a non-redemption agreement (the &#x201c;Non-Redemption Agreement&#x201d;) whereby the Sponsor
plans to transfer to RiverNorth &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesOther_c20240806__20240806__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--TypeOfArrangementAxis__custom--NonRedemptionAgreementMember_zwBDcFTaKxwg" title="Sponsor plans to transfer to Investor shares"&gt;167&lt;/span&gt; shares each month over the next three months for agreeing not to redeem the &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20240806__20240806__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--TypeOfArrangementAxis__custom--NonRedemptionAgreementMember_zT5H8fExCtca" title="Stock holds prior to business combination, shares"&gt;3,327&lt;/span&gt; that it currently
holds prior to the business combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 9, 2024, the Company, the Sponsor and RiverNorth entered into extended non-redemption agreement whereby the Sponsor plans to
transfer to RiverNorth &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesOther_c20241009__20241009__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--TypeOfArrangementAxis__custom--NonRedemptionAgreementMember_zPZt4HyH03rh" title="Sponsor plans to transfer to Investor shares"&gt;167&lt;/span&gt; shares each month over the next three months for agreeing not to redeem the &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20241009__20241009__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--TypeOfArrangementAxis__custom--NonRedemptionAgreementMember_zMVipSA5egWf" title="Stock holds prior to business combination, shares"&gt;3,327&lt;/span&gt; that it currently holds
prior to the business combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Employment
Agreements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 27, 2023, we entered into an employment agreement with James P. McCormick whereby the Company agreed to pay a total of $&lt;span id="xdx_90C_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20231227__20231227_zRh2zsdoy676" title="Compensation expense"&gt;125,000&lt;/span&gt;
of total compensation annually, including $&lt;span id="xdx_90C_eus-gaap--Cash_iI_c20231227_zgJTt0HbOHzg" title="Cash"&gt;40,000&lt;/span&gt; in cash and $&lt;span id="xdx_90D_eus-gaap--PaymentsOfStockIssuanceCosts_c20231227__20231227_zL60i435TLNe" title="Payment of stock"&gt;85,000&lt;/span&gt; in stock payment. On October 30, 2024, we entered into an amendment
to the employment agreement with James P. McCormick whereby the Company agreed to pay total compensation of $&lt;span id="xdx_908_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20241030__20241030_zNbmuncFwJGi" title="Compensation expense"&gt;200,000&lt;/span&gt;, including $&lt;span id="xdx_900_eus-gaap--Cash_iI_c20241030_ztaANnhAVYp6" title="Cash"&gt;40,000&lt;/span&gt;
in cash at the closing of the Business Combination and the remaining $&lt;span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_c20241030__20241030_zCB0p6zTt5q9" title="Cash proceeds"&gt;160,000&lt;/span&gt; in cash from the proceeds that the Company receives from
any capital raising transaction following the closing of the Business Combination, including the proceeds from an equity line of credit
to be entered into by and among the Company, Cycurion and the investors named therein; provided that the Company shall only be obligated
to apply up to &lt;span id="xdx_90F_eus-gaap--DebtInstrumentRedemptionPricePercentage_pid_dp_uPure_c20241030__20241030_zjoh32T2PaN" title="Proceeds percentage"&gt;15&lt;/span&gt;% of the proceeds from each capital raise until Mr. McCormick&#x2019;s compensation of $&lt;span id="xdx_904_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20241030__20241030_zYwd1B8AaU0a" title="Compensation expense"&gt;200,000&lt;/span&gt; has been paid in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 1, 2024, Cycurion and L. Kevin Kelly, Chief Executive Officer, entered into an employment agreement on a two-year &lt;span id="xdx_909_ecustom--EmploymentAgreementTerm_dtY_c20241201__20241201__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zvNkX74Y9dDd" style="display: none" title="Employment agreement period"&gt;2&lt;/span&gt; term,
commencing on December 1, 2024 and ending on December 1, 2026. During the employment period, Mr. Kelly will receive an annual base
salary of $&lt;span id="xdx_90B_eus-gaap--SalariesAndWages_c20241201__20241201__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_z4PDUxOkZnyc" title="Salaries and wages"&gt;325,000&lt;/span&gt;,
and equity compensation of $&lt;span id="xdx_90D_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20241201__20241201__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zt6L7seoKAWk" title="Equity compensation"&gt;500,000&lt;/span&gt;
of Company common stock in the first year of the employment agreement, payable quarterly. Mr. Kelly is eligible for a performance
bonus based on the Company&#x2019;s results. The targeted performance bonus is $&lt;span id="xdx_90B_ecustom--PerformanceBonus_c20241201__20241201__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zj18FsymsTM8" title="Performance bonus"&gt;325,000&lt;/span&gt;
for year-one, and the performance bonus will increase for subsequent years based on future financial and non-financial
results&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 1, 2025, Cycurion and Alvin McCoy, III, Chief Financial Officer, entered into an employment agreement on a two-year &lt;span id="xdx_905_ecustom--EmploymentAgreementTerm_dtY_c20250101__20250101__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_z1DDKJbDkNKd" style="display: none" title="Employment agreement period"&gt;2&lt;/span&gt; term,
commencing on January 1, 2025 and ending on December 31, 2026. During the employment period, Mr. McCoy, III will receive an annual
base salary of $&lt;span id="xdx_90D_eus-gaap--SalariesAndWages_c20250101__20250101__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_ztauaJGOkKci" title="Salaries and wages"&gt;325,000&lt;/span&gt;
and equity compensation of $&lt;span id="xdx_90B_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20250101__20250101__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zzMGd7L7c54h" title="Equity compensation"&gt;500,000&lt;/span&gt;
of Company stock in the first year of the employment agreement, payable quarterly. Mr. McCoy, III is eligible for a performance
bonus based on the Company&#x2019;s performance. The targeted performance bonus is $&lt;span id="xdx_905_ecustom--PerformanceBonus_c20250101__20250101__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_z80KWIQteSMe" title="Performance bonus"&gt;325,000&lt;/span&gt;
for year-one, and the performance bonus will increase for subsequent years based on future financial and non-financial
results.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Retention
Packages&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 16, 2025, the Board of Directors approved a retention package for L. Kevin Kelly, Chief Executive Officer, and Alvin McCoy III,
Chief Financial Officer, and issued each officer &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250616__20250616__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_znMgkLS1tTm5" title="Stock issued during period shares new issues"&gt;&lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250616__20250616__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_z7M6zccZy5ve" title="Stock issued during period shares new issues"&gt;100,000&lt;/span&gt;&lt;/span&gt; shares of common stock under the Company&#x2019;s 2025 Equity Incentive Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inflation
Reduction Act of 2022&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 16, 2022, the Inflation Reduction Act of 2022 (the &#x201c;IR Act&#x201d;) was signed into federal law. The IR Act provides for,
among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and
certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed
on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally
1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise
tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value
of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the
Treasury (the &#x201c;Treasury&#x201d;) has been given authority to provide regulations and other guidance to carry out and prevent the
abuse or avoidance of the excise tax.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Any
redemption or other repurchase that occurs after December 31, 2022, in connection with a business combination, extension vote or otherwise,
may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a business
combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions
and repurchases in connection with the business combination, extension or otherwise, (ii) the structure of a business combination, (iii)
the nature and amount of any &#x201c;PIPE&#x201d; or other equity issuances in connection with a business combination (or otherwise issued
not in connection with a business combination but issued within the same taxable year of a business combination) and (iv) the content
of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the
redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction
in the cash available on hand to complete a business combination and in the Company&#x2019;s ability to complete a business combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of both March 31, 2026 and December 31, 2025 the Company&#x2019;s stockholders have redeemed a total of &lt;span id="xdx_90B_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zyqKImxjXvdh" title="Stockholders redeemed shares"&gt;&lt;span id="xdx_901_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zq5CcpGAXXW7" title="Stockholders redeemed shares"&gt;380,701&lt;/span&gt;&lt;/span&gt; shares of common stock
resulting in $&lt;span id="xdx_90A_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn5n6_c20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zO5dSRpPVXPa" title="Excise tax liabilty"&gt;&lt;span id="xdx_905_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn5n6_c20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zApymrahlU38" title="Excise tax liabilty"&gt;1.2&lt;/span&gt;&lt;/span&gt; million of excise tax liability, calculated as 1% of the value of the shares redeemed.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <CYCU:DebtInstrumentAmortizationPercentage
      contextRef="From2022-01-112022-01-11"
      decimals="INF"
      id="Fact005290"
      unitRef="Pure">0.045</CYCU:DebtInstrumentAmortizationPercentage>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2022-01-112022-01-11"
      decimals="0"
      id="Fact005292"
      unitRef="USD">5175000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:PaymentsForFees
      contextRef="From2022-01-112022-01-11"
      decimals="0"
      id="Fact005294"
      unitRef="USD">500000</us-gaap:PaymentsForFees>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-01-11"
      decimals="INF"
      id="Fact005296"
      unitRef="Shares">16667</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-01-11"
      decimals="INF"
      id="Fact005298"
      unitRef="USDPShares">150.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <CYCU:TransactionFee
      contextRef="AsOf2022-01-11"
      decimals="0"
      id="Fact005300"
      unitRef="USD">2500000</CYCU:TransactionFee>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2022-01-11"
      decimals="INF"
      id="Fact005302"
      unitRef="Shares">16667</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:SharePrice
      contextRef="AsOf2022-01-11"
      decimals="INF"
      id="Fact005304"
      unitRef="USDPShares">5.00</us-gaap:SharePrice>
    <us-gaap:ProceedsFromSalesOfAssetsInvestingActivities
      contextRef="From2022-01-112022-01-11"
      decimals="0"
      id="Fact005306"
      unitRef="USD">2500000</us-gaap:ProceedsFromSalesOfAssetsInvestingActivities>
    <CYCU:AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock
      contextRef="From2022-01-112022-01-11_custom_AllianceGlobalPartnersMember_custom_TransactionFeeMember"
      decimals="INF"
      id="Fact005308"
      unitRef="Pure">0.75</CYCU:AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock>
    <CYCU:AdvisoryAgreementSharesLockUpEndingPeriodFromClosingDate
      contextRef="From2022-01-112022-01-11_custom_AllianceGlobalPartnersMember_custom_TransactionFeeMember"
      id="Fact005310">P3M</CYCU:AdvisoryAgreementSharesLockUpEndingPeriodFromClosingDate>
    <CYCU:AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock
      contextRef="From2022-01-112022-01-11_custom_AllianceGlobalPartnersMember_srt_MinimumMember_custom_TransactionFeeMember"
      decimals="INF"
      id="Fact005312"
      unitRef="Pure">0.10</CYCU:AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate
      contextRef="AsOf2022-01-11_custom_AllianceGlobalPartnersMember_custom_TransactionFeeMember"
      decimals="INF"
      id="Fact005314"
      unitRef="Pure">1</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2026-03-31_custom_AllianceGlobalPartnersMember"
      decimals="INF"
      id="Fact005316"
      unitRef="Shares">166667</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="AsOf2026-03-31_custom_AllianceGlobalPartnersMember"
      decimals="INF"
      id="Fact005318"
      unitRef="USDPShares">0.50</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2026-01-012026-03-31_custom_AllianceGlobalPartnersMember"
      decimals="0"
      id="Fact005320"
      unitRef="USD">2500000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <CYCU:AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock
      contextRef="From2022-01-112022-01-11_custom_AllianceGlobalPartnersMember_custom_AmendedTransactionFeeMember"
      decimals="INF"
      id="Fact005322"
      unitRef="Pure">0.75</CYCU:AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock>
    <CYCU:AdvisoryAgreementSharesLockUpEndingPeriodFromClosingDate
      contextRef="From2022-01-112022-01-11_custom_AllianceGlobalPartnersMember_custom_AmendedTransactionFeeMember"
      id="Fact005324">P6M</CYCU:AdvisoryAgreementSharesLockUpEndingPeriodFromClosingDate>
    <CYCU:AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock
      contextRef="From2022-01-112022-01-11_custom_AllianceGlobalPartnersMember_srt_MinimumMember_custom_AmendedTransactionFeeMember"
      decimals="INF"
      id="Fact005326"
      unitRef="Pure">0.10</CYCU:AdvisoryAgreementSharesLockUpEndingPercentageOfOutstandingPreferredStockConvertedIntoCommonStock>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate
      contextRef="AsOf2022-01-11_custom_AllianceGlobalPartnersMember_custom_AmendedTransactionFeeMember"
      decimals="INF"
      id="Fact005328"
      unitRef="Pure">1</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2022-01-11_custom_AllianceGlobalPartnersMember"
      decimals="INF"
      id="Fact005330"
      unitRef="Shares">8333</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:LegalFees
      contextRef="From2024-11-272024-11-27_custom_SewardAndKisselLLPMember"
      decimals="-5"
      id="Fact005332"
      unitRef="USD">1300000</us-gaap:LegalFees>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-11-272024-11-27_custom_SewardAndKisselLLPMember"
      decimals="INF"
      id="Fact005334"
      unitRef="Shares">8333</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-11-27_custom_SewardAndKisselLLPMember"
      decimals="-5"
      id="Fact005336"
      unitRef="USD">1300000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2025-02-14_custom_SewardAndKisselLLPMember"
      decimals="-5"
      id="Fact005338"
      unitRef="USD">1300000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-02-142025-02-14_custom_SewardAndKisselLLPMember"
      decimals="INF"
      id="Fact005340"
      unitRef="Shares">83333</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:LegalFees
      contextRef="From2025-02-142025-02-14_custom_SewardAndKisselLLPMember"
      decimals="-5"
      id="Fact005342"
      unitRef="USD">1300000</us-gaap:LegalFees>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-02-14_custom_SewardAndKisselLLPMember_custom_PreFundedWarrantMember71589796"
      decimals="INF"
      id="Fact005344"
      unitRef="USDPShares">0.0030</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:OtherCommitment
      contextRef="AsOf2023-12-31_custom_BakerHostetlerLlpMember"
      decimals="0"
      id="Fact005346"
      unitRef="USD">788030</us-gaap:OtherCommitment>
    <us-gaap:SharePrice
      contextRef="AsOf2023-12-31_custom_BakerHostetlerLlpMember"
      decimals="INF"
      id="Fact005348"
      unitRef="USDPShares">10.00</us-gaap:SharePrice>
    <us-gaap:SharesIssued
      contextRef="AsOf2023-12-31_custom_BakerHostetlerLlpMember"
      decimals="INF"
      id="Fact005350"
      unitRef="Shares">2627</us-gaap:SharesIssued>
    <CYCU:EquityPurchaseAgreementMaximumCommitmentAmount
      contextRef="AsOf2025-04-07_custom_EquityPurchaseAgreementMember"
      decimals="-5"
      id="Fact005352"
      unitRef="USD">60000000.0</CYCU:EquityPurchaseAgreementMaximumCommitmentAmount>
    <CYCU:EquityPurchaseAgreementMaximumTerm
      contextRef="AsOf2025-04-07_custom_EquityPurchaseAgreementMember"
      id="Fact005354">P12M</CYCU:EquityPurchaseAgreementMaximumTerm>
    <CYCU:EquityOfferingPricePerSharePercentageOfClosingPrice
      contextRef="AsOf2025-04-07_custom_EquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact005356"
      unitRef="Pure">0.90</CYCU:EquityOfferingPricePerSharePercentageOfClosingPrice>
    <us-gaap:Cash
      contextRef="AsOf2025-04-07_custom_EquityPurchaseAgreementMember"
      decimals="-5"
      id="Fact005358"
      unitRef="USD">1800000</us-gaap:Cash>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-04-07_custom_EquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact005360"
      unitRef="USDPShares">0.0030</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-04-072025-04-07_custom_EquityPurchaseAgreementMember"
      decimals="-5"
      id="Fact005362"
      unitRef="USD">1800000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-04-07_custom_PreFundedWarrantMember"
      decimals="INF"
      id="Fact005364"
      unitRef="Shares">150000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-04-07_custom_PreFundedWarrantMember"
      decimals="INF"
      id="Fact005366"
      unitRef="USDPShares">0.003</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-04-07_custom_PreFundedWarrantMember"
      decimals="INF"
      id="Fact005368"
      unitRef="USDPShares">0.003</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <CYCU:NumberOfWarrantsExercised
      contextRef="From2025-01-012025-12-31_us-gaap_WarrantMember71590187"
      decimals="INF"
      id="Fact005370"
      unitRef="Shares">150000</CYCU:NumberOfWarrantsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2024-08-062024-08-06_custom_SponsorMember_custom_NonRedemptionAgreementMember"
      decimals="INF"
      id="Fact005372"
      unitRef="Shares">167</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2024-08-062024-08-06_custom_SponsorMember_custom_NonRedemptionAgreementMember"
      decimals="INF"
      id="Fact005374"
      unitRef="Shares">3327</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2024-10-092024-10-09_custom_SponsorMember_custom_NonRedemptionAgreementMember"
      decimals="INF"
      id="Fact005376"
      unitRef="Shares">167</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2024-10-092024-10-09_custom_SponsorMember_custom_NonRedemptionAgreementMember"
      decimals="INF"
      id="Fact005378"
      unitRef="Shares">3327</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="From2023-12-272023-12-27"
      decimals="0"
      id="Fact005380"
      unitRef="USD">125000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:Cash
      contextRef="AsOf2023-12-27"
      decimals="0"
      id="Fact005382"
      unitRef="USD">40000</us-gaap:Cash>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2023-12-272023-12-27"
      decimals="0"
      id="Fact005384"
      unitRef="USD">85000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="From2024-10-302024-10-30"
      decimals="0"
      id="Fact005386"
      unitRef="USD">200000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:Cash
      contextRef="AsOf2024-10-30"
      decimals="0"
      id="Fact005388"
      unitRef="USD">40000</us-gaap:Cash>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="From2024-10-302024-10-30"
      decimals="0"
      id="Fact005390"
      unitRef="USD">160000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="From2024-10-302024-10-30"
      decimals="INF"
      id="Fact005392"
      unitRef="Pure">0.15</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="From2024-10-302024-10-30"
      decimals="0"
      id="Fact005394"
      unitRef="USD">200000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <CYCU:EmploymentAgreementTerm
      contextRef="From2024-12-012024-12-01_srt_ChiefExecutiveOfficerMember_custom_EmploymentAgreementMember"
      id="Fact005396">P2Y</CYCU:EmploymentAgreementTerm>
    <us-gaap:SalariesAndWages
      contextRef="From2024-12-012024-12-01_srt_ChiefExecutiveOfficerMember_custom_EmploymentAgreementMember"
      decimals="0"
      id="Fact005398"
      unitRef="USD">325000</us-gaap:SalariesAndWages>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="From2024-12-012024-12-01_srt_ChiefExecutiveOfficerMember_custom_EmploymentAgreementMember"
      decimals="0"
      id="Fact005400"
      unitRef="USD">500000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <CYCU:PerformanceBonus
      contextRef="From2024-12-012024-12-01_srt_ChiefExecutiveOfficerMember_custom_EmploymentAgreementMember"
      decimals="0"
      id="Fact005402"
      unitRef="USD">325000</CYCU:PerformanceBonus>
    <CYCU:EmploymentAgreementTerm
      contextRef="From2025-01-012025-01-01_srt_ChiefExecutiveOfficerMember_custom_EmploymentAgreementMember"
      id="Fact005404">P2Y</CYCU:EmploymentAgreementTerm>
    <us-gaap:SalariesAndWages
      contextRef="From2025-01-012025-01-01_srt_ChiefExecutiveOfficerMember_custom_EmploymentAgreementMember"
      decimals="0"
      id="Fact005406"
      unitRef="USD">325000</us-gaap:SalariesAndWages>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="From2025-01-012025-01-01_srt_ChiefExecutiveOfficerMember_custom_EmploymentAgreementMember"
      decimals="0"
      id="Fact005408"
      unitRef="USD">500000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <CYCU:PerformanceBonus
      contextRef="From2025-01-012025-01-01_srt_ChiefExecutiveOfficerMember_custom_EmploymentAgreementMember"
      decimals="0"
      id="Fact005410"
      unitRef="USD">325000</CYCU:PerformanceBonus>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-06-162025-06-16_custom_EquityIncentivePlanMember_srt_ChiefExecutiveOfficerMember"
      decimals="INF"
      id="Fact005412"
      unitRef="Shares">100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-06-162025-06-16_custom_EquityIncentivePlanMember_srt_ChiefFinancialOfficerMember"
      decimals="INF"
      id="Fact005414"
      unitRef="Shares">100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="From2026-01-012026-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact005416"
      unitRef="Shares">380701</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact005418"
      unitRef="Shares">380701</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="AsOf2026-03-31_us-gaap_CommonStockMember"
      decimals="-5"
      id="Fact005420"
      unitRef="USD">1200000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="AsOf2025-12-31_us-gaap_CommonStockMember"
      decimals="-5"
      id="Fact005422"
      unitRef="USD">1200000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact005424">&lt;p id="xdx_80D_eus-gaap--SubsequentEventsTextBlock_zSv2GMkGqFNk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20.
&lt;span id="xdx_821_z1Vr22d6a0Pa"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluates subsequent events that have occurred after the balance sheet date but before the financial statements are issued which
is up to and through May 14, 2026. There are two types of subsequent events: (i) recognized, or those that provide additional evidence
with respect to conditions that existed at the date of the balance sheet, including the estimates inherent in the process of preparing
consolidated financial statements, and (ii) nonrecognized, or those that provide evidence with respect to conditions that did not exist
at the date of the balance sheet but arose subsequent to that date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the period April 1, 2026 through May 12, 2026, the Company raised approximately $&lt;span id="xdx_904_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn5n6_c20260401__20260512__us-gaap--SubsidiarySaleOfStockAxis__custom--EquityPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zM99xC4OAV71" title="Proceeds from issuance of common stock"&gt;2.3&lt;/span&gt; million through sales of its common stock under
the Equity Purchase Agreement with Yield Point, pursuant to which the Company issued and aggregate &lt;span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260401__20260512__us-gaap--SubsidiarySaleOfStockAxis__custom--EquityPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zilq1Bhtx281" title="Stock issued"&gt;3,080,000&lt;/span&gt; shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 21, 2026, the Company provided an update on the revised non-binding memorandum of understanding with Kustom Entertainment, Inc.
(&#x201c;Kustom&#x201d;) for the acquisition of Kustom&#x2019;s legacy video solutions segment. The transaction is expected to contribute
approximately $&lt;span id="xdx_906_ecustom--BusinessCombinationEstimatedAnnualRevenue_pn5n6_c20260421__20260421__us-gaap--BusinessAcquisitionAxis__custom--KustomEntertainmentIncMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zZcIiAUAm8fb" title="Estimated annual revenue contribution"&gt;5.1&lt;/span&gt; million in annual revenue and an estimated $&lt;span id="xdx_90E_ecustom--BusinessCombinationEstimatedBacklog_iI_pn5n6_c20260421__us-gaap--BusinessAcquisitionAxis__custom--KustomEntertainmentIncMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zfktooZxtJUf" title="Estimated backlog"&gt;8.0&lt;/span&gt; million backlog comprised of established contracts and recurring subscription
revenue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 7, 2026, the Company announced it has executed a binding agreement to acquire Halo Privacy, an industry-leading secure communications
company, and fully integrate its elite digital investigations and attribution arm, HavenX. The Company expects to close the transaction
within &lt;span id="xdx_905_ecustom--BusinessCombinationExpectedTransactionClosingPeriod_iI_dtD_c20260507__us-gaap--BusinessAcquisitionAxis__custom--KustomEntertainmentIncMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zv4hh1zAsaAg" title="Expected transaction closing period"&gt;45&lt;/span&gt; days. This acquisition builds on Cycurion&#x2019;s disciplined growth strategy by delivering innovative new products and capabilities
that directly address its clients&#x2019; evolving needs for security, privacy, proactive threat defense and operational efficiency.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2026-04-012026-05-12_custom_EquityPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="Fact005426"
      unitRef="USD">2300000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2026-04-012026-05-12_custom_EquityPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact005428"
      unitRef="Shares">3080000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <CYCU:BusinessCombinationEstimatedAnnualRevenue
      contextRef="From2026-04-212026-04-21_custom_KustomEntertainmentIncMember_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="Fact005430"
      unitRef="USD">5100000</CYCU:BusinessCombinationEstimatedAnnualRevenue>
    <CYCU:BusinessCombinationEstimatedBacklog
      contextRef="AsOf2026-04-21_custom_KustomEntertainmentIncMember_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="Fact005432"
      unitRef="USD">8000000.0</CYCU:BusinessCombinationEstimatedBacklog>
    <CYCU:BusinessCombinationExpectedTransactionClosingPeriod
      contextRef="AsOf2026-05-07_custom_KustomEntertainmentIncMember_us-gaap_SubsequentEventMember"
      id="Fact005434">P45D</CYCU:BusinessCombinationExpectedTransactionClosingPeriod>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact001320"
          xlink:label="Fact001320"
          xlink:type="locator"/>
        <link:footnote id="Footnote001403" xlink:label="Footnote001403" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the fair value
                                                                                                                                                                of <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSERFVUxFIE9GIEZBSVIgVkFMVUUgT0YgQ09OU0lERVJBVElPTiBUUkFOU0ZFUlJFRCBBU1NFVFMgQUNRVUlSRUQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__"
  id="xdx_90E_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250331__20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_zAq8aQVuo1ca"
  title="Number of preferred stock converted">33,609</xhtml:span> Common Stock issued in the SLG transaction based on the quoted stock price on the date of issuance.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001320"
          xlink:to="Footnote001403"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001321"
          xlink:label="Fact001321"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001321"
          xlink:to="Footnote001403"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001322"
          xlink:label="Fact001322"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001322"
          xlink:to="Footnote001403"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001324"
          xlink:label="Fact001324"
          xlink:type="locator"/>
        <link:footnote id="Footnote001406" xlink:label="Footnote001406" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the fair value
                                                                                                                                                                of the Series E Convertible Preferred Stock as is converted to Common Stock based on the quoted price Common Stock on the date of
                                                                                                                                                                issuance.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001324"
          xlink:to="Footnote001406"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1325"
          xlink:label="xdx2ixbrl1325"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1325"
          xlink:to="Footnote001406"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001326"
          xlink:label="Fact001326"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001326"
          xlink:to="Footnote001406"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001332"
          xlink:label="Fact001332"
          xlink:type="locator"/>
        <link:footnote id="Footnote001407" xlink:label="Footnote001407" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the fair value
                                                                                                                                                                of the accounts receivable in Cycurion owing from SLG.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001332"
          xlink:to="Footnote001407"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1333"
          xlink:label="xdx2ixbrl1333"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1333"
          xlink:to="Footnote001407"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001334"
          xlink:label="Fact001334"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001334"
          xlink:to="Footnote001407"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003874"
          xlink:label="Fact003874"
          xlink:type="locator"/>
        <link:footnote id="Footnote003953" xlink:label="Footnote003953" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the
fair value of <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSERFVUxFIE9GIEZBSVIgVkFMVUUgT0YgQ09OU0lERVJBVElPTiBUUkFOU0ZFUlJFRCBBU1NFVFMgQUNRVUlSRUQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__"
  id="xdx_90E_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20250331__20250331__us-gaap--BusinessAcquisitionAxis__custom--SLGInnovationIncMember_z2l9FX7jcTOj"
  title="Number of preferred stock converted">33,609</xhtml:span> common stock issued in the SLG transaction based on the quoted stock price on the date of issuance.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003874"
          xlink:to="Footnote003953"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003875"
          xlink:label="Fact003875"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003875"
          xlink:to="Footnote003953"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003876"
          xlink:label="Fact003876"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003876"
          xlink:to="Footnote003953"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003878"
          xlink:label="Fact003878"
          xlink:type="locator"/>
        <link:footnote id="Footnote003956" xlink:label="Footnote003956" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the
fair value of the Series E Convertible Preferred Stock as is converted to common stock based on the quoted price common stock on the
date of issuance.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003878"
          xlink:to="Footnote003956"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3879"
          xlink:label="xdx2ixbrl3879"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3879"
          xlink:to="Footnote003956"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003880"
          xlink:label="Fact003880"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003880"
          xlink:to="Footnote003956"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003882"
          xlink:label="Fact003882"
          xlink:type="locator"/>
        <link:footnote id="Footnote003957" xlink:label="Footnote003957" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the
fair value of the accounts receivable in Cycurion owing from SLG.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003882"
          xlink:to="Footnote003957"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3883"
          xlink:label="xdx2ixbrl3883"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3883"
          xlink:to="Footnote003957"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003884"
          xlink:label="Fact003884"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003884"
          xlink:to="Footnote003957"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
